<SEC-DOCUMENT>0001104659-24-089766.txt : 20240815
<SEC-HEADER>0001104659-24-089766.hdr.sgml : 20240815
<ACCEPTANCE-DATETIME>20240814180833
ACCESSION NUMBER:		0001104659-24-089766
CONFORMED SUBMISSION TYPE:	N-2/A
PUBLIC DOCUMENT COUNT:		32
FILED AS OF DATE:		20240815
DATE AS OF CHANGE:		20240814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ares Dynamic Credit Allocation Fund, Inc.
		CENTRAL INDEX KEY:			0001515324
		ORGANIZATION NAME:           	
		IRS NUMBER:				454969053
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-22535
		FILM NUMBER:		241209958

	BUSINESS ADDRESS:	
		STREET 1:		2000 AVENUE OF THE STARS
		STREET 2:		12TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		(310) 201-4200

	MAIL ADDRESS:	
		STREET 1:		2000 AVENUE OF THE STARS
		STREET 2:		12TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ares Senior Credit Strategies Fund, Inc.
		DATE OF NAME CHANGE:	20110314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ares Dynamic Credit Allocation Fund, Inc.
		CENTRAL INDEX KEY:			0001515324
		ORGANIZATION NAME:           	
		IRS NUMBER:				454969053
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279977
		FILM NUMBER:		241209957

	BUSINESS ADDRESS:	
		STREET 1:		2000 AVENUE OF THE STARS
		STREET 2:		12TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		(310) 201-4200

	MAIL ADDRESS:	
		STREET 1:		2000 AVENUE OF THE STARS
		STREET 2:		12TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ares Senior Credit Strategies Fund, Inc.
		DATE OF NAME CHANGE:	20110314
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2/A
<SEQUENCE>1
<FILENAME>tm2416373d4_n2a.htm
<DESCRIPTION>N-2/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Wed Aug 14 18:10:34 UTC 2024 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ck0001515324="http://www.www.arespublicfunds.com/20240814" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2023"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Ares Dynamic Credit Allocation Fund, Inc. - 1515324 - 2024</title></head><body><!-- BannerFile="tm2416373d4_inlinepackge.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1" -->        <div style="display:none">
        <ix:header><ix:hidden><ix:footnote id="FN20240813151557943" xml:lang="en-US">In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares.</ix:footnote>
<ix:footnote id="FN20240813093858838_17" xml:lang="en-US">The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.</ix:footnote>
<ix:footnote id="FN20240813093858838_18" xml:lang="en-US">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</ix:footnote>
<ix:footnote id="FN20240813151619745" xml:lang="en-US">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.  The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#8217;s Managed Assets.  Based on the same assumptions, leverage would equal 55% of the Fund&#8217;s net assets.</ix:footnote>
<ix:footnote id="FN20240813093858838_20" xml:lang="en-US">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023.  We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December 31, 2023. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets and 55% of the Fund&#8217;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. See &#8220;Credit Facility.&#8221;</ix:footnote>
<ix:footnote id="FN20240813093858838_21" xml:lang="en-US">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</ix:footnote>
<ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20240814to20240814" id="F20240812221526044_0">0001515324</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20240814to20240814" id="F20240812221526044_1">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="C_20240814to20240814" id="Fdei_DocumentType20240813154129236">N-2/A</ix:nonNumeric><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20240814to20240814" id="Fxbrl_20240813101936164">No</ix:nonNumeric><ix:footnote id="FN20240813131137276" xml:lang="en-US">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December 31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December 31, 2023.</ix:footnote>
<ix:footnote id="FN20240813131152589" xml:lang="en-US">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December 31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December 31, 2023 to determine the "Corresponding Return to Common Shareholder."</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="ck0001515324-20240814.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20240814to20240814"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-14</xbrli:startDate>
        <xbrli:endDate>2024-08-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240331to20240331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-03-31</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231to20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930to20230930"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-09-30</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630to20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-06-30</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331to20230331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-12-31</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-06-30</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331to20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-31</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240806"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-08-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240806to20240806"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-06</xbrli:startDate>
        <xbrli:endDate>2024-08-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:CommonStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:PreferredStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:CommonStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-14</xbrli:startDate>
        <xbrli:endDate>2024-08-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:PreferredStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-14</xbrli:startDate>
        <xbrli:endDate>2024-08-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-14</xbrli:startDate>
        <xbrli:endDate>2024-08-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001515324:CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-14</xbrli:startDate>
        <xbrli:endDate>2024-08-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USDPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<ix:relationship fromRefs="F20240813093858837_2" toRefs="FN20240813151557943"/><ix:relationship fromRefs="F20240813093858837_3" toRefs="FN20240813093858838_17"/><ix:relationship fromRefs="F20240813093858837_4" toRefs="FN20240813093858838_18"/><ix:relationship fromRefs="F20240813093858837_6" toRefs="FN20240813151619745"/><ix:relationship fromRefs="F20240813093858837_7" toRefs="FN20240813093858838_20"/><ix:relationship fromRefs="F20240813093858837_8" toRefs="FN20240813093858838_21"/><ix:relationship fromRefs="Fxbrl_20240813130938642" toRefs="FN20240813131137276"/><ix:relationship fromRefs="Fxbrl_20240813130938642" toRefs="FN20240813131152589"/><ix:relationship fromRefs="Fxbrl_20240813130950435" toRefs="FN20240813131137276"/><ix:relationship fromRefs="Fxbrl_20240813130950435" toRefs="FN20240813131152589"/><ix:relationship fromRefs="Fxbrl_20240813130956563" toRefs="FN20240813131137276"/><ix:relationship fromRefs="Fxbrl_20240813130956563" toRefs="FN20240813131152589"/><ix:relationship fromRefs="Fxbrl_20240813131017531" toRefs="FN20240813131137276"/><ix:relationship fromRefs="Fxbrl_20240813131017531" toRefs="FN20240813131152589"/><ix:relationship fromRefs="Fxbrl_20240813131023322" toRefs="FN20240813131137276"/><ix:relationship fromRefs="Fxbrl_20240813131023322" toRefs="FN20240813131152589"/></ix:resources></ix:header></div><div>
  <div style="font:10pt Times New Roman, Times, Serif">
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>
    <p style="font:10pt Times New Roman, Times, serif;margin:0pt 0px;text-align:center"><strong>As filed with the Securities and Exchange Commission on August&#160;14, 2024</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><strong>Securities Act File No.&#160;<ix:nonNumeric id="Fxbrl_20240813095342882" name="dei:EntityFileNumber" contextRef="C_20240814to20240814">333-279977</ix:nonNumeric></strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><strong>Investment Company Act File No.&#160;<ix:nonNumeric id="Fxbrl_20240813095409603" name="dei:InvestmentCompanyActFileNumber" contextRef="C_20240814to20240814">811-22535</ix:nonNumeric></strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="width:100%">
      <div style="font-size:1pt;border-top:Black 2pt solid;border-bottom:Black 1pt solid">&#160;</div>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><strong>U.S. SECURITIES AND EXCHANGE COMMISSION</strong>&#160;</span></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>WASHINGTON, D.C. 20549</strong></span></span></p>
    <p style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><strong>FORM&#160;<ix:nonNumeric id="Fxbrl_20240813153530270" name="dei:EntityInvCompanyType" contextRef="C_20240814to20240814">N-2</ix:nonNumeric></strong></span></span></p>
    <p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:14pt"><strong>Registration Statement</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><i>under</i></strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr>
          <td style="width:5%">&#160;</td>
          <td style="vertical-align:top;text-align:center;width:90%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong><i>the Securities Act of 1933</i></strong></span></td>
          <td style="text-align:right;vertical-align:top;width:5%"><span><ix:nonNumeric id="Fxbrl_20240813095735844" name="dei:DocumentRegistrationStatement" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Pre-Effective Amendment No.&#160;<ix:nonNumeric id="Fxbrl_20240813100053971" name="dei:PreEffectiveAmendmentNumber" contextRef="C_20240814to20240814">1</ix:nonNumeric></strong></span></td>
          <td style="text-align:right;vertical-align:top"><span><ix:nonNumeric id="Fxbrl_20240813095809200" name="dei:PreEffectiveAmendment" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Post-Effective Amendment No.&#160;</strong></span></td>
          <td style="text-align:right;vertical-align:top"><span><ix:nonNumeric id="Fxbrl_20240813095834440" name="dei:PostEffectiveAmendment" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>and/or</strong></span></td>
          <td style="text-align:right;vertical-align:top">&#160;</td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Registration Statement</strong></span></span></span></td>
          <td style="text-align:right;vertical-align:top">&#160;</td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong><i>Under</i></strong></span></td>
          <td style="text-align:right;vertical-align:top">&#160;</td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong><i>the Investment Company Act of 1940</i></strong></span></td>
          <td style="text-align:right;vertical-align:top"><span><ix:nonNumeric id="Fxbrl_20240813095913940" name="dei:InvestmentCompanyActRegistration" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></td>
        </tr>
        <tr>
          <td>&#160;</td>
          <td style="vertical-align:top;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Amendment No.&#160;<ix:nonNumeric id="Fxbrl_20240814013928637" name="dei:InvestmentCompanyRegistrationAmendmentNumber" contextRef="C_20240814to20240814">6</ix:nonNumeric></strong></span></td>
          <td style="text-align:right;vertical-align:top">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span><ix:nonNumeric id="Fxbrl_20240814033509624" name="dei:InvestmentCompanyRegistrationAmendment" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></p>
          </td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>
    <div style="margin:3pt auto;width:25%">
      <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>
    <p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:18pt"><strong><ix:nonNumeric id="Fxbrl_20240813100134625" name="dei:EntityRegistrantName" contextRef="C_20240814to20240814">Ares Dynamic Credit Allocation Fund, Inc.</ix:nonNumeric></strong></span></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>(Exact Name of Registrant as Specified In Charter)</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin:3pt auto;width:25%">
      <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240813100209304" name="dei:EntityAddressAddressLine1" contextRef="C_20240814to20240814">2000 Avenue of the Stars</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240813134715877" name="dei:EntityAddressAddressLine2" contextRef="C_20240814to20240814" continuedAt="F20240813134725030">12</ix:nonNumeric><sup>th</sup> <ix:continuation id="F20240813134725030"><span>Floor</span></ix:continuation></strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240813100258989" name="dei:EntityAddressCityOrTown" contextRef="C_20240814to20240814">Los Angeles</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240813100323475" name="dei:EntityAddressStateOrProvince" contextRef="C_20240814to20240814" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20240813100344161" name="dei:EntityAddressPostalZipCode" contextRef="C_20240814to20240814">90067</ix:nonNumeric></strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>(Address of Principal Executive Offices)</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Registrant&#8217;s Telephone Number, including Area Code: (<ix:nonNumeric id="Fxbrl_20240813100417005" name="dei:CityAreaCode" contextRef="C_20240814to20240814">310</ix:nonNumeric>) <ix:nonNumeric id="Fxbrl_20240813100441809" name="dei:LocalPhoneNumber" contextRef="C_20240814to20240814">201-4100</ix:nonNumeric></strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240813100636897" name="dei:ContactPersonnelName" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Ian Fitzgerald</ix:nonNumeric></strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Ares Dynamic Credit Allocation Fund,&#160;Inc.</strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240813100710388" name="dei:EntityAddressAddressLine1" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">2000 Avenue of the Stars</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240813134756249" name="dei:EntityAddressAddressLine2" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">12th Floor</ix:nonNumeric></strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240813100739956" name="dei:EntityAddressCityOrTown" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Los Angeles</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240813100748083" name="dei:EntityAddressStateOrProvince" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20240813100804198" name="dei:EntityAddressPostalZipCode" contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">90067</ix:nonNumeric></strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>(Name and Address of Agent For Service)</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin:3pt auto;width:25%">
      <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><i>Copies of information to:</i></strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Jay Spinola,&#160;Esq.</strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Willkie Farr&#160;&amp; Gallagher LLP</strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>787 Seventh Avenue</strong>&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>New York, New York 10019</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin:3pt auto;width:25%">
      <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
    </div>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif"><strong>Approximate Date of Proposed Public Offering:</strong></span> <ix:nonNumeric id="Fxbrl_20240813101019177" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic" contextRef="C_20240814to20240814">As soon as practicable after the effective date of this Registration Statement.</ix:nonNumeric></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif">If </span>the only securities being registered on this Form&#160;are being offered pursuant to dividend or interest reinvestment plans, check the following box&#160;&#160;<span><ix:nonNumeric id="Fxbrl_20240813101101839" name="dei:DividendOrInterestReinvestmentPlanOnly" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif">If any securities being registered on this Form&#160;will be offered on a delayed or continuous basis in reliance on Rule&#160;415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan, check the following box.&#160;&#160;</span><span><ix:nonNumeric id="Fxbrl_20240813101126027" name="dei:DelayedOrContinuousOffering" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif">If this Form&#160;is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto, check the following box&#160;&#160;</span><span><ix:nonNumeric id="Fxbrl_20240813101153751" name="cef:PrimaryShelfFlag" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif">If this Form&#160;is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule&#160;462(e)&#160;under the Securities Act, check the following box&#160;&#160;</span><span><ix:nonNumeric id="Fxbrl_20240813101217858" name="dei:EffectiveUponFiling462e" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif">If this Form&#160;is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule&#160;413(b)&#160;under the Securities Act, check the following box&#160;&#160;</span><span><ix:nonNumeric id="Fxbrl_20240813101247417" name="dei:AdditionalSecuritiesEffective413b" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">It is proposed that this filing will become effective (check appropriate box)</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif"><span><ix:nonNumeric id="Fxbrl_20240813101410817" name="dei:EffectiveWhenDeclaredSection8c" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span> when declared effective pursuant to section 8(c).</p>
    <p style="font:10pt Times New Roman, Times, Serif;text-align:justify;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">If appropriate, check the following box:</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101453588" name="dei:NewEffectiveDateForPreviousFiling" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement].</span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101524507" name="dei:AdditionalSecurities462b" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">This Form&#160;is filed to register additional securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is:&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101602905" name="dei:NoSubstantiveChanges462c" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">This Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(c)&#160;under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is:&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101633578" name="dei:ExhibitsOnly462d" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">This Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(d)&#160;under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is:&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">Check each box that appropriately characterizes the Registrant:</p>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span><ix:nonNumeric id="Fxbrl_20240813101711607" name="cef:RegisteredClosedEndFundFlag" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101744579" name="cef:BusinessDevelopmentCompanyFlag" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Business Development Company (closed-end company that intends or has elected to be regulated as a business development company under the Investment Company Act). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813101804016" name="cef:IntervalFundFlag" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule&#160;23c-3 under the Investment Company Act). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span><ix:nonNumeric id="Fxbrl_20240813101834864" name="cef:PrimaryShelfQualifiedFlag" contextRef="C_20240814to20240814" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><span style="-sec-ix-hidden:Fxbrl_20240813101936164">&#9744;</span></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Well-Known Seasoned Issuer (as defined by Rule&#160;405 under the Securities Act). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813102009257" name="dei:EntityEmergingGrowthCompany" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Emerging Growth Company (as defined by Rule&#160;12b-2 under the Securities and Exchange Act of 1934). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9744;</span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B)&#160;of the Securities Act. </span></td>
        </tr>

    </table>
    <p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:top">
          <td style="text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20240813102041250" name="cef:NewCefOrBdcRegistrantFlag" contextRef="C_20240814to20240814" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
          <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </span></td>
        </tr>

    </table>
    <p style="text-align:justify;margin-top:0;margin-bottom:0">&#160;</p>
    <p style="text-align:justify;margin-top:0;margin-bottom:0"><span style="text-transform:uppercase">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a)&#160;of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</span></p>
    <div style="text-transform:uppercase">
      <p style="text-align:justify;margin-top:0;margin-bottom:0">&#160;</p>
      <div style="width:100%">
        <div style="font-size:1pt;border-top:Black 1pt solid;border-bottom:Black 2pt solid">&#160;</div>
      </div>
      <p style="margin-top:0;margin-bottom:0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="margin-top:0;margin-bottom:0">&#160;</p>
    </div>
  </div>
  <div style="font:10pt Times New Roman, Times, Serif">
    <div style="Page-Break-Before:Always"></div>
    <p style="margin:0">&#160;</p>
  </div>
<div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;color:#eb0029">The information in this Preliminary Prospectus is not complete and may be changed. Ares Dynamic Credit Allocation Fund,&#160;Inc. may not sell these securities until the registration statement filed with the Securities and Exchan<span style="font-size:10pt">ge Commission is effective. This Preliminary Prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;color:#eb0029"><span style="font-size:10pt"><strong>SUBJECT TO COMPLETION, DATED AUGUST 14, 2024</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong><span style="text-decoration:underline">BASE PROSPECTUS</span></strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $500,000,000 of Common Stock</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Ares Dynamic Credit Allocation Fund,&#160;Inc.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Common Shares</strong>&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Rights to Purchase Common Shares</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">Ares Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total return, primarily through current income and, secondarily, through capital appreciation.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">We may offer, from time to time, in one or more offerings, up</span> to $500,000,000 of our common stock, par value $0.001 per share (&#8220;common shares&#8221; and the holders thereof, &#8220;common shareholders&#8221;). We may also offer subscription rights to purchase our common shares. Common shares may be offered at prices and on terms to be set forth in one or more supplements to this Prospectus (each, a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Our common shares may be offered directly to one or more purchasers, including through a rights offering, through agents designated from time to time by us, or to or through underwriters or dealers. The Prospectus Supplement relating to the offering will identify any agents or underwriters involved in the sale of our common shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement relating to any offering of rights will set forth the number of common shares issuable upon the exercise of each right (or number of rights) and the other terms of such rights offering. We may not sell any of our common shares through agents, underwriters or dealers without delivery of a Prospectus Supplement describing the method and terms of the particular offering of our common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Our common shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; The last reported sale price of our common shares, as reported by the NYSE on August 6, 2024, was $15.09 per common share. The net asset value of our common shares at the close of business on August 6, 2024 was $14.65 per common share. Rights issued by the Fund may also be listed on a securities exchange.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Investing in the Fund&#8217;s common shares involves certain risks that are described in the &#8220;Risks&#8221; section beginning on page&#160;25 of this Prospectus.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Shares of closed-end management investment companies frequently trade at a discount to their net asset value. The Fund&#8217;s common shares have traded at a discount to net asset value, including during recent periods. If the Fund&#8217;s common shares trade at a discount to its net asset value, the risk of loss may increase for purchasers in a public offering.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Neither the Securities and Exchange Commission (&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved these securities or passed upon the adequacy of this Prospectus. Any representation to the contrary is a criminal offense.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">This Prospectus, together with any Prospectus Supplement, sets forth concisely the information about the Fund that a prospective investor should know before investing. You should read this Prospectus and applicable Prospectus Supplement, which contain important information, before deciding whether to invest in the common shares. You should retain the Prospectus and Prospectus Supplement for future reference. A Statement of Additional Information (&#8220;SAI&#8221;), dated [&#9679;], 2024, containing additional information about the Fund, has been filed with the SEC and, as amended from time to time, is incorporated by reference in its entirety into this Prospectus. You may call (888) 818-5298, visit the Fund&#8217;s website (www.arespublicfunds.com) or write to the Fund to obtain, free of charge, copies of the SAI and the Fund&#8217;s semi-annual and annual reports, as well as to obtain other information about the Fund or to make shareholder inquiries. The SAI, as well as the Fund&#8217;s semi-annual and annual reports, are also available for free on the SEC&#8217;s website (http://www.sec.gov). You may also e-mail requests for these documents to publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">2&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">You should not construe the contents of this Prospectus as legal, tax or financial advice. You should consult with your own professional advisers as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The Fund&#8217;s common shares do not represent a deposit or an obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Prospectus dated [&#9679;], 2024</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">3&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>TABLE OF CONTENTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:90%"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUMMARY</span></a></td><td style="width:10%;text-align:right"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td><td style="text-align:right"><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL HIGHLIGHTS</span></a></td><td style="text-align:right"><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">11</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td><td style="text-align:right"><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND</span></a></td><td style="text-align:right"><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF SHARES</span></a></td><td style="text-align:right"><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND&#8217;S INVESTMENTS</span></a></td><td style="text-align:right"><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">14</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEVERAGE</span></a></td><td style="text-align:right"><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RISKS</span></a></td><td style="text-align:right"><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">HOW THE FUND MANAGES RISK</span></a></td><td style="text-align:right"><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">MANAGEMENT OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">NET ASSET VALUE</span></a></td><td style="text-align:right"><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">27</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DISTRIBUTIONS</span></a></td><td style="text-align:right"><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">29</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DIVIDEND REINVESTMENT PLAN</span></a></td><td style="text-align:right"><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RIGHTS OFFERINGS</span></a></td><td style="text-align:right"><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAX MATTERS</span></a></td><td style="text-align:right"><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">31</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION OF HOLDERS OF RIGHTS</span></a></td><td style="text-align:right"><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">37</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CERTAIN PROVISIONS IN THE CHARTER AND BYLAWS</span></a></td><td style="text-align:right"><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">38</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CLOSED-END FUND STRUCTURE</span></a></td><td style="text-align:right"><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">REPURCHASE OF COMMON SHARES</span></a></td><td style="text-align:right"><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td><td style="text-align:right"><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">INCORPORATION BY REFERENCE</span></a></td><td style="text-align:right"><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRIVACY PRINCIPLES OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>You should rely only on the information contained in, or incorporated by reference into, this Prospectus and any related Prospectus Supplement in making your investment decisions. The Fund has not authorized any person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. The Fund is not making an offer to sell the common shares in any jurisdiction where the offer or sale is not permitted. You should assume that the information in this Prospectus and any Prospectus Supplement is accurate only as of the dates on their covers. The Fund&#8217;s business, financial condition and prospects may have changed since the date of its description in this Prospectus or the date of its description in any Prospectus Supplement.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">4&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_001_integixAnchor"><strong>PROSPECTUS SUMMARY</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><i>This is only a summary of certain information relating to Ares Dynamic Credit Allocation Fund,&#160;Inc. This summary may not contain all of the information that you should consider before investing in our common shares. You should consider the more detailed information contained in the Prospectus and in any related Prospectus Supplement and in the Statement of Additional Information (&#8220;SAI&#8221;) before purchasing common shares.</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;width:25%;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>The Fund</strong></span></td><td style="padding-bottom:10pt;width:75%;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Ares Dynamic Credit Allocation Fund,&#160;Inc. is a diversified, closed-end management investment company. Throughout this Prospectus, we refer to Ares Dynamic Credit Allocation Fund,&#160;Inc. simply as the &#8220;Fund&#8221; or as &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our.&#8221; See &#8220;The Fund.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund&#8217;s common shares are listed for trading on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; As of August 6, 2024 the net assets of the Fund were $335,600,000, the total assets of the Fund were $561,700,000 and the Fund had outstanding 22,915,000 common shares. The last reported sale price of the Fund&#8217;s common shares, as reported by the NYSE on August 6, 2024 was $15.09 per common share. The net asset value (&#8220;NAV&#8221;) of the Fund&#8217;s common shares at the close of business on August 6, 2024 was $14.65 per common share. See &#8220;Description of Shares.&#8221; Rights issued by the Fund may also be listed on a securities exchange.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>The Offering</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">We may offer, from time to time, in one or more offerings, up to $500,000,000 of our common shares on terms to be determined at the time of the offering. We may also offer subscription rights to purchase our common shares. The common shares may be offered at prices and on terms to be set forth in one or more Prospectus Supplements. You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our common shares. Our common shares may be offered directly to one or more purchasers, through agents designated from time to time by us, or to or through underwriters or dealers. The offering price per common share will not be less than the NAV per common share at the time we make the offering, exclusive of any underwriting commissions or discounts, provided that rights offerings that meet certain conditions may offer common shares at a price below the then current NAV. See &#8220;Rights Offerings.&#8221; The Prospectus Supplement relating to the offering will identify any agents, underwriters or dealers involved in the sale of our common shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. See &#8220;Plan of Distribution.&#8221; The Prospectus Supplement relating to any offering of rights will set forth the number of common shares issuable upon the exercise of each right (or number of rights) and the other terms of such rights offering. </span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Use of Proceeds</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The net proceeds from the issuance of common shares hereunder will be invested in accordance with our investment objective and policies as appropriate investment opportunities are identified, which is expected to be substantially completed in approximately three months from the date on which the proceeds from an offering are received by the Fund; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. See &#8220;Use of Proceeds.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Investment Objective and Policies</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objective and policies.</span></td></tr></table><p style="margin:0">&#160;</p></div><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">5&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid"><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Leverage</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:75%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund is authorized to utilize leverage to the maximum extent permitted by law for investment and other general corporate purposes. The Fund currently utilizes leverage through the issuance of its preferred stock, par value $0.001 per share (the &#8220;preferred shares&#8221;), and bank borrowings and may obtain additional leverage in the future by issuing preferred shares and/or notes and borrowing funds from banks and other financial institutions. The Fund may also gain leverage synthetically through swaps and other derivatives. The use of leverage to purchase additional securities creates an opportunity for increased common share dividends, but also creates risks for the common shareholders, including increased variability of the Fund&#8217;s net income, distributions, net asset value and/or market price of its common shares in relation to market changes. Leverage is a speculative technique that exposes the Fund to greater risk and increased costs than if it were not implemented. Increases and decreases in the value of the Fund&#8217;s portfolio will be magnified through the use of leverage. The Fund pays dividends on its preferred shares and interest on borrowings, which increases expenses and may reduce the Fund&#8217;s return. These dividend payments and interest expenses (which are borne entirely by common shareholders) may be greater than the Fund&#8217;s return on the underlying investments. </span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund will pay (and common shareholders will bear) all costs and expenses relating to the issuance and ongoing maintenance of preferred shares and other forms of indebtedness issued by the Fund, including higher advisory fees. As a result, the Fund cannot assure you that the issuance of preferred shares and/or notes or other forms of indebtedness will provide a higher yield or return to the holders of the common shares. The costs of any new offers and/or issuances of preferred shares and/or notes or other forms of indebtedness will be borne immediately by the common shareholders and result in a reduction of the net asset value of the common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">So long as the Fund&#8217;s portfolio provides a higher rate of return, net of expenses, than the interest or dividend rate on borrowed money, the leverage may cause common shareholders to receive a higher current rate of return than if the Fund were not leveraged. If, however, long-term and/or short-term rates rise, the interest rate on borrowed money could exceed the rate of return on securities held by the Fund, reducing returns to common shareholders. Developments in the credit markets may adversely affect the ability of the Fund to borrow for investment purposes and may increase the costs of such borrowings, which would reduce returns to common shareholders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">There is no assurance that a leveraging strategy will be successful. Leverage involves risks and special considerations for common shareholders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The preferred shares and indebtedness incurred by the Fund impose covenants and other restrictions imposed by its lenders are in addition to, and in certain cases more stringent than, those imposed by the </span>Investment Company Act of 1940, as amended, together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;). Certain types of borrowings by the Fund may result in the Fund being subject to covenants relating to asset coverage and portfolio composition requirements. These covenants and restrictions may negatively affect the Fund&#8217;s ability to achieve its investment objective. See &#8220;Leverage.&#8221;</p></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Preferred Shares</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund has authorized and issued 800,000 shares of Series&#160;A Mandatory Redeemable Preferred Stock, $0.001 par value per share (the &#8220;Series&#160;A MRP Shares&#8221;), for gross proceeds of $20 million, 1,200,000 shares of Series&#160;B Mandatory Redeemable Preferred Stock, $0.001 par value per share (the &#8220;Series&#160;B MRP Shares&#8221;), for gross proceeds of $30 million and 2,000,000 shares of Series&#160;C Mandatory Redeemable Preferred Stock, $0.001 par value per share (the &#8220;Series&#160;C MRP Shares&#8221; and, together with the Series&#160;A MRP Shares and Series&#160;B MRP Shares, the &#8220;MRP Shares&#8221;), for gross proceeds of $50 million. Each of the MRP Shares has a liquidation preference of $25.00 per share. The aggregate redemption amount of the MRP Shares is $100 million.</p></td></tr></table><p style="margin:0">&#160;</p></div><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">6&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid"><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:25%">&#160;</td><td style="padding-right:5.4pt;padding-left:5.4pt;width:75%"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly, with a redemption date of five years from issuance. The Series&#160;C MRP Shares have a dividend rate of 3.03% per annum, payable quarterly, with a redemption date of seven years from issuance. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the MRP Shares.</p></td></tr></table><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Credit Facility</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:75%"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span>Under the Investment Company Act, the Fund is permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately thereafter the Fund has asset coverage of at least 300%. In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span>&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Fund is a party to a senior secured revolving credit facility (as amended, the &#8220;Credit Facility&#8221;), that allows the Fund to borrow up to $212 million at any one time outstanding. The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a)&#160;limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b)&#160;limitations on certain investments, (c)&#160;limitations on certain restricted payments, and (d)&#160;maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, </span><span>t</span>he Fund was in compliance in all material respects with the terms of the Credit Facility. See &#8220;Credit Facility.&#8221;</span></span></p></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Investment Adviser</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund is externally managed by Ares Capital Management II LLC (the &#8220;Adviser&#8221;), a subsidiary of Ares Management Corporation (NYSE: ARES) (&#8220;Ares&#8221;), pursuant to an investment advisory and management agreement. The Adviser receives an annual fee of 1.00% of the average daily value of the Fund&#8217;s total assets (including any assets attributable to any preferred shares or to indebtedness) minus the Fund's liabilities other than liabilities relating to indebtedness (&#8220;Managed Assets&#8221;). See &#8220;Management of the Fund&#8212;Investment Adviser.&#8221;</span></td></tr></table><p style="margin:0">&#160;</p></div><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">7&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><div style="border:Black 1pt solid;padding-right:10pt;padding-left:10pt"><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Distributions</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:75%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund expects to distribute monthly all or a portion of its net investment income to common shareholders.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund intends to pay common shareholders at least annually all or substantially all of its net investment income after the payment of dividends and interest, if any, owed with respect to any outstanding preferred shares and/or notes or other forms of leverage utilized by the Fund. The Fund intends to pay any capital gains distributions at least annually. If the Fund makes a long-term capital gain distribution, it will be required to allocate such gain between the common shares and any preferred shares issued by the Fund in proportion to the total dividends paid to each class for the year in which the income is realized. The U.S. federal income tax treatment and characterization of the Fund&#8217;s distributions may vary from time to time because of the varied nature of the Fund&#8217;s investments. Various factors will affect the level of the Fund&#8217;s income, including the asset mix, the average maturity of the Fund&#8217;s portfolio and default rates, the amount of leverage utilized by the Fund, if any, and any use of hedging activities by the Fund.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The distributions for any full or partial year might not be made in equal amounts, and any one distribution may be larger than the other. The Fund will make a distribution only if authorized by the Board of Directors of the Fund (the &#8220;Board&#8221; and each member thereof, a &#8220;Director&#8221;) or by the officers of the Fund pursuant to delegated authority granted by the Board, and declared by the Fund out of assets legally available for these distributions. The Fund may pay a special distribution at the end of each fiscal year if necessary to maintain the Fund&#8217;s tax treatment as a registered investment company (&#8220;RIC&#8221;) and/or avoid the imposition of tax on the Fund. This distribution policy may, under certain circumstances, have certain adverse consequences to the Fund and its shareholders because it may result in a return of capital to shareholders, which would reduce the Fund&#8217;s net asset value and, over time, potentially increase the Fund&#8217;s expense ratio. If a distribution constitutes a return of capital, it means that the Fund is returning to shareholders a portion of their investment rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. The Board may elect to change the Fund&#8217;s distribution policy at any time.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Section&#160;19(b)&#160;of the Investment Company Act and Rule&#160;19b-1 thereunder generally limit the Fund to one long-term capital gain distribution per year, subject to certain exceptions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Shareholders will automatically have all dividends and distributions reinvested in common shares of the Fund in accordance with the Fund&#8217;s dividend reinvestment plan, unless an election is made to receive cash by contacting the plan administrator, at (877) 272-8164. See &#8220;Dividend Reinvestment Plan.&#8221;</p></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Listing</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund&#8217;s common shares are listed on the NYSE under the symbol &#8220;ARDC.&#8221; See &#8220;Description of Shares&#8212;Common Shares.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Administrator, Custodian and Transfer Agent and Other Services</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">State Street Bank and Trust Company (&#8220;State Street&#8221;) serves as the Fund&#8217;s administrator and fund accountant, custodian and transfer agent. Destra Capital Advisors LLC (&#8220;Destra&#8221;) provides investor support services in connection with the ongoing operations of the Fund.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Market Price of Shares</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common shares of closed-end investment companies frequently trade at prices lower than their NAV. The Fund cannot assure you that its common shares will trade at a price higher than or equal to NAV. See &#8220;Use of Proceeds.&#8221; The Fund&#8217;s common shares trade in the open market at market prices that are a function of several direct and indirect factors, including dividend levels (which are in turn affected by expenses), NAV, call protection for portfolio securities, portfolio credit quality, liquidity, dividend stability, relative demand for and supply of the common shares in the market, general market and economic conditions and other factors. See &#8220;Leverage,&#8221; &#8220;Risks,&#8221; &#8220;Description of Shares&#8221; and &#8220;Repurchase of Common Shares.&#8221; The common shares are designed primarily for long-term investors and you should not purchase common shares of the Fund if you intend to sell them shortly after purchase.</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Special Risk Considerations</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">An investment in common shares of the Fund involves risk. Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the risks of investing in the Fund. You should carefully consider those risks, which are described in more detail under &#8220;Risks&#8221; beginning on page&#160;</span>25 <span>of this Prospectus.</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">8&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>
  <div style="font:10pt Times New Roman, Times, Serif">
    <ix:nonNumeric id="Fxbrl_20240813162519030" name="cef:PurposeOfFeeTableNoteTextBlock" contextRef="C_20240814to20240814" escape="true">
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table is intended to assist you in understanding the costs and expenses that an investor in our common shares will bear, directly or indirectly, based on the assumptions set forth below. We caution you that some of the percentages indicated in the table below are estimates and may vary. The table reflects the use of leverage in the form of borrowings in an amount equal to 36% of the Fund&#8217;s Managed Assets (after the leverage is incurred), and shows Fund expenses as a percentage of net assets attributable to common shares. The extent of the Fund&#8217;s assets attributable to leverage following an offering, and the Fund&#8217;s associated expenses, are likely to vary (perhaps significantly) from these assumptions.</p>
    </ix:nonNumeric>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_003_integixAnchor"></span><strong>SUMMARY OF FUND EXPENSES</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <ix:nonNumeric id="F20240813093858837_1" name="cef:ShareholderTransactionExpensesTableTextBlock" contextRef="C_20240814to20240814" continuedAt="F20240813151201043" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
              <td style="font-size:10pt">&#160;</td>
              <td colspan="2" style="font-size:10pt">&#160;</td>
              <td style="font-size:10pt">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Sales load paid by you (<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240813093858836_0" name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="C_20240814to20240814" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">as a percentage of offering price</span></ix:nonNumeric></span></span>)(1)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_2" name="cef:SalesLoadPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">None</ix:nonFraction></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Offering expenses borne by the Fund (as a percentage of offering price)(2)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_3" name="cef:OtherTransactionExpense1Percent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">None</ix:nonFraction></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Dividend reinvestment plan fees(3)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_4" name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="C_20240814to20240814" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">None</ix:nonFraction></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
    <ix:nonNumeric id="F20240813093858837_5" name="cef:AnnualExpensesTableTextBlock" contextRef="C_20240814to20240814" continuedAt="F20240813154255910" escape="true">
      <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:bold 10pt Times New Roman, Times, Serif">Annual Expenses (as a percentage of net assets attributable to common shares)</td>
            <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="font-size:10pt;text-align:right">&#160;</td>
            <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:10pt Times New Roman, Times, Serif;width:87%;padding-left:0.25in">Advisory Fees(4)</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_6" name="cef:ManagementFeesPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.74</ix:nonFraction></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25in">Interest payments on borrowed funds(5)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_7" name="cef:InterestExpensesOnBorrowingsPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.42</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;padding-left:0.25in">Other Expenses(6)</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_8" name="cef:OtherAnnualExpensesPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.80</ix:nonFraction></td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:0.375in">Total Annual Fund Operating Expenses</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_9" name="cef:TotalAnnualExpensesPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.96</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>

      </table>
    </ix:nonNumeric>
    <div style="display:none">
      <ix:continuation id="F20240813154255910" continuedAt="F20240813105108995">
        <div>&#160;</div>
      </ix:continuation>
    </div>
    <ix:continuation id="F20240813151201043">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <div style="margin-bottom:0pt">
          <div style="margin-top:3pt;margin-bottom:3pt;width:25%">
            <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares. </span></td>
              </tr>
              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.</span></td>
              </tr>
              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt">(3)</span></td>
                <td style="padding-bottom:0pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</span></td>
              </tr>

          </table>
        </div>
      </div>
    </ix:continuation>&#160;<ix:continuation id="F20240813105108995">
      <div>
        <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

            <tr style="vertical-align:top">
              <td style="padding-bottom:10pt;text-align:justify;width:47px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(4)</span></p>
              </td>
              <td style="padding-bottom:10pt;text-align:justify;width:1196px"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage of </span>36<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal 55% of the Fund&#8217;s net assets. </span></span></td>
            </tr>
            <tr style="vertical-align:top">
              <td style="padding-bottom:10pt;text-align:justify;width:47px"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(5)</span></td>
              <td style="padding-bottom:10pt;text-align:justify;width:1196px"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023. We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December&#160;31, 2023. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets <span>and 55% of the Fund&#8217;s net assets</span>) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. See &#8220;Credit Facility.&#8221;</span></td>
            </tr>
            <tr style="vertical-align:top">
              <td style="text-align:justify;width:47px"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(6)</span></td>
              <td style="text-align:justify;width:1196px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20240813093858838_15" name="cef:OtherExpensesNoteTextBlock" contextRef="C_20240814to20240814" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</span></ix:nonNumeric></span></span></span></td>
            </tr>

        </table>
      </div>
    </ix:continuation>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <ix:nonNumeric id="F20240813093858837_10" name="cef:ExpenseExampleTableTextBlock" contextRef="C_20240814to20240814" continuedAt="F20240813151355909" escape="true">
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual expenses of </span>4.96% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:</p>
    </ix:nonNumeric>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">9&#160;</p>
    </div>
    <div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <ix:continuation id="F20240813151355909">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

              <tr style="vertical-align:bottom">
                <td style="font-size:10pt">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">One&#160;Year</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Three&#160;Years</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Five&#160;Years</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Ten&#160;Years</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_11" name="cef:ExpenseExampleYear01" contextRef="C_20240814to20240814" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">51</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_12" name="cef:ExpenseExampleYears1to3" contextRef="C_20240814to20240814" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">152</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858837_13" name="cef:ExpenseExampleYears1to5" contextRef="C_20240814to20240814" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">254</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="F20240813093858838_14" name="cef:ExpenseExampleYears1to10" contextRef="C_20240814to20240814" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">506</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The example should not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p>
        </div>
      </ix:continuation>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">10&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_004_integixAnchor"></span><strong>FINANCIAL HIGHLIGHTS</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The audited financial statements and financial highlights included in the <span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2023</a></span></span>, together with the report of Ernst&#160;&amp; Young LLP for the Fund&#8217;s Annual Report are incorporated herein by reference.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">11&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_005_integixAnchor"></span></p>
  </div>


  <div style="font:10pt Times New Roman, Times, Serif">
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>USE OF PROCEEDS</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The net proceeds from the issuance of common shares hereunder will be invested in accordance with the Fund&#8217;s investment objective and policies as stated below. We currently anticipate that we will be able to invest all of the net proceeds in accordance with our investment objective and policies within approximately three months from the date on which the proceeds from an offering are received by the Fund</span>; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment, it is anticipated that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market instruments<span>.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_006_integixAnchor"></span><strong>THE FUND</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act. The Fund was organized as a Maryland corporation on March&#160;14, 2011, pursuant to its charter (the &#8220;Charter&#8221;) and is governed by the laws of the State of Maryland. The Fund&#8217;s principal office is located at 2000 Avenue of the Stars, 12th Floor, Los Angeles, CA 90067, and its telephone number is (888) 818-5298.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <ix:nonNumeric id="Fxbrl_20240813111650959" name="cef:CapitalStockTableTextBlock" contextRef="C_20240814to20240814" continuedAt="F20240813154319016" escape="true">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_007_integixAnchor"><strong>DESCRIPTION OF SHARES</strong></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><ix:nonNumeric id="Fxbrl_20240813142352079" name="cef:SecurityTitleTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common Shares</span></ix:nonNumeric></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders are entitled to share pro rata in the net assets of the Fund available for distribution to shareholders upon liquidation of the Fund. <ix:nonNumeric id="Fxbrl_20240813151941914" name="cef:SecurityVotingRightsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders are entitled to one vote for each share held.</span></ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20240813152025187" name="cef:SecurityPreemptiveAndOtherRightsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders do not have preemptive, conversion or subscription rights and the Fund&#8217;s common shares are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.</span></ix:nonNumeric></span></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund intends to hold annual meetings of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required as a condition to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to all of its shareholders.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise. Shares of closed-end investment companies frequently trade on an exchange at prices lower than NAV. Shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and during other periods have traded at prices lower than NAV. Because the market value of the common shares may be influenced by such direct and indirect factors as dividend levels (which are in turn affected by expenses), call protection on its portfolio securities, dividend stability, portfolio credit quality, the Fund&#8217;s NAV, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that its common shares will trade at a price equal to or higher than NAV in the future. The common shares are designed primarily for long-term investors and you should not purchase the common shares if you intend to sell them soon after purchase. See &#8220;Repurchase of Common Shares&#8221; below and &#8220;Repurchase of Common Shares&#8221; in the SAI.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s outstanding common shares are, and when issued, the common shares offered by this Prospectus will be, publicly held and listed and traded on the NYSE under the symbol &#8220;ARDC.&#8221; The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.</p>
      </div>
    </ix:nonNumeric>
    <div style="display:none">
      <ix:continuation id="F20240813154319016" continuedAt="F20240813132318691">
        <div>&#160;</div>
      </ix:continuation>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">12&#160;</p>
    </div>
    <div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813132318691" continuedAt="F20240813154323865">
        <div>
          <ix:nonNumeric id="Fxbrl_20240813145756573" name="cef:SharePriceTableTextBlock" contextRef="C_20240814to20240814" escape="true">
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">During Quarter Ended</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NYSE&#160;Market&#160;Price<br/>Per&#160;Common Share</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NAV per Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">Trading</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Volume</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:30%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2024</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113734958" name="cef:HighestPriceOrBid" contextRef="C_20240331to20240331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.29</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114059742" name="cef:LowestPriceOrBid" contextRef="C_20240331to20240331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.41</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114407869" name="cef:HighestPriceOrBidNav" contextRef="C_20240331to20240331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.69</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115207908" name="cef:LowestPriceOrBidNav" contextRef="C_20240331to20240331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.56</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813115924099" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240331to20240331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.72</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120119633" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240331to20240331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.90</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">6,951,700</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113753501" name="cef:HighestPriceOrBid" contextRef="C_20231231to20231231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114121396" name="cef:LowestPriceOrBid" contextRef="C_20231231to20231231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.93</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114424684" name="cef:HighestPriceOrBidNav" contextRef="C_20231231to20231231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.51</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115228214" name="cef:LowestPriceOrBidNav" contextRef="C_20231231to20231231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.77</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813115942914" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231231to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">5.24</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120140663" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231231to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.43</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,020,500</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113758982" name="cef:HighestPriceOrBid" contextRef="C_20230930to20230930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.90</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114126133" name="cef:LowestPriceOrBid" contextRef="C_20230930to20230930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.10</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114431104" name="cef:HighestPriceOrBidNav" contextRef="C_20230930to20230930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.21</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115414196" name="cef:LowestPriceOrBidNav" contextRef="C_20230930to20230930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.78</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813115952506" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230930to20230930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.19</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120148394" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230930to20230930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.19</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,500,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113804361" name="cef:HighestPriceOrBid" contextRef="C_20230630to20230630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.33</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114135765" name="cef:LowestPriceOrBid" contextRef="C_20230630to20230630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.68</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114443885" name="cef:HighestPriceOrBidNav" contextRef="C_20230630to20230630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.87</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115421188" name="cef:LowestPriceOrBidNav" contextRef="C_20230630to20230630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.58</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813115958594" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230630to20230630" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">10.65</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120153275" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230630to20230630" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.99</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,473,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113815654" name="cef:HighestPriceOrBid" contextRef="C_20230331to20230331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.77</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114141300" name="cef:LowestPriceOrBid" contextRef="C_20230331to20230331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.42</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114451525" name="cef:HighestPriceOrBidNav" contextRef="C_20230331to20230331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.11</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115726220" name="cef:LowestPriceOrBidNav" contextRef="C_20230331to20230331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.39</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120003563" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230331to20230331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">9.22</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120158882" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230331to20230331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.78</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">7,627,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113825574" name="cef:HighestPriceOrBid" contextRef="C_20221231to20221231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.09</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114304199" name="cef:LowestPriceOrBid" contextRef="C_20221231to20221231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.27</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115103798" name="cef:HighestPriceOrBidNav" contextRef="C_20221231to20221231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.66</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115736683" name="cef:LowestPriceOrBidNav" contextRef="C_20221231to20221231" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.17</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120008940" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221231to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">9.90</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120205386" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221231to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.69</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,699,200</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113837613" name="cef:HighestPriceOrBid" contextRef="C_20220930to20220930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.45</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114315950" name="cef:LowestPriceOrBid" contextRef="C_20220930to20220930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.75</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115123292" name="cef:HighestPriceOrBidNav" contextRef="C_20220930to20220930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.69</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115804955" name="cef:LowestPriceOrBidNav" contextRef="C_20220930to20220930" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.34</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120018914" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.44</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120215930" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.26</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,773,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113843966" name="cef:HighestPriceOrBid" contextRef="C_20220630to20220630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.67</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114343726" name="cef:LowestPriceOrBid" contextRef="C_20220630to20220630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.89</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115132508" name="cef:HighestPriceOrBidNav" contextRef="C_20220630to20220630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.95</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115814972" name="cef:LowestPriceOrBidNav" contextRef="C_20220630to20220630" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120033953" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220630to20220630" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.03</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813132127089" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220630to20220630" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.44</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,461,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813113929526" name="cef:HighestPriceOrBid" contextRef="C_20220331to20220331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">16.29</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813114353469" name="cef:LowestPriceOrBid" contextRef="C_20220331to20220331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.76</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115139204" name="cef:HighestPriceOrBidNav" contextRef="C_20220331to20220331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">16.69</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813115820007" name="cef:LowestPriceOrBidNav" contextRef="C_20220331to20220331" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.66</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813120046795" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220331to20220331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.22</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813132133193" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220331to20220331" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.19</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,201,000</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As of August 6, 2024, the NAV per common share of the Fund was $<ix:nonFraction id="Fxbrl_20240813134647500" name="us-gaap:NetAssetValuePerShare" contextRef="C_20240806" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.65</ix:nonFraction> and the market price per common share was $<ix:nonFraction id="Fxbrl_20240813134655999" name="us-gaap:SharePrice" contextRef="C_20240806" unitRef="USDPerShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.09</ix:nonFraction>, representing a premium to NAV of <ix:nonFraction id="Fxbrl_20240813134719455" name="cef:LatestPremiumDiscountToNavPercent" contextRef="C_20240806to20240806" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.00</ix:nonFraction>%. Common shares of the Fund have historically traded at both a premium and discount to NAV.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">As of August 6, 2024, the Fund has 22,915,000 </span>outstanding common shares.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><ix:nonNumeric id="Fxbrl_20240813142429996" name="cef:SecurityTitleTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Preferred Shares</span></ix:nonNumeric></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that the Board may authorize and issue preferred shares, with rights as determined by the Board, without the approval of the holders of the common shares. Common shareholders have no preemptive right to purchase any preferred shares that might be issued. The Fund has $100 million of preferred shares outstanding. The Fund has authorized and issued 800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B MRP Shares for gross proceeds of $30 million and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif;font-size:10pt"><ix:nonNumeric id="Fxbrl_20240813152806209" name="cef:SecurityLiquidationRightsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Each of the MRP Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and the distribution of assets upon the Fund&#8217;s dissolution, liquidation or winding up, (i) on a parity with each other and any other class or series of preferred shares and (ii) senior to the common shares.</span></ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20240813152431122" name="cef:SecurityPreemptiveAndOtherRightsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of MRP Shares do not have any preemptive rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common shares or other securities of the Fund.</span></ix:nonNumeric></span></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Except for matters which do not require the vote of holders of MRP Shares under the Investment Company Act and except as otherwise provided in the Charter and the Bylaws, (i)&#160;each holder of MRP Shares is entitled to one vote per share on each matter submitted to a vote of the Fund&#8217;s stockholders, and (ii)&#160;the holders of MRP Shares, outstanding preferred shares and common shares will vote together as a single class on all matters submitted to the Fund&#8217;s stockholders; provided, however, that the holders of MRP Shares and outstanding preferred shares will be entitled, as a class, to the exclusion of the holders of all other classes of stock of the Fund, to elect two directors of the Fund. <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif;font-size:10pt"><ix:nonNumeric id="Fxbrl_20240813151820242" name="cef:SecurityVotingRightsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of preferred shares, voting as a separate class, are also generally entitled to vote on (i) certain amendments to the Charter and the Bylaws, (ii) the Fund&#8217;s ability to enter into certain agreements, (iii) the authorization, issuance or reclassification of shares of the Fund&#8217;s stock that would rank on a parity with or senior to the preferred shares, (iv) the liquidation or dissolution of the Fund and (v) the Fund&#8217;s ability to incur, authorize or guarantee any indebtedness for borrowed money.</span></ix:nonNumeric></span></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><ix:nonNumeric id="Fxbrl_20240813152619531" name="cef:SecurityDividendsTextBlock" contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly dividend date.</span></ix:nonNumeric> </span><span>We generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares of our stock ranking junior to the MRP Shares as to dividends or upon liquidation, including our common shares, or on a parity with the MRP Shares or call for redemption, redeem, purchase or otherwise acquire for consideration, unless (i)&#160;immediately after such transaction, certain asset coverage would be achieved, (ii)&#160;full, cumulative dividends on the preferred shares have been declared and paid and (iii)&#160;the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained in the terms of the MRP Shares.</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The aggregate redemption amount of the MRP Shares is $100 million. The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154323865" continuedAt="F20240813132418745">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    </div>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">13&#160;</p>
    </div>
    <div>
      <div>
        <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <ix:continuation id="F20240813132418745">
            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is 2.81% per annum. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject to redemption, at the option of the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. All rights and preferences of the holders of the MRP Shares of a particular series </span><span>will terminate if no MRP Shares of such series are outstanding. </span>Under the Investment Company Act, the Fund is not permitted to issue preferred shares unless immediately after such issuance the value of the Fund&#8217;s total assets is at least 200% of the liquidation value of the outstanding preferred shares (i.e., the liquidation value may not exceed 50% of the Fund&#8217;s total assets). In addition, the Fund is not permitted to declare any cash dividend or other distribution on its common shares unless, at the time of such declaration, the value of the Fund&#8217;s total assets is at least 200% of such liquidation value. Please see &#8220;Description of Shares&#8221; in the SAI for more information.</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Authorized Shares</strong></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <ix:nonNumeric id="Fxbrl_20240813145909403" name="cef:OutstandingSecuritiesTableTextBlock" contextRef="C_20240814to20240814" escape="true">
                <div>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table provides the Fund&#8217;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.</p>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

                      <tr style="vertical-align:bottom">
                        <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Authorized</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Held&#160;by<br/>Fund or for its<br/>Account</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Outstanding<br/>Exclusive of Amount<br/>held by Fund</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                        <td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"><ix:nonNumeric id="Fxbrl_20240813135254076" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" escape="true">Common Shares</ix:nonNumeric></td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135105847" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">996,000,000</ix:nonFraction></td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135133841" name="cef:OutstandingSecurityHeldShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135200964" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">22,914,939</ix:nonFraction></td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom">
                        <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"><ix:nonNumeric id="Fxbrl_20240813135312751" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" escape="true">Preferred Shares</ix:nonNumeric></td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135124246" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,000,000</ix:nonFraction></td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135136625" name="cef:OutstandingSecurityHeldShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813135204076" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,000,000</ix:nonFraction></td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
            </div>
          </ix:continuation>
        </div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240813142524060" name="cef:InvestmentObjectivesAndPracticesTextBlock" contextRef="C_20240814to20240814" continuedAt="F20240813154333472" escape="true">
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_008_integixAnchor"><strong>THE FUND&#8217;S INVESTMENTS</strong></span></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Objective and Policies</strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objective and policies. The Fund&#8217;s investment objective is non-fundamental and may be changed by the Board without shareholder approval.</span></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Portfolio Contents and Techniques</strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under normal circumstances, the Fund&#8217;s portfolio is expected to be comprised principally of the following types of investments:</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Senior Loans.</i></strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior loans (&#8220;Senior Loans&#8221;) generally hold the most senior position in the capital structure of a borrower, are typically secured with specific collateral and have a claim on the assets and/or stock of the borrower that is senior to that held by unsecured creditors, subordinated debt holders and holders of equity of the borrower. The majority of loans the Fund may invest in are rated below investment grade. Typically, in order to borrow money pursuant to a Senior Loan, a borrower will, for the term of the Senior Loan, pledge collateral (subject to typical exceptions), including but not limited to (i)&#160;working capital assets, such as accounts receivable and inventory; (ii)&#160;tangible fixed assets, such as real property, buildings and equipment; (iii)&#160;intangible assets, such as trademarks and patent rights; and (iv)&#160;security interests in shares of stock of subsidiaries or affiliates. In many instances, a Senior Loan may be secured only by shares in the borrower or its subsidiaries. Collateral may consist of assets that may not be readily liquidated, and there is no assurance that the liquidation of such assets would satisfy fully a borrower&#8217;s obligations under a Senior Loan.</p>
          </div>
        </ix:nonNumeric>
        <div style="display:none">
          <ix:continuation id="F20240813154333472" continuedAt="F20240813142540417">
            <div>&#160;</div>
          </ix:continuation>
        </div>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">14&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142540417" continuedAt="F20240813154338297">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior Loans typically have rates of interest that are determined daily, monthly, quarterly or semi-annually by reference to a base lending rate, plus a premium or credit spread. As a result, as short-term interest rates increase, interest payable to the Fund from its investments in Senior Loans should increase, and as short-term interest rates decrease, interest payable to the Fund from its investments in Senior Loans should decrease. These base lending rates are primarily the secured overnight funding rate (&#8220;SOFR&#8221;) or the Euro Interbank Offered Rate (&#8220;Euribor&#8221;) and secondarily the prime rate offered by one or more major U.S. banks and the certificate of deposit rate or other base lending rates used by commercial lenders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">There may be less readily available information about most Senior Loans and the borrowers thereunder than is the case for many other types of securities, including securities issued in transactions registered under the </span>Securities Act of 1933, as amended (&#8220;Securities Act&#8221;) or the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and borrowers subject to the periodic reporting requirements of Section&#160;13 of the Exchange Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">No active trading market may exist for some Senior Loans, and some loans may be subject to restrictions on resale. Any secondary market for Senior Loans may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability of a seller to realize full value and thus cause a material decline in the net asset value of the common shares. In addition, the Fund may not be able to readily dispose of its Senior Loans at prices that approximate those at which the Fund could sell such loans if they were more widely traded and, as a result of such illiquidity, the Fund may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. A limited supply or relative illiquidity of Senior Loans may adversely affect the Fund&#8217;s yield.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In the process of buying, selling and holding Senior Loans, the Fund may receive and/or pay certain fees. These fees are in addition to interest payments received and may include facility fees, commitment fees, amendment fees, commissions and prepayment penalty fees. On an ongoing basis, the Fund may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a Senior Loan. In certain circumstances, the Fund may receive a prepayment penalty fee upon the prepayment of a Senior Loan by a borrower. Other fees received by the Fund may include covenant waiver fees, covenant modification fees or other amendment fees.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Direct Assignments.</i></span>&#160;&#160;The Fund generally will seek to purchase Senior Loans on a direct assignment basis. If the Fund purchases a Senior Loan on direct assignment, it typically succeeds to all the rights and obligations under the Loan Agreement of the assigning lender and becomes a lender under the Loan Agreement with the same rights and obligations as the assigning lender.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Loan Participations.</i></span>&#160;&#160;To a lesser extent than direct assignments, the Fund may transact in participations in Senior Loans. The participation by the Fund in a lender&#8217;s portion of a Senior Loan typically will result in the Fund&#8217;s having a contractual relationship only with such lender, not with the borrower. As a result, the Fund may have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the participation and only upon receipt by such lender of payments from the borrower. Such indebtedness may be secured or unsecured. In connection with purchasing participations, the Fund generally will have no right to enforce compliance by the borrower with the terms of the Loan Agreement, nor any rights with respect to any funds acquired by other investors through set-off against the borrower and the Fund may not directly benefit from the collateral supporting the Senior Loan in which it has purchased the participation. In the event of the insolvency of the entity selling a participation, the Fund may be treated as a general creditor of such entity.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Corporate Bonds.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in corporate bonds that are fixed income securities typically issued by non-investment-grade borrowers, usually at a yield premium to the yield for investment-grade bonds (&#8220;Corporate Bonds&#8221;). Corporate Bonds generally provide for cash interest payments, but may include deferred, zero coupon, or payment-in-kind terms. These investments may be acquired during the primary offering process and may also be purchased in the secondary market as either private securities or publicly registered securities, and typically have multiple institutional holders.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154338297" continuedAt="F20240813142553395">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">15&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142553395" continuedAt="F20240813154342144">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Holders of high-yield bonds, as creditors, have a prior legal claim over common and preferred shareholders as to both income and assets of the issuer for the principal and interest due them and may have a prior claim over other creditors but are generally subordinate to any senior secured lenders in the issuer&#8217;s capital structure.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In most cases Corporate Bonds restrict the borrower&#8217;s ability to incur additional debt and may restrict payments to equity shareholders based upon financial ratios associated with general credit quality. In addition, Corporate Bonds often limit the borrower&#8217;s ability to repay or amortize its high-yield bonds, particularly during the initial portion of their contractual tenor. As such, these securities can provide the opportunity for capital appreciation or yield enhancement, especially when the borrower&#8217;s financial performance is consistent with or superior to expectations, when conditions are favorable in the borrower&#8217;s industry, or when the general economic environment is positive.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Secured bonds and notes. </i></span>These bonds and notes generally constitute the senior-most layer of a borrower&#8217;s capital structure and benefit from a lien on the borrower&#8217;s assets as well as senior ranking in repayment priority. Owing to their claim position and collateral support, secured bonds and secured notes tend to experience superior recoveries in a bankruptcy as compared to unsecured debt due to the collateral securing these instruments. Such bonds and notes may rank <i>pari passu</i> in many respects with secured loans.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Unsecured bonds. </i></span>Dependent upon their terms, these bonds can enjoy a senior ranking or subordinated ranking in repayment priority, but do not benefit from a lien on a borrower&#8217;s assets. Unsecured bonds typically form a layer between a borrower&#8217;s credit facility and its equity. Yields tend to reflect a premium in respect of a bond&#8217;s position within a borrower&#8217;s capital structure.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Alternative Credit Instruments.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">These instruments typically include trust certificates, collateralized debt obligations, collateralized loan obligations (&#8220;CLOs&#8221;), asset-backed securities, credit-linked notes or other structured finance securities. These securities are generally backed by pools of financials and other assets and tranched into different asset classes. The structure of these securities may consist of debt rated from AAA to B and equity. These securities typically make interest and principal payments in order of seniority.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>CLO Securities</i></span>. A CLO generally holds a portfolio consisting principally of loan obligations. CLOs are created, in part, to reapportion the risk and return characteristics of a portfolio of underlying assets. The CLO securitizes payment claims arising out of its portfolio of underlying assets and issues securities with payment characteristics linked to the underlying assets. The redemption of the securities issued by the CLO typically occurs from the cash flow generated by the portfolio of underlying assets. The vast majority of CLOs are actively managed by an investment manager that is independent of the CLO and the holders of its securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund expects to invest in securities issued by CLOs (&#8220;CLO Securities&#8221;) that principally hold Senior Loans, diversified by industry and borrower. It is also possible that the underlying obligations of CLOs in which the Fund invests will include (i)&#160;subordinated loans, (ii)&#160;debt tranches of other CLOs, and (iii)&#160;equity securities incidental to investments in Senior Loans. The cash flows on the underlying obligations will primarily determine the payments to holders of CLO Securities. CLO Securities may have floating interest rates, fixed interest rates or, in the case of subordinated CLO Securities, no set interest rate (but rather participate in residual cash flows of the relevant CLO). CLOs issue securities in tranches with different payment characteristics and different credit ratings. These tranches are generally categorized as senior, mezzanine, or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization of the cash flows from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual interest payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche). The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for each CLO.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154342144" continuedAt="F20240813142602400">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">16&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142602400" continuedAt="F20240813154346097">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The tranches of CLO Securities senior to the subordinated (or residual) tranche (called the &#8220;rated tranches&#8221;) are generally assigned credit ratings by one or more nationally recognized statistical rating organizations (whether or not such tranches are issued as part of a component of a composite instrument with one or more other instruments). The &#8220;equity&#8221; tranche does not receive ratings. The transaction documents relating to the issuance of CLO Securities impose eligibility criteria on the assets of the CLO, restrict the ability of the CLO&#8217;s investment manager to trade investments and impose certain portfolio-wide asset quality requirements.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">CLO Securities are generally limited recourse obligations of the CLO payable solely from the underlying assets of the CLO or the proceeds thereof. Consequently, holders of CLO Securities must rely solely on distributions on the underlying assets or proceeds thereof for payment in respect thereof. The cash flows generated by the underlying obligations held in a CLO&#8217;s portfolio will generally determine the interest payments on CLO Securities. Payments to holders of tranched CLO Securities are made in sequential order of priority.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Asset-Backed Securities</i></span>. Asset-backed securities are debt instruments that are backed by a pool of financial assets, generally consisting of certain kinds of receivables or loans, including, for example, commercial loans. Such assets are generally securitized through the use of trusts and special purpose corporations. Payments or distributions of principal and interest may be guaranteed up to certain amounts and for a certain time period by a letter of credit or a pool insurance policy issued by a financial institution unaffiliated with the trust or corporation, or other credit enhancements may be present.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Asset-backed securities are often subject to more rapid repayment than their stated maturity date would indicate as a result of the pass-through of prepayments of principal on the underlying loans. During periods of declining interest rates, prepayment of loans underlying asset-backed securities can be expected to accelerate. Accordingly, the Fund&#8217;s ability to maintain positions in such securities will be affected by reductions in the principal amount of such securities resulting from prepayments, and its ability to reinvest the returns of principal at comparable yields is subject to generally prevailing interest rates at that time. To the extent that the Fund invests in asset-backed securities, the values of the Fund&#8217;s portfolio securities will vary with changes in market interest rates generally and the differentials in yields among various kinds of asset-backed securities. Asset-backed securities also carry credit or default risks. If the issuer of an asset-backed security defaults on its payment obligations, there is the possibility that, in some cases, the Fund will be unable to possess and sell the underlying collateral and that the Fund&#8217;s recoveries on repossessed collateral may not be available to support payments on these securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Subordinated Loans.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in subordinated loans. Because subordinated loans are subordinated and thus lower in priority of payment and/or in priority of lien to Senior Loans, they are subject to the additional risk that the cash flow of the borrower and property securing the loan or debt, if any, may be insufficient to meet scheduled payments after giving effect to the senior secured obligations of the borrower. This risk is generally higher for subordinated unsecured loans or debt, which are not backed by a security interest in any specific collateral. Subordinated loans generally have greater price volatility than Senior Loans and may be less liquid.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Special Situations and Stressed and Distressed Investments.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in debt securities, preferred or common shares, or other instruments, of companies that are facing liquidity constraints or are undergoing, or that have recently completed, bankruptcies, reorganizations, insolvencies, liquidations or other fundamental changes or similar proceedings. These instruments may be the subject of bankruptcy proceedings or otherwise in default or at risk of being in default as to the repayment of principal and/or interest at the time of acquisition by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make any interest or other payments.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In any investment opportunity involving any such type of special situation, there also exists the risk that a contemplated transaction either will be unsuccessful, will take considerable time or will result in a distribution of cash or new securities, the value of which will be less than the purchase price to the Fund of the securities or other financial instruments in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can be prevented or delayed by a variety of factors, including but not limited to (i)&#160;market conditions resulting in material changes in securities prices; (ii)&#160;compliance with any applicable bankruptcy, insolvency or securities laws; and (iii)&#160;other factors resulting in the inability to obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled companies in which the Fund intends to invest, there is a potential risk of loss by the Fund of its entire investment in such companies. Distressed instruments may be highly illiquid and the prices at which they may be sold may represent a substantial discount to what the Adviser believes to be their ultimate value.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154346097" continuedAt="F20240813142619378">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">17&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142619378" continuedAt="F20240813154349489">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Equity Securities.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">From time to time, the Fund may invest in or hold common shares and other equity securities incident to the purchase or ownership of a Senior Loan, Corporate Bond or other instrument or in connection with a reorganization of a borrower. Investments in equity securities incidental to investment in Senior Loans entail certain risks in addition to those associated with investments in Senior Loans. Common shares represent an equity ownership interest in a company. Historical trends would indicate that common shares are subject to higher levels of volatility and market and issuer-specific risk than debt securities. The value of equity securities may be affected more rapidly, and to a greater extent, by company-specific developments and general market conditions. These risks may increase fluctuations in the net asset value of the common shares. In addition, the Fund frequently may possess material non-public information about a borrower. Because of prohibitions on trading in securities while in possession of material non-public information, the Fund might be unable to enter into a transaction in a security of the borrower when it would otherwise be advantageous to do so. The equity interests held by the Fund, if any, may not pay dividends or otherwise generate income or appreciate in value and, in fact, may decline in value. Accordingly, the Fund may not be able to realize gains from its equity investments, and any gains that the Fund does realize may not be sufficient to contribute materially to the Fund&#8217;s investment objective of seeking current income. Equity securities held by the Fund may be illiquid.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Short Sales.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may, from time to time, engage in short sales. A short sale is a transaction in which the Fund sells an instrument that it does not own in anticipation that the market price will decline. To deliver the securities to the buyer, the Fund arranges through a broker to borrow the securities and, in so doing, the Fund becomes obligated to replace the securities borrowed at their market price at the time of replacement. When selling short, the Fund intends to replace the securities at a lower price and therefore profit from the difference between the cost to replace the securities and the proceeds received from the sale of the securities. When the Fund makes a short sale, the proceeds it receives from the sale will be held on behalf of a broker until the Fund replaces the borrowed securities. The Fund may have to pay a premium to borrow the securities and must pay any dividends or interest payable on the securities until they are replaced. The Fund&#8217;s obligation to replace the securities borrowed in connection with a short sale will be secured by collateral deposited with the broker that consists of cash and/or liquid securities. Short sales involve certain risks and special considerations. If the Fund incorrectly predicts that the price of the borrowed security will decline, the Fund will have to replace the securities with securities with a greater value than the amount received from the sale. As a result, losses from short sales differ from losses that could be incurred from a purchase of a security because losses from short sales may be theoretically unlimited, whereas losses from purchases can equal only the total amount invested.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Warrants.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Warrants give holders the right, but not the obligation, to buy common shares of an issuer at a given price, usually higher than the market price at the time of issuance, during a specified period. The risk of investing in a warrant is that the warrant may expire prior to the market value of the common shares exceeding the price fixed by the warrant. Warrants have a subordinate claim on a borrower&#8217;s assets compared with Senior Loans. As a result, the values of warrants generally are dependent on the financial condition of the borrower and less dependent on fluctuations in interest rates than are the values of many debt securities. The values of warrants may be more volatile than those of Senior Loans or Corporate Bonds and this may increase the volatility of the net asset value of the common shares.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154349489" continuedAt="F20240813142627324">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">18&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142627324" continuedAt="F20240813154353048">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Non-U.S. Securities.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest a portion of its capital in non-U.S. securities. Some non-U.S. securities may be less liquid and more volatile than securities of comparable U.S. issuers. Similarly, there is less volume and liquidity in most foreign financial markets than in the U.S. and, at times, greater price volatility than in the U.S.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because evidences of ownership of such securities usually are held outside the U.S., the Fund will be subject to additional risks, including possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions that might adversely affect or restrict the payment of principal and interest on the foreign securities to investors located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may trade on days when the common shares are not traded on the NYSE, the market value or net asset value of the common shares can change at times when the common shares cannot be sold.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Foreign Currency Transactions.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may engage in foreign currency exchange transactions in connection with its investments in foreign securities. The Fund is not required to hedge its currency exposure, if any, and may choose not to do so. The Fund generally will conduct its foreign currency exchange transactions either on a spot (i.e.,&#160;cash) basis at the spot rate prevailing in the foreign currency exchange market or through forward contracts to purchase or sell foreign currencies, including the payment of dividends and the settlement of securities transactions that otherwise might require untimely dispositions of Fund securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A forward foreign currency exchange contract involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days (usually less than one year) from the date of the contract agreed upon by the parties, at a price and for an amount set at the time of the contract. These contracts are traded in the interbank market conducted directly between currency traders (usually large commercial banks) and their customers. A forward contract generally has a deposit requirement, and no commissions are charged at any stage for trades. Although foreign exchange dealers do not charge a fee for conversion, they do realize a profit based on the difference (the spread) between the price at which they are buying and selling various currencies. At the consummation of a forward contract, the Fund may either make delivery of the foreign currency or terminate its contractual obligation to deliver the foreign currency by purchasing an offsetting contract obligating it to purchase, at the same maturity date, the same amount of such foreign currency. If the Fund chooses to make delivery of the foreign currency, it may be required to obtain such currency through the sale of portfolio securities denominated in such currency or through conversion of other assets of the Fund into such currency. If the Fund engages in an offsetting transaction, the Fund will incur a gain or loss to the extent that there is a difference between the forward contract price and the offsetting forward contract price.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">It should be noted that this method of protecting the value of the Fund&#8217;s portfolio securities against a decline in the value of a currency does not eliminate fluctuations in the underlying prices of the securities. Rather, it simply establishes a rate of exchange that can be achieved at some future point in time. Additionally, although such contracts tend to minimize the risk of loss due to a decline in the value of the hedged currency, at the same time they tend to limit any potential gain should the value of the currency increase.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Derivatives.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may use derivatives. Derivatives are financial instruments the value of which is derived from another security, a commodity (such as gold or oil), a currency or an index (a measure of value or rates, such as the S&amp;P&#160;500 Index or the prime lending rate). Derivatives may allow the Fund to increase or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments. Pursuant to Rule&#160;18f-4 under the Investment Company Act, among other things, the Fund must either limit its derivatives exposure to no more than 10% of its net assets (the &#8220;Limited Derivatives User Exception&#8221;) or comply with an outer limit based on value-at-risk as specified in the rule. The Fund is currently relying on the Limited Derivatives User Exception. The Fund may or may not use derivatives for hedging purposes, as a form of leverage or to seek to enhance returns, including speculation on changes in credit spreads, interest rates or other characteristics of the market, individual securities or groups of securities. If the Fund invests in a derivative for speculative purposes, which it initially does not intend to do, the Fund will be fully exposed to the risks of loss of that derivative, which may sometimes be greater than the derivative&#8217;s cost. The use of derivatives may involve substantial leverage.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154353048" continuedAt="F20240813142634160">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">19&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20240813142634160" continuedAt="F20240813154356698">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swap Agreements.</i></span> The Fund may enter into swap agreements, including interest rate and index swap agreements, for hedging purposes, as a form of leverage or to seek to obtain a particular desired return at a lower cost to the Fund than if the Fund had invested directly in an instrument that yielded the desired return. Swap agreements are two-party contracts entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221; transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect to a &#8220;notional amount&#8221; (i.e., the dollar amount invested at a particular interest rate, in a particular foreign currency, or in a &#8220;basket&#8221; of securities representing a particular index). The &#8220;notional amount&#8221; of the swap agreement is only a basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange. The Fund&#8217;s obligations (or rights) under a swap agreement generally will be equal only to the &#8220;net amount&#8221; to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into credit default swap agreements and similar agreements, and may also buy credit-linked securities. Among other purposes, credit default swaps provide investment exposure to changes in credit spreads and relative interest rates. The credit default swap agreement or similar instrument may have as reference obligations one or more securities that are not currently held by the Fund (including a &#8220;basket&#8221; of securities representing an index). The protection &#8220;buyer&#8221; in a credit default contract may be obligated to pay the protection &#8220;seller&#8221; an upfront payment or a periodic stream of payments over the term of the contract provided generally that no credit event on a reference obligation has occurred. If a credit event occurs, the seller generally must pay the buyer the &#8220;par value&#8221; (full notional value) of the swap in exchange for an equal face amount of deliverable obligations of the reference entity described in the swap, if the swap is physically settled.&#160; If the swap is cash settled, an auction process is used to determine the &#8220;recovery value&#8221; of the contract, and the seller may be required to deliver the related net cash amount.&#160; The Fund may be either the buyer or seller in the transaction.&#160; If the Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is held through its termination date.&#160; However, if a credit event occurs and the credit default contract is required to physically settle, the Fund may elect to receive the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund may elect to receive a cash amount equal to the &#8220;par value&#8221; (full notional value) of the swap contract minus the &#8220;recovery value&#8221; as determined by the auction process.&#160; As a seller, the Fund generally receives an upfront payment or a fixed rate of income throughout the term of the swap, which typically is between six months and three years, provided that there is no credit event. If a credit event occurs and the credit default contract is required to physically settle, generally the seller must pay the buyer the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund will be generally obligated to pay the buyer the &#8220;par value&#8221; (full notional value) of the swap contract minus the &#8220;recovery value&#8221; as determined by the auction process.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into total return swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising a given market index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total return refers to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is then exchanged for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility of gaining exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the Fund with the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities or other instruments underlying the swap. Similar to interest rate swaps, the cash backing total return swaps is actively managed to seek to earn a return in excess of the floating rate paid on the swap.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swaptions.</i></span>&#160; The Fund, to the extent permitted under applicable law, may enter into &#8220;swaptions,&#8221; which are options on swap agreements on either an asset-based or liability-based basis. A swaption is a contract that gives a counterparty the right (but not the obligation) to enter into a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future time on specified terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option agreement, the Fund generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption. When the Fund purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire unexercised. When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the underlying agreement.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20240813154356698" continuedAt="F20240813143011150">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">20&#160;</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    </div>
  </div>


  <div style="font:10pt Times New Roman, Times, Serif">
    <ix:continuation id="F20240813143011150">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Credit-Linked Securities.</i></span>&#160; Among the income-producing securities in which the Fund may invest are credit-linked securities, which are issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative instrument or basket of derivative instruments, such as credit default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets. For instance, the Fund may invest in credit-linked securities as a cash management tool in order to gain exposure to a certain market and/or to remain fully invested when more traditional income-producing securities are not available.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Indexed and Inverse Floating Rate Securities.</i></span>&#160;The Fund may invest in securities that provide a potential return based on a particular index of value or interest rates. To the extent the Fund invests in these types of securities, the Fund&#8217;s return on such securities will be subject to risk with respect to the value of the particular index: that is, if the value of the index falls, the value of the indexed securities owned by the Fund will fall. Interest and principal payable on certain securities may also be based on relative changes among particular indices. The Fund may invest in so-called &#8220;inverse floating obligations&#8221; or &#8220;residual interest bonds&#8221; on which the interest rates vary inversely with a floating rate (which may be reset periodically by a Dutch auction, a remarketing agent, or by reference to a short-term tax-exempt interest rate index). The Fund may purchase synthetically-created inverse floating rate bonds evidenced by custodial or trust receipts. Generally, income on inverse floating rate bonds will decrease when interest rates increase, and will increase when interest rates decrease.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Repurchase Agreements and Reverse Repurchase Agreements.</i></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subject to its investment objective and policies, the Fund may invest in repurchase agreements. Repurchase agreements are transactions in which the Fund purchases securities or other obligations from a bank or securities dealer (or its affiliate) and simultaneously commits to resell them to the counterparty at an agreed upon date or upon demand and at a price reflecting a market rate of interest unrelated to the coupon rate or maturity of the purchased obligations. The Fund maintains custody of the underlying obligations prior to their repurchase, either through its regular custodian or through a special &#8220;triparty&#8221; custodian or sub-custodian that maintains separate accounts for both the Fund and its counterparty. The obligation of the counterparty to pay the repurchase price on the date agreed to or upon demand is, in effect, secured by such obligations.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Reverse repurchase agreements involve the sale of securities held by the Fund subject to the Fund&#8217;s agreement to repurchase the securities at an agreed upon date or upon demand and at a price reflecting a market rate of interest. Reverse repurchase agreements are a form of effective leverage and may be subject to the Fund&#8217;s limitation on borrowings and may be entered into only with banks or securities dealers or their affiliates.</p>
      </div>
    </ix:continuation>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_009_integixAnchor"></span><strong>LEVERAGE</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is authorized to utilize leverage to the maximum extent permitted by law for investment and other general corporate purposes. The Fund currently utilizes leverage through the issuance of preferred shares and bank borrowings and may obtain additional leverage in the future by issuing preferred shares and/or notes and borrowing funds from banks and other financial institutions. The Fund may also gain leverage synthetically through swaps and other derivatives. The use of leverage to purchase additional securities creates an opportunity for increased common share dividends, but also creates risks for the common shareholders, including increased variability of the Fund&#8217;s net income, distributions, net asset value and/or market price of its common shares in relation to market changes. Leverage is a speculative technique that exposes the Fund to greater risk and increased costs than if it were not implemented. Increases and decreases in the value of the Fund&#8217;s portfolio will be magnified through the use of leverage. In particular, leverage may magnify interest rate risk, which is the risk that the prices of portfolio securities will fall (or rise) if market interest rates for those types of securities rise (or fall). As a result, leverage may cause greater changes in the net asset value of the common shares, which will be borne entirely by the common shareholders, and in the price at which its common shares trade in the secondary market. For example, with respect to the Fund&#8217;s investments in Senior Loans or other debt instruments that provide an interest rate floor that helps protect the Fund&#8217;s income in falling or flat-rate environments, if interest rates increase, the Fund may not realize the same extent of additional income compared to any increase in the Fund&#8217;s cost of financing, which could result in the potential for a decrease in the level of income available for dividends or distributions made by the Fund. The Fund pays dividends on its preferred shares and interest on borrowings, which increases expenses and may reduce the Fund&#8217;s return. These dividend payments and interest expenses (which are borne entirely by common shareholders) may be greater than the Fund&#8217;s return on the underlying investments. The Fund&#8217;s leveraging strategy may not be successful.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">21&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s obligations under its preferred shares are senior to the common shares, such that holders of preferred shares and Fund indebtedness have priority over the common shareholders in the distribution of the Fund&#8217;s assets, including dividends, distributions of principal and liquidating distributions. Preferred shares vote together with the common shareholders on all matters, including the election of directors. Additionally, the holders of preferred shares have the right separately to elect two directors of the Fund, and vote separately as a class on certain matters which may at times give holders of preferred shares disproportionate influence over the Fund&#8217;s affairs. Limited term preferred shares may require the Fund to liquidate its investments and reduce the Fund&#8217;s use of leverage, which could negatively impact common shareholders. In addition, the Fund&#8217;s ability to make distributions to its common shareholders or to repurchase its share is limited by the asset coverage requirements and other limitations imposed by the Investment Company Act, Maryland law and the Fund&#8217;s lenders.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will pay (and common shareholders will bear) all costs and expenses relating to the issuance and ongoing maintenance of preferred shares and other forms of indebtedness issued by the Fund, including higher advisory fees. As a result, the Fund cannot assure you that the issuance of preferred shares and/or notes or other forms of indebtedness will provide a higher yield or return to the holders of the common shares. The costs of any new offers and/or issuances of preferred shares and/or notes or other forms of indebtedness will be borne immediately by the common shareholders and result in a reduction of the net asset value of the common shares.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">So long as the Fund&#8217;s portfolio provides a higher rate of return, net of expenses, than the interest or dividend rate on borrowed money, the leverage may cause common shareholders to receive a higher current rate of return than if the Fund were not leveraged. If, however, long-term and/or short-term rates rise, the interest rate on borrowed money could exceed the rate of return on securities held by the Fund, reducing returns to common shareholders. Developments in the credit markets may adversely affect the ability of the Fund to borrow for investment purposes and may increase the costs of such borrowings, which would reduce returns to common shareholders.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">22&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">There is no assurance that a leveraging strategy will be successful. Leverage involves risks and special considerations for common shareholders, including:</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

        <tr style="vertical-align:top">
          <td style="width:0.25in">&#160;</td>
          <td style="width:0.75in"><span>&#9679;</span></td>
          <td style="text-align:justify">the likelihood of greater volatility of net asset value, market price and dividend rate of common shares than a comparable portfolio without leverage;</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

        <tr style="vertical-align:top">
          <td style="width:0.25in">&#160;</td>
          <td style="width:0.75in"><span>&#9679;</span></td>
          <td style="text-align:justify">the risk that fluctuations in interest rates on borrowings or in dividend payments on, principal proceeds distributed to, or redemption of any preferred shares and/or notes or other forms of indebtedness that the Fund has issued will reduce the return to the common shareholders;</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

        <tr style="vertical-align:top">
          <td style="width:0.25in">&#160;</td>
          <td style="width:0.75in"><span>&#9679;</span></td>
          <td style="text-align:justify">the effect of leverage in a declining market, which is likely to cause a greater decline in the net asset value of the common shares than if the Fund were not leveraged, which may result in a greater decline in the market price of the common shares;</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

        <tr style="vertical-align:top">
          <td style="width:0.25in">&#160;</td>
          <td style="width:0.75in"><span>&#9679;</span></td>
          <td style="text-align:justify">when the Fund uses financial leverage, the investment advisory fees payable to the Adviser will be higher than if the Fund did not use leverage, and may provide a financial incentive to the Adviser to increase the Fund&#8217;s use of leverage and create an inherent conflict of interest; and</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

        <tr style="vertical-align:top">
          <td style="width:0.25in">&#160;</td>
          <td style="width:0.75in"><span>&#9679;</span></td>
          <td style="text-align:justify">leverage may increase expenses (which will be borne entirely by common shareholders), which may reduce total return.</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The preferred shares and indebtedness incurred by the Fund impose covenants and other restrictions imposed by its lenders are in addition to, and in certain cases more stringent than, those imposed by the Investment Company Act. Certain types of borrowings by the Fund may result in the Fund being subject to covenants relating to asset coverage and portfolio composition requirements. These covenants and restrictions may negatively affect the Fund&#8217;s ability to achieve its investment objective.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <ix:nonNumeric id="Fxbrl_20240813130256755" name="cef:EffectsOfLeverageTextBlock" contextRef="C_20240814to20240814" escape="true">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Effects of Leverage</strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As of December&#160;31, 2023, we had outstanding borrowings of approximately $163 million. In order for us to cover our annual interest payments on our outstanding indebtedness at December&#160;31, 2023, we must achieve annual returns on our December&#160;31, 2023 total assets of at least 1.29%. The weighted average stated interest rate charged on our principal amount of outstanding indebtedness as of December&#160;31, 2023 was 4.1%.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240813130347793" name="cef:EffectsOfLeveragePurposeTextBlock" contextRef="C_20240814to20240814" escape="true">
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table illustrates the effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate of <ix:nonFraction id="Fxbrl_20240813130828136" name="cef:AnnualInterestRatePercent" contextRef="C_20231231to20231231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.1</ix:nonFraction>% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately $163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses vary frequently and may be significantly higher or lower than the rate estimated above.</p>
        </ix:nonNumeric>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240813130326546" name="cef:EffectsOfLeverageTableTextBlock" contextRef="C_20240814to20240814" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify">Assumed Return on Portfolio (net of expenses)(1)</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">(10.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">(5.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">0</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">5.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">10.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:justify">Corresponding Return to Common Shareholder(2)</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813130938642" name="cef:ReturnAtMinusTenPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">17.83</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813130950435" name="cef:ReturnAtMinusFivePercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">9.93</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(<ix:nonFraction id="Fxbrl_20240813130956563" name="cef:ReturnAtZeroPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.04</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813131017531" name="cef:ReturnAtPlusFivePercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.86</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240813131023322" name="cef:ReturnAtPlusTenPercent" contextRef="C_20240814to20240814" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">13.76</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
                  <td style="text-align:justify">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December&#160;31, 2023.</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
                  <td style="text-align:justify">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the "Corresponding Return to Common Shareholder."</td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">23&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Preferred Shares</strong></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has authorized and issued 800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B MRP Shares for gross proceeds of $30 million and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. Each of the MRP Shares has a liquidation preference of $25.00 per share. The aggregate redemption amount of the MRP Shares is $100 million.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the MRP Shares is 2.81% per annum. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject to redemption, at the option of the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. Additionally, in accordance with the Investment Company Act, the Fund may not issue additional preferred shares if immediately after such issuance the Fund will not have an asset coverage ratio of at least 200%. As of December&#160;31, 2023, the Fund was in compliance in all material respects with the terms of the MRP Shares.</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <ix:nonNumeric id="Fxbrl_20240813150245156" name="cef:LongTermDebtTableTextBlock" contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember" escape="true">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><ix:nonNumeric id="Fxbrl_20240813150307556" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Credit Facility</span></ix:nonNumeric></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under the Investment Company Act, the Fund is permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately thereafter the Fund has asset coverage of at least 300%. In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a party to a senior secured revolving Credit Facility that allows the Fund to borrow up to $<ix:nonFraction id="Fxbrl_20240813150334973" name="cef:LongTermDebtPrincipal" contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">212</ix:nonFraction> million at any one time outstanding. <ix:nonNumeric id="Fxbrl_20240813150517564" name="cef:LongTermDebtStructuringTextBlock" contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a) limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b) limitations on certain investments, (c) limitations on certain restricted payments, and (d) maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.</span></ix:nonNumeric></p>
      </div>
    </ix:nonNumeric>
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20240813131638043" name="cef:RiskFactorsTableTextBlock" contextRef="C_20240814to20240814" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_010_integixAnchor"><strong>RISKS</strong></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the general risks of investing in the Fund.</span></p>
        </div>
      </ix:nonNumeric>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">24&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  </div>
<div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_011_integixAnchor"></span><strong>HOW THE FUND MANAGES RISK</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Limitations</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has adopted certain investment limitations designed to limit investment risk. Some of these limitations are fundamental and thus may not be changed without a vote of the holders of common shares and any preferred shares outstanding. See &#8220;Investment Objective and Policies&#8212;Investment Restrictions&#8221; in the SAI.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The restrictions and other limitations set forth throughout this Prospectus and in the SAI apply only at the time of purchase of securities and will not be considered violated unless an excess or deficiency occurs or exists immediately after and as a result of the acquisition of securities.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Management of Investment Portfolio and Capital Structure to Limit Leverage Risk</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may take certain actions if short-term interest rates increase or market conditions otherwise change (or the Fund anticipates such an increase or change) and any leverage the Fund may have outstanding begins (or is expected) to adversely affect common shareholders. In order to attempt to offset such a negative impact of any outstanding leverage on common shareholders, the Fund may shorten the average maturity of its investment portfolio (by investing in short-term securities) or may reduce any indebtedness that it may have incurred. Because of the difficulty of making such predictions, the Fund may elect not to attempt to manage its capital structure in the manner described in this paragraph.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If market conditions suggest that employing leverage, or employing additional leverage if the Fund already has outstanding leverage, would be beneficial, the Fund may enter into one or more credit facilities, increase any existing credit facilities, sell preferred shares or engage in additional leverage transactions (including through investment in derivatives), subject to the restrictions of the Investment Company Act.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Strategic Transactions</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may use certain strategic transactions designed to limit the risk of price fluctuations of securities and to preserve capital (&#8220;Strategic Transactions&#8221;). These Strategic Transactions include using swaps, financial futures contracts, options on financial futures or options based on either an index of long-term securities, or on securities whose prices, in the opinion of the Adviser, correlate with the prices of the Fund&#8217;s investments. There can be no assurance that Strategic Transactions will be used or used effectively to limit risk, and Strategic Transactions may be subject to their own risks.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_012_integixAnchor"></span><strong>MANAGEMENT OF THE FUND</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Directors and Officers</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The business and affairs of the Fund are overseen by the </span>Board. The Board <span style="font-family:Times New Roman, Times, Serif">performs the various duties imposed on the directors of investment companies by the Investment Company Act and Maryland law, </span>including supervision of the duties performed by the Adviser. There are five Directors. A majority of the Directors are not &#8220;interested persons&#8221; (as defined in the Investment Company Act) of the Fund (the &#8220;Independent Directors&#8221;). The name and business address of the Directors and officers of the Fund and their principal occupations and other affiliations during the past five years are set forth under &#8220;Management of the Fund&#8221; in the SAI.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Adviser</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is externally managed by the Adviser, a subsidiary of Ares, pursuant to an investment advisory and management agreement. The Adviser was registered as an investment adviser with the SEC under the Investment Advisers Act of 1940 (the "Advisers Act") on June&#160;9, 2011. The Adviser oversees the management of the Fund's activities and is responsible for making investment decisions for the Fund's portfolio. Ares Operations LLC, a subsidiary of Ares, provides certain administrative and other services necessary for the Fund to operate. The Adviser is located at 2000 Avenue of the Stars, 12th Floor, Los Angeles, CA 90067.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">25&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Portfolio Managers</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The members of the portfolio management team who are primarily responsible for the day-to-day management of the Fund&#8217;s portfolio are as follows:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Seth J. Brufsky </i></span>is a Partner, Portfolio Manager and Chairman of Global Liquid Credit in the Ares Credit Group. Seth J. Brufsky also serves as the Chief Executive Officer, President and is a Director of the Fund. Additionally, Seth J. Brufsky serves as a member of the Ares Credit Group&#8217;s Liquid Credit Investment Committee. Prior to joining Ares in 1998, Seth J. Brufsky was a member of the Corporate Strategy and Research Group of Merrill Lynch&#160;&amp; Co., where Seth J. Brufsky focused on analyzing and marketing non-investment grade securities. Previously, Seth J. Brufsky was a member of the Institutional Sales and Trading Group of the Global Fixed Income Division at Union Bank of Switzerland. Seth J. Brufsky serves on the Board of Trustees of Choate Rosemary Hall, a private, co-educational, college-preparatory boarding school, and serves on the Dean&#8217;s Advisory Boards for the College of Arts and Sciences and the College of Agriculture and Life Sciences of Cornell University. Seth J. Brufsky also serves on the Board of the Luminescence Foundation, a charitable giving organization.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Seth J. Brufsky holds a B.S. from Cornell University in Applied Economics and Business Management and a M.B.A., with honors, from the University of Southern California's Marshall School of Business in Finance, where Seth J. Brufsky was awarded the Glassick Scholarship for academic achievement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Keith Ashton </i></span>is a Partner, Portfolio Manager and Co-Head of Alternative Credit in the Ares Credit Group. Keith Ashton serves as a Vice President and Portfolio Manager for the Fund. Additionally, Keith Ashton serves as a member of the Ares Credit Group&#8217;s Alternative Credit, Pathfinder and Pathfinder Core Fund Investment Committees and the Ares Diversity, Equity and Inclusion Council. Prior to joining Ares in 2011, Keith Ashton was a Partner at Indicus Advisors LLP, where Keith Ashton focused on launching the global structured credit business in May&#160;2007. Previously, Keith Ashton was a Portfolio Manager and Head of Structured Credit at TIAA-CREF, where Keith Ashton focused on managing a portfolio of structured credit investments and helped launch TIAA&#8217;s institutional asset management business. Keith Ashton&#8217;s experience as an investor in alternative fixed income products spans virtually all securitized asset classes, including CLOs, consumer and commercial receivables, insurance and legal settlements, small business and trade receivables, whole business securitizations, timeshare and other mortgage-related receivables, and esoteric asset classes such as catastrophe risk and intellectual property.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Keith Ashton holds a B.A. from Brigham Young University in Economics and a M.B.A. from the University of Rochester William E. Simon School of Business in Finance&#160;&amp; Accounting.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Charles Arduini&#160;</i></span>is a Partner and Portfolio Manager in the Ares Credit Group, where Charles Arduini focuses on alternative credit investments. Charles Arduini serves as a Vice President and Portfolio Manager for the Fund. Additionally, Charles Arduini serves as a member of the Ares Credit Group&#8217;s Pathfinder Core Fund Investment Committee. Prior to joining Ares in 2011, Charles Arduini was a Managing Director at Indicus Advisors LLP, where Charles Arduini focused on structured credit investment opportunities. Previously, Charles Arduini was Director of Structured Credit in the Fixed Income Investment Group and a Manager in the Risk Management Group at TIAA-CREF. In addition, Charles Arduini worked in the telecommunications and information technology industries in various systems, operations and management roles.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Charles Arduini holds a B.A. from Bucknell University in Mathematics and an M.S. from Stevens Institute of Technology in Mathematics. Charles Arduini also holds an M.S. from Carnegie Mellon University in Computational Finance. Charles Arduini is a CFA&#174; charterholder and a member of the New York Society of Security Analysts.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Samantha Milner </i></span><span>is a Partner and U.S. Liquid Credit Portfolio Manager in the Ares Credit Group, where Samantha Milner is primarily responsible for managing Ares&#8217; U.S. bank loan credit strategies. Samantha Milner serves as a Vice President and Portfolio Manager for the Fund. Additionally, Samantha Milner serves as a member of the Ares Credit Group&#8217;s U.S. Liquid Credit Investment Committee. Samantha Milner also serves on the Ares Diversity, Equity and Inclusion Council. Prior to joining Ares in 2004, Samantha Milner was an Associate in the Financial Restructuring Group at Houlihan Lokey Howard&#160;&amp; Zukin, where Samantha Milner focused on providing advisory services in connection with restructurings, distressed mergers and acquisitions and private placements. Samantha Milner serves on the Board of Directors of STEAM:CODERS, a not-for-profit organization focused on underrepresented and underserved students through Science, Technology, Engineering, Art, and Math (STEAM), in preparation for academic and career opportunities. Samantha Milner holds a B.B.A., with distinction, from Emory University&#8217;s Goizueta Business School in Finance and Accounting.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">26&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The SAI provides additional information about other accounts managed by the portfolio management team, the compensation of each portfolio manager and the ownership of the Fund&#8217;s securities by each portfolio manager.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Advisory Agreement</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Pursuant to an investment advisory and management agreement between the Adviser and the Fund (the &#8220;Investment Advisory Agreement&#8221;), the Fund has agreed to pay the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A discussion regarding the basis for the approval of the Investment Advisory Agreement by the Board is available in the Fund&#8217;s Annual Report to shareholders for the year ended December&#160;31, 2023.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Administration, Accounting Services, Custodian, Transfer Agent and Other Services</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund has engaged State Street, whose principal business address is One Congress Street, Boston, Massachusetts 02114, to serve as the Fund's administrator, custodian and transfer agent. Under the service agreements between State Street and the Fund, State Street provides certain administrative services necessary for the operation of the Fund. Such services include maintaining certain Fund books and records, providing accounting and tax services and preparing certain regulatory filings. State Street also performs custodial, fund accounting and portfolio accounting services, as well as transfer agency and dividend paying services with respect to the common shares. The Fund pays State Street for these services. </span>The total expenses incurred by the Fund under the service agreements with State Street for the year ended December&#160;31, 2023 were $341,957.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has retained Destra, whose principal business address is 443 N. Willson Avenue, Bozeman, Montana 59715, to provide investor support services in connection with the ongoing operations of the Fund. Such services include providing ongoing contact with respect to the Fund and its performance with financial advisors that are representatives of broker-dealers and other financial intermediaries, communicating with the NYSE specialist for the Fund's common shares and with the closed-end fund analyst community regarding the Fund on a regular basis, and maintaining a website for the Fund. The Fund pays Destra for these services. The total expenses incurred by the Fund under the agreement with Destra for the year ended December&#160;31, 2023 were $289,508.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Independent Registered Public Accounting Firm</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ernst&#160;&amp; Young LLP, whose principal business address is 725 South Figueroa Street, Los Angeles, CA 90017, is the independent registered public accounting firm of the Fund and is expected to render an opinion annually on the financial statements of the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_013_integixAnchor"></span><strong>NET ASSET VALUE</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Effective October&#160;1, 2022, pursuant to Rule&#160;2a-5 under the Investment Company Act, the Fund's Board designated the Fund's Adviser as the Fund's &#8220;valuation designee&#8221; to perform the fair value determinations held by the Fund without readily available market quotations, subject to the oversight of the Board.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund follows ASC 825-10,&#160;<i>Recognition and Measurement of Financial Assets and Financial Liabilities</i>&#160;(&#8220;ASC 825-10&#8221;), which provides companies the option to report selected financial assets and liabilities at fair value. ASC 825-10 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities and a better understanding of the effect of the company's choice to use fair value on its earnings. ASC 825-10 also requires entities to display the fair value of the selected assets and liabilities on the face of the balance sheet. The Fund has not elected the ASC 825-10 option to report selected financial assets and liabilities at fair value. With the exception of the line items entitled &#8220;other assets,&#8221; &#8220;mandatory redeemable preferred shares,&#8221; and &#8220;debt,&#8221; which are reported at amortized cost, the carrying value of all other assets and liabilities approximate fair value.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">27&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund also follows ASC 820-10, <i>Fair Value Measurements and Disclosures</i> (&#8220;ASC 820-10&#8221;), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) and expands disclosure of fair value measurements. ASC 820-10 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. ASC 820-10 requires the Fund to assume that the portfolio investment is sold in its principal market to market participants or, in the absence of a principal market, the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820-10, the Fund has considered its principal market as the market in which the Fund exits its portfolio investments with the greatest volume and level of activity. ASC 820-10 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. In accordance with ASC 820-10, these inputs are summarized in the three broad levels listed below:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Level 1 &#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Level 2 &#8212; Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable either directly or indirectly.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Level 3 &#8212; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition to using the above inputs in investment valuations, the Valuation Designee continues to employ the net asset valuation policy and procedures that have been reviewed by the Fund&#8217;s Board in connection with their designation of the Adviser as the Fund&#8217;s valuation designee and are consistent with the provisions of Rule&#160;2a-5 under the Investment Company Act and ASC 820-10. Consistent with its valuation policies and procedures, the Valuation Designee evaluates the source of inputs, including any markets in which the Fund's investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. For investments where there is not a readily available market value, the fair value of these investments must typically be determined using unobservable inputs.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The investments classified as Level 1 or Level 2 are typically valued based on quoted market prices, forward foreign exchange rates, dealer quotations or alternative pricing sources supported by observable inputs. The Valuation Designee obtains prices from independent pricing services which generally utilize broker quotes and may use various other pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type of issue, trading characteristics and other data. The Valuation Designee is responsible for all inputs and assumptions related to the pricing of securities. The Valuation Designee has internal controls in place that support its reliance on information received from third-party pricing sources. As part of its internal controls, the Valuation Designee obtains, reviews, and tests information to corroborate prices received from third-party pricing sources. For any security, if market or dealer quotations are not readily available, or if the Valuation Designee determines that a quotation of a security does not represent a fair value, then the security is valued at a fair value as determined in good faith by the Valuation Designee subject to the oversight of the Board and will be classified as Level 3. In such instances, the Valuation Designee will use valuation techniques consistent with the market or income approach to measure fair value and will give consideration to all factors which might reasonably affect the fair value.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Senior loans and corporate debt</i></span>:&#160;The fair value of Senior Loans and Corporate Bonds is estimated based on quoted market prices, forward foreign exchange rates, dealer quotations or alternative pricing sources supported by observable inputs and are generally classified within Level 2 or 3. The Valuation Designee obtains prices from independent pricing services which generally utilize broker quotes and may use various other pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type of issue, trading characteristics and other data. If the pricing services are only able to obtain a single broker quote or utilize a pricing model the securities will be classified as Level 3. If the pricing services are unable to provide prices, the Valuation Designee will attempt to obtain one or more broker quotes directly from a dealer and price such securities at the last bid price obtained; such securities are classified as Level 3.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">28&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Collateralized loan obligations</i></span>:&#160;The fair value of CLOs is estimated based on various valuation models from third-party pricing services. The provided prices are checked using internally developed models. The valuation models generally utilize discounted cash flows and take into consideration prepayment and loss assumptions, based on historical experience and projected performance, economic factors, the characteristics and condition of the underlying collateral, comparable yields for similar securities and recent trading activity. These securities are classified as Level 3.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Common shares and warrants</i></span>:&#160;The fair value of common shares and warrants are estimated using either broker quotes or an analysis of the enterprise value (&#8220;EV&#8221;) of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The primary method for determining EV uses a multiple analysis whereby appropriate multiples are applied to the portfolio company's EBITDA (generally defined as net income before net interest expense, income tax expense, depreciation and amortization). EBITDA multiples are typically determined based upon review of market comparable transactions and publicly traded comparable companies, if any. The Valuation Designee may also employ other valuation multiples to determine EV, such as revenues. The second method for determining EV uses a discounted cash flow analysis whereby future expected cash flows of the portfolio company are discounted to determine a present value using estimated discount rates (typically a weighted average cost of capital based on costs of debt and equity consistent with current market conditions). The EV analysis is performed to determine the value of equity investments, the value of debt investments in portfolio companies where the Fund has control or could gain control through an option or warrant security, and to determine if there is credit impairment for debt investments. If debt investments are credit impaired, an EV analysis may be used to value such debt investments; however, in addition to the methods outlined above, other methods such as a liquidation or wind down analysis may be utilized to estimate EV.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_014_integixAnchor"></span><strong>DISTRIBUTIONS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund expects to distribute monthly all or a portion of its net investment income to common shareholders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund intends to pay common shareholders at least annually all or substantially all of its net investment income after the payment of dividends and interest, if any, owed with respect to any outstanding preferred shares and/or notes or other forms of leverage utilized by the Fund. The Fund intends to pay any capital gains distributions at least annually. If the Fund makes a long-term capital gain distribution, it will be required to allocate such gain between the common shares and any preferred shares issued by the Fund in proportion to the total dividends paid to each class for the year in which the income is realized.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The U.S. federal income tax treatment and characterization of the Fund&#8217;s distributions may vary significantly from time to time because of the varied nature of the Fund&#8217;s investments. In light of the Fund&#8217;s investment policies, the Fund anticipates that the Investment Company Act will require it to accompany each monthly distribution with a statement setting forth the estimated source (as between net income, capital gains and return of capital) of the distribution made. The Fund will indicate the proportion of its capital gains distributions that constitute long-term and short-term gains annually. The ultimate U.S. federal income tax characterization of the Fund&#8217;s distributions made in a calendar or fiscal year cannot finally be determined until after the end of that taxable year. As a result, there is a possibility that the Fund may make total distributions during a calendar or taxable year in an amount that exceeds the Fund&#8217;s net investment company taxable income and net capital gains for the relevant taxable year. In such situations, if a distribution exceeds the Fund&#8217;s current and accumulated earnings and profits (as determined for U.S. federal income tax purposes), a portion of each distribution paid with respect to such taxable year would generally be treated as a tax-free return of capital reducing the amount of a shareholder&#8217;s tax basis in such shareholder&#8217;s shares. When a shareholder sells shares in the Fund, the amount, if any, by which the sales price exceeds the shareholder&#8217;s basis in the Fund&#8217;s shares is gain subject to tax. Because a return of capital reduces a shareholder&#8217;s basis in the shares, it will increase the amount of such shareholder&#8217;s gain or decrease the amount of such shareholder&#8217;s loss when such shareholder sells the shares, all other things being equal. To the extent that the amount of any return of capital distribution exceeds the shareholder&#8217;s basis in such shareholder&#8217;s shares, the excess will be treated as gain from a sale or exchange of the shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">29&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Various factors will affect the level of the Fund&#8217;s income, including the asset mix, the average maturity of the Fund&#8217;s portfolio and default rates, the amount of leverage utilized by the Fund, if any, and any use of hedging activities by the Fund. To permit the Fund to maintain a more stable monthly distribution, the Fund may from time to time distribute less than the entire amount of income earned in a particular monthly period. The undistributed income would be available to supplement future distributions. As a result, the distributions paid by the Fund for any particular monthly period may be more or less than the amount of income actually earned by the Fund during that monthly period. Undistributed income will add to the Fund&#8217;s net asset value (and indirectly benefits the Adviser by increasing its fees) and, correspondingly, distributions from undistributed income will reduce the Fund&#8217;s net asset value.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The distributions for any full or partial year might not be made in equal amounts, and any one distribution may be larger than the other. The Fund will make a distribution only if authorized by the Board or by the officers of the Fund pursuant to delegated authority granted by the Board, and declared by the Fund out of assets legally available for these distributions. The Fund may pay a special distribution at the end of each fiscal year if necessary to maintain the Fund&#8217;s tax treatment as a RIC and/or avoid the imposition of tax on the Fund. This distribution policy may, under certain circumstances, have certain adverse consequences to the Fund and its shareholders because it may result in a return of capital to shareholders, which would reduce the Fund&#8217;s net asset value and, over time, potentially increase the Fund&#8217;s expense ratio. If a distribution constitutes a return of capital, it means that the Fund is returning to shareholders a portion of their investment rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. The Board may elect to change the Fund&#8217;s distribution policy at any time.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Section&#160;19(b)&#160;of the Investment Company Act and Rule&#160;19b-1 thereunder generally limit the Fund to one long-term capital gain distribution per year, subject to certain exceptions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Shareholders will automatically have all dividends and distributions reinvested in common shares of the Fund in accordance with the Fund&#8217;s dividend reinvestment plan, unless an election is made to receive cash by contacting the plan administrator at (877) 272-8164. See &#8220;Dividend Reinvestment Plan.&#8221;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_015_integixAnchor"></span><strong>DIVIDEND REINVESTMENT PLAN</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">Additional Information - Dividend Reinvestment Plan</a></span></span>,&#8221; which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment plan.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_016_integixAnchor"></span><strong>RIGHTS OFFERINGS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may in the future, and at its discretion, choose to make offerings of rights to its shareholders to purchase common shares. Rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the rights. In connection with a rights offering to shareholders, we would distribute certificates or other documentation (i.e., rights cards distributed in lieu of certificates) evidencing the rights and a Prospectus Supplement to our shareholders as of the record date that we set for determining the shareholders eligible to receive rights in such rights offering. Any such future rights offering will be made in accordance with the Investment Company Act. Under the laws of Maryland, the Board is authorized to approve rights offerings without obtaining shareholder approval.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The staff of the SEC has interpreted the Investment Company Act as not requiring shareholder approval of a transferable rights offering to purchase common shares at a price below the then current NAV so long as certain conditions are met, including: (i)&#160;a good faith determination by the Fund&#8217;s Board that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders&#8217; preemptive rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii)&#160;management uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and (iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">30&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The applicable Prospectus Supplement would describe the following terms of the rights in respect of which this Prospectus is being delivered:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the period of time the offering would remain open;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the underwriter or distributor, if any, of the rights and any associated underwriting fees or discounts applicable to purchases of the rights;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the title of such rights;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the exercise price for such rights (or method of calculation thereof);</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the number of such rights issued in respect of each share;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the number of rights required to purchase a single share;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the extent to which such rights are transferable and the market on which they may be traded if they are transferable;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such rights;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the date on which the right to exercise such rights will commence, and the date on which such right will expire (subject to any extension);</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege; and</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">termination rights we may have in connection with such rights offering.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A certain number of rights would entitle the holder of the right(s)&#160;to purchase for cash such number of common shares at such exercise price as in each case is set forth in, or be determinable as set forth in, the Prospectus Supplement relating to the rights offered thereby. Rights would be exercisable at any time up to the close of business on the expiration date for such rights set forth in the applicable Prospectus Supplement. After the close of business on the expiration date, all unexercised rights would become void. Upon expiration of the rights offering and the receipt of payment and the rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the rights agent, or any other office indicated in the applicable Prospectus Supplement, the common shares purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable Prospectus Supplement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_017_integixAnchor"></span><strong>TAX MATTERS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The following discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the purchase, ownership and disposition of the Fund&#8217;s common shares.</span> A more detailed discussion of the tax rules&#160;applicable to the Fund and its common shareholders can be found in the SAI that is incorporated by reference into this Prospectus. Except as otherwise noted, this discussion assumes you are a taxable U.S. holder (as defined below) and that you hold your common shares as capital assets for U.S. federal income tax purposes (generally, assets held for investment). This discussion is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal tax concerns affecting the Fund and its common shareholders. <strong>The discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the specific U.S. federal, state, local and foreign tax consequences to them of investing in the Fund.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">31&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition, no attempt is made to address tax considerations applicable to an investor with a special tax status, such as a financial institution, real estate income trust (&#8220;REIT&#8221;), insurance company, regulated investment company, individual retirement account, other tax-exempt organization, dealer in securities or currencies, person holding shares of the Fund as part of a hedging, integrated, conversion or straddle transaction, trader in securities that has elected the mark-to-market method of accounting for its securities, U.S. holder (as defined below) whose functional currency is not the U.S. dollar, investor with &#8220;applicable financial statements&#8221; within the meaning of Section&#160;451(b)&#160;of the Code, or non-U.S. investor. Furthermore, this discussion does not reflect possible application of the alternative minimum tax.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A U.S. holder is a beneficial owner that is for U.S. federal income tax purposes:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">a citizen or individual resident of the United States (including certain former citizens and former long-term residents);</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">a corporation or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof or the District of Columbia;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">a trust with respect to which a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons has the authority to control all of its substantial decisions or the trust has made a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Taxation of the Fund</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has elected to be treated as a RIC under Subchapter M of the Code, and operates in a manner so as to qualify for tax treatment applicable to RICs. To qualify for tax treatment as a RIC, the Fund must, among other things, satisfy certain requirements relating to the sources of its income, diversification of its assets, and distribution of its income to its shareholders. First, the Fund must derive at least 90% of its annual gross income from dividends, interest, payments with respect to securities loans, gains from the sale or other disposition of stock or securities or foreign currencies, or other income (including but not limited to gains from options, futures and forward contracts) derived with respect to its business of investing in such stock, securities or currencies, or net income derived from interests in &#8220;qualified publicly traded partnerships&#8221; (as defined in the Code) (the &#8220;90% gross income test&#8221;). Second, the Fund must diversify its holdings so that, at the close of each quarter of its taxable year, (i)&#160;at least 50% of the value of its total assets consists of cash, cash items, U.S. Government securities, securities of other RICs and other securities, with such other securities limited in respect of any one issuer to an amount not greater in value than 5% of the value of the Fund&#8217;s total assets and to not more than 10% of the outstanding voting securities of such issuer and (ii)&#160;not more than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. Government securities and securities of other RICs) of any one issuer, any two or more issuers controlled by the Fund and engaged in the same, similar or related trades or businesses, or any one or more &#8220;qualified publicly traded partnerships.&#8221;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As long as the Fund qualifies as a RIC, the Fund will generally not be subject to corporate-level U.S. federal income tax on income and gains that it distributes each taxable year to its shareholders, provided that in such taxable year it distributes at least 90% of the sum of (i)&#160;its net tax-exempt interest income, if any, and (ii)&#160;its &#8220;investment company taxable income&#8221; (which includes, among other items, dividends, taxable interest, taxable original issue discount and market discount income, income from securities lending, net short-term capital gain in excess of net long-term capital loss, and any other taxable income other than &#8220;net capital gain&#8221; (as defined below) and is reduced by deductible expenses) determined without regard to the deduction for dividends paid. The Fund may retain for investment its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). However, if the Fund retains any net capital gain or any investment company taxable income, it will be subject to tax at regular corporate rates on the amount retained.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Code imposes a 4% nondeductible excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i)&#160;98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii)&#160;98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election is made to use the Fund&#8217;s fiscal year). In addition, the minimum amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect the total amount of any under-distribution or over-distribution, as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on which it paid U.S. federal income tax. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event, the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">32&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If in any taxable year the Fund should fail to qualify under Subchapter M of the Code for tax treatment as a RIC, the Fund would incur a regular corporate U.S. federal income tax upon all of its taxable income for that year, and all distributions to its shareholders (including distributions of net capital gain) would be taxable to shareholders as ordinary dividend income for U.S. federal income tax purposes to the extent of the Fund&#8217;s earnings and profits. Provided that certain holding period and other requirements were met, such dividends would be eligible (i)&#160;to be treated as qualified dividend income in the case of shareholders taxed as individuals and (ii)&#160;for the dividends received deduction in the case of corporate shareholders. In addition, to qualify again to be taxed as a RIC in a subsequent year, the Fund would be required to distribute to shareholders its earnings and profits attributable to non-RIC years. In addition, if the Fund failed to qualify as a RIC for a period greater than two taxable years, then, in order to qualify as a RIC in a subsequent year, the Fund would be required to elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized for a period of five years.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The remainder of this discussion assumes that the Fund qualifies for taxation as a RIC.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>The Fund&#8217;s Investments</i></span>. Certain of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions (including mark-to-market, constructive sale, straddle, wash sale, short sale and other rules) that may, among other things, (i)&#160;disallow, suspend or otherwise limit the allowance of certain losses or deductions, (ii)&#160;convert lower taxed long-term capital gains or qualified dividend income into higher taxed short-term capital gains or ordinary income, (iii)&#160;convert ordinary loss or a deduction into capital loss (the deductibility of which is more limited), (iv)&#160;cause the Fund to recognize income or gain without a corresponding receipt of cash, (v)&#160;adversely affect the time as to when a purchase or sale of shares or securities is deemed to occur, (vi)&#160;adversely alter the characterization of certain complex financial transactions and (vii)&#160;produce income that will not be &#8220;qualified&#8221; income for purposes of the 90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing and character of distributions to common shareholders. The Fund monitors its transactions and may make certain tax elections and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a RIC. Additionally, the Fund may be required to limit its activities in derivative instruments in order to enable it to maintain its RIC status.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest a portion of its net assets in below investment grade securities. Investments in these types of securities may present special tax issues for the Fund. U.S. federal income tax rules&#160;are not entirely clear about issues such as when the Fund may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless securities, how payments received on obligations in default should be allocated between principal and income and whether modifications or exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues could affect the Fund&#8217;s ability to distribute sufficient income to preserve its status as a RIC or to avoid the imposition of U.S. federal income or excise tax.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Certain debt securities acquired by the Fund may be treated as debt securities that were originally issued at a discount. Generally, the amount of the original issue discount is treated as interest income and is included in taxable income (and required to be distributed by the Fund in order to qualify as a RIC and avoid U.S. federal income tax or the 4% excise tax on undistributed income) over the term of the security, even though payment of that amount is not received until a later time, usually when the debt security matures.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">33&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If the Fund purchases a debt security on a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase price is &#8220;market discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any gain realized on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary income to the extent the gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt security. Market discount generally accrues in equal daily installments. If the Fund ultimately collects less on the debt instrument than its purchase price plus the market discount previously included in income, the Fund may not be able to benefit from any offsetting loss deductions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in preferred securities or other securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization by the IRS. To the extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected by the Fund, it could affect the timing or character of income recognized by the Fund, potentially requiring the Fund to purchase or sell securities, or otherwise change its portfolio, in order to comply with the tax rules&#160;applicable to RICs under the Code.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Gain or loss on the sale of securities by the Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain or loss on the sale of securities held for one year or less will be short-term capital gain or loss.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because the Fund may invest in foreign securities, its income from such securities may be subject to non-U.S. taxes. If more than 50% of the Fund&#8217;s total assets at the close of its taxable year consists of stock or securities of foreign corporations, the Fund may elect for U.S. federal income tax purposes to treat foreign income taxes paid by it as paid by its shareholders. The Fund may qualify for and make this election in some, but not necessarily all, of its taxable years. If the Fund were to make such an election, shareholders would be required to take into account an amount equal to their pro rata portions of such foreign taxes in computing their taxable income and then treat an amount equal to those foreign taxes as a U.S. federal income tax deduction or as a foreign tax credit against their U.S. federal income tax liability. A taxpayer&#8217;s ability to use a foreign tax deduction or credit is subject to limitations under the Code. Shortly after any year for which it makes such an election, the Fund will report to its shareholders the amount per share of such foreign income tax that must be included in each shareholder&#8217;s gross income and the amount that may be available for the deduction or credit.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Foreign currency gain or loss on foreign currency exchange contracts, non-U.S. dollar-denominated securities contracts, and non-U.S. dollar-denominated futures contracts, options and forward contracts that are not section 1256 contracts (as defined below) generally will be treated as ordinary income and loss.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Income from options on individual securities written by the Fund will not be recognized by the Fund for tax purposes until an option is exercised, lapses or is subject to a &#8220;closing transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations with respect to the option are otherwise terminated. If the option lapses without exercise, the premiums received by the Fund from the writing of such options will generally be characterized as short-term capital gain. If the Fund enters into a closing transaction, the difference between the premiums received and the amount paid by the Fund to close out its position will generally be treated as short-term capital gain or loss. If an option written by the Fund is exercised, thereby requiring the Fund to sell the underlying security, the premium will increase the amount realized upon the sale of the security, and the character of any gain on such sale of the underlying security as short-term or long-term capital gain will depend on the holding period of the Fund in the underlying security. Because the Fund will not have control over the exercise of the options it writes, such exercises or other required sales of the underlying securities may cause the Fund to realize gains or losses at inopportune times.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Index options that qualify as &#8220;section 1256 contracts&#8221; will generally be treated as &#8220;marked-to-market&#8221; for U.S. federal income tax purposes. As a result, the Fund will generally recognize gain or loss on the last day of each taxable year equal to the difference between the value of the option on that date and the adjusted basis of the option. The adjusted basis of the option will consequently be increased by such gain or decreased by such loss. Any gain or loss with respect to options on indices and sectors that qualify as &#8220;section 1256 contracts&#8221; will be treated as short-term capital gain or loss to the extent of 40% of such gain or loss and long-term capital gain or loss to the extent of 60% of such gain or loss. Because the mark-to-market rules&#160;may cause the Fund to recognize gain in advance of the receipt of cash, the Fund may be required to dispose of investments in order to meet its distribution requirements. &#8220;Mark-to-market&#8221; losses may be suspended or otherwise limited if such losses are part of a straddle or similar transaction.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">34&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Taxation of Common Shareholders</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will either distribute or retain for reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a corporate income tax on such retained amount. In that event, the Fund expects to report the retained amount as undistributed capital gain in a notice to its common shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i)&#160;will be required to include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts, (ii)&#160;will be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds such liability and (iii)&#160;will increase its basis in its common shares by the amount of undistributed capital gains included in the common shareholder&#8217;s income less the tax deemed paid by the common shareholder under clause (ii).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Distributions paid to you by the Fund from its net capital gain, if any, that the Fund properly reports as capital gain dividends (&#8220;capital gain dividends&#8221;) are taxable as long-term capital gains, regardless of how long you have held your common shares. All other dividends paid to you by the Fund (including dividends from net short-term capital gains or tax-exempt interest, if any) from its current or accumulated earnings and profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income. Provided that certain holding period and other requirements are met, ordinary income dividends (if properly reported by the Fund) may qualify (i)&#160;for the dividends received deduction in the case of corporate common shareholders to the extent that the Fund&#8217;s income consists of dividend income from U.S. corporations, (ii)&#160;in the case of individual common shareholders, as &#8220;qualified dividend income&#8221; eligible to be taxed at long-term capital gains rates to the extent that the Fund receives qualified dividend income and (iii)&#160;in the case of individual common shareholders, as &#8220;section 199A dividends&#8221; eligible for a 20% &#8220;qualified business income&#8221; deduction in tax years beginning after December&#160;31, 2017 and before January&#160;1, 2026 to the extent the Fund receives ordinary REIT dividends, reduced by allocable Fund expenses. Qualified dividend income is, in general, dividend income from taxable domestic corporations and certain qualified foreign corporations (e.g., generally, foreign corporations incorporated in a possession of the United States or in certain countries with a qualifying comprehensive tax treaty with the United States, or whose stock with respect to which such dividend is paid is readily tradable on an established securities market in the United States). There can be no assurance as to what portion, if any, of the Fund&#8217;s distributions will constitute qualified dividend income or be eligible for the dividends received deduction or &#8220;qualified business income&#8221; deduction.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Any distributions you receive that are in excess of the Fund&#8217;s current and accumulated earnings and profits will be treated as a return of capital to the extent of your adjusted tax basis in your common shares, and thereafter as capital gain from the sale of common shares. The amount of any Fund distribution that is treated as a return of capital will reduce your adjusted tax basis in your common shares, thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other disposition of your common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Common shareholders may be entitled to offset their capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when capital losses may be offset against capital gain, and limiting the use of losses from certain investments and activities. Accordingly, common shareholders that have capital losses are urged to consult their tax advisers.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Dividends and other taxable distributions are taxable to you even though they are reinvested in additional common shares of the Fund. Dividends and other distributions paid by the Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend in January&#160;that was declared in the previous October, November&#160;or December&#160;to common shareholders of record on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions made after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the taxable year in which the distributions were actually made.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">35&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The price of common shares purchased at any time may reflect the amount of a forthcoming distribution. Those purchasing common shares just prior to the record date of a distribution will receive a distribution which will be taxable to them even though it represents, economically, a return of invested capital.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will send you information after the end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The sale or other disposition of common shares will generally result in capital gain or loss to you and will be long-term capital gain or loss if you have held such common shares for more than one year at the time of sale. Any loss upon the sale or other disposition of common shares held for six months or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited as an undistributed capital gain dividend) by you with respect to such common shares. Any loss you recognize on a sale or other disposition of common shares will be disallowed if you acquire other common shares (whether through the automatic reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the common shares. In such case, your tax basis in the common shares acquired will be adjusted to reflect the disallowed loss.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If the Fund liquidates, common shareholders generally will realize capital gain or loss upon such liquidation in an amount equal to the difference between the amount of cash or other property received by the common shareholder (including any property deemed received by reason of its being placed in a liquidating trust) and the common shareholder&#8217;s adjusted tax basis in its common shares. Any such gain or loss will be long-term if the common shareholder is treated as having a holding period in the Fund shares of greater than one year, and otherwise will be short-term.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Current U.S. federal income tax law taxes both long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term capital gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is taxed at a reduced maximum rate. The deductibility of capital losses is subject to limitations under the Code.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Certain U.S. holders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a portion of their &#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition of the Fund&#8217;s common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A common shareholder that is a nonresident alien individual or a foreign corporation (a &#8220;foreign investor&#8221;) generally will be subject to U.S. federal withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income dividends (except as discussed below). In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain or income realized by a foreign investor in respect of any distribution of net capital gain (including amounts credited as an undistributed capital gain dividend) or upon the sale or other disposition of common shares of the Fund. Different tax consequences may result if the foreign investor is engaged in a trade or business in the United States or, in the case of an individual, is present in the United States for 183 days or more during a taxable year and certain other conditions are met. Foreign investors should consult their tax advisers regarding the tax consequences of investing in the Fund&#8217;s common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ordinary income dividends properly reported by a RIC are generally exempt from U.S. federal withholding tax where they (i)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified net interest income&#8221; (generally, its U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation or partnership in which the RIC is at least a 10% shareholder, reduced by expenses that are allocable to such income) or (ii)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess of the RIC&#8217;s net short-term capital gain over its long-term capital loss for such taxable year). Depending on its circumstances, the Fund may report all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term capital gains, and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify for this exemption from withholding, a foreign investor needs to comply with applicable certification requirements relating to its non-U.S. status (including, in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E or substitute Form). In the case of common shares held through an intermediary, the intermediary may have withheld even if the Fund reported the payment as qualified net interest income or qualified short-term capital gain. Foreign investors should contact their intermediaries with respect to the application of these rules&#160;to their accounts. There can be no assurance as to what portion of the Fund&#8217;s distributions would qualify for favorable treatment as qualified net interest income or qualified short-term capital gains.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">36&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition, withholding at a rate of 30% will apply to dividends paid in respect of common shares of the Fund held by or through certain foreign financial institutions (including investment funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis, information with respect to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly, the entity through which common shares of the Fund are held will affect the determination of whether such withholding is required. Similarly, dividends paid in respect of common shares of the Fund held by an investor that is a non-financial foreign entity that does not qualify under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i)&#160;certifies that such entity does not have any &#8220;substantial United States owners&#8221; or (ii)&#160;provides certain information regarding the entity&#8217;s &#8220;substantial United States owners,&#8221; which the Fund or applicable withholding agent will in turn provide to the Secretary of the Treasury. An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance, may modify these requirements. The Fund will not pay any additional amounts to common shareholders in respect of any amounts withheld. Foreign investors are encouraged to consult with their tax advisers regarding the possible implications of these rules&#160;on their investment in the Fund&#8217;s common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">U.S. federal backup withholding tax may be required on dividends, distributions and sale proceeds payable to certain non-exempt common shareholders who fail to supply their correct taxpayer identification number (in the case of individuals, generally, their social security number) or to make required certifications, or who are otherwise subject to backup withholding. Backup withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S. federal income tax liability, if any, provided that you timely furnish the required information to the IRS.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ordinary income dividends, capital gain dividends, and gain from the sale or other disposition of common shares of the Fund also may be subject to state, local, and/or foreign taxes. Common shareholders are urged to consult their own tax advisers regarding specific questions about U.S. federal, state, local or foreign tax consequences to them of investing in the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The foregoing is a general and abbreviated summary of certain provisions of the Code and the Treasury regulations currently in effect as they directly govern the taxation of the Fund and its common shareholders. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive. A more detailed discussion of the tax rules&#160;applicable to the Fund and its common shareholders can be found in the SAI that is incorporated by reference into this Prospectus. Common shareholders are urged to consult their tax advisers regarding specific questions as to U.S. federal, state, local and foreign income or other taxes.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Please refer to the SAI for more detailed information. You are urged to consult your tax adviser.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_018_integixAnchor"></span><strong>TAXATION OF HOLDERS OF RIGHTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The value of a right will not be includible in the income of a common shareholder at the time the right is issued.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The basis of a right issued to a common shareholder will be zero, and the basis of the share with respect to which the subscription right was issued (the old share) will remain unchanged, unless either (a)&#160;the fair market value of the right on the date of distribution is at least 15% of the fair market value of the old share, or (b)&#160;such shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the subscription right a portion of the basis of the old share. If either (a)&#160;or (b)&#160;applies, then except as described below such shareholder must allocate basis between the old share and the right in proportion to their fair market values on the date of distribution.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The basis of a right purchased in the market will generally be its purchase price.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">37&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The holding period of a right issued to a common shareholder will include the holding period of the old share. No gain or loss will be recognized by a common shareholder upon the exercise of a right.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">No loss will be recognized by a common shareholder if a right distributed to such common shareholder expires unexercised because the basis of the old share may be allocated to a right only if the right is exercised. If a right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the right.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Any gain or loss on the sale of a right will be a capital gain or loss if the right is held as a capital asset (which in the case of rights issued to common shareholders will depend on whether the old common shares are held as a capital asset), and will be a long-term capital gain or loss if the holding period is deemed to exceed one year.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_019_integixAnchor"></span><strong>CERTAIN PROVISIONS IN THE CHARTER AND BYLAWS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the bylaws of the Fund (the &#8220;Bylaws&#8221;) contain provisions that could make it more difficult for a potential acquiror to acquire the Fund by means of a tender offer, proxy contest or otherwise. These provisions are designed to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of the Fund to negotiate first with the Board. The Fund believes that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><i>Classified Board</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s Directors (other than any Directors elected solely by the holders of one or more classes or series of preferred shares in connection with dividend arrearages) are divided into three classes serving staggered three-year terms. Upon expiration of their current terms, Directors of each class will be elected to serve until the third successive annual meeting of shareholders after the meeting at which they were elected and until their successors are duly elected and qualify, and each year one class of Directors will be nominated for election by the shareholders. A classified board may render a change in control of the Fund or the removal of the Fund&#8217;s incumbent management more difficult. The Fund believes, however, that the longer time required to elect a majority of a classified board will help to ensure the continuity and stability of the Fund&#8217;s management and policies.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Election of Directors</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the Bylaws provide that the affirmative vote of the holders of a majority of the shares outstanding and entitled to vote in the election of Directors will be required to elect a Director. Pursuant to the Charter, the Board may amend the Bylaws from time to time to alter the vote required to elect a Director.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Number of Directors; Vacancies; Removal</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that the number of Directors may be increased or decreased only by the Board in accordance with the Bylaws or in accordance with the Charter, but shall never be less than the minimum required by the Maryland General Corporation Law, which is one. The Bylaws provide that a majority of the entire Board may at any time establish, increase or decrease the number of Directors. However, unless the Bylaws are amended, the number of Directors cannot be less than the minimum number required by the Maryland General Corporation Law or more than 10.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has elected to be subject to the provision of Subtitle 8 of Title 3 of the Maryland General Corporation Law regarding the filling of vacancies on the Board. For that reason, except as may be provided by the Board in setting the terms of any class or series of preferred shares, any and all vacancies on the Board may be filled only by the affirmative vote of a majority of the Directors remaining in office, even if the remaining Directors do not constitute a quorum, and any Director elected to fill a vacancy will serve for the remainder of the full term of the directorship in which the vacancy occurred and until a successor is duly elected and qualifies, subject to any applicable requirements of the Investment Company Act.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">38&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that, subject to the rights of holders of one or more classes or series of preferred shares, a Director may be removed only for cause, as defined in the Charter, and then only by the affirmative vote of shareholders entitled to cast at least two-thirds of the votes entitled to be cast in the election of Directors.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Action by Shareholders</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under the Maryland General Corporation Law, common shareholders may act only at an annual or special meeting of shareholders or, unless the charter provides for shareholder action by less than unanimous written consent (which is not the case for the Charter), by unanimous consent in writing or by electronic transmission in lieu of a meeting. These provisions, combined with the requirements of the Bylaws regarding the calling of a shareholder-requested special meeting of shareholders discussed below, may have the effect of delaying consideration of a shareholder proposal until the next annual meeting of shareholders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Advance Notice Provisions for Shareholder Nominations and Shareholder Proposals</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that, with respect to an annual meeting of shareholders, the nomination of individuals for election as Directors and the proposal of other business to be considered by the Fund&#8217;s shareholders may be made only (1)&#160;pursuant to the Fund&#8217;s notice of the meeting, (2)&#160;by or at the direction of the Board or (3)&#160;by a shareholder who (A)&#160;is a shareholder of record both at the time the shareholder provides the notice required by the Bylaws and at the time of the annual meeting, (B)&#160;is entitled to vote at the meeting in the election of such individuals as Directors or on such other business and (C)&#160;has complied with the advance notice requirements of, and provided the information required by, the Bylaws. With respect to special meetings of the Fund&#8217;s shareholders, only the business specified in the notice of the meeting may be brought before the meeting. Nominations of individuals for election as Directors at a special meeting of shareholders may be made only (1)&#160;by or at the direction of the Board or (2)&#160;if the special meeting has been called in accordance with the Bylaws for the purpose of electing Directors, by any shareholder who (A)&#160;is a shareholder of record both at the time the shareholder provides the notice required by the Bylaws and at the time of the special meeting, (B)&#160;is entitled to vote at the meeting in the election of each individual so nominated and (C)&#160;has complied with the advance notice requirements of, and provided the information required by, the Bylaws.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Calling of Special Meetings of Shareholders</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that special meetings of the Fund&#8217;s shareholders may be called by the Board, the Chairman of the Board and certain of the Fund&#8217;s officers. The Bylaws also provide that, subject to the satisfaction of certain procedural and informational requirements by the shareholders requesting the meeting, a special meeting of shareholders must be called by the secretary of the Fund to act on any matter that may properly be considered at a meeting of shareholders upon the written request of shareholders entitled to cast not less than a majority of all the votes entitled to be cast on such matter at such meeting. The Fund&#8217;s secretary will inform the requesting shareholders of the reasonably estimated cost of preparing and mailing or delivering the notice of meeting (including the Fund&#8217;s proxy materials), and the requesting shareholders must pay the estimated cost before the secretary may prepare and mail or deliver notice of the special meeting.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Approval of Extraordinary Corporate Action; Amendment of the Charter and Bylaws</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under Maryland law, a Maryland corporation generally cannot dissolve, amend its charter, merge, consolidate, convert, sell all or substantially all of its assets or engage in a statutory stock exchange, unless the action is declared advisable by the corporation&#8217;s board of directors and approved by the affirmative vote of shareholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. However, a Maryland corporation may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">39&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter generally provides for approval of charter amendments and extraordinary transactions by the shareholders entitled to cast a majority of the votes entitled to be cast on the matter. However, the Charter provides that the following matters require the approval of shareholders entitled to cast at least 80 percent of the votes entitled to be cast on such matter:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">amendments to the provisions of the Charter relating to, or inconsistent with, the classification of the Board, the power of the Board to fix the number of Directors and to fill vacancies on the Board, the removal of Directors and, except as otherwise provided in the Bylaws, the vote required to elect a Director;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">charter amendments that would make the Fund&#8217;s common shares redeemable securities (within the meaning of the Investment Company Act);</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">the conversion of the Fund, whether by merger or otherwise, from a closed-end investment company into an open-end investment company;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">the liquidation or dissolution of the Fund or charter amendments to effect the liquidation or dissolution of the Fund;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">amendments to the provisions of the Charter relating to, or inconsistent with, the vote required to approve charter amendments and extraordinary transactions;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">any merger, consolidation, stock exchange or sale or exchange of all or substantially all of the Fund&#8217;s assets that the Maryland General Corporation Law requires be approved by the Fund&#8217;s shareholders; or</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%"><tr style="vertical-align:top;text-align:justify"><td style="width:0.5in">&#160;</td><td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td><td style="text-align:justify">any transaction between the Fund, on the one hand, and any person or group of persons acting together that is entitled to exercise or direct the exercise, or acquire the right to exercise or direct the exercise, directly or indirectly (other than solely by virtue of a revocable proxy), of one-tenth or more of the voting power in the election of Directors generally, or any person controlling, controlled by or under common control with any such person or member of such a group (collectively &#8220;Transacting Persons&#8221;), on the other hand.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">However, if such amendment, proposal or transaction is approved by at least two-thirds of the Fund&#8217;s continuing directors (in addition to approval by the Board), such amendment, proposal or transaction may instead be approved by the affirmative vote of shareholders entitled to cast a majority of all the votes entitled to be cast on such amendment, proposal or transaction, provided that any transaction with Transacting Persons that would not otherwise require shareholder approval under the Maryland General Corporation Law would not require further shareholder approval unless another provision of the Charter or the Bylaws requires such approval.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The &#8220;continuing directors&#8221; are defined in the Charter as its current Directors and Directors whose nomination for election by the Fund&#8217;s shareholders or whose election by the Directors to fill a vacancy on the Board is approved by the current Directors or any successor Directors whose nomination for election by the shareholders or whose election by the Board to fill vacancies is approved by a majority of the continuing directors or successor continuing directors then serving on the Board.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the Bylaws provide that the Board has the exclusive power to adopt, alter or repeal any provision of the Bylaws and to make new Bylaws.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Subtitle 8</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subtitle 8 of Title 3 of the Maryland General Corporation Law permits a Maryland corporation with a class of equity securities registered under the Exchange Act and at least three independent directors to elect to be subject, by provision in its charter or bylaws or a resolution of its board of directors and notwithstanding any contrary provision in the charter or bylaws, to any or all of five provisions of the Maryland General Corporation Law that provide, respectively, for:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.75in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td>a classified board;</td></tr><tr style="vertical-align:top"><td style="width:0.75in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td>a two-thirds vote requirement for removing a director;</td></tr><tr style="vertical-align:top"><td style="width:0.75in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td>a requirement that the number of directors be fixed only by vote of the board of directors;</td></tr><tr style="vertical-align:top"><td style="width:0.75in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td>a requirement that a vacancy on the board of directors be filled only by a vote of the remaining directors in office and for the remainder of the full term of the class of directors in which the vacancy occurred and until a successor is elected and qualifies; and</td></tr><tr style="vertical-align:top"><td style="width:0.75in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td>a majority requirement for the calling of a shareholder-requested special meeting of shareholders.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">40&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter sets forth our election to be subject to the provisions of Subtitle 8 relating to the filling of vacancies on the Board. Through provisions in the Charter and the Bylaws unrelated to Subtitle 8, we also (i)&#160;have a classified board, (ii)&#160;require a two-thirds vote to remove a Director, which removal also requires cause, (iii)&#160;vest in the Board the exclusive power to fix the number of directorships and (iv)&#160;require, unless called by the Board, the Chairman of the Board or certain of the Fund&#8217;s officers, the written request of shareholders entitled to cast a majority of all the votes entitled to be cast on any matter that may properly be considered at a meeting of shareholders to call a special meeting to act on such matter.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Exclusive Forum</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the courts in the State of Maryland or a federal court sitting in the State of Maryland, will be the sole and exclusive forum for: (i)&#160;any derivative action or proceeding brought on behalf of the Fund, (ii)&#160;any action asserting a claim of breach of a fiduciary duty owed by any of the Fund&#8217;s Directors, officers or employees to the Fund or to our shareholders, (iii)&#160;any action asserting a claim against the Fund or any of the Fund&#8217;s Directors, officers or employees arising pursuant to any provision of the Maryland General Corporation Law or the Charter or the Bylaws, or (iv)&#160;any action otherwise asserting a claim against the Fund or any of the Fund&#8217;s Directors, officers or employees that is governed by the internal corporate claims doctrine.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Although we believe that this provision will benefit us by limiting costly and time-consuming litigation in multiple forums and by providing increased consistency in the application of applicable law, this provision may limit the ability of a shareholder to bring a claim in a judicial forum that such shareholder finds favorable for disputes with us or any of our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Limitation of Liability</i></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Maryland law permits a Maryland corporation to include a provision in its charter limiting the liability of its directors and officers to the corporation and its shareholders for money damages, except for liability resulting from (a)&#160;actual receipt of an improper benefit or profit in money, property or services or (b)&#160;active and deliberate dishonesty that is established by a final judgment and is material to the cause of action. The Charter contains a provision that eliminates the Directors' and officers' liability to the maximum extent permitted by Maryland law and the Investment Company Act. </span>This limitation of liability will be limited to the extent superseded by applicable federal securities laws.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_020_integixAnchor"></span><strong>CLOSED-END FUND STRUCTURE</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a diversified, closed-end management investment company (commonly referred to as a closed-end fund). Closed-end funds differ from open-end funds (which are generally referred to as mutual funds) in that closed-end funds generally list their shares for trading on a stock exchange and do not redeem their shares at the request of the shareholder. This means that if you wish to sell your shares of a closed-end fund, you must sell them to a third party, generally by trading them on the stock exchange like any other stock at the prevailing market price at that time. In a mutual fund, if the shareholder wishes to sell shares of the fund, the mutual fund will redeem or buy back the shares at NAV. Also, mutual funds generally offer new shares on a continuous basis to new investors and closed-end funds generally do not. The continuous inflows and outflows of assets in a mutual fund can make it difficult to manage the fund&#8217;s investments. By comparison, closed-end funds are generally able to stay more fully invested in securities that are consistent with their investment objectives and also have greater flexibility to make certain types of investments and to use certain investment strategies, such as financial leverage and investments in illiquid securities.</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">41&#160;</span></span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Shares of closed-end funds frequently trade at a discount to their NAV. Because of this possibility and the recognition that any such discount may not be in the interest of shareholders, the Board might consider from time to time engaging in open-market repurchases, tender offers for shares or other programs intended to reduce the discount. We cannot guarantee or assure, however, that the Board will decide to engage in any of these actions. Nor is there any guarantee or assurance that such actions, if undertaken, would result in the shares trading at a price equal or close to the NAV. See &#8220;Repurchase of Common Shares&#8221; below and &#8220;Repurchase of Common Shares&#8221; in the SAI. The Board might also consider converting the Fund to an open-end mutual fund, which would also require a vote of the shareholders of the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_021_integixAnchor"></span><strong>REPURCHASE OF COMMON SHARES</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because the Fund is a closed-end management investment company, its shareholders will not have the right to cause the Fund to redeem their common shares. Instead, the Fund's common shares will trade in the open market at a price that will be a function of several direct and indirect factors, including dividend levels (which are in turn affected by expenses), net asset value, dividend stability, relative demand for and supply of such shares in the market, general market and economic conditions and other factors. Notice is hereby given in accordance with Section&#160;23(c)&#160;of the Investment Company Act that the Fund may purchase at market prices from time to time its common shares in the open market but is under no obligation to do so.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Notwithstanding the foregoing, at any time if the Fund has preferred shares outstanding, the Fund may not purchase, redeem or otherwise acquire any of its common shares unless (i)&#160;all accrued preferred share dividends, if any, have been paid and (ii)&#160;at the time of such purchase, redemption or acquisition, the Fund has an asset coverage of at least 200% after deducting the amount of such purchase, redemption or acquisition, as applicable. Similarly, if the Fund has outstanding indebtedness, the Fund may not purchase, redeem or acquire its capital stock unless the Fund has an asset coverage of at least 300% after deducting the amount of such purchase, redemption or acquisition, as applicable. See &#8220;Leverage&#8221;. Any service fees incurred in connection with any tender offer made by the Fund will be borne by the Fund and will not reduce the stated consideration to be paid to tendering shareholders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subject to its investment restrictions, the Fund may borrow to finance the repurchase of common shares or to make a tender offer for those shares. Interest on any borrowings to finance share repurchase transactions or the accumulation of cash by the Fund in anticipation of share repurchases or tenders will reduce the Fund's net income. Any share repurchase, tender offer or borrowing approved by the Board would have to comply with the NYSE listing requirements and the Exchange Act, the Investment Company Act, and the rules&#160;and regulations thereunder.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">There is no assurance that, if action is undertaken to repurchase or tender for common shares, such action will result in the Fund's common shares trading at a price that approximates their net asset value. Although share repurchases and tenders could have a favorable effect on the market price of the Fund's common shares, shareholders should be aware that the acquisition of common shares by the Fund will decrease the total net assets of the Fund and, therefore, may have the effect of increasing the Fund's expense ratio and decreasing the asset coverage with respect to any preferred shares outstanding and any amounts borrowed. For additional information, see &#8220;Repurchase of Common Shares&#8221; in the SAI.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_022_integixAnchor"></span><strong>PLAN OF DISTRIBUTION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">We may sell common shares, including through a rights offering, through underwriters or dealers, directly to one or more purchasers (including through a rights offering), through agents, to or through underwriters or dealers, or through a combination of any such methods of sale. The applicable Prospectus Supplement will identify any underwriter or agent involved in the offer and sale of our common shares, any sales loads, discounts, commissions, fees or other compensation paid to any underwriter, dealer or agent, the offering price, net proceeds and use of proceeds and the terms of any sale. In the case of a rights offering, the applicable Prospectus Supplement will set forth the number of our common shares issuable upon the exercise of each right and the other terms of such rights offering.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The distribution of our common shares may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at prevailing market prices at the time of sale, at prices related to such prevailing market prices, or at negotiated prices. Sales of our common shares may be made in transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">42&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">We may sell our common shares directly to, and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for any resales of the securities. In this case, no underwriters or agents would be involved. We may use electronic media, including the Internet, to sell offered securities directly.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In connection with the sale of our common shares, underwriters or agents may receive compensation from us in the form of discounts, concessions or commissions. Underwriters may sell our common shares to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of our common shares may be deemed to be underwriters under the Securities Act, and any discounts and commissions they receive from us and any profit realized by them on the resale of our common shares may be deemed to be underwriting discounts and commissions under the Securities Act. Any such underwriter or agent will be identified and any such compensation received from us will be described in the applicable Prospectus Supplement. The maximum amount of compensation to be received by any Financial Industry Regulatory Authority member or independent broker-dealer will not exceed eight percent for the sale of any securities being offered pursuant to Rule&#160;415 under the Securities Act. We will not pay any compensation to any underwriter or agent in the form of warrants, options, consulting or structuring fees or similar arrangements. In connection with any rights offering to existing shareholders, we may enter into a standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s)&#160;will purchase common shares remaining unsubscribed after the rights offering.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If a Prospectus Supplement so indicates, we may grant the underwriters an option to purchase additional common shares at the public offering price, less the underwriting discounts and commissions, within 45 days from the date of the Prospectus Supplement, to cover any over-allotments.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under agreements into which we may enter, underwriters, dealers and agents who participate in the distribution of our common shares may be entitled to indemnification by us against certain liabilities, including liabilities under the Securities Act. Underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If so indicated in the applicable Prospectus Supplement, we will ourselves, or will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase our common shares from us pursuant to contracts providing for payment and delivery on a future date. Institutions with which such contacts may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others, but in all cases such institutions must be approved by us. The obligation of any purchaser under any such contract will be subject to the condition that the purchase of the common shares shall not at the time of delivery be prohibited under the laws of the jurisdiction to which such purchaser is subject. The underwriters and such other agents will not have any responsibility in respect of the validity or performance of such contracts. Such contracts will be subject only to those conditions set forth in the Prospectus Supplement, and the Prospectus Supplement will set forth the commission payable for solicitation of such contracts.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">To the extent permitted under the Investment Company Act and the rules&#160;and regulations promulgated thereunder, the underwriters may from time to time act as brokers or dealers and receive fees in connection with the execution of our portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an underwriter.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A Prospectus and accompanying Prospectus Supplement in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of securities for sale to their online brokerage account holders. Such allocations of securities for Internet distributions will be made on the same basis as other allocations. In addition, securities may be sold by the underwriters to securities dealers who resell securities to online brokerage account holders.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In order to comply with the securities laws of certain states, if applicable, our common shares offered hereby will be sold in such jurisdictions only through registered or licensed brokers or dealers.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">43&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_023_integixAnchor"></span><strong>INCORPORATION BY REFERENCE</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This Prospectus is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. We incorporate by reference into this Prospectus the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d)&#160;of the Exchange Act, including any filings on or after the date of this Prospectus from the date of filing (excluding any information furnished, rather than filed), until we have sold all of the offered securities to which this Prospectus and any accompanying prospectus supplement relates or the offering is otherwise terminated. The information incorporated by reference is an important part of this Prospectus. Any statement in a document incorporated by reference into this Prospectus will be deemed to be automatically modified or superseded to the extent a statement contained in (1)&#160;this Prospectus or (2)&#160;any other subsequently filed document that is incorporated by reference into this Prospectus modifies or supersedes such statement. The documents incorporated by reference herein include:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr><td style="width:5%">&#160;</td><td style="vertical-align:top;width:3%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="vertical-align:top;width:1%">&#160;</td><td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund&#8217;s SAI, dated [<span>&#9679;</span>], 2024, filed with this Prospectus;</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr><td style="width:5%">&#160;</td><td style="vertical-align:top;width:3%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="vertical-align:top;width:1%">&#160;</td><td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">our&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">annual report</a></span></span>&#160;on Form&#160;N-CSR&#160;for the fiscal year ended December&#160;31, 2023, filed with the SEC on March&#160;6, 2024;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr><td style="width:5%">&#160;</td><td style="vertical-align:top;width:3%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="vertical-align:top;width:1%">&#160;</td><td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">our&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465923097217/tm2318740d1_ncsrs.htm" style="-sec-extract:exhibit">semi-annual report</a>&#160;</span></span>on Form&#160;N-CSR&#160;for the fiscal period ended June&#160;30, 2023, filed with the SEC on August&#160;31, 2023; and</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr><td style="width:5%">&#160;</td><td style="vertical-align:top;width:3%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="vertical-align:top;width:1%">&#160;</td><td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">the&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465912077964/a12-27073_18a12b.htm" style="-sec-extract:exhibit">description of the Fund&#8217;s common shares</a></span></span>&#160;contained in our Registration Statement on Form&#160;8-A&#160;(File&#160;No.&#160;811-22535),&#160;filed with the SEC on March&#160;22, 2011, including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Fund will provide without charge to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral request, a copy of any and all of the documents that have been or may be incorporated by reference in this Prospectus or the accompanying prospectus supplement. You should direct requests for documents by calling (888) 818-5298.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Fund makes available this Prospectus, SAI and the Fund&#8217;s annual and semi-annual reports, free of charge, at www.arespublicfunds.com. You may also obtain this Prospectus, the SAI, other documents incorporated by reference and other information the Fund files electronically, including reports and proxy statements, on the SEC website (http://www.sec.gov) or with the payment of a duplication fee, by electronic request at publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not incorporated by reference into this Prospectus and should not be considered to be part of this Prospectus or the accompanying prospectus supplement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_024_integixAnchor"></span><strong>PRIVACY PRINCIPLES OF THE FUND</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is committed to maintaining the privacy of its shareholders and to safeguarding their nonpublic personal information. The following information is provided to help you understand what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information with select other parties.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Generally, the Fund will not receive any non-public personal information about common shareholders of the Fund, although certain shareholders' non-public information may become available to the Fund. The non-public personal information that we may receive falls into the following categories:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Information the Fund receives from shareholders, whether we receive it orally, in writing or electronically. This includes shareholders' communications to the Fund concerning their investment;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Information about shareholders' transactions and history with the Fund; or</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> Other general information that we may obtain about shareholders, such as demographic and contact information such as address.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">44&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund does not disclose any non-public personal information about shareholders, except:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> to the Fund&#8217;s affiliates (such as our investment adviser) and their employees that have a legitimate business need for the information;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> to the Fund&#8217;s service providers (such as our administrator, accountants, attorneys, custodians, transfer agent, underwriter and proxy solicitors) and their employees as is necessary to service shareholder accounts or otherwise provide the applicable service;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> to comply with court orders, subpoenas, lawful discovery requests, or other legal or regulatory requirements; or</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679;</span> as allowed or required by applicable law or regulation.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">When the Fund shares non-public shareholder personal information referred to above, the information is made available for limited business purposes and under controlled circumstances designed to protect our shareholders' privacy. The Fund does not permit use of shareholder information for any non-business or marketing purpose, nor does the Fund permit third parties to rent, sell, trade or otherwise release or disclose information to any other party.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund's service providers, such as its Adviser, administrator, and transfer agent, are required to maintain physical, electronic, and procedural safeguards to protect shareholder nonpublic personal information; to prevent unauthorized access or use; and to dispose of such information when it is no longer required.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Personnel of affiliates may access shareholder information only for business purposes. The degree of access is based on the sensitivity of the information and on personnel need for the information to service a shareholder's account or comply with legal requirements.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If a shareholder ceases to be a shareholder, the Fund will adhere to the privacy policies and practices as described above. The Fund may choose to modify its privacy policies at any time. Before it does so, it will notify shareholders and provide a description of its privacy policy.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In the event of a corporate change in control resulting from, for example, a sale to, or merger with, another entity, or in the event of a sale of assets, the Fund reserves the right to transfer shareholders&#8217; non-public personal information to the new party in control or the party acquiring assets.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">45&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $500,000,000 of Common Stock</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Common Stock</strong>&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Rights to Purchase Common Stock</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><div style="margin:3pt auto;width:25%"><div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>PROSPECTUS</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>[<span>&#9679;</span>], 2024</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="margin:0pt">&#160;</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;color:#eb0029">The information in this Preliminary Prospectus Supplement is not complete and may be changed. Ares Dynamic Credit Allocation Fund,&#160;Inc. may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Preliminary Prospectus Supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;color:#eb0029"><strong>SUBJECT TO COMPLETION, DATED AUGUST 14, 2024</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">PROSPECTUS SUPPLEMENT&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(To Prospectus dated [<span>&#9679;</span>], 2024)</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><span style="font-size:10pt">Filed Pursuant to Rule&#160;424(b)[(2)][(5)]</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><span style="font-size:10pt">Registration Statement No.&#160;333-<strong>[<span>&#9679;</span>]</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $500,000,000 of Common Stock</strong></span></p><p style="border-bottom:Black thin solid;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Ares Dynam</span>ic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is offering for sale [<span>&#9679;</span>] shares of our common stock, par value $0.001 per share (&#8220;common shares&#8221;). Our common shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; As of the close of business on [<span>&#9679;</span>], 2024, the last reported net asset value per share of our common shares was $[<span>&#9679;</span>] and the last reported sales price per share of our common shares on the NYSE was $[<span>&#9679;</span>].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, </span>together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;). The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total return, primarily through current income and, secondarily, through capital appreciation. The Fund&#8217;s investment adviser is Ares Capital Management II LLC (the &#8220;Adviser&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Sales of our common shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>Investing in the Fund&#8217;s common shares involves certain risks that are described in the &#8220;Risks&#8221; section beginning on page&#160;25 of the accompanying Prospectus.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>NEITHER THE SECURITIES AND EXCHANGE COMMISSION (&#8220;SEC&#8221;) NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement, together with the accompanying Prospectus, sets forth concisely the information about the Fund that a prospective investor should know before investing. You should read this Prospectus Supplement and the accompanying Prospectus, which contain important information, before deciding whether to invest in the common shares. You should retain the accompanying Prospectus and this Prospectus Supplement for future reference. A Statement of Additional Information (&#8220;SAI&#8221;), dated [<span>&#9679;</span>], 2024, containing additional information about the Fund, has been filed with the SEC and, as amended from time to time, is incorporated by reference in its entirety into this Prospectus Supplement and the accompanying Prospectus. This Prospectus Supplement, the accompanying Prospectus and the SAI are part of a &#8220;shelf&#8221; registration statement filed with the SEC. This Prospectus Supplement describes the specific details regarding this offering, including the method of distribution. If information in this Prospectus Supplement is inconsistent with the accompanying Prospectus or the SAI, you should rely on this Prospectus Supplement. You may call (888) 818-5298, visit the Fund&#8217;s website (www.arespublicfunds.com) or write to the Fund to obtain, free of charge, copies of the SAI and the Fund&#8217;s semi-annual and annual reports, as well as to obtain other information about the Fund or to make shareholder inquiries. The SAI, as well as the Fund&#8217;s semi-annual and annual reports, are also available for free on the SEC&#8217;s website (http://www.sec.gov). You may also e-mail requests for these documents to publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus Supplement or the accompanying Prospectus.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-1 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">You should not construe the contents of this Prospectus Supplement and the accompanying Prospectus as legal, tax or financial advice. You should consult with your own professional advisers as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>The Fund&#8217;s common shares do not represent a deposit or an obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">[<span>&#9679;</span>], 2024</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. Neither the Fund nor the underwriters have authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to Ares Dynamic Credit Allocation Fund,&#160;Inc.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-2 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>TABLE OF CONTENTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Prospectus Supplement</strong></span></td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:90%"><a href="#s_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</span></a></td><td style="width:10%;text-align:right"><a href="#s_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">4</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_002_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUPPLEMENT SUMMARY</span></a></td><td style="text-align:right"><a href="#s_002_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">4</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#s_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td><td style="text-align:right"><a href="#s_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td><td style="text-align:right"><a href="#s_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">6</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#s_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAPITALIZATION</span></a></td><td style="text-align:right"><a href="#s_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">6</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td><td style="text-align:right"><a href="#s_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">6</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#s_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEGAL MATTERS</span></a></td><td style="text-align:right"><a href="#s_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">6</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">ADDITIONAL INFORMATION</span></a></td><td style="text-align:right"><a href="#s_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">7</span></a></td></tr><tr style="vertical-align:bottom"><td>&#160;</td><td style="text-align:right">&#160;</td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Prospectus</strong></span></td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUMMARY</span></a></td><td style="text-align:right"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td><td style="text-align:right"><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL HIGHLIGHTS</span></a></td><td style="text-align:right"><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">11</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td><td style="text-align:right"><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND</span></a></td><td style="text-align:right"><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF SHARES</span></a></td><td style="text-align:right"><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND&#8217;S INVESTMENTS</span></a></td><td style="text-align:right"><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">14</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEVERAGE</span></a></td><td style="text-align:right"><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RISKS</span></a></td><td style="text-align:right"><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">HOW THE FUND MANAGES RISK</span></a></td><td style="text-align:right"><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">MANAGEMENT OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">NET ASSET VALUE</span></a></td><td style="text-align:right"><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">27</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DISTRIBUTIONS</span></a></td><td style="text-align:right"><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">29</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DIVIDEND REINVESTMENT PLAN</span></a></td><td style="text-align:right"><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RIGHTS OFFERINGS</span></a></td><td style="text-align:right"><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAX MATTERS</span></a></td><td style="text-align:right"><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">31</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION OF HOLDERS OF RIGHTS</span></a></td><td style="text-align:right"><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">37</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CERTAIN PROVISIONS IN THE CHARTER AND BYLAWS</span></a></td><td style="text-align:right"><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">38</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CLOSED-END FUND STRUCTURE</span></a></td><td style="text-align:right"><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">REPURCHASE OF COMMON SHARES</span></a></td><td style="text-align:right"><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td><td style="text-align:right"><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">INCORPORATION BY REFERENCE</span></a></td><td style="text-align:right"><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRIVACY PRINCIPLES OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-3 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_001_integixAnchor"></span><strong>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the &#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement, as well as in the accompanying Prospectus. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221; section of the accompanying Prospectus. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus are made as of the date of this Prospectus Supplement or the accompanying Prospectus, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risks&#8221; section of the accompanying Prospectus. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in our common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_002_integixAnchor"></span><strong>PROSPECTUS SUPPLEMENT SUMMARY</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following summary is qualified in its entirety by reference to the more detailed information included elsewhere in this Prospectus Supplement and in the accompanying Prospectus and in the SAI.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The Fund</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund is a diversified, closed-end management investment company. The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total return, primarily through current income and, secondarily, through capital appreciation. The Fund is not intended as, and you should not construe it to be, a complete investment program. There can be no assurance that the Fund&#8217;s investment objective will be achieved or that the Fund&#8217;s investment program will be successful. The Fund&#8217;s common shares are listed for trading on the NYSE under the symbol &#8220;ARDC.&#8221;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Adviser</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Ares Capital Management II LLC (previously defined as the &#8220;Adviser&#8221;) is the Fund&#8217;s investment adviser. The Adviser receives a management fee at an annual rate of 1.00% of the average daily value of the Fund's total assets (including any assets attributable to any preferred shares or to indebtedness) minus the Fund's liabilities other than liabilities relating to indebtedness (&#8220;Managed Assets&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The Offering</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[The provisions of the Investment Company Act generally require that the public offering price of common shares (less any underwriting commissions and discounts) must equal or exceed the net asset value per share of a company&#8217;s common shares (calculated within 48 hours of pricing).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Sales of our common shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-4 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Use of Proceeds</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">We currently anticipate that we will be able to invest all of the net proceeds of any sales of common shares pursuant to this Prospectus Supplement in accordance with our investment objective and policies as described in the accompanying Prospectus under &#8220;The Fund&#8217;s Investments&#8221; within approximately three months of the receipt of such proceeds</span>; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment, it is anticipated that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market instruments. Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_003_integixAnchor"></span><strong>SUMMARY OF FUND EXPENSES</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table and example are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in our common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left">Shareholder Transaction Expenses</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:right">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;width:88%;text-align:left">Sales load paid by you (as a percentage of offering price)</td><td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Offering expenses borne by the Fund (as a percentage of offering price)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Dividend reinvestment plan fees(1)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">Annual Expenses (as a percentage of net assets attributable to common shares)</td><td style="font-size:10pt;padding-bottom:1pt">&#160;</td><td style="font-size:10pt;text-align:right">&#160;</td><td style="padding-bottom:1pt;font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Advisory Fees(2)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">[&#9679;]</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Interest payments on borrowed funds(3)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;padding-bottom:1pt">Other Expenses(4)</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Total Annual Fund Operating Expenses</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr></table><p style="margin-top:0;margin-bottom:0">&#160;</p><div style="margin-top:3pt;margin-bottom:3pt;width:25%"><div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage of </span>[&#9679;]<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal </span>[&#9679;]<span>% of the Fund&#8217;s net assets.</span></span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023. &#160;We had outstanding borrowings of approximately $[&#9679;] (with a carrying value of approximately $[&#9679;]) as of [&#9679;]. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of [&#9679;]% of the Fund&#8217;s Managed Assets <span>and </span>[&#9679;]<span>% of the Fund&#8217;s net assets</span>) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</span></td></tr></table><p style="margin-top:0;margin-bottom:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-5 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin-top:0;margin-bottom:0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual expenses of [&#9679;]% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom"><td style="font-size:10pt;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>One&#160;Year</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Three&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Five&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Ten&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The example should not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_004_integixAnchor"></span><strong>USE OF PROCEEDS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">We estimate the total net proceeds of the offering to be $[<span>&#9679;</span>], based on the public offering price of $[<span>&#9679;</span>] per share and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The net proceeds from the issuance of common shares hereunder will be invested in accordance with the Fund&#8217;s investment objective and policies as set forth in this Prospectus Supplement and the accompanying Prospectus. We currently anticipate that we will be able to invest all of the net proceeds in accordance with our investment objective and policies within approximately three months of the receipt of such proceeds</span>; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment, it is anticipated that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market instruments. Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital. A return of capital is a return to investors of a portion of their original investment in the Fund. In general terms, a return of capital would involve a situation in which the Fund distribution (or a portion thereof) represents a return of a portion of a shareholder&#8217;s investment in the Fund, rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. Although return of capital distributions may not be currently taxable, such distributions would decrease the basis of a shareholder&#8217;s shares, and therefore, may increase a shareholder&#8217;s tax liability for capital gains upon a sale of shares, even if sold at a loss to the shareholder&#8217;s original investments.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_005_integixAnchor"></span><strong>CAPITALIZATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table sets forth the unaudited capitalization of the Fund as of [<span>&#9679;</span>], 2024 and its adjusted capitalization assuming the common shares available in the offering discussed in this Prospectus Supplement had been issued.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[To be provided.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_006_integixAnchor"></span><strong>PLAN OF DISTRIBUTION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[To be provided.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_007_integixAnchor"></span><strong>LEGAL MATTERS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Certain legal matters in connection with the common shares will be passed upon for the Fund by Willkie Farr&#160;&amp; Gallagher LLP, New York, New York, counsel to the Fund. Willkie Farr&#160;&amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP, Baltimore, Maryland. [Certain legal matters will be passed on by [<span>&#9679;</span>] as special counsel to the Underwriters in connection with the offering.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-6 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_008_integixAnchor"></span><strong>ADDITIONAL INFORMATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement and the accompanying Prospectus constitute part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the Investment Company Act. This Prospectus Supplement and the accompanying Prospectus omit certain of the information contained in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with respect to the Fund and the common shares offered hereby. Any statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed by its rules&#160;and regulations or free of charge through the SEC&#8217;s website (<span style="text-decoration:underline">http://www.sec.gov</span>).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-7 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Common Stock</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>PROSPECTUS SUPPLEMENT</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>[<span>&#9679;</span>], 2024</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong>Until [&#160;&#160;&#160;&#160;], 2024 (25 days after the date of this Prospectus Supplement), all dealers that buy, sell or trade the common shares, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">S-8 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;color:#eb0029">The information in this Preliminary Prospectus Supplement is not complete and may be changed. Ares Dynamic Credit Allocation Fund,&#160;Inc. may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Preliminary Prospectus Supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;color:#eb0029"><strong>SUBJECT TO COMPLETION, DATED AUGUST 14, 2024</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">PROSPECTUS SUPPLEMENT&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(To Prospectus dated [&#9679;], 2024)</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right">Filed Pursuant to Rule&#160;424(b)[(2)][(5)]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right">Registration Statement No.&#160;333-[&#9679;]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>[</strong></span><span style="font-size:10pt">&#9679;<strong>] Rights for [</strong>&#9679;<strong>] Common Shares</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Subscription Rights to Acquire Common Shares</strong></span></p><p style="border-bottom:Black thin solid;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Ares Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is issuing subscription rights (the &#8220;Rights&#8221;) to our common stockholders (the &#8220;common shareholders&#8221;) to purchase additional shares of common stock, par value $0.001 per share (each, a &#8220;common share&#8221; and collectively, the &#8220;common shares&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended</span>, together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;). The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total return, primarily through current income and, secondarily, through capital appreciation. The Fund&#8217;s investment adviser is Ares Capital Management II LLC (the &#8220;Adviser&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The common shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; Common shareholders of record on [&#9679;], 2024 (the &#8220;Record Date&#8221;) will receive [&#9679;] Right for each common share held. These Rights are transferable and will allow the holders thereof to purchase additional common shares. The Rights will be listed for trading on the [&#9679;] under the symbol &#8220;[&#9679;]&#8221; during the course of the Rights offering.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">On [&#9679;], 2024 (the last trading date prior to the common shares trading ex-Rights), the last reported net asset value per share of the common shares was $[&#9679;] and the last reported sales price per share of common shares on the NYSE was $[&#9679;].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement, together with the accompanying Prospectus, sets forth concisely the information about the Fund that a prospective investor should know before investing. You should read this Prospectus Supplement and the accompanying Prospectus, which contain important information, before deciding whether to invest in the common shares. You should retain the accompanying Prospectus and this Prospectus Supplement for future reference. A Statement of Additional Information (&#8220;SAI&#8221;), dated [&#9679;], 2024, containing additional information about the Fund, has been filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) and, as amended from time to time, is incorporated by reference in its entirety into this Prospectus Supplement and the accompanying Prospectus. This Prospectus Supplement, the accompanying Prospectus and the SAI are part of a &#8220;shelf&#8221; registration statement filed with the SEC. This Prospectus Supplement describes the specific details regarding this offering, including the method of distribution. If information in this Prospectus Supplement is inconsistent with the accompanying Prospectus or the SAI, you should rely on this Prospectus Supplement. You may call (888) 818-5298, visit the Fund&#8217;s website (www.arespublicfunds.com) or write to the Fund to obtain, free of charge, copies of the SAI and the Fund&#8217;s semi-annual and annual reports, as well as to obtain other information about the Fund or to make shareholder inquiries. The SAI, as well as the Fund&#8217;s semi-annual and annual reports, are also available for free on the SEC&#8217;s website (http://www.sec.gov). You may also e-mail requests for these documents to publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus Supplement or the accompanying Prospectus. Common shareholders please call toll-free at [&#9679;] (banks and brokers please call [&#9679;]) or please send written requests to [&#9679;].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-1 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investing in common shares through Rights involves certain risks that are described in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>SHAREHOLDERS WHO DO NOT FULLY EXERCISE THEIR RIGHTS MAY, AT THE COMPLETION OF THE OFFERING, OWN A SMALLER PROPORTIONAL INTEREST IN THE FUND THAN IF THEY EXERCISED THEIR RIGHTS. AS A RESULT OF THE OFFERING YOU MAY&#160;EXPERIENCE SUBSTANTIAL DILUTION OF THE AGGREGATE NET ASSET VALUE OF YOUR COMMON SHARES DEPENDING UPON WHETHER THE FUND&#8217;S NET ASSET VALUE PER COMMON SHARE IS ABOVE OR BELOW THE SUBSCRIPTION PRICE ON THE EXPIRATION DATE. ALL COSTS OF THE OFFERING WILL BE BORNE BY THE FUND, AND INDIRECTLY BY CURRENT SHAREHOLDERS WHETHER THEY EXERCISE THEIR RIGHTS OR NOT. RIGHTS EXERCISED BY A SHAREHOLDER ARE IRREVOCABLE.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>ANY COMMON SHARES ISSUED AS A RESULT OF THE RIGHTS OFFERING WILL NOT BE RECORD DATE SHARES FOR THE FUND&#8217;S MONTHLY DISTRIBUTION TO BE PAID ON [</strong></span>&#9679;<strong>], 2024 AND WILL NOT BE ENTITLED TO RECEIVE SUCH DISTRIBUTION.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="font-size:10pt;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Per&#160;Share</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Total</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;width:74%;text-align:left;text-indent:-0.125in;padding-left:0.125in">Estimated subscription price of common shares to shareholders exercising Rights(1)</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right">[&#9679;]</td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right">[&#9679;]</td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Underwriting discounts and commissions</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">$</td><td style="font-size:10pt;text-align:right">[&#9679;]</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">$</td><td style="font-size:10pt;text-align:right">[&#9679;]</td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Estimated proceeds, before expenses, to the Fund(2)</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">$</td><td style="font-size:10pt;text-align:right">[&#9679;]</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">$</td><td style="font-size:10pt;text-align:right">[&#9679;]</td><td style="font-size:10pt;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The estimated subscription price to the public is based upon [&#9679;]% of the last reported sales price of the Fund&#8217;s common shares of beneficial interest on the NYSE on [&#9679;], 2024. </span></td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Before deduction of expenses related to the Rights offering, which are estimated approximately at $[&#9679;]. Any offering expenses are paid indirectly by shareholders. Such fees and expenses will immediately reduce the net asset value per share of each common share purchased by an investor in the Rights offering. The indirect expenses of the offering that shareholders will pay are estimated to be $[&#9679;] in the aggregate and $[&#9679;] per share. The amount of proceeds to the Fund net of any fees and expenses of the offering are estimated to be $[&#9679;] in the aggregate and $[&#9679;] per share. Shareholders will not directly bear any offering expenses. </span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[The common shares are expected to be ready for delivery in book-entry form through the [insert depository name] on or about [&#9679;], 2024, unless extended. If the offering is extended, the common shares are expected to be ready for delivery in book-entry form through the [&#9679;] on or about [&#9679;], 2024.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">You should not construe the contents of this Prospectus Supplement and the accompanying Prospectus as legal, tax or financial advice. You should consult with your own professional advisers as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>The Fund&#8217;s common shares do not represent a deposit or an obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>The date of this Prospectus Supplement is [&#9679;], 2024.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-2 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. This Prospectus Supplement will be amended to reflect material changes to the information contained herein and will be delivered to shareholders. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to Ares Dynamic Credit Allocation Fund,&#160;Inc., a Maryland corporation.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div><div style="font:10pt Times New Roman, Times, Serif"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">TABLE OF CONTENTS</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Prospectus Supplement</strong></span></td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:90%;padding-left:0.5in;text-indent:-0.5in"><a href="#s_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</span></a></td><td style="width:10%;text-align:right"><a href="#s_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">4</span></a></td></tr><tr style="vertical-align:bottom"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</span></a></td><td style="text-align:right"><a href="#s_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">4</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF THE RIGHTS OFFERING</span></a></td><td style="text-align:right"><a href="#s_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">8</span></a></td></tr><tr style="vertical-align:bottom"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td><td style="text-align:right"><a href="#s_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">17</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td><td style="text-align:right"><a href="#s_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">17</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAPITALIZATION</span></a></td><td style="text-align:right"><a href="#s_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">18</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SPECIAL CHARACTERISTICS AND RISKS OF THE RIGHTS OFFERING</span></a></td><td style="text-align:right"><a href="#s_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">18</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#s_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION</span></a></td><td style="text-align:right"><a href="#s_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">20</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td><td style="text-align:right"><a href="#s_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr><tr style="vertical-align:bottom"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEGAL MATTERS</span></a></td><td style="text-align:right"><a href="#s_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">23</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL STATEMENTS</span></a></td><td style="text-align:right"><a href="#s_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">23</span></a></td></tr><tr style="vertical-align:bottom"><td style="padding-left:0.5in;text-indent:-0.5in"><a href="#s_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">ADDITIONAL INFORMATION</span></a></td><td style="text-align:right"><a href="#s_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">23</span></a></td></tr><tr style="vertical-align:bottom"><td style="padding-left:0.5in;text-indent:-0.5in">&#160;</td><td style="text-align:right">&#160;</td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Prospectus</strong></span></td></tr><tr style="vertical-align:bottom"><td colspan="2" style="text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUMMARY</span></a></td><td style="text-align:right"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td><td style="text-align:right"><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL HIGHLIGHTS</span></a></td><td style="text-align:right"><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">1</span></a>1</td></tr><tr style="vertical-align:bottom"><td><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td><td style="text-align:right"><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND</span></a></td><td style="text-align:right"><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF SHARES</span></a></td><td style="text-align:right"><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND&#8217;S INVESTMENTS</span></a></td><td style="text-align:right"><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">14</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEVERAGE</span></a></td><td style="text-align:right"><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RISKS</span></a></td><td style="text-align:right"><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">HOW THE FUND MANAGES RISK</span></a></td><td style="text-align:right"><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">MANAGEMENT OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">NET ASSET VALUE</span></a></td><td style="text-align:right"><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">27</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DISTRIBUTIONS</span></a></td><td style="text-align:right"><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">29</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DIVIDEND REINVESTMENT PLAN</span></a></td><td style="text-align:right"><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RIGHTS OFFERINGS</span></a></td><td style="text-align:right"><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAX MATTERS</span></a></td><td style="text-align:right"><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">31</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION OF HOLDERS OF RIGHTS</span></a></td><td style="text-align:right"><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">37</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CERTAIN PROVISIONS IN THE CHARTER AND BYLAWS</span></a></td><td style="text-align:right"><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">38</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CLOSED-END FUND STRUCTURE</span></a></td><td style="text-align:right"><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">REPURCHASE OF COMMON SHARES</span></a></td><td style="text-align:right"><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td><td style="text-align:right"><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr><tr style="vertical-align:bottom"><td><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">INCORPORATION BY REFERENCE</span></a></td><td style="text-align:right"><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRIVACY PRINCIPLES OF THE FUND</span></a></td><td style="text-align:right"><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-3 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_009_integixAnchor"></span><strong>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (&#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement, as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221; section of the accompanying Prospectus and &#8220;Special Characteristics and Risks of the Rights Offering&#8221; in this Prospectus Supplement. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI, are made as of the date of this Prospectus Supplement or the accompanying Prospectus or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risks&#8221; section of the accompanying Prospectus, as well as in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in the common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_010_integixAnchor"></span><strong>SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;width:32%;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Terms of the Rights Offering</strong></span></td><td style="padding-bottom:10pt;width:68%;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">One transferable subscription right (a &#8220;Right&#8221;) will be issued for each share of common stock, par value $0.001 per share, of Ares Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) (each, a &#8220;common share,&#8221; and collectively, the &#8220;common shares&#8221;) held on the Record Date (as defined below). Rights are expected to trade on the [&#9679;] under the symbol &#8220;[&#9679;].&#8221; The Rights will allow common shareholders to subscribe for new common shares of the Fund. [&#9679;] common shares of the Fund are outstanding as of [&#9679;], 2024. [&#9679;] Rights will be required to purchase one common share. Shares of the Fund, as a closed-end fund, can trade at a discount to net asset value (&#8220;NAV&#8221;). Upon exercise of the Rights offering, Fund shares are expected to be issued at a price below NAV per common share. [An over-subscription privilege will be offered, [subject to the right of the Board of Directors of the Fund (the &#8220;Board&#8221; and each member thereof, a &#8220;Director&#8221;) to eliminate the over-subscription privilege.]] [&#9679;] common shares of the Fund will be issued if all Rights are exercised. See &#8220;Terms of the Rights Offering.&#8221; Any common shares issued as a result of the Rights offering will not be record date shares for the Fund&#8217;s monthly distribution to be paid on [&#9679;], 2024 and will not be entitled to receive such distribution. The exercise of rights by a shareholder is irrevocable.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Amount Available for Primary Subscription</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Approximately $[&#9679;], before expenses.</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Title</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Subscription Rights to Acquire Common Shares</span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-4 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:32%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Subscription Price</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:68%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The final subscription price per common share (the &#8220;Subscription Price&#8221;) will be determined based upon a formula equal to [&#9679;]% of the average of the last reported sales price of the Fund&#8217;s common shares on the New York Stock Exchange (&#8220;NYSE&#8221;) on the Expiration Date (as defined below) and each of the [four] preceding trading days (the &#8220;Formula Price&#8221;). If, however, the Formula Price is less than [&#9679;]% of the NAV per common share of the Fund&#8217;s common shares at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be [&#9679;]% of the Fund&#8217;s NAV per common share at the close of trading on the NYSE on that day. See &#8220;Terms of the Rights Offering.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Record Date</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Rights will be issued to holders of record of the Fund&#8217;s common shares as of the close of business on [&#9679;], 2024 (the &#8220;Record Date&#8221;). See &#8220;Terms of the Rights Offering.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Number of Rights Issued</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">One Right will be issued in respect of each common share of the Fund outstanding as of the close of business on the Record Date. See &#8220;Terms of the Rights Offering.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Number of Rights Required to Purchase One Common Share</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">A holder of Rights may purchase [&#9679;] common shares of the Fund for every [&#9679;] Rights exercised. The number of Rights to be issued to a shareholder as of the close of business on the Record Date will be rounded up to the nearest number of Rights evenly divisible by [&#9679;]. See &#8220;Terms of the Rights Offering.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Over-Subscription Privilege</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common shareholders as of the close of business on the Record Date (&#8220;Record Date Shareholders&#8221;) who fully exercise all Rights initially issued to them are entitled to buy those common shares, referred to as &#8220;primary over-subscription shares,&#8221; that were not purchased by other Rights holders at the same Subscription Price. If enough primary over-subscription shares are available, all such requests will be honored in full. If the requests for primary over-subscription shares exceed the primary over-subscription shares available, the available primary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. Common shares acquired pursuant to the primary over-subscription privilege are subject to allotment. Rights acquired in the secondary market may not participate in the primary over-subscription privilege.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[In addition, the Fund, in its sole discretion, may determine to issue additional common shares at the same Subscription Price in an amount of up to [&#9679;]% of the shares issued pursuant to the primary subscription, referred to as &#8220;secondary over-subscription shares.&#8221; Should the Fund determine to issue some or all of the secondary over-subscription shares, they will be allocated only among Record Date Shareholders who submitted over-subscription requests. Secondary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. Rights acquired in the secondary market may not participate in the secondary over-subscription privilege.]</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Notwithstanding the above, the Board has the right in its absolute discretion to eliminate the primary over-subscription privilege and/or secondary over-subscription privilege (together, the &#8220;over-subscription privilege&#8221;) if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the fifth day following the Expiration Date (as defined below). See &#8220;Over-Subscription Privilege.&#8221;</span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-5 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:32%">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:68%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Any common shares issued pursuant to the over-subscription privilege will be shares registered under the Prospectus.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Transfer of Rights</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[The Rights will be transferable. See &#8220;Terms of the Rights Offering,&#8221; &#8220;Sales by Rights Agent&#8221; and &#8220;Method of Transferring Rights.&#8221;]</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Subscription Period</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Rights may be exercised at any time after issuance and prior to expiration of the Rights (the &#8220;Subscription Period&#8221;), which will be [5:00 PM, Eastern Time] on [&#9679;], 2024 (the &#8220;Expiration Date&#8221;), unless otherwise extended. See &#8220;Terms of the Rights Offering&#8221; and &#8220;Method of Exercise of Rights.&#8221; The Rights offering may be terminated [or extended] by the Fund at any time for any reason before the Expiration Date. If the Fund terminates the Rights offering, the Fund will issue a press release announcing such termination and will direct the Rights Agent (defined below) to return, without interest, all subscription proceeds received to such shareholders who had elected to purchase common shares.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Offering Expenses</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The expenses of the Rights offering are expected to be approximately $[&#9679;] and will be borne by holders of the Fund&#8217;s common shares. See &#8220;Use of Proceeds.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Sale of Rights</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Rights are transferable until the completion of the Subscription Period and will be admitted for trading on the NYSE under the symbol &#8220;[&#9679;].&#8221; Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [&#9679;] is expected to begin two Business Days prior to the Record Date and may be conducted until the close of trading on the last [&#9679;] trading day prior to the Expiration Date. For purposes of this Prospectus Supplement, a &#8220;Business Day&#8221; shall mean any day on which trading is conducted on the [&#9679;].</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The value of the Rights, if any, will be reflected by their market price on the [&#9679;]. Rights may be sold by individual holders through their broker or financial adviser or may be submitted to the Rights Agent (defined below) for sale. Any Rights submitted to the Rights Agent for sale must be received by the Rights Agent prior to [5:00 PM, Eastern Time], on or before [&#9679;], 2024, [&#9679;] Business Days prior to the Expiration Date (or, if the Subscription Period is extended, prior to [5:00 PM, Eastern Time], on the [&#9679;] Business Day prior to the extended Expiration Date).</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Rights that are sold will not confer any right to acquire any common shares in any over-subscription, and any Record Date Shareholder who sells any Rights will not be eligible to participate in the over-subscription privilege, if any.</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Trading of the Rights on the [&#9679;] will be conducted on a when-issued basis until and including the date on which the Subscription Certificates (as defined below) are mailed to Record Date Shareholders of record and thereafter will be conducted on a regular-way basis until and including the last [&#9679;] trading day prior to the completion of the Subscription Period. The shares are expected to begin trading ex-Rights one Business Day prior to the Record Date.</span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-6 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:32%">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:68%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">If the Rights Agent receives Rights for sale in a timely manner, the Rights Agent will use its best efforts to sell the Rights on the [&#9679;]. The Rights Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States, or who have an APO or FPO address. See &#8220;Foreign Restrictions.&#8221; The Rights Agent will attempt to sell such Rights, including by first offering such Rights to the Dealer Manager (defined below) for purchase by the Dealer Manager at the then-current market price on the [&#9679;]. The Rights Agent may offer Rights to the Dealer Manager before attempting to sell them on the [&#9679;].</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Any commissions will be paid by the selling Rights holders. Neither the Fund nor the Rights Agent will be responsible if Rights cannot be sold and neither has guaranteed any minimum sales price for the Rights. If the Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses (i.e., costs incidental to the sale of Rights).</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">For a discussion of actions that may be taken by [&#9679;] (the &#8220;Dealer Manager&#8221;) to seek to facilitate the trading market for Rights and the placement of common shares pursuant to the exercise of Rights, including the purchase of Rights and the sale during the Subscription Period by the Dealer Manager of common shares acquired through the exercise of Rights and the terms on which such sales will be made, see &#8220;Plan of Distribution.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders are urged to obtain a recent trading price for the Rights on the [&#9679;] from their broker, bank, financial adviser or the financial press.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Banks, broker-dealers and trust companies that hold shares for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights will not participate in any over-subscription privilege. See &#8220;Terms of the Rights Offering&#8221; and &#8220;Sales by Rights Agent.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Use of Proceeds</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund estimates the net proceeds of the Rights offering to be approximately $[&#9679;]. This figure is based on the Subscription Price per common share of $[&#9679;] ([&#9679;]% of the last reported sales price of the Fund&#8217;s common shares on the NYSE on [&#9679;], 2024) and assumes all new common shares offered are sold and that the expenses related to the Rights offering estimated at approximately $[&#9679;] are paid.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Adviser anticipates that investment of the proceeds will be made in accordance with the Fund&#8217;s investment objective and policies as appropriate investment opportunities are identified, which is expected to be substantially completed in approximately three months; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months. Pending such investment, the proceeds will be held in [cash and/or high quality, short-term debt securities and instruments]. </span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt">&#160;</td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital. A return of capital is a return to investors of a portion of their original investment in the Fund. In general terms, a return of capital would involve a situation in which the Fund distribution (or a portion thereof) represents a return of a portion of a shareholder&#8217;s investment in the Fund, rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. Although return of capital distributions may not be currently taxable, such distributions would decrease the basis of a shareholder&#8217;s shares and, therefore, may increase a shareholder&#8217;s tax liability for capital gains upon a sale of shares, even if sold at a loss to the shareholder&#8217;s original investments. See &#8220;Use of Proceeds.&#8221;</span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-7 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:32%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Taxation/ERISA</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:68%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">See &#8220;Taxation&#8221; and &#8220;Employee Benefit Plan and IRA Considerations.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Rights Agent</strong></span></td><td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]. See &#8220;Rights Agent.&#8221;</span></td></tr><tr style="vertical-align:top"><td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Information Agent</strong></span></td><td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]. See &#8220;Information Agent.&#8221;</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_011_integixAnchor"></span><strong>DESCRIPTION OF THE RIGHTS OFFERING</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Terms of the Rights Offering</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund is issuing to Record Date Shareholders Rights to subscribe for common shares of the Fund. Each Record Date Shareholder is being issued one transferable Right for each common share owned on the Record Date. The Rights entitle the holder to acquire, at a subscription price per common share (the &#8220;Subscription Price&#8221;) determined based upon a formula equal to [&#9679;]% of the average of the last reported sales price of the Fund&#8217;s common shares on the NYSE on the Expiration Date (as defined below) and each of the [four] preceding trading days (the &#8220;Formula Price&#8221;), [&#9679;] new common share for each [&#9679;] Rights held. If, however, the Formula Price is less than [&#9679;]% of the NAV per common share of the Fund&#8217;s common shares at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be [&#9679;]% of the Fund&#8217;s NAV per common share at the close of trading on the NYSE on that day. The estimated Subscription Price to the public of $[&#9679;] is based upon [&#9679;]% of the last reported sales price of the Fund&#8217;s common shares on the NYSE on [&#9679;], 2024. Fractional shares will not be issued upon the exercise of the Rights. Accordingly, common shares may be purchased only pursuant to the exercise of Rights in integral multiples of [&#9679;]. The number of Rights to be issued to a Record Date Shareholder will be rounded up to the nearest number of Rights evenly divisible by [&#9679;]. In the case of common shares held of record by Cede&#160;&amp; Co. (&#8220;Cede&#8221;), as nominee for the Depository Fund Company (&#8220;DTC&#8221;), or any other depository or nominee, the number of Rights issued to Cede or such other depository or nominee will be adjusted to permit rounding up (to the nearest number of Rights evenly divisible by [&#9679;]) of the Rights to be received by beneficial owners for whom it is the holder of record only if [insert nominee name] or such other depository or nominee provides to the Fund on or before the close of business on [&#9679;], 2024 written representation of the number of Rights required for such rounding. Rights may be exercised at any time during the period (the &#8220;Subscription Period&#8221;) which commences on [&#9679;], 2024, and ends at [5:00 PM, Eastern Time] on [&#9679;], 2024 (the &#8220;Expiration Date&#8221;), unless otherwise extended. Shares of the Fund, as a closed-end fund, can trade at a discount to NAV. Upon exercise of the Rights offering, Fund shares are expected to be issued at a price below NAV per common share. The right to acquire one common share for each [&#9679;] Rights held during the Subscription Period (or any extension of the Subscription Period) at the Subscription Price will be referred to in the remainder of this Prospectus Supplement as the &#8220;Rights offering.&#8221; <i>Rights will expire on the Expiration Date and thereafter may not be exercised</i>. <strong><i>Any common shares issued as a result of the Rights offering will not be Record Date shares for the Fund&#8217;s monthly distribution to be paid on [</i></strong>&#9679;<strong><i>], 2024 and will not be entitled to receive such distribution</i></strong>.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund has entered into a dealer manager agreement with the Dealer Manager that allows the Dealer Manager to take actions to seek to facilitate the trading market for Rights and the placement of common shares pursuant to the exercise of Rights. Those actions are expected to involve the Dealer Manager purchasing and exercising Rights during the Subscription Period at prices determined at the time of such exercise, which are expected to vary from the Subscription Price. See &#8220;Plan of Distribution&#8221; for additional information.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-8 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Rights may be evidenced by subscription certificates or may be uncertificated and evidenced by other appropriate documentation (i.e., a rights card distributed to registered shareholders in lieu of a subscription certificate) (&#8220;Subscription Certificates&#8221;). The number of Rights issued to each holder will be stated on the Subscription Certificate delivered to the holder. The method by which Rights may be exercised and common shares paid for is set forth below in &#8220;Method of Exercise of Rights,&#8221; &#8220;Payment for Shares&#8221; and &#8220;Plan of Distribution.&#8221; A holder of Rights will have no right to rescind a purchase after [&#9679;] (the &#8220;Rights Agent&#8221;) has received payment. See &#8220;Payment for Shares&#8221; below. It is anticipated that the common shares issued pursuant to an exercise of Rights will be listed on the [&#9679;].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Holders of Rights [who are Record Date Shareholders] are entitled to subscribe for additional common shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations, allotment and the right of the Board to eliminate the primary over-subscription privilege [or secondary] over-subscription privilege. See &#8220;Over-Subscription Privilege&#8221; below.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">For purposes of determining the maximum number of common shares that may be acquired pursuant to the Rights offering, broker-dealers, trust companies, banks or others whose shares are held of record by Cede or by any other depository or nominee will be deemed to be the holders of the Rights that are held by Cede or such other depository or nominee on their behalf.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Rights are transferable until the completion of the Subscription Period and will be admitted for trading on the [&#9679;] under the symbol &#8220;[&#9679;].&#8221; Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels and also sold through the Rights Agent. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [&#9679;] is expected to begin two Business Days prior to the Record Date and may be conducted until the close of trading on the last [&#9679;] trading day prior to the Expiration Date. Trading of the Rights on the [&#9679;] is expected to be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders of record and thereafter is expected to be conducted on a regular way basis until and including the last [&#9679;] trading day prior to the Expiration Date. The method by which Rights may be transferred is set forth below under &#8220;Method of Transferring Rights.&#8221; The common shares are expected to begin trading ex-Rights one Business Day prior to the Record Date as determined and announced by the [&#9679;]. The Rights offering may be terminated or extended by the Fund at any time for any reason before the Expiration Date. If the Fund terminates the Rights offering, the Fund will issue a press release announcing such termination and will direct the Rights Agent to return, without interest, all subscription proceeds received to such shareholders who had elected to purchase common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Nominees who hold the Fund&#8217;s common shares for the account of others, such as banks, broker-dealers, trustees or depositories for securities, should notify the respective beneficial owners of such shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the nominee should complete the Subscription Certificate and submit it to the Rights Agent with proper payment. In addition, beneficial owners of the common shares or Rights held through such a nominee should contact the nominee and request the nominee to effect transactions in accordance with such beneficial owner&#8217;s instructions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Participants in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;) will be issued Rights in respect of the common shares held in their accounts in the Plan. Participants wishing to exercise these Rights must exercise the Rights in accordance with the procedures set forth in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221;]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Conditions of the Rights Offering</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Rights offering is being made in accordance with the Investment Company Act of 1940, as amended</span>, together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;), and is not subject to shareholder approval. The staff of the SEC has interpreted the Investment Company Act as not requiring shareholder approval of a transferable rights offering to purchase common shares at a price below the then-current NAV so long as certain conditions are met, including: (i)&#160;a good faith determination by the Fund&#8217;s Board that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders&#8217; preemptive rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii)&#160;management uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and (iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-9 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Important Dates to Remember</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Please note that the dates in the table below may change if the Rights offering is extended.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:80%;border-collapse:collapse;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="border-bottom:Black 1pt solid;white-space:nowrap"><strong>Event</strong></td><td style="padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Date</strong></span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Record Date</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Subscription Period</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024 through&#160;[&#9679;], 2024&#8224;</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Expiration Date*</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024&#8224;</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Payment for Guarantees of Delivery Due*</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024&#8224;</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Issuance Date</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024&#8224;</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Confirmation Date</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;], 2024&#8224;</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:3pt;margin-bottom:3pt;width:25%"><div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">*</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">A shareholder exercising Rights must deliver to the Rights Agent by [5:00 PM, Eastern Time] on [&#9679;], 2024 (unless the offer is extended) either (a)&#160;a Subscription Certificate and payment for common shares or (b)&#160;a notice of guaranteed delivery and payment for common shares. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8224;</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Unless the offer is extended. </span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>[Over-Subscription Privilege</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Board has the right in its absolute discretion to eliminate the over-subscription privilege with respect to primary over-subscription shares and secondary over-subscription shares if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the fifth day following the Expiration Date. If the primary over-subscription privilege is not eliminated, it will operate as set forth below.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Rights holders [who are Record Date Shareholders and who fully exercise their Rights] are entitled to subscribe for additional common shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Record Date Shareholders who fully exercise all Rights initially issued to them] are entitled to buy those common shares, referred to as &#8220;primary over-subscription shares,&#8221; that were not purchased by other holders of Rights at the same Subscription Price. If enough primary over-subscription shares are available, all such requests will be honored in full. If the requests for primary over-subscription shares exceed the primary over-subscription shares available, the available primary over-subscription shares will be allocated pro rata among those fully exercising [Record Date Shareholders] who over-subscribe based on the number of Rights originally issued to them by the Fund. Common shares <strong><i>acquired pursuant to the over-subscription privilege are subject to allotment</i></strong>.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[In addition, the Fund, in its sole discretion, may determine to issue additional common shares at the same Subscription Price in an amount of up to [ ]% of the shares issued pursuant to the primary subscription, referred to as &#8220;secondary over-subscription shares.&#8221; Should the Fund determine to issue some or all of the secondary over-subscription shares, they will be allocated only among Record Date Shareholders who submitted over-subscription requests. Secondary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. <i>Rights acquired in the secondary market may not participate in the over-subscription privilege</i>.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Record Date Shareholders who are fully exercising their Rights during the Subscription Period should indicate, on the Subscription Certificate that they submit with respect to the exercise of the Rights issued to them, how many common shares they are willing to acquire pursuant to the over-subscription privilege. Rights acquired in the secondary market may not participate in the over-subscription privilege.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">To the extent sufficient common shares are not available to fulfill all over-subscription requests, unsubscribed common shares (the &#8220;Excess Shares&#8221;) will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of Rights issued to them by the Fund. The allocation process may involve a series of allocations in order to assure that the total number of common shares available for over-subscriptions is distributed on a pro rata basis.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-10 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The formula to be used in allocating the Excess Shares is as follows:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:80%;border-collapse:collapse;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="white-space:nowrap;width:59%;border-bottom:black 1pt solid;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholder&#8217;s Record Date Position</span></td><td style="width:4%">&#160;</td><td style="width:37%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">X&#160;Excess&#160;Shares&#160;Remaining</span></td></tr><tr><td style="vertical-align:top;padding-left:10pt;text-indent:-10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Total&#160;Record&#160;Date&#160;Position&#160;of&#160;All Over-Subscribers</span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Banks, broker-dealers, trustees and other nominee holders of Rights will be required to certify to the Rights Agent, before any over-subscription privilege may be exercised with respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the Subscription Period and the number of common shares subscribed for pursuant to the over-subscription privilege by such beneficial owner and that such beneficial owner&#8217;s subscription was exercised in full. Nominee holder over-subscription forms and beneficial owner certification forms will be distributed to banks, broker-dealers, trustees and other nominee holders of Rights with the Subscription Certificates. [Nominees should also notify holders purchasing Rights in the secondary market that such Rights may not participate in the over-subscription privilege.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund will not otherwise offer or sell any common shares that are not subscribed for pursuant to the primary subscription, the primary over-subscription privilege or the secondary over-subscription privilege pursuant to the Rights offering.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Sales by Rights Agent</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Holders of Rights who are unable or do not wish to exercise any or all of their Rights may instruct the Rights Agent to sell any unexercised Rights. The Subscription Certificates representing the Rights to be sold by the Rights Agent must be received prior to [5:00 PM, Eastern Time], on [&#9679;], 2024, five Business Days prior to the Expiration Date (or, if the Subscription Period is extended, prior to [5:00 PM, Eastern Time], on the fifth Business Day prior to the extended Expiration Date). Upon the timely receipt of the appropriate instructions to sell Rights, the Rights Agent will use its best efforts to complete the sale and will remit the proceeds of sale, net of any commissions, to the holders. The Rights Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States, or who have an APO or FPO address. The selling Rights holder will pay all brokerage commissions incurred by the Rights Agent. These sales may be effected by the Rights Agent. The Rights Agent will automatically attempt to sell any unexercised Rights that remain unclaimed as a result of Subscription Certificates being returned by the postal authorities as undeliverable as of the [&#9679;] Business Day prior to the Expiration Date. The Rights Agent will attempt to sell such Rights, including by first offering such Rights to the Dealer Manager for purchase by the Dealer Manager at the then-current market price on the [&#9679;]. The Rights Agent will offer Rights to the Dealer Manager before attempting to sell them on the [&#9679;], which may affect the market price for Rights on the [&#9679;] and reduce the number of Rights available for purchase on the [&#9679;], thereby reducing the ability of new investors to participate in the offering. These sales will be made net of commissions, taxes and any other expenses paid on behalf of the nonclaiming holders of Rights. Proceeds from those sales will be held by State Street Bank and Trust Company in its capacity as the Fund&#8217;s transfer agent, for the account of the nonclaiming holder of Rights until the proceeds are either claimed or escheated. There can be no assurance that the Rights Agent will be able to complete the sale of any of these Rights and neither the Fund nor the Rights Agent has guaranteed any minimum sales price for the Rights. All of these Rights will be sold at the market price, if any, through an exchange or market trading the Rights. If the Rights can be sold, sales of the Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>[Dealer Manager</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[&#9679;] (previously defined as the &#8220;Dealer Manager&#8221;), a registered broker-dealer, may also act on behalf of its clients to purchase or sell Rights in the open market and may receive commissions from its clients for such services. Holders of Rights attempting to sell any unexercised Rights in the open market through a broker-dealer other than the Dealer Manager may be charged a different commission and should consider the commissions and fees charged by the broker-dealer prior to selling their Rights on the open market. The Dealer Manager is not expected to purchase Rights as principal for its own account in order to seek to facilitate the trading market for Rights or otherwise. See &#8220;Plan of Distribution&#8221; for additional information.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-11 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Sale of Rights</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Rights are transferable and will be admitted for trading on the [<span>&#9679;</span>] under the symbol &#8220;[<span>&#9679;</span>].&#8221; Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [<span>&#9679;</span>] is expected to begin two Business Days prior to the Record Date and may be conducted until the close of trading on the last [<span>&#9679;</span>] trading day prior to the Expiration Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The value of the Rights, if any, will be reflected by the market price. Rights may be sold by individual holders or may be submitted to the Rights Agent for sale. Any Rights submitted to the Rights Agent for sale must be received by the Rights Agent prior to [5:00 PM, Eastern Time], on [<span>&#9679;</span>], 2024, five Business Days prior to the Expiration Date (or, if the Subscription Period is extended, prior to [5:00 PM, Eastern Time], on the [<span>&#9679;</span>] Business Day prior to the extended Expiration Date).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Rights that are sold will not confer any right to acquire any common shares in any primary over-subscription privilege or secondary over-subscription privilege, if any, and any Record Date Shareholder who sells any Rights will not be eligible to participate in the primary over-subscription privilege or secondary over-subscription privilege, if any.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Trading of the Rights on the [<span>&#9679;</span>] will be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders of record and thereafter will be conducted on a regular-way basis until and including the last [<span>&#9679;</span>] trading day prior to the Expiration Date. The common shares are expected to begin trading ex-Rights one Business Day prior to the Record Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Shareholders are urged to obtain a recent trading price for the Rights on the [<span>&#9679;</span>] from their broker, bank, financial adviser or the financial press.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Method of Transferring Rights</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Rights evidenced by a single Subscription Certificate may be transferred in whole by endorsing the Subscription Certificate for transfer in accordance with the accompanying instructions. A portion of the Rights evidenced by a single Subscription Certificate (but not fractional Rights) may be transferred by delivering to the Rights Agent a Subscription Certificate properly endorsed for transfer, with instructions to register the portion of the Rights evidenced thereby in the name of the transferee (and to issue a new Subscription Certificate to the transferee evidencing the transferred Rights). In this event, a new Subscription Certificate evidencing the balance of the Rights will be issued to the Rights holder or, if the Rights holder so instructs, to an additional transferee.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Holders wishing to transfer all or a portion of their Rights (but not fractional Rights) should promptly transfer such Rights to ensure that: (i)&#160;the transfer instructions will be received and processed by the Rights Agent, (ii)&#160;a new Subscription Certificate will be issued and transmitted to the transferee or transferees with respect to transferred Rights, and to the holder with respect to retained Rights, if any, and (iii)&#160;the Rights evidenced by the new Subscription Certificates may be exercised or sold by the recipients thereof prior to the Expiration Date. Neither the Fund nor the Rights Agent shall have any liability to a transferee or holder of Rights if Subscription Certificates are not received in time for exercise or sale prior to the Expiration Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Except for the fees charged by the Rights Agent (which will be paid by the Fund as described below), all commissions, fees and other expenses (including brokerage commissions and transfer taxes) incurred in connection with the purchase, sale, transfer or exercise of Rights will be for the account of the holder of the Rights, and none of these commissions, fees or expenses will be borne by the Fund or the Rights Agent.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund anticipates that the Rights will be eligible for transfer through, and that the exercise of the Rights may be effected through, the facilities of [insert depository] (Rights exercised through [insert depository] are referred to as &#8220;[insert depository] Exercised Rights&#8221;).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-12 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Rights Agent</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Rights Agent is [<span>&#9679;</span>]. The Rights Agent will receive from the Fund an amount estimated to be $[<span>&#9679;</span>], comprised of the fee for its services and the reimbursement for certain expenses related to the Rights offering. The shareholders of the Fund will indirectly pay such amount.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Information Agent</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">INQUIRIES BY ALL HOLDERS OF RIGHTS SHOULD BE DIRECTED TO: THE INFORMATION AGENT, [<span>&#9679;</span>]; HOLDERS PLEASE CALL TOLL-FREE AT [<span>&#9679;</span>]; BANKS AND BROKERS PLEASE CALL [<span>&#9679;</span>].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Method of Exercise of Rights</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Rights may be exercised by completing and signing the Subscription Certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed Subscription Certificate to the Rights Agent, together with payment for the common shares as described below under &#8220;Payment for Shares.&#8221; Rights may also be exercised through the broker of a holder of Rights, who may charge the holder of Rights a servicing fee in connection with such exercise. See &#8220;Plan of Distribution&#8221; for additional information regarding the purchase and exercise of Rights by the Dealer Manager.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Completed Subscription Certificates and payment must be received by the Rights Agent prior to [5:00 PM, Eastern Time], on the Expiration Date (unless payment is effected by means of a notice of guaranteed delivery as described below under &#8220;Payment for Shares&#8221;). Your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier than [5:00 PM, Eastern Time], on the Expiration Date. The Subscription Certificate and payment should be delivered to the Rights Agent at the following address:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">If By Mail:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Ares Dynamic Credit Allocation Fund,&#160;Inc.<br/>[<span>&#9679;</span>]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">If By Overnight Courier:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Ares Dynamic Credit Allocation Fund,&#160;Inc.<br/>[<span>&#9679;</span>]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Payment for Shares</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Holders of Rights who acquire common shares in the Rights offering may choose between the following methods of payment:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.5in">(1)</td><td style="text-align:justify">A holder of Rights can send the Subscription Certificate, together with payment in the form of a check (which must include the name of the shareholder on the check) for the common shares subscribed for in the Rights offering and, if eligible, for any additional common shares subscribed for pursuant to the over-subscription privilege, to the Rights Agent based on the Subscription Price. To be accepted, the payment, together with the executed Subscription Certificate, must be received by the Rights Agent at one of the addresses noted above prior to [5:00 PM, Eastern Time] on the Expiration Date. The Rights Agent will deposit all share purchase checks received by it prior to the final due date into a segregated account pending proration and distribution of common shares. The Rights Agent will not accept cash as a means of payment for common shares.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in">&#160;</td><td style="width:0.5in">(2)</td><td style="text-align:justify">Alternatively, a subscription will be accepted by the Rights Agent if, prior to [5:00 PM, Eastern Time] on the Expiration Date, the Rights Agent has received a written notice of guaranteed delivery by mail or email from a bank, trust company, or a NYSE member, guaranteeing delivery of a properly completed and executed Subscription Certificate. In order for the notice of guarantee to be valid, full payment for the common shares at the Subscription Price must be received with the notice. The Rights Agent will not honor a notice of guaranteed delivery unless a properly completed and executed Subscription Certificate is received by the Rights Agent by the close of business on the [second] Business Day after the Expiration Date. The notice of guaranteed delivery must be emailed to the Rights Agent at [<span>&#9679;</span>] or delivered to the Rights Agent at one of the addresses noted above.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-13 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">A PAYMENT PURSUANT TO THIS METHOD MUST BE IN UNITED STATES DOLLARS BY CHECK (WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER ON THE CHECK) DRAWN ON A BANK LOCATED IN THE CONTINENTAL UNITED STATES, MUST BE PAYABLE TO ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC. AND MUST ACCOMPANY AN EXECUTED SUBSCRIPTION CERTIFICATE TO BE ACCEPTED.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The method and timing of payment for common shares acquired by the Dealer Manager through the exercise of Rights is described under &#8220;Plan of Distribution.&#8221;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">If a holder of Rights who acquires common shares pursuant to the Rights offering does not make payment of all amounts due, the Fund reserves the right to take any or all of the following actions: (i)&#160;find other purchasers for such subscribed-for and unpaid-for common shares; (ii)&#160;apply any payment actually received by it toward the purchase of the greatest whole number of common shares which could be acquired by such holder upon exercise of the Rights or any over-subscription privilege; (iii)&#160;sell all or a portion of the common shares purchased by the holder, in the open market, and apply the proceeds to the amounts owed; and (iv)&#160;exercise any and all other rights or remedies to which it may be entitled, including, without limitation, the right to set off against payments actually received by it with respect to such subscribed common shares and to enforce the relevant guarantee of payment.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Any payment required from a holder of Rights must be received by the Rights Agent prior to [5:00 PM, Eastern Time] on the Expiration Date. Issuance and delivery of the common shares purchased are subject to collection of checks.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Within [<span>&#9679;</span>] Business Days following the Expiration Date (the &#8220;Confirmation Date&#8221;), a confirmation will be sent by the Rights Agent to each holder of Rights (or, if the common shares are held by [insert nominee name] or any other depository or nominee, to [insert nominee name] or such other depository or nominee), showing (i)&#160;the number of common shares acquired pursuant to the subscription, (ii)&#160;the number of common shares, if any, acquired pursuant to the over-subscription privilege, and (iii)&#160;the per share and total purchase price for the common shares. Any payment required from a holder of Rights must be received by the Rights Agent on or prior to the Expiration Date. Any excess payment to be refunded by the Fund to a holder of Rights, or to be paid to a holder of Rights as a result of sales of Rights on its behalf by the Rights Agent, will be mailed by the Rights Agent to the holder within [<span>&#9679;</span>] Business Days after the Expiration Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">A holder of Rights will have no right to rescind a purchase after the Rights Agent has received payment either by means of a notice of guaranteed delivery or a check, which must include the name of the shareholder on the check.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Upon acceptance of a subscription, all funds received by the Rights Agent shall be held by the Rights Agent as agent for the Fund and deposited in one or more bank accounts. Such funds may be invested by the Rights Agent in: bank accounts, short-term certificates of deposit, bank repurchase agreements, and disbursement accounts with commercial banks meeting certain standards. The Rights Agent may receive interest, dividends or other earnings in connection with such deposits or investments.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Holders, such as broker-dealers, trustees or depositories for securities, who hold common shares for the account of others, should notify the respective beneficial owners of the common shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the record holder of the Rights should complete Subscription Certificates and submit them to the Rights Agent with the proper payment. In addition, beneficial owners of common shares or Rights held through such a holder should contact the holder and request that the holder effect transactions in accordance with the beneficial owner&#8217;s instructions. <strong>[Banks, broker-dealers, trustees and other nominee holders that hold common shares of the Fund for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights may not participate in any over-subscription privilege offered.]</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-14 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">THE INSTRUCTIONS ACCOMPANYING THE SUBSCRIPTION CERTIFICATES SHOULD BE READ CAREFULLY AND FOLLOWED IN DETAIL. DO NOT SEND SUBSCRIPTION CERTIFICATES TO THE FUND.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">THE METHOD OF DELIVERY OF SUBSCRIPTION CERTIFICATES AND PAYMENT OF THE SUBSCRIPTION PRICE TO THE RIGHTS AGENT WILL BE AT THE ELECTION AND RISK OF THE RIGHTS HOLDERS, BUT IF SENT BY MAIL,&#160;IT IS RECOMMENDED THAT THE CERTIFICATES AND PAYMENTS BE SENT BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED, AND THAT A SUFFICIENT NUMBER OF DAYS BE ALLOWED TO ENSURE DELIVERY TO THE RIGHTS AGENT AND CLEARANCE OF PAYMENT PRIOR TO [5:00 PM, EASTERN TIME], ON THE EXPIRATION DATE. BECAUSE UNCERTIFIED PERSONAL CHECKS MAY&#160;TAKE AT LEAST FIVE BUSINESS DAYS TO CLEAR, YOU ARE STRONGLY URGED TO PAY, OR ARRANGE FOR PAYMENT, BY MEANS OF A CERTIFIED OR CASHIER&#8217;S CHECK, WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER ON THE CHECK.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">All questions concerning the timeliness, validity, form and eligibility of any exercise of Rights will be determined by the Fund, whose determinations will be final and binding. The Fund in its sole discretion may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. Neither the Fund nor the Rights Agent will be under any duty to give notification of any defect or irregularity in connection with the submission of Subscription Certificates or incur any liability for failure to give such notification.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Foreign Restrictions</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Subscription Certificates will only be mailed to Record Date Shareholders of record whose addresses are within the United States (other than an APO or FPO address). Because the Rights offering will not be registered in any jurisdiction other than the United States, the Rights Agent will attempt to sell all of the Rights issued to shareholders of record outside of these jurisdictions and remit the net proceeds, if any, to such shareholders of record. If the Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day the Rights are sold, less any applicable brokerage commissions, taxes and other expenses.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Notice of Net Asset Value Decline</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund has, pursuant to the SEC&#8217;s regulatory requirements, undertaken to suspend the Rights offering until the Fund amends this Prospectus Supplement if, after [<span>&#9679;</span>], 2024 (the date of this Prospectus Supplement), the Fund&#8217;s NAV declines more than 10% from the Fund&#8217;s NAV as of that date. In that event, the Expiration Date will be extended and the Fund will notify Record Date Shareholders of record of any such decline and permit Rights holders to cancel their exercise of Rights.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Employee Benefit Plan and IRA Considerations</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Holders of Rights that are employee benefit plans subject to limitations imposed by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), such as employee plans subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), Keogh Plans and Individual Retirement Accounts (&#8220;IRA&#8221;) (each a &#8220;Benefit Plan&#8221; and collectively, &#8220;Benefit Plans&#8221;), should be aware that the use of additional contributions of cash outside of the Benefit Plan to exercise Rights may be treated as additional contributions to the Benefit Plan. When taken together with contributions previously made, such deemed additional contributions may be in excess of tax limitations and subject the Rights holder to excise taxes for excess or nondeductible contributions. In the case of Benefit Plans qualified under Section&#160;401(a)&#160;of the Code, additional contributions could cause the maximum contribution limitations of Section&#160;415 of the Code or other qualification rules&#160;to be violated. Benefit Plans contemplating making additional contributions to exercise Rights should consult with their legal and tax counsel prior to making such contributions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Benefit Plans and other tax-exempt entities, including governmental plans, should also be aware that if they borrow to finance their exercise of Rights, they may become subject to the tax on unrelated business taxable income under Section&#160;511 of the Code. If any portion of an IRA is used as security for a loan, the portion so used may also be treated as distributed to the IRA depositor.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-15 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">A Benefit Plan may also be subject to laws, such as ERISA, that impose certain requirements on the Benefit Plan and on those persons who are fiduciaries with respect to the Benefit Plans (the &#8220;Benefit Plan Fiduciary&#8221;). Such requirements may include prudence and diversification requirements and require that investments be made in accordance with the documents governing the Benefit Plan. The exercise of Rights by a Benefit Plan Fiduciary for a Benefit Plan should be considered in light of such fiduciary requirements.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In addition, ERISA and the Code prohibit certain transactions involving the assets of a Benefit Plan and certain persons (referred to as &#8220;parties in interest&#8221; for purposes of ERISA and &#8220;disqualified persons&#8221; for purposes of the Code) having certain relationships to such Benefit Plans, unless a statutory or administrative exemption is applicable to the transaction. A party in interest or disqualified person who engages in a nonexempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code (or with respect to certain Benefit Plans, such as IRAs, a prohibited transaction may cause the Benefit Plan to lose its tax-exempt status). In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions (&#8220;PTCEs&#8221;) that may apply to the exercise of the Rights and holding of the common shares. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts, PTCE 96-23 respecting transactions determined by in-house asset managers, PTCE 84-24 governing purchases of shares in investment companies, and PTCE 75-1 respecting sales of securities. In addition, Section&#160;408(b)(17) of ERISA and Section&#160;4975(d)(20) of the Code each provides a limited exemption, commonly referred to as the &#8220;service provider exemption,&#8221; from the prohibited transaction provisions of ERISA and Section&#160;4975 of the Code for certain transactions between a Benefit Plan and a person that is a party in interest and/or a disqualified person (other than a fiduciary or an affiliate that, directly or indirectly, has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Benefit Plan involved in the transaction) solely by reason of providing services to the Benefit Plan or by relationship to a service provider, provided that the Benefit Plan receives no less, nor pays no more, than adequate consideration. There can be no assurance that all of the conditions of any such exemptions or any other exemption will be satisfied at the time that the Rights are exercised, or thereafter while the common shares are held, if the facts relied upon for using a prohibited transaction exemption change.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">By its exercise of the Rights, each Benefit Plan will be deemed to have represented and warranted that (i)&#160;neither the exercise of the Rights, nor the investment in common shares pursuant to such exercise, will result in a non-exempt prohibited transaction under ERISA or Section&#160;4975 of the Code, or any substantially similar law, and (ii)&#160;neither the Adviser, the Dealer Manager, the Fund or any of their affiliates is or will be a Benefit Plan Fiduciary with respect to the Benefit Plan&#8217;s exercise of the Rights or its investment in common shares, for purposes of ERISA, Section&#160;4975 of the Code, or any applicable substantially similar law.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Due to the complexity of these rules&#160;and the penalties for noncompliance, fiduciaries of Benefit Plans, including the Benefit Plan Fiduciary, should consult with their legal and tax counsel regarding the consequences of their exercise of Rights and their investment in common shares under ERISA, the Code and other similar laws.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-16 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_012_integixAnchor"></span><strong>SUMMARY OF FUND EXPENSES</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table and example are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in our common shares as a percentage of net assets attributable to common shares. Amounts are for the current fiscal year after giving effect to anticipated net proceeds of the Rights offering, assuming that we incur the estimated offering expenses.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:bold 10pt Times New Roman, Times, Serif;text-indent:-0.25in;padding-left:0.25in;text-align:left">Shareholder Transaction Expenses</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;width:87%;text-align:left">Sales load paid by you (as a percentage of offering price)</td><td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Offering expenses borne by the Fund (as a percentage of offering price)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Dividend reinvestment plan fees(1)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:bold 10pt Times New Roman, Times, Serif;text-indent:-0.25in;padding-left:0.25in;text-align:left;padding-bottom:1pt">Annual Expenses (as a percentage of net assets attributable to common shares)</td><td style="font-size:10pt;padding-bottom:1pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right">&#160;</td><td style="padding-bottom:1pt;font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Advisory Fees(2)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">[&#9679;]</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Interest payments on borrowed funds(3)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;padding-bottom:1pt">Other Expenses(4)</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left;padding-bottom:1pt">Total Annual Fund Operating Expenses</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left">%</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:3pt;margin-bottom:3pt;width:25%"><div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:top"><td style="padding-bottom:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage of </span>[&#9679;]<span>% of the Fund&#8217;s Managed Assets. Based on the same assumptions, leverage would equal [&#9679;]% of the Fund&#8217;s net assets.</span></span></td></tr><tr style="vertical-align:top"><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td><td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023.&#160;&#160;We had outstanding borrowings of approximately $[&#9679;] (with a carrying value of approximately $[&#9679;]) as of [&#9679;]. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of [&#9679;]% of the Fund&#8217;s Managed Assets and [&#9679;]<span>% of the Fund&#8217;s net assets</span>) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual expenses of [&#9679;]% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="font-size:10pt;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>One&#160;Year</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Three&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Five&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Ten&#160;Years</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">$</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[&#9679;]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The example should not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_013_integixAnchor"></span><strong>USE OF PROCEEDS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund estimates the net proceeds of the Rights offering to be approximately $[<span>&#9679;</span>], based on the estimated Subscription Price per common share of $[<span>&#9679;</span>] ([<span>&#9679;</span>]% of the last reported sales price of the Fund&#8217;s common shares on the NYSE on [<span>&#9679;</span>], 2024), assuming all new common shares offered are sold and that the expenses related to the Rights offering estimated at approximately $[<span>&#9679;</span>] are paid.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The net proceeds from the Rights offering hereunder will be invested in accordance with the Fund&#8217;s investment objective and policies as set forth in this Prospectus Supplement and the accompanying Prospectus. We currently anticipate that we will be able to invest all of the net proceeds in accordance with our investment objective and policies within approximately three months of the receipt of such proceeds</span>; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment, it is anticipated that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market instruments. Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital. A return of capital is a return to investors of a portion of their original investment in the Fund. In general terms, a return of capital would involve a situation in which the Fund distribution (or a portion thereof) represents a return of a portion of a shareholder&#8217;s investment in the Fund, rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. Although return of capital distributions may not be currently taxable, such distributions would decrease the basis of a shareholder&#8217;s shares, and therefore, may increase a shareholder&#8217;s tax liability for capital gains upon a sale of shares, even if sold at a loss to the shareholder&#8217;s original investments.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-17 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_014_integixAnchor"></span><strong>CAPITALIZATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table sets forth the unaudited capitalization of the Fund as of [<span>&#9679;</span>], 2024 and its adjusted capitalization assuming the common shares available in the Rights offering discussed in this Prospectus Supplement had been issued.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[To be provided.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_015_integixAnchor"></span><strong>SPECIAL CHARACTERISTICS AND RISKS OF THE RIGHTS OFFERING</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Risk is inherent in all investing. Therefore, before investing in the common shares, you should consider the risks associated with such an investment carefully. See &#8220;Risks&#8221; in the Prospectus. The following summarizes some of the matters that you should consider before investing in the Fund through the Rights offering:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Dilution.</i></span> Record Date Shareholders who do not fully exercise their Rights will, at the completion of the Rights offering, own a smaller proportional interest in the Fund than owned prior to the Rights offering. The completion of the Rights offering will result in immediate voting dilution for such shareholders. Further, both the sales load and the expenses associated with the Rights offering will immediately reduce the NAV of each outstanding common share. In addition, if the Subscription Price is less than the NAV per common share as of the Expiration Date, the completion of this Rights offering will result in an immediate dilution of the NAV per common share for all existing common shareholders (i.e., will cause the NAV per common share to decrease). It is anticipated that existing common shareholders will experience immediate dilution even if they fully exercise their Rights. Such dilution is not currently determinable because it is not known how many common shares will be subscribed for, what the NAV per common share or market price of the common shares will be on the Expiration Date or what the Subscription Price per common share will be. If the Subscription Price is substantially less than the current NAV per common share, this dilution could be substantial. The Fund will pay expenses associated with the Rights offering, estimated at approximately $[<span>&#9679;</span>]. In addition, the Fund has agreed to pay a dealer manager fee (sales load) equal to [<span>&#9679;</span>]% of the Subscription Price per common share issued pursuant to the exercise of Rights (including pursuant to the Over-Subscription Privilege). The Fund, not investors, pays the sales load, which is ultimately borne by all common shareholders. All of the costs of the Rights offering will be borne by the Fund&#8217;s common shareholders. See &#8220;Table of Fees and Expenses&#8221; in this Prospectus Supplement and &#8220;Summary of Fund Expenses&#8221; in the accompanying Prospectus for more information.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">If you do not exercise all of your Rights, you may own a smaller proportional interest in the Fund when the Rights offering is over. In addition, you will experience an immediate dilution of the aggregate NAV per common share if you do not participate in the Rights offering and will experience a reduction in the NAV per common share whether or not you exercise your Rights, if the Subscription Price is below the Fund&#8217;s NAV per common share on the Expiration Date, because:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the offered common shares are being sold at less than their current NAV;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">you will indirectly bear the expenses of the Rights offering; and</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the number of common shares outstanding after the Rights offering will have increased proportionately more than the increase in the amount of the Fund&#8217;s net assets.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-18 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">On the other hand, if the Subscription Price is above the Fund&#8217;s NAV per common share on the Expiration Date, you may experience an immediate accretion of the aggregate NAV per share of your common shares even if you do not exercise your Rights and an immediate increase in the NAV per common share whether or not you participate in the Rights offering, because:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the offered common shares are being sold at more than their current NAV after deducting the expenses of the Rights offering; and</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">the number of common shares outstanding after the Rights offering will have increased proportionately less than the increase in the amount of the Fund&#8217;s net assets.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[Furthermore, if you do not participate in the secondary over-subscription, if it is available, your percentage ownership will also be diluted.] The Fund cannot state precisely the amount of any dilution because it is not known at this time what the NAV per common share will be on the Expiration Date or what proportion of the Rights will be exercised. The impact of the Rights offering on NAV per common share is shown by the following examples, assuming the Rights offering is fully subscribed and a $[<span>&#9679;</span>] Subscription Price:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:65%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left">Scenario 1: (assumes NAV per share is above Subscription Price)(1)</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:87%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">NAV(2)</td><td style="width:1%;font-size:10pt">&#160;</td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[<span>&#9679;</span>]</span></td><td style="width:1%;font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Subscription Price(3)</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[<span>&#9679;</span>]</span></td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Reduction in NAV ($)(4)</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[<span>&#9679;</span>]</span></td><td style="font-size:10pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Reduction in NAV (%)</td><td style="font-size:10pt">&#160;</td><td style="font-size:10pt;text-align:left">&#160;</td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[<span>&#9679;</span>]</span></td><td style="font-size:10pt;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:65%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"><tr style="vertical-align:bottom"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt">[Scenario 2: (assumes NAV per share is below Subscription Price)(1)</span></td><td style="font-size:10pt"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:right"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:87%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"><span style="font-size:10pt">NAV(2)</span></td><td style="width:1%;font-size:10pt"><span style="font-size:10pt">&#160;</span></td><td style="width:1%;font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td><td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[</span><span style="font-size:10pt">&#9679;</span><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">]</span></td><td style="width:1%;font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"><span style="font-size:10pt">Subscription Price(3)</span></td><td style="font-size:10pt"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[</span><span style="font-size:10pt">&#9679;</span><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">]</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt"><span style="font-size:10pt">Increase in NAV ($)(4)</span></td><td style="font-size:10pt"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[</span><span style="font-size:10pt">&#9679;</span><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">]</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td></tr><tr style="vertical-align:bottom"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt"><span style="font-size:10pt">Increase in NAV (%)</span></td><td style="font-size:10pt"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">&#160;</span></td><td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">[</span><span style="font-size:10pt">&#9679;</span><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">]</span></td><td style="font-size:10pt;text-align:left"><span style="font-size:10pt">]</span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:3pt;margin-bottom:3pt;width:25%"><div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Both examples assume the full primary subscription [and secondary over-subscription privilege] are exercised. Actual amounts may vary due to rounding. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">For illustrative purposes only; reflects the Fund&#8217;s NAV per common share as of [<span>&#9679;</span>], 2024. It is not known at this time what the NAV per common share will be on the Expiration Date. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">For illustrative purposes only; reflects an estimated Subscription Price of $[<span>&#9679;</span>] based upon [<span>&#9679;</span>]% of the last reported sales price of the Fund&#8217;s common shares on the NYSE on [<span>&#9679;</span>], 2024. It is not known at this time what the Subscription Price will be on the Expiration Date. </span></td></tr><tr style="vertical-align:top"><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td><td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Assumes $[<span>&#9679;</span>] in estimated offering expenses. </span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">If you do not wish to exercise your Rights, you should consider selling them as set forth in this Prospectus Supplement. Any cash you receive from selling your Rights may serve as partial compensation for any possible dilution of your interest in the Fund. The Fund cannot give assurance, however, that a market for the Rights will develop or that the Rights will have any marketable value.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[The Fund&#8217;s largest shareholders could increase their percentage ownership in the Fund through the exercise of the primary subscription and over-subscription privilege.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Risks of Investing in Rights</i></span>. Shares of closed-end funds, such as the Fund, frequently trade at a discount to NAV. If the Formula Price is less than [<span>&#9679;</span>]% of NAV on the Expiration Date, then the Subscription Price will likely be greater than the market price of a common share on that date. In addition, the Formula Price, even if above [<span>&#9679;</span>]% of NAV, may be still above the market price of a common share on the Expiration Date. If either event occurs, the Rights will have no value, and a person who exercises Rights will experience an immediate loss of value.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-19 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Leverage</i></span>. Leverage creates a greater risk of loss, as well as a potential for more gain, for the common shares than if leverage were not used. Following the completion of the Rights offering, the Fund&#8217;s amount of leverage outstanding will decrease. The leverage of the Fund as of [<span>&#9679;</span>], 2024 was approximately [<span>&#9679;</span>]% of the Fund&#8217;s Managed Assets. After the completion of the Rights offering, the amount of leverage outstanding is expected to decrease to approximately [<span>&#9679;</span>]% of the Fund&#8217;s Managed Assets. The use of leverage for investment purposes creates opportunities for greater total returns but at the same time increases risk. When leverage is employed, the NAV and market price of the common shares and the yield to common shareholders may be more volatile. Any investment income or gains earned with respect to the amounts borrowed in excess of the interest due on the borrowing will augment the Fund&#8217;s income. Conversely, if the investment performance with respect to the amounts borrowed fails to cover the interest on such borrowings, the value of the Fund&#8217;s common shares may decrease more quickly than would otherwise be the case, and distributions on the common shares could be reduced or eliminated. Interest payments and fees incurred in connection with such borrowings will reduce the amount of net income available for distribution to holders of the common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Because the fee paid to the Adviser is calculated on the basis of the Fund&#8217;s Managed Assets, which include the proceeds of leverage, the dollar amount of the management fee paid by the Fund to the Adviser will be higher (and the Adviser will be benefited to that extent) when leverage is used. The Adviser will use leverage only if it believes such action would result in a net benefit to the Fund&#8217;s shareholders after taking into account the higher fees and expenses associated with leverage (including higher management fees).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund&#8217;s leveraging strategy may not be successful.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Increase in Share Price Volatility; Decrease in Share Price.</i></span> The Rights offering may result in an increase in trading of the common shares, which may increase volatility in the market price of the common shares. The Rights offering may result in an increase in the number of shareholders wishing to sell their common shares, which would exert downward price pressure on the price of common shares.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Under-Subscription.</i></span> It is possible that the Rights offering will not be fully subscribed. Under-subscription of the Rights offering would have an impact on the net proceeds of the Rights offering and whether the Fund achieves any benefits.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_016_integixAnchor"></span><strong>TAXATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[The following is a general summary of the U.S. federal income tax consequences of the Rights offering to Record Date Shareholders who are U.S. persons for U.S. federal income tax purposes. The following summary supplements the discussion set forth in the accompanying Prospectus and SAI and is subject to the qualifications and assumptions set forth therein. The discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisor to determine the tax consequences of investing in the Fund.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Please refer to the &#8220;Tax Matters&#8221; section in the Fund&#8217;s Prospectus and SAI for a description of the consequences of investing in the common shares of the Fund. Special tax considerations relating to this Rights offering are summarized below:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">The value of a Right will not be includible in the income of a common shareholder at the time the Right is issued.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">The basis of a Right issued to a common shareholder will be zero, and the basis of the common share with respect to which the Right was issued (the &#8220;Old Common Share&#8221;) will not change, unless either the fair market value of the Right on the date of distribution is at least 15% of the fair market value of the Old Common Share, or such common shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the Right a portion of the basis of the Old Common Share. If the basis of a Right or Old Common Share changes, such common shareholder must allocate basis between the Old Common Share and the Right in proportion to their fair market values on the date of distribution.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">The basis of a Right purchased will generally be its purchase price.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">A common shareholder&#8217;s holding period in a Right issued includes the holding period of the Old Common Share.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-20 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">A common shareholder will not recognize a loss if a Right distributed to such common shareholder expires unexercised because the basis of the Old Common Share may be allocated to a Right only if the Right is sold or exercised. If a Right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the Right.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">Any gain or loss on the sale of a Right will be a capital gain or loss if the Right is held as a capital asset (which in the case of a Right issued to Record Date Shareholders will depend on whether the Old Common Share is held as a capital asset), and will be a long-term capital gain or loss if the holding period is deemed to exceed one year.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.25in">&#160;</td><td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span>&#9679;</span></span></td><td style="text-align:justify">No gain or loss will be recognized by a common shareholder upon the exercise of a Right, and the basis of any common share acquired upon exercise (the &#8220;New Common Share&#8221;) will equal the sum of the basis, if any, of the Right and the Subscription Price for the New Common Share. The holding period for the New Common Share will begin on the date when the Right is exercised (or, in the case of a Right purchased in the market, potentially the day after the date of exercise).</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The foregoing is a general and brief summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its common shareholders, with respect to U.S. federal income taxation only. Other tax issues such as state and local taxation may apply. Investors are urged to consult their own tax advisers to determine the tax consequences of investing in the Fund. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_017_integixAnchor"></span><strong>PLAN OF DISTRIBUTION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>[Distribution Arrangements</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">[<span>&#9679;</span>] will act as Dealer Manager for this Rights offering. Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Dealer Manager, the Fund and the Adviser, the Dealer Manager will provide financial structuring and solicitation services in connection with the Rights offering and will solicit the exercise of Rights and participation in the over-subscription privilege. The Rights offering is not contingent upon any number of Rights being exercised. The Dealer Manager will also be responsible for forming and managing a group of selling broker-dealers (each, a &#8220;Selling Group Member&#8221; and collectively, the &#8220;Selling Group Members&#8221;), whereby each Selling Group Member will enter into a Selling Group Agreement with the Dealer Manager to solicit the exercise of Rights and to sell common shares purchased by the Selling Group Member from the Dealer Manager. In addition, the Dealer Manager will enter into a Soliciting Dealer Agreement with other soliciting broker-dealers (each, a &#8220;Soliciting Dealer&#8221; and collectively, the &#8220;Soliciting Dealers&#8221;) to solicit the exercise of Rights. See &#8220;&#8212;Compensation to Dealer Manager&#8221; for a discussion of fees and other compensation to be paid to the Dealer Manager, Selling Group Members and Soliciting Dealers in connection with the Rights offering.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund and the Adviser have each agreed to indemnify the Dealer Manager for losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated by the Dealer Manager Agreement except for any act of willful misfeasance, bad faith or gross negligence of the Dealer Manager or reckless disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In order to seek to facilitate the trading market in the Rights for the benefit of non-exercising shareholders, and the placement of the common shares to new or existing investors pursuant to the exercise of the Rights, the Dealer Manager Agreement provides for special arrangements with the Dealer Manager. Under these arrangements, the Dealer Manager is expected to purchase Rights on the [<span>&#9679;</span>], as well as Rights received by the Rights Agent for sale by Record Date Shareholders and offered to the Dealer Manager and unexercised Rights of Record Date Shareholders whose record addresses are outside the United States that are held by the Subscription Agent and for which no instructions are received. The number of rights, if any, purchased by the Dealer Manager will be determined by the Dealer Manager in its sole discretion. The Dealer Manager is not obligated to purchase Rights or common shares as principal for its own account to facilitate the trading market for Rights or for investment purposes. Rather, its purchases are expected to be closely related to interest in acquiring common shares generated by the Dealer Manager through its marketing and soliciting activities. The Dealer Manager intends to exercise Rights purchased by it during the Subscription Period but prior to the Expiration Date. The Dealer Manager may exercise those Rights at its option on one or more dates, which are expected to be prior to the Expiration Date. The Subscription Price for the common shares issued through the exercise of Rights by the Dealer Manager prior to the Expiration Date will be the greater of [<span>&#9679;</span>]% of the last reported sale price of a common share on the NYSE on the date of exercise or [<span>&#9679;</span>]% of the last reported NAV of a common share on the date prior to the date of exercise. The price and timing of these exercises are expected to differ from those described herein for the Rights offering. The Subscription Price will be paid to the Fund and the dealer manager fee with respect to such proceeds will be paid by the Fund on the applicable settlement date(s)&#160;of such exercise(s).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-21 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">In connection with the exercise of Rights and receipt of common shares, the Dealer Manager intends to offer those common shares for sale to the public and/or through a group of selling members it has established. The Dealer Manager may set the price for those common shares at any price that it determines, in its sole discretion. The Dealer Manager has advised that the price at which such common shares are offered is expected to be at or slightly below the closing price of the common shares on the NYSE on the date the Dealer Manager exercises Rights. No portion of the amount paid to the Dealer Manager or to a Selling Group Member from the sale of common shares in this manner will be paid to the Fund. If the sales price of the common shares is greater than the Subscription Price paid by the Dealer Manager for such common shares, plus the costs to purchase Rights for the purpose of acquiring those common shares, the Dealer Manager will receive a gain. Alternatively, if the sales price of the common shares is less than the Subscription Price for such common shares</span>, plus the costs to purchase Rights for the purpose of acquiring those common shares, the Dealer Manager will incur a loss. The Dealer Manager will pay a concession to Selling Group Members in an amount equal to approximately [2.50]% of the aggregate price of the common shares sold by the respective Selling Group Member. Neither the Fund nor the Adviser has a role in setting the terms, including the sales price, on which the Dealer Manager offers for sale and sells common shares it has acquired through purchasing and exercising Rights or the timing of the exercise of Rights or sales of common shares by the Dealer Manager. Persons who purchase common shares from the Dealer Manager or the selling group will purchase shares at a price set by the Dealer Manager, which may be more or less than the Subscription Price, and at a time set by the Dealer Manager, which is expected to be prior to the Expiration Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Dealer Manager may purchase Rights as principal or act as agent on behalf of its clients for the resale of such Rights. The Dealer Manager may realize gains (or losses) in connection with the purchase and sale of Rights and the sale of common shares, although such transactions are intended by the Dealer Manager to facilitate the trading market in the Rights and the placement of the common shares to new or existing investors pursuant to the exercise of the Rights. Any gains (or losses) realized by the Dealer Manager from the purchase and sale of Rights and the sale of common shares are independent of and in addition to its fee as Dealer Manager. The Dealer Manager has advised that any such gains (or losses) are expected to be immaterial relative to its fee as Dealer Manager.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Since neither the Dealer Manager nor persons who purchase common shares from the Dealer Manager or members of the selling group were Record Date Shareholders, they would not be able to participate in the over-subscription privilege.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Persons who purchase common shares from the Dealer Manager or the selling group will not purchase shares at the Subscription Price based on the formula price mechanism through which common shares will be sold in the Rights offering. Instead, those persons will purchase common shares at a price set by the Dealer Manager, which may be more or less than the Subscription Price, and will not have the uncertainty of waiting for the determination of the Subscription Price on the Expiration Date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">There is no limit on the number of Rights the Dealer Manager can purchase or exercise. Common shares acquired by the Dealer Manager pursuant to the exercise of Rights acquired by it will reduce the number of common shares available pursuant to the over-subscription privilege, perhaps materially, depending on the number of Rights purchased and exercised by the Dealer Manager.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-22 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Although the Dealer Manager can seek to facilitate the trading market for Rights as described above, investors can acquire common shares at the Subscription Price by acquiring Rights on the [<span>&#9679;</span>] and exercising them in the method described above under &#8220;Description of the Rights&#8212;Method of Exercise of Rights&#8221; and &#8220;Description of the Rights&#8212;Payment for Shares.&#8221;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In the ordinary course of their businesses, the Dealer Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Adviser and their affiliates. In addition, in the ordinary course of their businesses, the Dealer Manager and/or its affiliates may, from time to time, own securities of the Fund or its affiliates.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The principal business address of the Dealer Manager is [<span>&#9679;</span>].</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Compensation to Dealer Manager</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Pursuant to the Dealer Manager Agreement, the Fund has agreed to pay the Dealer Manager a fee for its financial structuring and solicitation services equal to [<span>&#9679;</span>]% of the Subscription Price per common share for each common share issued pursuant to the exercise of Rights, including the over-subscription privilege.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Dealer Manager will reallow to Selling Group Members in the selling group to be formed and managed by the Dealer Manager selling fees equal to [<span>&#9679;</span>]% of the Subscription Price for each common share issued pursuant to the Rights offering or the over-subscription privilege as a result of their selling efforts. In addition, the Dealer Manager will reallow to Soliciting Dealers that have executed and delivered a Soliciting Dealer Agreement and have solicited the exercise of Rights, solicitation fees equal to [<span>&#9679;</span>]% of the Subscription Price for each common share issued pursuant to the exercise of Rights as a result of their soliciting efforts, subject to a maximum fee based on the number of common shares held by such Soliciting Dealer through [insert depository] on the Record Date. Fees will be paid to the broker-dealer designated on the applicable portion of the subscription certificates or, in the absence of such designation, to the Dealer Manager.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In addition, the Fund, has agreed to pay the Dealer Manager an amount up to $[<span>&#9679;</span>] as a partial reimbursement of its expenses incurred in connection with the Rights offering, including reasonable out-of-pocket fees and expenses, if any and not to exceed $[<span>&#9679;</span>], incurred by the Dealer Manager, Selling Group Members, Soliciting Dealers and other brokers, dealers and financial institutions in connection with their customary mailing and handling of materials related to the Rights offering to their customers. No other fees will be payable by the Fund or the Adviser to the Dealer Manager in connection with the Rights offering.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_018_integixAnchor"></span><strong>LEGAL MATTERS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Certain legal matters in connection with the common shares will be passed on for the Fund by Willkie Farr&#160;&amp; Gallagher LLP, New York, New York, counsel to the Fund. Willkie Farr&#160;&amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP, Baltimore, Maryland. [Certain legal matters will be passed on by [<span>&#9679;</span>] as special counsel to the Dealer Manager in connection with the Rights offering.]</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_019_integixAnchor"></span><strong>FINANCIAL STATEMENTS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, [<span>&#9679;</span>] [and the unaudited financial statements for the six months ended June&#160;30, [<span>&#9679;</span>]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (&#8220;SAI&#8221;). Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="s_020_integixAnchor"></span><strong>ADDITIONAL INFORMATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">This Prospectus Supplement and the accompanying Prospectus constitute part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the Investment Company Act. This Prospectus Supplement and the accompanying Prospectus omit certain of the information contained in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with respect to the Fund and the common shares offered hereby. Any statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed by its rules&#160;and regulations or free of charge through the SEC&#8217;s website (http://www.sec.gov).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt">R-23 </span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>[<span>&#9679;</span>] Rights for [<span>&#9679;</span>] Common Shares</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Subscription Rights to Acquire Common Shares</strong>&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Issuable Upon Exercise of Rights to Subscribe for</strong>&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Such Common Shares</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>PROSPECTUS SUPPLEMENT</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>[<span>&#9679;</span>], 2024</strong></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong>Until [<span>&#9679;</span>], 2024 (25 days after the date of this Prospectus Supplement), all dealers that buy, sell or trade the common shares, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters.</strong></p><p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p></div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2416373d4_sai.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1" --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #eb0029"><b style="-keep: true">SUBJECT TO COMPLETION, DATED
AUGUST 14, 2024</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #de1a1e; "><b>THE
INFORMATION IN THIS STATEMENT OF ADDITIONAL INFORMATION IS NOT COMPLETE AND MAY&#160;BE CHANGED. WE MAY&#160;NOT SELL THESE SECURITIES
UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS STATEMENT OF ADDITIONAL INFORMATION
IS NOT AN OFFER TO SELL THESE SECURITIES AND IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY JURISDICTION WHERE THE OFFER OR
SALE IS NOT PERMITTED</b></span><span style="color: #eb0029">.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ares Dynamic Credit Allocation Fund,&#160;Inc.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STATEMENT OF ADDITIONAL INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. This Statement
of Additional Information (&#8220;SAI&#8221;) relating to common stock, par value $0.001 per share (&#8220;common shares&#8221;), of the
Fund does not constitute a prospectus, but should be read in conjunction with the prospectus relating thereto dated </span><b>[&#8226;]</b>,
2024 and any related prospectus supplement. This SAI, which is not a prospectus, does not include all information that a prospective investor
should consider before purchasing common shares, and investors should obtain and read the prospectus and any related prospectus supplement
prior to purchasing such shares. A copy of the prospectus and any related prospectus supplement may be obtained without charge by calling
(888) 818-5298. You may also obtain a copy of the prospectus on the Securities and Exchange Commission&#8217;s (the &#8220;SEC&#8221;)
website (http://www.sec.gov). Capitalized terms used but not defined in this SAI have the meanings ascribed to them in the prospectus.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
to the Investment Company Act of 1940, as amended</span>, together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment
Company Act&#8221;), or other applicable law, will include any rules&#160;promulgated thereunder and any guidance, interpretations or
modifications by the SEC, SEC staff or other authority with appropriate jurisdiction, including court interpretations, and exemptive,
no-action or other relief or permission from the SEC, SEC staff or other authority.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_002" style="-sec-extract: exhibit">THE
    FUND</a></span></td>
    <td style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_002" style="-sec-extract: exhibit">1</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_003" style="-sec-extract: exhibit">INVESTMENT
    OBJECTIVE AND POLICIES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_003" style="-sec-extract: exhibit">1</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_004" style="-sec-extract: exhibit">MANAGEMENT
    OF THE FUND</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_004" style="-sec-extract: exhibit">2</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_005" style="-sec-extract: exhibit">PORTFOLIO
    TRANSACTIONS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_005" style="-sec-extract: exhibit">9</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_006" style="-sec-extract: exhibit">CONFLICTS
    OF INTEREST</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_006" style="-sec-extract: exhibit">10</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_007" style="-sec-extract: exhibit">DESCRIPTION
    OF SHARES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_007" style="-sec-extract: exhibit">12</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_008" style="-sec-extract: exhibit">REPURCHASE
    OF COMMON SHARES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_008" style="-sec-extract: exhibit">12</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_009" style="-sec-extract: exhibit">TAX
    MATTERS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_009" style="-sec-extract: exhibit">13</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_010" style="-sec-extract: exhibit">INDEPENDENT
    REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_010" style="-sec-extract: exhibit">20</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_011" style="-sec-extract: exhibit">CONTROL
    PERSONS AND PRINCIPAL HOLDERS OF SECURITIES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_011" style="-sec-extract: exhibit">20</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_012" style="-sec-extract: exhibit">INCORPORATION
    BY REFERENCE</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_012" style="-sec-extract: exhibit">22</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_013" style="-sec-extract: exhibit">FINANCIAL
    STATEMENTS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_013" style="-sec-extract: exhibit">23</a></span></td></tr>
  </table><div>
</div><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>This Statement of Additional Information is
dated [&#8226;], 2024.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund is a diversified,
closed-end management investment company registered under the Investment Company Act. The Fund was organized as a Maryland corporation
on March&#160;14, 2011, pursuant to the charter of the Fund (the &#8220;Charter&#8221;), which is governed by the laws of the State of
Maryland. The Fund&#8217;s investment adviser is Ares Capital Management II LLC (the &#8220;Adviser&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares of the Fund are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; As of August
6, 2024</span>, the Fund has outstanding 22,915,000 common shares.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INVESTMENT OBJECTIVE AND POLICIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Restrictions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following investment restrictions
are fundamental policies of the Fund and may not be changed without the approval of the holders of a majority of the Fund's outstanding
common shares (which for this purpose and under the Investment Company Act means the lesser of (i)&#160;67% of the common shares represented
at a meeting at which more than 50% of the outstanding common shares are represented or (ii)&#160;more than 50% of the outstanding shares).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to such shareholder
approval, the Fund may not:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">1.</td><td style="text-align: justify">make investments for the purpose of exercising control or management;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">2.</td><td style="text-align: justify">purchase or sell real estate, commodities or commodity contracts, except that, to the extent permitted
by applicable law, the Fund may (i)&#160;invest in securities directly or indirectly secured by real estate or interests therein or issued
by entities that invest in real estate or interests therein; (ii)&#160;acquire, hold and sell real estate acquired through default, liquidation,
or other distributions of an interest in real estate as a result of the Fund's ownership of other assets; (iii)&#160;invest in instruments
directly or indirectly secured by commodities or securities issued by entities that invest in or hold such commodities and acquire temporarily
commodities as a result thereof; and (iv)&#160;purchase and sell forward contracts, financial futures contracts and options thereon;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">3.</td><td style="text-align: justify">issue senior securities or borrow money except as permitted by Section&#160;18 of the Investment Company
Act or otherwise as permitted by applicable law;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">underwrite securities of other
issuers, except insofar as the Fund may be deemed an underwriter under the </span><span style="font-size: 10pt">Securities Act of 1933,
as amended</span>, in selling its own securities or portfolio securities;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make loans to other persons,
except that (i)&#160;the Fund will not be deemed to be making a loan to the extent that the Fund makes investments in accordance with
its stated investment strategies or otherwise purchases senior loans, subordinated loans, corporate bonds, </span>collateralized loan
obligations (&#8220;CLO&#8221;) securities, debentures or other loans or debt securities of any type, preferred securities, commercial
paper, pass through instruments, loan participation interests, corporate loans, certificates of deposit, bankers acceptances, repurchase
agreements or any similar instruments; (ii)&#160;the Fund may take short positions in any security or financial instrument; and (iii)&#160;the
Fund may lend its portfolio securities in an amount not in excess of 33 1/3% of its total assets, taken at market value, provided that
such loans shall be made in accordance with applicable law; and</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">6.</td><td style="text-align: justify">invest more than 25% of its total assets (taken at market value at the time of each investment) in the
securities of issuers of any one industry; provided that securities issued or guaranteed by the U.S. Government or its agencies or instrumentalities
and tax-exempt securities of governments and their political subdivisions will not be considered to represent an industry (other than
private purpose industrial development bonds issued on behalf of non-governmental issuers).</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT OF THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Advisory Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Advisory Services</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ares Capital Management II
LLC serves as the Fund&#8217;s investment adviser and is registered as an investment adviser under the Investment Advisers Act of 1940,
as amended. Subject to the overall supervision of the Board of Directors of the Fund (the &#8220;Board,&#8221; and each member thereof,
a &#8220;Director&#8221;), the Adviser manages the day-to-day operations of, and provides investment advisory and management services
to, the Fund. Under the terms of the investment advisory and management agreement between the Adviser and the Fund (the &#8220;Investment
Advisory Agreement&#8221;), the Adviser:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span>&#160;</td><td style="text-align: justify">obtains and evaluates pertinent economic, financial, and other information affecting the economy generally
and certain investment assets as such information relates to securities, loans or other financial instruments, that are purchased for
or considered for purchase by the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">makes investment decisions for the Fund (including the exercise or disposition of rights accompanying
portfolio securities, loans or other financial instruments, such as tender offers, exchanges, amendments, consents, waivers or forbearances,
and other attendant rights thereto);</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">places purchase and sale orders for portfolio transactions on behalf of the Fund and manages otherwise
uninvested cash assets of the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">arranges for the pricing of Fund securities, loans or other financial instruments;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">executes account documentation, agreements, contracts and other documents as may be requested by brokers,
dealers, assignors, assignees, participants, counterparties and other persons in connection with the Adviser&#8217;s management of the
assets of the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">employs professional portfolio managers and securities analysts who provide research services to the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">engages certain third-party professionals, consultants, experts or specialists in connection with the
Adviser&#8217;s management of the assets of the Fund; and</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">makes decisions with respect to the use by the Fund of borrowing for leverage or other investment purposes.</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adviser is an affiliate of Ares Management Corporation, a leading global alternative investment manager whose common units are listed
on the NYSE under the symbol &#8220;ARES&#8221; (&#8220;Ares&#8221;), and leverages the Ares investment platform and benefits from the
significant capital markets, trading and research expertise of Ares's investment professionals. Ares Operations LLC, a subsidiary of </span>Ares,
provides certain administrative and other services necessary for the Fund to operate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Adviser&#8217;s services
to the Fund under the Investment Advisory Agreement are not exclusive. The Adviser may provide investment advisory and administration
services to other entities. Similarly, affiliates of the Adviser may directly or indirectly manage funds or other accounts with investment
objectives similar to those of the Fund. Accordingly, the Fund may compete with these Ares funds or other investment vehicles managed
by the Adviser and its affiliates for capital and investment opportunities. The Adviser endeavors to allocate investment opportunities
in a fair and equitable manner, and in any event consistent with any fiduciary duties owed to the Fund. Nevertheless, it is possible that
the Fund may not be given the opportunity to participate in certain investments made by investment funds or other accounts managed by
the Adviser or its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Adviser is a wholly owned subsidiary of Ares Management LLC, an SEC-registered investment adviser, and an indirect subsidiary of Ares</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Management Fee</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Investment Advisory Agreement with the Fund and subject to the overall supervision of the Board, the Adviser provides investment
advisory and management services to the Fund. For providing these services, the Adviser receives a monthly fee at the annual rate of 1.00%
of the average daily value of the Fund&#8217;s Managed Assets. &#8220;Managed Assets&#8221; means the total assets of the Fund (including
any assets attributable to any preferred shares or to indebtedness)</span><span style="font-size: 10pt">,</span> minus <span style="font-size: 10pt">l</span>iabilities
(other than liabilities relating to indebtedness). Fees for any partial month are appropriately prorated. During periods when the Fund
is using leverage, the fees paid to the Adviser will be higher than if the Fund did not use leverage because the fees paid will be calculated
on the basis of the Fund&#8217;s Managed Assets, which include the assets purchased through leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may elect from
time to time, in its sole discretion, to waive its right to receive a portion of the advisory fee. If the Adviser elects to waive its
compensation, such action may have a positive effect on the Fund&#8217;s performance or yield. The Adviser is under no obligation to waive
its fees, may elect not to do so, or may decide to waive its compensation periodically.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Fund paid the Adviser advisory fees
of $</span>4.9 million, $5.6 million and $5.3 million, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Payment of the Fund&#8217;s Expenses and Reimbursement of Certain
Costs of the Adviser and its Affiliates</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The services of all investment
professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory and management services, and the
compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Adviser. The
Fund bears all other costs and expenses of its operations and transactions, including those relating to: organization; calculation of
its net asset value (including the cost and expenses of any independent valuation firm, agent, or other provider); expenses incurred by
the Adviser payable to third parties, including agents, consultants or other Advisers, in monitoring the financial and legal affairs of
the Fund and in monitoring the Fund&#8217;s investments; interest payable on indebtedness and dividends and distributions on preferred
shares, as applicable, if any, incurred to finance the Fund&#8217;s investments; offerings of the Fund&#8217;s common shares and other
securities (including all fees, costs and expenses related thereto); investment advisory and management fees; fees payable to third parties,
including agents, legal counsel (including, without limitation, any committee formed in accordance with Federal Rule&#160;of Bankruptcy
Procedure 2019 or unsecured committee counsel), consultants or other advisers, relating to, or associated with, evaluating and making
investments; administrator, transfer agent, custodian, investor support services and investor relation fees; federal and state registration
fees; all costs of registration and listing the Fund&#8217;s shares on any securities exchange; federal, state and local taxes; independent
directors&#8217; fees and expenses; costs of preparing and filing reports or other documents required by governmental bodies (including
the SEC), including printing costs; costs of any reports, proxy statements or other notices to shareholders, including printing costs;
insurance premiums for fidelity bond and other insurance coverage, including the Fund&#8217;s allocable portion of the fidelity bond,
directors&#8217; and officers&#8217; errors and omissions liability insurance, and any other insurance premium; direct costs and expenses
of administration, including printing, mailing, long-distance telephone, copying, secretarial and other staff, independent auditors and
outside legal costs; brokerage commissions, assignment fees and other costs in connection with the purchase, holding or sale of securities
and other investment instruments (including, without limitation, security settlement costs); costs incurred to implement and monitor agreements
governing the Fund&#8217;s financing or borrowing facilities and costs associated with issuances of preferred shares and ongoing related
expenses; such unusual, non-recurring or extraordinary expenses as may arise, including those relating to actions, suits or proceedings
to which the Fund is a party and legal obligations that the Fund may have to indemnify the Fund&#8217;s directors, officers and/or employees
or agents with respect to these actions, suits or proceedings; all other expenses incidental to holding meetings of the Fund&#8217;s shareholders,
including proxy solicitations therefor; and all other expenses incurred by the Fund in connection with administering the Fund&#8217;s
business (including the reimbursements contemplated in the following paragraph).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Fund&#8217;s Investment Advisory Agreement,
the Adviser may seek reimbursement from the Fund for certain administrative costs provided to the Fund by the Adviser and its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Duration, Termination and Amendment</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement between the
Fund and the Adviser became effective on November&#160;27, 2012. The Investment Advisory Agreement was renewed by the Board on August&#160;14,
2023 and will renew for successive annual periods thereafter if approved annually by the Board or by the affirmative vote of the holders
of a majority of the Fund&#8217;s outstanding voting securities, including, in either case, approval by a majority of the Fund&#8217;s
Directors who are not &#8220;interested persons.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement will automatically
terminate in the event of its assignment (within the meaning of the Investment Company Act). The Investment Advisory Agreement may be
terminated by either party without penalty upon 60 days&#8217; written notice to the other.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, material changes to the Investment
Advisory Agreement of the Fund must be submitted to the Fund&#8217;s shareholders for approval under the Investment Company Act and the
Fund may from time to time decide it is appropriate to seek shareholder approval to change the terms of the agreement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Indemnification</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement provides that,
absent willful misfeasance, bad faith or gross negligence in the performance of its duties or by reason of the reckless disregard of its
duties and obligations, the Adviser, its members and their respective officers, managers, partners, agents, employees, controlling persons,
members and any other person or entity affiliated with any of them are entitled to indemnification from the Fund for any damages, liabilities,
costs and expenses (including reasonable attorneys&#8217; fees and amounts reasonably paid in settlement) arising out of or otherwise
based upon the performance of any of the Adviser&#8217;s duties or obligations under the Investment Advisory Agreement or otherwise as
an investment adviser of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Board Approval of Investment Advisory Agreement</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A discussion regarding the basis of the Board&#8217;s
approval of the Investment Advisory Agreement is available in the Fund&#8217;s annual report to shareholders dated December&#160;31, 2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Administration and Accounting Services Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">State Street Bank and Trust
Company (&#8220;State Street&#8221;) provides certain administration and accounting services to the Fund pursuant to an Administration
and Accounting Services Agreement. The table below shows the amounts paid to State Street for such services for the periods indicated:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Fiscal&#160;Year&#160;Ended&#160;December&#160;31,</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid&#160;to&#160;State<br/>
Street</b></span></td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341,957</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358,873</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">515,050</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Destra Capital Advisors
LLC (&#8220;Destra&#8221;) provides investor support services in connection with the ongoing operations of the Fund pursuant to an Investor
Support Services Agreement. The table below shows the amounts paid to Destra for such services for the periods indicated:</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b style="-keep: true">Fiscal&#160;Year&#160;Ended&#160;December&#160;31,</b></p></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid&#160;to
    <br/>
    Destra</b></span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom"><span style="-keep: true">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,508</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="-keep: true">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom"><span style="-keep: true">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,811</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom"><span style="-keep: true">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,302</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="-keep: true">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Biographical Information Pertaining to the Directors</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund&#8217;s business
and affairs are managed under the direction of its Board. The Board of the Fund performs the various duties imposed on the directors of
investment companies by the Investment Company Act and Maryland law. The Board currently consists of five Directors, three of whom are
not &#8220;interested persons&#8221; of the Fund as defined in Section&#160;2(a)(19) of the Investment Company Act. The Fund refers to
these individuals as its &#8220;Independent Directors.&#8221; The Directors of the Fund are divided into three classes, serving staggered
three-year terms. The Board periodically elects the Fund&#8217;s officers, who serve at the discretion of the Board. The Board maintains
an audit committee and a nominating and governance committee and may establish additional committees from time to time as necessary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s April&#160;9, 2024 definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s
shareholders entitled: &#8220;<span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Information Concerning the Nominees and Members of the Board</a></span></span>,&#8221;
which is incorporated by reference herein, for a discussion of the Fund&#8217;s Directors, their principal occupations and other affiliates
during the past five years, and other information about them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Qualifications</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s April&#160;9, 2024 definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s
shareholders entitled: &#8220;<span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Director Qualifications</a></span></span>,&#8221; which is incorporated by reference
herein, for a summary of the experience, qualifications, attributes and skills of each Director that supports the conclusion that each
Director should serve as a Director of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Leadership Structure, Composition and Role of the Board of the Fund
in Risk Oversight</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Please
refer to the sections of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders
entitled: &#8220;</span><span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Leadership Structure, Composition and Role of Board of the Fund in Risk Oversight</a>&#8221;&#160;and &#8220;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Committees of the Board</a>,&#8221; which is incorporated by reference herein, for a discussion of the Board&#8217;s
leadership structure and oversight</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Share Ownership</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information relating to each Director&#8217;s
share ownership in the Fund as of December&#160;31, 2023 is set out in the chart below:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Name of Director(1)</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Dollar&#160;Range&#160;of&#160;Equity</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities&#160;in&#160;the&#160;Fund(2)</b></p></td>
    <td>&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent Directors</b></span></td>
    <td style="vertical-align: bottom; width: 5%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 43%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine Orr</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John J. Shaw</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Spector</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interested Directors</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David A. Sachs</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All are current Directors. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dollar ranges are as follows: None, $1-$10,000, $10,001-$50,000, $50,001-$100,000 or Over $100,000.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation of Directors</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the compensation paid by the Fund to the Directors during the fiscal year ended December&#160;31, 2023. The Directors who are "interested
persons," as defined in the Investment Company Act, of the Fund and the Fund's officers do not receive compensation from the Fund.
Under the Fund's Investment Advisory Agreement, however, the Adviser may seek reimbursement from the Fund for the costs of certain administrative
services provided to the Fund by the Adviser and its affiliates. The Fund currently pays each Independent Director an annual fee of $50,000.
The Chair of the Nominating and Governance Committee receives an additional annual fee of $5,000. Prior to December&#160;31, 2023, the
Chair of the Audit Committee received an additional annual fee of $5,000. Effective January&#160;1, 2024, the Chair of the Audit Committee
receives an additional annual fee of $10,000. The Nominating and Governance Committee Chair is Bruce H. Spector and the Audit Committee
Chair is Elaine Orr.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Name(1)</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
 Compensation<br/>
from the<br/>
Fund</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pension or</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Retirement Benefits</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Accrued As Part</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of Fund Expenses</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent Directors</b></span></td>
    <td style="vertical-align: bottom; width: 4%">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 17%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 20%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine Orr</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John J. Shaw</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Spector</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interested Directors</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David A. Sachs</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of </span>August 6, 2024, the Directors and officers of the Fund as a group beneficially owned less than 1% of the Fund&#8217;s outstanding
common shares.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of </span>August 6, 2024, none of the Independent Directors of the Fund or their immediate family members owned beneficially or of record
any securities in the Adviser.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Information Pertaining to the Officers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders
entitled: &#8220;<span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Officers of the Fund</a></span></span>,&#8221; which is incorporated by reference herein, for
certain biographical and other information relating to the officers of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Management</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Manager Assets Under Management</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth information about funds and accounts
other than the Fund for which the portfolio managers are primarily responsible for the day-to-day portfolio management as of December&#160;31,
2023:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of <br/>
Portfolio <br/>
Manager</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type of <br/>
Accounts</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total # of <br/>
Accounts <br/>
Managed</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Assets <br/>
(in millions)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8239;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b># of Accounts <br/>
Managed for <br/>
which <br/>
Advisory Fee <br/>
is Based on<br/>
Performance</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8239;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Assets <br/>
for which <br/>
Advisory Fee <br/>
is Based on<br/>
Performance<br/>
(in millions)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,948</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,419</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,846</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,246</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith Ashton</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,470</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,890</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,493</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,280</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Arduini</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,633</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,579</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,296</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Samantha Milner</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,813</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,602</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,931</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,767</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Portfolio Manager Compensation Overview</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The discussion below describes
the portfolio managers&#8217; compensation as of December&#160;31, 2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser&#8217;s financial
arrangements with the Portfolio Managers, its competitive compensation and its career path emphasis at all levels reflect the value senior
management places on key resources. Compensation may include a variety of components and may vary from year to year based on a number
of factors. The Portfolio Managers may receive, all or some combination of, salary, an annual bonus and interests in the carried interest
in certain of Ares&#8217;s funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Base
Compensation.</b></span> Generally, portfolio managers receive base compensation based on their position with the firm.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discretionary
Incentive Compensation. </b></span>In addition to base compensation, portfolio managers may receive discretionary compensation. Discretionary
compensation may be based on individual seniority and contribution.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Securities Ownership of Portfolio Managers</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth,
for each Portfolio Manager, the aggregate dollar range of the Fund&#8217;s equity securities beneficially owned as of December&#160;31,
2023:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio Manager</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar Range of Fund Shares Beneficially Owned</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500,001 - $1,000,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith Ashton</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10,001 - $50,000</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Arduini </span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Samantha Milner</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Material Conflicts of Interest</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual or apparent conflicts
of interest may arise when a Portfolio Manager has day-to-day management responsibilities with respect to more than one fund or other
account.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain inherent conflicts
of interest arise from the fact that the Portfolio Managers, the Adviser and its affiliates provide investment management services both
to the Fund and the other Ares-advised funds, including other funds, as well as client accounts, proprietary accounts and any other investment
vehicles that the Adviser and its affiliates may establish from time to time, managed by the Adviser and its affiliates in which the Fund
will not have an interest. The investment program of the Fund and the other Ares-advised funds or accounts may or may not be substantially
similar. The Portfolio Managers, the Adviser and its affiliates may give advice and recommend securities to the other Ares-advised funds
or accounts that may differ from advice given to, or securities recommended or bought for, the Fund, even though their investment objectives
may be the same or similar to those of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser will seek to manage
potential conflicts of interest in good faith; nonetheless, the portfolio strategies employed by the Portfolio Managers, the Adviser and
its affiliates in managing the other Ares-advised funds could conflict with the transactions and strategies employed by the Portfolio
Managers in managing the Fund and may affect the prices and availability of the securities and instruments in which the Fund invests.
Conversely, participation in specific investment opportunities may be appropriate, at times, for both the Fund and the other Ares-advised
funds or accounts.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser has adopted allocation
procedures that are intended to provide that all investment opportunities will be allocated among the Adviser&#8217;s or its related parties&#8217;
clients on a basis that over a period of time is fair and equitable to each client relative to other clients consistent with any fiduciary
duties owed to clients and in an effort to avoid favoring one client over another, taking into account the terms of the relevant governing
documents and all relevant facts and circumstances, including, but not limited to: (i)&#160;differences with respect to available capital,
size of client, and remaining life of a client; (ii)&#160;differences with respect to investment objectives or current investment strategies,
such as objectives or strategies regarding: (a)&#160;current and total return objectives, (b)&#160;emphasizing or limiting exposure to
specific investments, including, but not limited to, type of security, jurisdiction, industry, or other characteristic of the investment,
(c)&#160;diversification, including industry or company exposure, currency and jurisdiction, or (d)&#160;credit ratings; (iii)&#160;differences
in risk profile at the time an opportunity becomes available; (iv)&#160;the potential transaction and other costs of allocating an opportunity
among various clients; (v)&#160;actual or potential conflicts of interest, including whether multiple clients directly or indirectly have
an existing investment in the security in question or the issuer of such security; (vi)&#160;the nature of the security or the transaction
including size of investment opportunity, minimum investment amounts and the source of the opportunity; (vii)&#160;current and anticipated
market and general economic conditions; and (viii)&#160;prior or existing positions in an issuer/security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event investment opportunities
are allocated among the Fund and the other Ares-advised funds, the Fund may not be able to structure its investment portfolio in the manner
desired. Although the Adviser endeavors to allocate investment opportunities in a manner that, over a period of time, is fair and equitable,
it is possible that the Fund may not be given the opportunity to participate in certain investments made by the other Ares-advised funds
or portfolio managers affiliated with the Adviser. Furthermore, the Fund and the other Ares-advised funds may make investments in securities
where the prevailing trading activity may make impossible the receipt of the same price or execution on the entire volume of securities
purchased or sold by the Fund and the other Ares-advised funds. When this occurs, the various prices may be averaged, and the Fund will
be charged or credited with the average price. Thus, the effect of the aggregation may operate on some occasions to the disadvantage of
the Fund. In addition, under certain circumstances, the Fund may not be charged the same commission or commission equivalent rates in
connection with a bunched or aggregated order.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is likely that other Ares-advised
funds may make investments in the same or similar securities at different times and on different terms than the Fund. The Fund and the
other Ares-advised funds may make investments at different levels of a borrower&#8217;s capital structure or otherwise in different classes
of a borrower&#8217;s securities. Such investments may inherently give rise to conflicts of interest or perceived conflicts of interest
between or among the various classes of securities that may be held by such entities. Conflicts may also arise because portfolio decisions
regarding the Fund may benefit the other Ares-advised funds. For example, the sale of a long position or establishment of a short position
by the Fund may impair the price of the same security sold short by (and therefore benefit) one or more Ares-advised funds, and the purchase
of a security or covering of a short position in a security by the Fund may increase the price of the same security held by (and therefore
benefit) one or more Ares-advised funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While these conflicts cannot
be eliminated, the Adviser, when practicable, will cause the Fund and the other Ares-advised funds to hold investments in the same levels
of an issuer&#8217;s capital structure in the same proportion at each level; provided, however, that neither the Fund nor any other Ares-advised
fund will be required to hold an investment if holding such investment would result in a violation of the provisions of the organizational
documents of the Fund or the other Ares-advised fund, as applicable, or constitute a breach of, or default or debt repayment event with
respect to, any credit facility or other debt instrument or obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the professional
staff of the Adviser will devote as much time to the management of the Fund as the Adviser deems appropriate to perform its obligations,
the professional staff of the Adviser may have conflicts in allocating its time and services among the Fund and the Adviser&#8217;s other
investment vehicles and accounts. The Adviser and its affiliates are not restricted from forming additional investment funds, from entering
into other investment advisory relationships or from engaging in other business activities, even though such activities may be in competition
with the Fund and/or may involve substantial time and resources of the Adviser and its professional staff. These activities could be viewed
as creating a conflict of interest in that the time and effort of the members of the Adviser and their officers and employees will not
be devoted exclusively to the business of the Fund but will be allocated between the business of the Fund and the management of the monies
of other clients of the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Codes of Ethics</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund and the Adviser have
each adopted a code of ethics pursuant to Rule&#160;17j-1 under the Investment Company Act that establishes procedures for personal investments
and restricts certain personal securities transactions. Personnel subject to each code may invest in securities for their personal investment
accounts, including securities that may be purchased or held by the Fund, so long as such investments are made in accordance with the
code&#8217;s requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The codes of ethics may be
viewed and copied at the SEC&#8217;s Public Reference Room in Washington, D.C. Information about the SEC&#8217;s Public Reference Room
may be obtained by calling the SEC at (202) 551-8090. The codes of ethics also may be available on the EDGAR Database on the SEC&#8217;s
website, http://www.sec.gov, or be obtained, after paying a duplicating fee, by electronic request to publicinfo@sec.gov, or by writing
to: SEC&#8217;s Public Reference Section, 100 F Street, N.E., Washington, D.C. 20549-0102. This reference to the website does not incorporate
the contents of the website into this SAI.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PORTFOLIO TRANSACTIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is responsible
for decisions to buy and sell securities for the Fund, the selection of brokers and dealers to effect the transactions and the negotiation
of prices and any brokerage commissions. With respect to senior loans and subordinated loans, the Fund generally will engage in privately
negotiated transactions for purchase or sale in which the Adviser will negotiate on behalf of the Fund. Most of these transactions will
be principal transactions at net prices for which the Fund will generally incur little or no brokerage costs. The Fund may be required
to pay fees, or forgo a portion of interest and any fees payable to the Fund, to a lender selling assignment or participations to the
Fund. The Adviser will determine the lenders from whom the Fund will purchase assignments and participations by considering their professional
ability, level of service, relationship with the borrower, financial condition, credit standards and quality of management. Affiliates
of the Adviser may participate in the primary and secondary market for senior loans and subordinated loans. Because of certain limitations
imposed by the Investment Company Act, this may restrict the Fund&#8217;s ability to acquire some senior loans and subordinated loans.
The Adviser does not believe that this will have a material effect on the Fund&#8217;s ability to acquire senior loans and subordinated
loans consistent with its investment policies. Sales to dealers are effected at bid prices. The illiquidity of some senior loans, subordinated
loans and, to a more limited extent, CLOs may restrict the ability of the Adviser to locate in a timely manner persons willing to purchase
the Fund&#8217;s interests in senior loans, subordinated loans or CLOs at a fair price should the Fund desire to sell such interests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to other types
of securities, the Fund may purchase certain money market instruments directly from an issuer (in which case no commissions or discounts
are paid), may purchase securities in the over-the-counter (OTC) market from an underwriter or dealer serving as market maker for the
securities, in which case the price includes a fixed amount of compensation to the underwriter or dealer, and may purchase and sell listed
securities on an exchange, which are effected through brokers who charge a commission for their services.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is responsible
for arranging for the execution of the Fund&#8217;s portfolio transactions and will do so in a manner deemed fair and reasonable to the
Fund and in accordance with the Adviser&#8217;s conflicts policy. The primary consideration in all portfolio transactions is prompt execution
of orders in an effective manner at the most favorable price. In selecting broker-dealers and in negotiating prices and any brokerage
commissions on such transactions, the Adviser considers the firm&#8217;s reliability, integrity and financial condition and the firm&#8217;s
execution capability, the size and breadth of the market for the security, the size of and difficulty in executing the order, and the
best net price. There may be instances when, in the judgment of the Adviser, more than one firm can offer comparable execution services.
A commission paid to such brokers may be higher than that which another qualified broker would have charged for effecting the same transaction,
provided that the Adviser determine in good faith that such commission is reasonable in terms either of the transaction or the overall
responsibility of the Adviser to the Fund and its other clients and that the total commissions paid by the Fund will be reasonable in
relation to the benefits to the Fund over the long-term. The advisory fees that the Fund pays to the Adviser will not be reduced if the
Adviser receives brokerage and research services. Commission rates for brokerage transactions on foreign share exchanges are generally
fixed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information about the brokerage
commissions paid by the Fund is set forth in the following tables:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Fiscal Year Ended December&#160;31,</b></p></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate&#160;Brokerage<br/>
Commissions&#160;Paid</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commissions<br/>
Paid&#160;to&#160;Affiliates</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year ended
December&#160;31, 2023, the Fund paid no brokerage commissions to affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table shows
the dollar amount of brokerage commissions paid to brokers for providing third-party research services and the approximate dollar amount
of the transactions involved for the fiscal year ended December&#160;31, 2023. The provision of third-party research services was not
necessarily a factor in the placement of all brokerage business with such brokers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><b>Amount&#160;of&#160;Commissions&#160;Paid&#160;to&#160;Brokers&#160;for
    Providing<br/>
    Research Services</b></p></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount&#160;of&#160;Brokerage&#160;Transactions&#160;Involved</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2023,
the Fund held no securities of its &#8220;regular brokers or dealers&#8221; (as defined in Rule&#160;10b-1 under the Investment Company
Act) whose shares were purchased during the fiscal year ended December&#160;31, 2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONFLICTS OF INTEREST</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund&#8217;s executive
officers and directors, and the employees of the Adviser, serve or may serve as officers, directors or principals of entities that operate
in the same or a related line of business as the Fund or of other Ares-advised funds (&#8220;Other Managed Funds&#8221;). As a result,
they may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of the Fund or its
shareholders. Moreover, notwithstanding the difference in principal investment objectives between the Fund and the Other Managed Funds,
such other Ares-advised funds, including potential new pooled investment vehicles or managed accounts not yet established (whether managed
or sponsored by affiliates or the Adviser), have, and may from time to time have, overlapping investment objectives with the Fund and,
accordingly, invest in, whether principally or secondarily, asset classes similar to those targeted by the Fund. To the extent the Other
Managed Funds have overlapping investment objectives, the scope of opportunities otherwise available to the Fund may be adversely affected
and/or reduced. Additionally, certain employees of the Adviser and its management may face conflicts in their time management and commitments
as well as in the allocation of investment opportunities to other Ares funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The results of the Fund&#8217;s
investment activities may differ significantly from the results achieved by Other Managed Funds. It is possible that one or more of such
funds will achieve investment results that are substantially more or less favorable than the results achieved by the Fund. Moreover, it
is possible that the Fund will sustain losses during periods in which one or more affiliates achieve significant profits on their trading
for proprietary or other accounts. The opposite result is also possible. The investment activities of one or more Adviser affiliates for
their proprietary accounts and accounts under their management may also limit the investment opportunities for the Fund in certain markets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may determine
that the Fund should invest on a side-by-side basis with one or more Other Managed Funds. In certain circumstances, negotiated co-investments
may be made only in accordance with the terms of the exemptive order Ares received from the SEC (the &#8220;Order&#8221;). Co-investments
made under the Order are subject to compliance with the conditions and other requirements contained in the Order, which could limit the
Fund&#8217;s ability to participate in a co-investment transaction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Fund
and the Other Managed Funds may make investments at different levels of an issuer&#8217;s capital structure or otherwise in different
classes of an issuer&#8217;s securities. Such investments may inherently give rise to conflicts of interest or perceived conflicts of
interest between or among the various classes of securities that may be held by such entities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser, its affiliates
and their clients may pursue or enforce rights with respect to an issuer in which the Fund has invested, and those activities may have
an adverse effect on the Fund. As a result, prices, availability, liquidity and terms of the Fund&#8217;s investments may be negatively
impacted by the activities of the Adviser and its affiliates or their clients, and transactions for the Fund may be impaired or effected
at prices or terms that may be less favorable than would otherwise have been the case.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may enter into
transactions and invest in securities, instruments and currencies on behalf of the Fund in which customers of its affiliates, to the extent
permitted by applicable law, serve as the counterparty, principal or issuer. In such cases, such party&#8217;s interests in the transaction
could be adverse to the interests of the Fund, and such party may have no incentive to assure that the Fund obtains the best possible
prices or terms in connection with the transaction. In addition, the purchase, holding and sale of such investments by the Fund may enhance
the profitability of the Adviser or its affiliates. One or more affiliates may also create, write or issue derivatives for their customers,
the underlying securities, currencies or instruments of which may be those in which the Fund invests or which may be based on the performance
of the Fund. The Fund may, subject to applicable law, purchase investments that are the subject of an underwriting or other distribution
by one or more affiliates of the Adviser and may also enter into transactions with other clients of an affiliate where such other clients
have interests adverse to those of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will be required
to establish business relationships with its counterparties based on the Fund&#8217;s own credit standing. Neither the Adviser nor any
of its affiliates will have any obligation to allow its credit to be used in connection with the Fund&#8217;s establishment of its business
relationships, nor is it expected that the Fund&#8217;s counterparties will rely on the credit of the Adviser or its affiliates in evaluating
the Fund&#8217;s creditworthiness.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is paid a fee
based on a percentage of the Fund&#8217;s Managed Assets (as defined above). The participation of the Adviser&#8217;s investment professionals
in the valuation process could therefore result in a conflict of interest. The Adviser also may have a conflict of interest in deciding
whether to cause the Fund to incur leverage or to invest in more speculative investments or financial instruments, thereby potentially
increasing the assets or yield of the Fund and, accordingly, the Management Fees or Incentive Fees received by the Adviser. Certain other
Ares-advised funds pay the Adviser or its affiliates performance-based compensation, which could create an incentive for the Adviser or
affiliate to favor such investment fund or account over the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By reason of the various activities
of the Adviser and its affiliates, the Adviser and such affiliates may acquire confidential or material non-public information or otherwise
be restricted from purchasing certain potential Fund investments that otherwise might have been purchased or be restricted from selling
certain Fund investments that might otherwise have been sold at the time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser has adopted policies
and procedures designed to prevent conflicts of interest from influencing proxy voting decisions made on behalf of advisory clients, including
the Fund, and to help ensure that such decisions are made in accordance with its fiduciary obligations to clients. Nevertheless, notwithstanding
such proxy voting policies and procedures, actual proxy voting decisions may have the effect of favoring the interests of other clients,
provided that the Adviser believes such voting decisions to be in accordance with its fiduciary obligations. See &#8220;The Portfolio
Managers&#8212;Material Conflicts of Interest&#8221; for further discussion of conflicts of interest relevant to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF SHARES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund intends to hold annual
meetings of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required as a
condition to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to all
of its shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund has authorized and
issued 800,000 shares of Series&#160;A Mandatory Redeemable Preferred Stock, par value $0.001 per share (the &#8220;Series&#160;A MRP
Shares&#8221;), for gross proceeds of $20 million, 1,200,000 shares of Series&#160;B Mandatory Redeemable Preferred Stock, par value $0.001
per share (the &#8220;Series&#160;B MRP Shares&#8221;), for gross proceeds of $30 million and 2,000,000 shares of Series&#160;C Mandatory
Redeemable Preferred Stock, par value $0.001 per share (the &#8220;Series&#160;C MRP Shares&#8221; and together with the Series&#160;A
MRP Shares and Series&#160;B MRP Shares, the &#8220;preferred shares&#8221;), for gross proceeds of $50 million. Each of the preferred
shares has a liquidation preference of $25.00 per share. The aggregate redemption amount of the preferred shares is $100 million.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The redemption dates for
the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and
September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus
any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The Series&#160;A MRP
Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have
a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is 2.81% per annum.
Holders of the preferred shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following
each quarterly dividend date. The preferred shares are subject to optional and mandatory redemption in certain circumstances. The preferred
shares will be subject to redemption, at the option of the Fund, in whole or in part at any time only for the purposes of decreasing
leverage of the Fund. The Fund may be obligated to redeem certain of the preferred shares if the Fund fails to maintain an asset coverage
ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions
relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions
could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the preferred
shares. Additionally, in accordance with the Investment Company Act, the Fund may not issue additional preferred shares if immediately
after such issuance the Fund will not have an asset coverage ratio of at least 200%. As of December&#160;31, 2023, the Fund was in compliance
in all material respects with the terms of the preferred shares.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The Board (subject to
applicable law and the Charter) may authorize an offering, without the approval of the common shareholders and, depending on their terms,
any preferred shares outstanding at that time, of other classes of shares, or other classes or series of shares, as it determines to
be necessary, desirable or appropriate, having such terms, rights, preferences, privileges, limitations and restrictions as the Board
sees fit. The Fund currently does not expect to issue any other classes of shares, or series of shares, except for the common shares.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPURCHASE OF COMMON SHARES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the Fund is a closed-end
management investment company, its shareholders will not have the right to cause the Fund to redeem their common shares. Instead, the
Fund's common shares will trade in the open market at a price that will be a function of several direct and indirect factors, including
dividend levels (which are in turn affected by expenses), net asset value, dividend stability, relative demand for and supply of such
shares in the market, general market and economic conditions and other factors. Notice is hereby given in accordance with Section&#160;23(c)&#160;of
the Investment Company Act that the Fund may purchase at market prices from time to time its common shares in the open market but is under
no obligation to do so.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
at any time if the Fund has preferred shares outstanding, the Fund may not purchase, redeem or otherwise acquire any of its common shares
unless (i)&#160;all accrued preferred share dividends, if any, have been paid and (ii)&#160;at the time of such purchase, redemption or
acquisition, the Fund has an asset coverage of at least 200% after deducting the amount of such purchase, redemption or acquisition, as
applicable. Similarly, if the Fund has outstanding indebtedness, the Fund may not purchase, redeem or acquire its capital stock unless
the Fund has an asset coverage of at least 300% after deducting the amount of such purchase, redemption or acquisition, as applicable.
See &#8220;Leverage.&#8221; Any service fees incurred in connection with any tender offer made by the Fund will be borne by the Fund and
will not reduce the stated consideration to be paid to tendering shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to its investment
restrictions, the Fund may borrow to finance the repurchase of common shares or to make a tender offer for those shares. Interest on any
borrowings to finance share repurchase transactions or the accumulation of cash by the Fund in anticipation of share repurchases or tenders
will reduce the Fund's net income. Any share repurchase, tender offer or borrowing approved by the Board would have to comply with the
NYSE listing requirements and the Securities and Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), the Investment Company Act, and
the rules&#160;and regulations thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no assurance that,
if action is undertaken to repurchase or tender for common shares, such action will result in the Fund's common shares trading at a price
that approximates their net asset value. Although share repurchases and tenders could have a favorable effect on the market price of the
Fund's common shares, shareholders should be aware that the acquisition of common shares by the Fund will decrease the total net assets
of the Fund and, therefore, may have the effect of increasing the Fund's expense ratio and decreasing the asset coverage with respect
to any preferred shares outstanding and any amounts borrowed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TAX MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a description
of certain U.S. federal income tax consequences to a shareholder of acquiring, holding and disposing of common shares of the Fund. Except
as otherwise noted, this discussion assumes you are a taxable U.S. holder (as defined below). This discussion is based upon current provisions
of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative
authorities, all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal income tax concerns affecting
the Fund and its shareholders, and the discussions set forth here do not constitute tax advice. This discussion assumes that investors
hold common shares of the Fund as capital assets (generally, for investment). The Fund has not sought and will not seek any ruling from
the IRS regarding any matters discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain,
a position contrary to those set forth below. This summary does not discuss any aspects of foreign, state or local tax. Prospective investors
must consult their own tax advisers as to the U.S. federal income tax consequences (including the alternative minimum tax consequences)
of acquiring, holding and disposing of the Fund&#8217;s common shares, as well as the effects of state, local and non-U.S. tax laws.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, no attempt is
made to address tax considerations applicable to an investor with a special tax status, such as a financial institution, real estate income
trust (&#8220;REIT&#8221;), insurance company, regulated investment company, individual retirement account, other tax-exempt organization,
dealer in securities or currencies, person holding shares of the Fund as part of a hedging, integrated, conversion or straddle transaction,
trader in securities that has elected the mark-to-market method of accounting for its securities, U.S. holder (as defined below) whose
functional currency is not the U.S. dollar, investor with &#8220;applicable financial statements&#8221; within the meaning of Section&#160;451(b)&#160;of
the Code, or non-U.S. investor. Furthermore, this discussion does not reflect possible application of the alternative minimum tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A U.S. holder is a beneficial
owner that is for U.S. federal income tax purposes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a citizen or individual resident of the United States (including certain former citizens and former long-term
residents);</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a corporation or other entity treated as a corporation for U.S. federal income tax purposes, created or
organized in or under the laws of the United States or any state thereof or the District of Columbia;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a trust with respect to which a court within the United States is able to exercise primary supervision
over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or the trust has made
a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Taxation of the Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has elected to be treated as a registered investment company (&#8220;RIC&#8221;) under Subchapter M of the Code, and operates in
a manner so as to qualify for tax treatment applicable to RICs. To qualify as a RIC, the Fund must, among other things, satisfy certain
requirements relating to the sources of its income, diversification of its assets, and distribution of its income to its shareholders.
First, the Fund must derive at least 90% of its annual gross income from dividends, interest, payments with respect to securities loans,
gains from the sale or other disposition of shares or securities or foreign currencies, or other income (including but not limited to
gains from options, futures and forward contracts) derived with respect to its business of investing in such shares, securities or currencies,
or net income derived from interests in &#8220;qualified publicly traded partnerships&#8221; (as defined in the Code) (the &#8220;90%
gross income test&#8221;). Second, the Fund must diversify its holdings so that, at the close of each quarter of its taxable year, (i)&#160;at
least 50% of the value of its total assets consists of cash, cash items, U.S. Government securities, securities of other RICs and other
securities, with such other securities limited in respect of any one issuer </span>to an amount not greater in value than 5% of the value
of the Fund&#8217;s total assets and to not more than 10% of the outstanding voting securities of such issuer, and (ii)&#160;not more
than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. Government securities and
securities of other RICs) of any one issuer, any two or more issuers controlled by the Fund and engaged in the same, similar or related
trades or businesses, or any one or more &#8220;qualified publicly traded partnerships.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As long as the Fund qualifies
as a RIC, the Fund will generally not be subject to corporate-level U.S. federal income tax on income and gains that it distributes each
taxable year to its shareholders, provided that in such taxable year it distributes at least 90% of the sum of (i)&#160;its net tax-exempt
interest income, if any, and (ii)&#160;its &#8220;investment company taxable income&#8221; (which includes, among other items, dividends,
taxable interest, taxable original issue discount and market discount income, income from securities lending, net short-term capital gain
in excess of net long-term capital loss, and any other taxable income other than &#8220;net capital gain&#8221; (as defined below) and
is reduced by deductible expenses) determined without regard to the deduction for dividends paid. The Fund may retain for investment its
net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). However, if the
Fund retains any net capital gain or any investment company taxable income, it will be subject to tax at regular corporate rates on the
amount retained.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Code imposes a 4% nondeductible
excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i)&#160;98% of
its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii)&#160;98.2% of its capital gain in
excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar
year (unless an election is made to use the Fund&#8217;s fiscal year). In addition, the minimum amounts that must be distributed in any
year to avoid the excise tax will be increased or decreased to reflect the total amount of any under-distribution or over-distribution,
as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on
which it paid U.S. federal income tax. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize
imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and
capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event, the Fund will be liable for the excise
tax only on the amount by which it does not meet the foregoing distribution requirement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If in any taxable year the
Fund should fail to qualify under Subchapter M of the Code for tax treatment as a RIC, the Fund would incur a regular corporate U.S. federal
income tax upon all of its taxable income for that year, and all distributions to its shareholders (including distributions of net capital
gain) would be taxable to shareholders as ordinary dividend income for U.S. federal income tax purposes to the extent of the Fund&#8217;s
earnings and profits. Provided that certain holding period and other requirements were met, such dividends would be eligible (i)&#160;to
be treated as qualified dividend income in the case of shareholders taxed as individuals and (ii)&#160;for the dividends received deduction
in the case of corporate shareholders. In addition, to qualify again to be taxed as a RIC in a subsequent year, the Fund would be required
to distribute to shareholders its earnings and profits attributable to non-RIC years. In addition, if the Fund failed to qualify as a
RIC for a period greater than two taxable years, then, in order to qualify as a RIC in a subsequent year, the Fund would be required to
elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss
that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized
for a period of five years.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The remainder of this discussion
assumes that the Fund qualifies for taxation as a RIC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Fund&#8217;s Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions (including mark-to-market,
constructive sale, straddle, wash sale, short sale and other rules) that may, among other things, (i)&#160;disallow, suspend or otherwise
limit the allowance of certain losses or deductions, (ii)&#160;convert lower taxed long-term capital gains or qualified dividend income
into higher taxed short-term capital gains or ordinary income, (iii)&#160;convert ordinary loss or a deduction into capital loss (the
deductibility of which is more limited), (iv)&#160;cause the Fund to recognize income or gain without a corresponding receipt of cash,
(v)&#160;adversely affect the time as to when a purchase or sale of shares or securities is deemed to occur, (vi)&#160;adversely alter
the characterization of certain complex financial transactions and (vii)&#160;produce income that will not be &#8220;qualified&#8221;
income for purposes of the 90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore
affect the amount, timing and character of distributions to common shareholders. The Fund monitors its transactions </span>and may make
certain tax elections and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification
of the Fund as a RIC. Additionally, the Fund may be required to limit its activities in derivative instruments in order to enable it to
maintain its RIC status.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund may invest a portion
of its net assets in below investment grade securities, commonly known as &#8220;junk&#8221; securities. Investments in these types of
securities may present special tax issues for the Fund. U.S. federal income tax rules&#160;are not entirely clear about issues such as
when the Fund may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken
for bad debts or worthless securities, how payments received on obligations in default should be allocated between principal and income
and whether modifications or exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues could
affect the Fund&#8217;s ability to distribute sufficient income to preserve its status as a RIC or to avoid the imposition of U.S. federal
income or excise tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain debt securities acquired
by the Fund may be treated as debt securities that were originally issued at a discount. Generally, the amount of the original issue discount
is treated as interest income and is included in taxable income (and required to be distributed by the Fund in order to qualify as a RIC
and avoid U.S. federal income tax or the 4% excise tax on undistributed income) over the term of the security, even though payment of
that amount is not received until a later time, usually when the debt security matures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund purchases a debt
security on a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase
price is &#8220;market discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any
gain realized on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary
income to the extent the gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt security. Market
discount generally accrues in equal daily installments. If the Fund ultimately collects less on the debt instrument than its purchase
price, plus the market discount previously included in income, the Fund may not be able to benefit from any offsetting loss deductions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund may invest in preferred
securities or other securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization
by the IRS. To the extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected
by the Fund, it could affect the timing or character of income recognized by the Fund, potentially requiring the Fund to purchase or sell
securities, or otherwise change its portfolio, in order to comply with the tax rules&#160;applicable to RICs under the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gain or loss on the sale of
securities by the Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one
year. Gain or loss on the sale of securities held for one year or less will be short-term capital gain or loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the Fund may invest
in foreign securities, its income from such securities may be subject to non-U.S. taxes. If more than 50% of the Fund&#8217;s total assets
at the close of its taxable year consists of stock or securities of foreign corporations, the Fund may elect for U.S. federal income tax
purposes to treat foreign income taxes paid by it as paid by its shareholders. The Fund may qualify for and make this election in some,
but not necessarily all, of its taxable years. If the Fund were to make such an election, shareholders would be required to take into
account an amount equal to their pro rata portions of such foreign taxes in computing their taxable income and then treat an amount equal
to those foreign taxes as a U.S. federal income tax deduction or as a foreign tax credit against their U.S. federal income tax liability.
A taxpayer&#8217;s ability to use a foreign tax deduction or credit is subject to limitations under the Code. Shortly after any year for
which it makes such an election, the Fund will report to its shareholder the amount per share of such foreign income tax that must be
included in each shareholder&#8217;s gross income and the amount that may be available for the deduction or credit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Foreign currency gain or loss
on foreign currency exchange contracts, non-U.S. dollar-denominated securities contracts, and non-U.S. dollar-denominated futures contracts,
options and forward contracts that are not section 1256 contracts (as defined below) generally will be treated as ordinary income and
loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income from options on individual
securities written by the Fund will generally not be recognized by the Fund for tax purposes until an option is exercised, lapses or is
subject to a &#8220;closing transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations with
respect to the option are otherwise terminated. If the option lapses without exercise, the premiums received by the Fund from the writing
of such options will generally be characterized as short-term capital gain. If the Fund enters into a closing transaction, the difference
between the premiums received and the amount paid by the Fund to close out its position will generally be treated as short-term capital
gain or loss. If an option written by the Fund is exercised, thereby requiring the Fund to sell the underlying security, the premium will
increase the amount realized upon the sale of the security, and the character of any gain on such sale of the underlying security as short-term
or long-term capital gain will depend on the holding period of the Fund in the underlying security. Because the Fund will not have control
over the exercise of the options it writes, such exercises or other required sales of the underlying securities may cause the Fund to
realize gains or losses at inopportune times.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options on indices of securities
and sectors of securities that qualify as &#8220;section 1256 contracts&#8221; will generally be treated as &#8220;marked-to-market&#8221;
for U.S. federal income tax purposes. As a result, the Fund will generally recognize gain or loss on the last day of each taxable year
equal to the difference between the value of the option on that date and the adjusted basis of the option. The adjusted basis of the option
will consequently be increased by such gain or decreased by such loss. Any gain or loss with respect to options on indices and sectors
that qualify as &#8220;section 1256 contracts&#8221; will be treated as short-term capital gain or loss to the extent of 40% of such gain
or loss and long-term capital gain or loss to the extent of 60% of such gain or loss. Because the mark-to-market rules&#160;may cause
the Fund to recognize gain in advance of the receipt of cash, the Fund may be required to dispose of investments in order to meet its
distribution requirements. &#8220;Mark-to-market&#8221; losses may be suspended or otherwise limited if such losses are part of a straddle
or similar transaction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Taxation of Common Shareholders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will either distribute
or retain for reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a corporate
income tax on such retained amount. In that event, the Fund expects to report the retained amount as undistributed capital gain in a notice
to its common shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i)&#160;will be required
to include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts, (ii)&#160;will
be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds
to the extent that the credit exceeds such liability and (iii)&#160;will increase its basis in its common shares by the amount of undistributed
capital gains included in the shareholder&#8217;s income, less the tax deemed paid by the shareholder under clause (ii).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Distributions paid to you
by the Fund from its net capital gain, if any, that the Fund properly reports as capital gain dividends (&#8220;capital gain dividends&#8221;)
are taxable as long-term capital gains, regardless of how long you have held your common shares. All other dividends paid to you by the
Fund (including dividends from net short-term capital gains or tax-exempt interest, if any) from its current or accumulated earnings and
profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income. Provided that certain holding period
and other requirements are met, ordinary income dividends (if properly reported by the Fund) may qualify (i)&#160;for the dividends received
deduction in the case of corporate shareholders to the extent that the Fund&#8217;s income consists of dividend income from U.S. corporations,
and (ii)&#160;in the case of individual shareholders, as &#8220;qualified dividend income&#8221; eligible to be taxed at long-term capital
gains rates to the extent that the Fund receives qualified dividend income. Qualified dividend income is, in general, dividend income
from taxable domestic corporations and certain qualified foreign corporations (e.g., generally, foreign corporations incorporated in a
possession of the United States or in certain countries with a qualifying comprehensive tax treaty with the United States, or whose stock
with respect to which such dividend is paid is readily tradable on an established securities market in the United States). There can be
no assurance as to what portion, if any, of the Fund&#8217;s distributions will constitute qualified dividend income or be eligible for
the dividends received deduction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any distributions you receive
that are in excess of the Fund&#8217;s current and accumulated earnings and profits will be treated as a return of capital to the extent
of your adjusted tax basis in your common shares, and thereafter as capital gain from the sale of common shares. The amount of any Fund
distribution that is treated as a return of capital will reduce your adjusted tax basis in your common shares, thereby increasing your
potential gain or reducing your potential loss on any subsequent sale or other disposition of your common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common shareholders may be
entitled to offset their capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when
capital losses may be offset against capital gain, and limiting the use of losses from certain investments and activities. Accordingly,
common shareholders that have capital losses are urged to consult their tax advisor.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividends and other taxable
distributions are taxable to you even though they are reinvested in additional common shares of the Fund. Dividends and other distributions
paid by the Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however,
the Fund pays you a dividend in January&#160;that was declared in the previous October, November&#160;or December&#160;to common shareholders
of record on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being
paid by the Fund and received by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions
made after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes
of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the
taxable year in which the distributions were actually made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The price of common shares
purchased at any time may reflect the amount of a forthcoming distribution. Those purchasing common shares just prior to the record date
for a distribution will receive a distribution which will be taxable to them even though it represents, economically, a return of invested
capital.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will send you information
after the end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale or other disposition
of common shares will generally result in capital gain or loss to you and will be long-term capital gain or loss if you have held such
common shares for more than one year at the time of sale. Any loss upon the sale or other disposition of common shares held for six months
or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited as
an undistributed capital gain dividend) by you with respect to such common shares. Any loss you recognize on a sale or other disposition
of common shares will be disallowed if you acquire other common shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the common shares. In such case, your
tax basis in the common shares acquired will be adjusted to reflect the disallowed loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any sales charges paid upon
a purchase of common shares cannot be taken into account for purposes of determining gain or loss on a sale of the common shares before
the 91st day after their purchase to the extent a sales charge is reduced or eliminated in a subsequent acquisition of common shares of
the Fund (or of another fund), during the period beginning on the date of such sale and ending on January&#160;31 of the calendar year
following the calendar year in which such sale was made, pursuant to the reinvestment or exchange privilege. Any disregarded amounts will
result in an adjustment to the shareholder&#8217;s tax basis in some or all of any other shares acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund conducts a tender
offer for its shares, a repurchase by the Fund of a shareholder&#8217;s shares pursuant to such tender offer generally will be treated
as a sale or exchange of the shares by a shareholder, provided that either (i)&#160;the shareholder tenders, and the Fund repurchases,
all of such shareholder&#8217;s shares, thereby reducing the shareholder&#8217;s percentage ownership of the Fund, directly and by attribution
under Section&#160;318 of the Code, to 0%, (ii)&#160;the shareholder meets numerical safe harbors under the Code with respect to percentage
voting interest and reduction in ownership of the Fund following completion of the tender offer, or (iii)&#160;the tender offer otherwise
results in a &#8220;meaningful reduction&#8221; of the shareholder&#8217;s ownership percentage interest in the Fund, which determination
depends on a particular shareholder&#8217;s facts and circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a tendering shareholder&#8217;s
proportionate ownership of the Fund (determined after applying the ownership attribution rules&#160;under Section&#160;318 of the Code)
is not reduced to the extent required under the tests described above, such shareholder will be deemed to receive a distribution from
the Fund under Section&#160;301 of the Code with respect to the shares held (or deemed held under Section&#160;318 of the Code) by the
shareholder after the tender offer (a &#8220;Section&#160;301 distribution&#8221;). The amount of this distribution will equal the price
paid by the Fund to such shareholder for the shares sold, and will be taxable as a dividend, i.e., as ordinary income, to the extent of
the Fund&#8217;s current or accumulated earnings and profits allocable to such distribution, with the excess treated as a return of capital
reducing the shareholder&#8217;s tax basis in the shares held after the tender offer, and thereafter as capital gain. Any Fund shares
held by a shareholder after a tender offer will be subject to basis adjustments in accordance with the provisions of the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provided that no tendering
shareholder is treated as receiving a Section&#160;301 distribution as a result of selling shares pursuant to a particular tender offer,
shareholders who do not sell shares pursuant to that tender offer will not realize constructive distributions on their shares as a result
of other shareholders selling shares in the tender offer. In the event that any tendering shareholder is deemed to receive a Section&#160;301
distribution, it is possible that shareholders whose proportionate ownership of the Fund increases as a result of that tender offer, including
shareholders who do not tender any shares, will be deemed to receive a constructive distribution under Section&#160;305(c)&#160;of the
Code in an amount equal to the increase in their percentage ownership of the Fund as a result of the tender offer. Such constructive distribution
will be treated as a dividend to the extent of current or accumulated earnings and profits allocable to it.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Use of the Fund&#8217;s cash
to repurchase shares may adversely affect the Fund&#8217;s ability to satisfy the distribution requirements for treatment as a regulated
investment company described above. The Fund may also recognize income in connection with the sale of portfolio securities to fund share
purchases, in which case the Fund would take any such income into account in determining whether such distribution requirements have been
satisfied.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund liquidates, shareholders
generally will realize capital gain or loss upon such liquidation in an amount equal to the difference between the amount of cash or other
property received by the shareholder (including any property deemed received by reason of its being placed in a liquidating trust) and
the shareholder&#8217;s adjusted tax basis in its shares. Any such gain or loss will be long-term if the shareholder is treated as having
a holding period in Fund shares of greater than one year, and otherwise will be short-term.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing discussion does
not address the tax treatment of shareholders who do not hold their shares as a capital asset. Such shareholders should consult their
own tax advisers on the specific tax consequences to them of participating or not participating in the tender offer or upon liquidation
of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current U.S. federal income
tax law taxes both long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate
taxpayers, short-term capital gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is
taxed at a reduced maximum rate. The deductibility of capital losses is subject to limitations under the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain U.S. holders who are
individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a portion
of their &#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other
disposition of the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A common shareholder that
is a nonresident alien individual or a foreign corporation (a &#8220;foreign investor&#8221;) generally will be subject to U.S. federal
withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income dividends (except
as discussed below). In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain or income realized
by a foreign investor in respect of any distribution of net capital gain (including amounts credited as an undistributed capital gain
dividend) or upon the sale or other disposition of common shares of the Fund. Different tax consequences may result if the foreign investor
is engaged in a trade or business in the United States or, in the case of an individual, is present in the United States for 183 days
or more during a taxable year and certain other conditions are met. Foreign investors should consult their tax advisor regarding the tax
consequences of investing in the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ordinary income dividends
properly reported by the RIC are generally exempt from U.S. federal withholding tax where they (i)&#160;are paid in respect of the RIC&#8217;s
&#8220;qualified net interest income&#8221; (generally, its U.S.-source interest income, other than certain contingent interest and interest
from obligations of a corporation or partnership in which the RIC is at least a 10% shareholder, reduced by expenses that are allocable
to such income) or (ii)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess
of the RIC&#8217;s net short-term capital gain over its long-term capital loss for such taxable year). Depending on its circumstances,
the Fund may report all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term
capital gains, and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify
for this exemption from withholding, a foreign investor needs to comply with applicable certification requirements relating to its non-U.S.
status (including, in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E, or substitute Form). In the case of common shares held through
an intermediary, the intermediary may have withheld even if the Fund reported the payment as qualified net interest income or qualified
short-term capital gain. Foreign investors should contact their intermediaries with respect to the application of these rules&#160;to
their accounts. There can be no assurance as to what portion of the Fund&#8217;s distributions would qualify for favorable treatment as
qualified net interest income or qualified short-term capital gains.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, withholding at
a rate of 30% will apply to dividends paid in respect of common shares of the Fund held by or through certain foreign financial institutions
(including investment funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis, information
with respect to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S.
persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly,
the entity through which common shares of the Fund are held will affect the determination of whether such withholding is required. Similarly,
dividends paid in respect of common shares of the Fund held by an investor that is a non-financial foreign entity that does not qualify
under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i)&#160;certifies that such entity
does not have any &#8220;substantial United States owners&#8221; or (ii)&#160;provides certain information regarding the entity&#8217;s
&#8220;substantial United States owners,&#8221; which the applicable withholding agent will in turn provide to the Secretary of the Treasury.
An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance,
may modify these requirements. The Fund will not pay any additional amounts to common shareholders in respect of any amounts withheld.
Foreign investors are encouraged to consult with their tax advisers regarding the possible implications of these rules&#160;on their investment
in the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. federal backup withholding
tax may be required on dividends, distributions and sale proceeds payable to certain non-exempt common shareholders who fail to supply
their correct taxpayer identification number (in the case of individuals, generally, their social security number) or to make required
certifications, or who are otherwise subject to backup withholding. Backup withholding is not an additional tax and any amount withheld
may be refunded or credited against your U.S. federal income tax liability, if any, provided that you timely furnish the required information
to the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ordinary income dividends,
capital gain dividends, and gain from the sale or other disposition of common shares of the Fund also may be subject to state, local,
and/or foreign taxes. Common shareholders are urged to consult their own tax advisers regarding specific questions about U.S. federal,
state, local or foreign tax consequences to them of investing in the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">***</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing is a general
and abbreviated summary of certain provisions of the Code and the Treasury regulations presently in effect as they directly govern the
taxation of the Fund and its shareholders. For complete provisions, reference should be made to the pertinent Code sections and Treasury
regulations. The Code and the Treasury regulations are subject to change by legislative or administrative action, and any such change
may be retroactive with respect to Fund transactions. Holders of common shares are advised to consult their own tax advisor for more detailed
information concerning the U.S. federal income taxation of the Fund and the income tax consequences to its holders of common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>ADMINISTRATIVE, CUSTODIAN,
TRANSFER AGENT AND OTHER SERVICES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The custodian of the assets
of the Fund is State Street, located at One Congress Street, Boston, Massachusetts 02114. The custodian performs custodial, fund accounting
and portfolio accounting services. State Street serves as the Fund&#8217;s transfer agent and dividend paying agent with respect to the
common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund has engaged State
Street to serve as the Fund's administrator, custodian and transfer agent. Under the service agreements between State Street and the Fund,
State Street provides certain administrative services necessary for the operation of the Fund. Such services include maintaining certain
Fund books and records, providing accounting and tax services and preparing certain regulatory filings. State Street also performs custodial,
fund accounting and portfolio accounting services, as well as transfer agency and dividend paying services with respect to the common
shares. The Fund pays State Street for these services. The total expenses incurred by the Fund under the service agreements with State
Street for the year ended December&#160;31, 2023 were $342.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The Fund has retained
Destra to provide investor support services in connection with the on-going operations of the Fund. Such services include providing ongoing
contact with respect to the Fund and its performance with financial advisors that are representatives of broker-dealers and other financial
intermediaries, communicating with the NYSE specialist for the Fund's common shares and with the closed-end fund analyst community regarding
the Fund on a regular basis, and maintaining a website for the Fund. Effective January&#160;1, 2021, the Fund pays Destra a variable
service fee based on the Fund's closing stock price to net asset value at the end of each day. The total expenses incurred by the Fund
under the agreement with Destra for the year ended December&#160;31, 2023 were $290.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ernst&#160;&amp;
Young LLP serves as the Fund&#8217;s independent registered public accounting firm. The <a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">financial
statements of the Fund as of December&#160;31, 2023</a></span> have been audited by Ernst&#160;&amp; Young LLP and are incorporated by
reference herein. The principal business address of Ernst&#160;&amp; Young LLP is 725 South Figueroa Street, Los Angeles, California
90017.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONTROL PERSONS AND PRINCIPAL HOLDERS OF SECURITIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A control person includes
a person who beneficially owns more than 25% of the voting securities of a company. Neither the Adviser nor its affiliates own more than
25% of the common shares of the Fund. However, the Adviser may be considered a controlling person of the Fund under the Investment Company
Act to the extent it has the power to exercise a controlling influence over the management or policies of the Fund. The principal executive
offices of the Adviser are located at 2000 Avenue of the Stars, 12th Floor, Los Angeles, California 90067.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information with respect to persons or organizations that are known to the Fund to be beneficial owners of more than 5%
of the Fund&#8217;s outstanding preferred shares as of </span><span style="-keep: true"><span style="font-size: 10pt">August 6</span>, 2024. This information
is based on the Fund&#8217;s records and publicly available information such as Schedule 13D, Schedule 13G and Form&#160;13F disclosures
filed with the SEC.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Name and Address</b></td><td style="padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Preferred
                                            Shares Held</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Percentage
                                            of Preferred Shares Held</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: left">Thrivent Financial for Lutherans<br/>
 901 Marquette Avenue, Suite&#160;25<br/>
 Minneapolis, Minnesota 55402</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">760,000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">19.00</td><td style="width: 3%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Athene Annuity and Life Company<br/>
 Athene Annuity&#160;&amp; Life Assurance <br/>
Company7700 Mills Civic Parkway<br/>
 West Des Moines,&#160;Iowa 50266</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">760,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(a)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sun Life Assurance Company of<br/>
 Canada<br/>
 Sun Life Financial Inc. <br/>
One York Street<br/> Toronto, Ontario<br/>
 Canada M5J OB6</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">560,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(b)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Principal Life Insurance Company<br/>
 711 High Street <br/>
Des Moines,&#160;Iowa 50392</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(c)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Voya Retirement Insurance and Annuity Company <br/>
5780 Powers Ferry Road, NW <br/>
Suite&#160;300 <br/>
Atlanta, Georgia 30327</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">288,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">The Guardian Life Insurance Company <br/>
of America <br/>
10 Hudson Yards<br/>
New York, New York 10001</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">280,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(d)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Minnesota Life Insurance Company <br/>
Attn: Securian Asset Management,&#160;Inc. <br/>
400 Robert Street North <br/>
St. Paul, Minnesota 55101-2098</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">223,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.58</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(e)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Arch Reinsurance Ltd. <br/>
Waterloo House <br/>
100 Pitts Bay Road <br/>
Pembroke HM 08 <br/>
Bermuda</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">(a)&#160;&#160;Athene Annuity and Life Company ("AAIA") and
Athene Annuity&#160;&amp; Life Assurance Company ("AADE") filed their amended Schedule 13G jointly with the SEC on February&#160;14,
2024 and beneficially owned shares of the Fund in the aggregate amount of 760,000, or 19.00% of the Fund's outstanding preferred shares.
AAIA owned 260,000 Series&#160;A MRP Shares of the Fund with shared voting power and 260,000 Series&#160;A MRP Shares with shared dispositive
power, 160,000 Series&#160;B MRP Shares of the Fund with shared voting power and 160,000 Series&#160;B MRP Shares with shared dispositive
power, and 240,000 Series&#160;C MRP Shares of the Fund with shared voting power and 240,000 Series&#160;C MRP Shares with shared dispositive
power. AADE owned 360,000 Series&#160;A MRP Shares with shared voting power and 360,000 Series&#160;A MRP Shares with shared dispositive
power, 160,000 Series&#160;B MRP Shares with shared voting power and 160,000 Series&#160;B MRP Shares with shared dispositive power, and
240,000 Series&#160;C MRP Shares with shared voting power and 240,000 Series&#160;C MRP Shares with shared dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">(b)&#160;&#160;Sun Life Assurance Company of Canada and Sun Life Financial
Inc. filed their amended Schedule 13G jointly with the SEC on February&#160;14, 2022 and beneficially owned shares of the Fund in the
aggregate amount of 560,000, or 14.00% of the Fund's outstanding preferred shares. Sun Life Assurance Company of Canada owned 240,000
Series&#160;A MRP Shares of the Fund with sole voting power and 240,000 Series&#160;A MRP Shares of the Fund with sole dispositive power.
Sun Life Assurance Company of Canada owned 320,000 Series&#160;C MRP Shares of the Fund with sole voting power and 320,000 Series&#160;C
MRP Shares of the Fund with sole dispositive power. Sun Life Financial Inc. owned 240,000 Series&#160;A MRP Shares of the Fund with shared
voting power and 240,000 Series&#160;A MRP Shares of the Fund with shared dispositive power. Sun Life Financial Inc. owned 320,000 Series&#160;C
MRP Shares of the Fund with shared voting power and 320,000 Series&#160;C MRP Shares of the Fund with shared dispositive power.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&#160;&#160;Principal Life Insurance Company filed its Schedule
13G with the SEC on June&#160;16, 2023 and beneficially owned shares of the Fund in the aggregate amount of 360,000, or 9.00% of the Fund's
outstanding preferred shares. Principal Life Insurance Company owned an aggregate amount of 360,000 Series&#160;A MRP Shares and Series&#160;B
MRP Shares with shared voting power and an aggregate amount of 360,000 Series&#160;A MRP Shares and Series&#160;B MRP Shares with shared
dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;The Guardian Life Insurance Company of America filed
its Schedule 13G with the SEC on February&#160;15, 2022 and beneficially owned shares of the Fund in the aggregate amount of 280,000,
or 7.00% of the Fund's outstanding preferred shares. The Guardian Life Insurance Company of America owned 280,000 Series&#160;C MRP Shares
of the Fund with sole voting power and 280,000 Series&#160;C MRP Shares of the Fund with sole dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&#160;&#160;Minnesota Life Insurance Company filed its Schedule
13G with the SEC on February&#160;14, 2022 and beneficially owned shares of the Fund in the aggregate amount of 223,000, or 5.58% of the
Fund's outstanding preferred shares. Minnesota Life Insurance Company owned 223,000 Series&#160;B MRP Shares of the Fund with sole voting
power and 223,000 Series&#160;B MRP Shares of the Fund with sole dispositive power.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INCORPORATION BY REFERENCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">This
SAI is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the
information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents.
We incorporate by reference into this SAI the documents listed below and any future filings we make with the SEC under Section&#160;13(a),
13(c), 14 or 15(d)&#160;of the Exchange Act, including any filings on or after the date of this SAI from the date of filing (excluding
any information furnished, rather than filed), until we have sold all of the offered securities to which this SAI, the Prospectus and
any accompanying prospectus supplement relates or the offering is otherwise terminated. The information incorporated by reference is an
important part of this SAI. Any statement in a document incorporated by reference into this SAI will be deemed to be automatically modified
or superseded to the extent a statement contained in (1)&#160;this SAI or (2)&#160;any other subsequently filed document that is incorporated
by reference into this SAI modifies or supersedes such statement. The documents incorporated by reference herein include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Prospectus, dated </span><span style="font-size: 10pt"><b>[&#9679;]</b></span>, 2024, filed with this SAI;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">annual report</a></span>&#160;on Form&#160;N-CSR&#160;for the fiscal year ended December&#160;31, 2023 filed with the SEC on March&#160;6, 2024;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465923097217/tm2318740d1_ncsrs.htm" style="-sec-extract: exhibit">semi-annual report</a>&#160;</span>on Form&#160;N-CSR&#160;for the fiscal period ended June&#160;30, 2023 filed with the SEC on August&#160;31, 2023;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Fund&#8217;s&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">definitive proxy statement</a></span>&#160;on Schedule 14A, filed with the SEC on April&#160;9, 2024; and</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465912077964/a12-27073_18a12b.htm" style="-sec-extract: exhibit">description of the Fund&#8217;s common shares</a></span>&#160;contained in our Registration Statement on Form&#160;8-A&#160;(File&#160;No.&#160;811-22535)&#160;filed
    with the SEC on March&#160;22, 2011, including any amendment or report filed for the purpose of updating such description prior to
    the termination of the offering registered hereby.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Fund will provide without charge to each person, including any beneficial owner, to whom this SAI is delivered, upon written or oral request,
a copy of any and all of the documents that have been or may be incorporated by reference in this SAI, the Prospectus or the accompanying
prospectus supplement. You should direct requests for documents by calling: (888) 818-5298.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Fund makes available this Prospectus, SAI and the Fund&#8217;s annual and semi-annual reports, free of charge, at www.arespublicfunds.com.
You may also obtain this SAI, the Prospectus, other documents incorporated by reference and other information the Fund files electronically,
including reports and proxy statements, on the SEC&#8217;s website (http://www.sec.gov) or with the payment of a duplication fee, by electronic
request at publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this
SAI, the Prospectus or the accompanying prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FINANCIAL STATEMENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audited financial statements and financial highlights included in the <a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">Annual
Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2023</a></span>, together with the report of Ernst&#160;&amp;
Young LLP for the Fund&#8217;s Annual Report are incorporated herein by reference.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 24; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2416373d4_partc.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1" --><div>

</div><p style="margin: 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART&#8239;C</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Other Information</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;25. Financial Statements And Exhibits</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The agreements included or
incorporated by reference as exhibits to this Registration Statement contain representations and warranties by each of the parties to
the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable
agreement and (i)&#8239;were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to
one of the parties if those statements prove to be inaccurate; (ii)&#8239;may have been qualified in such agreement by disclosures that
were made to the other party in connection with the negotiation of the applicable agreement; (iii)&#8239;may apply contract standards of
&#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv)&#8239;were made
only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Registrant acknowledges
that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific
disclosures of material information regarding material contractual provisions are required to make the statements in this Registration
Statement not misleading.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td colspan="3" style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements</span></td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#160;</td>
<td colspan="3" style="vertical-align: bottom; font-size: 10pt">&#8239;</td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#160;</td>
<td colspan="2" style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part&#8239;A:</span></td>
<td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Highlights</span></td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#160;</td>
<td colspan="2" style="vertical-align: bottom; font-size: 10pt">&#8239;</td>
<td style="vertical-align: bottom; font-size: 10pt">&#8239;</td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#160;</td>
<td colspan="2" style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part&#8239;B:</span></td>
<td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">Audited
financial statements for the fiscal year ended December&#8239;31, 2023 and related Report of Independent Registered Public Accounting
Firm</a></span> <span style="font-size: 10pt">are incorporated herein by reference. </span></td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#160;</td>
<td colspan="2" style="vertical-align: top; font-size: 10pt">&#160;</td>
<td style="vertical-align: bottom; font-size: 10pt">&#160;</td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td colspan="3" style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td></tr>
<tr>
<td style="vertical-align: top; font-size: 10pt">&#8239;</td>
<td colspan="3" style="vertical-align: bottom; font-size: 10pt">&#8239;</td></tr>
<tr>
<td style="width: 4%; font-size: 10pt">&#160;</td>
<td style="vertical-align: top; width: 3%; font-size: 10pt; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000104746912009250/a2211184zex-99_a.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></a></td>
<td style="vertical-align: top; width: 3%"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000104746912009250/a2211184zex-99_a.htm" style="-sec-extract: exhibit">(1)</a></td>
<td style="vertical-align: top; width: 90%; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000104746912009250/a2211184zex-99_a.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
of Amendment and Restatement are incorporated by reference to Exhibit&#8239;(a)&#8239;to the Registration Statement of the Registrant
on Form&#8239;N-2 (File Nos. 333-172987 and 811-22535) filed on October&#8239;2, 2012.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top"><a href="tm2416373d4_ex99-xax2.htm" style="-sec-extract: exhibit">(a)</a></td>
<td style="vertical-align: top"><a href="tm2416373d4_ex99-xax2.htm" style="-sec-extract: exhibit">(2)</a></td>
<td style="vertical-align: top"><a href="tm2416373d4_ex99-xax2.htm" style="-sec-extract: exhibit">Articles Supplementary dated July
14, 2021 are filed herewith.</a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465918059058/a18-36063_1ex99d31.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></a></td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465918059058/a18-36063_1ex99d31.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws are incorporated by reference to Exhibit&#8239;3.1 to the Registrant&#8217;s Report on Form&#8239;8-K (File No.&#8239;811-22535) filed on September&#8239;27, 2018.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">(d) &#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions of the Articles of Amendment and Restatement and Amended and Restated Bylaws of the Registrant defining the rights of holders of shares of common stock of the Registrant (reference is made to Articles V, VI and VIII of the Registrant&#8217;s Articles of Amendment and Restatement, see Exhibit&#8239;(a)&#8239;to this Registration Statement, and to Articles II, VII,&#8239;IX and XI of the Registrant&#8217;s Amended and Restated Bylaws, see Exhibit&#8239;(b)&#8239;to this Registration Statement).</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top; font-size: 10pt">&#160;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xe.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xe.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
Reinvestment Plan is filed herewith.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable </span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top; font-size: 10pt">&#160;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xg.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xg.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Advisory and Management Agreement between the Registrant and Ares Capital Management II LLC is </span>filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt"/>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#8239;of
Dealer Manager Agreement to be filed by amendment.</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td>
<td style="vertical-align: top">&#8239;</td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xj.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></a></td>
<td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xj.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Master
Custodian Agreement between the Registrant and State Street Bank and Trust Company is filed herewith.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="text-align: center; vertical-align: top"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xkx1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
Agency and Service Agreement between the Registrant and State Street Bank and Trust Company is </span>filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xkx2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration
Agreement between Registrant and State Street Bank and Trust Company is </span>filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
<td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td></tr>
<tr>
<td style="font-size: 10pt">&#160;</td>
<td style="vertical-align: top; font-size: 10pt; text-align: center"><a href="tm2416373d4_ex99-xkx3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></a></td>
<td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark
License Agreement is </span>filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
</table><div>




</div><p style="margin: 0">&#8239;</p><div>


</div><p style="margin: 0"></p><div>


</div><!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="margin: 0"><span style="-keep: true">&#8239;</span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="font-size: 10pt; width: 4%">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right; width: 3%"><a href="tm2416373d4_ex99-xkx4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt; width: 3%"><a href="tm2416373d4_ex99-xkx4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt; width: 90%"><a href="tm2416373d4_ex99-xkx4.htm"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    Agreement between the Registrant and the Directors and Officers of the Registrant is </span>filed herewith<span style="font-size: 10pt">.</span></span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xkx5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
    Support Services Agreement between the Registrant and Destra Capital Investments LLC is </span>filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xkx6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx6.htm"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to Investor Support Services Agreement between the Registrant and Destra Capital Investments LLC i</span>s filed herewith<span style="font-size: 10pt">.</span></span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#8239;</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465915044849/a15-13925_1ex99d13f.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465915044849/a15-13925_1ex99d13f.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465915044849/a15-13925_1ex99d13f.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    Limitation Agreement between the Registrant and Ares Capital Management II LLC is incorporated by reference to Exhibit&#8239;(13)(f)&#8239;of
    the Registration Statement of the Registrant on Form&#8239;N-14 (File No.&#8239;333-203285) filed on June&#8239;11, 2015.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="-keep: true">&#160;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#160;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="-keep: true">&#160;</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xkx8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xkx8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company i</span>s filed herewith<span style="font-size: 10pt">.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xl.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></a></td>
    <td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xl.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    and Consent of </span><span style="-keep: true"><span style="font-size: 10pt">Venable LLP with Respect to the Legality of the common shares is </span>filed
    herewith<span style="font-size: 10pt">.</span></span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xn.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xn.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm is filed herewith.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ex99-codeeth.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</span></a></td>
    <td style="vertical-align: top; font-size: 10pt">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ex99-codeeth.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Codes of Ethics are incorporated by reference to Exhibit&#8239;(a)(1)&#8239;of the Registrant&#8217;s Annual Report on Form&#8239;N-CSR (File No.&#8239;811-22535) filed on March&#8239;6, 2024.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xs.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</span></a></td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xs.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Filing Fee Tables is filed herewith.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td>
    <td style="vertical-align: top">&#8239;</td></tr>
  <tr>
    <td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right"><a href="tm2416373d4_ex99-xt.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</span></a></td>
    <td style="vertical-align: top"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2416373d4_ex99-xt.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of Attorney is filed herewith.</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;26. Marketing Arrangements</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information contained
under the section entitled &#8220;Plan of Distribution&#8221; in the Prospectus is incorporated by reference, and any information concerning
any underwriters will be contained in the accompanying Prospectus Supplement, if any.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;27. Other Expenses Of Issuance And
Distribution</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the estimated expenses to be incurred in connection with the offering described in this Registration Statement:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Registration
    fee</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">73,800</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">NYSE listing fee</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">55,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Accounting fees
    and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">22,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Legal fees and
    expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">175,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Printing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Promotion expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Miscellaneous</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">10,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">FINRA Fee</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">75,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 30pt"><span style="-keep: true">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-keep: true">&#8239;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-keep: true">761,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-keep: true">(1)</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#8239;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimate is based on the aggregate estimated expenses to be incurred during a three-year shelf offering period. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 2; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;28. Persons Controlled By Or Under
Common Control With The Registrant</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item&#8239;29. Number Of Holders Of Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of </span>August 6, 2024:</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 48%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b style="-keep: true">Title Of Class</b></p></td>
    <td style="width: 3%"><span style="-keep: true">&#8239;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number&#8239;Of&#8239;Record&#8239;Holders</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    shares, par value $0.001 per share</span></td>
    <td style="vertical-align: bottom"><span style="-keep: true">&#8239;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;30. Indemnification</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maryland
law permits a Maryland corporation to include a provision in its charter limiting the liability of its directors and officers to the corporation
and its shareholders for money damages, except for liability resulting from (a)&#8239;actual receipt of an improper benefit or profit in
money, property or services or (b)&#8239;active and deliberate dishonesty that is established by a final judgment and is material to the
cause of action. The Registrant's charter contains a provision that eliminates its directors' and officers' liability to the maximum extent
permitted by Maryland law and the Investment Company Act of 1940, as amended</span>, together with the rules&#8239;and regulations promulgated
thereunder (the &#8220;Investment Company Act&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Registrant's charter authorizes
it to obligate itself, and its bylaws require it, to the maximum extent permitted by Maryland law and subject to the requirements of the
Investment Company Act, to indemnify and, without requiring a preliminary determination of the ultimate entitlement to indemnification,
pay or reimburse reasonable expenses in advance of final disposition of a proceeding to (a)&#8239;any individual who is a present or former
director or officer and who is made or threatened to be made a party to the proceeding by reason of his or her service in that capacity
or (b)&#8239;any individual who, while a director or officer of the Registrant and at the request of the Registrant, serves or has served
another corporation, partnership, joint venture, limited liability company, trust, employee benefit plan or other enterprise as a director,
officer, partner, manager, managing member or trustee and who is made or threatened to be made a party to the proceeding by reason of
his or her service in any of the foregoing capacities. The Registrant's charter and bylaws also permit it, with the approval of the Registrant&#8217;s
board of directors, to indemnify and advance expenses to any individual who served any predecessor of the Registrant in any of the capacities
described in (a)&#8239;or (b)&#8239;above and any employee or agent of the Registrant or any predecessor of the Registrant. In accordance
with the Investment Company Act, the Registrant will not indemnify any person for any liability to which such person would be subject
by reason of such person's willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct
of his office.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Maryland law requires a Maryland
corporation (unless its charter provides otherwise, which the Registrant's charter does not) to indemnify a director or officer who has
been successful, on the merits or otherwise, in the defense of any proceeding to which he or she is made or threatened to be made a party
by reason of his or her service in that capacity. Maryland law permits a Maryland corporation to indemnify its present and former directors
and officers, among others, against judgments, penalties, fines, settlements and reasonable expenses actually incurred by them in connection
with any proceeding to which they may be made or threatened to be made a party by reason of their service in those or other capacities
unless it is established that (a)&#8239;the act or omission of the director or officer was material to the matter giving rise to the proceeding
and (i)&#8239;was committed in bad faith or (ii)&#8239;was the result of active and deliberate dishonesty, (b)&#8239;the director or officer
actually received an improper personal benefit in money, property or services or (c)&#8239;in the case of any criminal proceeding, the
director or officer had reasonable cause to believe that the act or omission was unlawful. A Maryland corporation may not indemnify a
director or officer who has been adjudged liable in a suit by or in the right of the corporation or on the basis that a personal benefit
was improperly received. A court may order indemnification if it determines that the director or officer is fairly and reasonably entitled
to indemnification, even though the director or officer did not meet the prescribed standard of conduct, was adjudged liable to the corporation
or was adjudged liable on the basis that personal benefit was improperly received; however, indemnification for an adverse judgment in
a suit by or in the right of the corporation, or for a judgment of liability on the basis that personal benefit was improperly received,
is limited to expenses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Maryland law
permits a Maryland corporation to advance reasonable expenses to a director or officer upon the corporation's receipt of (a)&#8239;a written
affirmation by the director or officer of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification
by the corporation and (b)&#8239;a written undertaking by him or her or on his or her behalf to repay the amount paid or reimbursed by
the corporation if it is ultimately determined that the standard of conduct was not met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liability arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), may be permitted to directors,
officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised
that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;31. Business And Other Connections
Of Investment Adviser</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The description of the Adviser
under the caption &#8220;Management of the Fund&#8221; in the prospectus, which forms part of this registration statement, is incorporated
by reference herein. Information as to the directors and officers of the Adviser together with information as to any other business, profession,
vocation or employment of a substantial nature engaged in by the directors and officers of the Adviser in the last two years, will be
included in its application for registration as an investment adviser on Form&#8239;ADV (File No.&#8239;801-72399) filed under the Investment
Advisers Act of 1940, as amended, and is incorporated herein by reference. The Adviser's principal business address is 2000 Avenue of
the Stars, 12th Floor, Los Angeles, California 90067.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;32. Location Of Accounts And Records</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Omitted pursuant to the instruction
to Item 32 of Form&#8239;N-2.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;33. Management Services</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not Applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8239;34. Undertakings</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;Not applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;Not applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
securities being registered will be offered on a delayed or continuous basis in reliance on Rule&#8239;415 under the Securities Act. Accordingly,
the Registrant undertakes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
include any prospectus required by Section&#8239;10(a)(3)&#8239;of the Securities Act;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
reflect in the prospectus any facts or events after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#8239;424(b)&#8239;if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration
Fee&#8221; table in the effective registration statement; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">provided, however, that paragraphs
a(1), a(2), and a(3)&#8239;of this section do not apply if the information required to be included in a post-effective amendment by those
paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section&#8239;13 or Section&#8239;15(d)&#8239;of
the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) that are incorporated by reference into the registration statement,
or is contained in a form of prospectus filed pursuant to Rule&#8239;424(b)&#8239;that is part of the registration statement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;that
for the purpose of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;that,
for the purpose of determining liability under the Securities Act to any purchaser:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the Registrant is relying on Rule&#8239;430B [17 CFR 230.430B]:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
prospectus filed by the Registrant pursuant to Rule&#8239;424(b)(3)&#8239;shall be deemed to be part of the registration statement as of
the date the filed prospectus was deemed part of and included in the registration statement; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
prospectus required to be filed pursuant to Rule&#8239;424(b)(2), (b)(5), or (b)(7)&#8239;as part of a registration statement in reliance
on Rule&#8239;430B relating to an offering made pursuant to Rule&#8239;415(a)(1)(i), (x), or (xi)&#8239;for the purpose of providing the
information required by Section&#8239;10(a)&#8239;of the Securities Act shall be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities
in the offering described in the prospectus. As provided in Rule&#8239;430B, for liability purposes of the issuer and any person that is
at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities
in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the Registrant is subject to Rule&#8239;430C [17 CFR 230.430C]: Each prospectus filed pursuant to Rule&#8239;424(b)&#8239;under the Securities
Act as part of a registration statement relating to an offering, other than registration statements relying on Rule&#8239;430B or other
than prospectuses filed in reliance on Rule&#8239;430A, shall be deemed to be part of and included in the registration statement as of
the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that
is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use,
supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;that
for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities:
The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this Registration
Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to
such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to the purchaser: (1)&#8239;any preliminary prospectus or prospectus of the undersigned
Registrant relating to the offering required to be filed pursuant to Rule&#8239;424 under the Securities Act; (2)&#8239;free writing prospectus
relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;
(3)&#8239;the portion of any other free writing prospectus or advertisement pursuant to Rule&#8239;482 under the Securities Act relating
to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned
Registrant; and (4)&#8239;any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
applicable:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
the purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of a registration statement in reliance upon Rule&#8239;430A and contained in the form of prospectus filed by the Registrant under Rule&#8239;424(b)(1)&#8239;under
the Securities Act shall be deemed to be part of the Registration Statement as of the time it was declared effective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time
shall be deemed to be the initial bona fide offering thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the
Registrant&#8217;s annual report pursuant to Section&#8239;13(a)&#8239;or Section&#8239;15(d)&#8239;of the Exchange Act that is incorporated
by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(6)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(7)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery within two business days of
receipt of a written or oral request, any prospectus or Statement of Additional Information constituting Part&#8239;B of this Registration
Statement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p><div>


</div><!-- Field: Page; Sequence: 6; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</p><div>


</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2416373d4_signpage.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1" --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Pursuant to the requirements
of the Securities Act of 1933 and the Investment Company Act of 1940, the Fund has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of New York, and the State of New York, on the 14th day
of August, 2024.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&#160;INC.</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="width: 45%">&#160;</td>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="vertical-align: top; border-bottom: black 1pt solid; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Seth J. Brufsky</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer and Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the
dates indicated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
<td style="padding-bottom: 1pt; width: 1%"><span style="-keep: true">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 54%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="padding-bottom: 1pt; width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 15%"><b style="-keep: true">Date</b></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="-keep: true">&#160;</span></td>
<td style="padding-bottom: 1pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="-keep: true">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true">/s/ Seth J. Brufsky</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
President and Chief Executive Officer (Principal Executive Officer)</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">August 14, 2024</span></td>
</tr>
<tr>
<td style="text-align: center"><span style="-keep: true">(Seth J. Brufsky)</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true">/s/ Scott C. Lem</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer (Principal Financial and Accounting Officer)</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">August 14, 2024</span></td>
</tr>
<tr>
<td style="text-align: center; vertical-align: bottom"><span style="-keep: true">(Scott C. Lem)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">David
A. Sachs</span>*</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="text-align: center; vertical-align: bottom"><span style="-keep: true">(David A. Sachs)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">Elaine
Orr</span>*</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="text-align: center; vertical-align: bottom"><span style="-keep: true">(Elaine Orr)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">John
J. Shaw</span>*</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="text-align: center; vertical-align: bottom"><span style="-keep: true">(John J. Shaw)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">Bruce
H. Spector</span>*</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="text-align: center; vertical-align: bottom"><span style="-keep: true">(Bruce H. Spector)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
<tr>
<td style="text-align: center"><span style="-keep: true">&#160;</span></td>
<td colspan="2"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
</tr>
<tr>
<td style="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><span style="-keep: true">*By: /s/ Scott C. Lem</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">August 14, 2024</span></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: bottom"><span style="-keep: true">(Scott C. Lem, Attorney-In-Fact)</span></td>
<td style="vertical-align: top"><span style="-keep: true">&#160;</span></td>
<td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td></tr>
</table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 1; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2416373d4_exbtindex.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1" --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT&#160;INDEX</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xax2.htm" style="-sec-extract: exhibit">(a)(2)</a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xax2.htm" style="-sec-extract: exhibit">Articles
    Supplementary</a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top; width: 7%"><a href="tm2416373d4_ex99-xe.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom; width: 93%"><a href="tm2416373d4_ex99-xe.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xg.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xg.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    Advisory and Management Agreement between the Registrant and Ares Capital Management II LLC</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xj.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xj.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Master
    Custodian Agreement between the Registrant and State Street Bank and Trust Company</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(1)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Agency and Service Agreement between the Registrant and State Street Bank and Trust Company </span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(2)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration
    Agreement between Registrant and State Street Bank and Trust Company</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(3)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark
    License Agreement</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(4)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    Agreement between the Registrant and the Directors and Officers of the Registrant</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(5)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
    Support Services Agreement between the Registrant and Destra Capital Investments LLC</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(6)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to Investor Support Services Agreement between the Registrant and Destra Capital Investments LLC</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xkx8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(8)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xkx8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xl.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xl.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    and Consent of Venable LLP with Respect to the Legality of the common shares</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt; vertical-align: top"><a href="tm2416373d4_ex99-xn.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xn.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Independent Registered Public Accounting Firm</span></a></td></tr>
  <tr>
    <td style="padding-bottom: 5pt"><a href="tm2416373d4_ex99-xs.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</span></a></td>
    <td style="padding-bottom: 5pt; vertical-align: bottom"><a href="tm2416373d4_ex99-xs.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation
    of Filing Fee Tables</span></a></td></tr>
  <tr>
    <td><a href="tm2416373d4_ex99-xt.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2416373d4_ex99-xt.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of Attorney</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 1; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(2)
<SEQUENCE>2
<FILENAME>tm2416373d4_ex99-xax2.htm
<DESCRIPTION>EXHIBIT 99.(A)(2)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xax2.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(a)(2)</I></B></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Ares
Dynamic Credit Allocation Fund,&nbsp;Inc.</B></FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Articles
Supplementary</B></FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Series
A Mandatory Redeemable Preferred Stock</B></FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Series
B Mandatory Redeemable Preferred Stock</B></FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Series
C Mandatory Redeemable Preferred Stock</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ares
Dynamic Credit Allocation Fund,&nbsp;Inc. (the <I>&ldquo;Corporation&rdquo;</I></FONT>), a Maryland corporation, certifies to the State
Department of Assessments and Taxation of Maryland that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">F</FONT>IRST:
Under a power contained in Article&nbsp;VI of the charter of the Corporation (which, as restated, amended or supplemented from time to
time, together with these Articles Supplementary, is referred to herein as the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Charter&rdquo;</I></FONT>),
the Board of Directors by duly adopted resolutions classified and designated (i)&nbsp;800,000 shares of authorized but unissued Common
Stock (as defined in the Charter) as shares of a new series of Preferred Stock (as defined in the Charter) designated as Series&nbsp;A
Mandatory Redeemable Preferred Stock, liquidation preference $25.00 per share, (ii)&nbsp;1,200,000 shares of authorized but unissued Common
Stock (as defined in the Charter) as shares of a new series of Preferred Stock (as defined in the Charter) designated as Series&nbsp;B
Mandatory Redeemable Preferred Stock, liquidation preference $25.00 per share, and (iii)&nbsp;2,000,000 shares of authorized but unissued
Common Stock (as defined in the Charter) as shares of a new series of Preferred Stock (as defined in the Charter) designated as Series&nbsp;C
Mandatory Redeemable Preferred Stock, liquidation preference $25.00 per share, each with the following preferences, rights, voting powers,
restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption, which, upon
any restatement of the Charter, shall become part of Article&nbsp;VI of the Charter, with any necessary or appropriate renumbering or
relettering of the sections or subsections hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Mandatory
Redeemable Preferred (&ldquo;<I>MRP</I>&rdquo;) Shares</B></FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Designation</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Preferred
Stock</I></FONT>: (i)&nbsp;800,000 shares of Common Stock are reclassified and designated as Series&nbsp;A Mandatory Redeemable Preferred
Stock, liquidation preference $25.00 per share (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;A MRP
Shares&rdquo;</I></FONT>), (ii)&nbsp;1,200,000 shares of Common Stock are reclassified and designated as Series&nbsp;B Mandatory Redeemable
Preferred Stock, liquidation preference $25.00 per share (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;B
MRP Shares&rdquo;</I></FONT>) and (iii)&nbsp;2,000,000 shares of Common Stock are reclassified and designated as Series&nbsp;C Mandatory
Redeemable Preferred Stock, liquidation preference $25.00 per share (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;C
MRP Shares,&rdquo;</I></FONT> and together with the Series&nbsp;A MRP Shares and the Series&nbsp;B MRP Shares, the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MRP
Shares&rdquo;</I></FONT>).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The initial Dividend Period
for the Series&nbsp;A MRP Shares shall be the period from and including the Original Issue Date thereof to and including September&nbsp;30,
2021. Each Series&nbsp;A&#8239;MRP Share will have a dividend rate equal to the Applicable Rate, as determined from time to time; and subject
to adjustment pursuant to Section&nbsp;2(c)&nbsp;hereof. Each Series&nbsp;A MRP Share shall have such other preferences, rights, voting
powers, privileges, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption,
in addition to those required by applicable law or set forth in the Charter applicable to shares of Preferred Stock, as are set forth
herein. The Series&nbsp;A MRP Shares shall constitute a separate series of Preferred Stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The initial Dividend Period
for the Series&nbsp;B MRP Shares shall be the period from and including the Original Issue Date thereof to and including September&nbsp;30,
2021. Each Series&nbsp;B MRP Share will have a dividend rate equal to the Applicable Rate, as determined from time to time and subject
to adjustment pursuant to Section&nbsp;2(c)&nbsp;hereof. Each Series&nbsp;B MRP Share shall have such other preferences, rights, voting
powers, privileges, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption,
in addition to those required by applicable law or set forth in the Charter applicable to shares of Preferred Stock, as are set forth
herein. The Series&nbsp;B MRP Shares shall constitute a separate series of Preferred Stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The initial Dividend Period
for the Series&nbsp;C MRP Shares shall be the period from and including the Original Issue Date thereof to and including September&nbsp;30,
2021. Each Series&nbsp;C MRP Share will have a dividend rate equal to the Applicable Rate, as determined from time to time and subject
to adjustment pursuant to Section&nbsp;2(c)&nbsp;hereof. Each Series&nbsp;C MRP Share shall have such other preferences, rights, voting
powers, privileges, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption,
in addition to those required by applicable law or set forth in the Charter applicable to shares of Preferred Stock, as are set forth
herein. The Series&nbsp;C MRP Shares shall constitute a separate series of Preferred Stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of Section&nbsp;3(i)&nbsp;and Section&nbsp;6 hereof, the Board of Directors of the Corporation may, in the future, authorize the issuance
of additional Preferred Stock with the same preferences, rights, voting powers, restrictions, limitations as to dividends and other distributions,
qualifications and terms and conditions of redemption and other terms herein described, except that the initial Dividend Period, the Applicable
Rate for the initial Dividend Period and the initial Dividend Payment Date shall be as set forth in the Articles Supplementary relating
to such additional Preferred Stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used herein, capitalized
terms not otherwise defined herein shall have the meanings provided in Section&nbsp;12 hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;1.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Number
of Shares; Ranking.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;The number
of authorized Series&nbsp;A MRP Shares is 800,000 shares, (ii)&nbsp;the number of authorized Series&nbsp;B MRP Shares is 1,200,000 shares
and (iii)&nbsp;the number of authorized Series&nbsp;C MRP Shares is 2,000,000 shares. No fractional MRP Shares shall be issued.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
MRP Shares which at any time have been redeemed or purchased by the Corporation shall, after redemption or purchase, be returned to the
status of authorized but unissued Common Stock of the Corporation, until reclassified by the Board of Directors.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
MRP Shares shall rank (i)&nbsp;on a parity with each other and any other class or series of Preferred Stock as to the payment of dividends
to which the shares are entitled and the distribution of assets upon dissolution, liquidation or winding up of the affairs of the Corporation
and (ii)&nbsp;senior to Common Stock as to payment of dividends to which the shares are entitled and the distribution of assets upon dissolution,
liquidation or winding up of the affairs of the Corporation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Holder of MRP Shares shall have, solely by reason of being a Holder, any preemptive right, or, unless otherwise determined by the Board
of Directors, other right to acquire, purchase or subscribe for any MRP Shares, Common Stock or other securities of the Corporation which
it may hereafter issue or sell.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Holder of MRP Shares shall be entitled to exercise the rights of an objecting stockholder under Title 3, Subtitle 2 of the Maryland General
Corporation Law (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MGCL&rdquo;</I></FONT>) or any successor provision,
except that each such Holder shall be entitled to exercise such rights if and so long as any of the holders of Common Stock or Preferred
Stock is entitled to exercise such rights.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;2.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Dividends.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Holders of MRP Shares shall be entitled to receive quarterly cumulative cash dividends, when, as and if authorized by the Board of Directors
and declared by the Corporation, out of funds legally available therefor, at the rate per annum equal to the Applicable Rate (or the
Default Rate), and no more, payable on the respective dates determined as set forth in paragraph&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></FONT>&#8239;<FONT STYLE="font-size: 10pt">of
this Section&nbsp;2. Dividends on Outstanding MRP Shares shall accumulate from and including the Original Issue Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;Dividends
shall be payable quarterly on MRP Shares when, as and if authorized by the Board of Directors and declared by the Corporation beginning
on the initial Dividend Payment Date, on MRP Shares, and with respect to any Dividend Period thereafter on the first (1st) Business Day
following each Quarterly Dividend Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as otherwise set forth herein, the Corporation shall pay an aggregate amount of federal funds or similar same-day funds, equal to the
dividends to be paid to all Holders of such shares on each Dividend Payment Date in accordance with Section&nbsp;14 of the Securities
Purchase Agreement. The Corporation shall not be required to establish any reserves for the payment of dividends.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
dividend on MRP Shares shall be paid on the Dividend Payment Date therefor to the Holders as their names appear on the stock ledger or
stock records of the Corporation at the close of business on the fifth (5th) day prior to the Quarterly Dividend Date (or if such day
is not a Business Day, the next preceding Business Day). Dividends in arrears for any past Dividend&#8239;</FONT>Period may be declared and
paid at any time, without reference to any regular Dividend Payment Date, to the Holders as their names appear on the stock ledger or
stock records of the Corporation at the close of business on a date, not exceeding 5 days preceding the payment date thereof, as may
be fixed by the Board of Directors. No interest will be payable in respect of any dividend payment or payments which may be in arrears;
provided however that the Dividend Rate may be increased in such circumstances as set forth herein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;(i)&nbsp;So long as each series of the MRP Shares are rated on any date no less than &ldquo;A&rdquo; by
Kroll (and no less than an equivalent of such rating by each Other Rating Agency), the dividend rate on the Outstanding MRP Shares
(the <I>&ldquo;Dividend Rate&rdquo;</I></FONT>) shall be the Applicable Rate. If the lowest credit rating assigned on any date of
any series of the MRP Shares by Kroll or any Other Rating Agency is equal to one of the ratings set forth in the table below (or its
equivalent by an Other Rating Agency), the Dividend Rate for such series of MRP Shares shall be adjusted during such period by
adding the respective enhanced dividend amount (which shall not be cumulative) set opposite such rating (or the equivalent rating
from any Other Rating Agency) to the Applicable Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: small-caps 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Kroll Equivalent</TD><TD STYLE="font: small-caps 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: small-caps 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Enhanced Dividend Amount</TD><TD STYLE="padding-bottom: 1pt; font: small-caps 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&ldquo;A-&rdquo;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.5</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&ldquo;BBB+&rdquo; to &ldquo;BBB-&rdquo;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&ldquo;BB+&rdquo; or below</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation shall, at
all times, use reasonable efforts to cause at least one NRSRO to maintain a current rating on each series of the MRP Shares. If, notwithstanding
the foregoing requirements of this Section&nbsp;2(c)(i), no Rating Agency is rating the Outstanding MRP Shares, the Dividend Rate (so
long as no such rating exists) on the Outstanding MRP Shares shall be equal to the Applicable Rate plus 4.0% unless the Dividend Rate
is the Default Rate, in which case the Dividend Rate shall remain the Default Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the cure provisions below, a &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Default Peri</I></FONT>od&rdquo; will
commence on any&#8239;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend Payment Date or any date on which the Corporation
would be required to redeem any MRP Shares regardless of whether any of the conditions of the Special Proviso in Section&nbsp;3(a)(iv)&nbsp;were
applicable, if the Corporation fails to pay directly in accordance with Section&nbsp;14 of the Securities Purchase Agreement by 1:00
p.m., New York City time, (A)&nbsp;the full amount of any dividends payable on the Dividend Payment Date (a <I>&ldquo;Dividend Default&rdquo;</I></FONT>)
or (B)&nbsp;the full amount of any redemption price payable with respect to any redemption required hereunder regardless of whether any
of the conditions of the Special Proviso exists (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Redemption Date&rdquo;</I></FONT>)
(a <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Redemption Default,&rdquo; </I></FONT>and together with a Dividend
Default, is hereinafter referred to as <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default&rdquo;</I></FONT>).
Subject to the cure provisions of Section&nbsp;2(c)(iii)&nbsp;below, a Default Period with respect to a Dividend Default or a Redemption
Default shall end on the Business Day on which, by 12:00 noon, New York City time, all unpaid dividends, and in the case of a Redemption
Date, any unpaid redemption price, shall have been directly paid in accordance with Section&nbsp;14 of the Securities Purchase Agreement.
In the case of a Default, the Dividend Rate for each day during the Default Period will be equal to the Default Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Default Period with respect to a Dividend Default or Redemption Default shall be deemed to commence if the amount of any dividend or any
redemption price due is paid in accordance with Section&nbsp;14 of the Securities Purchase Agreement within five Business Days (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default
Rate Cure Period&rdquo;</I></FONT>) after the applicable Dividend Payment Date or Redemption Date, together with an amount equal to the
Default Rate applied to the amount of such non-payment based on the actual number of days within the Default Rate Cure Period divided
by 360.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
amount of dividends per share payable on each Dividend Payment Date of each Dividend Period (including the first Dividend Period) shall
be computed by multiplying the Applicable Rate (or the Default Rate) for such Dividend Period by a fraction, the numerator of which shall
be 90 and the denominator of which shall be 360, multiplying the amount so obtained by the liquidation preference per MRP Share, and rounding
the amount so obtained to the nearest cent. Dividends payable on any MRP Shares for any period of less than a full quarterly Dividend
Period, including upon any redemption of such shares on any date other than on a Dividend Payment Date, shall be computed by multiplying
the Applicable Rate (or the Default Rate, if applicable) for such period by a fraction, the numerator of which shall be the actual number
of days in such period and the denominator of which shall be 360, multiplying the amount so obtained by the liquidation preference per
MRP Share, and rounding the amount so obtained to the nearest cent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
dividend payment made on MRP Shares shall first be credited against the earliest accumulated but unpaid dividends due with respect to
such MRP Shares.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
so long as the MRP Shares are Outstanding, except as contemplated herein, the Corporation will not declare, pay or set apart for payment
any dividend or other distribution (other than a dividend or distribution paid in shares of, or options, warrants or rights to subscribe
for or purchase, Common Stock or other shares of capital stock, if any, ranking junior to the MRP Shares as to dividends or upon liquidation)
with respect to Common Stock or any other stock of the Corporation ranking junior to or on a parity with the MRP Shares as to dividends
or upon liquidation, or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Stock or any other such
junior stock (except by conversion into or exchange for shares of the Corporation ranking junior to the MRP Shares as to dividends and
upon liquidation) or any such parity shares (except by conversion into or exchange for shares of the Corporation ranking junior to or
on a parity with the MRP Shares as to dividends and upon liquidation), unless (1)&nbsp;immediately after such transaction the MRP Shares
Asset Coverage would be achieved, (2)&nbsp;full cumulative dividends on the MRP Shares due on or prior to the date of the transaction
have been declared and paid, and (3)&nbsp;the Corporation has redeemed the full number of MRP Shares required to be redeemed by any provision
for mandatory redemption contained in Section&nbsp;3(a)&nbsp;(without regard to the provisions of the Special Proviso).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;3.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Redemption.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> (a) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;The Corporation may, at its option, redeem in whole or in part out of funds legally available therefor, MRP Shares at any time and from time to time, subject to the notice provisions of Section&nbsp;3(b)&nbsp;at the sum of (A)&nbsp;the MRP Liquidation Preference Amount (as defined herein) plus an amount equal to accumulated but unpaid dividends and other distributions on the MRP Shares (whether or not earned or declared by the Corporation, but excluding interest thereon), to, but excluding, the date fixed for redemption, plus (B)&nbsp;the Make-Whole Amount (which in no event shall be less than zero), provided however, the Corporation may, at its option (i)&nbsp;redeem the Series&nbsp;A MRP Shares within 90 days prior to the Series&nbsp;A Term Redemption Date, (ii)&nbsp;redeem the Series&nbsp;B MRP Shares within 90 days prior to the Series&nbsp;B Term Redemption Date and (iii)&nbsp;redeem the Series&nbsp;C MRP Shares within 90 days prior to the Series&nbsp;C Term Redemption Date, each at the MRP Liquidation Preference Amount plus accumulated but unpaid dividends and distributions thereon (whether or not earned or declared by the Corporation, but excluding interest thereon), to, but excluding, the date fixed for redemption. Notwithstanding the foregoing, the Corporation shall not give a notice of or effect any redemption pursuant to this Section&nbsp;3(a)(i)&nbsp;unless (in the case of any partial redemption of MRP Shares), on the date on which the Corporation intends to give such notice and on the date of redemption, the MRP Shares Asset Coverage is greater than or equal to 225% immediately subsequent to such redemption, if such redemption were to occur on such date.</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In addition to subparagraph
(a)(i)&nbsp;of this Section, if the MRP Shares Asset Coverage is less than or equal to 235%, for any five Business Days within a ten-Business
Day period, determined on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays) next preceding
the time of such determination within the ten-Business Day period, the Corporation, upon not less than 12 days nor more than 40 days&rsquo;
notice as provided below, may redeem the MRP Shares at the MRP Liquidation Preference Amount plus accumulated but unpaid dividends and
distributions thereon (whether or not earned or declared by the Corporation, but excluding interest thereon) to, but excluding, the date
fixed for redemption, plus a redemption amount equal to 2% of the MRP Liquidation Preference Amount. The amount of MRP Shares that may
be redeemed under this provision shall not exceed an amount of MRP Shares which results in a MRP Shares Asset Coverage of more than 250%
pro forma for such redemption, determined on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays)
next preceding the time of such determination.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Corporation fails to maintain on any Valuation Date, the MRP Shares Asset Coverage (any such day, an <I>&ldquo;Asset Coverage Cure
Date&rdquo;</I></FONT>), the Corporation shall, subject to Section&nbsp;3(a)(iv), redeem the number of MRP Shares provided below at the
MRP Liquidation Preference Amount plus an amount equal to accumulated but unpaid dividends and distributions thereon (whether or not
earned or declared by the Corporation, but excluding interest thereon) to, but excluding, the date fixed for redemption, plus a redemption
amount equal to 1% of the MRP Liquidation Preference Amount. The number of MRP Shares to be redeemed upon the Corporation&rsquo;s failure
to maintain the MRP Shares Asset Coverage on any Valuation Date will be equal to the product of (A)&nbsp;the quotient of the number of
Outstanding MRP Shares divided by the aggregate number of outstanding Preferred Stock of the Corporation (including the MRP Shares) which
have an asset coverage test greater than or equal to 225% times and (B)&nbsp;the minimum number of outstanding shares of Preferred Stock
of the Corporation (including the MRP Shares) the redemption of which would result in the Corporation satisfying the MRP Shares Asset
Coverage as of a date that is no more than 30 days after an Asset Coverage Cure Date (provided that, if there is no such number of MRP
Shares the redemption of which would have such result,&#8239;the Corporation shall, subject to Section&nbsp;3(a)(iv), redeem all MRP Shares
then Outstanding). Notwithstanding the foregoing, if the Corporation satisfies the MRP Shares Asset Coverage as of a date that is no
more than 30 days after an Asset Coverage Cure Date before taking into account any redemptions of Preferred Stock, the Corporation shall
not be obligated to redeem any shares of Preferred Stock under this Section&nbsp;3(a)(iii). The asset coverage in respect of the MRP
Shares provided for in this Section&nbsp;3(a)(iii)&nbsp;shall be determined on the basis of values calculated as of a time within 48
hours (not including Sundays or holidays) next preceding the time of such determination.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
determining the MRP Shares to be redeemed in accordance with the foregoing Section&nbsp;3(a)&nbsp;in the case of a partial redemption,
the Corporation shall allocate the number of shares to be redeemed pursuant to this Section&nbsp;3 pro rata among the Holders of MRP
Shares in proportion to the number of MRP Shares they hold. The Corporation shall effect any redemption pursuant to subparagraph (a)(iii)&nbsp;of
this Section&nbsp;3 no later than 40 calendar days after the Asset Coverage Cure Date (a <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Mandatory
Redemption Date&rdquo;</I></FONT>), <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided,</I></FONT> that if (1)&nbsp;the
Corporation does not have funds legally available for the redemption of, or (2)&nbsp;is not permitted under the Credit Agreement or any
agreement or instrument consented to by the holders of a 1940 Act Majority of the Outstanding Preferred Stock pursuant to Section&nbsp;4(f)(iii)&nbsp;to
redeem or (3)&nbsp;is not otherwise legally permitted to redeem, the number of MRP Shares which would be required to be redeemed by the
Corporation under subparagraph (a)(iii)&nbsp;of this Section&nbsp;3 if sufficient funds were available, together with shares of other
Preferred Stock which are subject to mandatory redemption under provisions similar to those contained in this Section&nbsp;3 (the foregoing
provisions of clauses (1), (2)&nbsp;and (3)&nbsp;of this proviso being referred to as the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Special
Proviso&rdquo;</I></FONT>), the Corporation shall redeem those MRP Shares, and other shares of Preferred Stock which it was unable to
redeem, on the earliest practicable date on which the Corporation will have such funds available and is otherwise not prohibited from
redeeming pursuant to the Credit Agreement, such agreement or instrument consented to by the holders of the 1940 Act Majority of the
Outstanding Preferred Stock pursuant to Section&nbsp;4(f)(iii)&nbsp;or applicable laws, upon notice pursuant to Section&nbsp;3(b)&nbsp;to
record owners of the MRP Shares to be redeemed. The Corporation will make a payment of funds to the Holders of the MRP Shares sufficient
to redeem the specified number of MRP Shares with respect to a redemption required under subparagraph (a)(iii)&nbsp;of this Section&nbsp;3,
by 1:00 p.m., New York City time, on or prior to the Mandatory Redemption Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Corporation shall redeem all Outstanding Series&nbsp;A MRP Shares, Series&nbsp;B MRP Shares and Series&nbsp;C MRP Shares on the respective
Term Redemption Dates at the MRP Liquidation Preference Amount plus an amount equal to accumulated but unpaid dividends and distributions
thereon (whether or not earned or declared by the Corporation, but excluding interest thereon), to, but excluding, the respective Term
Redemption Dates.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event of a redemption pursuant to Section&nbsp;3(a), the Corporation will, if required by law or regulation, file a notice of its
intention to redeem with the Commission under Rule&nbsp;23c-2 under the 1940 Act or any successor provision to the extent applicable.
In addition, the Corporation shall deliver a notice of redemption (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Notice
of Redemption&rdquo;</I></FONT>) containing the information set forth below to the Holders of MRP Shares to be redeemed not less than
20 days (in the case of Section&nbsp;3 (a)(i)), 12 days (in the case of Section&nbsp;3(a)(ii)), or 3 Business Days (in the case of Section&nbsp;3(a)(iii))
and not more than 40 days prior to the applicable redemption date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of the Securities Purchase
Agreement regarding notices to the Holders, the Notice of Redemption will be addressed to the Holders of MRP Shares at their addresses
appearing on the stock records of the Corporation. Such Notice of Redemption will set forth (1)&nbsp;the date fixed for redemption, (2)&nbsp;the
number and identity of MRP Shares to be redeemed, (3)&nbsp;the redemption price (specifying the amount of accumulated dividends to be
included therein and the amount of the Make-Whole Amount, if any, or the redemption premium, if any), (4)&nbsp;that dividends on the shares
to be redeemed will cease to accumulate on such date fixed for redemption (so long as redeemed), and (5)&nbsp;the provision of these terms
of the MRP Shares under which redemption shall be made. No defect in the Notice of Redemption or in the transmittal or mailing thereof
will affect the validity of the redemption proceedings, except as required by applicable law.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
the provisions of paragraph (a)&nbsp;of this Section&nbsp;3, but subject to Section&nbsp;5(b), no MRP Shares may be redeemed unless all
dividends in arrears on the Outstanding MRP Shares and all shares of capital stock of the Corporation ranking on a parity with the MRP
Shares with respect to payment of dividends or upon liquidation have been or are being contemporaneously paid or set apart for payment;
<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided, however,</I></FONT> that the foregoing shall not prevent the purchase
or acquisition by the Corporation of all Outstanding MRP Shares pursuant to the successful completion of an otherwise lawful purchase,
tender or exchange offer made on the same terms to, and accepted by, Holders of all Outstanding MRP Shares.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;<FONT STYLE="font-size: 10pt">Upon
payment in accordance with Section&nbsp;14 of the Securities Purchase Agreement on or prior to the date fixed for redemption and the
giving of the Notice of Redemption to the Holders of the MRP Shares under paragraph (b)&nbsp;of this Section&nbsp;3, dividends on such
shares shall cease to accumulate and such shares shall no longer be deemed to be Outstanding for any purpose (including, without limitation,
for purposes of calculating whether the Corporation has maintained the MRP Shares Asset Coverage), and all rights of the Holder of the
shares so called for redemption shall cease and terminate, except the right of such Holder to receive the redemption price specified
herein, but without any interest or other additional amount.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the extent that any redemption for which a Notice of Redemption has been given is not made by reason of the Special Proviso, such redemption
shall be made as soon as practicable to the extent such funds become legally available or such redemption is no longer otherwise prohibited.
Failure to redeem MRP Shares shall be deemed to exist when the Corporation shall have failed, for any reason whatsoever, to pay in accordance
with Section&nbsp;14 of the Securities Purchase Agreement the redemption price with respect to any shares for which such Notice of Redemption
has been given in accordance with Sections 3(a)&nbsp;and 3(b)&nbsp;hereof. Notwithstanding the fact that the Corporation may not have
redeemed MRP Shares for which a Notice of Redemption has been given, dividends may be declared and paid on MRP Shares and shall include
those MRP Shares for which Notice of Redemption has been given but for which deposit of funds has not been made.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;<FONT STYLE="font-size: 5pt">&#8239;
</FONT>[Intentionally omitted.]</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for the provisions described above, nothing contained in these terms of the MRP Shares limits any right of the Corporation to purchase
or otherwise acquire any MRP Shares at any price, whether higher or lower than the price that would be paid in connection with an&#8239;</FONT>optional
or mandatory redemption, so long as, at the time of any such purchase, (1)&nbsp;there is no arrearage in the payment of dividends on,
or the mandatory or optional redemption price with respect to, any MRP Shares for which Notice of Redemption has been given, (2)&nbsp;the
Corporation is in compliance with the MRP Shares Asset Coverage after giving effect to such purchase or acquisition on the date thereof
and (3)&nbsp;an offer to purchase or otherwise acquire any MRP Shares is made by the Corporation pro rata to the Holders of all of the
Outstanding MRP Shares upon the same terms and conditions with respect to other Outstanding MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the case of any redemption pursuant to this Section&nbsp;3, only whole MRP Shares shall be redeemed, and in the event that any provision
of the Charter would require redemption of a fractional share, the Corporation shall be authorized to round up so that only whole shares
are redeemed.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything herein to the contrary, the Board of Directors may authorize, create or issue any class or series of shares of capital stock,
including other series of mandatory redeemable preferred stock, ranking on a parity with the MRP Shares with respect to the payment of
dividends or the distribution of assets upon dissolution, liquidation or winding up of the affairs of the Corporation (<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Parity
Stock&rdquo;</I></FONT>), to the extent permitted by the 1940 Act, if,&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;</FONT>upon
issuance, the Corporation would meet the MRP Shares Asset Coverage and (ii)&nbsp;in the event the holders of such Parity Stock have the
benefit of any rights substantially similar to Sections 2(e), 3(a)(iii), 4(f)(iv)&nbsp;or 4(l)&nbsp;which are additional to or more beneficial
than the rights of the Holders of the MRP Shares under such sections, these Articles Supplementary shall be deemed to include such additional
or more beneficial rights for the benefit of the Holders of the MRP Shares. Such rights incorporated herein shall be terminated when
and if terminated with respect to such other Parity Stock and shall be deemed amended or modified concurrently with any amendment or
modification of such other Parity Stock but, in no event, shall any such termination, amendment or modification affect the remaining
rights of the Holders of the MRP Shares).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;4.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Voting
Rights.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for matters which do not require the vote of Holders of MRP Shares under the 1940 Act and except as otherwise provided in the Charter
or Bylaws, herein or as otherwise required by applicable law, (1)&nbsp;each Holder of MRP Shares shall be entitled to one vote for each
MRP Share held on each matter submitted to a vote of stockholders of the Corporation, and (2)&nbsp;the holders of Outstanding Preferred
Stock and Common Stock shall vote together as a single class on all matters submitted to stockholders; <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided,
however,</I></FONT> that the holders of Outstanding Preferred Stock shall be entitled, as a class, to the exclusion of the holders of
shares of all other classes of stock of the Corporation, to elect two Directors of the Corporation at all times. Subject to the foregoing
rights of the Holders of the MRP Shares, the identity and class (if the Board of Directors is then classified) of the nominees for such
Directors may be fixed by the Board of Directors. Subject to paragraph (b)&nbsp;of this Section&nbsp;4, the holders of Outstanding Common
Stock and Preferred Stock, voting together as a single class, shall elect the balance of the Directors.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Voting
Period&rdquo;</I></FONT>), the number of Directors constituting the Board of Directors shall automatically increase by the smallest number
that, when&#8239;</FONT>added to the two Directors elected exclusively by the holders of Preferred Stock would constitute a majority of the
Board of Directors as so increased by such smallest number; and the holders of Preferred Stock shall be entitled, voting as a class on
a one-vote-per-share basis (to the exclusion of the holders of all other securities and classes of shares of stock of the Corporation),
to elect such smallest number of additional Directors, together with the two Directors that such holders are in any event entitled to
elect. A Voting Period shall commence:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
at the close of business on any Dividend Payment Date accumulated dividends (whether or not earned or declared) on Preferred Stock equal
to at least two full years&rsquo; dividends shall be due and unpaid; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
at any time holders of any shares of Preferred Stock are entitled under the 1940 Act to elect a majority of the Directors of the Corporation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a Voting Period has commenced pursuant to Section&nbsp;4(b)(i),
the Voting Period shall not end until all such accumulated dividends are paid to the holders of Preferred Stock or have been otherwise
provided for in a manner approved by the holders of the Preferred Stock. Upon the termination of a Voting Period, the voting rights described
in this paragraph (b)&nbsp;of Section&nbsp;4 shall cease, subject always, however, to the revesting of such voting rights in the holders
of Preferred Stock upon the further occurrence of any of the events described in this paragraph (b)&nbsp;of Section&nbsp;4.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
soon as practicable after the accrual of any right of the holders of Preferred Stock to elect additional Directors as described in paragraph
(b)&nbsp;of this Section&nbsp;4, the Corporation shall call a special meeting of such holders, and mail a notice of such special meeting
to such holders, such meeting to be held not less than 10 nor more than 30 calendar days after the date of mailing of such notice. If
the Corporation fails to send such notice or if a special meeting is not called at the expense of the Corporation, it may be called by
any such holder on like notice. The record date for determining the holders entitled to notice of and to vote at such special meeting
shall be the close of business on the fifth Business Day preceding the day on which such notice is mailed. At any such special meeting
and at each meeting of holders of Preferred Stock held during a Voting Period at which Directors are to be elected, a majority of such
holders, voting as a separate class (to the exclusion of the holders of all other securities and classes of capital stock of the Corporation),
shall be entitled to elect the number of Directors prescribed in paragraph (b)&nbsp;of this Section&nbsp;4 on a one-vote-per-share basis.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
terms of office of all persons who are Directors of the Corporation at the time of a special meeting of Holders of the MRP Shares and
holders of other Preferred Stock to elect Directors shall continue, notwithstanding the election at such meeting by the Holders of the
MRP Shares and such holders of other Preferred Stock of the number of Directors that they are entitled to elect, and the persons so elected
by such holders, together with the two incumbent Directors elected by such holders and the remaining incumbent Directors, shall constitute
the duly elected Directors of the Corporation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Simultaneously
with the termination of a Voting Period, the terms of office of the additional Directors elected by the Holders of the MRP Shares and
holders of shares of other&#8239;</FONT>Preferred Stock pursuant to paragraph (b)&nbsp;of this Section&nbsp;4 shall terminate, the number of
Directors constituting the Board of Directors shall decrease accordingly, the remaining Directors shall constitute the Directors of the
Corporation and the voting rights of such holders to elect additional Directors pursuant to paragraph (b)&nbsp;of this Section&nbsp;4
shall cease, subject to the provisions of the last sentence of paragraph (b)&nbsp;of this Section&nbsp;4.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>So
long as any series of the Preferred Stock are Outstanding, the Corporation will not, without the affirmative vote of the holders of a
majority of the outstanding Preferred Stock determined with reference to a &ldquo;majority of outstanding voting securities&rdquo; as
that term is defined in Section&nbsp;2(a)(42) of the 1940 Act (a <I>&ldquo;1940 Act Majority&rdquo;</I></FONT>), voting as a separate
class:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">amend,
alter or repeal (including by merger, consolidation or otherwise) any of the preferences, rights or powers of such class of Preferred
Stock so as to adversely affect such preferences, rights or powers and will not amend any provision of the Charter or Bylaws in a manner
which would restrict or limit the ability of the Corporation to comply with the terms and provisions of the Securities Purchase Agreement;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">amend,
alter or repeal (including by merger, consolidation or otherwise) any of the provisions of the Charter or Bylaws if such amendment, alteration
or repeal would adversely affect any privilege, preference, right or power of the MRP Shares or the Holders thereof;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">enter
into, become a party to, be bound by or adopt or allow to exist any agreement or instrument or any evidence of indebtedness which contains
restrictive covenants intended to limit the right of the Corporation to make dividends, distributions, redemptions or repurchases of Preferred
Stock (each a <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Restricted Payment Covenant&rdquo;</I></FONT>) which
are more restrictive than the most restrictive of the provisions of Section&nbsp;5.21 of the Credit Agreement, as such Credit Agreement
is in effect on July&nbsp;15, 2021 (other than Restricted Payment Covenants that are more restrictive as a result of (1)&nbsp;a change
in the laws or regulations or the Rating Agency Guidelines to which the Corporation is subject or (2)&nbsp;dividends, distributions, redemptions
or repurchases of Preferred Stock being blocked or restricted as a result of the occurrence of any default or event of default as such
terms are defined under any such agreement or instrument). For the avoidance of doubt, an amendment to, or adoption of, a covenant (other
than a Restricted Payment Covenant) in any instrument or agreement evidencing indebtedness of the Corporation (including, without limitation
the Credit Agreement) shall not require the affirmative vote of a 1940 Act Majority of the Holders of the Preferred Stock pursuant to
this Section&nbsp;4(f)(iii);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">create,
authorize or issue shares of any class of capital stock ranking on a parity with the Preferred Stock with respect to the payment of dividends
or the distribution of assets, or any securities convertible into, or warrants, options or similar rights to purchase, acquire or receive,
such shares of capital stock ranking on a parity with the Preferred Stock or reclassify any authorized shares of capital stock of the
Corporation into any shares ranking on a parity with the Preferred Stock (except that, notwithstanding the foregoing, but subject to
the provision of Section&nbsp;3(i), the Board of Directors, without the vote or consent of the holders of the Preferred Stock may from
time to time authorize,&#8239;</FONT>create and classify, and the Corporation, to the extent permitted by the 1940 Act, may from time
to time issue, shares or series of Preferred Stock, including other series of Mandatory Redeemable Preferred Stock, ranking on a parity
with the MRP Shares with respect to the payment of dividends and the distribution of assets upon dissolution, liquidation or winding
up of the affairs of the Corporation, and may authorize, reclassify and/or issue any additional MRP Shares, including shares previously
purchased or redeemed by the Corporation, subject to (i)&nbsp;continuing compliance by the Corporation with MRP Shares Asset Coverage
requirement and, in all material respects, the other provisions of these Articles Supplementary, and (ii)&nbsp;the payment in full of
all accrued and unpaid dividends on the MRP Shares and the effectuation of all redemptions required in respect of the MRP Shares, in
each case, without regard to the Special Proviso in Section&nbsp;3(a)(iv)&nbsp;except to the extent the proceeds of the issuance of such
Preferred Stock are used to pay such dividends in full and to effect all such redemptions);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>liquidate
or dissolve the Corporation;</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 10pt">create,
incur or suffer to exist, or agree to create, incur or suffer to exist, or consent to cause or permit in the future (upon the happening
of a contingency or otherwise) the creation, incurrence or existence of any material lien, mortgage, pledge, charge, security interest,
security agreement, conditional sale or trust receipt or other material encumbrance of any kind upon any of the Corporation&rsquo;s assets
as a whole, except (A)&nbsp;liens the validity of which are being contested in good faith by appropriate proceedings, (B)&nbsp;liens
for taxes that are not then due and payable or that can be paid thereafter without penalty,&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">(C)</FONT></FONT>&#8239;<FONT STYLE="font-size: 10pt">liens,
pledges, charges, security interests, security agreements or other encumbrances arising in connection with any indebtedness senior to
the MRP Shares or arising in connection with any futures contracts or options thereon, interest rate swap or cap transactions, forward
rate transactions, put or call options, short sales of securities or other similar transactions, (D)&nbsp;liens, pledges, charges, security
interests, security agreements or other encumbrances arising in connection with any indebtedness permitted under clause (vii)&nbsp;below
and (E)&nbsp;liens to secure payment for services rendered, including, without limitation, services rendered by the Corporation&rsquo;s
custodian or otherwise arising pursuant to the Custody Agreement or any future custody agreement;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT><FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">create,
authorize, issue, incur or suffer to exist any indebtedness for borrowed money or any direct or indirect guarantee of such indebtedness
for borrowed money or any direct or indirect guarantee of such indebtedness, except the Corporation may borrow and issue indebtedness
as may be permitted by the Corporation&rsquo;s investment restrictions or as may be permitted by the 1940 Act;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">create,
authorize or issue any shares of capital stock of the Corporation which are senior to the MRP Shares with respect to the payment of dividends,
the making of redemptions, liquidation preference or the distribution of assets of the Corporation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
affirmative vote of the holders of a 1940 Act Majority of the Outstanding shares&#8239;of Preferred Stock, voting as a separate class,
shall be required to approve any plan of&#8239;reorganization (as such term is used in the 1940 Act) adversely affecting such shares or any
action requiring a vote of security holders of the Corporation under Section&nbsp;13(a)&nbsp;of the 1940 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
affirmative vote of the holders of a 1940 Act Majority of the MRP Shares, voting separately as a series, shall be required with respect
to any matter that materially and adversely affects the rights, preferences, or powers of the MRP Shares in a manner different from that
of other separate series of classes of the Corporation&rsquo;s shares of capital stock. The vote of holders of any shares described in
this Section&nbsp;4(h)&nbsp;will in each case be in addition to a separate vote of the requisite percentage of Common Stock and/or Preferred
Stock, if any, necessary to authorize the action in question.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Unless
otherwise required by law, Holders of MRP Shares shall not have any relative rights or preferences or other special rights other than
those specifically set forth herein. The Holders of MRP Shares shall have no rights to cumulative voting.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
foregoing voting provisions will not apply with respect to the MRP Shares if, at or prior to the time when a vote is required, such shares
have been (i)&nbsp;redeemed or (ii)&nbsp;called for redemption and sufficient funds shall have been deposited in trust to effect such
redemption.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
vote, amendment, waiver, or consent granted or to be effected by any Holder of MRP Shares that has agreed to transfer such MRP Shares
to the Corporation or any Affiliate of the Corporation and has agreed to provide such waiver, vote, amendment or modification as a condition
to such transfer shall be void and of no effect except as to such Holder.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">So
long as any shares of Preferred Stock are Outstanding, the Corporation will not, without the affirmative vote of (1)&nbsp;the holders
of a 1940 Act Majority of the outstanding shares of Preferred Stock, voting as a separate class, and (2)&nbsp;the holders of a 1940 Act
Majority of the holders of the MRP Shares, voting as a separate series, create, authorize or issue shares of any class or series of capital
stock ranking senior to the Preferred Stock with respect to the payment of dividends or the distribution of assets, or any securities
convertible into, or warrants, options or similar rights to purchase, acquire or receive, such shares of capital stock ranking senior
to the Preferred Stock or reclassify any authorized shares of capital stock of the Corporation into any shares ranking senior to the Preferred
Stock.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Holders of MRP Shares shall have exclusive voting rights on any Charter amendment that would alter the contract rights, as expressly set
forth in the Charter, of only the MRP Shares.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;5.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Liquidation
Rights.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the dissolution, liquidation or winding up of the affairs of the Corporation, whether voluntary or involuntary, the Holders of MRP Shares
then Outstanding, together with holders of shares of any Preferred Stock ranking on a parity with the MRP Shares upon dissolution, liquidation
or winding up, shall be entitled to receive and to be paid out of the assets of the Corporation (or the proceeds thereof) available for
distribution to its stockholders after satisfaction of claims of creditors of the Corporation, but before any distribution or payment
shall be made in&#8239;respect of the Common Stock, an amount equal to the liquidation preference with respect to such shares. The liquidation
preference for MRP Shares shall be $25.00 per share, plus an amount equal to all accumulated and unpaid dividends thereon (whether or
not earned or declared but without interest) to the date payment of such distribution is made in full. No redemption premium (including
without limitation any Make-Whole Amount) shall be paid upon any liquidation even if such redemption premium would be paid upon optional
or mandatory redemption of the relevant shares. In determining whether a distribution (other than upon voluntary or involuntary liquidation),
by dividend, redemption or otherwise, is permitted under the MGCL, amounts that would be needed, if the Corporation were to be dissolved
at the time of distribution, to satisfy the liquidation preference of the MRP Shares will not be added to the Corporation&rsquo;s total
liabilities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If,
upon any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the assets of the
Corporation available for distribution among the holders of all outstanding shares of Preferred Stock shall be insufficient to permit
the payment in full to holders of the amounts to which they are entitled, then the available assets shall be distributed among the holders
of all outstanding shares of Preferred Stock ratably in any distribution of assets according to the respective amounts which would be
payable on all the shares if all amounts thereon were paid in full.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the dissolution, liquidation or winding up of the affairs of the Corporation, whether voluntary or involuntary, until payment in full
is made to the Holders of MRP Shares of the liquidation distribution to which they are entitled, (1)&nbsp;no dividend or other distribution
shall be made to the holders of Common Stock or any other class or series of shares of capital stock of the Corporation ranking junior
to MRP Shares upon dissolution, liquidation or winding up and (2)&nbsp;no purchase, redemption or other acquisition for any consideration
by the Corporation shall be made in respect of the Common Stock or any other class of shares of capital stock of the Corporation ranking
junior to MRP Shares upon dissolution, liquidation or winding up.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
consolidation, reorganization or merger of the Corporation with or into any company, trust or other legal entity, or a sale, lease or
exchange of all or substantially all of the assets of the Corporation in consideration for the issuance of equity securities of another
company, trust of other legal entity shall not be deemed to be a liquidation, dissolution or winding up, whether voluntary or involuntary,
for the purposes of this Section&nbsp;5.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">After
the payment to the holders of Preferred Stock of the full preferential amounts provided for in this Section&nbsp;5, the holders of Preferred
Stock as such shall have no right or claim to any of the remaining assets of the Corporation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the rights of the holders of shares of any series or class or classes of stock ranking on a parity with MRP Shares with respect to
the distribution of assets upon dissolution, liquidation or winding up of the affairs of the Corporation, after payment shall have been
made in full to the Holders of the MRP Shares as provided in paragraph (a)&nbsp;of this Section&nbsp;5, but not prior thereto, any other
series or class or classes of stock ranking junior to MRP Shares with respect to the distribution of assets upon dissolution, liquidation
or winding up of the affairs of the Corporation shall, subject to any respective terms and provisions (if any) applying thereto, be&#8239;</FONT>entitled
to receive any and all assets remaining to be paid or distributed, and the Holders of the MRP Shares shall not be entitled to share therein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;6.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Certain
Other Restrictions.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Rating Agency Guidelines
require the Corporation to receive a prior written confirmation that certain actions would not impair the rating then assigned by the
Rating Agency to the MRP Shares, then the Corporation will not engage in such actions unless it has received written confirmation from
each such Rating Agency that such actions would not impair the rating then assigned by such Rating Agency.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;7.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Compliance
Procedures for Asset Maintenance Tests.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so long as any MRP Shares
are Outstanding and Kroll or any Other Rating Agency which so requires is then rating such shares, the Corporation shall deliver to each
rating agency which is then rating MRP Shares and any other party specified in the Rating Agency Guidelines all certificates that are
set forth in the respective Rating Agency Guidelines at such times and containing such information as set forth in the respective Rating
Agency Guidelines.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;8.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notice.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All notices and communications
provided for hereunder shall be made in accordance with Section&nbsp;18 of the Securities Purchase Agreement, except as otherwise provided
in these terms of the MRP Shares or by the MGCL for notices of stockholders&rsquo; meetings.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;9.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Waiver.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting Section&nbsp;4(k)&nbsp;and
Section&nbsp;4(l)&nbsp;above, to the extent permitted by Maryland law and the 1940 Act, holders of a 1940 Act Majority of the outstanding
shares of Preferred Stock, acting collectively or voting separately from any other series, may by affirmative vote waive any provision
hereof intended for their respective benefit in accordance with such procedures as may from time to time be established by the Board of
Directors.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;10.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Termination.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If no MRP Shares of a particular
series are Outstanding, all rights and preferences of such shares of such series established and designated hereunder shall cease and
terminate, and all obligations of the Corporation under these terms of the MRP Shares, shall terminate as to such series of MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;11.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Rating
Agency Requests.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>In
the event the Corporation has been requested by an NRSRO which is then rating any series of the MRP Shares to take any action with respect
to such series of MRP Shares to maintain the rating of such NRSRO thereon and such action would require the vote of the Holders&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">of
such series of MRP Shares, if the Corporation shall give written notice of such request in reasonable detail of such action by the related
NRSRO in writing to each Holder of such series of MRP Shares in accordance with the requirements of Schedule A to the Securities Purchase
Agreement, (but only by delivery by nationally recognized courier service of hard copies and only if such &ldquo;courier&rdquo; receives
written acknowledgement of receipt by such Holder) (such notice being referred to as the <I>&ldquo;Corporation Request&rdquo;</I></FONT>),
a Holder shall be deemed to have agreed to the matters requested by the Corporation in such Corporation Request if such Holder does not
object to the Corporation Request within 30 days after receipt of the Corporation Request.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>Subject
to the provisions of these terms of the MRP Shares, including Section&nbsp;11(a), the Board of Directors may, by resolution duly adopted,
without stockholder approval (except as otherwise provided by these terms of the MRP Shares or required by applicable law), modify these
terms of the MRP Shares to reflect any modification hereto which the Board of Directors is entitled to adopt pursuant to the terms of
Section&nbsp;11(a)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;12.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Definitions.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used herein, the following
terms shall have the following meanings (with terms defined in the singular having comparable meanings when used in the plural and vice
versa), unless the context otherwise requires:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Affiliate&rdquo;
</I></FONT>means, at any time, and with respect to any Person, any other Person that at such time directly or indirectly through one or
more intermediaries Controls, or is Controlled by, or is under common Control with, such first Person. As used in this definition, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Control&rdquo;</I></FONT>
means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise. Unless the context otherwise clearly requires, any reference
to an <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Affiliate&rdquo; </I></FONT>is a reference to an Affiliate of
the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Applicable
Rate&rdquo; </I></FONT>means (i)&nbsp;the Series&nbsp;A Applicable Rate for the Series&nbsp;A MRP Shares, (ii)&nbsp;the Series&nbsp;B
Applicable Rate for the Series&nbsp;B MRP Shares and (iii)&nbsp;the Series&nbsp;C Applicable Rate for the Series&nbsp;C MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Asset
Coverage Cure Date&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;3(a)(iii).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Board
of Directors&rdquo; </I></FONT>or <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Board&rdquo; </I></FONT>means the
Board of Directors of the Corporation or any duly authorized committee thereof as permitted by applicable law.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Business
Day&rdquo; </I></FONT>means any day other than a Saturday, a Sunday or a day on which commercial banks in New York City are required or
authorized to be closed or any day on which the New York Stock Exchange is closed for trading.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Bylaws&rdquo;
</I></FONT>means the bylaws of the Corporation as adopted on June&nbsp;12, 2018, as may be amended from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Commission&rdquo;
</I></FONT>means the United States Securities and Exchange Commission.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Common
Stock&rdquo; </I></FONT>means the shares of Common Stock, par value $.001 per share, of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Credit
Agreement&rdquo; </I></FONT>means that certain Credit Agreement dated as of January&nbsp;3, 2013 among the Corporation, the banks and
other financial institutions parties thereto, and State Street Bank and Trust Company, as agent for the financial institutions thereto,
as amended, modified, supplemented, replaced or refinanced from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<I>Custody
Agreement</I></FONT>&rdquo; means that certain Master Custodian Agreement dated November&nbsp;30, 2012 by and between the Corporation
and State Street Bank and Trust Company.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default&rdquo;
</I></FONT>has the meaning set forth in Section&nbsp;2(c)(ii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default
Period&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(ii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default
Rate&rdquo; </I></FONT>means, with respect to any series of the MRP Shares, for any calendar day, the Applicable Rate in effect on such
day (without adjustment for any credit rating change on such series of the MRP Shares) plus 5% per annum.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Default
Rate Cure Period&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(iii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Dividend
Default&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(ii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Dividend
Payment Date&rdquo; </I></FONT>with respect to any series of the MRP Shares means the first (1st) Business Day of the month next following
each Dividend Period.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Dividend
Period&rdquo; </I></FONT>means, with respect to any series of the MRP Shares, the period from and including the Original Issue Date or
other date of the original issuance thereof, as applicable, and ending on and including the next following Quarterly Dividend Date, and
each subsequent period from but excluding a Quarterly Dividend Date and ending on and including the next following Quarterly Dividend
Date.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Dividend
Rate&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(i)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Holder&rdquo;
</I></FONT>means, with respect to MRP Shares, the registered holder of MRP Shares as the same appears on the stock ledger or stock records
of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Kroll&rdquo;
</I></FONT>means Kroll Bond Rating Agency,&nbsp;Inc. and its successors at law.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Make</I></FONT>-<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Whole
Amount&rdquo; </I></FONT>for each MRP Share means, with respect to any MRP Share, an amount equal to the excess, if any, of the Discounted
Value of the Remaining Scheduled Payments with respect to the MRP Liquidation Preference Amount of such MRP Share over the amount of
such MRP Liquidation Preference Amount, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided</I></FONT> that the Make-Whole
Amount may in no event be less than zero. For the purposes of determining the Make-Whole Amount, the following terms have the following
meanings:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>&ldquo;Discounted
Value&rdquo;</I></FONT> means, with respect to the MRP Liquidation Preference Amount of any MRP Share, the amount obtained by discounting
all Remaining Scheduled Payments with respect to such MRP Liquidation Preference Amount from their respective scheduled due dates to the
Settlement Date with respect to such MRP Liquidation Preference Amount, in accordance with accepted financial practice and at a discount
factor (applied quarterly on a Quarterly Dividend Date) equal to the Reinvestment Yield with respect to such MRP Liquidation Preference
Amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>&ldquo;Reinvestment
Yield&rdquo;</I></FONT> means, with respect to the MRP Liquidation Preference Amount of any MRP Share, 0.50% over the yield to
maturity implied by (i)&nbsp;the &ldquo;Ask-Yield(s)&rdquo; reported as of 10:00 a.m.&nbsp;(New York City time) on the second
Business Day preceding the Settlement Date with respect to such MRP Liquidation Preference Amount, on the display designated as
 &ldquo;Page&nbsp;PX1&rdquo; (or such other display as may replace <FONT STYLE="font-family: Times New Roman, Times, Serif">Page&nbsp;PX1)
on Bloomberg Financial Markets for the most recently issued actively traded on the run U.S. Treasury securities
(&ldquo;<I>Reported</I></FONT>&rdquo;) having a maturity equal to the Remaining Average Life of such MRP Liquidation Preference
Amount as of such Settlement Date. If there are no such U.S. Treasury securities Reported having a maturity equal to such Remaining
Average Life, then such implied yield to maturity will be determined by (i)&nbsp;converting U.S. Treasury bill quotations to bond
equivalent yields in accordance with accepted financial practice and (ii)&nbsp;interpolating linearly between the &ldquo;Ask
Yields&rdquo; Reported for the applicable most recently issued actively traded on-the-run U.S. Treasury securities with the
maturities (1)&nbsp;closest to and greater than such Remaining Average Life and (2)&nbsp;closest to and less than such Remaining
Average Life. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the dividend rate of the
applicable MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
such yields are not Reported or the yields Reported as of such time are not ascertainable (including by way of interpolation), then <I>&ldquo;Reinvestment
Yield&rdquo;</I></FONT> means, with respect to the MRP Liquidation Preference Amount of any MRP Shares, the sum of (x)&nbsp;0.50% plus
(y)&nbsp;the yield to maturity implied by the U.S. Treasury constant maturity yields reported, for the latest day for which such yields
have been so reported as of the second Business Day preceding the Settlement Date with respect to such MRP Liquidation Preference Amount,
in Federal Reserve Statistical Release H.15 (or any comparable successor publication) for the U.S. Treasury constant maturity having a
term equal to the Remaining Average Life of such MRP Liquidation Preference Amount as of such Settlement Date. If there is no such U.S.
Treasury constant maturity having a term equal to such Remaining Average Life, such implied yield to maturity will be determined by interpolating
linearly between (1)&nbsp;the U.S. Treasury constant maturity so reported with the term closest to and greater than such Remaining Average
Life and (2)&nbsp;the U.S. Treasury constant maturity so reported with the term closest to and less than such Remaining Average Life.
The Reinvestment Yield shall be rounded to the number of decimal places as appears in the dividend rate of the applicable MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>&ldquo;Remaining
Average Life&rdquo;</I></FONT> means, with respect to any MRP Liquidation Preference Amount, the number of years (calculated to the
nearest one-twelfth year) that will elapse between the Settlement Date with respect to such MRP Liquidation Preference Amount and
the scheduled due date of such Remaining Scheduled Payment.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;Remaining
Scheduled Payments&rdquo; </I></FONT><FONT STYLE="font-size: 10pt">means, with respect to the MRP Liquidation Preference Amount of any
MRP Share, all payments of such MRP Liquidation Preference Amount and dividends thereon at the original (i)&nbsp;Applicable Rate on July&nbsp;15,
2021 for the Series&nbsp;A MRP Shares and (ii)&nbsp;Applicable Rate on September&nbsp;15, 2021 for the Series&nbsp;B MRP Shares and the
Series&nbsp;C MRP Shares, as if they were paid on each Quarterly Dividend Payment Date after the Settlement Date with respect to such
MRP Liquidation Preference Amount if no payment of such MRP Liquidation Preference Amount were made prior to the respective Term Redemption
Dates, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided</I></FONT> that if such Settlement Date is not a Quarterly
Dividend Payment Date, then the amount of the next succeeding scheduled dividend payment will be reduced by the amount of dividends accrued
to such Settlement Date and required to be paid on such Settlement Date pursuant to Section&nbsp;3.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;Settlement
Date&rdquo; </I></FONT><FONT STYLE="font-size: 10pt">means, with respect to the MRP Liquidation Preference Amount of any MRP Share, the
date on which such MRP Liquidation Preference Amount is to be prepaid pursuant to Section&nbsp;3.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Mandatory
Redemption Date&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;3(a)(iv)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MGCL&rdquo;
</I></FONT>has the meaning set forth in Section&nbsp;1(e)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MRP
Liquidation Preference Amount&rdquo; </I></FONT>means, for the MRP Shares, liquidation preference, $25.00 per share.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MRP
Shares&rdquo; </I></FONT>means the Series&nbsp;A Mandatory Redeemable Preferred Stock, the Series&nbsp;B Mandatory Redeemable Preferred
Stock and the Series&nbsp;C Mandatory Redeemable Preferred Stock of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;MRP
Shares Asset Coverage&rdquo; </I></FONT>means asset coverage, as determined in accordance with Section&nbsp;18(h)&nbsp;of the 1940 Act,
as in effect on the date of issuance of the MRP Shares, of at least 225% with respect to all outstanding Senior Securities and Preferred
Stock, including all outstanding MRP Shares, determined on the basis of values calculated as of a time within 48 hours (not including
Sundays or holidays) next preceding the time of such determination.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;1940
Act&rdquo; </I></FONT>means the Investment Company Act of 1940, as amended from time to time, and the rules&nbsp;and regulations adopted
by the Commission thereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;1940
Act Majority&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;4(f)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Notice
of Redemption&rdquo; </I></FONT>is defined in Section&nbsp;3(b).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>&ldquo;NRSRO&rdquo; </I>means a nationally recognized
statistical ratings organization.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>&ldquo;Other Rating
Agency&rdquo; </I></FONT>means each NRSRO, if any, other than Kroll then providing a rating for any series of the MRP Shares pursuant
to the request of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Original
Issue Date&rdquo; </I></FONT>means (i)&nbsp;July&nbsp;15, 2021 in the case of the Series&nbsp;A MRP Shares and (ii)&nbsp;September&nbsp;15,
2021 in the case of the Series&nbsp;B MRP Shares and Series&nbsp;C MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Outstanding&rdquo;
</I></FONT>or <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;outstanding&rdquo; </I></FONT>means, with respect to
a series of the MRP Shares as of any date, the MRP Shares of such series theretofore issued by the Corporation except, without duplication,
any MRP Shares theretofore canceled, redeemed or repurchased by the Corporation. Notwithstanding the foregoing, for purposes of voting
rights (including the determination of the number of shares required to constitute a quorum), any of the MRP Shares to which the Corporation
or any Affiliate of the Corporation shall be the Holder shall be disregarded and not deemed outstanding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Parity
Stock&rdquo; </I></FONT>shall have the meaning set forth in Section&nbsp;3(i)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Person&rdquo;
</I></FONT>or <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;person&rdquo; </I></FONT>means and includes an individual,
a corporation, a partnership, a trust, a company, an unincorporated association, a joint venture or other entity or a government or any
agency or political subdivision thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Preferred
Stock&rdquo; </I></FONT>means the shares of Preferred Stock, par value $0.001 per share, including the MRP Shares, of the Corporation
from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;Quarterly
Dividend Date&rdquo; </I></FONT><FONT STYLE="font-size: 10pt">means the 31st day of each March, the 30th day of each June, the 30th day
of each September&nbsp;and the <FONT STYLE="font-family: Times New Roman, Times, Serif">31<SUP>st</SUP> d</FONT>ay of each December.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&ldquo;Rating Agency&rdquo;
</I>means each of Kroll (if Kroll is then rating MRP Shares) and any Other Rating Agency.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Rating
Agency Guidelines&rdquo; </I></FONT>mean the guidelines provided by each Rating Agency, as may be amended from time to time, in connection
with such Rating Agency&rsquo;s rating of any series of&#8239;MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Redemption
Date&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(ii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Redemption
Default&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;2(c)(ii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Restricted
Payment Covenant&rdquo; </I></FONT>has the meaning set forth in Section&nbsp;4(f)(iii)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Securities
Purchase Agreement&rdquo; </I></FONT>means the Securities Purchase Agreement dated as of July&nbsp;15, 2021, as amended from time to time,
of the Corporation in respect of the MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Senior
Securities&rdquo; </I></FONT>means indebtedness for borrowed money of the Corporation including, without limitation, the bank borrowings
and (without duplication) other indebtedness of the Corporation within the meaning of Section&nbsp;18 of the 1940 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;A
Applicable Rate&rdquo; </I></FONT>means 2.58% per annum, as adjusted (if applicable) in accordance with Section&nbsp;2(c)(i)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;B
Applicable Rate&rdquo; </I></FONT>means 2.58% per annum, as adjusted (if applicable) in accordance with Section&nbsp;2(c)(i)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;C
Applicable Rate&rdquo; </I></FONT>means 3.03% per annum, as adjusted (if applicable) in accordance with Section&nbsp;2(c)(i)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;A
MRP Shares&rdquo; </I></FONT>means the Series&nbsp;A Mandatory Redeemable Preferred Stock of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;B
MRP Shares&rdquo; </I></FONT>means the Series&nbsp;B Mandatory Redeemable Preferred Stock of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;C
MRP Shares&rdquo; </I></FONT>means the Series&nbsp;C Mandatory Redeemable Preferred Stock of the Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;A
Term Redemption Date&rdquo; </I></FONT>means July&nbsp;15, 2026 for the Series&nbsp;A MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;B
Term Redemption Date&rdquo; </I></FONT>means September&nbsp;15, 2026 for the Series&nbsp;B MRP&#8239;Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Series&nbsp;C
Term Redemption Date&rdquo; </I></FONT>means September&nbsp;15, 2028 for the Series&nbsp;C MRP&#8239;Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Special
Proviso&rdquo; </I></FONT>shall have the meaning set forth in Section&nbsp;3(a)(iv).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Term
Redemption Date&rdquo; </I></FONT>means (i)&nbsp;the Series&nbsp;A Term Redemption Date for the Series&nbsp;A MRP Shares, (ii)&nbsp;the
Series&nbsp;B Term Redemption Date for the Series&nbsp;B MRP Shares and (iii)&nbsp;the Series&nbsp;C Term Redemption Date for the Series&nbsp;C
MRP Shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Valuation
Date&rdquo; </I></FONT>means every Friday, or, if such day is not a Business Day, the next preceding Business Day; <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided,
however,</I></FONT> that the first Valuation Date may occur on any other date established by the Corporation; <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided,
further, however,</I></FONT> that such first Valuation Date shall be not more than one week after the date on which MRP Shares initially
are issued.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;Voting
Period&rdquo; </I></FONT>shall have the meaning set forth in Section&nbsp;4(b)&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">S</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">ection&nbsp;13.</FONT><FONT STYLE="font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Interpretation.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">References to sections, subsections,
clauses, sub-clauses, paragraphs and subparagraphs are to such sections, subsections, clauses, sub-clauses, paragraphs and subparagraphs
contained herein, unless specifically identified otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps">S</FONT><FONT STYLE="font-variant: small-caps">econd</FONT>:
The MRP Shares have been classified and designated by the Board of Directors under the authority contained in the Charter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps">T</FONT><FONT STYLE="font-variant: small-caps">hird</FONT>:
These Articles Supplementary have been approved by the Board of Directors in the manner and by the vote required by law.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps">F</FONT><FONT STYLE="font-variant: small-caps">ourth</FONT>:
These Articles Supplementary shall be effective at 9:00 a.m., Eastern time, on July&nbsp;15, 2021.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps">F</FONT><FONT STYLE="font-variant: small-caps">ifth</FONT>:
The undersigned acknowledges these Articles Supplementary to be the corporate act of the Corporation and, as to all matters or facts
required to be verified under oath, the undersigned acknowledges that, to the best of his or her knowledge, information and belief, these
matters and facts are true in all material respects and that this statement is made under the penalties for perjury.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">[<FONT STYLE="font-variant: small-caps">S</FONT></FONT><FONT STYLE="font-variant: small-caps">ignature
Page Follows</FONT>]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">In
Witness Whereof</FONT>, the Corporation has caused these Articles Supplementary to be&#8239;signed in its name and on its behalf by its
Chief Financial Officer and attested to by its Secretary on this 14<SUP>th</SUP> day of July, 2021.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ATTEST:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Ares Dynamic Credit
    Allocation Fund,&nbsp;Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">/s/
    Ian Fitzgerald</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">/s/
    Scott Lem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-size: 10pt">Ian Fitzgerald</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-size: 10pt">Scott Lem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Secretary</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(E)
<SEQUENCE>3
<FILENAME>tm2416373d4_ex99-xe.htm
<DESCRIPTION>EXHIBIT 99.(E)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xe.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(e)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIVIDEND REINVESTMENT PLAN</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>effective as of October&nbsp;25, 2012</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland corporation
(the &ldquo;Fund&rdquo;), hereby adopts the following plan (the &ldquo;Plan&rdquo;) with respect to the cash portion of dividends and
distributions (collectively, &ldquo;Cash Dividends&rdquo;) declared by its Board of Directors (the &ldquo;Board of Directors&rdquo;) on
shares of its common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;):</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Unless a shareholder of record (a &ldquo;shareholder&rdquo;) specifically elects to receive cash as set forth below, all Cash Dividends
shall be payable in shares of the Common Stock of the Fund, and no action shall be required on such shareholder&rsquo;s part to receive
a Cash Dividends in Common Stock. All shareholders are deemed to be participants in the Plan (&ldquo;Participants&rdquo;) unless they
specifically elect not to participate in the Plan by notifying the Plan Administrator pursuant to the instructions in Section&nbsp;8 hereof.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>State Street Bank and Trust Company, as plan agent (the &ldquo;Plan Administrator&rdquo;), serves as agent for the Participants of
the Fund in administering the Plan. The shares are acquired by the Plan Administrator for a Participant&rsquo;s account, depending upon
the circumstances described below, either (i)&nbsp;through receipt of additional authorized and unissued Common Stock from the Fund (&ldquo;Newly
Issued Shares&rdquo;) or (ii)&nbsp;by purchase of outstanding shares of Common Stock on the open market (&ldquo;Open-Market Purchases&rdquo;)
on the New York Stock Exchange (&ldquo;NYSE&rdquo;) or elsewhere. If, on a Fund dividend payment date, the Fund&rsquo;s net asset value
per share is equal to or less than the market price per share for a share of Common Stock on the NYSE plus estimated brokerage commissions
(such condition being referred to as &ldquo;market premium&rdquo;), the Plan Administrator will invest the dividend amount in Newly Issued
Shares on behalf of the Participant. The number of Newly Issued Shares to be credited to the Participant&rsquo;s account will be determined
by dividing the dollar amount of the dividend by the Fund&rsquo;s net asset value per share on the date the shares are issued, unless
the Fund&rsquo;s net asset value per share is less than 95% of the then current market price on the NYSE of a share of Common Stock, in
which case the dollar amount of the dividend will be divided by 95% of the then current market price on the NYSE of a share of Common
Stock. If on the dividend payment date the Fund&rsquo;s net asset value per share is greater than the market price on the NYSE of a share
of Common Stock (such condition being referred to as &ldquo;market discount&rdquo;), the Plan Administrator will invest the dividend
amount in Common Stock acquired on behalf of the Participant in Open-Market Purchases.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>A shareholder may, however, elect to receive any Cash Dividends in cash. To exercise this option, such shareholder shall notify
                                                                the Plan Administrator in writing or by telephone (pursuant to the instructions in Section&nbsp;8 hereof) so that such notice is
                                                                received by the Plan Administrator no later than 1:00 p.m.&nbsp;Eastern time, no less than 10 days prior to the record date fixed by
                                                                the Board of Directors for the Cash Dividend involved. Persons who hold their shares of Common Stock through a broker or other
                                                                nominee and who wish to elect to receive any Cash Dividends in cash
must contact their broker or nominee.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Plan Administrator will set up a Plan account for shares acquired pursuant to the Plan for each Participant. The Plan Administrator
may hold each Participant&rsquo;s shares, together with the shares of other Participants, in non-certificated form in the Plan Administrator&rsquo;s
name or that of its nominee. In the case of shareholders such as banks, brokers or nominees that hold Common Shares for others who are
the beneficial owners, the Plan Administrator will administer the Plan on the basis of the number of shares of Common Stock certified
from time to time by the record shareholder and held for the account of beneficial owners who participate in the Plan.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Plan Administrator will confirm to each Participant each acquisition made pursuant to the Plan as soon as practicable. Each Participant
may from time to time have an undivided fractional interest (computed to three decimal places) in a share of Common Stock of the Fund
and dividends and distributions on fractional shares will be credited to each Participant&rsquo;s Plan account.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">6.</TD><TD>In the event that the Fund makes available to its shareholders rights to purchase additional shares or other securities, the shares
or other securities held by the Plan Administrator for each Participant under the Plan will be added to any other shares or other securities
held by the Participant (in book-entry or certificated form) in calculating the number of rights to be issued to the Participant.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">7.</TD><TD>The Plan Administrator&rsquo;s service fee, if any, and expenses for administering the Plan will be paid for by the Fund. There will
be no brokerage charges to shareholders with respect to shares of Common Stock issued directly by the Fund as a result of dividends or
distributions payable either in Common Shares or in cash. However, each Participant will pay a pro-rata share of brokerage commissions
incurred with respect to the Plan Administrator&rsquo;s Open-Market Purchases in connection with the reinvestment of dividends and distributions.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">8.</TD><TD>Each Participant may terminate his or its account under the Plan by so notifying the Plan Administrator by writing to the Plan Administrator
at State Street Bank and Trust Company, 200 Clarendon Street, 16th Floor, Boston, MA 20116 or by calling the Plan Administrator&rsquo;s
hotline at (877) 272-8164. Such termination will be effective immediately if the Participant&rsquo;s notice is received by the Plan Administrator
at least 10 days prior to any dividend or distribution record date; otherwise, such termination will be effective only with respect to
any subsequent dividend or distribution. The Plan may be terminated by the Fund upon notice in writing mailed to each Participant at least
30 days prior to any record date for the payment of any dividend or distribution by the Fund. Persons who hold their shares of Common
Stock through a broker or other nominee and who wish to terminate their account under the Plan may do so by notifying their broker or
nominee.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">9.</TD><TD>Upon any termination of the Plan by the Fund or upon any termination by a Participant of its or his account under the Plan, the Plan
Administrator will cause full and fractional shares held for the Participant under the Plan to be credited to the Participant in book-entry
form with the Fund&rsquo;s transfer agent. In advance of such termination, a Participant may instead elect to have the Plan Administrator
sell part or all of the Participant&rsquo;s shares and remit the proceeds to the Participant. A sale request that is received before 1:00
p.m.&nbsp;Eastern time, will, subject to market conditions and their factors, generally be sold the same business day. Sales usually take
place on a daily basis during trading days on the NYSE, and are generally processed on the day that a sale request is received by the
Plan Administrator (if received during a trading day) and no later than five business days of the receipt of that request. Persons who
hold their shares of Common Stock through a broker or other nominee and who wish sell part or all of their shares under the Plan may do
so by notifying their broker or nominee.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">10.</TD><TD>These terms and conditions may be amended or supplemented by the Fund at any time but, except when necessary or appropriate to comply
with applicable law or the rules&nbsp;or policies of the Securities and Exchange Commission or any other regulatory authority, only by
mailing to each Participant appropriate written notice at least 30 days prior to the effective date thereof. The amendment or supplement
shall be deemed to be accepted by each Participant unless, prior to the effective date thereof, the Plan Administrator receives written
notice from the Participant of the termination of such Participant&rsquo;s account under the Plan. Any such amendment may include an appointment
by the Plan Administrator, in its place and stead, of a successor agent under these terms and conditions, with full power and authority
to perform all or any of the acts to be performed by the Plan Administrator under these terms and conditions. Upon any such appointment
of any agent for the purpose of receiving dividends and distributions, the Fund will be authorized to pay to such successor agent, for
each Participant&rsquo;s account, all dividends and distributions payable on shares of the Fund held in the Participant&rsquo;s name or
under the Plan for retention or application by such successor agent as provided in these terms and conditions.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">11.</TD><TD>The Plan Administrator will at all times act in good faith and use its commercially reasonable best efforts to ensure its full and
timely performance of all services to be performed by it under this Plan and to comply with applicable law, but assumes no responsibility
and shall not be liable for loss or damage due to errors unless such error is caused by the Plan Administrator&rsquo;s negligence, bad
faith, or willful misconduct or that of its employees or agents.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">12.</TD><TD STYLE="text-align: justify">These terms and conditions shall be governed by the laws of the Commonwealth of Massachusetts, without
regard to its conflicts of laws rules.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(G)
<SEQUENCE>4
<FILENAME>tm2416373d4_ex99-xg.htm
<DESCRIPTION>EXHIBIT 99.(G)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xg.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(g)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 309pt; text-align: right">EXECUTION VERSION</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INVESTMENT ADVISORY AND MANAGEMENT AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BETWEEN</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARES DYNAMIC CREDIT ALLOCATION
FUND,&nbsp;INC.</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARES CAPITAL MANAGEMENT II LLC</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Investment Advisory and
Management Agreement (the &ldquo;Agreement&rdquo;) is entered into as of November&nbsp;28, 2012, by and between ARES DYNAMIC CREDIT ALLOCATION
FUND,&nbsp;INC. (the &ldquo;Fund&rdquo;), a corporation duly organized and existing under the laws of the State of Maryland, and ARES
CAPITAL MANAGEMENT II LLC, a limited liability company duly organized and existing under the laws of the State of Delaware (the &ldquo;Adviser&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund is, or will
be prior to commencing operations, a closed-end management investment company registered under the Investment Company Act of 1940, as
amended (the &ldquo;Investment Company Act&rdquo;);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Adviser has the
power to engage in management and investment advisory services and is, or will be prior to commencing operations, registered as an investment
adviser under the Investment Advisers Act of 1940, as amended (the &ldquo;Advisers Act&rdquo;); and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Adviser is willing
to provide management and investment advisory services to the Fund on the terms and conditions hereinafter set forth.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants and agreements set out in this Agreement, the Fund and the Adviser agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Appointment; Duties of the Adviser</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund hereby employs the Adviser to act as the investment adviser to the Fund and to furnish, or arrange for its affiliates to furnish,
the management and investment advisory services described below, for the period and upon the terms herein set forth,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
accordance with the investment objectives, policies and restrictions that are determined by the Board of Directors of the Fund (the &ldquo;Board&rdquo;)
from time to time and disclosed to the Adviser, which objectives, policies and restrictions shall initially be those set forth in the
Fund&rsquo;s Registration Statement on Form&nbsp;N-2, filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on March&nbsp;22,
2011 (the &ldquo;Registration Statement&rdquo;), as it may be periodically amended or supplemented;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
accordance with the Investment Company Act; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;during
the term of this Agreement in accordance with all other applicable federal and state laws, rules&nbsp;and regulations, and the Fund&rsquo;s
articles of incorporation and bylaws.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Administration
Services</U>. The Adviser shall perform, or arrange for its affiliates to perform, the management services necessary for the operation
of the Fund, including providing the Fund necessary personnel and such other services as the Adviser, subject to review by the Board,
from time to time shall determine to be necessary or useful to perform its obligations under this Agreement. The Adviser, also on behalf
of the Fund, shall conduct relations with custodians, depositories, transfer agents, pricing agents, investor support service providers,
investor relations providers, dividend disbursing agents, other shareholder servicing agents, accountants, attorneys, underwriters, brokers
and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Advisory Services</U>. Subject to the supervision, direction and approval of the Board, the Adviser will conduct a continual program of
investment, evaluation, sale, and reinvestment of the Fund&rsquo;s assets. The Adviser is authorized, in its sole discretion, to: (i)&nbsp;obtain
and evaluate pertinent economic, financial, and other information affecting the economy generally and certain investment assets as such
information relates to securities, loans or other financial instruments that are purchased for or considered for purchase by the Fund;
(ii)&nbsp;make investment decisions for the Fund (including the exercise or disposition of rights accompanying portfolio securities, loans
or other financial instruments (such as tender offers, exchanges, amendments, consents, waivers or forbearances) and other attendant rights
thereto); (iii)&nbsp;place purchase and sale orders for portfolio transactions on behalf of the Fund and manage otherwise uninvested cash
assets of the Fund; (iv)&nbsp;arrange for the pricing of Fund securities, loans or other financial instruments; (v)&nbsp;execute account
documentation, agreements, contracts and other documents as may be requested by brokers, dealers, assignors, assignees, participants,
counterparties and other persons in connection with the Adviser&rsquo;s management of the assets of the Fund (in such respect, the Adviser
will act as the Fund&rsquo;s agent and attorney-in-fact); (vi)&nbsp;employ professional portfolio managers and securities analysts who
provide research services to the Fund; (vii)&nbsp;engage certain third party professionals, consultants, experts or specialists in connection
with the Adviser&rsquo;s management of the assets of the Fund (in such respect, the Adviser will act as the Fund&rsquo;s agent and attorney-in-fact);
and (viii)&nbsp;make decisions with respect to the use by the Fund of borrowing for leverage or other investment purposes. The Adviser
will in general take such action as is appropriate to effectively manage the Fund&rsquo;s investment practices. In addition:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser will maintain and preserve the records specified in Section&nbsp;13 of this Agreement and any other records related to the Fund&rsquo;s
transactions as are required under any applicable state or federal securities law or regulation, including the Investment Company Act,
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and the Advisers Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The Adviser will comply with
procedures of the Fund (&ldquo;Fund Procedures&rdquo;) provided to the Adviser by the Fund. The Adviser will notify the Fund as soon as
reasonably practicable upon detection of any material breach of such Fund Procedures.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser will maintain a written code of ethics (the &ldquo;Code of Ethics&rdquo;), a copy of which will be provided to the Fund, and will
adhere to such Code of Ethics in performing its services under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser, as directed by the Board, will manage the investment and reinvestment of the assets of the Fund in a manner consistent with the
requirements of Subchapter M of the Internal Revenue Code of 1986, as amended, subject to the best interests of the Fund. In addition,
the Adviser will manage the Fund&rsquo;s assets in compliance with the Fund&rsquo;s investment objectives and policies as stated in the
Registration Statement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser shall for all purposes herein provided be deemed to be an independent contractor and, except as expressly provided or authorized
herein, shall have no authority to act for or represent the Fund in any way or otherwise be deemed an agent of the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Information and Reports</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser will keep the Fund informed of developments relating to its duties as investment adviser of which the Adviser has, or should have,
knowledge that would materially affect the Fund. In this regard, the Adviser will provide the Fund and its officers with such periodic
reports concerning the obligations the Adviser has assumed under this Agreement as the Fund may from time to time reasonably request.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser also will provide the Fund with any information reasonably requested regarding its management of the Fund required for any shareholder
report, amended registration statement, or prospectus supplement to be filed by the Fund with the SEC. The Adviser will promptly inform
the Fund if any information in the Registration Statement, as amended from time to time, is (or will become) inaccurate or incomplete.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Standard of Care</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser will exercise
its reasonable judgment and will act in good faith and use reasonable care and in a manner consistent with applicable federal and state
laws and regulations in rendering the services it agrees to provide under this Agreement. The Adviser shall not be liable for any error
of judgment or mistake of law or for any loss arising out of any investment or for any act or omission in the management of the Fund,
except for willful misfeasance, bad faith or gross negligence in the performance of its duties, or by reason of reckless disregard of
its obligations and duties hereunder. As used in this Section&nbsp;3, the term &ldquo;Adviser&rdquo; shall include any affiliates of
the Adviser performing services for the Fund contemplated hereby, and directors, officers and employees of the Adviser and of such affiliates.
The Adviser assumes no responsibility under this Agreement other than to render the services called for hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Adviser&rsquo;s Duties Regarding Fund Transactions</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Placement
of Orders</U>. The Adviser will take all actions that it considers necessary to implement the investment policies of the Fund, and, in
particular, to place all orders for the purchase or sale of securities or other investments for the Fund with brokers or dealers the Adviser,
in its sole discretion, selects. To that end, the Adviser is authorized as the Fund&rsquo;s agent to give instructions to the Fund&rsquo;s
custodian as to deliveries of securities or other investments and payments of cash for the Fund&rsquo;s account. In connection with the
selection of brokers or dealers and the placement of purchase and sale orders, the Adviser is subject to the supervision of the Board
and is directed at all times to seek to obtain best execution, subject to provisions (b)&nbsp;and (c)&nbsp;of this Section&nbsp;4.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Selection
of Brokers and Dealers</U>. In the selection of brokers and dealers to execute portfolio transactions, the Adviser is authorized to consider
not only the available prices and rates of brokerage commissions, but also other relevant factors, which may include, without limitation:
the execution capabilities of the brokers and dealers; the research and other services provided by the brokers and dealers that the Adviser
believes will enhance its general portfolio management capabilities; the size of the transaction; the difficulty of execution; the operational
facilities of these brokers and dealers; the risk to a broker or dealer of positioning a block of securities; and the overall quality
of brokerage and research services provided by the brokers and dealers. In connection with the foregoing, the Adviser is specifically
authorized to pay those brokers and dealers who provide brokerage and research services to the Adviser a higher commission than that charged
by other brokers and dealers if the Adviser determines in good faith that the amount of the commission is reasonable in relation to the
value of the services in terms of either the particular transaction or in terms of the Adviser&rsquo;s overall responsibilities with respect
to the Fund and to any other client accounts or portfolios that the Adviser may advise. The execution of such transactions will not be
considered to represent an unlawful breach of any duty created by this Agreement or otherwise. To the extent permitted by applicable law,
the Adviser may selected affiliated brokers and dealers to execute portfolio transactions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Aggregated
Transactions</U>. On occasions when the Adviser deems the purchase or sale of a security or other financial instrument to be in the best
interest of the Fund, as well as other funds or accounts managed by the Adviser or its affiliates (&ldquo;Ares-advised funds&rdquo;),
the Adviser is authorized, but not required, to aggregate purchase and sale orders for securities or other financial instruments held
(or to be held) by the Fund with similar orders being made on the same day for other Ares-advised funds to the extent permitted by the
Investment Company Act. When an order is so aggregated, the Adviser may allocate the recommendations or transactions among all accounts
and portfolios for whom the recommendation is made or transaction is effected. The Adviser will endeavor to allocate investment opportunities
in a manner that, over a period of time, is fair and equitable, and in any event consistent with any fiduciary duties owed to the Fund
and in an effort to avoid favoring one client over another and taking into account all relevant facts and circumstances, including (without
limitation): (i)&nbsp;differences with respect to available capital, (ii)&nbsp;differences with respect to investment objectives or current
investment strategies, (iii)&nbsp;differences in risk profile at the time the opportunity becomes available, (iv)&nbsp;the potential
transaction and other costs of allocating an opportunity among the Ares-advised funds, (v)&nbsp;potential conflicts of interests, (vi)&nbsp;the
nature of the investment or transaction, (vii)&nbsp;current and anticipated market and general economic conditions and (viii)&nbsp;existing
and prior positions in the obligor on the Fund&rsquo;s investments.The Adviser and the Fund recognize that in some cases this procedure
may adversely affect the size of the position obtainable for the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Expenses</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>The
Adviser</U>. The services of all investment professionals and staff of the Adviser, when and to the extent engaged in providing investment
advisory and management services hereunder, and the compensation and routine overhead expenses of such personnel allocable to such services,
will be provided and paid for by the Adviser and not by the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>The
Fund</U>. The Fund will bear all other costs, fees and expenses of its operations and transactions, including those relating to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;organization;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;calculation
of the Fund&rsquo;s net asset value (including the cost and expenses of any independent valuation firm, agent or other provider);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;expenses
incurred by the Adviser payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs
for the Fund and in monitoring the Fund&rsquo;s investments;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;interest
payable on indebtedness and dividends and distributions on preferred shares, as applicable, if any, incurred to finance the Fund&rsquo;s
investments;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;&#8239;offerings of the Fund&rsquo;s common shares and other securities (including, all fees, costs and
expenses related thereto);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;investment
advisory and management fees;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;fees
payable to third parties, including agents, legal counsel (including, without limitation, any 2019 committee or unsecured committee counsel),
consultants or other advisors, relating to, or associated with, evaluating and making investments;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;administrator,
transfer agent, custodian, investor support services and investor relation fees;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;federal
and state registration fees;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
costs of registration and listing the Fund&rsquo;s shares on any securities exchange;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;federal,
state and local taxes;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;independent
directors&rsquo; fees and expenses;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;costs
of preparing and filing reports or other documents required by governmental bodies (including the SEC), including printing costs;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;costs
of any reports, proxy statements or other notices to shareholders, including printing costs;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xv)&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;&#8239;insurance premiums for fidelity bond and other insurance coverage, including the Fund&rsquo;s
allocable portion of the fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance
premium;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;direct
costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent
auditors and outside legal costs;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;brokerage
commissions, assignment fees and other costs in connection with the purchase, holding or sale of securities and other investment instruments
(including, without limitation, security settlement costs);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xviii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;costs
incurred to implement and monitor agreements governing the Fund&rsquo;s financing or borrowing facilities and costs associated with issuances
of preferred shares and ongoing related expenses;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;such
unusual, non-recurring or extraordinary expenses as may arise, including those relating to actions, suits or proceedings to which the
Fund is a party and legal obligations that the Fund may have to indemnify the Fund&rsquo;s directors, officers and/or employees or agents
with respect to these actions, suits or proceedings;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xx)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
other expenses incidental to holding meetings of the Fund&rsquo;s shareholders, including proxy solicitations therefor; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xxi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
other expenses incurred by the Fund in connection with administering the Fund&rsquo;s business (including the reimbursements contemplated
by the last paragraph of this Section&nbsp;5).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It also is understood and
agreed that if persons associated with the Adviser or any of its affiliates, including persons who are officers of the Fund, provide
accounting, legal, clerical or administrative services to the Fund at the request of the Fund, the Fund will reimburse the Adviser and
its affiliates for their costs in providing such accounting, legal, clerical or administrative services to the Fund (which costs may
include an allocation of overhead including rent and the allocable portion of the salaries and benefits of the relevant persons and their
respective staffs, including travel expenses), using a methodology for determining costs approved by the Board. provided, however, that
no such reimbursements shall be payable by the Fund in respect of costs of the Adviser or its affiliates incurred in any of the first
two fiscal years of the Fund&rsquo;s operations. Nothing contained herein shall be construed to restrict the Fund&rsquo;s right to hire
its own employees or to contract for services to be performed by third parties.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><B>Compensation</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the services rendered
and the expenses assumed by the Adviser, the Fund shall pay to the Adviser at the end of each calendar month a fee at the annual rate
of 1.0% of the average daily value of the Fund&rsquo;s Managed Assets. &ldquo;Managed Assets&rdquo; means the total assets of the Fund
(including any assets attributable to any preferred shares that may be issued or to indebtedness) minus the Fund&rsquo;s liabilities other
than liabilities relating to indebtedness. The fee for the period from the Effective Date (defined below) of the Agreement to the end
of the month during which the Effective Date occurs will be prorated according to the proportion that such period bears to the full monthly
period. Upon any termination of this Agreement before the end of a month, the fee for such part of that month will be prorated according
to the proportion that such period bears to the full monthly period and will be payable upon the date of termination of this Agreement.For
the purpose of determining fees payable to the Adviser, the value of the Fund&rsquo;s assets will be computed at the times and in the
manner specified in the Registration Statement, and on days on which the value of Fund assets are not so determined, the asset value computation
to be used will be as determined on the immediately preceding day on which the assets were determined. The Adviser shall also be entitled
to reimbursement of its costs for providing to the Fund accounting, legal, clerical or administrative services as provided in Section&nbsp;5
hereof. The Adviser may elect from time to time, in its sole discretion, to waive its right to reimbursement or its receipt of the advisory
fee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><B>Services
                                            to Other Companies or Accounts</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund understands that
the Adviser and its affiliates now act, will continue to act and may act in the future as investment manager or adviser to fiduciary
and other managed accounts, and as an investment manager or adviser to other investment companies that have the same, similar or different
investment objectives and strategies as the Fund, including any offshore entities or private accounts. The Fund understands that the
persons employed by the Adviser to assist in the performance of the Adviser&rsquo;s duties under this Agreement may not devote their
full time to such service, and that nothing contained in this Agreement will be deemed to limit or restrict the right of the Adviser
to engage in and devote time and attention to other businesses or to render services of whatever kind or nature. This Agreement will
not in any way limit or restrict the Adviser or any of its directors, officers, employees, or agents from buying, selling or trading
any securities or other investment instruments for its or their own account or for the account of others for whom it or they may be acting,
provided that such activities will not adversely affect or otherwise impair the performance by the Adviser of its duties and obligations
under this Agreement. The Adviser and the Fund understand that directors, officers, employees and shareholder of the Fund are or may
become interested in the Adviser and its affiliates, as directors, officers, employees, partners, shareholders, members, managers or
otherwise, and that the Adviser and directors, officers, employees, partners, shareholders, members and managers of the Adviser and its
affiliates are or may become similarly interested in the Fund as shareholders or otherwise. If any person who is a member, manager, partner,
officer or employee of the Adviser is or becomes a director, officer and/or employee of the Fund and acts as such in any business of
the Fund, then such member, manager, partner, officer and/or employee of the Adviser shall be deemed to be acting in such capacity solely
for the Fund, and not as a manager, partner, officer or employee of the Adviser or under the control or direction of the Adviser, even
if paid by the Adviser.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><B>Custody</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing in this Agreement
will require the Adviser to take or receive physical possession of cash, securities, or other investments of the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD STYLE="text-align: justify"><B>Term of Agreement; Termination of Agreement; Amendment of Agreement</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
This Agreement will become effective November&nbsp; 30, 2012 (the &ldquo;Effective Date&rdquo;), and, unless terminated in accordance
with its terms, will remain in effect for two years and will renew for successive annual periods thereafter if approved at least annually
by the Board of Directors or by the affirmative vote of the holders of a majority of the outstanding shares of the Fund, including, in
either case, a majority vote of those directors of the Fund who are not parties to this Agreement or &ldquo;interested persons&rdquo;
of any party to this Agreement cast in person at a meeting called for the purpose of voting on the Agreement&rsquo;s approval.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement may be terminated, without penalty, (i)&nbsp;by the Board or by vote of holders of a majority of the outstanding shares
of the Fund upon sixty (60) days&rsquo; written notice to the Adviser, and (ii)&nbsp;by the Adviser upon sixty (60) days&rsquo; written
notice to the Fund. This Agreement also will terminate automatically in the event of its assignment by the Adviser. The provisions of
Section&nbsp;12 of this Agreement shall remain in full force and effect, and the Adviser shall remain entitled to the benefits thereof,
notwithstanding any termination of this Agreement. Further, notwithstanding the termination or expiration of this Agreement as aforesaid,
the Adviser shall be entitled to any amounts owed under Section&nbsp;6 through the date of termination or expiration and Section&nbsp;12
shall continue in full force and effect and apply to the Adviser and its representatives as and to the extent applicable.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Agreement may be amended by written agreement executed by all the parties hereto only if the amendment is specifically approved by:
(i)&nbsp;a majority vote of those directors of the Fund who are not parties to this Agreement or &ldquo;interested persons&rdquo; of any
party to this Agreement cast in person at a meeting called for the purpose of voting on the Agreement&rsquo;s approval; and (ii)&nbsp;if
required by applicable law, the vote of a majority of the outstanding shares of the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD STYLE="text-align: justify"><B>Representations and Covenants of the Fund</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund represents and covenants
to the Adviser as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund is duly organized and validly existing under the laws of the State of Maryland with the power to own and possess its assets.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution, delivery and performance by the Fund of this Agreement are within the Fund&rsquo;s powers and have been duly authorized by
all necessary actions of the Board, and the execution, delivery and performance of this Agreement by the parties to this Agreement do
not contravene or constitute a default under (i)&nbsp;any provision of applicable law, rule&nbsp;or regulation, (ii)&nbsp;the Fund&rsquo;s
governing instruments, or (iii)&nbsp;any agreement, judgment, injunction, order, decree or other instruments binding upon the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund is, or will be prior to commencing operations, registered as a closed-end management investment company under the Investment Company
Act and the Fund&rsquo;s shares are, or will be prior to commencing operations, registered under the Securities Act of 1933, as amended,
and under any applicable state securities laws.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD STYLE="text-align: justify"><B>Representations and Covenants of the Adviser</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Adviser represents and covenants to the Fund
that as of the commencement of operations of the Fund:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser is duly organized and validly existing under the laws of the State of Delaware with the power to own and possess its assets.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution, delivery and performance by the Adviser of this Agreement are within the Adviser&rsquo;s powers and have been duly authorized
by all necessary action, and no action by or in respect of, or filing with, any governmental body, agency or official is required on the
part of the Adviser for the execution, delivery and performance of this Agreement by the parties to this Agreement, and the execution,
delivery and performance of this Agreement by the parties to this Agreement do not contravene or constitute a default under (i)&nbsp;any
provision of applicable law, rule&nbsp;or regulation, (ii)&nbsp;the Adviser&rsquo;s governing instruments, or (iii)&nbsp;any agreement,
judgment, injunction, order, decree or other instruments binding upon the Adviser.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser is not prohibited by the Investment Company Act or the Advisers Act from performing the services contemplated by this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Adviser is registered with the SEC as an investment adviser under the Advisers Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.</B></TD><TD STYLE="text-align: justify"><B>Indemnification</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Adviser, its members and their respective
officers, managers, partners, agents, employees, controlling persons, members and any other person affiliated with any of them (collectively,
the &ldquo;Indemnified Parties&rdquo;), shall not be liable to the Fund for any action taken or omitted to be taken by the Adviser in
connection with the performance of any of its duties or obligations under this Agreement or otherwise as an investment adviser of the
Fund, except to the extent specified in Section&nbsp;36(b)&nbsp;of the Investment Company Act concerning loss resulting from a breach
of fiduciary duty (as the same is finally determined by judicial proceedings) with respect to the receipt of compensation for services.
The Fund shall indemnify, defend and protect the Indemnified Parties (each of whom shall be deemed a third party beneficiary hereof)
and hold them harmless from and against all damages, liabilities, costs and expenses (including reasonable attorneys&rsquo; fees and
amounts reasonably paid in settlement) incurred by the Indemnified Parties in or by reason of any pending, threatened or completed action,
suit, investigation or other proceeding (including an action or suit by or in the right of the Fund or its security holders) arising
out of or otherwise based upon the performance of any of the Adviser&rsquo;s duties or obligations under this Agreement or otherwise
as an investment adviser of the Fund. Notwithstanding the foregoing provisions of this Section&nbsp;12 to the contrary, nothing contained
herein shall protect or be deemed to protect the Indemnified Parties against or entitle or be deemed to entitle the Indemnified Parties
to indemnification in respect of, any liability to the Fund or its security holders to which the Indemnified Parties would otherwise
be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of any Indemnified Party&rsquo;s duties
or by reason of the reckless disregard of the Adviser&rsquo;s duties and obligations under this Agreement (as the same shall be determined
in accordance with the Investment Company Act and any interpretations or guidance by the SEC or its staff thereunder).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.</B></TD><TD STYLE="text-align: justify"><B>Records</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Maintenance
of Records</U>. The Adviser hereby undertakes and agrees to maintain for the Fund, in the form and for the period required by Rule&nbsp;31a-2
under the Investment Company Act, all records relating to the Fund&rsquo;s investments that are required to be maintained by the Fund
pursuant to the Investment Company Act with respect to the Adviser&rsquo;s responsibilities under this Agreement (the &ldquo;Fund&rsquo;s
Books and Records&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership
of Records</U>. The Adviser agrees that the Fund&rsquo;s Books and Records are the Fund&rsquo;s property and further agrees to surrender
them promptly to the Fund upon the request of the Fund; <U>provided</U>, however, that the Adviser may retain copies of the Fund&rsquo;s
Books and Records at its own cost. The Fund&rsquo;s Books and Records will be made available, within two (2)&nbsp;business days of a written
request, to the Fund&rsquo;s accountants or auditors during regular business hours at the Adviser&rsquo;s offices. The Fund or its authorized
representatives will have the right to copy any records in the Adviser&rsquo;s possession that pertain to the Fund. These books, records,
information, or reports will be made available to properly authorized government representatives consistent with state and federal law
and/or regulations. In the event of the termination of this Agreement, the Fund&rsquo;s Books and Records will be returned to the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.</B></TD><TD STYLE="text-align: justify"><B>Governing Law</B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement will be governed by, construed
under and interpreted and enforced in accordance with the laws of the state of New York, without regard to principles of conflicts of
laws of any jurisdiction to the contrary and the applicable provisions of the Investment Company Act, if any. The parties unconditionally
and irrevocably consent to the exclusive jurisdiction of the courts located in the State of New York and waive any objection with respect
thereto, for the purpose of any action, suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="text-align: justify"><B>No
                                            Waiver</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The failure of either party
to enforce at any time for any period the provisions of or any rights deriving from this Agreement shall not be construed to be a waiver
of such provisions or rights or the right of such party thereafter to enforce such provisions, and no waiver shall be binding unless executed
in writing by all parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.</B></FONT></TD><TD STYLE="text-align: justify"><B>Severability</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any provision of this Agreement
is held or made invalid by a court decision, statute, rule, or otherwise, the remainder of this Agreement shall not be affected thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.</B></FONT></TD><TD STYLE="text-align: justify"><B>Headings</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The descriptive headings contained
in this Agreement are for convenience of reference only and shall not affect in any way the meaning or interpretation of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.</B></FONT></TD><TD STYLE="text-align: justify"><B>Definitions</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms &ldquo;assignment,&rdquo;
 &ldquo;affiliated person,&rdquo; and &ldquo;interested person,&rdquo; when used in this Agreement, will have the respective meanings specified
in Section&nbsp;2(a)&nbsp;of the Investment Company Act. The term &ldquo;majority of the outstanding shares&rdquo; means the lesser of
(a)&nbsp;sixty-seven percent (67%) or more of the shares present at a meeting if more than fifty percent (50%) of the outstanding shares
are present or represented by proxy, or (b)&nbsp;more than fifty percent (50%) of the outstanding shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.</B></FONT></TD><TD STYLE="text-align: justify"><B>Notices</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All notices, requests, claims,
demands and other communications hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly given
or made upon receipt) by delivery in person, by overnight courier service (with signature required), by facsimile, e-mail, or by registered
or certified mail (postage prepaid, return receipt requested) to the respective parties at their respective principal executive office
addresses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20.</B></FONT></TD><TD STYLE="text-align: justify"><B>Entire
Agreement</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement constitutes
the entire agreement of the parties with respect to the subject matter hereof and supersedes all prior agreements and undertakings, both
written and oral, between the parties with respect to such subject matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21.</B></FONT></TD><TD STYLE="text-align: justify"><B>Counterparts</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be executed
in one or more counterparts, each of which will be deemed an original, and all of such counterparts together will constitute one and the
same instrument.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Remainder of Page&nbsp;Intentionally Left Blank]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B></FONT> the parties to this Agreement have executed and delivered this Agreement as of the date first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.</B></FONT></TD>
</TR>
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel J. Hall</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR>
  <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD>
</TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES CAPITAL MANAGEMENT II LLC</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel Nguyen</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel Nguyen</FONT></TD></TR>
  <TR>
  <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President, Chief Financial Officer and Treasurer</FONT></TD>
</TR>
</TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">** <I>Signature Page to
Investment Advisory and Management Agreement</I> **</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(J)
<SEQUENCE>5
<FILENAME>tm2416373d4_ex99-xj.htm
<DESCRIPTION>EXHIBIT 99.(J)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xj.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(j)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution copy</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B><U>Master
Custodian Agreement</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
Agreement is made as of November&nbsp;30, 2012 by and among each management investment company identified on Appendix A hereto (each
such investment company and each management investment company made subject to this Agreement in accordance with Section&nbsp;19.5 below,
shall hereinafter be referred to as a &ldquo;<B><I>Fund</I></B>&rdquo;), and STATE STREET BANK AND TRUST COMPANY, a Massachusetts trust
company (the &ldquo;<B><I>Custodian</I></B>&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><I>Wi<B>tnesseth:</B></I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Whereas</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
</FONT></B><FONT STYLE="font-size: 10pt">each Fund may or may not be authorized to issue shares of common stock or shares of beneficial
interest in separate series (&ldquo;<B><I>Shares</I></B>&rdquo;), with each such series representing interests in a separate portfolio
of securities and other assets;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Whereas</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
</FONT></B><FONT STYLE="font-size: 10pt">each Fund so authorized intends that this Agreement be applicable to each of its series set
forth on Appendix A hereto (such series together with all other series subsequently established by the Fund and made subject to this
Agreement in accordance with Section&nbsp;19.6 below, shall hereinafter be referred to as the &ldquo;<B><I>Portfolio(s)</I></B>&rdquo;);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Whereas</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
</FONT></B><FONT STYLE="font-size: 10pt">each Fund not so authorized intends that this Agreement be applicable to it and all references
hereinafter to one or more &ldquo;Portfolio(s)&rdquo; shall be deemed to refer to such Fund(s); and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Now,
Therefore</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT></B><FONT STYLE="font-size: 10pt">in
consideration of the mutual</FONT> covenants and agreements hereinafter contained, the parties hereto agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Section&nbsp;1.</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Employment
of Custodian and Property to be Held by It</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Fund hereby employs the Custodian as the
custodian of assets of the Portfolios, including securities which the Fund, on behalf of the applicable Portfolio, desires to be held
in places within the United States (&ldquo;<B><I>domestic securities</I></B>&rdquo;) and securities it desires to be held outside the
United States (&ldquo;<B><I>foreign securities</I></B>&rdquo;). Each Fund, on behalf of its Portfolio(s), agrees to deliver to the Custodian
all securities and cash of the Portfolios, and all payments of income, payments of principal or capital distributions received by it
with respect to all securities owned by the Portfolio(s)&nbsp;from time to time, and the cash consideration received by it for such Shares
as may be issued or sold from time to time. The Custodian shall not be responsible for any property of a Portfolio which is not received
by it or which is delivered out in accordance with Proper Instructions (as such term is defined in Section&nbsp;8 hereof) including,
without limitation, Portfolio property (i)&nbsp;held by brokers, private bankers or other entities on behalf of the Portfolio (each a
 &ldquo;<B><I>Local Agent</I></B>&rdquo;), (ii)&nbsp;held by Special Sub-Custodians (as such term is defined in Section&nbsp;6 hereof),
(iii)&nbsp;held by entities which have advanced monies to or on behalf of the Portfolio and which have received Portfolio property as
security for such advance(s)&nbsp;(each a &ldquo;<B><I>Pledgee</I></B>&rdquo;), or (iv)&nbsp;delivered or otherwise removed from the
custody of the Custodian (a)&nbsp;in connection with any Free Trade (as such term is defined in Sections 2.2(14) and 2.6(7)&nbsp;hereof)
or (b)&nbsp;pursuant to Special Instructions (as such term is defined in Section&nbsp;8 hereof). With respect to uncertificated shares
(the &ldquo;<B><I>Underlying Shares</I></B>&rdquo;) of registered &ldquo;investment companies&rdquo; (as defined in Section&nbsp;3(a)(1)&nbsp;of
the Investment Company Act of 1940, as amended (the &ldquo;<B><I>1940 Act</I></B>&rdquo;)), whether in&#8239;the same &ldquo;group of investment
companies&rdquo; (as defined in Section&nbsp;12(d)(1)(G)(ii)&nbsp;of the 1940 Act) or otherwise, including pursuant to Section&nbsp;12(d)(1)(F)&nbsp;of
the 1940 Act (hereinafter sometimes referred to as the &ldquo;<B><I>Underlying Portfolios</I></B>&rdquo;) the holding of confirmation
statements that identify the shares as being recorded in the Custodian&rsquo;s name on behalf of the Portfolios will be deemed custody
for purposes hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon receipt of Proper Instructions, the Custodian
shall on behalf of the applicable Portfolio(s)&nbsp;from time to time employ one or more sub-custodians located in the United States,
but only in accordance with an applicable vote by the Board of Trustees or the Board of Directors of the Fund (as appropriate, and in
each case, the &ldquo;<B><I>Board</I></B>&rdquo;) on behalf of the applicable Portfolio(s), and provided that the Custodian shall have
no more or less responsibility or liability to any Fund on account of any actions or omissions of any sub-custodian so employed than any
such sub-custodian has to the Custodian. The Custodian may place and maintain each Fund&rsquo;s foreign securities with foreign banking
institution sub-custodians employed by the Custodian and/or foreign securities depositories, all as designated in Schedules A and B hereto,
but only in accordance with the applicable provisions of Sections 3 and 4 hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Duties
of the Custodian with Respect to Property of the Portfolios to be Held in the United States</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Holding
Securities</U></FONT>. The Custodian shall hold and physically segregate for the account of each Portfolio all non-cash property, to
be held by it in the United States, including all domestic securities owned by such Portfolio other than (a)&nbsp;securities which are
maintained pursuant to Section&nbsp;2.8 in a clearing agency which acts as a securities depository or in a book-entry system authorized
by the U.S. Department of the Treasury (each, a &ldquo;<B><I>U.S. Securities System</I></B>&rdquo;) and (b)&nbsp;Underlying Shares owned
by each Fund which are maintained pursuant to Section&nbsp;2.10 hereof in an account with State Street Bank and Trust Company or such
other entity which may from time to time act as a transfer agent for the Underlying Portfolios and with respect to which the Custodian
is provided with Proper Instructions (the &ldquo;<B><I>Underlying Transfer Agent</I></B>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Securities</U></FONT>. The Custodian shall release and deliver domestic securities owned by a Portfolio held by the Custodian, in
a U.S. Securities System account of the Custodian or in an account at the Underlying Transfer Agent, only upon receipt of Proper Instructions
on behalf of the applicable Portfolio, which may be continuing instructions when deemed appropriate by the parties, and only in the following
cases:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1)</TD><TD STYLE="text-align: justify">Upon sale of such securities for the account of the Portfolio in accordance with customary or established
market practices and procedures, including, without limitation, delivery to the purchaser thereof or to a dealer therefor (or an agent
of such purchaser or dealer) against expectation of receiving later payment;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2)</TD><TD STYLE="text-align: justify">Upon the receipt of payment in connection with any repurchase agreement related to such securities entered
into by the Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3)</TD><TD STYLE="text-align: justify">In the case of a sale effected through a U.S. Securities System, in accordance with the provisions of
Section&nbsp;2.8 hereof;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4)</TD><TD STYLE="text-align: justify">To the depository agent in connection with tender or other similar offers for securities of the Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5)</TD><TD STYLE="text-align: justify">To the issuer thereof or its agent when such securities are called, redeemed, retired or otherwise become
payable; provided that, in any such case, the cash or other consideration is to be delivered to the Custodian;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6)</TD><TD STYLE="text-align: justify">To the issuer thereof, or its agent, for transfer into the name of the Portfolio or into the name of any
nominee or nominees of the Custodian or into the name or nominee name of any agent appointed pursuant to Section&nbsp;2.7 or into the
name or nominee name of any sub-custodian appointed pursuant to Section&nbsp;1; or for exchange for a different number of bonds, certificates
or other evidence representing the same aggregate face amount or number of units; provided that, in any such case, the new securities
are to be delivered to the Custodian;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7)</TD><TD STYLE="text-align: justify">Upon the sale of such securities for the account of the Portfolio, to the broker or its clearing agent,
against a receipt, for examination in accordance with &ldquo;street delivery&rdquo; custom; provided that in any such case, the Custodian
shall have no responsibility or liability for any loss arising from the delivery of such securities prior to receiving payment for such
securities except as may arise from the Custodian&rsquo;s own negligence, bad faith or willful misconduct;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8)</TD><TD STYLE="text-align: justify">For exchange or conversion pursuant to any plan of merger, consolidation, recapitalization, reorganization
or readjustment of the securities of the issuer of such securities, or pursuant to provisions for conversion contained in such securities,
or pursuant to any deposit agreement; provided that, in any such case, the new securities and cash, if any, are to be delivered to the
Custodian;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9)</TD><TD STYLE="text-align: justify">In the case of warrants, rights or similar securities, the surrender thereof in the exercise of such warrants,
rights or similar securities or the surrender of interim receipts or temporary securities for definitive securities; provided that, in
any such case, the new securities and cash, if any, are to be delivered to the Custodian;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10)</TD><TD STYLE="text-align: justify">For delivery in connection with any loans of securities made by the Portfolio (a)&nbsp;against receipt
of collateral as agreed from time to time by the Fund on behalf of the Portfolio, except that in connection with any loans for which collateral
is to be credited to the Custodian&rsquo;s account in the book-entry system authorized by the U.S. Department of the Treasury, the Custodian
will not be held liable or responsible for the delivery of securities owned by the Portfolio prior to the receipt of such collateral or
(b)&nbsp;to the lending agent, or the lending agent&rsquo;s custodian, in accordance with written Proper Instructions (which may not provide
for the receipt by the Custodian of collateral therefor) agreed upon from time to time by the Custodian and the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">11)</TD><TD STYLE="text-align: justify">For delivery as security in connection with any borrowing by a Fund on behalf of a Portfolio requiring
a pledge of assets by the Fund on behalf of such Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">12)</TD><TD STYLE="text-align: justify">For delivery in accordance with the provisions of any agreement among the Fund on behalf of the Portfolio,
the Custodian and a broker-dealer registered under the Securities Exchange Act of 1934 (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;)
and a member of the Financial Industry Regulatory Authority,&nbsp;Inc. (&ldquo;<B><I>FINRA</I></B>,&rdquo; formerly known as The National
Association of Securities Dealers,&nbsp;Inc.), relating to compliance with the rules&nbsp;of The Options Clearing Corporation and of any
registered national securities exchange, or of any similar organization or organizations, regarding escrow or other arrangements in connection
with transactions by the Fund on behalf of a Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">13)</TD><TD STYLE="text-align: justify">For delivery in accordance with the provisions of any agreement among a Fund on behalf of the Portfolio,
the Custodian, and a futures commission merchant registered under the Commodity Exchange Act, relating to compliance with the rules&nbsp;of
the Commodity Futures Trading Commission (the &ldquo;<B><I>CFTC</I></B>&rdquo;) and/or any contract market, or any similar organization
or organizations, regarding account deposits in connection with transactions by the Fund on behalf of a Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">14)</TD><TD STYLE="text-align: justify">Upon the sale or other delivery of such investments (including, without limitation, to one or more (a)&nbsp;Special
Sub-Custodians or (b)&nbsp;additional custodians appointed by the Fund, and communicated to the Custodian from time to time via a writing
duly executed by an authorized officer of the Fund, for the purpose of engaging in repurchase agreement transactions(s), each a &ldquo;<B><I>Repo
Custodian</I></B>&rdquo;), and prior to receipt of payment therefor, as set forth in written Proper Instructions (such delivery in advance
of payment, along with payment in advance of delivery made in accordance with Section&nbsp;2.6(7), as applicable, shall each be referred
to herein as a &ldquo;<B><I>Free Trade</I></B>&rdquo;), provided that such Proper Instructions shall set forth (a)&nbsp;the securities
of the Portfolio to be delivered and (b)&nbsp;the person(s)&nbsp;to whom delivery of such securities shall be made;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15)</TD><TD STYLE="text-align: justify">Upon receipt of instructions from the Fund&rsquo;s transfer agent (the &ldquo;<B><I>Transfer Agent</I></B>&rdquo;)
for delivery to such Transfer Agent or to the holders of Shares in connection with distributions in kind, as may be described from time
to time in the currently effective prospectus and statement of additional information of the Fund related to the Portfolio (the &ldquo;<B><I>Prospectus</I></B>&rdquo;),
in satisfaction of requests by holders of Shares for repurchase or redemption;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">16)</TD><TD STYLE="text-align: justify">In the case of a sale processed through the Underlying Transfer Agent of Underlying Shares, in accordance
with Section&nbsp;2.10 hereof;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">17)</TD><TD STYLE="text-align: justify">For delivery as initial or variation margin in connection with futures or options on futures contracts
entered into by the Fund on behalf of the Portfolio; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">18)</TD><TD STYLE="text-align: justify">For any other purpose, but only upon receipt of Proper Instructions from the Fund on behalf of the applicable
Portfolio specifying (a)&nbsp;the securities of the Portfolio to be delivered and (b)&nbsp;the person or persons to whom delivery of such
securities shall be made.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
of Securities</U></FONT>. Domestic securities held by the Custodian (other than bearer securities) shall be registered in the name of
the Portfolio or in the name of any nominee of a Fund on behalf of the Portfolio or of any nominee of the Custodian which nominee shall
be assigned exclusively to the Portfolio, unless the Fund has authorized in writing the appointment of a nominee to be used in common
with other registered management investment companies having the same investment adviser as the Portfolio, or in the name or nominee
name of any agent appointed pursuant to Section&nbsp;2.7 or in the name or nominee name of any sub-custodian appointed pursuant to Section&nbsp;1.
All securities accepted by the Custodian on behalf of the Portfolio under the terms of this Agreement shall be in &ldquo;street name&rdquo;
or other good delivery form. If, however, a Fund directs the Custodian to maintain securities in &ldquo;street name&rdquo;, the Custodian
shall utilize its best efforts only to timely collect income due the Fund on such securities and to notify the Fund on a best efforts
basis only of relevant corporate actions including, without limitation, pendency of calls, maturities, tender or exchange offers.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Bank
Accounts</U></FONT>. The Custodian shall open and maintain a separate bank account or accounts in the United States in the name of each
Portfolio of each Fund, subject only to draft or order by the Custodian acting pursuant to the terms of this Agreement, and shall hold
in such account or accounts, subject to the provisions hereof, all monies received by it from or for the account of the Portfolio, other
than cash maintained by the Portfolio in a bank account established and used in accordance with Rule&nbsp;17f-3 under the 1940 Act. Monies
held by the Custodian for a Portfolio may be deposited by it to its credit as Custodian in the banking department of the Custodian or
in such other banks or trust companies as it may in its discretion deem necessary or desirable; provided, however, that every such bank
or trust company shall be qualified to act as a custodian under the 1940 Act and that each such bank or trust company and the monies
to be deposited with each such bank or trust company shall on behalf of each applicable Portfolio be approved by vote of a majority of
the Board. Such monies shall be deposited by the Custodian in its capacity as Custodian and shall be withdrawable by the Custodian only
in that capacity.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Collection
of Income</U></FONT>. Except with respect to Portfolio property released and delivered pursuant to Section&nbsp;2.2(14) or purchased
pursuant to Section&nbsp;2.6(7), and subject to the provisions of Section&nbsp;2.3, the Custodian shall collect on a timely basis all
income and other payments with respect to registered domestic securities held hereunder to which each Portfolio shall be entitled either
by law or pursuant to custom in the securities business, and shall collect on a timely basis all income and other payments with respect
to bearer domestic securities if, on the date of payment by the issuer, such securities are held by the Custodian or its agent. Without
limiting the generality of the foregoing, the Custodian shall detach and present for payment all coupons and other income items requiring
presentation as and when they become due and shall collect interest when due on securities held hereunder. The Custodian shall credit
income to the Portfolio as such income is received or in accordance with the Custodian&rsquo;s then current payable date income schedule.
Any credit to the Portfolio in advance of receipt may be reversed when the Custodian determines that payment will not occur in due course
and the Portfolio may be charged at the Custodian&rsquo;s applicable rate for time credited. Income due each Portfolio on securities
loaned pursuant to the provisions of Section&nbsp;2.2 (10)&nbsp;shall be the responsibility of the applicable Fund. The Custodian will
have no duty or responsibility in connection therewith, other than to provide the Fund with such information or data as may be necessary
to assist the Fund in arranging for the timely delivery to the Custodian of the income to which the Portfolio is properly entitled.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Portfolio Monies</U></FONT>. The Custodian shall pay out monies of a Portfolio as provided in Section&nbsp;5 and otherwise upon receipt
of Proper Instructions on behalf of the applicable Portfolio, which may be continuing instructions when deemed appropriate by the parties,
the Custodian shall pay out monies of a Portfolio in the following cases only:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1)</TD><TD STYLE="text-align: justify">Upon the purchase of domestic securities, options, futures contracts or options on futures contracts for
the account of the Portfolio but only (a)&nbsp;in accordance with customary or established market practices and procedures, including,
without limitation, delivering money to the seller thereof or to a dealer therefor (or an agent for such seller or dealer) against expectation
of receiving later delivery of such securities or evidence of title to such options, futures contracts or options on futures contracts
to the Custodian (or any bank, banking firm or trust company doing business in the United States or abroad which is qualified under the
1940 Act to act as a custodian and has been designated by the Custodian as its agent for this purpose) registered in the name of the Portfolio
or in the name of a nominee of the Custodian referred to in Section&nbsp;2.3 hereof or in proper form for transfer; (b)&nbsp;in the case
of a purchase effected through a U.S. Securities System, in accordance with the conditions set forth in Section&nbsp;2.8 hereof; (c)&nbsp;in
the case of a purchase of Underlying Shares, in accordance with the conditions set forth in Section&nbsp;2.10 hereof; (d)&nbsp;in the
case of repurchase agreements entered into between the applicable Fund on behalf of a Portfolio and the Custodian, or another bank, or
a broker-dealer which is a member of FINRA, (i)&nbsp;against delivery of the securities either in certificate form or through an entry
crediting the Custodian&rsquo;s account at the Federal Reserve Bank with such securities or (ii)&nbsp;against delivery of the receipt
evidencing purchase by the Portfolio of securities owned by the Custodian along with written evidence of the agreement by the Custodian
to repurchase such securities from the Portfolio; or (e)&nbsp;for transfer to a time deposit account of the Fund in any bank, whether
domestic or foreign; such transfer may be effected prior to receipt of a confirmation from a broker and/or the applicable bank pursuant
to Proper Instructions from the Fund as defined herein;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2)</TD><TD STYLE="text-align: justify">In connection with conversion, exchange or surrender of securities owned by the Portfolio as set forth
in Section&nbsp;2.2 hereof;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3)</TD><TD STYLE="text-align: justify">For the redemption or repurchase of Shares issued as set forth in Section&nbsp;7 hereof;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4)</TD><TD STYLE="text-align: justify">For the payment of any expense or liability incurred by the Portfolio, including but not limited to the
following payments for the account of the Portfolio: interest, taxes, management, accounting, transfer agent and legal fees, and operating
expenses of the Fund whether or not such expenses are to be in whole or part
capitalized or treated as deferred expenses;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5)</TD><TD STYLE="text-align: justify">For the payment of any dividends on Shares declared pursuant to the Fund&rsquo;s articles of incorporation
or organization and by-laws or agreement or declaration of trust, as applicable, and Prospectus (collectively, &ldquo;<B><I>Governing
Documents</I></B>&rdquo;);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6)</TD><TD STYLE="text-align: justify">For payment of the amount of dividends received in respect of securities sold short;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7)</TD><TD STYLE="text-align: justify">Upon the purchase of domestic investments including, without limitation, repurchase agreement transactions
involving delivery of Portfolio monies to Repo Custodian(s), and prior to receipt of such investments, as set forth in written Proper
Instructions (such payment in advance of delivery, along with delivery in advance of payment made in accordance with Section&nbsp;2.2(14),
as applicable, shall each be referred to herein as a &ldquo;<B><I>Free Trade</I></B>&rdquo;), provided that such Proper Instructions shall
also set forth (a)&nbsp;the amount of such payment and (b)&nbsp;the person(s)&nbsp;to whom such payment is made;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8)</TD><TD STYLE="text-align: justify">For payment as initial or variation margin in connection with futures or options on futures contracts
entered into by the Fund on behalf of the Portfolio; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9)</TD><TD STYLE="text-align: justify">For any other purpose, but only upon receipt of Proper Instructions from the Fund on behalf of the Portfolio
specifying (a)&nbsp;the amount of such payment and (b)&nbsp;the person or persons to whom such payment is to be made.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Appointment
of Agents</U></FONT>. The Custodian may at any time or times in its discretion appoint (and may at any time remove) any other bank or
trust company which is itself qualified under the 1940 Act to act as a custodian, as its agent to carry out such of the provisions of
this Section&nbsp;2 as the Custodian may from time to time direct; provided, however, that the appointment of any agent shall not relieve
the Custodian of its responsibilities or liabilities hereunder. The Underlying Transfer Agent shall not be deemed an agent or sub-custodian
of the Custodian for purposes of this Section&nbsp;2.7 or any other provision of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deposit
of Fund Assets in U.S. Securities Systems</U></FONT>. The Custodian may deposit and/or maintain securities owned by a Portfolio in a
U.S. Securities System in compliance with the conditions of Rule&nbsp;17f-4 under the 1940 Act, as amended from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Segregated
Account</U></FONT>. The Custodian shall upon receipt of Proper Instructions on behalf of each applicable Portfolio, establish and maintain
a segregated account or accounts for and on behalf of each such Portfolio, into which account or accounts may be transferred cash and/or
securities, including securities maintained in an account by the Custodian pursuant to Section&nbsp;2.8 hereof, (a)&nbsp;in accordance
with the provisions of any agreement among the Fund on behalf of the Portfolio, the Custodian and a broker-dealer registered under the
Exchange Act and a member of FINRA (or any futures commission merchant registered under the Commodity Exchange Act), relating to compliance
with the rules&nbsp;of The Options Clearing Corporation and of any&#8239;registered national securities exchange (or the CFTC or any
registered contract market), or of any similar organization or organizations, regarding escrow or other arrangements in connection with
transactions by the Portfolio, (b)&nbsp;for purposes of segregating cash or government securities in connection with options purchased,
sold or written by the Portfolio or commodity futures contracts or options thereon purchased or sold by the Portfolio, (c)&nbsp;for the
purposes of compliance by the Portfolio with the procedures required by Investment Company Act Release No.&nbsp;10666, or any subsequent
release of the U.S. Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;), or interpretative opinion of the staff
of the SEC, relating to the maintenance of segregated accounts by registered management investment companies, and (d)&nbsp;for any other
purpose in accordance with Proper Instructions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deposit
of Fund Assets with the Underlying Transfer Agent</U></FONT>. Underlying Shares beneficially owned by the Fund, on behalf of a
Portfolio, shall be deposited and/or maintained in an account or accounts maintained with an Underlying Transfer Agent and the
Custodian&rsquo;s only responsibilities with respect thereto shall be limited to the following:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1)</TD><TD STYLE="text-align: justify">Upon receipt of a confirmation or statement from an Underlying Transfer Agent that such Underlying Transfer
Agent is holding or maintaining Underlying Shares in the name of the Custodian (or a nominee of the Custodian) for the benefit of a Portfolio,
the Custodian shall identify by book-entry that such Underlying Shares are being held by it as custodian for the benefit of such Portfolio.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2)</TD><TD STYLE="text-align: justify">In respect of the purchase of Underlying Shares for the account of a Portfolio, upon receipt of Proper
Instructions, the Custodian shall pay out monies of such Portfolio as so directed, and record such payment from the account of such Portfolio
on the Custodian&rsquo;s books and records.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3)</TD><TD STYLE="text-align: justify">In respect of the sale or redemption of Underlying Shares for the account of a Portfolio, upon receipt
of Proper Instructions, the Custodian shall transfer such Underlying Shares as so directed, record such transfer from the account of such
Portfolio on the Custodian&rsquo;s books and records and, upon the Custodian&rsquo;s receipt of the proceeds therefor, record such payment
for the account of such Portfolio on the Custodian&rsquo;s books and records.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Custodian shall not be liable to
the Fund for any loss or damage to the Fund or any Portfolio resulting from the maintenance of Underlying Shares with an Underlying Transfer
Agent except for losses resulting directly from the fraud, negligence or willful misconduct of the Custodian or any of its agents or of
any of its or their employees.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership
Certificates for Tax Purposes</U></FONT>. The Custodian shall execute ownership and other certificates and affidavits for all federal
and state tax purposes in connection with receipt of income or other payments with respect to domestic securities of each Portfolio held
by it and in connection with transfers of securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Proxies</U></FONT>.
Except with respect to Portfolio property released and delivered pursuant to Section&nbsp;2.2(14), or purchased pursuant to Section&nbsp;2.6(7),
the Custodian shall, with respect to the domestic securities held hereunder, cause to be promptly executed by the registered holder of
such securities, if the securities are registered otherwise than in the name of the Portfolio or a nominee of the Portfolio, all proxies,
without indication of the manner in which such proxies are to be voted, and shall promptly deliver to the Fund such proxies, all proxy
soliciting materials and all notices relating to such securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;2.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Communications
Relating to Portfolio Securities</U></FONT>. Except with respect to Portfolio property released and delivered pursuant to Section&nbsp;2.2(14),
or purchased pursuant to Section&nbsp;2.6(7), and subject to the provisions of Section&nbsp;2.3, the Custodian shall transmit promptly
to the applicable Fund for each Portfolio all written information (including, without limitation, pendency of calls and maturities of
domestic securities and expirations of rights in connection therewith and notices of exercise of call and put options written by the
Fund on behalf of the Portfolio and the maturity of futures contracts purchased or sold by the Fund on behalf of the Portfolio) received
by the Custodian from issuers of the securities being held for the Portfolio. With respect to tender or exchange offers, the Custodian
shall transmit promptly to the applicable Fund all written information received by the Custodian from issuers of the securities whose
tender or exchange is sought and from the party (or its agents) making the tender or exchange offer. The Custodian shall not be liable
for any untimely exercise of any tender, exchange or other right or power in connection with domestic securities or other property of
the Portfolios at any time held by it unless (i)&nbsp;the Custodian is in actual possession of such domestic securities or property and
(ii)&nbsp;the Custodian receives Proper Instructions with regard to the exercise of any such right or power, and both (i)&nbsp;and (ii)&nbsp;occur
at least three business days prior to the date on which the Custodian is to take action to exercise such right or power. The Custodian
shall also transmit promptly to the applicable Fund for each Portfolio all written information received by the Custodian regarding any
class action or other litigation in connection with Portfolio securities or other assets issued in the United States and then held, or
previously held, during the term of this Agreement by the Custodian for the account of the Fund for such Portfolio, including, but not
limited to, opt-out notices and proof-of-claim forms. For avoidance of doubt, upon and after the effective date of any termination of
this Agreement, with respect to a Fund or its Portfolio(s), as may be applicable, the Custodian shall have no responsibility to so transmit
any information under this Section&nbsp;2.13.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Provisions
Relating to Rules 17f-5 and 17f-7</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;3.1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U></FONT>.
As used throughout this Agreement, the capitalized terms set forth below shall have the indicated meanings:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&ldquo;<B><I>Country
Risk</I></B>&rdquo; means all factors reasonably related to the systemic risk of holding Foreign Assets in a particular country including,
but not limited to, such country&rsquo;s political environment, economic and financial infrastructure (including any Eligible Securities
Depository operating in the country), prevailing or developing custody and settlement practices, insolvency of a Foreign Sub-Custodian,
and laws and regulations applicable to the safekeeping and recovery of Foreign Assets held in custody in that country.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B><I>Eligible Foreign Custodian</I></B>&rdquo;
has the meaning set forth in section (a)(1)&nbsp;of Rule&nbsp;17f-5, including a majority-owned or indirect subsidiary of a U.S. Bank
(as defined in Rule&nbsp;17f-5), a bank holding company meeting the requirements of an Eligible Foreign Custodian (as set forth in Rule&nbsp;17f-5
or by other appropriate action of the SEC), or a foreign branch of a Bank (as defined in Section&nbsp;2(a)(5)&nbsp;of the 1940 Act) meeting
the requirements of a custodian under Section&nbsp;17(f)&nbsp;of the 1940 Act; the term does not include any Eligible Securities Depository.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Eligible Securities Depository</I></B>&rdquo; has the
meaning set forth in section (b)(1)&nbsp;of Rule&nbsp;17f-7.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B><I>Foreign Assets</I></B>&rdquo; means
any of the Portfolios&rsquo; investments (including foreign currencies) for which the primary market is outside the United States and
such cash and cash equivalents as are reasonably necessary to effect the Portfolios&rsquo; transactions in such investments.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Foreign Custody Manager</I></B>&rdquo; has the meaning
set forth in section (a)(3)&nbsp;of Rule&nbsp;17f-5.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Rule&nbsp;17f-5</I></B>&rdquo; means Rule&nbsp;17f-5 promulgated
under the 1940 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Rule&nbsp;17f-7</I></B>&rdquo; means Rule&nbsp;17f-7 promulgated
under the 1940 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;3.2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>the
Custodian as Foreign Custody Manager</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delegation
to the Custodian as Foreign Custody Manager</U></FONT>. Each Fund, by resolution adopted by its Board, hereby delegates to the Custodian,
subject to Section&nbsp;(b)&nbsp;of Rule&nbsp;17f-5, the responsibilities set forth in this Section&nbsp;3.2 with respect to Foreign
Assets of the Portfolios held outside the United States, and the Custodian hereby accepts such delegation as Foreign Custody Manager
with respect to the Portfolios.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Countries
Covered</U></FONT>. The Foreign Custody Manager shall be responsible for performing the delegated responsibilities defined below only
with respect to the countries and custody arrangements for each such country listed on Schedule A to this Agreement, which list of countries
may be amended from time to time by any Fund with the agreement of the Foreign Custody Manager. The Foreign Custody Manager shall list
on Schedule A the Eligible Foreign Custodians selected by the Foreign Custody Manager to maintain the assets of the Portfolios, which
Schedule A may be amended from time to time in the sole discretion of the Foreign Custody Manager. The Foreign Custody Manager will provide
amended versions of Schedule A in accordance with Section&nbsp;3.2.5 hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the receipt by the Foreign Custody Manager
of Proper Instructions to open an account or to place or maintain Foreign Assets in a country listed on Schedule A, and the fulfillment
by each Fund, on behalf of the applicable Portfolio(s), of the applicable account opening requirements for such country, the Foreign
Custody Manager shall be deemed to have been delegated by such Fund&rsquo;s Board on behalf of such Portfolio(s)&nbsp;responsibility
as Foreign Custody Manager with respect to that country and to have accepted such delegation. Execution of this Agreement by each Fund
shall be deemed to be a Proper Instruction to open an account, or to place or maintain Foreign Assets, in each country listed on Schedule
A. Following the receipt of Proper Instructions directing the Foreign&#8239;Custody Manager to close the account of a Portfolio with the Eligible
Foreign Custodian selected by the Foreign Custody Manager in a designated country, the delegation by the Board on behalf of such Portfolio
to the Custodian as Foreign Custody Manager for that country shall be deemed to have been withdrawn and the Custodian shall immediately
cease to be the Foreign Custody Manager with respect to such Portfolio with respect to that country.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Foreign Custody Manager may withdraw its acceptance
of delegated responsibilities with respect to a designated country upon written notice to the Fund. Thirty days (or such longer period
to which the parties agree in writing) after receipt of any such notice by the Fund, the Custodian shall have no further responsibility
in its capacity as Foreign Custody Manager to the Fund with respect to the country as to which the Custodian&rsquo;s acceptance of delegation
is withdrawn.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Scope
of Delegated Responsibilities</U></FONT>:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">(</FONT>a<FONT STYLE="font-variant: small-caps">)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Selection
of Eligible Foreign Custodians</U></FONT>. Subject to the provisions of this Section&nbsp;3.2, the Foreign Custody Manager may place
and maintain the Foreign Assets in the care of the Eligible Foreign Custodian selected by the Foreign Custody Manager in each country
listed on Schedule A, as amended from time to time. In performing its delegated responsibilities as Foreign Custody Manager to place
or maintain Foreign Assets with an Eligible Foreign Custodian, the Foreign Custody Manager shall determine that the Foreign Assets will
be subject to reasonable care, based on the standards applicable to custodians in the country in which the Foreign Assets will be held
by that Eligible Foreign Custodian, after considering all factors relevant to the safekeeping of such assets, including, without limitation
the factors specified in Rule&nbsp;17f-5(c)(1).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">(</FONT>b<FONT STYLE="font-variant: small-caps">)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contracts
With Eligible Foreign Custodians</U></FONT>. The Foreign Custody Manager shall determine that the contract governing the foreign custody
arrangements with each Eligible Foreign Custodian selected by the Foreign Custody Manager will satisfy the requirements of Rule&nbsp;17f-5(c)(2).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">(</FONT>c<FONT STYLE="font-variant: small-caps">)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Monitoring</U></FONT>.
In each case in which the Foreign Custody Manager maintains Foreign Assets with an Eligible Foreign Custodian selected by the Foreign
Custody Manager, the Foreign Custody Manager shall establish a system to monitor (i)&nbsp;the appropriateness of maintaining the Foreign
Assets with such Eligible Foreign Custodian and (ii)&nbsp;the contract governing the custody arrangements established by the Foreign
Custody Manager with the Eligible Foreign Custodian. In the event the Foreign Custody Manager determines that the custody arrangements
with an Eligible Foreign Custodian it has selected are no longer appropriate, the Foreign Custody Manager shall notify the Board in accordance
with Section&nbsp;3.2.5 hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Guidelines
for the Exercise of Delegated Authority</U></FONT>. For purposes of this Section&nbsp;3.2, the Board shall be deemed to have considered
and determined to accept such Country Risk as is incurred by placing and maintaining the Foreign Assets in each country for which the
Custodian is serving as Foreign Custody Manager of the Portfolios.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reporting
Requirements</U></FONT>. The Foreign Custody Manager shall report the withdrawal of the Foreign Assets from an Eligible Foreign Custodian
and the placement of such&#8239;Foreign Assets with another Eligible Foreign Custodian by providing to the Board an amended Schedule
A at the end of the calendar quarter in which an amendment to such Schedule has occurred. The Foreign Custody Manager shall make written
reports notifying the Board of any other material change in the foreign custody arrangements of the Portfolios described in this Section&nbsp;3.2
after the occurrence of the material change.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Standard
of&#8239;Care as Foreign Custody Manager of a Portfolio</U></FONT>. In performing the responsibilities delegated to it, the Foreign Custody
Manager agrees to exercise reasonable care, prudence and diligence such as a person having responsibility for the safekeeping of assets
of management investment companies registered under the 1940 Act would exercise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-variant: small-caps"><U>Representations
with Respect to Rule 17f-5</U></FONT>. The Foreign Custody Manager represents to each Fund that it is a U.S. Bank as defined in section
(a)(7)&nbsp;of Rule&nbsp;17f-5. Each Fund represents to the Custodian that its Board has determined that it is reasonable for such Board
to rely on the Custodian to perform the responsibilities delegated pursuant to this Agreement to the Custodian as the Foreign Custody
Manager of the Portfolios.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.2.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effective
Date and Termination of the Custodian as Foreign Custody Manager</U></FONT>. Each Board&rsquo;s delegation to the Custodian as Foreign
Custody Manager of the Portfolios shall be effective as of the date hereof and shall remain in effect until terminated at any time, without
penalty, by written notice from the terminating party to the non-terminating party. Termination will become effective thirty (30) days
after receipt by the non-terminating party of such notice. The provisions of Section&nbsp;3.2.2 hereof shall govern the delegation to
and termination of the Custodian as Foreign Custody Manager of the Portfolios with respect to designated countries.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Eligible
Securities Depositories</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Analysis
and Monitoring</U></FONT>. The Custodian shall (a)&nbsp;provide the Fund (or its duly-authorized investment manager or investment adviser)
with an analysis of the custody risks associated with maintaining assets with the Eligible Securities Depositories set forth on Schedule
B hereto in accordance with section (a)(1)(i)(A)&nbsp;of Rule&nbsp;17f-7, and (b)&nbsp;monitor such risks on a continuing basis, and
promptly notify the Fund (or its duly-authorized investment manager or investment adviser) of any material change in such risks, in accordance
with section (a)(1)(i)(B)&nbsp;of Rule&nbsp;17f-7.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">3.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Standard
of Care</U></FONT>. The Custodian agrees to exercise reasonable care, prudence and diligence in performing the duties set forth in Section&nbsp;3.3.1.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Duties
of the Custodian with Respect to Property of the Portfolios to be Held Outside the United States</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U></FONT>.
As used throughout this Agreement, the capitalized terms set forth below shall have the indicated meanings:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Foreign Securities System</I></B>&rdquo; means an Eligible
Securities Depository listed on Schedule B hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Foreign Sub-Custodian</I></B>&rdquo; means an Eligible
Foreign Custodian.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Holding
Securities</U></FONT>. The Custodian shall identify on its books as belonging to the Portfolios the foreign securities held by each Foreign
Sub-Custodian or Foreign Securities System. The Custodian may hold foreign securities for all of its customers, including the Portfolios,
with any Foreign Sub-Custodian in an account that is identified as belonging to the Custodian for the benefit of its customers, provided
however, that (i)&nbsp;the records of the Custodian with respect to foreign securities of the Portfolios which are maintained in such
account shall identify those securities as belonging to the Portfolios and (ii), to the extent required under applicable law or permitted
and customary in the market in which the account is maintained, the Custodian shall require that securities so held by the Foreign Sub-Custodian
be held separately from any assets of such Foreign Sub-Custodian or of other customers of such Foreign Sub-Custodian.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Foreign
Securities Systems</U></FONT>. Foreign securities shall be maintained in a Foreign Securities System in a designated country through
arrangements implemented by the Custodian or a Foreign Sub-Custodian, as applicable, in such country.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transactions
in Foreign Custody Account</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">4.4.1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Foreign Assets</U></FONT>. The Custodian or a Foreign Sub-Custodian shall release and deliver foreign securities of the Portfolios
held by the Custodian or such Foreign Sub-Custodian, or in a Foreign Securities System account, only upon receipt of Proper Instructions,
which may be continuing instructions when deemed appropriate by the parties, and only in the following cases:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Upon the sale of such foreign securities for the Portfolio in accordance with commercially reasonable
market practice in the country where such foreign securities are held or traded, including, without limitation: (A)&nbsp;delivery against
expectation of receiving later payment; or (B)&nbsp;in the case of a sale effected through a Foreign Securities System, in accordance
with the rules&nbsp;governing the operation of the Foreign Securities System;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">In connection with any repurchase agreement related to foreign securities;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">To the depository agent in connection with tender or other similar offers for foreign securities of the
Portfolios;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">To the issuer thereof or its agent when such foreign securities are called, redeemed, retired or otherwise
become payable;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">To the issuer thereof, or its agent, for transfer into the name of the Custodian (or the name of the respective
Foreign Sub-Custodian or of any nominee of the Custodian or such Foreign Sub-Custodian) or for exchange for a different number of bonds,&#8239;certificates or other evidence representing the
same aggregate face amount or number of units;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">To brokers, clearing banks or other clearing agents for examination or trade execution in accordance with
market custom; provided that in any such case, the Foreign Sub-Custodian shall have no responsibility or liability for any loss arising
from the delivery of such foreign securities prior to receiving payment for such foreign securities except as may arise from the Foreign
Sub-Custodian&rsquo;s own negligence or willful misconduct;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">For exchange or conversion pursuant to any plan of merger, consolidation, recapitalization, reorganization
or readjustment of the securities of the issuer of such securities, or pursuant to provisions for conversion contained in such securities,
or pursuant to any deposit agreement;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">In the case of warrants, rights or similar foreign securities, the surrender thereof in the exercise of
such warrants, rights or similar securities or the surrender of interim receipts or temporary securities for definitive securities;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ix)</TD><TD STYLE="text-align: justify">For delivery as security in connection with any borrowing by a Fund on behalf of a Portfolio requiring
a pledge of assets by the Fund on behalf of such Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">In connection with trading in options and futures contracts, including delivery as original margin and
variation margin;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xi)</TD><TD STYLE="text-align: justify">Upon the sale or other delivery of such foreign securities (including, without limitation, to one or more
Special Sub-Custodians or Repo Custodians) as a Free Trade, provided that applicable Proper Instructions shall set forth (A)&nbsp;the
foreign securities to be delivered and (B)&nbsp;the person or persons to whom delivery shall be made;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xii)</TD><TD STYLE="text-align: justify">In connection with the lending of foreign securities; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xiii)</TD><TD STYLE="text-align: justify">For any other purpose, but only upon receipt of Proper Instructions specifying (A)&nbsp;the foreign securities
to be delivered and (B)&nbsp;the person or persons to whom delivery of such securities shall be made.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">4.4.2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Portfolio Monies</U></FONT>. Upon receipt of Proper Instructions, which may be continuing instructions when deemed appropriate by
the parties, the Custodian shall pay out, or direct the respective Foreign Sub-Custodian or the respective Foreign Securities System
to pay out, monies of a Portfolio in the following cases only:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Upon the purchase of foreign securities for the Portfolio, unless otherwise directed by Proper Instructions,
by (A)&nbsp;delivering money to the seller thereof or to a dealer therefor (or an agent for such seller or dealer) against expectation
of receiving later&#8239;delivery of such foreign securities; or
(B)&nbsp;in the case of a purchase effected through a Foreign Securities System, in accordance with the rules&nbsp;governing the operation
of such Foreign Securities System;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">In connection with the conversion, exchange or surrender of foreign securities of the Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">For the payment of any expense or liability of the Portfolio, including but not limited to the following
payments: interest, taxes, investment advisory fees, transfer agency fees, fees under this Agreement, legal fees, accounting fees, and
other operating expenses;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">For the purchase or sale of foreign exchange or foreign exchange contracts for the Portfolio, including
transactions executed with or through the Custodian or its Foreign Sub-Custodians;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">In connection with trading in options and futures contracts, including delivery as original margin and
variation margin;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">Upon the purchase of foreign investments including, without limitation, repurchase agreement transactions
involving delivery of Portfolio monies to Repo Custodian(s), as a Free Trade, provided that applicable Proper Instructions shall set forth
(A)&nbsp;the amount of such payment and (B)&nbsp;the person or persons to whom payment shall be made;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">For payment of part or all of the dividends received in respect of securities sold short;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">In connection with the borrowing or lending of foreign securities; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ix)</TD><TD STYLE="text-align: justify">For any other purpose, but only upon receipt of Proper Instructions specifying (A)&nbsp;the amount of
such payment and (B)&nbsp;the person or persons to whom such payment is to be made.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-variant: small-caps">4.4.3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Market
Conditions</U></FONT>. Notwithstanding any provision of this Agreement to the contrary, settlement and payment for Foreign Assets received
for the account of the Portfolios and delivery of Foreign Assets maintained for the account of the Portfolios may be effected in accordance
with the customary established securities trading or processing practices and procedures in the country or market in which the transaction
occurs, including, without limitation, delivering Foreign Assets to the purchaser thereof or to a dealer therefor (or an agent for such
purchaser or dealer) with the expectation of receiving later payment for such Foreign Assets from such purchaser or dealer.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall provide to each Board the
information with respect to custody and settlement practices in countries in which the Custodian employs a Foreign Sub-Custodian described
on&#8239;Schedule C hereto (as may be amended from time to time) at the time or times set forth on such Schedule. The Custodian may revise
Schedule C from time to time, provided that no such revision shall result in a Board being provided with substantively less information
than had been previously provided hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
of Foreign Securities</U></FONT>. The foreign securities maintained in the custody of a Foreign Sub-Custodian (other than bearer securities)
shall be registered in the name of the applicable Portfolio or in the name of the Custodian or in the name of any Foreign Sub-Custodian
or in the name of any nominee of the foregoing, and the applicable Fund on behalf of such Portfolio agrees to hold any such nominee harmless
from any liability as a holder of record of such foreign securities. The Custodian or a Foreign Sub-Custodian shall not be obligated
to accept securities on behalf of a Portfolio under the terms of this Agreement unless the form of such securities and the manner in
which they are delivered are in accordance with reasonable market practice.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Bank
Accounts</U></FONT>. The Custodian shall identify on its books as belonging to the applicable Fund cash (including cash denominated in
foreign currencies) deposited with the Custodian. Where the Custodian is unable to maintain, or market practice does not facilitate the
maintenance of, cash on the books of the Custodian, a bank account or bank accounts shall be opened and maintained outside the United
States on behalf of a Portfolio with a Foreign Sub-Custodian. All accounts referred to in this Section&nbsp;shall be subject only to
draft or order by the Custodian (or, if applicable, such Foreign Sub-Custodian) acting pursuant to the terms of this Agreement to hold
cash received by or from or for the account of the Portfolio. Cash maintained on the books of the Custodian (including its branches,
subsidiaries and affiliates), regardless of currency denomination, is maintained in bank accounts established under, and subject to the
laws of, The Commonwealth of Massachusetts.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Collection
of Income</U></FONT>. The Custodian shall use reasonable commercial efforts to collect all income and other payments with respect to
the Foreign Assets held hereunder to which the Portfolios shall be entitled. In the event that extraordinary measures are required to
collect such income, the Fund and the Custodian shall consult as to such measures and as to the compensation and expenses of the Custodian
relating to such measures. The Custodian shall credit income to the applicable Portfolio as such income is received or in accordance
with Custodian&rsquo;s then current payable date income schedule. Any credit to the Portfolio in advance of receipt may be reversed when
the Custodian determines that payment will not occur in due course and the Portfolio may be charged at the Custodian&rsquo;s applicable
rate for time credited. Income on securities loaned other than from the Custodian&rsquo;s securities lending program shall be credited
as received.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Shareholder
Rights</U></FONT>. With respect to the foreign securities held pursuant to this Section&nbsp;4, the Custodian shall use reasonable commercial
efforts to facilitate the exercise of voting and other shareholder rights, subject always to the laws, regulations and practical constraints
that may exist in the country where such securities are issued. Each Fund acknowledges that local conditions, including lack of regulation,
onerous procedural obligations, lack of notice and other factors may have the effect of severely limiting the ability of such Fund to
exercise shareholder rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Communications
Relating to Foreign Securities</U></FONT>. The Custodian shall transmit promptly to the applicable Fund written information with respect
to materials received by the Custodian via the Foreign Sub-Custodians from issuers of the foreign securities being held for the account
of the Portfolios (including, without limitation, pendency of calls and maturities of foreign securities and expirations of rights in
connection therewith). With respect to tender or exchange offers, the Custodian shall transmit promptly to the applicable Fund written
information with respect to materials so received by the Custodian from issuers of the foreign securities whose tender or exchange is
sought or from the party (or its agents) making the tender or exchange offer. The Custodian shall not be liable for any untimely exercise
of any tender, exchange or other right or power in connection with foreign securities or other property of the Portfolios at any time
held by it unless (i)&nbsp;the Custodian or the respective Foreign Sub-Custodian is in actual possession of such foreign securities or
property and (ii)&nbsp;the Custodian receives Proper Instructions with regard to the exercise of any such right or power, and both (i)&nbsp;and
(ii)&nbsp;occur at least three business days prior to the date on which the Custodian is to take action to exercise such right or power.
The Custodian shall also transmit promptly to the applicable Fund all written information received by the Custodian via the Foreign Sub-Custodians
from issuers of the foreign securities being held for the account of the Portfolios regarding any class action or other litigation in
connection with Portfolio foreign securities or other assets issued outside the United States and then held, or previously held, during
the term of this Agreement by the Custodian via a Foreign Sub-Custodian for the account of the Fund for such Portfolio, including, but
not limited to, opt-out notices and proof-of-claim forms. For avoidance of doubt, upon and after the effective date of any termination
of this Agreement, with respect to a Fund or its Portfolio(s), as may be applicable, the Custodian shall have no responsibility to so
transmit any information under this Section&nbsp;4.9.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liability
of Foreign Sub-Custodians</U></FONT>. Each agreement pursuant to which the Custodian employs a Foreign Sub-Custodian shall, to the extent
possible, require the Foreign Sub-Custodian to exercise reasonable care in the performance of its duties, and to indemnify, and hold
harmless, the Custodian from and against any loss, damage, cost, expense, liability or claim arising out of or in connection with the
Foreign Sub-Custodian&rsquo;s performance of such obligations. At a Fund&rsquo;s election, the Portfolios shall be entitled to be subrogated
to the rights of the Custodian with respect to any claims against a Foreign Sub-Custodian as a consequence of any such loss, damage,
cost, expense, liability or claim if and to the extent that the Portfolios have not been made whole for any such loss, damage, cost,
expense, liability or claim.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Tax
Law</U></FONT>. The Custodian shall have no responsibility or liability for any obligations now or hereafter imposed on any Fund, the
Portfolios or the Custodian as custodian of the Portfolios by the tax law of the United States or of any state or political subdivision
thereof. It shall be the responsibility of each Fund to notify the Custodian of the obligations imposed on such Fund with respect to
the Portfolios or the Custodian as custodian of the Portfolios by the tax law of countries other than those mentioned in the above sentence,
including responsibility for withholding and other taxes, assessments or other governmental charges, certifications and governmental
reporting. The sole responsibility of the Custodian with regard to such tax law shall be to use reasonable efforts to assist the Fund
with respect to any claim for exemption or refund under the tax law of countries for which such Fund has provided such information.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;4.12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liability
of Custodian</U></FONT>. The Custodian shall be liable for the acts or omissions of a Foreign Sub-Custodian to the same extent as set
forth with respect to sub-custodians generally in this Agreement and, regardless of whether assets are maintained in the custody of a
Foreign Sub-Custodian or a Foreign Securities System, the Custodian shall not be liable for any loss, damage, cost, expense, liability
or claim resulting from nationalization, expropriation, currency restrictions, or acts of war or terrorism, or any other loss where the
Sub-Custodian has otherwise acted with reasonable care.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contractual
Settlement Services (Purchase / Sales)</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Custodian shall, in accordance with the terms set out in this section, debit or credit the appropriate cash account of each Portfolio
in connection with (i)&nbsp;the purchase of securities for such Portfolio, and (ii)&nbsp;proceeds of the sale of securities held on behalf
of such Portfolio, on a contractual settlement basis.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
services described above (the &ldquo;<B><I>Contractual Settlement Services</I></B>&rdquo;) shall be provided for such instruments and
in such markets as the Custodian may advise from time to time. The Custodian may terminate or suspend any part of the provision of the
Contractual Settlement Services under this Agreement at its sole discretion immediately upon notice to the applicable Fund on behalf
of each Portfolio, including, without limitation, in the event of force majeure events affecting settlement, any disorder in markets,
or other changed external business circumstances affecting the markets or the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
consideration payable in connection with a purchase transaction shall be debited from the appropriate cash account of the Portfolio as
of the time and date that monies would ordinarily be required to settle such transaction in the applicable market. The Custodian shall
promptly recredit such amount at the time that the Portfolio or the Fund notifies the Custodian by Proper Instruction that such transaction
has been canceled.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;With
respect to the settlement of a sale of securities, a provisional credit of an amount equal to the net sale price for the transaction
(the &ldquo;<B><I>Settlement Amount</I></B>&rdquo;) shall be made to the account of the Portfolio as if the Settlement Amount had been
received as of the close of business on the date that monies would ordinarily be available in good funds in the applicable market. Such
provisional credit will be made conditional upon the Custodian having received Proper Instructions with respect to, or reasonable notice
of, the transaction, as applicable; and the Custodian or its agents having possession of the asset(s)&nbsp;(which shall exclude assets
subject to any third party lending arrangement entered into by a Portfolio) associated with the transaction in good deliverable form
and not being aware of any facts which would lead them to believe that the transaction will not settle in the time period ordinarily
applicable to such transactions in the applicable market.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.5</FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;Simultaneously
with the making of such provisional credit, the Portfolio agrees that the Custodian shall have, and hereby grants to the Custodian, a
security interest in any property at any time held for the account of the Portfolio to the full extent of the credited amount, and each
Portfolio hereby pledges, assigns and grants to the Custodian a continuing security interest&#8239;and a lien on any and all such property
under the Custodian&rsquo;s possession, in accordance with the terms of this Agreement. In the event that the applicable Portfolio fails
to promptly repay any provisional credit, the Custodian shall have all of the rights and remedies of a secured party under the Uniform
Commercial Code of The Commonwealth of Massachusetts.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Custodian shall have the right to reverse any provisional credit or debit given in connection with the Contractual Settlement Services
at any time when the Custodian believes, in its reasonable judgment, that such transaction will not settle in accordance with its terms
or amounts due pursuant thereto, will not be collectable or where the Custodian has not been provided Proper Instructions with respect
thereto, as applicable, and the Portfolio shall be responsible for any costs or liabilities resulting from such reversal. Upon such reversal,
a sum equal to the credited or debited amount shall become immediately payable by the Portfolio to the Custodian and may be debited from
any cash account held for benefit of the Portfolio.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;5.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that the Custodian is unable to debit an account of the Portfolio, and the Portfolio fails to pay any amount due to the Custodian
at the time such amount becomes payable in accordance with this Agreement, (i)&nbsp;the Custodian may charge the Portfolio for reasonable
costs and expenses associated with providing the provisional credit, including without limitation the cost of funds associated therewith,
(ii)&nbsp;the amount of any accrued dividends, interest and other distributions with respect to assets associated with such transaction
may be set off against the credited amount, (iii)&nbsp;the provisional credit and any such costs and expenses shall be considered an
advance of cash for purposes of the Agreement and (iv)&nbsp;the Custodian shall have the right to setoff against any property and to
sell, exchange, convey, transfer or otherwise dispose of any property at any time held for the account of the Portfolio to the full extent
necessary for the Custodian to make itself whole.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Special
Sub-Custodians</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon receipt of Special Instructions (as such
term is defined in Section&nbsp;8 hereof), the Custodian shall, on behalf of one or more Portfolios, appoint one or more banks, trust
companies or other entities designated in such Special Instructions to act as a sub-custodian for the purposes of effecting such transaction(s)&nbsp;as
may be designated by a Fund in Special Instructions. Each such designated sub-custodian is referred to herein as a &ldquo;<B><I>Special
Sub-Custodian</I></B>.&rdquo; Each such duly appointed Special Sub-Custodian shall be listed on Schedule D hereto, as it may be amended
from time to time by a Fund, with the acknowledgment of the Custodian. In connection with the appointment of any Special Sub-Custodian,
and in accordance with Special Instructions, the Custodian shall enter into a sub-custodian agreement with the Fund and the Special Sub-Custodian
in form and substance approved by such Fund, provided that such agreement shall in all events comply with the provisions of the 1940 Act
and the rules&nbsp;and regulations thereunder and the terms and provisions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payments
for Sales or Repurchases or Redemptions of Shares</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall receive from the distributor
of the Shares or from the Transfer Agent and deposit into the account of the appropriate Portfolio such payments as are received for
Shares thereof&#8239;issued or sold from time to time by the applicable Fund. The Custodian will provide timely notification to such Fund on
behalf of each such Portfolio and the Transfer Agent of any receipt by it of payments for Shares of such Portfolio.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From such funds as may be available for the purpose,
the Custodian shall, upon receipt of instructions from the Transfer Agent, make funds available for payment to holders of Shares who have
delivered to the Transfer Agent a request for redemption or repurchase of their Shares. In connection with the redemption or repurchase
of Shares, the Custodian is authorized upon receipt of instructions from the Transfer Agent to wire funds to or through a commercial bank
designated by the redeeming shareholders. In connection with the redemption or repurchase of Shares, the Custodian shall honor checks
drawn on the Custodian by a holder of Shares, which checks have been furnished by a Fund to the holder of Shares, when presented to the
Custodian in accordance with such procedures and controls as are mutually agreed upon from time to time between such Fund and the Custodian.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Proper
Instructions and Special Instructions</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B><I>Proper Instructions</I></B>,&rdquo;
which may also be standing instructions, as such term is used throughout this Agreement shall mean instructions received by the Custodian
from a Fund, a Fund&rsquo;s duly authorized investment manager or investment adviser, or a person or entity duly authorized by either
of them. Such instructions may be in writing signed by the authorized person or persons or may be in a tested communication or in a communication
utilizing access codes effected between electro-mechanical or electronic devices or may be by such other means and utilizing such intermediary
systems and utilities as may be agreed from time to time by the Custodian and the person(s)&nbsp;or entity giving such instruction, provided
that the Fund has followed any security procedures agreed to from time to time by the applicable Fund and the Custodian including, but
not limited to, the security procedures selected by the Fund via the form of Funds Transfer Addendum hereto, the terms of which are hereby
agreed to. Oral instructions will be considered Proper Instructions if the Custodian reasonably believes them to have been given by a
person authorized to provide such instructions with respect to the transaction involved; the Fund shall cause all oral instructions to
be confirmed in writing. For purposes of this Section, Proper Instructions shall include instructions received by the Custodian pursuant
to any multi-party agreement which requires a segregated asset account in accordance with Section&nbsp;2.9 hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B><I>Special Instructions</I></B>,&rdquo;
as such term is used throughout this Agreement, means Proper Instructions countersigned or confirmed in writing by the Treasurer or any
Assistant Treasurer of the applicable Fund or any other person designated in writing by the Treasurer of such Fund, which countersignature
or confirmation shall be (a)&nbsp;included on the same instrument containing the Proper Instructions or on a separate instrument clearly
relating thereto and (b)&nbsp;delivered by hand, by facsimile transmission, or in such other manner as the Fund and the Custodian agree
in writing.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concurrently with the execution of this Agreement,
and from time to time thereafter, as appropriate, each Fund shall deliver to the Custodian, duly certified by such Fund&rsquo;s Treasurer
or Assistant Treasurer, a certificate setting forth: (i)&nbsp;the names, titles, signatures and scope of authority of all persons authorized
to give Proper Instructions or any other notice, request, direction, instruction,&#8239;certificate or instrument on behalf of the Fund and
(ii)&nbsp;the names, titles and signatures of those persons authorized to give Special Instructions. Such certificate may be accepted
and relied upon by the Custodian as conclusive evidence of the facts set forth therein and shall be considered to be in full force and
effect until receipt by the Custodian of a similar certificate to the contrary.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Evidence
of Authority</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall be protected in acting upon
any instructions, notice, request, consent, certificate or other instrument or paper believed by it to be genuine and to have been properly
executed by or on behalf of the applicable Fund. The Custodian may receive and accept a copy of a resolution certified by the Secretary
or an Assistant Secretary of any Fund as conclusive evidence (a)&nbsp;of the authority of any person to act in accordance with such resolution
or (b)&nbsp;of any determination or of any action by the applicable Board as described in such resolution, and such resolution may be
considered as in full force and effect until receipt by the Custodian of written notice to the contrary.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;10.&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Actions
Permitted Without Express Authority</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian may in its discretion, without express
authority from the applicable Fund on behalf of each applicable Portfolio:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1)</TD><TD STYLE="text-align: justify">Make payments to itself or others for expenses of handling securities or other similar items relating
to its duties under this Agreement; provided that all such payments shall be accounted for to the Fund on behalf of the Portfolio;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2)</TD><TD STYLE="text-align: justify">Surrender securities in temporary form for securities in definitive form;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3)</TD><TD STYLE="text-align: justify">Endorse for collection, in the name of the Portfolio, checks, drafts and other negotiable instruments;
and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4)</TD><TD STYLE="text-align: justify">In general, attend to all non-discretionary details in connection with the sale, exchange, substitution,
purchase, transfer and other dealings with the securities and property of the Portfolio except as otherwise directed by the applicable
Board.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-variant: small-caps">Section&nbsp;11.&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;&#8239;<U>Duties of Custodian with Respect to the Books of Account and Calculation of Net Asset Value
and Net Income</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall cooperate with and supply
necessary information to the entity or entities appointed by the applicable Board to keep the books of account of each Portfolio and/or
compute the net asset value per Share of the outstanding Shares or, if directed in writing to do so by a Fund on behalf of a Portfolio,
shall itself keep such books of account and/or compute such net asset value per Share. If so directed, the Custodian shall also calculate
daily the net income of the Portfolio as described in the Prospectus and shall advise the Fund and the Transfer Agent daily of the total
amounts of such net income and, if instructed in writing by an officer of the Fund to do so, shall advise the Transfer Agent periodically
of the division of such net income among its various components. Each Fund acknowledges and agrees that, with respect to investments
maintained with&#8239;the Underlying Transfer Agent, the Underlying Transfer Agent is the sole source of information on the number of shares
of a fund held by it on behalf of a Portfolio and that the Custodian has the right to rely on holdings information furnished by the Underlying
Transfer Agent to the Custodian in performing its duties under this Agreement, including without limitation, the duties set forth in
this Section&nbsp;11 and in Section&nbsp;12 hereof; provided, however, that the Custodian shall be obligated to reconcile information
as to purchases and sales of Underlying Shares contained in trade instructions and confirmations received by the Custodian and to report
promptly any discrepancies to the Underlying Transfer Agent. The calculations of the net asset value per Share and the daily income of
each Portfolio shall be made at the time or times described from time to time in the Prospectus. Each Fund acknowledges that, in keeping
the books of account of the Portfolio and/or making the calculations described herein with respect to Portfolio property released and
delivered pursuant to Section&nbsp;2.2(14), or purchased pursuant to Section&nbsp;2.6(7)&nbsp;hereof, the Custodian is authorized and
instructed to rely upon information provided to it by the Fund, the Fund&rsquo;s counterparty(ies), or the agents of either of them.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Records</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall with respect to each Portfolio
create and maintain all records relating to its activities and obligations under this Agreement in such manner as will meet the obligations
of each Fund under the 1940 Act, with particular attention to section 31 thereof and Rules&nbsp;31a-1 and 31a-2 thereunder. All such records
shall be the property of the Fund and shall at all times during the regular business hours of the Custodian be open for inspection by
duly authorized officers, employees or agents of such Fund and employees and agents of the SEC. The Custodian shall, at a Fund&rsquo;s
request, supply the Fund with a tabulation of securities owned by each Portfolio and held by the Custodian and shall, when requested to
do so by the Fund and for such compensation as shall be agreed upon between the Fund and the Custodian, include certificate numbers in
such tabulations. Each Fund acknowledges that, in creating and maintaining the records as set forth herein with respect to Portfolio property
released and delivered pursuant to Section&nbsp;2.2(14), or purchased pursuant to Section&nbsp;2.6(7)&nbsp;hereof, the Custodian is authorized
and instructed to rely upon information provided to it by the Fund, the Fund&rsquo;s counterparty(ies), or the agents of either of them.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Opinion
of Fund&rsquo;s Independent Accountant</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall take all reasonable action,
as a Fund with respect to a Portfolio may from time to time request, to obtain from year to year favorable opinions from the Fund&rsquo;s
independent accountants with respect to its activities hereunder in connection with the preparation of the Fund&rsquo;s Form&nbsp;N-1A
or Form&nbsp;N-2, as applicable, and Form&nbsp;N-SAR or other annual reports to the SEC and with respect to any other requirements thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports
to Fund by Independent Public Accountants</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall provide the applicable Fund,
on behalf of each of the Portfolios at such times as such Fund may reasonably require, with reports by independent public accountants
on the accounting system, internal accounting control and procedures for safeguarding securities, futures contracts and options on futures
contracts, including securities deposited and/or maintained in a U.S. Securities System or a Foreign Securities System (either, a &ldquo;<B><I>Securities
System</I></B>&rdquo;), relating to the services provided by the Custodian under this Agreement; such reports, shall be of sufficient
scope and in sufficient detail, as may reasonably be required by the Fund to provide reasonable assurance that any material inadequacies
would be disclosed by such examination, and, if there are no such inadequacies, the reports shall so state.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
of Custodian</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Custodian shall be entitled to reasonable
compensation for its services and expenses as Custodian, as agreed upon from time to time between each Fund on behalf of each applicable
Portfolio and the Custodian.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Responsibility
of Custodian</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So long as and to the extent that it is in the
exercise of reasonable care, the Custodian shall not be responsible for the title, validity or genuineness of any property or evidence
of title thereto received by it or delivered by it pursuant to this Agreement and shall be held harmless in acting upon any notice, request,
consent, certificate or other instrument reasonably believed by it to be genuine and to be signed by the proper party or parties, including
any futures commission merchant acting pursuant to the terms of a three-party futures or options agreement. The Custodian shall be held
to the exercise of reasonable care in carrying out the provisions of this Agreement, but shall be kept indemnified by and shall be without
liability to any Fund for any action taken or omitted by it in good faith without negligence, including, without limitation, acting in
accordance with any Proper Instruction. It shall be entitled to rely on and may act upon advice of counsel (who may be counsel for the
Fund) on all matters, and shall be without liability for any action reasonably taken or omitted pursuant to such advice. The Custodian
shall be without liability to any Fund or Portfolio for any loss, liability, claim or expense resulting from or caused by anything that
is part of Country Risk (as defined in Section&nbsp;3 hereof), including without limitation nationalization, expropriation, currency restrictions,
insolvency of a Foreign Sub-custodian, acts of war, revolution, riots or terrorism. In no event shall the Custodian be liable for indirect,
special or consequential damages.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as may arise from the Custodian&rsquo;s
own negligence or willful misconduct or the negligence or willful misconduct of a sub-custodian or agent, the Custodian shall be without
liability to any Fund for any loss, liability, claim or expense resulting from or caused by: (i)&nbsp;events or circumstances beyond
the reasonable control of the Custodian or any sub-custodian or Securities System or any agent or nominee of any of the foregoing, including,
without limitation, the interruption, suspension or restriction of trading on or the closure of any securities market, power or other
mechanical or technological failures or interruptions, computer viruses or communications disruptions, work stoppages, natural disasters,
or other similar events or acts; (ii)&nbsp;errors by any Fund or its duly&#8239;authorized investment manager or investment adviser in their
instructions to the Custodian provided such instructions have been in accordance with this Agreement; (iii)&nbsp;the insolvency of or
acts or omissions by a Securities System; (iv)&nbsp;any act or omission of a Special Sub-Custodian including, without limitation, reliance
on reports prepared by a Special Sub-Custodian; (v)&nbsp;any delay or failure of any broker, agent or intermediary, central bank or other
commercially prevalent payment or clearing system to deliver to the Custodian&rsquo;s sub-custodian or agent securities purchased or
in the remittance or payment made in connection with securities sold; (vi)&nbsp;any delay or failure of any company, corporation, or
other body in charge of registering or transferring securities in the name of the Custodian, any Fund, the Custodian&rsquo;s sub-custodians,
nominees or agents or any consequential losses arising out of such delay or failure to transfer such securities including non-receipt
of bonus, dividends and rights and other accretions or benefits; (vii)&nbsp;delays or inability to perform its duties due to any disorder
in market infrastructure with respect to any particular security or Securities System; and (viii)&nbsp;any provision of any present or
future law or regulation or order of the United States of America, or any state thereof, or any other country, or political subdivision
thereof or of any court of competent jurisdiction. The Custodian shall be liable for the acts or omissions of a Foreign Sub-Custodian
to the same extent as set forth with respect to sub-custodians generally in this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a Fund on behalf of a Portfolio requires the
Custodian to take any action with respect to securities, which action involves the payment of money or which action may, in the opinion
of the Custodian, result in the Custodian or its nominee assigned to the Fund or the Portfolio being liable for the payment of money or
incurring liability of some other form, such Fund on behalf of the Portfolio, as a prerequisite to requiring the Custodian to take such
action, shall provide indemnity to the Custodian in an amount and form satisfactory to it.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Custodian, its affiliates, subsidiaries
or agents advances cash or securities to the Fund for any purpose (including but not limited to securities settlements, foreign exchange
contracts and assumed settlement), or in the event that the Custodian or its nominee shall incur or be assessed any taxes, charges, expenses,
assessments, claims or liabilities in connection with the performance of this Agreement, except such as may arise from its or its nominee&rsquo;s
own negligent action, negligent failure to act or willful misconduct, or if a Fund fails to compensate the Custodian pursuant to Section&nbsp;15
hereof, any property at any time held for the account of the applicable Portfolio shall be security therefor and should the Fund fail
to pay or reimburse the Custodian promptly, the Custodian shall be entitled to utilize available cash and to dispose of such Portfolio&rsquo;s
assets to the extent necessary to obtain payment or reimbursement. The Custodian may at any time decline to follow Proper Instructions
to deliver out to the Fund cash or securities if the Custodian determines in its reasonable discretion that, after giving effect to the
Proper Instructions, the cash or securities remaining will not have sufficient value fully to secure the Fund's payment or reimbursement
obligations, whether contingent or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as may arise from the Custodian&rsquo;s
own negligence or willful misconduct, each Fund shall indemnify and hold the Custodian harmless from and against any and all losses,
liabilities, payments, damages, charges, counsel fees, costs and expenses which may be asserted against the Custodian (a)&nbsp;acting
in accordance with any Proper Instruction or Special Instruction including, without limitation, any Proper Instruction with respect to
Free Trades including, but not limited to, cost, expense, loss,&#8239;damage, liability, tax, charge, assessment or claim resulting from (i)&nbsp;the
failure of the applicable Fund to receive income with respect to purchased investments, (ii)&nbsp;the failure of the applicable Fund
to recover amounts invested on maturity of purchased investments, (iii)&nbsp;the failure of the Custodian to respond to or be aware of
notices or other corporate communications with respect to purchased investments, or (iv)&nbsp;the Custodian&rsquo;s reliance upon information
provided by the applicable Fund, such Fund&rsquo;s counterparty(ies) or the agents of either of them with respect to Fund property released,
delivered or purchased pursuant to either of Section&nbsp;2.2(14) or Section&nbsp;2.6(7)&nbsp;hereof; (b)&nbsp;for the acts or omissions
of any Special Sub-Custodian; or (c)&nbsp;for the acts or omissions of any Local Agent or Pledgee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effective
Period, Termination and Amendment</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall remain in full force and
effect for an initial term ending November&nbsp;30, 2014 (the &ldquo;<B><I>Initial Term</I></B>&rdquo;). After the expiration of the Initial
Term, this Agreement shall automatically renew for successive two-year terms (each, a &ldquo;<B><I>Renewal Term</I></B>&rdquo;) unless
a written notice of non-renewal is delivered by the non-renewing party no later than sixty (60) days prior to the expiration of the Initial
Term or any Renewal Term, as the case may be. During the Initial Term and thereafter, either party may terminate this Agreement: (i)&nbsp;in
the event of the other party&rsquo;s material breach of a material provision of this Agreement that the other party has either (a)&nbsp;failed
to cure or (b)&nbsp;failed to establish a remedial plan to cure that is reasonably acceptable to the non-breaching party, within 60 days&rsquo;
written notice of such breach, or (ii)&nbsp;in the event of the appointment of a conservator or receiver for the other party or upon the
happening of a like event to the other party at the direction of an appropriate agency or court of competent jurisdiction. Upon termination
of this Agreement pursuant to this paragraph with respect to any Fund or Portfolio, the applicable Fund shall pay the Custodian its compensation
due and shall reimburse the Custodian for its costs, expenses and disbursements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of: (i)&nbsp;any Fund's termination
of this Agreement with respect to such Fund or its Portfolio(s)&nbsp;for any reason other than as set forth in the immediately preceding
paragraph or (ii)&nbsp;a transaction not in the ordinary course of business pursuant to which the Custodian is not retained to continue
providing services hereunder to a Fund or Portfolio (or its respective successor), the applicable Fund shall pay the Custodian its compensation
due through the end of the then-current term (based upon the average monthly compensation previously earned by the Custodian with respect
to such Fund or Portfolio) and shall reimburse the Custodian for its costs, expenses and disbursements. Upon receipt of such payment and
reimbursement, the Custodian will deliver such Fund&rsquo;s or Portfolio&rsquo;s securities and cash as set forth hereinbelow. For the
avoidance of doubt, no payment will be required pursuant to clause (ii)&nbsp;of this paragraph in the event of any transaction such as
(a)&nbsp;the liquidation or dissolution of a Fund or a Portfolio and distribution of such Fund&rsquo;s or Portfolio&rsquo;s assets as
a result of the Board&rsquo;s determination in its reasonable business judgment that the Fund or Portfolio is no longer viable (b)&nbsp;a
merger of a Fund or Portfolio into, or the consolidation of a Fund or Portfolio with, another entity, or (c)&nbsp;the sale by a Fund or
Portfolio of all, or substantially all, of its assets to another entity, in each of (b)&nbsp;and (c)&nbsp;where the Custodian is retained
to continue providing services to such Fund or Portfolio (or its respective successor) on substantially the same terms as this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Termination of this Agreement with respect to
any one particular Fund or Portfolio shall in no way affect the rights and duties under this Agreement with respect to any other Fund
or Portfolio. The provisions of Sections 4.11, 15 and 16 of this Agreement shall survive termination of this Agreement for any reason.&#8239;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This
Agreement may be amended at any time in writing by mutual agreement of the parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successor
Custodian</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a successor custodian for one or more Portfolios
shall be appointed by the applicable Board, the Custodian shall, upon termination and receipt of Proper Instructions, deliver to such
successor custodian at the office of the Custodian, duly endorsed and in the form for transfer, all securities of each applicable Portfolio
then held by it hereunder and shall transfer to an account of the successor custodian all of the securities of each such Portfolio held
in a Securities System or at the Underlying Transfer Agent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If no such successor custodian shall be appointed,
the Custodian shall, in like manner, upon receipt of Proper Instructions, deliver at the office of the Custodian and transfer such securities,
funds and other properties in accordance with such resolution.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that no Proper Instructions designating
a successor custodian or alternative arrangements shall have been delivered to the Custodian on or before the date when such termination
shall become effective, then the Custodian shall have the right to deliver to a bank or trust company, which is a &ldquo;bank&rdquo; as
defined in the 1940 Act, doing business in Boston, Massachusetts or New York, New York, of its own selection, having an aggregate capital,
surplus, and undivided profits, as shown by its last published report, of not less than $25,000,000, all securities, funds and other properties
held by the Custodian on behalf of each applicable Portfolio and all instruments held by the Custodian relative thereto and all other
property held by it under this Agreement on behalf of each applicable Portfolio, and to transfer to an account of such successor custodian
all of the securities of each such Portfolio held in any Securities System or at the Underlying Transfer Agent. Thereafter, such bank
or trust company shall be the successor of the Custodian under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that securities, funds and other
properties remain in the possession of the Custodian after the date of termination hereof owing to failure of any Fund to provide Proper
Instructions as aforesaid, the Custodian shall be entitled to fair compensation for its services during such period as the Custodian retains
possession of such securities, funds and other properties and the provisions of this Agreement relating to the duties and obligations
of the Custodian shall remain in full force and effect.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Massachusetts
Law to Apply</U></FONT>. This Agreement shall be construed and the provisions thereof interpreted under and in accordance with laws of
The Commonwealth of Massachusetts.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Prior
Agreements</U></FONT>. This Agreement supersedes and terminates, as of the date hereof, all prior agreements between each Fund on behalf
of each of the Portfolios and the Custodian relating to the custody of such Fund&rsquo;s assets.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment</U></FONT>.
This Agreement may not be assigned by (a)&nbsp;any Fund without the written consent of the Custodian or (b)&nbsp;by the Custodian without
the written consent of each applicable Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.4&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;<U>Interpretive and Additional Provisions</U></FONT>. In connection with the operation of this Agreement, the Custodian
and each Fund on behalf of each of the Portfolios, may from time to time agree on such provisions interpretive of or in addition to the
provisions of this Agreement as may in their joint opinion be consistent with the general tenor of this Agreement. Any such interpretive
or additional provisions shall be in a writing signed by all parties and shall be annexed hereto, provided that no such interpretive
or additional provisions shall contravene any applicable federal or state regulations or any provision of a Fund&rsquo;s Governing Documents.
No interpretive or additional provisions made as provided in the preceding sentence shall be deemed to be an amendment of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Funds</U></FONT>. In the event that any management investment company in addition to those listed on Appendix A hereto desires to have
the Custodian render services as custodian under the terms hereof, it shall so notify the Custodian in writing, and if the Custodian
agrees in writing to provide such services, such management investment company shall become a Fund hereunder and be bound by all terms
and conditions and provisions hereof including, without limitation, the representations and warranties set forth in Section&nbsp;19.7
below.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION&nbsp;19.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-variant: small-caps"><U>Additional
Portfolios</U></FONT>. In the event that any Fund establishes one or more series of Shares in addition to those set forth on Appendix
A hereto with respect to which it desires to have the Custodian render services as custodian under the terms hereof, it shall so notify
the Custodian in writing, and if the Custodian agrees in writing to provide such services, such series of Shares shall become a Portfolio
hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>The
Parties</U></FONT>. All references herein to the &ldquo;Fund&rdquo; are to each of the management investment companies listed on Appendix
A hereto, and each management investment company made subject to this Agreement in accordance with Section&nbsp;19.5 above, individually,
as if this Agreement were between such individual Fund and the Custodian. In the case of a series corporation, trust or other entity,
all references herein to the &ldquo;Portfolio&rdquo; are to the individual series or portfolio of such corporation, trust or other entity,
or to such corporation, trust or other entity on behalf of the individual series or portfolio, as appropriate. Any reference in this
Agreement to &ldquo;the parties&rdquo; shall mean the Custodian and such other individual Fund as to which the matter pertains. Each
Fund hereby represents and warrants that (a)&nbsp;it is duly incorporated or organized and is validly existing in good standing in its
jurisdiction of incorporation or organization; (b)&nbsp;it has the requisite power and authority under applicable law and its Governing
Documents to enter into and perform this Agreement; (c)&nbsp;all requisite proceedings have been taken to authorize it to enter into
and perform this Agreement; (d)&nbsp;this Agreement constitutes its legal, valid, binding and enforceable agreement; and (e)&nbsp;its
entrance into this Agreement shall not cause a material breach or be in&#8239;material conflict with any other agreement or obligation
of the Fund or any law or regulation applicable to it.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remote
Access Services Addendum</U></FONT>. The Custodian and each Fund agree to be bound by the terms of the Remote Access Services Addendum
hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U></FONT>.
Any notice, instruction or other instrument required to be given hereunder may be delivered in person to the offices of the parties as
set forth herein during normal business hours or delivered prepaid registered mail or by telex, cable or telecopy to the parties at the
following addresses or such other addresses as may be notified by any party from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To any Fund:</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Name of Fund]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Avenue of the Stars, 12<SUP>th</SUP> Floor</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los Angeles, CA 90067</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Daniel Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: (310) 201-4100</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telecopy: (310) 201-4170</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the Custodian:</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATE STREET BANK AND TRUST COMPANY</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200 Clarendon Street</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston, MA 02110</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Michael Foutes</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: 617-662-9079</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telecopy: 617-662-1970</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such notice, instruction or other instrument shall
be deemed to have been served in the case of a registered letter at the expiration of five business days after posting, in the case of
cable twenty-four hours after dispatch and, in the case of telex, immediately on dispatch and if delivered outside normal business hours
it shall be deemed to have been received at the next time after delivery when normal business hours commence and in the case of cable,
telex or telecopy on the business day after the receipt thereof. Evidence that the notice was properly addressed, stamped and put into
the post shall be conclusive evidence of posting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U></FONT>.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, and all such counterparts taken
together shall constitute one and the same Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U></FONT>.
If any provision or provisions of this Agreement shall be held to be invalid, unlawful or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidentiality</U></FONT>.
The parties hereto agree that each shall treat confidentially all information provided by each party to the other party regarding its
business and operations. All confidential information provided by a party hereto shall be used by any other party hereto solely for the
purpose of rendering or receiving services pursuant to this Agreement and,&#8239;except as may be required in carrying out this Agreement,
shall not be disclosed to any third party. The foregoing shall not be applicable to any information (i)&nbsp;that is publicly available
when provided or thereafter becomes publicly available, other than through a breach of this Agreement, (ii)&nbsp;that is independently
derived by any party hereto without the use of any information provided by the other party hereto in connection with this Agreement,
(iii)&nbsp;that is required in any legal or regulatory proceeding, investigation, audit, examination, subpoena, civil investigative demand
or other similar process, or by operation of law or regulation, or (iv)&nbsp;where the party seeking to disclose has received the prior
written consent of the party providing the information, which consent shall not be unreasonably withheld. Notwithstanding anything herein
to the contrary, the Custodian and its affiliates may report and use nonpublic portfolio holdings information of its clients, including
a Fund or Portfolio, on an aggregated basis with all or substantially all other client information and without specific reference to
any Fund or Portfolio.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reproduction
of Documents</U></FONT>. This Agreement and all schedules, addenda, exhibits, appendices, attachments and amendments hereto may be reproduced
by any photographic, photostatic, microfilm, micro-card, miniature photographic or other similar process. The parties hereto all/each
agree that any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding,
whether or not the original is in existence and whether or not such reproduction was made by a party in the regular course of business,
and that any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulation
GG</U></FONT>. Each Fund hereby represents and warrants that it does not engage in an &ldquo;Internet gambling business,&rdquo; as such
term is defined in Section&nbsp;233.2(r)&nbsp;of Federal Reserve Regulation GG (12 CFR 233) (&ldquo;<B><I>Regulation GG</I></B>&rdquo;).
Each Fund hereby covenants and agrees that it shall not engage in an Internet gambling business. In accordance with Regulation GG, each
Fund is hereby notified that &ldquo;restricted transactions,&rdquo; as such term is defined in Section&nbsp;233.2(y)&nbsp;of Regulation
GG, are prohibited in any dealings with the Custodian pursuant to this Agreement or otherwise between or among any party hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.15&#8239;
 &#8239;&#8239;&#8239;&#8239;<U>Data Privacy</U></FONT>.&#8239;The Custodian will implement and maintain a written information security program that contains appropriate security measures to safeguard
the personal information of the Funds&rsquo; shareholders, employees, directors and/or officers that the Custodian receives, stores, maintains,
processes or otherwise accesses in connection with the provision of services hereunder. For these purposes, &ldquo;personal information&rdquo;
shall mean (i) an individual&rsquo;s name (first initial and last name or first name and last name), address or telephone number plus
(a) social security number, (b) drivers license number, (c) state identification card number, (d) debit or credit card number, (e) financial
account number or (f) personal identification number or password that would permit access to a person&rsquo;s account or (ii) any combination
of the foregoing that would allow a person to log onto or access an individual&rsquo;s account. Notwithstanding the foregoing &ldquo;personal
information&rdquo; shall not include information that is lawfully obtained from publicly available information, or from federal, state
or local government records lawfully made available to the general public.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loan
Services Addendum</U></FONT>. In the event the Fund directs Custodian in&#8239;writing to perform loan services, Custodian and the Fund
hereby agree to be bound by the terms of the Loan Services Addendum attached hereto and the Fund shall reimburse Custodian for its fees
and expenses related thereto as agreed upon from time to time in writing by the Fund and Custodian.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Section&nbsp;19.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Shareholder
Communications Election</U></FONT>. SEC Rule&nbsp;14b-2 requires banks which hold securities for the account of customers to respond
to requests by issuers of securities for the names, addresses and holdings of beneficial owners of securities of that issuer held by
the bank unless the beneficial owner has expressly objected to disclosure of this information. In order to comply with the rule, the
Custodian needs each Fund to indicate whether it authorizes the Custodian to provide such Fund&rsquo;s name, address, and share position
to requesting companies whose securities the Fund owns. If a Fund tells the Custodian &ldquo;no,&rdquo; the Custodian will not provide
this information to requesting companies. If a Fund tells the Custodian &ldquo;yes&rdquo; or does not check either &ldquo;yes&rdquo;
or &ldquo;no&rdquo; below, the Custodian is required by the rule&nbsp;to treat the Fund as consenting to disclosure of this information
for all securities owned by the Fund or any funds or accounts established by the Fund. For a Fund&rsquo;s protection, the Rule&nbsp;prohibits
the requesting company from using the Fund&rsquo;s name and address for any purpose other than corporate communications. Please indicate
below whether the Fund consents or objects by checking one of the alternatives below.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">YES <FONT STYLE="font-family: Wingdings">&#168;</FONT> &nbsp;&nbsp;&nbsp;The
Custodian is authorized to release the Fund&rsquo;s name, address, and share positions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">NO <FONT STYLE="font-family: Wingdings">&#120;</FONT>&#8239;&#8239;&nbsp;&nbsp;The Custodian
is not authorized to release the Fund&rsquo;s name, address, and share positions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><U>Signature
Page</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>In
Witness Whereof</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT></B>each of the parties
has caused this instrument to be executed in its name and behalf by its duly authorized representative under seal as of the date first
above-written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EACH OF THE ENTITIES</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SET FORTH ON APPENDIX A HERETO</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel J. Hall</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel J. Hall</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel, Chief Legal Officer and Secretary,&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</FONT></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>STATE STREET BANK AND TRUST COMPANY</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael F. Rogers</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael F. Rogers</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT><I>**
Signature Page&nbsp;to Master Custodian Agreement **</I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPENDIX A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><U>Master
Custodian Agreement</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 33; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">App-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE D</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><U>Master
Custodian Agreement</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><U>Special Sub-Custodians</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Options: NewSection Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(1)
<SEQUENCE>6
<FILENAME>tm2416373d4_ex99-xkx1.htm
<DESCRIPTION>EXHIBIT 99.(K)(1)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx1.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(k)(1)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution copy</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRANSFER AGENCY AND SERVICE AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Transfer Agency and Service
Agreement (&ldquo;Agreement&rdquo;) is dated and effective as of November&nbsp;30, 2012, by and between State Street Bank and Trust Company,
a Massachusetts trust company (&ldquo;State Street&rdquo; or the &ldquo;Transfer Agent&rdquo;), and Ares Dynamic Credit Allocation Fund,&nbsp;Inc.,
a Maryland corporation (the &ldquo;Fund&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund is a closed-end
management investment company registered with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), and has registered shares
of its common stock, par value $0.001 per share (&ldquo;Shares&rdquo;) with the SEC by means of a registration statement (&ldquo;Registration
Statement&rdquo;) under the Investment Company Act of 1940, as amended (the &ldquo;1940 Act&rdquo;) and under the Securities Act of 1933,
as amended (the &ldquo;1933 Act&rdquo;); and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund desires
to appoint the Transfer Agent as its transfer agent, dividend disbursing agent, and agent in connection with certain other activities,
and the Transfer Agent desires to accept such appointment;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants herein contained, the parties hereto agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>TERMS OF APPOINTMENT</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">Subject to the terms and conditions set forth in this Agreement, the Fund hereby employs and appoints
the Transfer Agent to act as, and the Transfer Agent agrees to act as, transfer agent for the Fund&rsquo;s authorized and issued Shares,
dividend disbursing agent, and agent in connection with certain other services provided to holders of the Fund&rsquo;s Shares (&ldquo;Shareholders&rdquo;)
and set out in the Fund&rsquo;s prospectus (the &ldquo;Offering Material&rdquo;).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify"><I>Transfer Agency Services</I>. In accordance with procedures established from time to time by agreement
between the Fund and the Transfer Agent, the Transfer Agent shall:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">act as the Fund&rsquo;s fast automated securities transfer (&ldquo;FAST&rdquo;) program transfer agent;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">receive orders for the purchase of Shares from the Fund, and promptly deliver payment and appropriate
documentation thereof to the custodian of the Fund (the &ldquo;Custodian&rdquo;);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">pursuant to such purchase orders, book such Share issuance to the appropriate Shareholder account;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">process transfers of Shares owned by the registered owners thereof upon receipt of proper instruction;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD>process and transmit payments for any dividends and distributions declared by the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">record the issuance of Shares and maintain pursuant to SEC Rule&nbsp;17Ad-10(e)&nbsp;a record of the total
number of Shares which are authorized, based upon data provided to the Transfer Agent by the Fund, and issued and outstanding; and provide
the Fund on a regular basis with the total number of Shares which are issued and outstanding but the Transfer Agent shall have no obligation,
when recording the issuance of Shares, to monitor the issuance of such Shares to determine if there are authorized Shares available for
issuance or to take cognizance of any laws relating to, or corporate actions required for, the issue or sale of such Shares, which functions
shall be the sole responsibility of the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify"><U>p</U>erform certain other customary services of a transfer agent and dividend disbursing agent, including,
but not limited to: maintaining Depository Trust Company (&ldquo;DTC&rdquo;) and direct Shareholder accounts, providing direct Shareholder
registration information for the mailing of Shareholder reports and proxies to direct Shareholders, maintaining such bank accounts as
the Transfer Agent shall deem necessary for the performance of its duties under this Agreement, withholding taxes on U.S. resident and
non-resident alien accounts, preparing and filing U.S. Treasury Department Forms 1099 and other appropriate forms required by federal
authorities with respect to dividends and distributions to direct Shareholders, preparing and mailing confirmation forms and statements
of account to DTC and direct Shareholders for all purchases and transfers of Shares and other confirmable transactions in Shareholder
accounts, preparing and mailing activity statements for direct Shareholders, and providing Shareholder account information and processing
direct Shareholder correspondence and complaints; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">provide sub-certificates in connection with the certification requirements of the Sarbanes-Oxley Act of
2002 with respect to the services provided by the Transfer Agent.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Transfer Agent shall perform such
other services for the Fund as are mutually agreed to by the parties from time to time, for which the Fund will pay such fees as may be
mutually agreed upon, including the Transfer Agent&rsquo;s reasonable out-of-pocket expenses. The provision of such services shall be
subject to the terms and conditions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify"><I>Authorized Persons</I>. The Fund hereby agrees and acknowledges that the Transfer Agent may rely on
the current list of authorized persons, as provided or agreed to by the Fund and as may be amended from time to time by the Fund, in receiving
instructions to issue Shares.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.5</TD><TD STYLE="text-align: justify"><I>Anti-Money Laundering and Client Screening</I>. With respect to the Fund&rsquo;s offering and sale
of Shares at any time, and for all subsequent transfers of such interests, the Fund or its delegate shall, directly or indirectly and
to the extent required by law: (i)&nbsp;conduct know your customer/client identity due diligence with respect to potential investors and
transferees in the Shares and shall obtain and retain due diligence records for each investor and transferee; (ii)&nbsp;use its best efforts
to ensure that each investor&rsquo;s and any transferee&rsquo;s funds used to purchase Shares shall not be derived from, nor the product
of, any criminal activity; (iii)&nbsp;if requested, provide periodic written verifications that such investors/transferees have been checked
against the United States Department of the Treasury Office of Foreign Assets Control database for any non-compliance or exceptions; and
(iv)&nbsp;perform its obligations under this Section&nbsp;in accordance with all applicable anti-money laundering laws and regulations.
In the event that the Transfer Agent has received advice from counsel that access to underlying due diligence records pertaining to the
investors/transferees is necessary to ensure compliance by the Transfer Agent with relevant anti-money laundering (or other applicable)
laws or regulations, the Fund shall, upon receipt of written request from the Transfer Agent, provide the Transfer Agent copies of such
due diligence records.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.6</TD><TD STYLE="text-align: justify"><I>Tax Law</I>. The Transfer Agent shall have no responsibility or liability for any obligations now or
hereafter imposed on the Fund, the Shares, a Shareholder or the Transfer Agent in connection with the services provided by the Transfer
Agent hereunder by the tax laws of any country or of any state or political subdivision thereof. It shall be the responsibility of the
Fund to notify the Transfer Agent of the obligations imposed on the Fund, the Shares, a Shareholder or the Transfer Agent in connection
with the services provided by the Transfer Agent hereunder by the tax law of countries, states and political subdivisions thereof, including
responsibility for withholding and other taxes, assessments or other governmental charges, certifications and governmental reporting.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.7</TD><TD STYLE="text-align: justify">The Transfer Agent shall provide and maintain such office facilities and personnel as it considers reasonable
and appropriate to provide the services contemplated herein.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.8</TD><TD STYLE="text-align: justify">The Transfer Agent will cooperate with the Fund and its Chief Compliance Officer (&ldquo;CCO&rdquo;) in
respect of compliance matters, including the Fund Board&rsquo;s review of the Transfer Agent&rsquo;s compliance policies and procedures
that are relevant in respect of the Fund and the CCO&rsquo;s oversight of the Fund&rsquo;s compliance program, which includes oversight
of compliance by the Transfer Agent</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>FEES AND EXPENSES</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transfer Agent shall be entitled
to reasonable compensation for its services and expenses as Transfer Agent, as agreed upon from time to time between the Fund and the
Transfer Agent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><U>REPRESENTATIONS AND WARRANTIES OF THE TRANSFER AGENT</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transfer Agent represents
and warrants to the Fund that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">It is a Massachusetts trust company duly organized and existing under the laws of The Commonwealth of
Massachusetts.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">It is duly registered as a transfer agent under Section&nbsp;17A(c)(2)&nbsp;of the Securities Exchange
Act of 1934, as amended (the &ldquo;1934 Act&rdquo;), it will remain so registered for the duration of this Agreement, and it will promptly
notify the Fund in the event of any change in its status as a registered transfer agent.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">It is duly qualified and has the trust power and authority to carry on its business in the Commonwealth
of Massachusetts.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">It is empowered under applicable laws and by its organizational documents to enter into and perform the
services contemplated in this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.5</TD><TD STYLE="text-align: justify">All requisite corporate proceedings have been taken to authorize it to enter into and perform this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.6</TD><TD STYLE="text-align: justify">No legal or administrative proceedings have been instituted or threatened which would materially impair
the Transfer Agent&rsquo;s ability to perform its duties and obligations under this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.7</TD><TD STYLE="text-align: justify">Its entrance into this Agreement shall not cause a material breach or be in material conflict with any
other agreement or obligation of the Transfer Agent or any law or regulation applicable to it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><U>REPRESENTATIONS AND WARRANTIES OF THE FUND</U> The Fund represents and warrants to the Transfer Agent
that:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Fund is a corporation, duly organized, existing and in good standing under the laws of the State of
Maryland.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The Fund has the requisite corporate power and authority under applicable laws and by its Article&nbsp;of
Incorporation, as amended, and By-laws, as amended to enter into and perform this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">All requisite corporate proceedings have been taken to authorize the Fund to enter into and perform this
Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">All appropriate state securities law filings have been made and will continue to be made, with respect
to all Shares offered for sale.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">No legal or administrative proceedings have been instituted or threatened which would materially impair
the Fund&rsquo;s ability to perform its duties and obligations under this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.6</TD><TD STYLE="text-align: justify">Its entrance into this Agreement will not cause a material breach or be in material conflict with any
other agreement or obligation of the Fund or any law or regulation applicable to it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.7</TD><TD STYLE="text-align: justify">As of the close of business on the date of this Agreement, the Fund is authorized to issue the Shares
identified in the Offering Material.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><U>DATA ACCESS AND PROPRIETARY INFORMATION</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">The Fund acknowledges that the databases, computer programs, screen formats, report formats, interactive
design techniques, and documentation manuals furnished to the Fund by the Transfer Agent as part of the Fund&rsquo;s ability to access
certain Fund-related data maintained by the Transfer Agent or another third party on databases under the control and ownership of the
Transfer Agent (&ldquo;Data Access Services&rdquo;) constitute copyrighted, trade secret, or other proprietary information (collectively,
 &ldquo;Proprietary Information&rdquo;) of substantial value to the Transfer Agent or another third party. In no event shall Proprietary
Information be deemed Customer Information (as defined below) or the confidential information of the Fund. The Fund agrees to treat all
Proprietary Information as proprietary to the Transfer Agent and further agrees that it shall not divulge any Proprietary Information
to any person or organization except as may be provided hereunder. Without limiting the foregoing, the Fund agrees for itself and its
officers and directors, and their agents, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">use such programs and databases solely on the Fund&rsquo;s, or its agents&rsquo; computers, or solely
from equipment at the location(s)&nbsp;agreed to between the Fund and the Transfer Agent, and solely in accordance with the Transfer Agent&rsquo;s
applicable user documentation;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">refrain from copying or duplicating in any way the Proprietary Information;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">refrain from obtaining unauthorized access to any portion of the Proprietary Information, and if such
access is inadvertently obtained, to inform the Transfer Agent in a timely manner of such fact and dispose of such information in accordance
with the Transfer Agent&rsquo;s instructions;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">refrain from causing or allowing Proprietary Information transmitted from the Transfer Agent&rsquo;s computers
to the Fund&rsquo;s, or its agents&rsquo; computer to be retransmitted to any other computer facility or other location, except with the
prior written consent of the Transfer Agent;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">access only to those authorized transactions agreed upon by the Fund and the Transfer Agent; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">honor all reasonable written requests made by the Transfer Agent to protect at the Transfer Agent&rsquo;s
expense the rights of the Transfer Agent in Proprietary Information at common law, under federal copyright law and under other federal
or state law.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">Proprietary Information shall not include all or any portion of any of the foregoing items that are or
become publicly available without breach of this Agreement; that are released for general disclosure by a written release by the Transfer
Agent; that are independently developed by the Fund without reference to proprietary information or that are already in the possession
of the receiving party at the time of receipt without obligation of confidentiality or breach of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">If the Fund notifies the Transfer Agent that any of the Data Access Services do not operate in material
compliance with the most recently issued user documentation for such services, the Transfer Agent shall endeavor in a timely manner to
correct such failure. Organizations from which the Transfer Agent may obtain certain data included in the Data Access Services are solely
responsible for the contents of such data, and the Fund agrees to make no claim against the Transfer Agent arising out of the contents
of such third-party data, including, but not limited to, the accuracy thereof. DATA ACCESS SERVICES AND ALL COMPUTER PROGRAMS AND SOFTWARE
SPECIFICATIONS USED IN CONNECTION THEREWITH ARE PROVIDED ON AN &ldquo;AS IS, AS AVAILABLE&rdquo; BASIS. THE TRANSFER AGENT EXPRESSLY DISCLAIMS
ALL WARRANTIES EXCEPT THOSE EXPRESSLY STATED HEREIN INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS
FOR A PARTICULAR PURPOSE.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.4</TD><TD STYLE="text-align: justify">If the transactions available to the Fund include the ability to originate electronic instructions to
the Transfer Agent in order to effect the transfer or movement of cash or Shares, Shareholder information or other information, then in
such event the Transfer Agent shall be entitled to rely on the validity and authenticity of such instruction without undertaking any further
inquiry as long as such instruction is undertaken in conformity with security procedures established by the Transfer Agent from time to
time.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.5</TD><TD STYLE="text-align: justify">Each party shall take reasonable efforts to advise its employees of their obligations pursuant to this
Section. The obligations of this Section&nbsp;shall survive any earlier termination of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><U>WIRE TRANSFER OPERATING GUIDELINES</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify"><I>Obligation of Sender</I>. The Transfer Agent is authorized to promptly debit the appropriate Fund account(s)&nbsp;upon
the receipt of a payment order in compliance with the selected security procedure
(the &ldquo;Security Procedure&rdquo;) chosen for funds transfer in the Funds Transfer Addendum to the Custody Agreement between State
Street and the Fund and in the amount of money that the Transfer Agent has been instructed to transfer. The Transfer Agent shall execute
payment orders in compliance with the Security Procedure and with the Fund&rsquo;s instructions on the execution date, provided that such
payment order is received by the customary deadline for processing such a request, unless the payment order specifies a later time. All
payment orders and communications received after the customary deadline will be deemed to have been received the next business day.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify"><I>Security Procedure</I>. The Fund acknowledges that the Security Procedure it has designated on the
Funds Transfer Addendum was selected by the Fund from security procedures offered. The Fund shall restrict access to confidential information
relating to the Security Procedure to authorized persons as communicated to the Transfer Agent in writing. The Fund must notify the Transfer
Agent immediately if it has reason to believe unauthorized persons may have obtained access to such information or of any change in the
Fund&rsquo;s authorized personnel. The Transfer Agent shall verify the authenticity of all instructions received from the Fund according
to the Security Procedure.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify"><I>Account Numbers</I>. The Transfer Agent shall process all payment orders on the basis of the account
number contained in the payment order. In the event of a discrepancy between any name indicated on the payment order and the account number,
the account number shall take precedence and govern.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify"><I>Rejection</I>. The Transfer Agent reserves the right to decline to process or delay the processing
of a payment order which (i)&nbsp;is in excess of the collected balance in the account to be charged at the time of the Transfer Agent&rsquo;s
receipt of such payment order; (ii)&nbsp;if initiating such payment order would cause the Transfer Agent, in the Transfer Agent&rsquo;s
sole judgment, to exceed any volume, aggregate dollar, network, time, credit or similar limits which are applicable to the Transfer Agent;
or (iii)&nbsp;if the Transfer Agent, in good faith is unable to satisfy itself that the transaction has been properly authorized.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify"><I>Cancellation Amendment</I>. The Transfer Agent shall use reasonable efforts to act on all authorized
requests to cancel or amend payment orders received in compliance with the Security Procedure, provided that such requests are received
in a timely manner affording the Transfer Agent reasonable opportunity to act. However, the Transfer Agent assumes no liability if the
request for amendment or cancellation cannot be satisfied.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.6</TD><TD STYLE="text-align: justify"><I>Errors</I>. The Transfer Agent shall assume no responsibility for failure to detect any erroneous payment
order provided that the Transfer Agent complies with the payment order instructions as received and the Transfer Agent complies with the
Security Procedure. The Security Procedure is established for the purpose of authenticating payment orders only and not for the detection
of errors in payment orders.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.7</TD><TD STYLE="text-align: justify"><I>Interest</I>. The Transfer Agent shall assume no responsibility for lost interest with respect to the
refundable amount of any unauthorized payment order, unless the Transfer Agent is notified of the unauthorized payment order within thirty
(30) days of notification by the Transfer Agent of the acceptance of such payment order.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.8</TD><TD STYLE="text-align: justify"><I>ACH Credit Entries/Provisional Payments</I>. When a Fund initiates or receives Automated Clearing House
(&ldquo;ACH&rdquo;) credit and debit entries pursuant to these guidelines and the rules&nbsp;of the National Automated Clearing House
Association and the New England Clearing House Association, the Transfer Agent will act as an Originating Depository Financial Institution
and/or Receiving Depository Financial Institution, as the case may be, with respect to such entries. Credits given by the Transfer Agent
with respect to an ACH credit entry are provisional until the Transfer Agent receives final settlement for such entry from the Federal
Reserve Bank. If the Transfer Agent does not receive such final settlement, the Fund agrees that the Transfer Agent shall receive a refund
of the amount credited to the applicable Fund in connection with such entry, and the party making payment to the Fund via such entry shall
not be deemed to have paid the amount of the entry.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.9</TD><TD STYLE="text-align: justify"><I>Confirmation</I>. Confirmation of the Transfer Agent&rsquo;s execution of payment orders shall ordinarily
be provided within twenty four (24) hours notice of which may be delivered through the Transfer Agent&rsquo;s proprietary information
systems, or by facsimile or call-back. The Fund must report any objections to the execution of an order within thirty (30) calendar days.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><U>STANDARD OF CARE / LIMITATION OF LIABILITY</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transfer Agent shall at
all times act with reasonable care and without negligence in its performance of all services performed under this Agreement, but assumes
no responsibility and shall not be liable for loss or damage due to errors, including encoding and payment processing errors, unless said
errors are caused by its negligence, bad faith, or willful misconduct or that of its employees or agents. The parties agree that any encoding
or payment processing errors shall be governed by this standard of care, and that Section&nbsp;4-209 of the Uniform Commercial Code is
superseded by this Section. In any event, the Transfer Agent&rsquo;s cumulative liability for each calendar year (a &ldquo;Liability Period&rdquo;)
with respect to the Fund under this Agreement regardless of the form of action or legal theory shall be limited to its total annual compensation
earned and fees payable hereunder during the preceding Compensation Period, as defined herein, for any liability or loss suffered by the
Fund including, but not limited to, any liability relating to the Fund&rsquo;s compliance with any federal or state tax or securities
statute, regulation or ruling during such Liability Period. &ldquo;Compensation Period&rdquo; shall mean the calendar year ending immediately
prior to each Liability Period in which the event(s)&nbsp;giving rise to the Transfer Agent&rsquo;s liability for that period have occurred.
Notwithstanding the foregoing, the Compensation Period for purposes of calculating the annual cumulative liability of the Transfer Agent
for the Liability Period commencing on the date of this Agreement and terminating on December&nbsp;31, 2012 shall be the date of this
Agreement through December&nbsp;31, 2012, calculated on an annualized basis, and the Compensation Period for the Liability Period commencing
January&nbsp;1, 2013 and terminating on December&nbsp;31, 2013
shall be the date of this Agreement through December&nbsp;31, 2012, calculated on an annualized basis. In no event shall the Transfer
Agent be liable for special, indirect or consequential damages, regardless of the form of action and even if the same were foreseeable.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><U>INDEMNIFICATION</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">The Transfer Agent shall not be responsible for, and the Fund, shall indemnify and hold the Transfer Agent
harmless from and against, any and all losses, damages, costs, charges, counsel fees (including the defense of any lawsuit in which the
Transfer Agent or affiliate is a named party), payments, expenses and liability arising out of or attributable to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">all actions of the Transfer Agent or its agents or subcontractors required to be taken pursuant to this
Agreement and taken in accordance with this Agreement, provided that such actions are taken in good faith and without negligence, bad
faith or willful misconduct;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the breach of any representation, warranty or covenant of the Fund hereunder;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the Fund&rsquo;s bad faith, gross negligence or willful misconduct;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">reasonable reliance upon, and any subsequent use of or action taken or omitted, by the Transfer Agent,
or its agents or subcontractors on: (a)&nbsp;any information, records, documents, data, share certificates (if any) or services, which
are received by the Transfer Agent or its agents or subcontractors by machine readable input, facsimile, CRT data entry, electronic instructions
or other similar means authorized by the Fund, and which have been prepared, maintained or performed by the Fund or any other person or
firm on behalf of the Fund, including but not limited to any broker-dealer, third party administrator or previous transfer agent; (b)&nbsp;any
instructions or requests of the Fund or the Fund&rsquo;s agents or subcontractors, or any of their respective officers, directors or employees;
(c)&nbsp;any instructions or opinions of legal counsel to the Fund with respect to any matter arising in connection with the services
to be performed by the Transfer Agent under this Agreement which are provided to the Transfer Agent after consultation with such legal
counsel; or (d)&nbsp;any paper or document, reasonably believed to be genuine, authentic, or signed by the proper person or persons;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the offer or sale of Shares in violation of any requirement under the federal or state securities laws
or regulations requiring that such Shares be registered, or in violation of any stop order or other determination or ruling by any federal
or state agency with respect to the offer or sale of such Shares;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">the negotiation and processing of any checks, wires and ACH transmissions, including without limitation,
for deposit into, or credit to, the Fund&rsquo;s demand deposit accounts maintained by the Transfer Agent;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">all actions relating to the transmission of Fund or Shareholder data through the NSCC clearing systems,
if applicable; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">any tax obligations under the tax laws of any country or of any state or political subdivision thereof,
including taxes, withholding and reporting requirements, claims for exemption and refund, additions for late payment, interest, penalties
and other expenses (including legal expenses) that may be assessed, imposed or charged against the Transfer Agent as transfer agent hereunder.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">At any time the Transfer Agent may apply to any officer of the Fund for instructions, and may consult
with legal counsel with respect to any matter arising in connection with the services to be performed by the Transfer Agent under this
Agreement, and the Transfer Agent and its agents or subcontractors shall not be liable and shall be indemnified by the Fund for any action
taken or omitted by it in reliance upon such instructions or upon the opinion of such counsel. The Transfer Agent, its agents and subcontractors
shall be protected and indemnified in acting upon any paper or document furnished by or on behalf of the Fund, reasonably believed to
be genuine and to have been signed by the proper person or persons, or upon any instruction, information, data, records or documents provided
the Transfer Agent or its agents or subcontractors by machine readable input, electronic data entry or other similar means authorized
by the Fund, and shall not be held to have notice of any change of authority of any person, until receipt of written notice thereof from
the Fund. The Transfer Agent, its agents and subcontractors shall also be protected and indemnified in recognizing Share certificates,
if any, which are reasonably believed to bear the proper manual or facsimile signatures of the officers of the Fund, and the proper countersignature
of any former transfer agent or former registrar, or of a co-transfer agent or co-registrar.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">In order that the indemnification provisions contained in this Section&nbsp;shall apply, upon the assertion
of a claim for which the Fund may be required to indemnify the Transfer Agent, the Transfer Agent shall notify the Fund of such assertion,
and shall keep the Fund advised with respect to all material developments concerning such claim. The Fund shall have the option to participate
with the Transfer Agent in the defense of such claim or to defend against said claim in its own name. The Transfer Agent shall in no case
confess any claim or make any compromise in any case in which the Fund may be required to indemnify the Transfer Agent except with the
Fund&rsquo;s prior written consent which shall not be unreasonably withheld.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><U>ADDITIONAL COVENANTS OF THE FUND AND THE TRANSFER AGENT</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">The Fund shall promptly furnish to the Transfer Agent the following:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">A certificate of the Secretary of the Fund certifying resolutions of the Board of Directors of the Fund
authorizing the appointment of the Transfer Agent and the execution and delivery of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">A copy of the Articles of Incorporation and Bylaws of the Fund and all amendments thereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">A copy of the Offering Material.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">The Transfer Agent hereby agrees to establish and maintain facilities and procedures for safekeeping check
forms and facsimile signature imprinting devices, if any; and for the preparation or use, and for keeping account of, such certificates,
forms and devices.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.3</TD><TD STYLE="text-align: justify"><I>Records</I>. The Transfer Agent shall keep records relating to the services to be performed hereunder,
in the form and manner as it may deem advisable. To the extent required by Section&nbsp;31 of the 1940 Act and the Rules&nbsp;thereunder,
the Transfer Agent agrees that all such records prepared or maintained by the Transfer Agent relating to the services to be performed
by the Transfer Agent hereunder are the property of the Fund and will be preserved, maintained and made available in accordance with such
Section&nbsp;and Rules, and will be surrendered promptly to the Fund on and in accordance with its request.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><U>CONFIDENTIALITY</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties hereto agree that
each shall treat confidentially all information provided by each party to the other party regarding its business and operations. All confidential
information provided by a party hereto shall be used by any other party hereto solely for the purpose of rendering or receiving services
pursuant to this Agreement and, except as may be required in carrying out this Agreement, shall not be disclosed to any third party. The
foregoing shall not be applicable to any information (i)&nbsp;that is publicly available when provided or thereafter becomes publicly
available, other than through a breach of this Agreement, (ii)&nbsp;that is independently derived by any party hereto without the use
of any information provided by the other party hereto in connection with this Agreement, (iii)&nbsp;that is required in any legal or regulatory
proceeding, investigation, audit, examination, subpoena, civil investigative demand or other similar process, or by operation of law or
regulation, or (iv)&nbsp;where the party seeking to disclose has received the prior written consent of the party providing the information,
which consent shall not be unreasonably withheld.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">11.</TD><TD STYLE="text-align: justify"><U>EFFECTIVE PERIOD, TERMINATION AND AMENDMENT</U></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall remain
in full force and effect for an initial term ending November&nbsp;30, 2014 (the &ldquo;<B><I>Initial Term</I></B>&rdquo;). After the expiration
of the Initial Term, this Agreement shall automatically renew for successive two-year terms (each, a &ldquo;<B><I>Renewal Term</I></B>&rdquo;)
unless a written notice of non-renewal is delivered by the non-renewing
party no later than sixty (60) days prior to the expiration of the Initial Term or any Renewal Term, as the case may be. During the Initial
Term and thereafter, either party may terminate this Agreement: (i)&nbsp;in the event of the other party&rsquo;s material breach of a
material provision of this Agreement that the other party has either (a)&nbsp;failed to cure or (b)&nbsp;failed to establish a remedial
plan to cure that is reasonably acceptable to the non-breaching party, within 60 days&rsquo; written notice of such breach, or (ii)&nbsp;in
the event of the appointment of a conservator or receiver for the other party or upon the happening of a like event to the other party
at the direction of an appropriate agency or court of competent jurisdiction. Upon termination of this Agreement pursuant to this paragraph,
the Fund shall pay the Transfer Agent its compensation due and shall reimburse the Transfer Agent for its costs, expenses and disbursements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of: (i)&nbsp;the
Fund&rsquo;s termination of this Agreement for any reason other than as set forth in the immediately preceding paragraph or (ii)&nbsp;a
transaction not in the ordinary course of business pursuant to which the Transfer Agent is not retained to continue providing services
hereunder to the Fund (or its respective successor), the Fund shall pay the Transfer Agent its compensation due through the end of the
then-current term (based upon the average monthly compensation previously earned by the Transfer Agent) and shall reimburse the Transfer
Agent for its costs, expenses and disbursements. For the avoidance of doubt, no payment will be required pursuant to clause (ii)&nbsp;of
this paragraph in the event of any transaction such as (a)&nbsp;the liquidation or dissolution of the Fund and distribution of the Fund&rsquo;s
assets as a result of the Board&rsquo;s determination in its reasonable business judgment that the Fund is no longer viable (b)&nbsp;a
merger of the Fund into, or the consolidation of the Fund with, another entity, or (c)&nbsp;the sale by the Fund of all, or substantially
all, of its assets to another entity, in each of (b)&nbsp;and (c)&nbsp;where the Transfer Agent is retained to continue providing services
to the Fund (or its respective successor) on substantially the same terms as this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be amended
at any time in writing by mutual agreement of the parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of Sections
2 and 8 of this Agreement shall survive termination of this Agreement for any reason.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><U>ASSIGNMENT</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">Except as provided in Section&nbsp;14 below, neither this Agreement nor any rights or obligations hereunder
may be assigned by either party without the written consent of the other party.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">Except as explicitly stated elsewhere in this Agreement, nothing under this Agreement shall be construed
to give any rights or benefits in this Agreement to anyone other than the Transfer Agent and the Fund, and the duties and responsibilities
undertaken pursuant to this Agreement shall be for the sole and exclusive benefit of the Transfer Agent and the Fund. This Agreement shall
inure to the benefit of, and be binding upon, the parties and their respective permitted successors and assigns.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify">This Agreement does not constitute an agreement for a partnership or joint venture between the Transfer
Agent and the Fund. Other than as provided in Section&nbsp;14, neither party shall make any commitments with third parties that are binding
on the other party without the other party&rsquo;s prior written consent.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><U>SUBCONTRACTORS</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transfer Agent may, without
further consent on the part of the Fund, subcontract for the performance hereof with (i)&nbsp;Boston Financial Data Services,&nbsp;Inc.,
a Massachusetts corporation (&ldquo;BFDS&rdquo;) which is duly registered as a transfer agent pursuant to Section&nbsp;17A(c)(2)&nbsp;of
the 1934 Act (&ldquo;Section&nbsp;17A(c)(2)&rdquo;), (ii)&nbsp;a BFDS subsidiary duly registered as a transfer agent pursuant to Section&nbsp;17A(c)(2),
(iii)&nbsp;a BFDS affiliate duly registered as a transfer agent or (iv)&nbsp;another affiliated third party duly registered as a transfer
agent pursuant to Section&nbsp;17A(c)(2); provided, however, that the Transfer Agent shall remain liable to the Fund for the acts and
omissions of any subcontractor under this Section&nbsp;as it is for its own acts and omissions under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><U>MISCELLANEOUS</U></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify"><I>Amendment</I>. This Agreement may be amended or modified by a written agreement executed by both parties.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify"><I>Massachusetts Law to Apply</I>. This Agreement shall be construed and the provisions thereof interpreted
under and in accordance with the laws of The Commonwealth of Massachusetts without regard to the conflict of laws provisions thereof.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify"><I>Force Majeure</I>. In the event either party is unable to perform its obligations under the terms of
this Agreement because of acts of God, strikes, equipment or transmission failure or damage reasonably beyond its control, or other causes
reasonably beyond its control, such party shall not be liable for damages to the other for any damages resulting from such failure to
perform or otherwise from such causes.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.4</TD><TD STYLE="text-align: justify"><I>Survival</I>. All provisions regarding indemnification, warranty, liability, and limits thereon, and
confidentiality and/or protections of proprietary rights and trade secrets shall survive the termination of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.5</TD><TD STYLE="text-align: justify"><I>Severability</I>. If any provision or provisions of this Agreement shall be held invalid, unlawful,
or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.6</TD><TD STYLE="text-align: justify"><I>Priorities Clause</I>. In the event of any conflict, discrepancy or ambiguity between the terms and
conditions contained in this Agreement and any schedules or attachments hereto, the terms and conditions contained in this Agreement shall
take precedence.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.7</TD><TD STYLE="text-align: justify"><I>Waiver. </I>No waiver by either party or any breach or default of any of the covenants or conditions
herein contained and performed by the other party shall be construed as a waiver of any succeeding breach of the same or of any other
covenant or condition.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.8</TD><TD STYLE="text-align: justify"><I>Merger of Agreement</I>. This Agreement and any schedules, exhibits, attachments or amendments hereto
constitute the entire agreement between the parties hereto and supersedes any prior agreement with respect to the subject matter hereof
whether oral or written.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.9</TD><TD STYLE="text-align: justify"><I>Counterparts</I>. This Agreement may be executed by the parties hereto on any number of counterparts,
and all of said counterparts taken together shall be deemed to constitute one and the same instrument.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.10</TD><TD STYLE="text-align: justify"><I>Reproduction of Documents</I>. This Agreement and all schedules, exhibits, attachments and amendments
hereto may be reproduced by any photographic, photostatic, microfilm, micro-card, miniature photographic or other similar process. The
parties hereto all/each agree that any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative
proceeding, whether or not the original is in existence and whether or not such reproduction was made by a party in the regular course
of business, and that any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.11</TD><TD STYLE="text-align: justify"><I>Data Protection</I>. The Transfer Agent shall implement and maintain a comprehensive written information
security program that contains appropriate security measures to safeguard the personal information of the Shareholders, employees, directors
and/or officers that the Transfer Agent receives, stores, maintains, processes or otherwise accesses in connection with the provision
of services hereunder. For these purposes, &ldquo;personal information&rdquo; shall mean (i)&nbsp;an individual&rsquo;s name (first initial
and last name or first name and last name), address or telephone number <U>plus</U> (a)&nbsp;social security number, (b)&nbsp;driver&rsquo;s
license number, (c)&nbsp;state identification card number, (d)&nbsp;debit or credit card number, (e)&nbsp;financial account number or
(f)&nbsp;personal identification number or password that would permit access to a person&rsquo;s account or (ii)&nbsp;any combination
of the foregoing that would allow a person to log onto or access an individual&rsquo;s account. Notwithstanding the foregoing &ldquo;personal
information&rdquo; shall not include information that is lawfully obtained from publicly available information, or from federal, state
or local government records lawfully made available to the general public.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.12</TD><TD STYLE="text-align: justify"><I>Notices</I>. All notices and other communications as required or permitted hereunder shall be in writing
and sent by first class mail, postage prepaid, addressed as follows or to such other address or addresses of which the respective party
shall have notified the other.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If to Transfer Agent, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 25%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State Street Bank and Trust Company</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200 Clarendon Street, 16th Floor</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston, Massachusetts 02116</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Sheila McClorey, Transfer Agent Vice President</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: (617) 937-6912</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: (617) 937-8139</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State Street Bank and Trust Company</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.O.&nbsp;Box 5049</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston, MA 02206-5049</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: Mary Moran Zeven, Senior Vice President and Senior Counsel</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: (617) 662-2702</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Fund, to:</FONT></TD>
</TR></TABLE>






<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 25%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Avenue of the Stars, 12<SUP>th</SUP> Floor</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los Angeles, CA 90067</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Daniel Hall</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: (310) 201-4100</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: (310) 201-4170</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder of Page&nbsp;Intentionally Left Blank]</I></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be executed in their names and on their behalf by and through their duly authorized officers, as of the day and year
first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATE STREET BANK AND TRUST COMPANY</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael F. Rogers</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Michael F. Rogers</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Executive Vice President</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Daniel J. Hall</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Daniel J. Hall</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: General Counsel, Chief Legal Officer and Secretary</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><I>**
Signature Page&nbsp;to Transfer Agency and Services Agreement **</I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0"></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(2)
<SEQUENCE>7
<FILENAME>tm2416373d4_ex99-xkx2.htm
<DESCRIPTION>EXHIBIT 99.(K)(2)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx2.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit (k)(2)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution copy</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>ADMINISTRATION AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 140pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
Administration Agreement (&ldquo;Agreement&rdquo;) dated and effective as of November 30, 2012 is by and between State Street Bank and
Trust Company, a Massachusetts trust company (the &ldquo;Administrator&rdquo;), and Ares Dynamic Credit Allocation Fund, Inc., a Maryland
corporation (the </FONT>&ldquo;Fund&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund is a closed-end
management investment company registered with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), and has registered shares
of its common stock, par value $0.001 per share (&ldquo;Shares&rdquo;) with the SEC by means of a registration statement (&ldquo;Registration
Statement&rdquo;) under the Investment Company Act of 1940, as amended (the &ldquo;1940 Act&rdquo;) and under the Securities Act of 1933,
as amended (the &ldquo;1933 Act&rdquo;); and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund desires
to retain the Administrator to furnish certain administrative services to the Fund, and the Administrator is willing to furnish such
services, on the terms and conditions set forth in this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and mutual covenants herein contained, the parties hereto agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><B>A<FONT STYLE="font-variant: small-caps">ppointment
                                            of</FONT> A<FONT STYLE="font-variant: small-caps">dministrator</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund hereby appoints
the Administrator to act as administrator to the Fund for purposes of providing certain services for the period and on the terms set
forth in this Agreement. The Administrator accepts such appointment and agrees to render the services stated herein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><B>D<FONT STYLE="font-variant: small-caps">elivery
                                            of</FONT> D<FONT STYLE="font-variant: small-caps">ocuments</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As promptly as practicable
after the date hereof, the Fund will deliver to the Administrator copies of each of the following documents with respect to the Fund,
if any, and all final amendments and supplements thereto:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">The Fund&rsquo;s Articles of Incorporation
                                            and By-laws;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">The Fund&rsquo;s Registration Statement
                                            on Form N-2 (the &ldquo;Registration Statement&rdquo;) under the 1933 Act and the 1940 Act,
                                            including any Prospectus and Statement of Additional Information (&ldquo;SAI&rdquo;), if
                                            any, incorporated therein;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c.</TD><TD STYLE="text-align: justify">Resolutions of the Board of Directors of
                                            the Fund (the &ldquo;Board&rdquo;) certified by the Fund&rsquo;s Secretary authorizing (i)
                                            the Fund to enter into this Agreement and (ii) certain individuals on behalf of the Fund
                                            to (a) give instructions to the Administrator pursuant to this Agreement and (b) sign checks
                                            and pay expenses;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d.</TD><TD STYLE="text-align: justify">The investment advisory agreement between
                                            the Fund and its investment adviser; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">e.</TD><TD STYLE="text-align: justify">Such other certificates or documents of
                                            the Fund which the Administrator may, in its reasonable discretion, deem necessary or appropriate
                                            in the proper performance of its duties.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>R</B></FONT><B><FONT STYLE="font-variant: small-caps">epresentations
                                            and</FONT> W<FONT STYLE="font-variant: small-caps">arranties of the</FONT> A<FONT STYLE="font-variant: small-caps">dministrator</FONT></B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Administrator represents and warrants
to the Fund that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">It is a Massachusetts trust company duly
                                            organized and existing under the laws of The Commonwealth of Massachusetts;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">It is duly qualified and has the trust
                                            power and authority to carry on its business in The Commonwealth of Massachusetts;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c.</TD><TD STYLE="text-align: justify">All requisite trust proceedings have been
                                            taken to authorize it to enter into and perform this Agreement;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d.</TD><TD STYLE="text-align: justify">It is empowered under applicable laws and
                                            by its organizational documents to enter into and perform the services contemplated by this
                                            Agreement;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">e.</TD><TD STYLE="text-align: justify">No legal or administrative proceedings
                                            have been instituted or threatened which would materially impair the Administrator&rsquo;s
                                            ability to perform its duties and obligations under this Agreement; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">f.</TD><TD STYLE="text-align: justify">Its entrance into this Agreement shall
                                            not cause a material breach or be in material conflict with any other agreement or obligation
                                            of the Administrator or any law or regulation applicable to it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>R</B></FONT><B><FONT STYLE="font-variant: small-caps">epresentations
                                            and</FONT> W<FONT STYLE="font-variant: small-caps">arranties of the</FONT> F<FONT STYLE="font-variant: small-caps">und</FONT></B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Fund represents and warrants to
the Administrator that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">It is a corporation, duly organized, existing
                                            and in good standing under the laws of the State of Maryland;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">It has the requisite corporate power and
                                            authority under applicable laws and by its Articles of Incorporation, as amended, and By-laws,
                                            as amended, to enter into and perform this Agreement;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c.</TD><TD STYLE="text-align: justify">All requisite corporate proceedings have
                                            been taken to authorize it to enter into and perform this Agreement;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d.</TD><TD STYLE="text-align: justify">It is an investment company properly registered
                                            with the SEC under the 1940 Act (or will be upon the effectiveness of the Registration Statement);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">e.</TD><TD STYLE="text-align: justify">The Registration Statement has been filed
                                            and become effective;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">f.</TD><TD STYLE="text-align: justify">No legal or administrative proceedings
                                            have been instituted or threatened which would materially impair the Fund&rsquo;s ability
                                            to perform its duties and obligations under this Agreement; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">g.</TD><TD STYLE="text-align: justify">Its entrance into this Agreement will not
                                            cause a material breach or be in material conflict with any other agreement or obligation
                                            of the Fund or any law or regulation applicable to it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>A</B></FONT><B><FONT STYLE="font-variant: small-caps">dministration
                                            </FONT>S<FONT STYLE="font-variant: small-caps">ervices</FONT></B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator shall provide
the following services, subject to the authorization and direction of the Fund and, in each case where appropriate, the review and comment
by the Fund&rsquo;s independent accountants and legal counsel and in accordance with procedures which may be established from time to
time between the Fund and the Administrator:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><U>Fund Administration Treasury Services</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">Prepare for the review by designated officer(s)
                                            of the Fund financial information regarding the Fund that will be included in the Fund&rsquo;s
                                            semi-annual and annual shareholder reports, Form N-Q reports and other quarterly reports
                                            (as mutually agreed upon), including tax footnote disclosures where applicable;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">Coordinate the audit of the Fund&rsquo;s
                                            financial statements by the Fund&rsquo;s independent accountants, including the preparation
                                            of supporting audit workpapers and other schedules;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c.</TD><TD STYLE="text-align: justify">Prepare for the review by designated officer(s)
                                            of the Fund the Fund&rsquo;s periodic financial reports required to be filed with the SEC
                                            on Form N-SAR and financial information required by Form N-2, proxy statements and such other
                                            reports, forms or filings as may be mutually agreed upon;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d.</TD><TD STYLE="text-align: justify">Prepare for the review by designated officer(s)
                                            of the Fund annual fund expense budgets, perform accrual analyses and roll-forward calculations
                                            and recommend changes to fund expense accruals on a periodic basis, arrange for payment of
                                            the Fund&rsquo;s expenses, review calculations of fees paid to the Fund&rsquo;s investment
                                            adviser, custodian, fund accountant, distributor and transfer agent, and obtain authorization
                                            of accrual changes and expense payments;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">e.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provide
                                            periodic testing of the Fund with respect to compliance with the Internal Revenue Code&rsquo;s
                                            mandatory qualification requirements, the requirements of the </FONT>1940 Act and the investment
                                            limitations by which the Fund must abide as described in the Registration Statement as may
                                            be mutually agreed upon, including quarterly compliance reporting to the designated officer(s)
                                            of the Fund as well as preparation of Board compliance materials;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">f.</TD><TD STYLE="text-align: justify">Prepare and furnish total return performance
                                            information for the Fund, calculated in accordance with applicable U.S. securities laws and
                                            regulations, as may be reasonably requested by Fund management;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">g.</TD><TD STYLE="text-align: justify">Prepare and disseminate vendor survey information;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">h.</TD><TD STYLE="text-align: justify">Provide sub-certificates in connection
                                            with the certification requirements of the Sarbanes-Oxley Act of 2002 with respect to the
                                            services provided by the Administrator;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">i.</TD><TD STYLE="text-align: justify">Maintain certain books and records of the
                                            Fund as required under Rule 31a-1(b) of the 1940 Act, as may be mutually agreed upon;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><U>Fund Administration Legal Services</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">j.</TD><TD STYLE="text-align: justify">Prepare the agenda and resolutions for
                                            all meetings of the Board of Directors of the Fund (the &ldquo;Board&rdquo;) and committees
                                            of the Board as requested by the Fund, make presentations at such Board and committee meetings
                                            where appropriate or upon reasonable request by the Fund, prepare minutes for such Board
                                            and committee meetings, and attend the Fund&rsquo;s shareholder meetings and prepare minutes
                                            of such shareholder meetings;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">k.</TD><TD STYLE="text-align: justify">Prepare and mail quarterly and annual Code
                                            of Ethics forms for Directors who are not &ldquo;interested persons&rdquo; of the Fund under
                                            the 1940 Act;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">l.</TD><TD STYLE="text-align: justify">Prepare for filing with the SEC the following
                                            documents: Form N-CSR, Form N-PX and all amendments to the Registration Statement, including
                                            updates of the Prospectus and SAI for the Fund, if any, and any sticker supplements to the
                                            Prospectus and SAI, if any, for the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">m.</TD><TD STYLE="text-align: justify">Prepare for filing with the SEC proxy statements
                                            and provide consultation on proxy solicitation matters;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">n.</TD><TD STYLE="text-align: justify">Maintain general Board calendars and regulatory
                                            filings calendars;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">o.</TD><TD STYLE="text-align: justify">Maintain copies of the Fund&rsquo;s Articles
                                            of Incorporation and By-laws;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">p.</TD><TD STYLE="text-align: justify">Assist in developing guidelines and procedures
                                            to improve overall compliance by the Fund with all applicable laws and regulations, including
                                            the rules and regulations of the SEC and the other Federal Securities Laws (as defined in
                                            Rule 38a-1 under the 1940 Act);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">q.</TD><TD STYLE="text-align: justify">Assist the Fund in the handling of routine
                                            regulatory examinations of the Fund and work closely with the Fund&rsquo;s internal and external
                                            legal counsel in response to any non-routine regulatory matters;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">r.</TD><TD STYLE="text-align: justify">Maintain awareness of significant emerging
                                            regulatory and legislative developments that may affect the Fund, update the Board and the
                                            investment adviser on those developments and provide related planning assistance where requested
                                            or appropriate;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">s.</TD><TD STYLE="text-align: justify">Coordinate with insurance providers, including
                                            soliciting bids for Directors &amp; Officers/Errors &amp; Omissions (&ldquo;D&amp;O/E&amp;O&rdquo;)
                                            insurance and fidelity bond coverage, file fidelity bonds with the SEC and make related Board
                                            presentations;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">t.</TD><TD STYLE="text-align: justify">Cooperate with the Fund and its Chief Compliance
                                            Officer (&ldquo;CCO&rdquo;) in respect of compliance matters, including the Fund Board&rsquo;s
                                            review of the Administrator&rsquo;s compliance policies and procedures that are relevant
                                            in respect of the Fund and the CCO&rsquo;s oversight of the Fund&rsquo;s compliance program,
                                            which includes oversight of compliance by the Administrator;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B><U>Fund Administration Tax Services</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">u.</TD><TD STYLE="text-align: justify">Prepare annual tax basis provisions for
                                            both excise and income tax purposes, including wash sales and all tax financial statement
                                            disclosure;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">v.</TD><TD STYLE="text-align: justify">Prepare the Fund&rsquo;s annual federal,
                                            state, and local income tax returns and extension requests for review and for execution and
                                            filing by the Fund&rsquo;s independent accountants and execution and filing by the Fund&rsquo;s
                                            treasurer, including Form 1120-RIC, Form 8613 and Form 1099-MISC;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">w.</TD><TD STYLE="text-align: justify">Prepare annual shareholder reporting information
                                            relating to Form 1099-DIV;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">x.</TD><TD STYLE="text-align: justify">Prepare financial information relating
                                            to Form 1099-DIV, including completion of the ICI Primary and Secondary forms, Qualified
                                            Dividend Income, Dividends Received Deduction, Alternative Minimum Tax, Foreign Tax Credit,
                                            United States Government obligations;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">y.</TD><TD STYLE="text-align: justify">Review annual minimum distribution calculations
                                            (income and capital gain) for both federal and excise tax purposes prior to their declaration;
                                            and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">z.</TD><TD STYLE="text-align: justify">Participate in discussions of potential
                                            tax issues with the Fund and the Fund&rsquo;s audit firm.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Tax services, as described in &ldquo;Fund Administration
Tax Services&rdquo; above and in this Agreement, do not include identification of passive foreign investment companies or Internal Revenue
Code Section 1272(a)(6) tax calculations for asset backed securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator shall perform
such other services for the Fund that are mutually agreed to by the parties from time to time, for which the Fund will pay such fees
as may be mutually agreed upon, including the Administrator&rsquo;s reasonable out-of-pocket expenses. The provision of such services
shall be subject to the terms and conditions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator shall provide
the office facilities and the personnel determined by it to perform the services contemplated herein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><B>F<FONT STYLE="font-variant: small-caps">ees</FONT>;
                                            E<FONT STYLE="font-variant: small-caps">xpenses</FONT>; E<FONT STYLE="font-variant: small-caps">xpense
                                            </FONT>R<FONT STYLE="font-variant: small-caps">eimbursement</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator shall be
entitled to reasonable compensation for its services and expenses as Administrator, as agreed upon from time to time between the Fund
and the Administrator. All rights of compensation and expense reimbursement under this Agreement for services performed as of the termination
date shall survive the termination of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will bear all expenses
that are incurred in its operation and not specifically assumed by the Administrator. Expenses to be borne by the Fund include, but are
not limited to: organizational expenses; cost of services of the Fund&rsquo;s independent accountants or other accountants and outside
legal and tax advisers (including review, if any, by such accountants and advisers of the Registration Statement, Form N-CSR, Form N-Q,
Form N-PX, Form N-SAR, proxy materials, federal and state tax qualification as a regulated investment company and other notices, registrations,
reports, filings and materials prepared by the Administrator under this Agreement); cost of any services contracted for by the Fund directly
from parties other than the Administrator; cost of trading operations and brokerage fees, commissions and transfer taxes in connection
with the purchase and sale of securities for the Fund; investment advisory fees; taxes, insurance premiums and other fees and expenses
applicable to its operation; costs incidental to any meetings of shareholders including, but not limited to, legal and accounting fees,
proxy filing fees and the costs of preparation (e.g., typesetting, XBRL-tagging, page changes and all other print vendor and EDGAR charges,
collectively referred to herein as &ldquo;Preparation&rdquo;), printing, distribution and mailing of any proxy materials; costs incidental
to Board meetings, including fees and expenses of Board members; the salary and expenses of any officer, director or employee of the
Fund; costs of Preparation, printing, distribution and mailing, as applicable, of the Registration Statement and any amendments and supplements
thereto and shareholder reports; cost of Preparation and filing of the Fund&rsquo;s tax returns, Form N-2, Form N-CSR, Form N-Q, Form
N-PX and Form N-SAR, and all notices, registrations and amendments associated with applicable federal and state tax and securities laws;
all applicable registration fees and filing fees required under federal and state securities laws; the cost of fidelity bond and D&amp;O/E&amp;O
liability insurance; and the cost of independent pricing services used in computing the Fund&rsquo;s net asset value.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator is authorized
to and may employ, associate or contract with such person or persons as the Administrator may deem desirable to assist the Administrator
in performing its duties under this Agreement; provided, however, that the compensation of such person or persons shall be paid by the
Administrator and that the Administrator shall be as fully responsible to the Fund for the acts and omissions of any such person or persons
as it is for its own acts and omissions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>I</B></FONT><B><FONT STYLE="font-variant: small-caps">nstructions
                                            and</FONT> A<FONT STYLE="font-variant: small-caps">dvice</FONT></B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
any time, the Administrator may apply to any officer of the Fund or his or her designee for instructions and may consult with its own
legal counsel or, in consultation with the Fund, outside counsel for the Fund or the independent accountants for the Fund at the expense
of the Fund, with respect to any matter arising in connection with the services to be performed by the Administrator under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Administrator shall not be liable, and shall be indemnified by the Fund, for any action taken or omitted by it in good faith in reliance
upon any such instructions or advice or upon any paper or document believed by it to be genuine and to have been signed by the proper
person or persons. The Administrator shall not be held to have notice of any change of authority of any person until receipt of written
notice thereof from the Fund. Nothing in this section shall be construed as imposing upon the Administrator any obligation to seek such
instructions or advice, or to act in accordance with such advice when received.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>L</B></FONT><B><FONT STYLE="font-variant: small-caps">imitation
                                            of Liability and</FONT> I<FONT STYLE="font-variant: small-caps">ndemnification</FONT></B></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Administrator agrees to perform its services under this Agreement with reasonable care and without negligence. The Administrator shall
be responsible for the performance only of such duties as are set forth in this Agreement and, except as otherwise provided under Section
6, shall have no responsibility for the actions or activities of any other party, including other service providers. The Administrator
shall have no liability in respect of any loss, damage or expense suffered by the Fund insofar as such loss, damage or expense arises
from the performance of the </FONT>Administrator&rsquo;s duties hereunder in reliance upon records that were maintained for the Fund
by entities other than the Administrator prior to the Administrator&rsquo;s appointment as administrator for the Fund. The Administrator
shall have no liability for any error of judgment or mistake of law or for any loss or damage resulting from the performance or nonperformance
of its duties hereunder unless solely caused by or resulting from the negligence, bad faith or willful misconduct of the Administrator,
its officers, employees or agents. The Administrator shall not be liable for any special, indirect, incidental, punitive or consequential
damages, including lost profits, of any kind whatsoever (including, without limitation, attorneys&rsquo; fees) under any provision of
this Agreement or for any such damages arising out of any act or failure to act hereunder, each of which is hereby excluded by agreement
of the parties regardless of whether such damages were foreseeable or whether either party or any entity had been advised of the possibility
of such damages. In any event, the Administrator&rsquo;s cumulative liability for each calendar year (a &ldquo;Liability Period&rdquo;)
under this Agreement regardless of the form of action or legal theory shall be limited to its total annual compensation earned and fees
payable hereunder during the preceding Compensation Period, as defined herein, for any liability or loss suffered by the Fund including,
but not limited to, any liability relating to qualification of the Fund as a regulated investment company or any liability relating to
the Fund&rsquo;s compliance with any federal or state tax or securities statute, regulation or ruling during such Liability Period. &ldquo;Compensation
Period&rdquo; shall mean the calendar year ending immediately prior to each Liability Period in which the event(s) giving rise to the
Administrator&rsquo;s liability for that period have occurred. Notwithstanding the foregoing, the Compensation Period for purposes of
calculating the annual cumulative liability of the Administrator for the Liability Period commencing on the date of this Agreement and
terminating on December 31, 2012 shall be the date of this Agreement through December 31, 2012, calculated on an annualized basis, and
the Compensation Period for the Liability Period commencing January 1, 2013 and terminating on December 31, 2013 shall be the date of
this Agreement through December 31, 2012, calculated on an annualized basis.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator shall not
be responsible or liable for any failure or delay in performance of its obligations under this Agreement arising out of or caused, directly
or indirectly, by circumstances beyond its control, including without limitation, work stoppage, power or other mechanical failure, computer
virus, natural disaster, governmental action or communication disruption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund shall indemnify
and hold the Administrator and its directors, officers, employees and agents harmless from all loss, cost, damage and expense, including
reasonable fees and expenses for counsel, incurred by the Administrator resulting from any claim, demand, action or suit in connection
with the Administrator&rsquo;s acceptance of this Agreement, any action or omission by it in the performance of its duties hereunder,
or as a result of acting upon any instructions reasonably believed by it to have been duly authorized by the Fund or upon reasonable
reliance on information or records given or made by the Fund or its investment adviser, provided that this indemnification shall not
apply to actions or omissions of the Administrator, its officers, employees or agents in cases of its or their own negligence, bad faith
or willful misconduct.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The limitation of liability
and indemnification contained herein shall survive the termination of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><B>C<FONT STYLE="font-variant: small-caps">onfidentiality</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties hereto agree
that each shall treat confidentially all information provided by each party to the other party regarding its business and operations.
All confidential information provided by a party hereto shall be used by any other party hereto solely for the purpose of rendering or
receiving services pursuant to this Agreement and, except as may be required in carrying out this Agreement, shall not be disclosed to
any third party. The foregoing shall not be applicable to any information (i) that is publicly available when provided or thereafter
becomes publicly available, other than through a breach of this Agreement, (ii) that is independently derived by any party hereto without
the use of any information provided by the other party hereto in connection with this Agreement, (iii) that is required in any legal
or regulatory proceeding, investigation, audit, examination, subpoena, civil investigative demand or other similar process, or by operation
of law or regulation, or (iv) where the party seeking to disclose has received the prior written consent of the party providing the information,
which consent shall not be unreasonably withheld.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><B>C<FONT STYLE="font-variant: small-caps">ompliance
                                            with</FONT> G<FONT STYLE="font-variant: small-caps">overnmental </FONT>R<FONT STYLE="font-variant: small-caps">ules
                                            and </FONT>R<FONT STYLE="font-variant: small-caps">egulations</FONT>; R<FONT STYLE="font-variant: small-caps">ecords</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund assumes full responsibility
for complying with all securities, tax, commodities and other laws, rules and regulations applicable to it.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In compliance with the requirements
of Rule 31a-3 under the 1940 Act, the Administrator agrees that all records which it maintains for the Fund shall at all times remain
the property of the Fund, shall be readily accessible during normal business hours, and shall be promptly surrendered upon the termination
of the Agreement or otherwise on written request except as otherwise provided in Section 12. The Administrator further agrees that all
records that it maintains for the Fund pursuant to Rule 31a-1 under the 1940 Act will be preserved for the periods prescribed by Rule
31a-2 under the 1940 Act unless any such records are earlier surrendered as provided above. Records may be surrendered in either written
or machine-readable form, at the option of the Administrator.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.</B></FONT></TD><TD STYLE="text-align: justify"><B>S<FONT STYLE="font-variant: small-caps">ervices
                                            </FONT>N<FONT STYLE="font-variant: small-caps">ot</FONT> E<FONT STYLE="font-variant: small-caps">xclusive</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The services of the Administrator
are not to be deemed exclusive, and the Administrator shall be free to render similar services to others. The Administrator shall be
deemed to be an independent contractor and shall, unless otherwise expressly provided herein or authorized by the Fund from time to time,
have no authority to act or represent the Fund in any way or otherwise be deemed an agent of the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>12.</B></FONT></TD><TD STYLE="text-align: justify"><B>E<FONT STYLE="font-variant: small-caps">ffective
                                            </FONT>P<FONT STYLE="font-variant: small-caps">eriod and </FONT>T<FONT STYLE="font-variant: small-caps">ermination</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall remain
in full force and effect for an initial term ending November 30, 2014 (the &ldquo;<B><I>Initial Term</I></B>&rdquo;). After the expiration
of the Initial Term, this Agreement shall automatically renew for successive two-year terms (each, a &ldquo;<B><I>Renewal Term</I></B>&rdquo;)
unless a written notice of non-renewal is delivered by the non-renewing party no later than sixty (60) days prior to the expiration of
the Initial Term or any Renewal Term, as the case may be. During the Initial Term and thereafter, either party may terminate this Agreement:
(i) in the event of the other party&rsquo;s material breach of a material provision of this Agreement that the other party has either
(a) failed to cure or (b) failed to establish a remedial plan to cure that is reasonably acceptable to the non-breaching party, within
60 days&rsquo; written notice of such breach, or (ii) in the event of the appointment of a conservator or receiver for the other party
or upon the happening of a like event to the other party at the direction of an appropriate agency or court of competent jurisdiction.
Upon termination of this Agreement pursuant to this paragraph, the Fund shall pay the Administrator its compensation due and shall reimburse
the Administrator for its costs, expenses and disbursements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of: (i) the
Fund&rsquo;s termination of this Agreement for any reason other than as set forth in the immediately preceding paragraph or (ii) a transaction
not in the ordinary course of business pursuant to which the Administrator is not retained to continue providing services hereunder to
the Fund (or its respective successor), the Fund shall pay the Administrator its compensation due through the end of the then-current
term (based upon the average monthly compensation previously earned by the Administrator) and shall reimburse the Administrator for its
costs, expenses and disbursements. For the avoidance of doubt, no payment will be required pursuant to clause (ii) of this paragraph
in the event of any transaction such as (a) the liquidation or dissolution of the Fund and distribution of the Fund&rsquo;s assets as
a result of the Board&rsquo;s determination in its reasonable business judgment that the Fund is no longer viable (b) a merger of the
Fund into, or the consolidation of the Fund with, another entity, or (c) the sale by the Fund of all, or substantially all, of its assets
to another entity, in each of (b) and (c) where the Administrator is retained to continue providing services to the Fund (or its respective
successor) on substantially the same terms as this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of Sections
6 and 8 of this Agreement shall survive termination of this Agreement for any reason.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.</B></FONT></TD><TD STYLE="text-align: justify"><B>N<FONT STYLE="font-variant: small-caps">otices</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any notice or other communication
authorized or required by this Agreement to be given to either party shall be in writing and deemed to have been given when delivered
in person or by confirmed facsimile, by overnight delivery through a commercial courier service, or posted by certified mail, return
receipt requested, to the following address (or such other address as a party may specify by written notice to the other):</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to the Fund:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Ares Dynamic Credit Allocation Fund, Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000
Avenue of the Stars, 12<SUP>th</SUP> F</FONT><FONT STYLE="font-size: 10pt">loor</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Daniel Hall</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: (310)201-4100</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Facsimile: (310) 201-4170</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to the Administrator:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">State Street Bank and Trust Company</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">P.O. Box 5049</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Boston, MA 02206-5049</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Mary Moran Zeven, Senior Vice President and Senior Counsel</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: (617) 662-1783</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Facsimile: (617) 662-2702</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14.</B></FONT></TD><TD STYLE="text-align: justify"><B>A<FONT STYLE="font-variant: small-caps">mendment</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement may be amended at any time in writing
by mutual agreement of the parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.</B></FONT></TD><TD STYLE="text-align: justify"><B>A<FONT STYLE="font-variant: small-caps">ssignment</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement shall not be assigned by either
party hereto without the prior consent in writing of the other party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>16.</B></FONT></TD><TD STYLE="text-align: justify"><B>S<FONT STYLE="font-variant: small-caps">uccessors</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement shall be binding on and shall inure
to the benefit of the Fund and the Administrator and their respective successors and permitted assigns.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>17.</B></FONT></TD><TD STYLE="text-align: justify"><B>D<FONT STYLE="font-variant: small-caps">ata
                                            </FONT>P<FONT STYLE="font-variant: small-caps">rotection</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Administrator shall implement and maintain a comprehensive written information security program that contains appropriate security measures
to safeguard the personal information of the Fund&rsquo;s shareholders, employees, directors and/or officers that the Administrator receives,
stores, maintains, processes or otherwise accesses in connection with the provision of services hereunder. For these purposes, &ldquo;personal
information&rdquo; shall mean </FONT>(i) an individual&rsquo;s name (first initial and last name or first name and last name), address
or telephone number <U>plus</U> (a) social security number, (b) driver&rsquo;s license number, (c) state identification card number,
(d) debit or credit card number, (e) financial account number or (f) personal identification number or password that would permit access
to a person&rsquo;s account or (ii) any combination of the foregoing that would allow a person to log onto or access an individual&rsquo;s
account. Notwithstanding the foregoing &ldquo;personal information&rdquo; shall not include information that is lawfully obtained from
publicly available information, or from federal, state or local government records lawfully made available to the general public.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>18.</B></FONT></TD><TD STYLE="text-align: justify"><B>E<FONT STYLE="font-variant: small-caps">ntire
                                            </FONT>A<FONT STYLE="font-variant: small-caps">greement</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement contains the
entire understanding between the parties hereto with respect to the subject matter hereof and supersedes all previous representations,
warranties or commitments regarding the services to be performed hereunder whether oral or in writing.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>19.</B></FONT></TD><TD STYLE="text-align: justify"><B>W<FONT STYLE="font-variant: small-caps">aiver</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The failure of a party to
insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver nor shall it deprive such
party of the right thereafter to insist upon strict adherence to that term or any term of this Agreement. Any waiver must be in writing
signed by the waiving party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>20.</B></FONT></TD><TD STYLE="text-align: justify"><B>S<FONT STYLE="font-variant: small-caps">everability</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any provision of this
Agreement is invalid or unenforceable, the balance of the Agreement shall remain in effect, and if any provision is inapplicable to any
person or circumstance it shall nevertheless remain applicable to all other persons and circumstances.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>21.</B></FONT></TD><TD STYLE="text-align: justify"><B>G<FONT STYLE="font-variant: small-caps">overning
                                            </FONT>L<FONT STYLE="font-variant: small-caps">aw</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall be construed
and the provisions thereof interpreted under and in accordance with the laws of The Commonwealth of Massachusetts, without regard to
its conflicts of laws provisions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>22.</B></FONT></TD><TD STYLE="text-align: justify"><B>R<FONT STYLE="font-variant: small-caps">eproduction
                                            of</FONT> D<FONT STYLE="font-variant: small-caps">ocuments</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement and all schedules,
exhibits, attachments and amendments hereto may be reproduced by any photographic, xerographic, photostatic, microfilm, micro-card, miniature
photographic or other similar process. The parties hereto all/each agree that any such reproduction shall be admissible in evidence as
the original itself in any judicial or administrative proceeding, whether or not the original is in existence and whether or not such
reproduction was made by a party in the regular course of business, and that any enlargement, facsimile or further reproduction of such
reproduction shall likewise be admissible in evidence.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>23.</B></FONT></TD><TD STYLE="text-align: justify"><B>C<FONT STYLE="font-variant: small-caps">ounterparts</FONT></B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be executed
by the parties hereto on any number of counterparts, and all of said counterparts taken together shall be deemed to constitute one and
the same instrument.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>[Remainder of page intentionally
left blank.]</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be executed by their officers designated below as of the date first written above.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES DYNAMIC CREDIT ALLOCATION FUND,
    INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel
    J. Hall</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel J. Hall</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE STREET BANK AND TRUST COMPANY</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael F. Rogers</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael F. Rogers</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.1in; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">** <I>Signature Page to
Administration Agreement</I> **</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(3)
<SEQUENCE>8
<FILENAME>tm2416373d4_ex99-xkx3.htm
<DESCRIPTION>EXHIBIT 99.(K)(3)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx3.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit (k)(3)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">EXECUTION VERSION</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 345pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>TRADEMARK LICENSE AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This TRADEMARK LICENSE AGREEMENT (this &ldquo;Agreement&rdquo;)
is entered into as of November 30, 2012 (the &ldquo;Effective Date&rdquo;), by and between Ares Management LLC ( &ldquo;Licensor&rdquo;)
and Ares Dynamic Credit Allocation Fund, Inc., a corporation organized under the laws of the State of Maryland (the &ldquo;Fund&rdquo;)
(each a &ldquo;party,&rdquo; and collectively, the &ldquo;parties&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, to its knowledge Licensor is the owner
of the trade name &ldquo;ARES&rdquo; (the &ldquo;Licensed Mark&rdquo;) in the United States of America (the &ldquo;Territory&rdquo;);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Fund is a newly
organized closed-end management investment company that is registered with the Securities and Exchange Commission as an investment company
under the Investment Company Act of 1940 (the &ldquo;1940 Act&rdquo;);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, pursuant to the Investment Advisory and
Management Agreement dated as of November 30, 2012, by and between Ares Capital Management II LLC, a subsidiary of Licensor (the &ldquo;Adviser&rdquo;),
and the Fund (the &ldquo;Advisory Agreement&rdquo;), the Fund has engaged the Adviser to act as the investment adviser to the Fund; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Fund desires to use the Licensed
Mark in connection with the operation of its business, and Licensor is willing to permit the Fund to use the Licensed Mark, subject to
the terms and conditions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the mutual
covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
1</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>LICENSE GRANT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 184pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>License.
</I>Subject to the terms and conditions of this Agreement, Licensor hereby grants to the Fund, and the Fund hereby accepts from Licensor,
a personal, non-exclusive, non-transferable, royalty-free right and license to use the Licensed Mark solely and exclusively as an element
of the Fund&rsquo;s own company name. The Fund shall use the Licensed Mark solely and exclusively in connection with the business of
the Fund. Except as provided above, neither the Fund nor any affiliate, owner, director, officer, employee, or agent thereof shall use
the Licensed Mark or any derivative thereof or any mark that is confusingly similar to the Licensed Mark without the prior express written
consent of Licensor in its sole and absolute discretion. All rights not expressly granted to the Fund hereunder shall remain the exclusive
property of Licensor. The Fund shall not have a right to sublicense the Licensed Mark except to a wholly-owned subsidiary of the Fund,
and any sublicense shall terminate if such entity ceases to be a wholly-owned subsidiary of the Fund. Except as expressly provided herein,
neither party may use any trademark or service mark of the other party without that party&rsquo;s prior written consent, which consent
shall be given in that party&rsquo;s sole discretion.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Licensor&rsquo;s
Use. </I>Nothing in this Agreement shall preclude Licensor, its affiliates, or any of their respective successors or assigns from using
or permitting other entities to use the Licensed Mark whether or not such entity directly or indirectly competes or conflicts with the
Fund&rsquo;s business in any manner.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
2</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OWNERSHIP</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 197pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Ownership.
</I>The Fund acknowledges and agrees that Licensor is the owner of all right, title, and interest in and to the Licensed Mark, and that
all such right, title, and interest shall remain with Licensor. During the term of this Agreement or anytime thereafter, the Fund shall
not contest, dispute, or challenge in any manner Licensor&rsquo;s right, title, and interest in and to the Licensed Mark or the validity
or enforceability of the Licensed Mark, or knowingly assist any third party to do any of the above. The Fund shall not register or attempt
to register the Licensed Mark or any derivative thereof or any mark that is confusingly similar to the Licensed Mark as a trademark or
domain name or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Goodwill.
</I>All goodwill and reputation generated by the use of the Licensed Mark by the Fund or by any authorized sub-licensee of the Fund shall
inure solely to the benefit of Licensor. To the extent that any rights in and to the Licensed Mark are deemed to accrue to the Fund pursuant
to this Agreement or otherwise, the Fund hereby irrevocably assigns any and all such rights, at such time as they may be deemed to accrue,
to Licensor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
3</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>COMPLIANCE</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 192pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Quality
Control. </I>In order to preserve the inherent value of the Licensed Mark, the Fund agrees to maintain the quality and integrity of the
Fund&rsquo;s business and the operation thereof equal to the standards prevailing in the operation of Licensor&rsquo;s business. The
Fund further agrees to use the Licensed Mark in accordance with quality standards established by Licensor. The Fund shall not, by any
act or omission, use the Licensed Mark in any manner that disparages or reflects adversely on Licensor or its business or reputation
(as determined by the Licensor in its sole discretion). At Licensor&rsquo;s request, the Fund shall promptly provide Licensor with samples
of the Fund&rsquo;s use of the Licensed Mark and, if Licensor determines that any such use does not conform to Licensor&rsquo;s standards,
the Fund shall, within 30 days of written notice from Licensor, make all changes that Licensor requests.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Compliance
With Laws. </I>The Fund agrees that the business operated by it in connection with the Licensed Mark shall comply with all laws, rules,
regulations and requirements of any governmental body in the Territory or elsewhere as may be applicable to the operation, advertising
and promotion of the business, and shall notify Licensor of any action that must be taken by the Fund to comply with such law, rules,
regulations or requirements. The Fund shall use the Licensed Mark with all notices and legends required by any such law, rule, regulation,
or requirement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Notification
of Infringement. </I>Each party shall promptly notify the other party and provide to the other party all relevant background facts upon
becoming aware of (i) any registrations of, or applications for registration of, marks in the Territory that do or may conflict with
the Licensed Mark, and (ii) any infringements, imitations, or illegal use or misuse of the Licensed Mark in the Territory. Licensor,
in its sole discretion, shall determine whether to take any action with respect to any such registration, application, infringement,
imitation, or illegal use or misuse, and, at Licensor&rsquo;s request and expense, the Fund shall cooperate with Licensor in any such
action that it undertakes.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
4</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>REPRESENTATIONS AND WARRANTIES</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 118pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Mutual
Representations. </I>Each party hereby represents and warrants to the other party as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Due
Authorization. </I>Such party is an entity duly formed and in good standing as of the Effective Date, and the execution, delivery and
performance of this Agreement by such party have been duly authorized by all necessary action on the part of such party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Due
Execution. </I>This Agreement has been duly executed and delivered by such party and, with the other party&rsquo;s due authorization,
execution and delivery, constitutes a legal, valid and binding obligation of such party, enforceable against such party in accordance
with its terms.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>No
Conflict. </I>Such party&rsquo;s execution, delivery and performance of this Agreement do not: (i) violate, conflict with or result in
the breach of any provision of the charter, by-laws or limited liability company agreement (or similar organizational documents) of such
party; (ii) conflict with or violate any law or governmental order applicable to such party or any of its assets, properties or businesses;
or (iii) conflict with, result in any breach of, constitute a default (or event which, with the giving of notice or lapse of time, or
both, would become a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration,
suspension, revocation or cancellation of any contract, agreement, lease, sublease, license, permit, franchise or other instrument or
arrangement to which it is a party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">4.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Licensor
makes no representation or warranty to the Fund with respect to Licensor&rsquo;s right to use and/or license the Licensed Mark.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
5</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>TERM AND TERMINATION</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 156pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Term.
</I>This Agreement shall expire upon the earliest to occur of: (i) expiration or termination of the Advisory Agreement in accordance
with its terms; (ii) if Adviser ceases to serve as investment adviser to the Fund; or (iii) by Licensor or the Fund upon sixty (60) days&rsquo;
written notice to the other party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Upon
Termination. </I>Upon expiration or termination of this Agreement, all rights granted to the Fund under this Agreement with respect to
the Licensed Mark shall cease, and the Fund shall immediately discontinue use of the Licensed Mark. For one year following termination
of this Agreement, the Fund shall specify on all public-facing materials in a prominent place and in prominent typeface, which display
must be acceptable to Licensor, that the Fund is no longer operating under the Licensed Mark and is no longer associated with Licensor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #010000"><B>ARTICLE
6</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 202pt; color: #010000">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>MISCELLANEOUS</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 181pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Assignment.
</I>This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted
assigns. Neither party may assign, delegate or otherwise transfer this Agreement or any of its rights or obligations hereunder without
the prior written consent of the other party. Any purported assignment in violation of this provision shall be null and void ab initio.
No assignment by either party permitted hereunder shall relieve the applicable party of its obligations under this Agreement. Any assignment
by either party in accordance with the terms of this Agreement shall be pursuant to a written assignment agreement in which the assignee
expressly assumes the assigning party&rsquo;s rights and obligations hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Independent
Contractor. </I>Except as expressly provided or authorized in the Advisory Agreement, neither party shall have, or shall represent that
it has, any power, right or authority to bind the other party to any obligation or liability, or to assume or create any obligation or
liability on behalf of the other party.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Notices.
</I>All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given
if (i) delivered by hand or overnight courier service and receipted for by the party to whom said notice or other communication shall
have been directed, on receipt, or (ii) mailed by certified or registered mail with postage prepaid, on the third business day after
the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">(a)</FONT></TD><TD STYLE="text-align: justify">If
                                            to Licensor, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Ares Management LLC</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">2000 Avenue of the Stars</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Los Angeles, California 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attn: General Counsel</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">(b)</FONT></TD><TD STYLE="text-align: justify">If
                                            to the Fund to:</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Ares Dynamic Credit Allocation Fund, Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">2000 Avenue of the Stars</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Los Angeles, California 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attn: Chief Legal Counsel</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished to Licensor by
the Fund or to the Fund by Licensor, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Governing
Law. </I>This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, including without
limitation Sections 5-1401 and 5-1402 of the New York General Obligations Law and New York Civil Practice Laws and Rules 327(b). The
parties unconditionally and irrevocably consent to the exclusive jurisdiction of the courts located in the State of New York, and waive
any objection with respect thereto, for the purpose of any action, suit or proceeding arising out of or relating to this Agreement or
the transactions contemplated hereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Amendment.
</I>This Agreement may not be amended or modified except by an instrument in writing signed by all parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>No
Waiver. </I>The failure of either party to enforce at any time for any period the provisions of or any rights deriving from this Agreement
shall not be construed to be a waiver of such provisions or rights or the right of such party thereafter to enforce such provisions,
and no waiver shall be binding unless executed in writing by all parties hereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Severability.
</I>If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any law or public policy,
all other terms and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner, in order
that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Headings.
</I>The descriptive headings contained in this Agreement are for convenience of reference only and shall not affect in any way the meaning
or interpretation of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Counterparts.
</I>This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original instrument
and all of which taken together shall constitute one and the same agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Entire
Agreement. </I>This Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof and supersedes
all prior agreements and undertakings, both written and oral, between the parties with respect to such subject matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010000">6.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Third
Party Beneficiaries. </I>Nothing in this Agreement, either express or implied, is intended to or shall confer upon any third party any
legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>[REMAINDER OF PAGE INTENTIONALLY
BLANK]</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103pt">&nbsp;</P>




<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">IN
</FONT>WITNESS WHEREOF, each party has caused this Agreement to be executed as of the Effective Date by its duly authorized officer.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>LICENSOR:</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES</FONT> <FONT STYLE="font-size: 10pt">MANAGEMENT
    LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel
    J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized Signatory</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FUND:</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/
    Seth J. Brufsky</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>** Signature Page to
Trademark License Agreement **</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(4)
<SEQUENCE>9
<FILENAME>tm2416373d4_ex99-xkx4.htm
<DESCRIPTION>EXHIBIT 99.(K)(4)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx4.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(k)(4)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">[Execution Version]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>INDEMNIFICATION AGREEMENT</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS INDEMNIFICATION AGREEMENT (&ldquo;Agreement&rdquo;)
is made and entered into as of the 30th day of November, 2012, by and between Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland
corporation (the &ldquo;Fund&rdquo;), and Seth J. Brufsky (&ldquo;Indemnitee&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, at the request of the Fund,&nbsp;Indemnitee
currently serves as a director and an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS,&nbsp;Indemnitee may be subjected to claims,
suits or proceedings arising as a result of Indemnitee&rsquo;s service a director and an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as an inducement to Indemnitee to serve
or continue to serve a director and an officer, the Fund has agreed to indemnify and to advance expenses and costs incurred by Indemnitee
in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Fund and Indemnitee do hereby covenant and agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
For purposes of this Agreement:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Change in Control&rdquo;
means a change in control of the Fund occurring after the Effective Date of a nature that would be required to be reported in response
to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), whether or not the Fund is then subject to such reporting
requirement; provided, however, that, without limitation, such a Change in Control shall be deemed to have occurred if, after the Effective
Date (i)&nbsp;any &ldquo;person&rdquo; (as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) is or becomes
the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly, of securities of the
Fund representing 15% or more of the combined voting power of all of the Fund&rsquo;s then-outstanding securities without the prior approval
of at least two-thirds of the members of the Board of Directors of the Fund (the &ldquo;Board&rdquo;) in office immediately prior to such
person&rsquo;s attaining such percentage interest; (ii)&nbsp;there occurs a proxy contest, or the Fund is a party to a merger, consolidation,
sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds of the members of the Board then in office,
as a consequence of which members of the Board in office immediately prior to such transaction or event constitute less than a majority
of the Board thereafter; or (iii)&nbsp;at any time, a majority of the members of the Board are not individuals (A)&nbsp;who were directors
as of the Effective Date or (B)&nbsp;whose election by the Board or nomination for election by the Fund&rsquo;s stockholders was approved
by the affirmative vote of at least two-thirds of the directors then in office who were directors as of the Effective Date or whose election
or nomination for election was previously so approved.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Corporate
Status&rdquo; means the status of a person as a present or former director, officer, employee or agent of the Fund or as a director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity
at the request of the Fund. As a clarification and without limiting the circumstances in which Indemnitee may be serving at the request
of the Fund, service by Indemnitee shall be deemed to be at the request of the Fund: (i)&nbsp;if Indemnitee serves or served as a director,
trustee, officer, partner, manager, managing member, fiduciary, employee or agent of any corporation, partnership, limited liability company,
joint venture, trust or other enterprise (1)&nbsp;of which a majority of the voting power or equity interest is owned directly or indirectly
by the Fund or (2)&nbsp;the management of which is controlled directly or indirectly by the Fund and (ii)&nbsp;if, as a result of Indemnitee&rsquo;s
service to the Fund,&nbsp;Indemnitee is subject to duties by, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as deemed fiduciary thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Disinterested
Director&rdquo; means a director of the Fund who is not and was not a party to the Proceeding in respect of which indemnification and/or
advance of Expenses is sought by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Effective Date&rdquo; means the date
set forth in the first paragraph of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Expenses&rdquo;
means any and all reasonable and out-of-pocket attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement,
ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding. Expenses shall
also include Expenses incurred in connection with any appeal resulting from any Proceeding including, without limitation, the premium,
security for and other costs relating to any cost bond, supersedeas bond or other appeal bond or its equivalent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Independent
Counsel&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is, nor in the
past five years has been, retained to represent: (i)&nbsp;the Fund or Indemnitee in any matter material to either such party (other than
with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements),
or (ii)&nbsp;any other party to or participant or witness in the Proceeding giving rise to a claim for indemnification or advance of Expenses
hereunder. Notwithstanding the foregoing, the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Fund or Indemnitee in
an action to determine Indemnitee&rsquo;s rights under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Proceeding&rdquo; means
any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative
hearing or any other proceeding, whether brought by or in the right of the Fund or otherwise and whether of a civil (including intentional
or unintentional tort claims), criminal, administrative or investigative (formal or informal) nature, including any appeal therefrom,
except one pending or completed on or before the Effective Date, unless otherwise specifically agreed in writing by the Fund and Indemnitee.
If Indemnitee reasonably believes that a given situation may lead to or culminate in the institution of a Proceeding, such situation shall
also be considered a Proceeding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services
by Indemnitee</U>. Indemnitee serves as a director and an officer of the Fund. However, this Agreement shall not impose any independent
obligation on Indemnitee or the Fund to continue Indemnitee&rsquo;s service to the Fund. This Agreement shall not be deemed an employment
contract between the Fund (or any other entity) and Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Fund shall indemnify, and advance Expenses to,&nbsp;Indemnitee (a)&nbsp;as provided in this Agreement and (b)&nbsp;otherwise to
the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; provided, however,
that no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland
law as in effect on the Effective Date. The rights of Indemnitee provided in this Section&nbsp;3 shall include, without limitation,
the rights set forth in the other sections of this Agreement, including any additional indemnification permitted by
Section&nbsp;2-418(g)&nbsp;of the Maryland General Corporation Law (the &ldquo;MGCL&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Standard
for Indemnification</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a
party to any Proceeding, the Fund shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement
and all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with any such
Proceeding unless it is established that (a)&nbsp;the act or omission of Indemnitee was material to the matter giving rise to the
Proceeding and (i)&nbsp;was committed in bad faith or (ii)&nbsp;was the result of active and deliberate dishonesty,
(b)&nbsp;Indemnitee actually received an improper personal benefit in money, property or services or (c)&nbsp;in the case of any
criminal Proceeding,&nbsp;Indemnitee had reasonable cause to believe that his conduct was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain Limits on Indemnification</U>.
Notwithstanding any other provision of this Agreement (other than Section&nbsp;6),&nbsp;Indemnitee shall not be entitled to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if the Proceeding was one by or in the right of the Fund and Indemnitee is adjudged, in a final adjudication of the Proceeding
not subject to further appeal, to be liable to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit was improperly received in any Proceeding charging improper personal benefit to Indemnitee, whether or not involving
action in the Indemnitee&rsquo;s Corporate Status; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification or advance of
Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i)&nbsp;the Proceeding was brought to enforce indemnification
under this Agreement, and then only to the extent in accordance with and as authorized by Section&nbsp;12 of this Agreement, or (ii)&nbsp;the
Fund&rsquo;s Articles of Incorporation or Bylaws, a resolution of the stockholders entitled to vote generally in the election of directors
or of the Board or an agreement approved by the Board to which the Fund is a party expressly provide otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Court-Ordered Indemnification</U>.
Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee and such notice
as the court shall require, may order indemnification of Indemnitee by the Fund in the following circumstances:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is entitled to reimbursement under Section&nbsp;2-418(d)(1)&nbsp;of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant
circumstances, whether or not Indemnitee (i) has
met the standards of conduct set forth in Section&nbsp;2-418(b)&nbsp;of the MGCL or (ii)&nbsp;has been adjudged liable for receipt
of an improper personal benefit under Section&nbsp;2-418(c)&nbsp;of the MGCL, the court may order such indemnification as the court
shall deem proper. However, indemnification with respect to any Proceeding by or in the right of the Fund or in which liability
shall have been adjudged in the circumstances described in Section&nbsp;2-418(c)&nbsp;of the MGCL shall be limited to Expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
for Expenses of an Indemnitee Who is Wholly or Partially Successful</U>. Notwithstanding any other provision of this Agreement, and
without limiting any such provision, to the extent that Indemnitee was or is, by reason of his Corporate Status, made a party to (or
otherwise becomes a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such
Proceeding,&nbsp;Indemnitee shall be indemnified for all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on
the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Fund shall indemnify
Indemnitee under this Section&nbsp;7 for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf
in connection with each such claim, issue or matter, allocated on a reasonable and proportionate basis. For purposes of this
Section&nbsp;7 and, without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or
without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Advance
of Expenses for Indemnitee</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be,
made a party to any Proceeding, the Fund shall, without requiring a preliminary determination of Indemnitee&rsquo;s ultimate
entitlement to indemnification hereunder, advance all reasonable Expenses incurred by or on behalf of Indemnitee in connection with
such Proceeding. Such advance or advances shall be made within ten days after the receipt by the Fund of a statement or statements
requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding and may be in
the form of, in the reasonable discretion of the Indemnitee (but without duplication) (a)&nbsp;payment of such Expenses directly to
third parties on behalf of Indemnitee, (b)&nbsp;advancement to Indemnitee of funds in an amount sufficient to pay such Expenses or
(c)&nbsp;reimbursement to Indemnitee for Indemnitee&rsquo;s payment of such Expenses. Such statement or statements shall reasonably
evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written affirmation by Indemnitee
of Indemnitee&rsquo;s good faith belief that the standard of conduct necessary for indemnification by the Fund as authorized by law
and by this Agreement has been met and a written undertaking by or on behalf of Indemnitee, in substantially the form attached
hereto as <U>Exhibit&nbsp;A</U> or in such form as may be required under applicable law as in effect at the time of the execution
thereof, to reimburse the portion of any Expenses advanced to Indemnitee relating to claims, issues or matters in the Proceeding as
to which it shall ultimately be established that the standard of conduct has not been met by Indemnitee and which have not been
successfully resolved as described in Section&nbsp;7 of this Agreement. For so long as the Fund is subject to the Investment Company
Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;), any advancement of Expenses shall be subject to at least one of
the following as a condition of the advancement: (a)&nbsp;Indemnitee shall provide a security for Indemnitee&rsquo;s undertaking,
(b)&nbsp;the Fund shall be insured against losses arising by reason of any lawful advances or (c)&nbsp;a majority of a quorum of the
Disinterested Directors, or Independent Counsel, in a written opinion, shall determine, based on a review of readily available facts
(as opposed to a full-trial-type inquiry), that there is no reason to believe that Indemnitee ultimately will be found to not be
entitled to indemnification. To the extent that Expenses advanced to Indemnitee do not relate to a specific claim, issue or matter
in the Proceeding, such Expenses shall be allocated on a reasonable and proportionate basis. The undertaking required by this
Section&nbsp;8 shall be an unlimited general obligation by or on behalf of Indemnitee and shall be accepted without reference to
Indemnitee&rsquo;s financial ability to repay such advanced Expenses and without any requirement to post security therefor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification and
Advance of Expenses as a Witness or Other Participant</U>. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is or may be, by reason of Indemnitee&rsquo;s Corporate Status, made a witness or otherwise asked to participate in any
Proceeding, whether instituted by the Fund or any other party, and to which Indemnitee is not a party,&nbsp;Indemnitee shall be
advanced all reasonable Expenses and indemnified against all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith within ten days after the receipt by the Fund of a statement or statements
requesting any such advance or indemnification from time to time, whether prior to or after final disposition of such Proceeding.
Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Procedure
for Determination of Entitlement to Indemnification</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To obtain indemnification under this
Agreement,&nbsp;Indemnitee shall submit to the Fund a written request, including therein or therewith such documentation and
information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee
is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at such time(s)&nbsp;as
Indemnitee deems appropriate in Indemnitee&rsquo;s sole discretion. The officer of the Fund receiving any such request from
Indemnitee shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has
requested indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request by Indemnitee for indemnification pursuant to Section&nbsp;10(a)&nbsp;above, a determination, if required by
applicable law, with respect to Indemnitee&rsquo;s entitlement thereto shall promptly be made in the specific case: (i)&nbsp;if a
Change in Control shall have occurred, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered
to Indemnitee, which Independent Counsel shall be selected by the Indemnitee and approved by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL, which approval shall not be unreasonably withheld; or (ii)&nbsp;if a Change in
Control shall not have occurred, (A)&nbsp;by the Board by a majority vote of a quorum consisting of Disinterested Directors or, if
such a quorum cannot be obtained, then by a majority vote of a duly authorized committee of the Board consisting solely of one or
more Disinterested Directors, (B)&nbsp;if Independent Counsel has been selected by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL and approved by the Indemnitee, which approval shall not be unreasonably withheld, by
Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (C)&nbsp;if so directed
by a majority of the members of the Board, by the stockholders of the Fund. If it is so determined that Indemnitee is entitled to
indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee shall cooperate with the
person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including
providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such
determination in the discretion of the Board or Independent Counsel if retained pursuant to clause (ii)(B)&nbsp;of this
Section&nbsp;10(b). Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such
determination shall be borne by the Fund (irrespective of the determination as to Indemnitee&rsquo;s entitlement to indemnification)
and the Fund shall indemnify and hold Indemnitee harmless therefrom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Presumptions
and Effect of Certain Proceedings</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
making any determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
in accordance with Section&nbsp;10(a)&nbsp;of this Agreement, and the Fund shall have the burden of proof, by clear and convincing evidence,
to overcome that presumption in connection with the making of any determination contrary to that presumption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of <I>nolo
contendere</I> or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did
not meet the requisite standard of conduct described herein for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The knowledge and/or actions, or failure
to act, of any other director, officer, employee or agent of the Fund or any other director, trustee, officer, partner, manager, managing
member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited liability company, joint venture,
trust, employee benefit plan or other enterprise shall not be imputed to Indemnitee for purposes of determining any other right to indemnification
under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remedies
of Indemnitee</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;a determination is made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advance of Expenses is not timely made pursuant to Sections 8 or 9 of this
Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made pursuant to Section&nbsp;10(b)&nbsp;of
this Agreement within 60 days after receipt by the Fund of the request for indemnification, (iv)&nbsp;payment of indemnification is
not made pursuant to Sections 7 or 9 of this Agreement within ten days after receipt by the Fund of a written request therefor, or
(v)&nbsp;payment of indemnification pursuant to any other section of this Agreement or the Articles of Incorporation or Bylaws of
the Fund is not made within ten days after a determination has been made that Indemnitee is entitled to
indemnification,&nbsp;Indemnitee shall be entitled to an adjudication in an appropriate court located in the State of Maryland, or
in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement to such indemnification or advance of Expenses.
Alternatively,&nbsp;Indemnitee, at Indemnitee&rsquo;s option, may seek an award in arbitration to be conducted by a single
arbitrator pursuant to the Commercial Arbitration Rules&nbsp;of the American Arbitration Association. Indemnitee shall commence a
proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the
right to commence such proceeding pursuant to this Section&nbsp;12(a); provided, however, that the foregoing clause shall not apply
to a proceeding brought by Indemnitee to enforce his rights under Section&nbsp;7 of this Agreement. Except as set forth herein, the
provisions of Maryland law (without regard to its conflicts of laws rules) shall apply to any such arbitration. The Fund shall not
oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall be presumed to be entitled to
indemnification or advance of Expenses, as the case may be, under this Agreement and the Fund shall have the burden of proving that Indemnitee
is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a judicial proceeding or arbitration
pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall not be required to reimburse the Fund for any advances pursuant to Section&nbsp;8
of this Agreement until a final determination is made with respect to Indemnitee&rsquo;s entitlement to indemnification (as to which all
rights of appeal have been exhausted or lapsed). The Fund shall, to the fullest extent not prohibited by law, be precluded from asserting
in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12 that the procedures and presumptions of this Agreement
are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Fund is bound by all
of the provisions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a determination shall have been made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is entitled to
indemnification, the Fund shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this
Section&nbsp;12, absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that Indemnitee is successful in seeking, pursuant to this Section&nbsp;12, a judicial adjudication of or an award in arbitration
to enforce Indemnitee&rsquo;s rights under, or to recover damages for breach of, this Agreement,&nbsp;Indemnitee shall be entitled to
recover from the Fund, and shall be indemnified by the Fund for, any and all Expenses actually and reasonably incurred by him in such
judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee is entitled
to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in connection with
such judicial adjudication or arbitration shall be appropriately prorated.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Interest
shall be paid by the Fund to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article&nbsp;of the Annotated Code of Maryland for amounts which the Fund pays or is obligated to pay for the period (i) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing
with either the tenth day after the date on which the Fund was requested to advance Expenses in accordance with Sections 8 or 9 of this
Agreement or the 60<SUP>th</SUP> day after the date on which the Fund was requested to make the determination of entitlement to indemnification
under Section&nbsp;10(b)&nbsp;of this Agreement, as applicable, and (ii)&nbsp;ending on the date such payment is made to Indemnitee by
the Fund.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Defense
of the Underlying Proceeding</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnitee
shall notify the Fund promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or other
document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall include
with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure to give
any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to indemnification
or the advance of Expenses under this Agreement unless the Fund&rsquo;s ability to defend in such Proceeding or to obtain proceeds under
any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Fund is thereby actually so prejudiced.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject to the provisions of the last
sentence of this Section&nbsp;13(b)&nbsp;and of Section&nbsp;13(c)&nbsp;below, the Fund shall have the right to defend Indemnitee in
any Proceeding which may give rise to indemnification hereunder; provided, however, that the Fund shall notify Indemnitee of any
such decision to defend within 15 calendar days following receipt of notice of any such Proceeding under
Section&nbsp;13(a)&nbsp;above. The Fund shall not, without the prior written consent of Indemnitee, which shall not be unreasonably
withheld or delayed, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise which
(i)&nbsp;includes an admission of fault of Indemnitee, (ii)&nbsp;does not include, as an unconditional term thereof, the full
release of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably
satisfactory to Indemnitee or (iii)&nbsp;would impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This
Section&nbsp;13(b)&nbsp;shall not apply to a Proceeding brought by Indemnitee under Section&nbsp;12 of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding the provisions of Section&nbsp;13(b)&nbsp;above,
if in a Proceeding to which Indemnitee is a party by reason of Indemnitee&rsquo;s Corporate Status, (i)&nbsp;Indemnitee reasonably concludes,
based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that Indemnitee may have separate
defenses or counterclaims to assert with respect to any issue which may not be consistent with other defendants in such Proceeding, (ii)&nbsp;Indemnitee
reasonably concludes, based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that an
actual or apparent conflict of interest or potential conflict of interest exists between Indemnitee and the Fund, or (iii)&nbsp;if the
Fund fails to assume the defense of such Proceeding in a timely manner,&nbsp;Indemnitee shall be entitled to be represented by separate
legal counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld,
at the expense of the Fund. In addition, if the Fund fails to comply with any of its obligations under this Agreement or in the event
that the Fund or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny
or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,&nbsp;Indemnitee shall have the right to retain
counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld, at
the expense of the Fund (subject to Section&nbsp;12(d)&nbsp;of this Agreement), to represent Indemnitee in connection with any such matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Non-Exclusivity;
Survival of Rights; Subrogation; Investment Company <FONT STYLE="font-family: Times New Roman, Times, Serif">Act</FONT></U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
rights of indemnification and advance of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the Articles of Incorporation or Bylaws of the Fund, any agreement or a resolution
of the stockholders entitled to vote generally in the election of directors or of the Board, or otherwise. Unless consented to in writing
by Indemnitee, no amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee
under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration
or repeal, regardless of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration
or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy
shall be cumulative and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or
otherwise. The assertion of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of
any other right or remedy.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of any payment under this Agreement, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Fund to bring suit to enforce such rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that (i)&nbsp;Indemnitee has otherwise actually received such payment under any insurance
policy, contract, agreement or otherwise, or (ii)&nbsp;for so long as the Fund is subject to the Investment Company Act,
indemnification or payment or reimbursement of expenses would not be permissible under the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of his Corporate Status and
covering the Fund for any indemnification or advance of Expenses made by the Fund to Indemnitee for any claims made against Indemnitee
by reason of his Corporate Status. In the event of a Change in Control, the Fund shall maintain in force any and all directors and officers
liability insurance policies that were maintained by the Fund immediately prior to the Change in Control for a period of six years with
the insurance carrier or carriers and through the insurance broker in place at the time of the Change of Control; provided, however, (i)&nbsp;if
the carriers will not offer the same policy and an expiring policy needs to be replaced, a policy substantially comparable in scope and
amount shall be obtained and (ii)&nbsp;if any replacement insurance carrier is necessary to obtain a policy substantially comparable in
scope and amount, such insurance carrier shall have an AM Best rating that is the same or better than the AM Best rating of the existing
insurance carrier; provided, further, however, in no event shall the Fund be required to expend in the aggregate in excess of 250% of
the annual premium or premiums paid by the Fund for directors and officers liability insurance in effect on the date of the Change in
Control. In the event that 250% of the annual premium paid by the Fund for such existing directors and officers liability insurance is
insufficient for such coverage, the Fund shall spend up to that amount to purchase such lesser coverage as may be obtained with such amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
in any way limiting any other obligation under this Agreement, the Fund shall indemnify Indemnitee for any payment by Indemnitee arising
out of the amount of any deductible or retention and the amount of any excess of the aggregate of all judgments, penalties, fines, settlements
and Expenses incurred by Indemnitee in connection with a Proceeding over the coverage of any insurance referred to in the previous sentence.
The purchase, establishment and maintenance of any such insurance shall not in any way limit or affect the rights or obligations of the
Fund or Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Fund
and the Indemnitee shall not in any way limit or affect the rights or obligations of the Fund under any such insurance policies. If, at
the time the Fund receives notice from any source of a Proceeding to which Indemnitee is a party or a participant (as a witness or otherwise)
the Fund has directors and officers liability insurance in effect, the Fund shall give prompt notice of such Proceeding to the insurers
in accordance with the procedures set forth in the respective policies.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Coordination of Payments</U>.
The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract,
agreement or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>. If the indemnification
provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason, other than for failure
to satisfy the standard of conduct set forth in Section&nbsp;4 or due to the provisions of Section 5, then, in respect to any Proceeding
in which the Fund is jointly liable with Indemnitee (or would be if joined in such Proceeding), to the fullest extent permissible under
applicable law, the Fund, in lieu or indemnifying and holding harmless Indemnitee, shall pay, in the first instance, the entire amount
incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be paid in settlement, in connection with
any Proceeding without requiring Indemnitee to contribute to such payment, and the Fund hereby waives and relinquished any right of contribution
it may have at any time against Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports to Stockholders</U>.
To the extent required by the MGCL, the Fund shall report in writing to its stockholders the payment of any amounts for indemnification
of, or advance of Expenses to,&nbsp;Indemnitee under this Agreement arising out of a Proceeding by or in the right of the Fund with the
notice of the meeting of stockholders of the Fund next following the date of the payment of any such indemnification or advance of Expenses
or prior to such meeting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration
of Agreement; Binding Effect</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall continue until and terminate on the later of (i)&nbsp;the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Fund or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Fund, and (ii)&nbsp;the
date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and any Proceeding
commenced by Indemnitee pursuant to Section&nbsp;12 of this Agreement).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Fund), shall continue as to an Indemnitee
who has ceased to (i)&nbsp;be a director, officer, employee or agent of the Fund, or (ii)&nbsp;be a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such
capacity at the request of the Fund, and shall inure to the benefit of Indemnitee and Indemnitee&rsquo;s spouse, assigns, heirs,
devisees, executors and administrators and other legal representatives.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Fund, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Fund would be required to perform
if no such succession had taken place.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable
and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto
agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any
necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific
performance,&nbsp;Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled.
Indemnitee shall further be entitled to such specific performance and injunctive relief, including temporary restraining orders,
preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertakings in connection
therewith. The Fund acknowledges that, in the absence of a waiver, a bond or undertaking may be required of Indemnitee by a court,
and the Fund hereby waives any such requirement of such a bond or undertaking.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>. If any provision
or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity,
legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Identical Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. One such counterpart signed by the party against whom enforceability is sought
shall be sufficient to evidence the existence of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Modification and Waiver</U>.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether
or not similar) nor shall such waiver constitute a continuing waiver.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;24.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. All notices, requests,
demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i)&nbsp;delivered by hand
and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery, or (ii)&nbsp;mailed
by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If to Indemnitee, to the address set forth on the signature page&nbsp;hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If to the Fund, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund,&nbsp;Inc.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Avenue of the Stars, 12</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> <FONT STYLE="font-size: 10pt">Floor</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: Chief Legal Officer</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished in writing to Indemnitee
by the Fund or to the Fund by Indemnitee, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section&nbsp;25.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Daniel J. Hall</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">INDEMNITEE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Seth J. Brufsky</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">Seth J. Brufsky</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">**
<I>Signature Page&nbsp;to Brufsky Indemnification Agreement</I> **</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To:&#8239;&#8239;The Board of Directors of Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&#8239;&#8239;Affirmation and Undertaking</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated as of the _____ day of ______________, 20____, by and between Ares Dynamic Credit
Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;Fund&rdquo;), and the undersigned Indemnitee (the &ldquo;Indemnification
Agreement&rdquo;), pursuant to which I am entitled to advance of Expenses in connection with <B>[Description of Proceeding]</B> (the &ldquo;Proceeding&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I am subject to the Proceeding by reason of
my Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that
at all times, insofar as I was involved as <B>[a director] [an officer]</B> of the Fund, in any of the facts or events giving rise
to the Proceeding,&nbsp;I (1)&nbsp;did not act with bad faith or active or deliberate dishonesty, (2)&nbsp;did not receive any
improper personal benefit in money, property or services and (3)&nbsp;in the case of any criminal proceeding, had no reasonable
cause to believe that any act or omission by me was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the advance of Expenses by
the Fund for reasonable attorneys&rsquo; fees and related Expenses incurred by me in connection with the Proceeding (the &ldquo;Advanced
Expenses&rdquo;),&nbsp;I hereby agree that if, in connection with the Proceeding, it is established that (1)&nbsp;an act or omission by
me was material to the matter giving rise to the Proceeding and (a)&nbsp;was committed in bad faith or (b)&nbsp;was the result of active
and deliberate dishonesty or (2)&nbsp;I actually received an improper personal benefit in money, property or services or (3)&nbsp;in the
case of any criminal proceeding,&nbsp;I had reasonable cause to believe that the act or omission was unlawful, then I shall promptly reimburse
the portion of the Advanced Expenses relating to the claims, issues or matters in the Proceeding as to which the foregoing findings have
been established.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">IN WITNESS WHEREOF,&nbsp;I have executed this Affirmation
and Undertaking on this ___ day of ____________________, 20____.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">[Execution Version]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>INDEMNIFICATION AGREEMENT</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS INDEMNIFICATION AGREEMENT (&ldquo;Agreement&rdquo;)
is made and entered into as of the 30th day of November, 2012, by and between Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland
corporation (the &ldquo;Fund&rdquo;), and John J. Shaw (&ldquo;Indemnitee&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, at the request of the Fund,&nbsp;Indemnitee
currently serves as a director of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS,&nbsp;Indemnitee may be subjected to claims,
suits or proceedings arising as a result of Indemnitee&rsquo;s service as a director of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as an inducement to Indemnitee to
serve or continue to serve as a director, the Fund has agreed to indemnify and to advance expenses and costs incurred
by Indemnitee in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Fund and Indemnitee do hereby covenant and agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
For purposes of this Agreement:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Change in Control&rdquo;
means a change in control of the Fund occurring after the Effective Date of a nature that would be required to be reported in response
to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), whether or not the Fund is then subject to such reporting
requirement; provided, however, that, without limitation, such a Change in Control shall be deemed to have occurred if, after the Effective
Date (i)&nbsp;any &ldquo;person&rdquo; (as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) is or becomes
the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly, of securities of the
Fund representing 15% or more of the combined voting power of all of the Fund&rsquo;s then-outstanding securities without the prior approval
of at least two-thirds of the members of the Board of Directors of the Fund (the &ldquo;Board&rdquo;) in office immediately prior to such
person&rsquo;s attaining such percentage interest; (ii)&nbsp;there occurs a proxy contest, or the Fund is a party to a merger, consolidation,
sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds of the members of the Board then in office,
as a consequence of which members of the Board in office immediately prior to such transaction or event constitute less than a majority
of the Board thereafter; or (iii)&nbsp;at any time, a majority of the members of the Board are not individuals (A)&nbsp;who were directors
as of the Effective Date or (B)&nbsp;whose election by the Board or nomination for election by the Fund&rsquo;s stockholders was approved
by the affirmative vote of at least two-thirds of the directors then in office who were directors as of the Effective Date or whose election
or nomination for election was previously so approved.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Corporate
Status&rdquo; means the status of a person as a present or former director, officer, employee or agent of the Fund or as a director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity
at the request of the Fund. As a clarification and without limiting the circumstances in which Indemnitee may be serving at the request
of the Fund, service by Indemnitee shall be deemed to be at the request of the Fund: (i)&nbsp;if Indemnitee serves or served as a director,
trustee, officer, partner, manager, managing member, fiduciary, employee or agent of any corporation, partnership, limited liability company,
joint venture, trust or other enterprise (1)&nbsp;of which a majority of the voting power or equity interest is owned directly or indirectly
by the Fund or (2)&nbsp;the management of which is controlled directly or indirectly by the Fund and (ii)&nbsp;if, as a result of Indemnitee&rsquo;s
service to the Fund,&nbsp;Indemnitee is subject to duties by, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as deemed fiduciary thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Disinterested
Director&rdquo; means a director of the Fund who is not and was not a party to the Proceeding in respect of which indemnification and/or
advance of Expenses is sought by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Effective Date&rdquo; means the date
set forth in the first paragraph of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Expenses&rdquo;
means any and all reasonable and out-of-pocket attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement,
ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding. Expenses shall
also include Expenses incurred in connection with any appeal resulting from any Proceeding including, without limitation, the premium,
security for and other costs relating to any cost bond, supersedeas bond or other appeal bond or its equivalent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Independent
Counsel&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is, nor in the
past five years has been, retained to represent: (i)&nbsp;the Fund or Indemnitee in any matter material to either such party (other than
with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements),
or (ii)&nbsp;any other party to or participant or witness in the Proceeding giving rise to a claim for indemnification or advance of Expenses
hereunder. Notwithstanding the foregoing, the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Fund or Indemnitee in
an action to determine Indemnitee&rsquo;s rights under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Proceeding&rdquo; means
any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative
hearing or any other proceeding, whether brought by or in the right of the Fund or otherwise and whether of a civil (including intentional
or unintentional tort claims), criminal, administrative or investigative (formal or informal) nature, including any appeal therefrom,
except one pending or completed on or before the Effective Date, unless otherwise specifically agreed in writing by the Fund and Indemnitee.
If Indemnitee reasonably believes that a given situation may lead to or culminate in the institution of a Proceeding, such situation shall
also be considered a Proceeding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services
by Indemnitee</U>. Indemnitee serves as a director of the Fund. However, this Agreement shall not impose any independent
obligation on Indemnitee or the Fund to continue Indemnitee&rsquo;s service to the Fund. This Agreement shall not be deemed an employment
contract between the Fund (or any other entity) and Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Fund shall indemnify, and advance Expenses to,&nbsp;Indemnitee (a)&nbsp;as provided in this Agreement and (b)&nbsp;otherwise to
the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; provided, however,
that no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland
law as in effect on the Effective Date. The rights of Indemnitee provided in this Section&nbsp;3 shall include, without limitation,
the rights set forth in the other sections of this Agreement, including any additional indemnification permitted by
Section&nbsp;2-418(g)&nbsp;of the Maryland General Corporation Law (the &ldquo;MGCL&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Standard
for Indemnification</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a
party to any Proceeding, the Fund shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement
and all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with any such
Proceeding unless it is established that (a)&nbsp;the act or omission of Indemnitee was material to the matter giving rise to the
Proceeding and (i)&nbsp;was committed in bad faith or (ii)&nbsp;was the result of active and deliberate dishonesty,
(b)&nbsp;Indemnitee actually received an improper personal benefit in money, property or services or (c)&nbsp;in the case of any
criminal Proceeding,&nbsp;Indemnitee had reasonable cause to believe that his conduct was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain Limits on Indemnification</U>.
Notwithstanding any other provision of this Agreement (other than Section&nbsp;6),&nbsp;Indemnitee shall not be entitled to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if the Proceeding was one by or in the right of the Fund and Indemnitee is adjudged, in a final adjudication of the Proceeding
not subject to further appeal, to be liable to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit was improperly received in any Proceeding charging improper personal benefit to Indemnitee, whether or not involving
action in the Indemnitee&rsquo;s Corporate Status; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification or advance of
Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i)&nbsp;the Proceeding was brought to enforce indemnification
under this Agreement, and then only to the extent in accordance with and as authorized by Section&nbsp;12 of this Agreement, or (ii)&nbsp;the
Fund&rsquo;s Articles of Incorporation or Bylaws, a resolution of the stockholders entitled to vote generally in the election of directors
or of the Board or an agreement approved by the Board to which the Fund is a party expressly provide otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Court-Ordered Indemnification</U>.
Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee and such notice
as the court shall require, may order indemnification of Indemnitee by the Fund in the following circumstances:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is entitled to reimbursement under Section&nbsp;2-418(d)(1)&nbsp;of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant
circumstances, whether or not Indemnitee (i) has
met the standards of conduct set forth in Section&nbsp;2-418(b)&nbsp;of the MGCL or (ii)&nbsp;has been adjudged liable for receipt
of an improper personal benefit under Section&nbsp;2-418(c)&nbsp;of the MGCL, the court may order such indemnification as the court
shall deem proper. However, indemnification with respect to any Proceeding by or in the right of the Fund or in which liability
shall have been adjudged in the circumstances described in Section&nbsp;2-418(c)&nbsp;of the MGCL shall be limited to Expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
for Expenses of an Indemnitee Who is Wholly or Partially Successful</U>. Notwithstanding any other provision of this Agreement, and
without limiting any such provision, to the extent that Indemnitee was or is, by reason of his Corporate Status, made a party to (or
otherwise becomes a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such
Proceeding,&nbsp;Indemnitee shall be indemnified for all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on
the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Fund shall indemnify
Indemnitee under this Section&nbsp;7 for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf
in connection with each such claim, issue or matter, allocated on a reasonable and proportionate basis. For purposes of this
Section&nbsp;7 and, without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or
without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Advance
of Expenses for Indemnitee</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be,
made a party to any Proceeding, the Fund shall, without requiring a preliminary determination of Indemnitee&rsquo;s ultimate
entitlement to indemnification hereunder, advance all reasonable Expenses incurred by or on behalf of Indemnitee in connection with
such Proceeding. Such advance or advances shall be made within ten days after the receipt by the Fund of a statement or statements
requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding and may be in
the form of, in the reasonable discretion of the Indemnitee (but without duplication) (a)&nbsp;payment of such Expenses directly to
third parties on behalf of Indemnitee, (b)&nbsp;advancement to Indemnitee of funds in an amount sufficient to pay such Expenses or
(c)&nbsp;reimbursement to Indemnitee for Indemnitee&rsquo;s payment of such Expenses. Such statement or statements shall reasonably
evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written affirmation by Indemnitee
of Indemnitee&rsquo;s good faith belief that the standard of conduct necessary for indemnification by the Fund as authorized by law
and by this Agreement has been met and a written undertaking by or on behalf of Indemnitee, in substantially the form attached
hereto as <U>Exhibit&nbsp;A</U> or in such form as may be required under applicable law as in effect at the time of the execution
thereof, to reimburse the portion of any Expenses advanced to Indemnitee relating to claims, issues or matters in the Proceeding as
to which it shall ultimately be established that the standard of conduct has not been met by Indemnitee and which have not been
successfully resolved as described in Section&nbsp;7 of this Agreement. For so long as the Fund is subject to the Investment Company
Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;), any advancement of Expenses shall be subject to at least one of
the following as a condition of the advancement: (a)&nbsp;Indemnitee shall provide a security for Indemnitee&rsquo;s undertaking,
(b)&nbsp;the Fund shall be insured against losses arising by reason of any lawful advances or (c)&nbsp;a majority of a quorum of the
Disinterested Directors, or Independent Counsel, in a written opinion, shall determine, based on a review of readily available facts
(as opposed to a full-trial-type inquiry), that there is no reason to believe that Indemnitee ultimately will be found to not be
entitled to indemnification. To the extent that Expenses advanced to Indemnitee do not relate to a specific claim, issue or matter
in the Proceeding, such Expenses shall be allocated on a reasonable and proportionate basis. The undertaking required by this
Section&nbsp;8 shall be an unlimited general obligation by or on behalf of Indemnitee and shall be accepted without reference to
Indemnitee&rsquo;s financial ability to repay such advanced Expenses and without any requirement to post security therefor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification and
Advance of Expenses as a Witness or Other Participant</U>. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is or may be, by reason of Indemnitee&rsquo;s Corporate Status, made a witness or otherwise asked to participate in any
Proceeding, whether instituted by the Fund or any other party, and to which Indemnitee is not a party,&nbsp;Indemnitee shall be
advanced all reasonable Expenses and indemnified against all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith within ten days after the receipt by the Fund of a statement or statements
requesting any such advance or indemnification from time to time, whether prior to or after final disposition of such Proceeding.
Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Procedure
for Determination of Entitlement to Indemnification</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To obtain indemnification under this
Agreement,&nbsp;Indemnitee shall submit to the Fund a written request, including therein or therewith such documentation and
information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee
is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at such time(s)&nbsp;as
Indemnitee deems appropriate in Indemnitee&rsquo;s sole discretion. The officer of the Fund receiving any such request from
Indemnitee shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has
requested indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request by Indemnitee for indemnification pursuant to Section&nbsp;10(a)&nbsp;above, a determination, if required by
applicable law, with respect to Indemnitee&rsquo;s entitlement thereto shall promptly be made in the specific case: (i)&nbsp;if a
Change in Control shall have occurred, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered
to Indemnitee, which Independent Counsel shall be selected by the Indemnitee and approved by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL, which approval shall not be unreasonably withheld; or (ii)&nbsp;if a Change in
Control shall not have occurred, (A)&nbsp;by the Board by a majority vote of a quorum consisting of Disinterested Directors or, if
such a quorum cannot be obtained, then by a majority vote of a duly authorized committee of the Board consisting solely of one or
more Disinterested Directors, (B)&nbsp;if Independent Counsel has been selected by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL and approved by the Indemnitee, which approval shall not be unreasonably withheld, by
Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (C)&nbsp;if so directed
by a majority of the members of the Board, by the stockholders of the Fund. If it is so determined that Indemnitee is entitled to
indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee shall cooperate with the
person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including
providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such
determination in the discretion of the Board or Independent Counsel if retained pursuant to clause (ii)(B)&nbsp;of this
Section&nbsp;10(b). Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such
determination shall be borne by the Fund (irrespective of the determination as to Indemnitee&rsquo;s entitlement to indemnification)
and the Fund shall indemnify and hold Indemnitee harmless therefrom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Presumptions
and Effect of Certain Proceedings</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
making any determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
in accordance with Section&nbsp;10(a)&nbsp;of this Agreement, and the Fund shall have the burden of proof, by clear and convincing evidence,
to overcome that presumption in connection with the making of any determination contrary to that presumption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of <I>nolo
contendere</I> or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did
not meet the requisite standard of conduct described herein for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt"></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The knowledge and/or actions, or failure
to act, of any other director, officer, employee or agent of the Fund or any other director, trustee, officer, partner, manager, managing
member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited liability company, joint venture,
trust, employee benefit plan or other enterprise shall not be imputed to Indemnitee for purposes of determining any other right to indemnification
under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remedies
of Indemnitee</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;a determination is made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advance of Expenses is not timely made pursuant to Sections 8 or 9 of this
Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made pursuant to Section&nbsp;10(b)&nbsp;of
this Agreement within 60 days after receipt by the Fund of the request for indemnification, (iv)&nbsp;payment of indemnification is
not made pursuant to Sections 7 or 9 of this Agreement within ten days after receipt by the Fund of a written request therefor, or
(v)&nbsp;payment of indemnification pursuant to any other section of this Agreement or the Articles of Incorporation or Bylaws of
the Fund is not made within ten days after a determination has been made that Indemnitee is entitled to
indemnification,&nbsp;Indemnitee shall be entitled to an adjudication in an appropriate court located in the State of Maryland, or
in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement to such indemnification or advance of Expenses.
Alternatively,&nbsp;Indemnitee, at Indemnitee&rsquo;s option, may seek an award in arbitration to be conducted by a single
arbitrator pursuant to the Commercial Arbitration Rules&nbsp;of the American Arbitration Association. Indemnitee shall commence a
proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the
right to commence such proceeding pursuant to this Section&nbsp;12(a); provided, however, that the foregoing clause shall not apply
to a proceeding brought by Indemnitee to enforce his rights under Section&nbsp;7 of this Agreement. Except as set forth herein, the
provisions of Maryland law (without regard to its conflicts of laws rules) shall apply to any such arbitration. The Fund shall not
oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall be presumed to be entitled to
indemnification or advance of Expenses, as the case may be, under this Agreement and the Fund shall have the burden of proving that Indemnitee
is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a judicial proceeding or arbitration
pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall not be required to reimburse the Fund for any advances pursuant to Section&nbsp;8
of this Agreement until a final determination is made with respect to Indemnitee&rsquo;s entitlement to indemnification (as to which all
rights of appeal have been exhausted or lapsed). The Fund shall, to the fullest extent not prohibited by law, be precluded from asserting
in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12 that the procedures and presumptions of this Agreement
are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Fund is bound by all
of the provisions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a determination shall have been made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is entitled to
indemnification, the Fund shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this
Section&nbsp;12, absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that Indemnitee is successful in seeking, pursuant to this Section&nbsp;12, a judicial adjudication of or an award in arbitration
to enforce Indemnitee&rsquo;s rights under, or to recover damages for breach of, this Agreement,&nbsp;Indemnitee shall be entitled to
recover from the Fund, and shall be indemnified by the Fund for, any and all Expenses actually and reasonably incurred by him in such
judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee is entitled
to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in connection with
such judicial adjudication or arbitration shall be appropriately prorated.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Interest
shall be paid by the Fund to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article&nbsp;of the Annotated Code of Maryland for amounts which the Fund pays or is obligated to pay for the period (i) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing
with either the tenth day after the date on which the Fund was requested to advance Expenses in accordance with Sections 8 or 9 of this
Agreement or the 60<SUP>th</SUP> day after the date on which the Fund was requested to make the determination of entitlement to indemnification
under Section&nbsp;10(b)&nbsp;of this Agreement, as applicable, and (ii)&nbsp;ending on the date such payment is made to Indemnitee by
the Fund.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Defense
of the Underlying Proceeding</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnitee
shall notify the Fund promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or other
document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall include
with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure to give
any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to indemnification
or the advance of Expenses under this Agreement unless the Fund&rsquo;s ability to defend in such Proceeding or to obtain proceeds under
any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Fund is thereby actually so prejudiced.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject to the provisions of the last
sentence of this Section&nbsp;13(b)&nbsp;and of Section&nbsp;13(c)&nbsp;below, the Fund shall have the right to defend Indemnitee in
any Proceeding which may give rise to indemnification hereunder; provided, however, that the Fund shall notify Indemnitee of any
such decision to defend within 15 calendar days following receipt of notice of any such Proceeding under
Section&nbsp;13(a)&nbsp;above. The Fund shall not, without the prior written consent of Indemnitee, which shall not be unreasonably
withheld or delayed, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise which
(i)&nbsp;includes an admission of fault of Indemnitee, (ii)&nbsp;does not include, as an unconditional term thereof, the full
release of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably
satisfactory to Indemnitee or (iii)&nbsp;would impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This
Section&nbsp;13(b)&nbsp;shall not apply to a Proceeding brought by Indemnitee under Section&nbsp;12 of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding the provisions of Section&nbsp;13(b)&nbsp;above,
if in a Proceeding to which Indemnitee is a party by reason of Indemnitee&rsquo;s Corporate Status, (i)&nbsp;Indemnitee reasonably concludes,
based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that Indemnitee may have separate
defenses or counterclaims to assert with respect to any issue which may not be consistent with other defendants in such Proceeding, (ii)&nbsp;Indemnitee
reasonably concludes, based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that an
actual or apparent conflict of interest or potential conflict of interest exists between Indemnitee and the Fund, or (iii)&nbsp;if the
Fund fails to assume the defense of such Proceeding in a timely manner,&nbsp;Indemnitee shall be entitled to be represented by separate
legal counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld,
at the expense of the Fund. In addition, if the Fund fails to comply with any of its obligations under this Agreement or in the event
that the Fund or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny
or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,&nbsp;Indemnitee shall have the right to retain
counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld, at
the expense of the Fund (subject to Section&nbsp;12(d)&nbsp;of this Agreement), to represent Indemnitee in connection with any such matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Non-Exclusivity;
Survival of Rights; Subrogation; Investment Company <FONT STYLE="font-family: Times New Roman, Times, Serif">Act</FONT></U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
rights of indemnification and advance of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the Articles of Incorporation or Bylaws of the Fund, any agreement or a resolution
of the stockholders entitled to vote generally in the election of directors or of the Board, or otherwise. Unless consented to in writing
by Indemnitee, no amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee
under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration
or repeal, regardless of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration
or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy
shall be cumulative and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or
otherwise. The assertion of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of
any other right or remedy.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of any payment under this Agreement, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Fund to bring suit to enforce such rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that (i)&nbsp;Indemnitee has otherwise actually received such payment under any insurance
policy, contract, agreement or otherwise, or (ii)&nbsp;for so long as the Fund is subject to the Investment Company Act,
indemnification or payment or reimbursement of expenses would not be permissible under the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of his Corporate Status and
covering the Fund for any indemnification or advance of Expenses made by the Fund to Indemnitee for any claims made against Indemnitee
by reason of his Corporate Status. In the event of a Change in Control, the Fund shall maintain in force any and all directors and officers
liability insurance policies that were maintained by the Fund immediately prior to the Change in Control for a period of six years with
the insurance carrier or carriers and through the insurance broker in place at the time of the Change of Control; provided, however, (i)&nbsp;if
the carriers will not offer the same policy and an expiring policy needs to be replaced, a policy substantially comparable in scope and
amount shall be obtained and (ii)&nbsp;if any replacement insurance carrier is necessary to obtain a policy substantially comparable in
scope and amount, such insurance carrier shall have an AM Best rating that is the same or better than the AM Best rating of the existing
insurance carrier; provided, further, however, in no event shall the Fund be required to expend in the aggregate in excess of 250% of
the annual premium or premiums paid by the Fund for directors and officers liability insurance in effect on the date of the Change in
Control. In the event that 250% of the annual premium paid by the Fund for such existing directors and officers liability insurance is
insufficient for such coverage, the Fund shall spend up to that amount to purchase such lesser coverage as may be obtained with such amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
in any way limiting any other obligation under this Agreement, the Fund shall indemnify Indemnitee for any payment by Indemnitee arising
out of the amount of any deductible or retention and the amount of any excess of the aggregate of all judgments, penalties, fines, settlements
and Expenses incurred by Indemnitee in connection with a Proceeding over the coverage of any insurance referred to in the previous sentence.
The purchase, establishment and maintenance of any such insurance shall not in any way limit or affect the rights or obligations of the
Fund or Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Fund
and the Indemnitee shall not in any way limit or affect the rights or obligations of the Fund under any such insurance policies. If, at
the time the Fund receives notice from any source of a Proceeding to which Indemnitee is a party or a participant (as a witness or otherwise)
the Fund has directors and officers liability insurance in effect, the Fund shall give prompt notice of such Proceeding to the insurers
in accordance with the procedures set forth in the respective policies.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Coordination of Payments</U>.
The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract,
agreement or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>. If the indemnification
provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason, other than for failure
to satisfy the standard of conduct set forth in Section&nbsp;4 or due to the provisions of Section 5, then, in respect to any Proceeding
in which the Fund is jointly liable with Indemnitee (or would be if joined in such Proceeding), to the fullest extent permissible under
applicable law, the Fund, in lieu or indemnifying and holding harmless Indemnitee, shall pay, in the first instance, the entire amount
incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be paid in settlement, in connection with
any Proceeding without requiring Indemnitee to contribute to such payment, and the Fund hereby waives and relinquished any right of contribution
it may have at any time against Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports to Stockholders</U>.
To the extent required by the MGCL, the Fund shall report in writing to its stockholders the payment of any amounts for indemnification
of, or advance of Expenses to,&nbsp;Indemnitee under this Agreement arising out of a Proceeding by or in the right of the Fund with the
notice of the meeting of stockholders of the Fund next following the date of the payment of any such indemnification or advance of Expenses
or prior to such meeting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration
of Agreement; Binding Effect</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall continue until and terminate on the later of (i)&nbsp;the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Fund or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Fund, and (ii)&nbsp;the
date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and any Proceeding
commenced by Indemnitee pursuant to Section&nbsp;12 of this Agreement).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Fund), shall continue as to an Indemnitee
who has ceased to (i)&nbsp;be a director, officer, employee or agent of the Fund, or (ii)&nbsp;be a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such
capacity at the request of the Fund, and shall inure to the benefit of Indemnitee and Indemnitee&rsquo;s spouse, assigns, heirs,
devisees, executors and administrators and other legal representatives.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Fund, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Fund would be required to perform
if no such succession had taken place.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable
and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto
agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any
necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific
performance,&nbsp;Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled.
Indemnitee shall further be entitled to such specific performance and injunctive relief, including temporary restraining orders,
preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertakings in connection
therewith. The Fund acknowledges that, in the absence of a waiver, a bond or undertaking may be required of Indemnitee by a court,
and the Fund hereby waives any such requirement of such a bond or undertaking.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>. If any provision
or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity,
legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Identical Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. One such counterpart signed by the party against whom enforceability is sought
shall be sufficient to evidence the existence of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Modification and Waiver</U>.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether
or not similar) nor shall such waiver constitute a continuing waiver.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;24.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. All notices, requests,
demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i)&nbsp;delivered by hand
and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery, or (ii)&nbsp;mailed
by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If to Indemnitee, to the address set forth on the signature page&nbsp;hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If to the Fund, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund,&nbsp;Inc.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Avenue of the Stars, 12</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> <FONT STYLE="font-size: 10pt">Floor</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: Chief Legal Officer</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished in writing to Indemnitee
by the Fund or to the Fund by Indemnitee, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section&nbsp;25.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Daniel J. Hall</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">INDEMNITEE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ John J. Shaw</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">John J. Shaw</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Director</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">**
<I>Signature Page&nbsp;to Shaw Indemnification Agreement</I> **</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To:&#8239;&#8239;The Board of Directors of Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&#8239;&#8239;Affirmation and Undertaking</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated as of the _____ day of ______________, 20____, by and between Ares Dynamic Credit
Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;Fund&rdquo;), and the undersigned Indemnitee (the &ldquo;Indemnification
Agreement&rdquo;), pursuant to which I am entitled to advance of Expenses in connection with <B>[Description of Proceeding]</B> (the &ldquo;Proceeding&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I am subject to the Proceeding by reason of
my Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that
at all times, insofar as I was involved as <B>[a director] [an officer]</B> of the Fund, in any of the facts or events giving rise
to the Proceeding,&nbsp;I (1)&nbsp;did not act with bad faith or active or deliberate dishonesty, (2)&nbsp;did not receive any
improper personal benefit in money, property or services and (3)&nbsp;in the case of any criminal proceeding, had no reasonable
cause to believe that any act or omission by me was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the advance of Expenses by
the Fund for reasonable attorneys&rsquo; fees and related Expenses incurred by me in connection with the Proceeding (the &ldquo;Advanced
Expenses&rdquo;),&nbsp;I hereby agree that if, in connection with the Proceeding, it is established that (1)&nbsp;an act or omission by
me was material to the matter giving rise to the Proceeding and (a)&nbsp;was committed in bad faith or (b)&nbsp;was the result of active
and deliberate dishonesty or (2)&nbsp;I actually received an improper personal benefit in money, property or services or (3)&nbsp;in the
case of any criminal proceeding,&nbsp;I had reasonable cause to believe that the act or omission was unlawful, then I shall promptly reimburse
the portion of the Advanced Expenses relating to the claims, issues or matters in the Proceeding as to which the foregoing findings have
been established.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">IN WITNESS WHEREOF,&nbsp;I have executed this Affirmation
and Undertaking on this ___ day of ____________________, 20____.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">[Execution Version]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>INDEMNIFICATION AGREEMENT</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS INDEMNIFICATION AGREEMENT (&ldquo;Agreement&rdquo;)
is made and entered into as of the 30th day of November, 2012, by and between Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland
corporation (the &ldquo;Fund&rdquo;), and David A. Sachs (&ldquo;Indemnitee&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, at the request of the Fund,&nbsp;Indemnitee
currently serves as a director of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS,&nbsp;Indemnitee may be subjected to claims,
suits or proceedings arising as a result of Indemnitee&rsquo;s service as a director of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as an inducement to Indemnitee to
serve or continue to serve as a director, the Fund has agreed to indemnify and to advance expenses and costs incurred
by Indemnitee in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Fund and Indemnitee do hereby covenant and agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
For purposes of this Agreement:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Change in Control&rdquo;
means a change in control of the Fund occurring after the Effective Date of a nature that would be required to be reported in response
to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), whether or not the Fund is then subject to such reporting
requirement; provided, however, that, without limitation, such a Change in Control shall be deemed to have occurred if, after the Effective
Date (i)&nbsp;any &ldquo;person&rdquo; (as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) is or becomes
the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly, of securities of the
Fund representing 15% or more of the combined voting power of all of the Fund&rsquo;s then-outstanding securities without the prior approval
of at least two-thirds of the members of the Board of Directors of the Fund (the &ldquo;Board&rdquo;) in office immediately prior to such
person&rsquo;s attaining such percentage interest; (ii)&nbsp;there occurs a proxy contest, or the Fund is a party to a merger, consolidation,
sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds of the members of the Board then in office,
as a consequence of which members of the Board in office immediately prior to such transaction or event constitute less than a majority
of the Board thereafter; or (iii)&nbsp;at any time, a majority of the members of the Board are not individuals (A)&nbsp;who were directors
as of the Effective Date or (B)&nbsp;whose election by the Board or nomination for election by the Fund&rsquo;s stockholders was approved
by the affirmative vote of at least two-thirds of the directors then in office who were directors as of the Effective Date or whose election
or nomination for election was previously so approved.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Corporate
Status&rdquo; means the status of a person as a present or former director, officer, employee or agent of the Fund or as a director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity
at the request of the Fund. As a clarification and without limiting the circumstances in which Indemnitee may be serving at the request
of the Fund, service by Indemnitee shall be deemed to be at the request of the Fund: (i)&nbsp;if Indemnitee serves or served as a director,
trustee, officer, partner, manager, managing member, fiduciary, employee or agent of any corporation, partnership, limited liability company,
joint venture, trust or other enterprise (1)&nbsp;of which a majority of the voting power or equity interest is owned directly or indirectly
by the Fund or (2)&nbsp;the management of which is controlled directly or indirectly by the Fund and (ii)&nbsp;if, as a result of Indemnitee&rsquo;s
service to the Fund,&nbsp;Indemnitee is subject to duties by, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as deemed fiduciary thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Disinterested
Director&rdquo; means a director of the Fund who is not and was not a party to the Proceeding in respect of which indemnification and/or
advance of Expenses is sought by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Effective Date&rdquo; means the date
set forth in the first paragraph of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Expenses&rdquo;
means any and all reasonable and out-of-pocket attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement,
ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding. Expenses shall
also include Expenses incurred in connection with any appeal resulting from any Proceeding including, without limitation, the premium,
security for and other costs relating to any cost bond, supersedeas bond or other appeal bond or its equivalent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Independent
Counsel&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is, nor in the
past five years has been, retained to represent: (i)&nbsp;the Fund or Indemnitee in any matter material to either such party (other than
with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements),
or (ii)&nbsp;any other party to or participant or witness in the Proceeding giving rise to a claim for indemnification or advance of Expenses
hereunder. Notwithstanding the foregoing, the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Fund or Indemnitee in
an action to determine Indemnitee&rsquo;s rights under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 32; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;Proceeding&rdquo; means
any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative
hearing or any other proceeding, whether brought by or in the right of the Fund or otherwise and whether of a civil (including intentional
or unintentional tort claims), criminal, administrative or investigative (formal or informal) nature, including any appeal therefrom,
except one pending or completed on or before the Effective Date, unless otherwise specifically agreed in writing by the Fund and Indemnitee.
If Indemnitee reasonably believes that a given situation may lead to or culminate in the institution of a Proceeding, such situation shall
also be considered a Proceeding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services
by Indemnitee</U>. Indemnitee serves as a director of the Fund. However, this Agreement shall not impose any independent
obligation on Indemnitee or the Fund to continue Indemnitee&rsquo;s service to the Fund. This Agreement shall not be deemed an employment
contract between the Fund (or any other entity) and Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Fund shall indemnify, and advance Expenses to,&nbsp;Indemnitee (a)&nbsp;as provided in this Agreement and (b)&nbsp;otherwise to
the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; provided, however,
that no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland
law as in effect on the Effective Date. The rights of Indemnitee provided in this Section&nbsp;3 shall include, without limitation,
the rights set forth in the other sections of this Agreement, including any additional indemnification permitted by
Section&nbsp;2-418(g)&nbsp;of the Maryland General Corporation Law (the &ldquo;MGCL&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Standard
for Indemnification</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a
party to any Proceeding, the Fund shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement
and all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with any such
Proceeding unless it is established that (a)&nbsp;the act or omission of Indemnitee was material to the matter giving rise to the
Proceeding and (i)&nbsp;was committed in bad faith or (ii)&nbsp;was the result of active and deliberate dishonesty,
(b)&nbsp;Indemnitee actually received an improper personal benefit in money, property or services or (c)&nbsp;in the case of any
criminal Proceeding,&nbsp;Indemnitee had reasonable cause to believe that his conduct was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain Limits on Indemnification</U>.
Notwithstanding any other provision of this Agreement (other than Section&nbsp;6),&nbsp;Indemnitee shall not be entitled to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if the Proceeding was one by or in the right of the Fund and Indemnitee is adjudged, in a final adjudication of the Proceeding
not subject to further appeal, to be liable to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit was improperly received in any Proceeding charging improper personal benefit to Indemnitee, whether or not involving
action in the Indemnitee&rsquo;s Corporate Status; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification or advance of
Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i)&nbsp;the Proceeding was brought to enforce indemnification
under this Agreement, and then only to the extent in accordance with and as authorized by Section&nbsp;12 of this Agreement, or (ii)&nbsp;the
Fund&rsquo;s Articles of Incorporation or Bylaws, a resolution of the stockholders entitled to vote generally in the election of directors
or of the Board or an agreement approved by the Board to which the Fund is a party expressly provide otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Court-Ordered Indemnification</U>.
Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee and such notice
as the court shall require, may order indemnification of Indemnitee by the Fund in the following circumstances:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is entitled to reimbursement under Section&nbsp;2-418(d)(1)&nbsp;of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant
circumstances, whether or not Indemnitee (i) has
met the standards of conduct set forth in Section&nbsp;2-418(b)&nbsp;of the MGCL or (ii)&nbsp;has been adjudged liable for receipt
of an improper personal benefit under Section&nbsp;2-418(c)&nbsp;of the MGCL, the court may order such indemnification as the court
shall deem proper. However, indemnification with respect to any Proceeding by or in the right of the Fund or in which liability
shall have been adjudged in the circumstances described in Section&nbsp;2-418(c)&nbsp;of the MGCL shall be limited to Expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
for Expenses of an Indemnitee Who is Wholly or Partially Successful</U>. Notwithstanding any other provision of this Agreement, and
without limiting any such provision, to the extent that Indemnitee was or is, by reason of his Corporate Status, made a party to (or
otherwise becomes a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such
Proceeding,&nbsp;Indemnitee shall be indemnified for all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on
the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Fund shall indemnify
Indemnitee under this Section&nbsp;7 for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf
in connection with each such claim, issue or matter, allocated on a reasonable and proportionate basis. For purposes of this
Section&nbsp;7 and, without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or
without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Advance
of Expenses for Indemnitee</U>. If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be,
made a party to any Proceeding, the Fund shall, without requiring a preliminary determination of Indemnitee&rsquo;s ultimate
entitlement to indemnification hereunder, advance all reasonable Expenses incurred by or on behalf of Indemnitee in connection with
such Proceeding. Such advance or advances shall be made within ten days after the receipt by the Fund of a statement or statements
requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding and may be in
the form of, in the reasonable discretion of the Indemnitee (but without duplication) (a)&nbsp;payment of such Expenses directly to
third parties on behalf of Indemnitee, (b)&nbsp;advancement to Indemnitee of funds in an amount sufficient to pay such Expenses or
(c)&nbsp;reimbursement to Indemnitee for Indemnitee&rsquo;s payment of such Expenses. Such statement or statements shall reasonably
evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written affirmation by Indemnitee
of Indemnitee&rsquo;s good faith belief that the standard of conduct necessary for indemnification by the Fund as authorized by law
and by this Agreement has been met and a written undertaking by or on behalf of Indemnitee, in substantially the form attached
hereto as <U>Exhibit&nbsp;A</U> or in such form as may be required under applicable law as in effect at the time of the execution
thereof, to reimburse the portion of any Expenses advanced to Indemnitee relating to claims, issues or matters in the Proceeding as
to which it shall ultimately be established that the standard of conduct has not been met by Indemnitee and which have not been
successfully resolved as described in Section&nbsp;7 of this Agreement. For so long as the Fund is subject to the Investment Company
Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;), any advancement of Expenses shall be subject to at least one of
the following as a condition of the advancement: (a)&nbsp;Indemnitee shall provide a security for Indemnitee&rsquo;s undertaking,
(b)&nbsp;the Fund shall be insured against losses arising by reason of any lawful advances or (c)&nbsp;a majority of a quorum of the
Disinterested Directors, or Independent Counsel, in a written opinion, shall determine, based on a review of readily available facts
(as opposed to a full-trial-type inquiry), that there is no reason to believe that Indemnitee ultimately will be found to not be
entitled to indemnification. To the extent that Expenses advanced to Indemnitee do not relate to a specific claim, issue or matter
in the Proceeding, such Expenses shall be allocated on a reasonable and proportionate basis. The undertaking required by this
Section&nbsp;8 shall be an unlimited general obligation by or on behalf of Indemnitee and shall be accepted without reference to
Indemnitee&rsquo;s financial ability to repay such advanced Expenses and without any requirement to post security therefor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification and
Advance of Expenses as a Witness or Other Participant</U>. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is or may be, by reason of Indemnitee&rsquo;s Corporate Status, made a witness or otherwise asked to participate in any
Proceeding, whether instituted by the Fund or any other party, and to which Indemnitee is not a party,&nbsp;Indemnitee shall be
advanced all reasonable Expenses and indemnified against all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&rsquo;s behalf in connection therewith within ten days after the receipt by the Fund of a statement or statements
requesting any such advance or indemnification from time to time, whether prior to or after final disposition of such Proceeding.
Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Procedure
for Determination of Entitlement to Indemnification</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To obtain indemnification under this
Agreement,&nbsp;Indemnitee shall submit to the Fund a written request, including therein or therewith such documentation and
information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee
is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at such time(s)&nbsp;as
Indemnitee deems appropriate in Indemnitee&rsquo;s sole discretion. The officer of the Fund receiving any such request from
Indemnitee shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has
requested indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request by Indemnitee for indemnification pursuant to Section&nbsp;10(a)&nbsp;above, a determination, if required by
applicable law, with respect to Indemnitee&rsquo;s entitlement thereto shall promptly be made in the specific case: (i)&nbsp;if a
Change in Control shall have occurred, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered
to Indemnitee, which Independent Counsel shall be selected by the Indemnitee and approved by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL, which approval shall not be unreasonably withheld; or (ii)&nbsp;if a Change in
Control shall not have occurred, (A)&nbsp;by the Board by a majority vote of a quorum consisting of Disinterested Directors or, if
such a quorum cannot be obtained, then by a majority vote of a duly authorized committee of the Board consisting solely of one or
more Disinterested Directors, (B)&nbsp;if Independent Counsel has been selected by the Board in accordance with
Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL and approved by the Indemnitee, which approval shall not be unreasonably withheld, by
Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (C)&nbsp;if so directed
by a majority of the members of the Board, by the stockholders of the Fund. If it is so determined that Indemnitee is entitled to
indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee shall cooperate with the
person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including
providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such
determination in the discretion of the Board or Independent Counsel if retained pursuant to clause (ii)(B)&nbsp;of this
Section&nbsp;10(b). Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such
determination shall be borne by the Fund (irrespective of the determination as to Indemnitee&rsquo;s entitlement to indemnification)
and the Fund shall indemnify and hold Indemnitee harmless therefrom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Presumptions
and Effect of Certain Proceedings</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
making any determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
in accordance with Section&nbsp;10(a)&nbsp;of this Agreement, and the Fund shall have the burden of proof, by clear and convincing evidence,
to overcome that presumption in connection with the making of any determination contrary to that presumption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of <I>nolo
contendere</I> or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did
not meet the requisite standard of conduct described herein for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt"></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 227pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The knowledge and/or actions, or failure
to act, of any other director, officer, employee or agent of the Fund or any other director, trustee, officer, partner, manager, managing
member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited liability company, joint venture,
trust, employee benefit plan or other enterprise shall not be imputed to Indemnitee for purposes of determining any other right to indemnification
under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remedies
of Indemnitee</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;a determination is made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advance of Expenses is not timely made pursuant to Sections 8 or 9 of this
Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made pursuant to Section&nbsp;10(b)&nbsp;of
this Agreement within 60 days after receipt by the Fund of the request for indemnification, (iv)&nbsp;payment of indemnification is
not made pursuant to Sections 7 or 9 of this Agreement within ten days after receipt by the Fund of a written request therefor, or
(v)&nbsp;payment of indemnification pursuant to any other section of this Agreement or the Articles of Incorporation or Bylaws of
the Fund is not made within ten days after a determination has been made that Indemnitee is entitled to
indemnification,&nbsp;Indemnitee shall be entitled to an adjudication in an appropriate court located in the State of Maryland, or
in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement to such indemnification or advance of Expenses.
Alternatively,&nbsp;Indemnitee, at Indemnitee&rsquo;s option, may seek an award in arbitration to be conducted by a single
arbitrator pursuant to the Commercial Arbitration Rules&nbsp;of the American Arbitration Association. Indemnitee shall commence a
proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the
right to commence such proceeding pursuant to this Section&nbsp;12(a); provided, however, that the foregoing clause shall not apply
to a proceeding brought by Indemnitee to enforce his rights under Section&nbsp;7 of this Agreement. Except as set forth herein, the
provisions of Maryland law (without regard to its conflicts of laws rules) shall apply to any such arbitration. The Fund shall not
oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall be presumed to be entitled to
indemnification or advance of Expenses, as the case may be, under this Agreement and the Fund shall have the burden of proving that Indemnitee
is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a judicial proceeding or arbitration
pursuant to this Section&nbsp;12,&nbsp;Indemnitee shall not be required to reimburse the Fund for any advances pursuant to Section&nbsp;8
of this Agreement until a final determination is made with respect to Indemnitee&rsquo;s entitlement to indemnification (as to which all
rights of appeal have been exhausted or lapsed). The Fund shall, to the fullest extent not prohibited by law, be precluded from asserting
in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;12 that the procedures and presumptions of this Agreement
are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Fund is bound by all
of the provisions of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a determination shall have been made pursuant to Section&nbsp;10(b)&nbsp;of this Agreement that Indemnitee is entitled to
indemnification, the Fund shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this
Section&nbsp;12, absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that Indemnitee is successful in seeking, pursuant to this Section&nbsp;12, a judicial adjudication of or an award in arbitration
to enforce Indemnitee&rsquo;s rights under, or to recover damages for breach of, this Agreement,&nbsp;Indemnitee shall be entitled to
recover from the Fund, and shall be indemnified by the Fund for, any and all Expenses actually and reasonably incurred by him in such
judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee is entitled
to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in connection with
such judicial adjudication or arbitration shall be appropriately prorated.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Interest
shall be paid by the Fund to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article&nbsp;of the Annotated Code of Maryland for amounts which the Fund pays or is obligated to pay for the period (i) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing
with either the tenth day after the date on which the Fund was requested to advance Expenses in accordance with Sections 8 or 9 of this
Agreement or the 60<SUP>th</SUP> day after the date on which the Fund was requested to make the determination of entitlement to indemnification
under Section&nbsp;10(b)&nbsp;of this Agreement, as applicable, and (ii)&nbsp;ending on the date such payment is made to Indemnitee by
the Fund.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Defense
of the Underlying Proceeding</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnitee
shall notify the Fund promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or other
document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall include
with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure to give
any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to indemnification
or the advance of Expenses under this Agreement unless the Fund&rsquo;s ability to defend in such Proceeding or to obtain proceeds under
any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Fund is thereby actually so prejudiced.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject to the provisions of the last
sentence of this Section&nbsp;13(b)&nbsp;and of Section&nbsp;13(c)&nbsp;below, the Fund shall have the right to defend Indemnitee in
any Proceeding which may give rise to indemnification hereunder; provided, however, that the Fund shall notify Indemnitee of any
such decision to defend within 15 calendar days following receipt of notice of any such Proceeding under
Section&nbsp;13(a)&nbsp;above. The Fund shall not, without the prior written consent of Indemnitee, which shall not be unreasonably
withheld or delayed, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise which
(i)&nbsp;includes an admission of fault of Indemnitee, (ii)&nbsp;does not include, as an unconditional term thereof, the full
release of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably
satisfactory to Indemnitee or (iii)&nbsp;would impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This
Section&nbsp;13(b)&nbsp;shall not apply to a Proceeding brought by Indemnitee under Section&nbsp;12 of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding the provisions of Section&nbsp;13(b)&nbsp;above,
if in a Proceeding to which Indemnitee is a party by reason of Indemnitee&rsquo;s Corporate Status, (i)&nbsp;Indemnitee reasonably concludes,
based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that Indemnitee may have separate
defenses or counterclaims to assert with respect to any issue which may not be consistent with other defendants in such Proceeding, (ii)&nbsp;Indemnitee
reasonably concludes, based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that an
actual or apparent conflict of interest or potential conflict of interest exists between Indemnitee and the Fund, or (iii)&nbsp;if the
Fund fails to assume the defense of such Proceeding in a timely manner,&nbsp;Indemnitee shall be entitled to be represented by separate
legal counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld,
at the expense of the Fund. In addition, if the Fund fails to comply with any of its obligations under this Agreement or in the event
that the Fund or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny
or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,&nbsp;Indemnitee shall have the right to retain
counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld, at
the expense of the Fund (subject to Section&nbsp;12(d)&nbsp;of this Agreement), to represent Indemnitee in connection with any such matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Non-Exclusivity;
Survival of Rights; Subrogation; Investment Company <FONT STYLE="font-family: Times New Roman, Times, Serif">Act</FONT></U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
rights of indemnification and advance of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the Articles of Incorporation or Bylaws of the Fund, any agreement or a resolution
of the stockholders entitled to vote generally in the election of directors or of the Board, or otherwise. Unless consented to in writing
by Indemnitee, no amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee
under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration
or repeal, regardless of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration
or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy
shall be cumulative and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or
otherwise. The assertion of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of
any other right or remedy.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of any payment under this Agreement, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Fund to bring suit to enforce such rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that (i)&nbsp;Indemnitee has otherwise actually received such payment under any insurance
policy, contract, agreement or otherwise, or (ii)&nbsp;for so long as the Fund is subject to the Investment Company Act,
indemnification or payment or reimbursement of expenses would not be permissible under the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Section&nbsp;15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of his Corporate Status and
covering the Fund for any indemnification or advance of Expenses made by the Fund to Indemnitee for any claims made against Indemnitee
by reason of his Corporate Status. In the event of a Change in Control, the Fund shall maintain in force any and all directors and officers
liability insurance policies that were maintained by the Fund immediately prior to the Change in Control for a period of six years with
the insurance carrier or carriers and through the insurance broker in place at the time of the Change of Control; provided, however, (i)&nbsp;if
the carriers will not offer the same policy and an expiring policy needs to be replaced, a policy substantially comparable in scope and
amount shall be obtained and (ii)&nbsp;if any replacement insurance carrier is necessary to obtain a policy substantially comparable in
scope and amount, such insurance carrier shall have an AM Best rating that is the same or better than the AM Best rating of the existing
insurance carrier; provided, further, however, in no event shall the Fund be required to expend in the aggregate in excess of 250% of
the annual premium or premiums paid by the Fund for directors and officers liability insurance in effect on the date of the Change in
Control. In the event that 250% of the annual premium paid by the Fund for such existing directors and officers liability insurance is
insufficient for such coverage, the Fund shall spend up to that amount to purchase such lesser coverage as may be obtained with such amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
in any way limiting any other obligation under this Agreement, the Fund shall indemnify Indemnitee for any payment by Indemnitee arising
out of the amount of any deductible or retention and the amount of any excess of the aggregate of all judgments, penalties, fines, settlements
and Expenses incurred by Indemnitee in connection with a Proceeding over the coverage of any insurance referred to in the previous sentence.
The purchase, establishment and maintenance of any such insurance shall not in any way limit or affect the rights or obligations of the
Fund or Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Fund
and the Indemnitee shall not in any way limit or affect the rights or obligations of the Fund under any such insurance policies. If, at
the time the Fund receives notice from any source of a Proceeding to which Indemnitee is a party or a participant (as a witness or otherwise)
the Fund has directors and officers liability insurance in effect, the Fund shall give prompt notice of such Proceeding to the insurers
in accordance with the procedures set forth in the respective policies.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Coordination of Payments</U>.
The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract,
agreement or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>. If the indemnification
provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason, other than for failure
to satisfy the standard of conduct set forth in Section&nbsp;4 or due to the provisions of Section 5, then, in respect to any Proceeding
in which the Fund is jointly liable with Indemnitee (or would be if joined in such Proceeding), to the fullest extent permissible under
applicable law, the Fund, in lieu or indemnifying and holding harmless Indemnitee, shall pay, in the first instance, the entire amount
incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be paid in settlement, in connection with
any Proceeding without requiring Indemnitee to contribute to such payment, and the Fund hereby waives and relinquished any right of contribution
it may have at any time against Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports to Stockholders</U>.
To the extent required by the MGCL, the Fund shall report in writing to its stockholders the payment of any amounts for indemnification
of, or advance of Expenses to,&nbsp;Indemnitee under this Agreement arising out of a Proceeding by or in the right of the Fund with the
notice of the meeting of stockholders of the Fund next following the date of the payment of any such indemnification or advance of Expenses
or prior to such meeting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration
of Agreement; Binding Effect</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall continue until and terminate on the later of (i)&nbsp;the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Fund or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Fund, and (ii)&nbsp;the
date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and any Proceeding
commenced by Indemnitee pursuant to Section&nbsp;12 of this Agreement).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Fund), shall continue as to an Indemnitee
who has ceased to (i)&nbsp;be a director, officer, employee or agent of the Fund, or (ii)&nbsp;be a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such
capacity at the request of the Fund, and shall inure to the benefit of Indemnitee and Indemnitee&rsquo;s spouse, assigns, heirs,
devisees, executors and administrators and other legal representatives.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Fund, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Fund would be required to perform
if no such succession had taken place.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable
and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto
agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any
necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific
performance,&nbsp;Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled.
Indemnitee shall further be entitled to such specific performance and injunctive relief, including temporary restraining orders,
preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertakings in connection
therewith. The Fund acknowledges that, in the absence of a waiver, a bond or undertaking may be required of Indemnitee by a court,
and the Fund hereby waives any such requirement of such a bond or undertaking.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>. If any provision
or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity,
legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Identical Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. One such counterpart signed by the party against whom enforceability is sought
shall be sufficient to evidence the existence of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Modification and Waiver</U>.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether
or not similar) nor shall such waiver constitute a continuing waiver.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;24.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. All notices, requests,
demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i)&nbsp;delivered by hand
and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery, or (ii)&nbsp;mailed
by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If to Indemnitee, to the address set forth on the signature page&nbsp;hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If to the Fund, to:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund,&nbsp;Inc.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Avenue of the Stars, 12</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> <FONT STYLE="font-size: 10pt">Floor</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: Chief Legal Officer</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished in writing to Indemnitee
by the Fund or to the Fund by Indemnitee, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section&nbsp;25.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Daniel J. Hall</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">INDEMNITEE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ David A. Sachs</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">David A. Sachs</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chairman of the Board of Directors</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">**
<I>Signature Page&nbsp;to Sachs Indemnification Agreement</I> **</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To:&#8239;&#8239;The Board of Directors of Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&#8239;&#8239;Affirmation and Undertaking</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated as of the _____ day of ______________, 20____, by and between Ares Dynamic Credit
Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;Fund&rdquo;), and the undersigned Indemnitee (the &ldquo;Indemnification
Agreement&rdquo;), pursuant to which I am entitled to advance of Expenses in connection with <B>[Description of Proceeding]</B> (the &ldquo;Proceeding&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I am subject to the Proceeding by reason of
my Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that
at all times, insofar as I was involved as <B>[a director] [an officer]</B> of the Fund, in any of the facts or events giving rise
to the Proceeding,&nbsp;I (1)&nbsp;did not act with bad faith or active or deliberate dishonesty, (2)&nbsp;did not receive any
improper personal benefit in money, property or services and (3)&nbsp;in the case of any criminal proceeding, had no reasonable
cause to believe that any act or omission by me was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the advance of Expenses by
the Fund for reasonable attorneys&rsquo; fees and related Expenses incurred by me in connection with the Proceeding (the &ldquo;Advanced
Expenses&rdquo;),&nbsp;I hereby agree that if, in connection with the Proceeding, it is established that (1)&nbsp;an act or omission by
me was material to the matter giving rise to the Proceeding and (a)&nbsp;was committed in bad faith or (b)&nbsp;was the result of active
and deliberate dishonesty or (2)&nbsp;I actually received an improper personal benefit in money, property or services or (3)&nbsp;in the
case of any criminal proceeding,&nbsp;I had reasonable cause to believe that the act or omission was unlawful, then I shall promptly reimburse
the portion of the Advanced Expenses relating to the claims, issues or matters in the Proceeding as to which the foregoing findings have
been established.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">IN WITNESS WHEREOF,&nbsp;I have executed this Affirmation
and Undertaking on this ___ day of ____________________, 20____.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>FORM&nbsp;OF INDEMNIFICATION AGREEMENT</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">THIS
INDEMNIFICATION AGREEMENT (&ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of the 29<SUP>th</SUP> day of January, 2014,
by and between Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;<U>Fund</U>&rdquo;), and Bruce H. Spector (&ldquo;I<U>ndemnitee</U>&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, at the request of the Fund,&nbsp;Indemnitee
currently serves as a director and/or an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS,&nbsp;Indemnitee may be subjected to claims,
suits or proceedings arising as a result of Indemnitee&rsquo;s service as a director and/or an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as an inducement to Indemnitee to serve
or continue to serve as a director and/or an officer, the Fund has agreed to indemnify and to advance expenses and costs incurred by Indemnitee
in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Fund and Indemnitee do hereby covenant and agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Definitions</U>.
For purposes of this Agreement:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Change in Control</U>&rdquo;
means a change in control of the Fund occurring after the Effective Date of a nature that would be required to be reported in response
to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under
the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), whether or not the Fund is then subject to such
reporting requirement; <U>provided</U>, <U>however</U>, that, without limitation, such a Change in Control shall be deemed to have occurred
if, after the Effective Date (i)&nbsp;any &ldquo;person&rdquo; (as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange
Act) is or becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly,
of securities of the Fund representing 15% or more of the combined voting power of all of the Fund&rsquo;s then-outstanding securities
without the prior approval of at least two-thirds of the members of the Board of Directors of the Fund (the &ldquo;<U>Board</U>&rdquo;)
in office immediately prior to such person&rsquo;s attaining such percentage interest; (ii)&nbsp;there occurs a proxy contest, or the
Fund is a party to a merger, consolidation, sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds
of the members of the Board then in office, as a consequence of which members of the Board in office immediately prior to such transaction
or event constitute less than a majority of the Board thereafter; or (iii)&nbsp;at any time, a majority of the members of the Board are
not individuals (A)&nbsp;who were directors as of the Effective Date or (B)&nbsp;whose election by the Board or nomination for election
by the Fund&rsquo;s stockholders was approved by the affirmative vote of at least two-thirds of the directors then in office who were
directors as of the Effective Date or whose election or nomination for election was previously so approved.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Corporate Status</U>&rdquo;
means the status of a person as a present or former director, officer, employee or agent of the Fund or as a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited liability
company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity at the request
of the Fund. As a clarification and without limiting the circumstances in which Indemnitee may be serving at the request of the Fund,
service by Indemnitee shall be deemed to be at the request of the Fund: (i)&nbsp;if Indemnitee serves or served as a director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any corporation, partnership, limited liability company, joint
venture, trust or other enterprise (1)&nbsp;of which a majority of the voting power or equity interest is owned directly or indirectly
by the Fund or (2)&nbsp;the management of which is controlled directly or indirectly by the Fund and (ii)&nbsp;if, as a result of Indemnitee&rsquo;s
service to the Fund,&nbsp;Indemnitee is subject to duties by, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as deemed fiduciary thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Disinterested
Director</U>&rdquo; means a director of the Fund who is not and was not (i)&nbsp;a party to the Proceeding in respect of which indemnification
and/or advance of Expenses is sought by Indemnitee and (ii)&nbsp;an &ldquo;interested person&rdquo; of the Fund, as defined in Section&nbsp;2(a)(19)
of the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Effective Date</U>&rdquo; means
the date set forth in the first paragraph of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Expenses</U>&rdquo;
means any and all reasonable and out-of-pocket attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement,
ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding. Expenses shall
also include Expenses incurred in connection with any appeal resulting from any Proceeding including, without limitation, the premium,
security for and other costs relating to any cost bond, supersedes bond or other appeal bond or its equivalent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Independent
Counsel</U>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is,
nor in the past five years has been, retained to represent: (i)&nbsp;the Fund or Indemnitee in any matter material to either such
party (other than with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar
indemnification agreements), or (ii)&nbsp;any other party to or participant or witness in the Proceeding giving rise to a claim for
indemnification or advance of Expenses hereunder. Notwithstanding the foregoing, the term &ldquo;Independent Counsel&rdquo; shall
not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of
interest in representing either the Fund or Indemnitee in an action to determine Indemnitee&rsquo;s rights under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 47; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Investment Company Act</U>&rdquo; means the Investment Company Act of 1940, as amended.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Proceeding</U>&rdquo;
means any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry,
administrative hearing or any other proceeding, whether brought by or in the right of the Fund or otherwise and whether of a civil (including
intentional or unintentional tort claims), criminal, administrative or investigative (formal or informal) nature, including any appeal
therefrom, except one pending or completed on or before the Effective Date, unless otherwise specifically agreed in writing by the Fund
and Indemnitee. If Indemnitee reasonably believes that a given situation may lead to or culminate in the institution of a Proceeding,
such situation shall also be considered a Proceeding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services by Indemnitee</U>.
Indemnitee serves as a director and/or an officer of the Fund. However, this Agreement shall not impose any independent obligation on
Indemnitee or the Fund to continue Indemnitee&rsquo;s service to the Fund. This Agreement shall not be deemed an employment contract between
the Fund (or any other entity) and Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>General</U>.
The Fund shall indemnify, and advance Expenses to,&nbsp;Indemnitee </FONT>(a)&nbsp;as provided in this Agreement and
(b)&nbsp;otherwise to the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; <U>provided</U>, <U>however</U>,
that no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland
law as in effect on the Effective Date. The rights of Indemnitee provided in this <U>Section&nbsp;3</U> shall include, without
limitation, the rights set forth in the other sections of this Agreement, including any additional indemnification permitted by
Section&nbsp;2-418(g)&nbsp;of the Maryland General Corporation Law (the &ldquo;<U>MGCL</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Standard for Indemnification</U>.
If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a party to any Proceeding, the
Fund shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement and all Expenses actually and reasonably
incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with any such Proceeding unless it is established that (a)&nbsp;the
act or omission of Indemnitee was material to the matter giving rise to the Proceeding and (i)&nbsp;was committed in bad faith or (ii)&nbsp;was
the result of active and deliberate dishonesty, (b)&nbsp;Indemnitee actually received an improper personal benefit in money, property
or services or (c)&nbsp;in the case of any criminal Proceeding,&nbsp;Indemnitee had reasonable cause to believe that his conduct was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain Limits on Indemnification</U>.
Notwithstanding any other provision of this Agreement (other than <U>Section&nbsp;6</U>),&nbsp;Indemnitee shall not be entitled to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification hereunder if
the Proceeding was one by or in the right of the Fund and Indemnitee is adjudged, in a final adjudication of the Proceeding not subject
to further appeal, to be liable to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit was improperly received in any Proceeding charging improper personal benefit to Indemnitee, whether or not involving
action in the Indemnitee&rsquo;s Corporate Status; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
or advance of Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i)&nbsp;the Proceeding was brought to enforce indemnification
under this Agreement, and then only to the extent in accordance with and as authorized by <U>Section&nbsp;12</U> of this Agreement, or
(ii)&nbsp;the Fund&rsquo;s Articles of Incorporation or Bylaws, a resolution of the stockholders entitled to vote generally in the election
of directors or of the Board or an agreement approved by the Board to which the Fund is a party expressly provide otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Court-Ordered Indemnification</U>.
Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee and such notice
as the court shall require, may order indemnification of Indemnitee by the Fund in the following circumstances:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is entitled to reimbursement under Section&nbsp;2-418(d)(1)&nbsp;of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant
circumstances, whether or not Indemnitee (i)&#8239;has
met the standards of conduct set forth in Section&nbsp;2-418(b)&nbsp;of the MGCL or (ii)&nbsp;has been adjudged liable for receipt
of an improper personal benefit under Section&nbsp;2-418(c)&nbsp;of the MGCL, the court may order such indemnification as the court
shall deem proper. However, indemnification with respect to any Proceeding by or in the right of the Fund or in which liability
shall have been adjudged in the circumstances described in Section&nbsp;2-418(c)&nbsp;of the MGCL shall be limited to Expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;7. <U>Indemnification for Expenses
of an Indemnitee Who is Wholly or Partially Successful</U>. Notwithstanding any other provision of this Agreement, and without limiting
any such provision, to the extent that Indemnitee was or is, by reason of his Corporate Status, made a party to (or otherwise becomes
a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such Proceeding,&nbsp;Indemnitee shall
be indemnified for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than
all claims, issues or matters in such Proceeding, the Fund shall indemnify Indemnitee under this <U>Section&nbsp;7</U> for all Expenses
actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with each such claim, issue or matter, allocated
on a reasonable and proportionate basis. For purposes of this <U>Section&nbsp;7</U> and, without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim,
issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Advance of Expenses for Indemnitee</U>.
If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a party to any Proceeding, the
Fund shall, without requiring a preliminary determination of Indemnitee&rsquo;s ultimate entitlement to indemnification hereunder (except
as set out in this Section&nbsp;8), advance all reasonable Expenses incurred by or on behalf of Indemnitee in connection with such Proceeding.
Such advance or advances shall be made within ten days after the receipt by the Fund of a statement or statements requesting such advance
or advances from time to time, whether prior to or after final disposition of such Proceeding and may be in the form of, in the reasonable
discretion of the Indemnitee (but without duplication) (a)&nbsp;payment of such Expenses directly to third parties on behalf of Indemnitee,
(b)&nbsp;advancement to Indemnitee of funds in an amount sufficient to pay such Expenses or (c)&nbsp;reimbursement to Indemnitee for Indemnitee&rsquo;s
payment of such Expenses. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee and shall include
or be preceded or accompanied by a written affirmation by Indemnitee of Indemnitee&rsquo;s good faith belief that the standard of conduct
necessary for indemnification by the Fund as authorized by law and by this Agreement has been met and a written undertaking by or on behalf
of Indemnitee, in substantially the form attached hereto as <U>Exhibit&nbsp;A</U> or in such form as may be required under applicable
law as in effect at the time of the execution thereof, to reimburse the portion of any Expenses advanced to Indemnitee relating to claims,
issues or matters in the Proceeding as to which it shall ultimately be established that the standard of conduct has not been met by Indemnitee
and which have not been successfully resolved as described in <U>Section&nbsp;7</U> of this Agreement. For so long as the Fund is subject
to the Investment Company Act, any advancement of Expenses under this Agreement shall be subject to at least one of the following as a
condition of the advancement: (a)&nbsp;Indemnitee shall provide a security for Indemnitee&rsquo;s undertaking, (b)&nbsp;the Fund shall
be insured against losses arising by reason of any lawful advances or (c)&nbsp;a majority of a quorum of the Disinterested Directors,
or Independent Counsel, in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full-trial-type
inquiry), that there is no reason to believe that Indemnitee ultimately will be found to not be entitled to indemnification. To the extent
that Expenses advanced to Indemnitee do not relate to a specific claim, issue or matter in the Proceeding, such Expenses shall be allocated
on a reasonable and proportionate basis. The undertaking required by this <U>Section&nbsp;8</U> shall be an unlimited general obligation
by or on behalf of Indemnitee and shall be accepted without reference to Indemnitee&rsquo;s financial ability to repay such advanced Expenses
and without any requirement to post security therefor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification and Advance
of Expenses as a Witness or Other Participant</U>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee
is or may be, by reason of Indemnitee&rsquo;s Corporate Status, made a witness or otherwise asked to participate in any Proceeding, whether
instituted by the Fund or any other party, and to which Indemnitee is not a party,&nbsp;Indemnitee shall be advanced all reasonable Expenses
and indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection therewith
within ten days after the receipt by the Fund of a statement or statements requesting any such advance or indemnification from time to
time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses
incurred by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Procedure
for Determination of Entitlement to Indemnification</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
obtain indemnification under this Agreement,&nbsp;Indemnitee shall submit to the Fund a written request, including therein or therewith
such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what
extent Indemnitee is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at such time(s)&nbsp;as
Indemnitee deems appropriate in Indemnitee&rsquo;s sole discretion. The officer of the Fund receiving any such request from Indemnitee
shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request by Indemnitee for indemnification pursuant to <U>Section&nbsp;10(a)</U>&nbsp;above, a determination, if required by applicable
law, with respect to Indemnitee&rsquo;s entitlement thereto shall promptly be made in the specific case: (i)&nbsp;if a Change in Control
shall have occurred, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, which
Independent Counsel shall be selected by the Indemnitee and approved by the Board in accordance with Section&nbsp;2-418(e)(2)(ii)&nbsp;of
the MGCL, which approval shall not be unreasonably withheld; or (ii)&nbsp;if a Change in Control shall not have occurred, (A)&nbsp;by
the Board by a majority vote of a quorum consisting of Disinterested Directors or, if such a quorum cannot be obtained, then by a majority
vote of a duly authorized committee of the Board consisting solely of one or more Disinterested Directors, (B)&nbsp;if Independent Counsel
has been selected by the Board in accordance with Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL and approved by the Indemnitee, which
approval shall not be unreasonably withheld, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered
to Indemnitee or (C)&nbsp;if so directed by a majority of the members of the Board, by the stockholders of the Fund. If it is so determined
that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee
shall cooperate with the person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination
in the discretion of the Board or Independent Counsel if retained pursuant to clause (ii)(B)&nbsp;of this <U>Section&nbsp;10(b)</U>. Any
Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Fund
(irrespective of the determination as to Indemnitee&rsquo;s entitlement to indemnification) and the Fund shall indemnify and hold Indemnitee
harmless therefrom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Presumptions
and Effect of Certain Proceedings</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In making any determination with
respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that
Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in
accordance with <U>Section&nbsp;10(a)</U>&nbsp;of this Agreement, and the Fund shall have the burden of proof, by clear and
convincing evidence, to overcome that presumption in connection with the making of any determination contrary to that
presumption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of nolo
contendere or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did not
meet the requisite standard of conduct described herein for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
knowledge and/or actions, or failure to act, of any other director, officer, employee or agent of the Fund or any other director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise shall not be imputed to Indemnitee for purposes of
determining any other right to indemnification under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Remedies
of Indemnitee</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;a determination is made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advance of Expenses is not timely made pursuant to <U>Sections 8</U> or <U>9</U> of
this Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of
this Agreement within 60 days after receipt by the Fund of the request for indemnification, (iv)&nbsp;payment of indemnification is
not made pursuant to <U>Sections 7</U> or <U>9</U> of this Agreement within ten days after receipt by the Fund of a written request
therefor, or (v)&nbsp;payment of indemnification pursuant to any other section of this Agreement or the Articles of Incorporation or
Bylaws of the Fund is not made within ten days after a determination has been made that Indemnitee is entitled to
indemnification,&nbsp;Indemnitee shall be entitled to an adjudication in an appropriate court located in the State of Maryland, or
in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement to such indemnification or advance of Expenses.
Alternatively, Indemnitee, at Indemnitee&rsquo;s option, may seek an award in arbitration to be conducted by a single arbitrator
pursuant to the Commercial Arbitration Rules&nbsp;of the American Arbitration Association. Indemnitee shall commence a proceeding
seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to
commence such proceeding pursuant to this <U>Section&nbsp;12(a)</U>; <U>provided</U>, <U>however</U>, that the foregoing clause
shall not apply to a proceeding brought by Indemnitee to enforce his rights under <U>Section&nbsp;7</U> of this Agreement. Except as
set forth herein, the provisions of Maryland law (without regard to its conflicts of laws rules) shall apply to any such
arbitration. The Fund shall not oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any judicial proceeding or arbitration commenced pursuant to this <U>Section&nbsp;12</U>,&nbsp;Indemnitee shall be presumed to be
entitled to indemnification or advance of Expenses, as the case may be, under this Agreement and the Fund shall have the burden of
proving that Indemnitee is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a
judicial proceeding or arbitration pursuant to this <U>Section&nbsp;12</U>,&nbsp;Indemnitee shall not be required to reimburse the
Fund for any advances pursuant to <U>Section&nbsp;8</U> of this Agreement until a final determination is made with respect to
Indemnitee&rsquo;s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). The Fund shall,
to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced
pursuant to this <U>Section&nbsp;12</U> that the procedures and presumptions of this Agreement are not valid, binding and
enforceable and shall stipulate in any such court or before any such arbitrator that the Fund is bound by all of the provisions of
this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a determination shall have been made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement that Indemnitee is entitled to indemnification,
the Fund shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this <U>Section&nbsp;12</U>,
absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s statement
not materially misleading, in connection with the request for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that Indemnitee is successful in seeking, pursuant to this <U>Section&nbsp;12</U>, a judicial adjudication of or an award in
arbitration to enforce Indemnitee&rsquo;s rights under, or to recover damages for breach of, this Agreement,&nbsp;Indemnitee shall be
entitled to recover from the Fund, and shall be indemnified by the Fund for, any and all Expenses actually and reasonably incurred by
him in such judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee
is entitled to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in connection
with such judicial adjudication or arbitration shall be appropriately prorated.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Interest
shall be paid by the Fund to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article&nbsp;of the Annotated Code of Maryland for amounts which the Fund pays or is obligated to pay for the period (i)&nbsp;commencing
with either the tenth day after the date on which the Fund was requested to advance Expenses in accordance with <U>Sections 8</U> or
<U>9</U> of this Agreement or the 60th day after the date on which the Fund was requested to make the determination of entitlement to
indemnification under <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement, as applicable, and (ii)&nbsp;ending on the date such payment
is made to Indemnitee by the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Defense
of the Underlying Proceeding</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnitee
shall notify the Fund promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or other
document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall include
with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure to give
any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to indemnification
or the advance of Expenses under this Agreement unless the Fund&rsquo;s ability to defend in such Proceeding or to obtain proceeds under
any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Fund is thereby actually so prejudiced.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the provisions of the last sentence of this <U>Section&nbsp;13(b)</U>&nbsp;and of <U>Section&nbsp;13(c)</U> below, the Fund shall
have the right to defend Indemnitee in any Proceeding which may give rise to indemnification hereunder; <U>provided</U>, <U>however</U>,
that the Fund shall notify Indemnitee of any such decision to defend within 15 calendar days following receipt of notice of any such
Proceeding under <U>Section&nbsp;13(a)</U>&nbsp;above. The Fund shall not, without the prior written consent of Indemnitee, which shall
not be unreasonably withheld or delayed, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise
which (i)&nbsp;includes an admission of fault of Indemnitee, (ii)&nbsp;does not include, as an unconditional term thereof, the full release
of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably satisfactory
to Indemnitee or (iii)&nbsp;would impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This <U>Section&nbsp;13(b)</U>&nbsp;shall
not apply to a Proceeding brought by Indemnitee under <U>Section&nbsp;12</U> of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding the provisions of <U>Section&nbsp;13(b)</U>&nbsp;above,
if in a Proceeding to which Indemnitee is a party by reason of Indemnitee&rsquo;s Corporate Status, (i)&nbsp;Indemnitee reasonably concludes,
based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that Indemnitee may have separate
defenses or counterclaims to assert with respect to any issue which may not be consistent with other defendants in such Proceeding, (ii)&nbsp;Indemnitee
reasonably concludes, based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that an
actual or apparent conflict of interest or potential conflict of interest exists between Indemnitee and the Fund, or (iii)&nbsp;if the
Fund fails to assume the defense of such Proceeding in a timely manner,&nbsp;Indemnitee shall be entitled to be represented by separate
legal counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld,
at the expense of the Fund. In addition, if the Fund fails to comply with any of its obligations under this Agreement or in the event
that the Fund or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny
or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,&nbsp;Indemnitee shall have the right to retain
counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld, at
the expense of the Fund (subject to <U>Section&nbsp;12(d)</U>&nbsp;of this Agreement), to represent Indemnitee in connection with any
such matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Non-Exclusivity;
Survival of Rights; Subrogation; Investment Company </U></FONT><U>Act</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The rights of indemnification and advance
of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled
under applicable law, the Articles of Incorporation or Bylaws of the Fund, any agreement or a resolution of the stockholders entitled
to vote generally in the election of directors or of the Board, or otherwise. Unless consented to in writing by Indemnitee, no amendment,
alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement
in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal, regardless
of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration or repeal. No right
or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy shall be cumulative
and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion
of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of any other right or remedy.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of any payment under this Agreement, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Fund to bring suit to enforce such rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything contained in this Agreement to the contrary, the Fund shall not be liable under this Agreement to make any payment of amounts
otherwise indemnifiable or payable or reimbursable as Expenses hereunder if and to the extent that (i)&nbsp;Indemnitee has otherwise actually
received such payment under any insurance policy, contract, agreement or otherwise, or (ii)&nbsp;for so long as the Fund is subject to
the Investment Company Act, indemnification or payment or reimbursement of expenses would not be permissible under the Investment Company
Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Insurance</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of his Corporate Status and
covering the Fund for any indemnification or advance of Expenses made by the Fund to Indemnitee for any claims made against Indemnitee
by reason of his Corporate Status. In the event of a Change in Control, the Fund shall maintain in force any and all directors and officers
liability insurance policies that were maintained by the Fund immediately prior to the Change in Control for a period of six years with
the insurance carrier or carriers and through the insurance broker in place at the time of the Change of Control; <U>provided</U>, <U>however</U>,
(i)&nbsp;if the carriers will not offer the same policy and an expiring policy needs to be replaced, a policy substantially comparable
in scope and amount shall be obtained and (ii)&nbsp;if any replacement insurance carrier is necessary to obtain a policy substantially
comparable in scope and amount, such insurance carrier shall have an AM Best rating that is the same or better than the AM Best rating
of the existing insurance carrier; <U>provided</U>, <U>further</U>, <U>however</U>, in no event shall the Fund be required to expend in
the aggregate in excess of 250% of the annual premium or premiums paid by the Fund for directors and officers liability insurance in effect
on the date of the Change in Control. In the event that 250% of the annual premium paid by the Fund for such existing directors and officers
liability insurance is insufficient for such coverage, the Fund shall spend up to that amount to purchase such lesser coverage as may
be obtained with such amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
in any way limiting any other obligation under this Agreement, the Fund shall indemnify Indemnitee for any payment by Indemnitee
arising out of the amount of any deductible or retention and the amount of any excess of the aggregate of all judgments, penalties,
fines, settlements and Expenses incurred by Indemnitee in connection with a Proceeding over the coverage of any insurance referred
to in the previous sentence. The purchase, establishment and maintenance of any such insurance shall not in any way limit or affect
the rights or obligations of the Fund or Indemnitee under this Agreement except as expressly provided herein, and the execution and
delivery of this Agreement by the Fund and the Indemnitee shall not in any way limit or affect the rights or obligations of the Fund
under any such insurance policies. If, at the time the Fund receives notice from any source of a Proceeding to which Indemnitee is a
party or a participant (as a witness or otherwise) the Fund has directors and officers liability insurance in effect, the Fund shall
give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Coordination of Payments</U>.
The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract,
agreement or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>. If the indemnification
provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason, other than for failure
to satisfy the standard of conduct set forth in <U>Section&nbsp;4</U> or <U>Section&nbsp;8</U> or due to the provisions of <U>Section&nbsp;5</U>,
then, in respect to any Proceeding in which the Fund is jointly liable with Indemnitee (or would be if joined in such Proceeding), to
the fullest extent permissible under applicable law, the Fund, in lieu or indemnifying and holding harmless Indemnitee, shall pay, in
the first instance, the entire amount incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be
paid in settlement, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Fund hereby
waives and relinquished any right of contribution it may have at any time against Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports to Stockholders</U>.
To the extent required by the MGCL, the Fund shall report in writing to its stockholders the payment of any amounts for indemnification
of, or advance of Expenses to,&nbsp;Indemnitee under this Agreement arising out of a Proceeding by or in the right of the Fund with the
notice of the meeting of stockholders of the Fund next following the date of the payment of any such indemnification or advance of Expenses
or prior to such meeting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Duration
of Agreement; Binding Effect</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall continue until and terminate on the later of (i)&nbsp;the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Fund or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Fund, and (ii)&nbsp;the
date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and any Proceeding
commenced by Indemnitee pursuant to <U>Section&nbsp;12</U> of this Agreement).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Fund), shall continue as to an Indemnitee
who has ceased to (i)&nbsp;be a director, officer, employee or agent of the Fund, or (ii)&nbsp;be a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such
capacity at the request of the Fund, and shall inure to the benefit of Indemnitee and Indemnitee&rsquo;s spouse, assigns, heirs,
devisees, executors and administrators and other legal representatives.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Fund, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Fund would be required to perform
if no such succession had taken place.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and
difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that
Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing
actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance,&nbsp;Indemnitee shall not be precluded
from seeking or obtaining any other relief to which Indemnitee may be entitled. Indemnitee shall further be entitled to such specific
performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without
the necessity of posting bonds or other undertakings in connection therewith. The Fund acknowledges that, in the absence of a waiver,
a bond or undertaking may be required of Indemnitee by a court, and the Fund hereby waives any such requirement of such a bond or undertaking.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>. If any provision
or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity,
legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Identical Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. One such counterpart signed by the party against whom enforceability is sought
shall be sufficient to evidence the existence of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Modification and Waiver</U>.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether
or not similar) nor shall such waiver constitute a continuing waiver.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;24.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. All notices, requests,
demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i)&nbsp;delivered by hand
and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery, or (ii)&nbsp;mailed
by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 33pt">(a)</TD><TD STYLE="text-align: justify">If to Indemnitee, to the address set forth on the signature page&nbsp;hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 33pt">(b)</TD><TD STYLE="text-align: justify">If to the Fund, to:</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">Ares Dynamic
Credit Allocation Fund,&nbsp;Inc.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">2000 Avenue of the Stars, 12</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> <FONT STYLE="font-size: 10pt">Floor</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Attn: Chief Legal Officer</P>


</TD></TR>
                                                                                                                          </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished in writing to Indemnitee
by the Fund or to the Fund by Indemnitee, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;25.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/
    Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">INDEMNITEE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
    Bruce H. Spector</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Bruce H. Spector</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Address:&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">10286
    Century Woods Drive</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Los
    Angeles, CA 90067</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 59; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To: The Board of Directors of Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Affirmation and Undertaking</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated as of the ____ day of _____________, 20___, by and between Ares Dynamic Credit
Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;<U>Fund</U>&rdquo;), and the undersigned Indemnitee (the &ldquo;<U>Indemnification
Agreement</U>&rdquo;), pursuant to which I am entitled to advance of Expenses in connection with <B>[Description of Proceeding]</B> (the
 &ldquo;<U>Proceeding</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I am subject to the Proceeding by reason of
my Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that
at all times, insofar as I was involved as <B>[a director] [an officer]</B> of the Fund, in any of the facts or events giving rise
to the Proceeding,&nbsp;I (1)&nbsp;did not act with bad faith or active or deliberate dishonesty, (2)&nbsp;did not receive any
improper personal benefit in money, property or services and (3)&nbsp;in the case of any criminal proceeding, had no reasonable
cause to believe that any act or omission by me was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the advance of Expenses by
the Fund for reasonable attorneys&rsquo; fees and related Expenses incurred by me in connection with the Proceeding (the &ldquo;<U>Advanced
Expenses</U>&rdquo;),&nbsp;I hereby agree that if, in connection with the Proceeding, it is established that (1)&nbsp;an act or omission
by me was material to the matter giving rise to the Proceeding and (a)&nbsp;was committed in bad faith or (b)&nbsp;was the result of active
and deliberate dishonesty or (2)&nbsp;I actually received an improper personal benefit in money, property or services or (3)&nbsp;in the
case of any criminal proceeding,&nbsp;I had reasonable cause to believe that the act or omission was unlawful, then I shall promptly reimburse
the portion of the Advanced Expenses relating to the claims, issues or matters in the Proceeding as to which the foregoing findings have
been established.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">IN WITNESS WHEREOF,&nbsp;I have executed this Affirmation
and Undertaking on this ____ day of __________________, 20___.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>FORM&nbsp;OF INDEMNIFICATION AGREEMENT</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS INDEMNIFICATION AGREEMENT
(&ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of the 12<SUP>th</SUP> day of August, 2024, by and between Ares Dynamic
Credit Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;<U>Fund</U>&rdquo;), and Elaine Orr (&ldquo;<U>Indemnitee</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, at the request of the Fund,&nbsp;Indemnitee
currently serves as a director and/or an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS,&nbsp;Indemnitee may be subjected to claims,
suits or proceedings arising as a result of Indemnitee&rsquo;s service as a director and/or an officer of the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as an inducement to Indemnitee to serve
or continue to serve as a director and/or an officer, the Fund has agreed to indemnify and to advance expenses and costs incurred by Indemnitee
in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Fund and Indemnitee do hereby covenant and agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Definitions</U>.
For purposes of this Agreement:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Change in Control</U>&rdquo;
means a change in control of the Fund occurring after the Effective Date of a nature that would be required to be reported in response
to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under
the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), whether or not the Fund is then subject to such
reporting requirement; <U>provided</U>, <U>however</U>, that, without limitation, such a Change in Control shall be deemed to have occurred
if, after the Effective Date (i)&nbsp;any &ldquo;person&rdquo; (as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange
Act) is or becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly,
of securities of the Fund representing 15% or more of the combined voting power of all of the Fund&rsquo;s then-outstanding securities
without the prior approval of at least two-thirds of the members of the Board of Directors of the Fund (the &ldquo;<U>Board</U>&rdquo;)
in office immediately prior to such person&rsquo;s attaining such percentage interest; (ii)&nbsp;there occurs a proxy contest, or the
Fund is a party to a merger, consolidation, sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds
of the members of the Board then in office, as a consequence of which members of the Board in office immediately prior to such transaction
or event constitute less than a majority of the Board thereafter; or (iii)&nbsp;at any time, a majority of the members of the Board are
not individuals (A)&nbsp;who were directors as of the Effective Date or (B)&nbsp;whose election by the Board or nomination for election
by the Fund&rsquo;s stockholders was approved by the affirmative vote of at least two-thirds of the directors then in office who were
directors as of the Effective Date or whose election or nomination for election was previously so approved.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Corporate Status</U>&rdquo;
means the status of a person as a present or former director, officer, employee or agent of the Fund or as a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited liability
company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity at the request
of the Fund. As a clarification and without limiting the circumstances in which Indemnitee may be serving at the request of the Fund,
service by Indemnitee shall be deemed to be at the request of the Fund: (i)&nbsp;if Indemnitee serves or served as a director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any corporation, partnership, limited liability company, joint
venture, trust or other enterprise (1)&nbsp;of which a majority of the voting power or equity interest is owned directly or indirectly
by the Fund or (2)&nbsp;the management of which is controlled directly or indirectly by the Fund and (ii)&nbsp;if, as a result of Indemnitee&rsquo;s
service to the Fund,&nbsp;Indemnitee is subject to duties by, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as deemed fiduciary thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Disinterested
Director</U>&rdquo; means a director of the Fund who is not and was not (i)&nbsp;a party to the Proceeding in respect of which indemnification
and/or advance of Expenses is sought by Indemnitee and (ii)&nbsp;an &ldquo;interested person&rdquo; of the Fund, as defined in Section&nbsp;2(a)(19)
of the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Effective Date</U>&rdquo; means
the date set forth in the first paragraph of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Expenses</U>&rdquo;
means any and all reasonable and out-of-pocket attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement,
ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding. Expenses shall
also include Expenses incurred in connection with any appeal resulting from any Proceeding including, without limitation, the premium,
security for and other costs relating to any cost bond, supersedes bond or other appeal bond or its equivalent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Independent
Counsel</U>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is,
nor in the past five years has been, retained to represent: (i)&nbsp;the Fund or Indemnitee in any matter material to either such
party (other than with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar
indemnification agreements), or (ii)&nbsp;any other party to or participant or witness in the Proceeding giving rise to a claim for
indemnification or advance of Expenses hereunder. Notwithstanding the foregoing, the term &ldquo;Independent Counsel&rdquo; shall
not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of
interest in representing either the Fund or Indemnitee in an action to determine Indemnitee&rsquo;s rights under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 62; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Investment Company Act</U>&rdquo; means the Investment Company Act of 1940, as amended.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<U>Proceeding</U>&rdquo;
means any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry,
administrative hearing or any other proceeding, whether brought by or in the right of the Fund or otherwise and whether of a civil (including
intentional or unintentional tort claims), criminal, administrative or investigative (formal or informal) nature, including any appeal
therefrom, except one pending or completed on or before the Effective Date, unless otherwise specifically agreed in writing by the Fund
and Indemnitee. If Indemnitee reasonably believes that a given situation may lead to or culminate in the institution of a Proceeding,
such situation shall also be considered a Proceeding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services by Indemnitee</U>.
Indemnitee serves as a director and/or an officer of the Fund. However, this Agreement shall not impose any independent obligation on
Indemnitee or the Fund to continue Indemnitee&rsquo;s service to the Fund. This Agreement shall not be deemed an employment contract between
the Fund (or any other entity) and Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>General</U>.
The Fund shall indemnify, and advance Expenses to,&nbsp;Indemnitee </FONT>(a)&nbsp;as provided in this Agreement and
(b)&nbsp;otherwise to the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; <U>provided</U>, <U>however</U>,
that no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland
law as in effect on the Effective Date. The rights of Indemnitee provided in this <U>Section&nbsp;3</U> shall include, without
limitation, the rights set forth in the other sections of this Agreement, including any additional indemnification permitted by
Section&nbsp;2-418(g)&nbsp;of the Maryland General Corporation Law (the &ldquo;<U>MGCL</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Standard for Indemnification</U>.
If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a party to any Proceeding, the
Fund shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement and all Expenses actually and reasonably
incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with any such Proceeding unless it is established that (a)&nbsp;the
act or omission of Indemnitee was material to the matter giving rise to the Proceeding and (i)&nbsp;was committed in bad faith or (ii)&nbsp;was
the result of active and deliberate dishonesty, (b)&nbsp;Indemnitee actually received an improper personal benefit in money, property
or services or (c)&nbsp;in the case of any criminal Proceeding,&nbsp;Indemnitee had reasonable cause to believe that her conduct was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain Limits on Indemnification</U>.
Notwithstanding any other provision of this Agreement (other than <U>Section&nbsp;6</U>),&nbsp;Indemnitee shall not be entitled to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification hereunder if
the Proceeding was one by or in the right of the Fund and Indemnitee is adjudged, in a final adjudication of the Proceeding not subject
to further appeal, to be liable to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit was improperly received in any Proceeding charging improper personal benefit to Indemnitee, whether or not involving
action in the Indemnitee&rsquo;s Corporate Status; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;indemnification
or advance of Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i)&nbsp;the Proceeding was brought to enforce indemnification
under this Agreement, and then only to the extent in accordance with and as authorized by <U>Section&nbsp;12</U> of this Agreement, or
(ii)&nbsp;the Fund&rsquo;s Articles of Incorporation or Bylaws, a resolution of the stockholders entitled to vote generally in the election
of directors or of the Board or an agreement approved by the Board to which the Fund is a party expressly provide otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Court-Ordered Indemnification</U>.
Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee and such notice
as the court shall require, may order indemnification of Indemnitee by the Fund in the following circumstances:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is entitled to reimbursement under Section&nbsp;2-418(d)(1)&nbsp;of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant
circumstances, whether or not Indemnitee (i)&#8239;has
met the standards of conduct set forth in Section&nbsp;2-418(b)&nbsp;of the MGCL or (ii)&nbsp;has been adjudged liable for receipt
of an improper personal benefit under Section&nbsp;2-418(c)&nbsp;of the MGCL, the court may order such indemnification as the court
shall deem proper. However, indemnification with respect to any Proceeding by or in the right of the Fund or in which liability
shall have been adjudged in the circumstances described in Section&nbsp;2-418(c)&nbsp;of the MGCL shall be limited to Expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;7. <U>Indemnification for Expenses
of an Indemnitee Who is Wholly or Partially Successful</U>. Notwithstanding any other provision of this Agreement, and without limiting
any such provision, to the extent that Indemnitee was or is, by reason of her Corporate Status, made a party to (or otherwise becomes
a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such Proceeding,&nbsp;Indemnitee shall
be indemnified for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than
all claims, issues or matters in such Proceeding, the Fund shall indemnify Indemnitee under this <U>Section&nbsp;7</U> for all Expenses
actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection with each such claim, issue or matter, allocated
on a reasonable and proportionate basis. For purposes of this <U>Section&nbsp;7</U> and, without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim,
issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Advance of Expenses for Indemnitee</U>.
If, by reason of Indemnitee&rsquo;s Corporate Status,&nbsp;Indemnitee is, or is threatened to be, made a party to any Proceeding, the
Fund shall, without requiring a preliminary determination of Indemnitee&rsquo;s ultimate entitlement to indemnification hereunder (except
as set out in this Section&nbsp;8), advance all reasonable Expenses incurred by or on behalf of Indemnitee in connection with such Proceeding.
Such advance or advances shall be made within ten days after the receipt by the Fund of a statement or statements requesting such advance
or advances from time to time, whether prior to or after final disposition of such Proceeding and may be in the form of, in the reasonable
discretion of the Indemnitee (but without duplication) (a)&nbsp;payment of such Expenses directly to third parties on behalf of Indemnitee,
(b)&nbsp;advancement to Indemnitee of funds in an amount sufficient to pay such Expenses or (c)&nbsp;reimbursement to Indemnitee for Indemnitee&rsquo;s
payment of such Expenses. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee and shall include
or be preceded or accompanied by a written affirmation by Indemnitee of Indemnitee&rsquo;s good faith belief that the standard of conduct
necessary for indemnification by the Fund as authorized by law and by this Agreement has been met and a written undertaking by or on behalf
of Indemnitee, in substantially the form attached hereto as <U>Exhibit&nbsp;A</U> or in such form as may be required under applicable
law as in effect at the time of the execution thereof, to reimburse the portion of any Expenses advanced to Indemnitee relating to claims,
issues or matters in the Proceeding as to which it shall ultimately be established that the standard of conduct has not been met by Indemnitee
and which have not been successfully resolved as described in <U>Section&nbsp;7</U> of this Agreement. For so long as the Fund is subject
to the Investment Company Act, any advancement of Expenses under this Agreement shall be subject to at least one of the following as a
condition of the advancement: (a)&nbsp;Indemnitee shall provide a security for Indemnitee&rsquo;s undertaking, (b)&nbsp;the Fund shall
be insured against losses arising by reason of any lawful advances or (c)&nbsp;a majority of a quorum of the Disinterested Directors,
or Independent Counsel, in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full-trial-type
inquiry), that there is no reason to believe that Indemnitee ultimately will be found to not be entitled to indemnification. To the extent
that Expenses advanced to Indemnitee do not relate to a specific claim, issue or matter in the Proceeding, such Expenses shall be allocated
on a reasonable and proportionate basis. The undertaking required by this <U>Section&nbsp;8</U> shall be an unlimited general obligation
by or on behalf of Indemnitee and shall be accepted without reference to Indemnitee&rsquo;s financial ability to repay such advanced Expenses
and without any requirement to post security therefor.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification and Advance
of Expenses as a Witness or Other Participant</U>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee
is or may be, by reason of Indemnitee&rsquo;s Corporate Status, made a witness or otherwise asked to participate in any Proceeding, whether
instituted by the Fund or any other party, and to which Indemnitee is not a party,&nbsp;Indemnitee shall be advanced all reasonable Expenses
and indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection therewith
within ten days after the receipt by the Fund of a statement or statements requesting any such advance or indemnification from time to
time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses
incurred by Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Procedure
for Determination of Entitlement to Indemnification</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
obtain indemnification under this Agreement,&nbsp;Indemnitee shall submit to the Fund a written request, including therein or therewith
such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what
extent Indemnitee is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at such time(s)&nbsp;as
Indemnitee deems appropriate in Indemnitee&rsquo;s sole discretion. The officer of the Fund receiving any such request from Indemnitee
shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request by Indemnitee for indemnification pursuant to <U>Section&nbsp;10(a)</U>&nbsp;above, a determination, if required by applicable
law, with respect to Indemnitee&rsquo;s entitlement thereto shall promptly be made in the specific case: (i)&nbsp;if a Change in Control
shall have occurred, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, which
Independent Counsel shall be selected by the Indemnitee and approved by the Board in accordance with Section&nbsp;2-418(e)(2)(ii)&nbsp;of
the MGCL, which approval shall not be unreasonably withheld; or (ii)&nbsp;if a Change in Control shall not have occurred, (A)&nbsp;by
the Board by a majority vote of a quorum consisting of Disinterested Directors or, if such a quorum cannot be obtained, then by a majority
vote of a duly authorized committee of the Board consisting solely of one or more Disinterested Directors, (B)&nbsp;if Independent Counsel
has been selected by the Board in accordance with Section&nbsp;2-418(e)(2)(ii)&nbsp;of the MGCL and approved by the Indemnitee, which
approval shall not be unreasonably withheld, by Independent Counsel, in a written opinion to the Board, a copy of which shall be delivered
to Indemnitee or (C)&nbsp;if so directed by a majority of the members of the Board, by the stockholders of the Fund. If it is so determined
that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee
shall cooperate with the person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination
in the discretion of the Board or Independent Counsel if retained pursuant to clause (ii)(B)&nbsp;of this <U>Section&nbsp;10(b)</U>. Any
Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Fund
(irrespective of the determination as to Indemnitee&rsquo;s entitlement to indemnification) and the Fund shall indemnify and hold Indemnitee
harmless therefrom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Presumptions
and Effect of Certain Proceedings</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In making any determination with
respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that
Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in
accordance with <U>Section&nbsp;10(a)</U>&nbsp;of this Agreement, and the Fund shall have the burden of proof, by clear and
convincing evidence, to overcome that presumption in connection with the making of any determination contrary to that
presumption.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of nolo
contendere or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did not
meet the requisite standard of conduct described herein for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
knowledge and/or actions, or failure to act, of any other director, officer, employee or agent of the Fund or any other director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise shall not be imputed to Indemnitee for purposes of
determining any other right to indemnification under this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Remedies
of Indemnitee</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;a determination is made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advance of Expenses is not timely made pursuant to <U>Sections 8</U> or <U>9</U> of
this Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of
this Agreement within 60 days after receipt by the Fund of the request for indemnification, (iv)&nbsp;payment of indemnification is
not made pursuant to <U>Sections 7</U> or <U>9</U> of this Agreement within ten days after receipt by the Fund of a written request
therefor, or (v)&nbsp;payment of indemnification pursuant to any other section of this Agreement or the Articles of Incorporation or
Bylaws of the Fund is not made within ten days after a determination has been made that Indemnitee is entitled to
indemnification,&nbsp;Indemnitee shall be entitled to an adjudication in an appropriate court located in the State of Maryland, or
in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement to such indemnification or advance of Expenses.
Alternatively, Indemnitee, at Indemnitee&rsquo;s option, may seek an award in arbitration to be conducted by a single arbitrator
pursuant to the Commercial Arbitration Rules&nbsp;of the American Arbitration Association. Indemnitee shall commence a proceeding
seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to
commence such proceeding pursuant to this <U>Section&nbsp;12(a)</U>; <U>provided</U>, <U>however</U>, that the foregoing clause
shall not apply to a proceeding brought by Indemnitee to enforce her rights under <U>Section&nbsp;7</U> of this Agreement. Except as
set forth herein, the provisions of Maryland law (without regard to its conflicts of laws rules) shall apply to any such
arbitration. The Fund shall not oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any judicial proceeding or arbitration commenced pursuant to this <U>Section&nbsp;12</U>,&nbsp;Indemnitee shall be presumed to be
entitled to indemnification or advance of Expenses, as the case may be, under this Agreement and the Fund shall have the burden of
proving that Indemnitee is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a
judicial proceeding or arbitration pursuant to this <U>Section&nbsp;12</U>,&nbsp;Indemnitee shall not be required to reimburse the
Fund for any advances pursuant to <U>Section&nbsp;8</U> of this Agreement until a final determination is made with respect to
Indemnitee&rsquo;s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). The Fund shall,
to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced
pursuant to this <U>Section&nbsp;12</U> that the procedures and presumptions of this Agreement are not valid, binding and
enforceable and shall stipulate in any such court or before any such arbitrator that the Fund is bound by all of the provisions of
this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a determination shall have been made pursuant to <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement that Indemnitee is entitled to indemnification,
the Fund shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this <U>Section&nbsp;12</U>,
absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s statement
not materially misleading, in connection with the request for indemnification.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that Indemnitee is successful in seeking, pursuant to this <U>Section&nbsp;12</U>, a judicial adjudication of or an award in
arbitration to enforce Indemnitee&rsquo;s rights under, or to recover damages for breach of, this Agreement,&nbsp;Indemnitee shall be
entitled to recover from the Fund, and shall be indemnified by the Fund for, any and all Expenses actually and reasonably incurred by
her in such judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee
is entitled to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in connection
with such judicial adjudication or arbitration shall be appropriately prorated.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Interest
shall be paid by the Fund to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article&nbsp;of the Annotated Code of Maryland for amounts which the Fund pays or is obligated to pay for the period (i)&nbsp;commencing
with either the tenth day after the date on which the Fund was requested to advance Expenses in accordance with <U>Sections 8</U> or
<U>9</U> of this Agreement or the 60th day after the date on which the Fund was requested to make the determination of entitlement to
indemnification under <U>Section&nbsp;10(b)</U>&nbsp;of this Agreement, as applicable, and (ii)&nbsp;ending on the date such payment
is made to Indemnitee by the Fund.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Defense
of the Underlying Proceeding</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnitee
shall notify the Fund promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or other
document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall include
with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure to give
any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to indemnification
or the advance of Expenses under this Agreement unless the Fund&rsquo;s ability to defend in such Proceeding or to obtain proceeds under
any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Fund is thereby actually so prejudiced.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the provisions of the last sentence of this <U>Section&nbsp;13(b)</U>&nbsp;and of <U>Section&nbsp;13(c)</U> below, the Fund shall
have the right to defend Indemnitee in any Proceeding which may give rise to indemnification hereunder; <U>provided</U>, <U>however</U>,
that the Fund shall notify Indemnitee of any such decision to defend within 15 calendar days following receipt of notice of any such
Proceeding under <U>Section&nbsp;13(a)</U>&nbsp;above. The Fund shall not, without the prior written consent of Indemnitee, which shall
not be unreasonably withheld or delayed, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise
which (i)&nbsp;includes an admission of fault of Indemnitee, (ii)&nbsp;does not include, as an unconditional term thereof, the full release
of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably satisfactory
to Indemnitee or (iii)&nbsp;would impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This <U>Section&nbsp;13(b)</U>&nbsp;shall
not apply to a Proceeding brought by Indemnitee under <U>Section&nbsp;12</U> of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding the provisions of <U>Section&nbsp;13(b)</U>&nbsp;above,
if in a Proceeding to which Indemnitee is a party by reason of Indemnitee&rsquo;s Corporate Status, (i)&nbsp;Indemnitee reasonably concludes,
based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that Indemnitee may have separate
defenses or counterclaims to assert with respect to any issue which may not be consistent with other defendants in such Proceeding, (ii)&nbsp;Indemnitee
reasonably concludes, based upon an opinion of counsel approved by the Fund, which approval shall not be unreasonably withheld, that an
actual or apparent conflict of interest or potential conflict of interest exists between Indemnitee and the Fund, or (iii)&nbsp;if the
Fund fails to assume the defense of such Proceeding in a timely manner,&nbsp;Indemnitee shall be entitled to be represented by separate
legal counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld,
at the expense of the Fund. In addition, if the Fund fails to comply with any of its obligations under this Agreement or in the event
that the Fund or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny
or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,&nbsp;Indemnitee shall have the right to retain
counsel of Indemnitee&rsquo;s choice, subject to the prior approval of the Fund, which approval shall not be unreasonably withheld, at
the expense of the Fund (subject to <U>Section&nbsp;12(d)</U>&nbsp;of this Agreement), to represent Indemnitee in connection with any
such matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Non-Exclusivity;
Survival of Rights; Subrogation; Investment Company </U></FONT><U>Act</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The rights of indemnification and advance
of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled
under applicable law, the Articles of Incorporation or Bylaws of the Fund, any agreement or a resolution of the stockholders entitled
to vote generally in the election of directors or of the Board, or otherwise. Unless consented to in writing by Indemnitee, no amendment,
alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement
in respect of any action taken or omitted by such Indemnitee in her Corporate Status prior to such amendment, alteration or repeal, regardless
of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration or repeal. No right
or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy shall be cumulative
and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion
of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of any other right or remedy.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of any payment under this Agreement, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Fund to bring suit to enforce such rights.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything contained in this Agreement to the contrary, the Fund shall not be liable under this Agreement to make any payment of amounts
otherwise indemnifiable or payable or reimbursable as Expenses hereunder if and to the extent that (i)&nbsp;Indemnitee has otherwise actually
received such payment under any insurance policy, contract, agreement or otherwise, or (ii)&nbsp;for so long as the Fund is subject to
the Investment Company Act, indemnification or payment or reimbursement of expenses would not be permissible under the Investment Company
Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Insurance</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of her Corporate Status and
covering the Fund for any indemnification or advance of Expenses made by the Fund to Indemnitee for any claims made against Indemnitee
by reason of her Corporate Status. In the event of a Change in Control, the Fund shall maintain in force any and all directors and officers
liability insurance policies that were maintained by the Fund immediately prior to the Change in Control for a period of six years with
the insurance carrier or carriers and through the insurance broker in place at the time of the Change of Control; <U>provided</U>, <U>however</U>,
(i)&nbsp;if the carriers will not offer the same policy and an expiring policy needs to be replaced, a policy substantially comparable
in scope and amount shall be obtained and (ii)&nbsp;if any replacement insurance carrier is necessary to obtain a policy substantially
comparable in scope and amount, such insurance carrier shall have an AM Best rating that is the same or better than the AM Best rating
of the existing insurance carrier; <U>provided</U>, <U>further</U>, <U>however</U>, in no event shall the Fund be required to expend in
the aggregate in excess of 250% of the annual premium or premiums paid by the Fund for directors and officers liability insurance in effect
on the date of the Change in Control. In the event that 250% of the annual premium paid by the Fund for such existing directors and officers
liability insurance is insufficient for such coverage, the Fund shall spend up to that amount to purchase such lesser coverage as may
be obtained with such amount.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
in any way limiting any other obligation under this Agreement, the Fund shall indemnify Indemnitee for any payment by Indemnitee
arising out of the amount of any deductible or retention and the amount of any excess of the aggregate of all judgments, penalties,
fines, settlements and Expenses incurred by Indemnitee in connection with a Proceeding over the coverage of any insurance referred
to in the previous sentence. The purchase, establishment and maintenance of any such insurance shall not in any way limit or affect
the rights or obligations of the Fund or Indemnitee under this Agreement except as expressly provided herein, and the execution and
delivery of this Agreement by the Fund and the Indemnitee shall not in any way limit or affect the rights or obligations of the Fund
under any such insurance policies. If, at the time the Fund receives notice from any source of a Proceeding to which Indemnitee is a
party or a participant (as a witness or otherwise) the Fund has directors and officers liability insurance in effect, the Fund shall
give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Coordination of Payments</U>.
The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable or reimbursable as
Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract,
agreement or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>. If the indemnification
provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason, other than for failure
to satisfy the standard of conduct set forth in <U>Section&nbsp;4</U> or <U>Section&nbsp;8</U> or due to the provisions of <U>Section&nbsp;5</U>,
then, in respect to any Proceeding in which the Fund is jointly liable with Indemnitee (or would be if joined in such Proceeding), to
the fullest extent permissible under applicable law, the Fund, in lieu or indemnifying and holding harmless Indemnitee, shall pay, in
the first instance, the entire amount incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be
paid in settlement, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Fund hereby
waives and relinquished any right of contribution it may have at any time against Indemnitee.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports to Stockholders</U>.
To the extent required by the MGCL, the Fund shall report in writing to its stockholders the payment of any amounts for indemnification
of, or advance of Expenses to,&nbsp;Indemnitee under this Agreement arising out of a Proceeding by or in the right of the Fund with the
notice of the meeting of stockholders of the Fund next following the date of the payment of any such indemnification or advance of Expenses
or prior to such meeting.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section&nbsp;19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Duration
of Agreement; Binding Effect</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall continue until and terminate on the later of (i)&nbsp;the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Fund or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Fund, and (ii)&nbsp;the
date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and any Proceeding
commenced by Indemnitee pursuant to <U>Section&nbsp;12</U> of this Agreement).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Fund), shall continue as to an Indemnitee
who has ceased to (i)&nbsp;be a director, officer, employee or agent of the Fund, or (ii)&nbsp;be a director, trustee, officer,
partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, partnership, limited
liability company, joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such
capacity at the request of the Fund, and shall inure to the benefit of Indemnitee and Indemnitee&rsquo;s spouse, assigns, heirs,
devisees, executors and administrators and other legal representatives.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Fund, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Fund would be required to perform
if no such succession had taken place.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and
difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that
Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing
actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance,&nbsp;Indemnitee shall not be precluded
from seeking or obtaining any other relief to which Indemnitee may be entitled. Indemnitee shall further be entitled to such specific
performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without
the necessity of posting bonds or other undertakings in connection therewith. The Fund acknowledges that, in the absence of a waiver,
a bond or undertaking may be required of Indemnitee by a court, and the Fund hereby waives any such requirement of such a bond or undertaking.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>. If any provision
or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity,
legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Identical Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. One such counterpart signed by the party against whom enforceability is sought
shall be sufficient to evidence the existence of this Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Modification and Waiver</U>.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether
or not similar) nor shall such waiver constitute a continuing waiver.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;24.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. All notices, requests,
demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i)&nbsp;delivered by hand
and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery, or (ii)&nbsp;mailed
by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 33pt">(a)</TD><TD STYLE="text-align: justify">If to Indemnitee, to the address set forth on the signature page&nbsp;hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 33pt">(b)</TD><TD STYLE="text-align: justify">If to the Fund, to:</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Ares Dynamic Credit Allocation Fund, Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">1800 Avenue of the Stars, Suite 1400</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Los Angeles, CA 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Attn: Chief Legal Officer</P>


</TD></TR>
                                                                                                                          </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as may have been furnished in writing to Indemnitee
by the Fund or to the Fund by Indemnitee, as the case may be.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;25.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/
    Ian Fitzgerald</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Ian Fitzgerald</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Corporate Secretary and General Counsel</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">INDEMNITEE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
    Elaine Orr</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Elaine Orr</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Address:&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">C/O
    Ares Dynamic Credit Allocation Fund, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Suite
    1400</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1800
    Avenue of the Stars</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Los
    Angeles, CA 90067</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 74; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To: The Board of Directors of Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Affirmation and Undertaking</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated as of the ____ day of _____________, 20___, by and between Ares Dynamic Credit
Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;<U>Fund</U>&rdquo;), and the undersigned Indemnitee (the &ldquo;<U>Indemnification
Agreement</U>&rdquo;), pursuant to which I am entitled to advance of Expenses in connection with <B>[Description of Proceeding]</B> (the
 &ldquo;<U>Proceeding</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I am subject to the Proceeding by reason of
my Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that
at all times, insofar as I was involved as <B>[a director] [an officer]</B> of the Fund, in any of the facts or events giving rise
to the Proceeding,&nbsp;I (1)&nbsp;did not act with bad faith or active or deliberate dishonesty, (2)&nbsp;did not receive any
improper personal benefit in money, property or services and (3)&nbsp;in the case of any criminal proceeding, had no reasonable
cause to believe that any act or omission by me was unlawful.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the advance of Expenses by
the Fund for reasonable attorneys&rsquo; fees and related Expenses incurred by me in connection with the Proceeding (the &ldquo;<U>Advanced
Expenses</U>&rdquo;),&nbsp;I hereby agree that if, in connection with the Proceeding, it is established that (1)&nbsp;an act or omission
by me was material to the matter giving rise to the Proceeding and (a)&nbsp;was committed in bad faith or (b)&nbsp;was the result of active
and deliberate dishonesty or (2)&nbsp;I actually received an improper personal benefit in money, property or services or (3)&nbsp;in the
case of any criminal proceeding,&nbsp;I had reasonable cause to believe that the act or omission was unlawful, then I shall promptly reimburse
the portion of the Advanced Expenses relating to the claims, issues or matters in the Proceeding as to which the foregoing findings have
been established.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">IN WITNESS WHEREOF,&nbsp;I have executed this Affirmation
and Undertaking on this ____ day of __________________, 20___.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 75; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(5)
<SEQUENCE>10
<FILENAME>tm2416373d4_ex99-xkx5.htm
<DESCRIPTION>EXHIBIT 99.(K)(5)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx5.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(k)(5)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>INVESTOR SUPPORT SERVICES AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement is made as of November&nbsp;30,
2012, by and among Ares Dynamic Credit Allocation Fund,&nbsp;Inc., a Maryland corporation (the &ldquo;<U>Fund</U>&rdquo;) and Destra Capital
Investments LLC, a Delaware limited liability company (&ldquo;<U>Destra</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Fund has filed a notification on Form&nbsp;N-8A
of registration as an investment company under the Investment Company Act of 1940, as amended (the &ldquo;<U>1940 Act</U>&rdquo;) and
a registration statement on Form&nbsp;N-2, as amended (the &ldquo;<U>Registration Statement</U>&rdquo;), relating to the initial public
offering of shares of common stock of the Fund (the &ldquo;<U>Common Shares</U>&rdquo;, and such offering, the &ldquo;<U>Offering</U>&rdquo;);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Fund is expected to be operated as
a closed-end management investment company under the 1940 Act;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, Ares Management II LLC, a Delaware limited
liability company (the &ldquo;Adviser&rdquo;), intends to serve as the investment adviser to the Fund;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Fund and the Adviser are party to
a Trademark License Agreement (the &ldquo;License Agreement&rdquo;), dated as of November&nbsp;30, 2012, 2012, pursuant to which the Adviser
has licensed to the Fund the &ldquo;Ares Marks&rdquo; (as hereinafter defined); and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Fund wishes to retain Destra to provide,
following the closing of the Offering (excluding any &ldquo;Green Shoe&rdquo; period) (the &ldquo;<U>Closing</U>&rdquo;), the Services
(as defined herein) under the terms and conditions stated herein, and Destra is willing to provide such Services for the compensation
set forth herein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the premises
and mutual covenants contained herein, and intending to be legally bound, the parties hereby agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>APPOINTMENT. The Fund hereby retains Destra to furnish, and Destra hereby agrees to furnish, in accordance with the highest commercial
standards, the Services.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">SERVICES AND DUTIES OF DESTRA. From the Closing until the termination or expiration of this Agreement,
Destra shall:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>provide ongoing contact with respect to the Fund and its performance with financial advisors (including, without limitation, broker-dealers
and registered investment advisers) that are representatives of financial intermediaries, including providing investor relations materials
(to the extent deemed advisable by Destra) that are prepared by, or
reviewed and approved by, the Fund, with a view to keeping such financial advisors informed regarding the benefits to their clients of
investing in the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: left">respond to questions from such financial advisors regarding the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>communicate with the stock exchange specialist for the Fund&rsquo;s shares, and with the closed-end fund analyst community regarding
the Fund on a regular basis (no less frequently than quarterly);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: left">host each year a conference or meetings with the closed-end fund analyst community at which Fund and its
portfolio managers will be highlighted;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: left">host the Fund&rsquo;s website and maintain such website with such information about the Fund as is initially mutually agreed by Destra
and the Fund, with performance, financial and other data regarding the Fund to be provided to Destra by the Fund promptly as such data
becomes available, and with such other information about the Fund to be provided to Destra by the Fund from time to time;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">ensure all updates to the Fund&rsquo;s website are completed within a timely manner;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: left">provide data, software and hardware security protections for the Fund&rsquo;s website consistent with best industry practices, including
but not limited to use of network &ldquo;firewalls&rdquo;, the latest patches and restrictive access to data networks and server equipment;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: left">secure or back-up all data, files, file systems and other material used on the Fund&rsquo;s website and storing such material (i)&nbsp;in
a different city from where such website is hosted and (ii)&nbsp;in a manner that can be retrieved easily and economically in the case
of data and file loss;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: left">restore promptly the operation of the Fund&rsquo;s website in the event of disaster or other event that halts or significantly interferes
with the operation of the servers hosting the Fund&rsquo;s website;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: left">provide periodic check-ups to ensure the Fund&rsquo;s website is up to date, that the Fund&rsquo;s domain name directs and resolves
to the Fund&rsquo;s website and that all links within the Fund&rsquo;s website function as intended;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD>provide information of each time the Fund&rsquo;s website is accessed and indicating the time allotment as well as the materials accessed
and providing such information to management of the Fund on a quarterly basis (unless reasonably requested by management of the Fund more
frequently);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">provide necessary ongoing technical assistance with respect to subclauses (e)&nbsp;through (k);</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">provide quarterly reports to the Fund summarizing Destra&rsquo;s activities in respect of the Fund; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD>provide such other services as to which the Fund and Destra may from time to time mutually agree (collectively, (a)&nbsp;through (n),
the &ldquo;<U>Services</U>&rdquo;).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Destra acknowledges and agrees that it is not authorized
to provide any information or make any representation regarding the Fund or the Common Shares other than (i)&nbsp;information contained
in the Fund&rsquo;s public statements or filings with the SEC and (ii)&nbsp;any other information approved in writing by the Fund for
use by Destra in connection with the performance of the Services by Destra.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>COMPLIANCE WITH THE FUND&rsquo;S GOVERNING DOCUMENTS AND APPLICABLE LAW. In all matters pertaining to the performance of this Agreement,
Destra will act in accordance with the written directions of the Fund, and will conform to, and comply with, the requirements of the 1940
Act and the rules&nbsp;and regulations thereunder and all other applicable federal, state and foreign laws and regulations.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>EXCLUSIVITY. The services of Destra hereunder are not deemed to be exclusive, and Destra and its officers, employees and affiliates
may, without the prior written consent of the Fund, render such services to others.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">REPRESENTATIONS AND WARRANTIES OF DESTRA.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>Destra represents and warrants that (i)&nbsp;it has obtained all necessary registrations, licenses and approvals in order to perform
the Services contemplated by this Agreement and (ii)&nbsp;is registered as a broker-dealer with the SEC and is in good standing with FINRA.
Destra covenants to maintain all necessary registrations, licenses and approvals to perform the Services contemplated by this Agreement
in effect during the term of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>Destra agrees that it shall promptly notify the Fund (i)&nbsp;in the event that the SEC, FINRA or any other authority (including
                                                               any self-regulatory or state authority) has censured its activities, functions or operations, suspended or revoked any registration,
                                                               license or approval, or has commenced proceedings or an investigation that may result in any of these actions, (ii)&nbsp;in the
                                                               event that there is a change of control of Destra or any change in the senior management of Destra or (iii)&nbsp;of any change to
                                                               Destra that may be reasonably expected to adversely affect its ability to perform
the Services contemplated by this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Destra represents and warrants that (i)&nbsp;it is a validly existing entity and has full limited liability company power and authority
to perform its obligations under this Agreement, (ii)&nbsp;this Agreement has been duly and validly authorized, executed and delivered
on its behalf and constitutes its binding and enforceable obligation in accordance with its terms and (iii)&nbsp;the execution and delivery
of this Agreement, the incurrence of the obligations herein set forth and the performance of the Services will not constitute a breach
of, or default under, its constituent documents, other instruments to which Destra is a party or by which Destra is bound or affected,
or under any order, rule&nbsp;or regulation applicable to it of any court or any governmental body or administrative agency having jurisdiction
over it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Destra acknowledges that it shall act as an independent contractor in providing the Services.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>Destra acknowledges and agrees that neither the Fund, nor the legal or accounting advisors to the Fund, is an advisor to Destra as
to legal, tax, accounting or regulatory matters in any jurisdiction and Destra shall consult with its own advisors concerning such matters
and shall be responsible for making its own independent investigation and appraisal of the Services contemplated hereby.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: left">Destra represents and warrants that (i)&nbsp;it has not compensated, directly or indirectly, any third party in connection with securing
the Fund as a client and (ii)&nbsp;it will not shares its fees with any third party, without the prior written consent of the Fund.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: left">Destra acknowledges that all rights and interests to the Fund&rsquo;s domain name are owned by the Fund, and that it has reviewed
and received a copy of the License Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">PERFORMANCE OF SERVICES STANDARDS.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: left">Destra shall perform the Services (i)&nbsp;using sound, commercial practices and in a competent and professional manner by personnel
who are knowledgeable, qualified and trained in performing each of the Services and (ii)&nbsp;in accordance with any written direction
by the Fund in order for the Fund to ensure that such Services are in compliance with the Fund&rsquo;s legal, regulatory and compliance
obligations.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: left">Destra shall cooperate with the authorized officers, employees, subcontractors and agents of the Fund in performing Services as reasonably
requested by the Fund.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Destra shall use best industry practices to scan for any computer viruses, worms, time bombs, Trojan horses or other harmful or destructive
code in performing the Services, as applicable.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Destra shall ensure that the Fund&rsquo;s domain name shall direct and resolve to the Fund&rsquo;s website.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>Destra shall ensure that the Fund&rsquo;s website and the related Services performed hereunder, as applicable, shall conform to and
operate in accordance with functional and technical specifications, as agreed by Destra and the Fund.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD>Destra shall operate the Fund&rsquo;s website such that the Fund&rsquo;s website shall not infringe, violate, misappropriate or misuse
the patent, trademark, copyright, trade secret, privacy rights or other intellectual property of any party; <U>provided</U>, that, Destra
shall not be responsible for any material, marks or intellectual property provided by the Fund.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD>Destra shall operate the Fund&rsquo;s website, including the collection and processing of data relating to persons, in a manner not
to infringe on any applicable law, including without limitation applicable privacy laws. Without prejudice to the foregoing, Destra shall
ensure that each person accessing the Fund&rsquo;s website or subscribing to an alert has access to such notices as are required under
applicable privacy laws.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">REPRESENTATIONS AND WARRANTIES OF THE FUND.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The Fund agrees with Destra that it shall promptly notify Destra (i)&nbsp;in the event that the SEC or any other regulatory authority
has censured in writing the Fund&rsquo;s activities, functions or operations, suspended or revoked any registration, license or approval,
or has commenced proceedings that may result in any of these actions, (ii)&nbsp;in the event that there is a change of control of the
Fund or (iii)&nbsp;of any change to the Fund that materially and adversely affects the Fund&rsquo;s ability to perform its obligations
under this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The Fund represents and warrants to Destra that (i)&nbsp;it is a validly existing entity and has full corporate power and
                                                               authority to perform its obligations under this Agreement, (ii)&nbsp;this Agreement has been duly and validly authorized, executed
                                                               and delivered on its behalf and constitutes its binding and enforceable obligation in accordance with its terms, and (iii)&nbsp;the execution and delivery of this Agreement, the incurrence of
its obligations herein set forth and the consummation of the transactions contemplated herein will not constitute a breach of, or default
under, its constituent documents, other instruments to which the Fund is a party or by which the Fund is bound or affected, or under any
order, rule&nbsp;or regulation applicable to it of any court or any governmental body or administrative agency having jurisdiction over
it.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">COMPENSATION.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>As compensation for the Services to be provided by Destra under this Agreement, the Fund shall pay to Destra a services fee in an
annual amount equal to (i)&nbsp;0.12% (12 bps) of the average aggregate daily value of the Fund&rsquo;s Managed Assets (as defined in
the Investment Management and Advisory Agreement between the Fund and the Adviser) from the Closing through the first Anniversary of the
Closing and (ii)&nbsp;0.10% (10 bps) of the average aggregate daily value of the Fund&rsquo;s Managed Assets from the date immediately
following such first Anniversary through the remaining term of this Agreement, such fee to be accrued and paid in the same manner, over
the same period and paid on the same day as the Adviser&rsquo;s investment advisory fee is paid by the Fund under such Investment Management
and Advisory Agreement (the &ldquo;<U>Services Fee</U>&rdquo;).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>If this Agreement is terminated, other than pursuant to Sections 11(b)(ii), the Fund shall pay within 30 days of the termination date
to Destra the pro-rata portion of the Services Fee computed on the average aggregate daily Managed Assets for the unpaid period preceding
the termination date.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD>LIMITATION OF LIABILITY OF DESTRA. Destra will not be liable for any act or omission or for any error of judgment or for any loss
suffered by the Fund in connection with the performance of the Services by Destra under this Agreement, except a loss directly or indirectly
resulting from willful misfeasance, bad faith or gross negligence on Destra&rsquo;s part in the performance of its duties, from the reckless
disregard by Destra of its duties under this Agreement or the material breach by Destra of any of Destra&rsquo;s representations, warranties
or covenants hereunder (including, for the avoidance of doubt, Sections 5 or 6) (&ldquo;<U>Destra Disabling Conduct</U>&rdquo;).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Fund agrees to indemnify, defend
and hold harmless Destra, and any person who controls Destra within the meaning of Section&nbsp;15 of the Securities Act of 1933, as
amended (collectively, &ldquo;<U>Destra Indemnified Persons</U>&rdquo;), against any and all claims, demands, liabilities and expenses
(including the reasonable and documented out-of-pocket costs of investigating or defending such claims, demands or liabilities and any
reasonable and documented out-of-pocket fees of one counsel incurred in connection therewith) which Destra Indemnified Persons may incur
arising out of or relating to providing the Services under this Agreement, but only to the extent that such claims, demands, liabilities
and expenses do not arise out of or are not based upon Destra Disabling Conduct.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD>LIMITATION OF LIABILITY OF THE ADVISER AND THE FUND. Neither the Adviser nor the Fund will be liable for any act or omission or for
any error of judgment or for any loss suffered by Destra in connection with the performance of the Fund&rsquo;s duties under this Agreement,
except a loss resulting from willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or from the
reckless disregard by it of its duties under this Agreement or the material breach by the Fund of any of the Fund&rsquo;s representations,
warranties or covenants hereunder (&ldquo;<U>Fund Disabling Conduct</U>&rdquo;).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Destra agrees to indemnify, defend and hold harmless the
Adviser and the Fund, each of their officers, directors and agents, and any person who controls the Adviser or the Fund within the meaning
of Section&nbsp;15 of the Securities Act of 1933, as amended (collectively, &ldquo;<U>Fund Indemnified Persons</U>&rdquo;), against any
and all claims, demands, liabilities and expenses (including the reasonable and documented out-of-pocket costs of investigating or defending
such claims, demands or liabilities and any reasonable and documented out-of-pocket fees of one counsel for each of the Adviser and the
Fund incurred in connection therewith) that any Fund Indemnified Persons may incur arising out of or relating to (i)&nbsp;Destra&rsquo;s
material breach of any of its obligations, representations, warranties or covenants contained in this Agreement or (ii)&nbsp;Destra&rsquo;s
failure to comply with any applicable laws or regulations, but only to the extent that such claims, demands, liabilities and expenses
do not arise out of or are not based upon Fund Disabling Conduct.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">TERM; TERMINATION.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The term of this Agreement shall commence upon the date referred to above and shall be in effect for a period of two years from and
after the Closing. Thereafter the Agreement will continue for successive one year periods unless either party provides written notice
to the other party at least 30 days prior to the end of applicable period (i.e, at least 30 days prior to the two year period for the
initial term and then at least 30 days prior to the end for each one year term thereafter).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">This Agreement may be terminated solely as follows:</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>by Destra in the event of a material breach of this Agreement by the Fund and such material breach goes uncured for five days, upon
10 days&rsquo; prior written notice to the Fund;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">by the Fund in the event of a material breach of this Agreement by Destra and such material breach goes
uncured for five days, upon 10 days&rsquo; prior written notice to Destra; provided that in the case of a material breach of Section&nbsp;2(g)&nbsp;or
Section&nbsp;12, the Fund may terminate this agreement immediately upon written notice to Destra;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">following the second Anniversary of the Closing, by the Fund or by Destra on 30 days written notice to
the other party hereto; and</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">by the express written mutual agreement of all of the parties hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Section&nbsp;9, Section&nbsp;10, Section&nbsp;11(c)&nbsp;and Sections 12 through 25 shall survive any
termination of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Upon termination of this Agreement by either party, Destra agrees to relinquish any and all materials and files relating to the Fund&rsquo;s
website, along with all user name/passwords and links associated with the Fund&rsquo;s website.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">WEBSITE.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>Destra acknowledges that the Fund and the Adviser are party to the License Agreement, and that the Fund and the Adviser reserve all
rights in and to the trademarks, trade names, trade devices, symbols, insignias, service marks, logos, slogans and other indicia of origin
and proprietary identifying symbols that the Adviser, the Fund or any of their affiliates owns or any abbreviation, contraction, designation
or simulation thereof used by the Adviser or the Fund or any of their affiliates (the &ldquo;<U>Ares Marks</U>&rdquo;). Destra and its
employees, agents, contractors and representatives shall not make use of the Ares Marks, except as authorized in writing by the Adviser
or the Fund (as the case may be) in connection with Destra providing the Services. Nothing in this Agreement transfers any rights in any
Ares Marks to Destra or it employees, agents, contractors or representatives.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: left">Destra agrees and acknowledges that the Fund owns all right, title, and interest, in or to, the Fund&rsquo;s website, the source code
underlying the Fund&rsquo;s website, any patentable inventions or copyrightable material that Destra develops specifically for the purpose
of performing the Services for the Fund, including any moral rights, and that any such copyrightable material is a &ldquo;work made for
hire.&rdquo; To the extent that ownership of the Fund&rsquo;s website, the source code underlying the Fund&rsquo;s website, any such patentable
inventions or copyrightable material are not vested in the Fund, Destra hereby assigns all right, title, and interest, in or
to, any rights under copyright, patent or otherwise to the Fund. Destra further agrees to execute, or to cause Destra&rsquo;s employees,
agents, contractors or representatives to execute, any documents or do such other acts as the Fund may reasonably require in order to
confirm the Fund&rsquo;s ownership in any such copyrights or patents with the appropriate governmental authority. Any intellectual property
rights licensed by Destra for the purposes of performing the Services shall be assignable to the Fund upon the Fund&rsquo;s request, unless
the Fund gives prior, written consent to enter such a license.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">AMENDMENT OF THIS AGREEMENT. This Agreement may not be amended, supplemented or otherwise modified except
by written agreement executed by all the parties hereto.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD>CONFIDENTIALITY. Destra and the Fund each acknowledge that it may obtain certain confidential information of the other parties to
this Agreement, or, in the case of Destra, of the Fund and shareholders of the Fund, during the performance of its duties under this Agreement
and each party hereto agrees to treat all such confidential information as proprietary information of the applicable party and to keep
such information confidential by using the same care and discretion it uses with respect to its own confidential information, property
and trade secrets; <U>provided</U>, that a party may disclose confidential information if (i)&nbsp;such disclosure is approved in writing
by the applicable party from which the confidential information originates or (ii)&nbsp;such disclosure is required by applicable laws,
rules, and regulations (including, for the avoidance of doubt, disclosures required in any document filed, provided or furnished with
or to the SEC or other regulatory authority), or such disclosure is made in response to a valid request by a regulatory authority. If
Destra is required or requested to disclose confidential information of the Fund pursuant to (ii)&nbsp;above, Destra shall immediately
notify the Fund, as the case may be, in order to provide the Fund, as the case may be, the opportunity to pursue such legal or other action
as such parties may desire to prevent the release of such confidential information, and such party agrees to provide reasonable assistance
to any party seeking to prevent the release of such confidential information, at the expense of the requesting party. For purposes of
this Agreement, &ldquo;confidential information&rdquo; does not include information which, without any breach of Destra or the Fund of
the foregoing, (1)&nbsp;is or becomes publicly available (other than in breach of this Agreement or a violation of a confidentiality obligation
owed to a party hereto), (2), is in such the possession of the Fund or Destra (as the case may be) prior to disclosure, (3)&nbsp;is independently
developed by Destra or the Fund (as the case may be) outside the scope of this Agreement and without use of confidential information or
(4)&nbsp;is rightfully obtained by Destra or the Fund (as the case may be) from third parties who have no duty of confidentiality to the
Adviser or the Fund, respectively.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">GOVERNING LAW. This Agreement shall be construed in accordance with the laws of the State of New York,
without regard to principles of conflict of laws of any jurisdiction to the contrary.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD>SUBMISSION TO JURISDICTION; WAIVER OF JURY TRIAL. Each party hereto agrees that it shall bring any action or proceeding in respect
of any questions, claims, disputes, remedies or damages arising out of or related to this Agreement or the transactions contained in or
contemplated hereby exclusively in the United States District Court for the District of Delaware or any Delaware State court sitting in
New Castle County (the &ldquo;<U>Chosen Courts</U>&rdquo;), and, solely in connection with claims arising under this Agreement or the
transactions that are the subject hereof (i)&nbsp;irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives
and agrees not to assert any objection to laying venue in any such action or proceeding in the Chosen Courts, (iii)&nbsp;waives any objection
that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any Party and (iv)&nbsp;agrees that a final judgment
in any such action or proceeding shall be conclusive and may be enforced in any other jurisdictions by suit on the judgment or in any
other manner provided by applicable Legal Requirements. EACH PARTY HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LEGAL REQUIREMENTS, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">BOOKS AND RECORDS</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>In compliance with the requirements of the 1940 Act, Destra hereby agrees that all records which it may maintain for the Fund or the
Adviser are the property of the Adviser or the Fund, as the case may be, and further agrees to surrender promptly to the Adviser or the
Fund, as the case may be, any of such records upon request.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>Destra hereby agrees to furnish to regulatory authorities having the requisite authority any information or reports in connection
with Services that Destra renders pursuant to this Agreement which may be requested in order to ascertain whether the operations of the
Fund are being conducted in a manner consistent with applicable laws and regulations. Subject to the proviso below, if Destra is required
or requested to provide any information or reports to regulatory authorities, Destra shall immediately notify the Fund in order to provide
the Fund the opportunity to pursue such legal or other action as it may desire to prevent the release of the information or reports, and
Destra agrees to provide reasonable assistance to the Fund in seeking to prevent the release of the information, in each case; <U>provided</U>,
that such disclosure by Destra is not prohibited by applicable law.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD>BENEFIT TO OTHERS. The understandings contained in this Agreement are for the sole benefit of the parties hereto (and the Adviser)
and their respective successors and assigns and, except as specifically contemplated herein with respect to Destra Indemnified Persons
and Fund Indemnified Persons, they shall not be construed as conferring, and are not intended to confer, any rights on any other persons
except the Adviser. For the avoidance of doubt, the Adviser is an express third-party beneficiary of this Agreement.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.</TD><TD>BINDING NATURE OF AGREEMENT; NO ASSIGNMENT. This Agreement shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and assigns, except that no party may assign or transfer its rights nor delegate its obligations under this
Agreement without the prior written consent of other parties hereto. Any assignment not in accordance with this Section&nbsp;19 shall
be void ab initio.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.</TD><TD>EXECUTION IN COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original
as against the any party whose signature appears thereon, and all of which shall together constitute one and the same instrument. This
Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all
of the parties reflected hereon as signatories.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.</TD><TD>ENTIRE AGREEMENT. This Agreement contains the entire understanding among the parties hereto with respect to the subject matter hereof,
and supersedes all prior and contemporaneous agreements and understandings, inducements or conditions, express or implied, oral or written,
except as herein contained. The express terms hereof control and supersede any course of performance and/or usage of the trade inconsistent
with any of the terms hereof. This Agreement may not be modified or amended other than by an agreement in writing.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.</TD><TD>WAIVERS. Neither the failure nor any delay on the part of any party to this Agreement to exercise any right, remedy, power or privilege
under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege
preclude any other or further exercise of the same or of any other right, remedy, power or privilege, nor shall any waiver of any right,
remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect
to any other occurrence. No waiver shall be effective unless it is in writing and signed by the party asserted to have granted such waiver.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.</TD><TD>CONSTRUCTION. The captions of this Agreement are included for convenience of reference only and in no way define or delimit any of
the provisions hereof or otherwise affect their construction or effect.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.</TD><TD>SEVERABILITY. If any provision (or part thereof) of this Agreement is held illegal, invalid or unenforceable by a final decision of
a court of competent jurisdiction, statute, rule, regulation, law or ordinance, the parties hereto shall negotiate in good faith to replace
such provision with a legal, suitable and equitable substitute therefor in order to carry out, so far as may be valid and enforceable,
the intent and purpose of such illegal, invalid or unenforceable provisio and the remaining provisions of this Agreement shall remain
in full force and effect.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify">NOTICES.</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All notices required or permitted to
be sent under this Agreement shall be sent:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Fund, to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2000 Avenue of the Stars&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">12th Floor&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Los Angeles, California 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With a copy emailed to: weiner@aresmgmt.com
and dhall@aresmgmt.com</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to Destra, to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Destra Capital Investments LLC&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">901 Warrenville Road, Suite&nbsp;15&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Lisle,&nbsp;Illinois 60532</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">With a copy emailed to: nick.dalmaso@destracaptial.com and
thomas.hale@destracapital.com</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereto have caused the instrument to
be executed by their officers designated below as of the day and year first above written.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel J. Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel, Chief Legal Officer and Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESTRA CAPITAL INVESTMENTS LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Nicholas Dalmaso</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas Dalmaso</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and General Counsel</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>** Signature Page&nbsp;to Investor Support Services
Agreement **</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(6)
<SEQUENCE>11
<FILENAME>tm2416373d4_ex99-xkx6.htm
<DESCRIPTION>EXHIBIT 99.(K)(6)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx6.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(k)(6)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT TO INVESTOR SUPPORT SERVICES AGREEMENT</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amendment to Investor
Support Services Agreement, dated as of this 1st day of January, 2020 (this &ldquo;<U>Amendment</U>&rdquo;), to that certain Investor
Support Services Agreement, dated as of November&nbsp;30, 2012 (as amended by this Amendment and as hereafter amended, restated or otherwise
modified, the &ldquo;<U>Agreement</U>&rdquo;), is entered into by and between Ares Dynamic Credit Allocation Fund,&nbsp;Inc, a closed-end
investment company registered under the Investment Company Act of 1940, as amended (the &ldquo;<U>1940 Act</U>&rdquo;) and organized
as a Maryland Corporation (the &ldquo;<U>Fund</U>&rdquo;), and Destra Capital Investments LLC, a Delaware limited liability company (the
 &ldquo;<U>Destra</U>&rdquo;). Capitalized terms used herein and not defined shall have the meanings set forth in the Agreement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Destra wish to make certain amendments to the Agreement as and to the extent set forth herein.</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Fund and Destra are willing to consent to the amendments set forth herein pursuant to, and subject to, the terms and conditions set forth
in this Amendment.</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants hereinafter contained and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Compensation</U>.
Section&nbsp;8(a)&nbsp;of the Agreement is deleted in its entirety and replaced with the following:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;</FONT>As
compensation for the Services to be provided by Destra under this Agreement, the Fund shall pay to Destra a services fee calculated as
follows: (1)&nbsp;multiply the end of day AUM balance times (2)&nbsp;the Applicable Service Rate (ASR) outlined in Exhibit&nbsp;A of
this Amendment. The ASR is determined based on the degree of discount or premium of ARDC&rsquo;s stock price relative to its Net Asset
Value at the end of each day, such fee to be accrued and paid in the same manner, over the same period and paid on the same day as the
Adviser&rsquo;s investment advisory fee is paid by the Fund under such investment advisory agreement (the &ldquo;<U>Services Fee</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Notices</U>. Section&nbsp;25 of the Agreement is amended so that the Destra notice information is as follows:</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to Destra, to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Destra Capital Investments LLC</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">444 West Lake Street, Suite&nbsp;1700</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Chicago,&nbsp;Illinois 60606</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy emailed </FONT>to: <U>legal@destracapital.com</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The effectiveness of this Amendment
is subject to the satisfaction of each of the following conditions precedent:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts</U>.
This Amendment may be executed in any number of identical counterparts, and each counterpart hereof shall be deemed to be an original
instrument, but all counterparts hereof taken together shall constitute but a single instrument.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows.]</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the parties hereto have executed
this Amendment to Investor Support Services Agreement as of the date first set forth above.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARES DYNAMIC CREDIT ALLOCATION FUND,&nbsp;INC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESTRA CAPITAL INVESTMENTS LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">/s/&#8239;<FONT STYLE="text-transform: none">Dominic C.
    Martellaro</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="text-transform: none">Dominic C. Martellaro</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>CEO</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2416373d4_ex99-xkx6img001.jpg" ALT=""></P>


<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(8)
<SEQUENCE>12
<FILENAME>tm2416373d4_ex99-xkx8.htm
<DESCRIPTION>EXHIBIT 99.(K)(8)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xkx8.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>


<P STYLE="margin: 0; text-align: right"><B>Exhibit (k)(8)</B></P>


<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 374pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution
Version</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 374pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
NO. 11 TO CREDIT AGREEMENT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT
NO. 11, dated as of April 12, 2024 (this &ldquo;<U>Amendment</U>&rdquo;), to the Credit Agreement, dated as of January 3, 2013,
by and among ARES DYNAMIC CREDIT ALLOCATION FUND, INC., a Maryland corporation (the &ldquo;<U>Borrower</U>&rdquo;), the Banks
party thereto, and STATE STREET BANK AND TRUST COMPANY, as agent for the Banks (in such capacity, the &ldquo;<U>Agent</U>&rdquo;),
as amended by Amendment No. 1, dated as of April 5, 2013, Amendment No. 2, dated as of October 2, 2014, Amendment No. 3 and Consent
No. 1, dated as of August 31, 2015, Amendment No. 4, dated as of September 30, 2016, Amendment No. 5, dated as of October 2, 2018,
Amendment No. 6, dated as of October 2, 2019, Amendment No. 7, dated as of June 8, 2020, Amendment No. 8, dated as of July 7,
2021, Amendment No. 9, dated as of December 22, 2021, and Amendment No. 10, dated as of June 14, 2022 (as the same may be further
amended, supplemented or otherwise modified from time to time, the &ldquo;<U>Credit Agreement</U>&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 203pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
 &nbsp;&nbsp;Each term that is defined in the Credit Agreement and not herein defined has the meaning ascribed thereto by the Credit Agreement
when used herein.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II.
The Borrower desires an amendment of the Credit Agreement upon the terms and conditions herein contained, and all Banks have agreed
thereto upon the terms and conditions herein contained.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
in consideration of the Recitals and the covenants, conditions and agreements hereinafter set forth, and for other good and valuable
consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Amendment, the following terms have the following meanings when used herein:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Added
Text</U>&rdquo; means characters indicated textually in the same manner as the following example: <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>double
underlined text</U></FONT>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Marked
Credit Agreement</U>&rdquo; means the copy of the Existing Credit Agreement attached hereto as Annex A.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stricken
Text</U>&rdquo; means characters indicated textually in the same manner as the following example: <FONT STYLE="color: red"><STRIKE>stricken
text</STRIKE></FONT>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.


 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Existing Credit Agreement (including Schedule 1 and Exhibit D, but excluding each other Schedule and Exhibit) is hereby amended
to delete the Stricken Text and to add the Added Text, in each case as set forth in the Marked Credit Agreement (the Existing
Credit Agreement, as so amended, the &ldquo;<U>Amended Credit Agreement</U>&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Exhibit D to Existing Credit Agreement is hereby amended and restated in the form of Exhibit D hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Paragraphs 1 through 3 of this Amendment shall not be effective until each of the following conditions is satisfied (the date,
if any, on which such conditions shall have first been satisfied being referred to herein as the &ldquo;<U>Amendment Effective
Date</U>&rdquo;):</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Agent shall have received from the Borrower and each Bank either (i) a counterpart of this Amendment executed on behalf of
such party, or (ii) written evidence satisfactory to the Agent (which may include a transmission by electronic mail of a signed
signature page of this Amendment) that each such party has executed a counterpart of this Amendment;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Agent shall have received from the Borrower a manually signed certificate from the Secretary of the Borrower, dated the
Amendment Effective Date and in all respects reasonably satisfactory to the Agent, (i) certifying as to (x) the incumbency of
authorized persons of the Borrower executing this Amendment and (y)&nbsp; persons authorized to act on behalf of the Borrower
in connection with the Credit Agreement, including, without limitation, with respect to any Notice of Borrowing,
(ii)&nbsp;attaching true, complete and correct copies of resolutions duly adopted by the Borrower&rsquo;s Managing
Body approving this Amendment and the transactions contemplated hereby, all of which shall be in full force and effect on the
Amendment Effective Date, (iii) certifying that the Borrower&rsquo;s Charter Documents, Prospectus, statement of additional
information, registration statement, Pricing Procedures, investment management agreement between the Borrower and the
Investment Adviser, and Custody Agreement have not been amended, supplemented or otherwise modified since June 14, 2022, or,
if so, attaching true, complete and correct copies of each such amendment, supplement or modification (or, in the case of the
Borrower&rsquo;s Prospectus, statement of additional information, and/or registration statement, attaching a true, complete
and correct copy of the most recent Prospectus, statement of additional information, or registration statement, as
applicable);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Agent shall have received a new Federal Reserve Form FR U-1, for each Bank, duly executed by or on behalf of the Borrower,
in form and substance satisfactory to such Bank;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Agent shall have received an upfront fee, for the account of each Bank, in an amount equal to $193,744.44;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Agent shall have received such documents and information as the Agent or any Bank shall have requested in order to comply
with &ldquo;know-your-customer&rdquo; and other anti-terrorism, anti-money laundering and similar rules and regulations and related
policies applicable to the Borrower; and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 195pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39pt 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall have paid all reasonable and documented out-of-pocket fees and expenses incurred by the Agent (including, without
limitation, reasonable and documented legal fees and disbursements of counsel to the Agent) in connection herewith.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower (a) reaffirms and admits the validity and enforceability of each Loan Document to which it is a party and all of
its obligations thereunder and agrees and admits that (i) it has no defense to any such obligation and (ii) it shall not exercise
any setoff or offset to any such obligation, and (b)(i) represents and warrants that, as of the date of execution and delivery
hereof by the Borrower, no Default has occurred and is continuing and (ii) the representations and warranties of the Borrower
contained in the Credit Agreement and the other Loan Documents are true on and as of the date hereof with the same force and effect
as if made on and as of such date (or, if any such representation or warranty is expressly stated to have been made as of a specific
date, as of such specific date).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
In all other respects, the Loan Documents shall remain in full force and effect, and no amendment in respect of any term or condition
of any Loan Document shall be deemed to be an amendment in respect of any other term or condition contained in any Loan Document.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
This Amendment may be executed in any number of counterparts, each of which shall constitute an original but all of which when
taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by
telecopy, emailed pdf. or any other electronic means that reproduces an image of the actual executed signature page shall be effective
as delivery of a manually executed counterpart of this Amendment. The words &ldquo;execution,&rdquo; &ldquo;signed,&rdquo; &ldquo;signature,&rdquo;
 &ldquo;delivery,&rdquo; and words of like import in or relating to any document to be signed in connection with this Amendment
and the transactions contemplated hereby shall be deemed to include Electronic Signatures, deliveries or the keeping of records
in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature,
physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided
for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State
Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; <U>provided</U>&nbsp;that
nothing herein shall require the Agent or any Bank to accept electronic signatures in any form or format without its prior written
consent. Without limiting the generality of the foregoing, the Borrower hereby (i) agrees that, for all purposes, including without
limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among
the Agent, any Bank and the Borrower, electronic images of this Amendment or any other Loan Documents (in each case, including
with respect to any signature pages thereto) shall have the same legal effect, validity and enforceability as any paper original,
and (ii) waives any argument, defense or right to contest the validity or enforceability of the Loan Documents based solely on
the lack of paper original copies of any Loan Documents, including with respect to any signature pages thereto. For purposes hereof,
 &ldquo;<U>Electronic Signature</U>&rdquo; means an electronic sound, symbol, or process attached to, or associated with, a contract
or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES
THAT WOULD REQUIRE THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>the
remainder of this page has been intentionally left blank</I>]</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 231pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Amendment No. 11 to be duly executed and delivered by their proper and duly
authorized officers as of the day and year first above written.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES DYNAMIC CREDIT ALLOCATION
    FUND, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Scott Lem</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Scott Lem</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;&nbsp;Chief Financial
    Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE STREET BANK AND TRUST COMPANY,
    as a Bank and as the Agent</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Charles W. Reid<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Charles W. Reid</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;&nbsp;Vice President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Black"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ares
Dynamic Credit Allocation Fund, Inc.&ndash; Amendment No. 11</FONT></FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
D</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF BORROWING BASE REPORT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
__________</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE
STREET BANK AND TRUST COMPANY</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
Credit Finance</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
Congress Street</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston,
MA 02214</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Charles Reid</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(617) 662-0286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is hereby made to the Credit Agreement, dated as of January 3, 2013, by and between Ares Dynamic Credit Allocation Fund, Inc.,
a Maryland corporation (the &ldquo;<U>Borrower</U>&rdquo;), and State Street Bank and Trust Company, as Agent, as amended by Amendment
No. 1, dated as of April 5, 2013, Amendment No. 2, dated as of October 2, 2014, Amendment No. 3 and Consent No. 1, dated as of
August 31, 2015, Amendment No. 4, dated as of September 30, 2016, Amendment No. 5, dated as of October 2, 2018, Amendment No.
6, dated as of October 2, 2019, Amendment No. 7, dated as of June 8, 2020, Amendment No. 8, dated as of July 7, 2021, Amendment
No. 9, dated as of December 22, 2021, Amendment No. 10, dated as of June 14, 2022, and Amendment No. 11, dated as of April 12,
2024 (as the same may be further amended, supplemented or otherwise modified from time to time, the &ldquo;<U>Credit Agreement</U>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Credit Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The undersigned, an authorized representative of the Borrower, hereby certifies with respect to the Borrower that (a) this Certificate
is being delivered pursuant to <U>Section 5.01(d)</U>&nbsp;of the Credit Agreement, and (b) as of the date hereof, [[no Event of Default
has occurred and is continuing] or [the following Event(s) of Default [has/have] occurred and [is/are] continuing: _____________________.<SUP>1</SUP></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
This Borrowing Base Report is delivered to you pursuant to <B>[<U>Section 2.02(a)</U> or <U>Section 5.01(c)]</U></B>&nbsp;of the Credit
Agreement. The undersigned hereby certifies to you as follows:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
as of the close of business on <B>[Date]<SUP>2</SUP></B> (the &ldquo;<U>Notice Time</U>&rdquo;), the Borrowing Base was $____________
(the &ldquo;<U>Applicable Borrowing Base</U>&rdquo;),</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0in; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this certificate is being delivered in connection with the delivery of a Borrowing Base Report or Valuation Report in accordance
with Section 5.01(c) then complete both paragraphs 1 and 2 and Annex 1; if this certificate is being delivered for any other purpose
under Section 5.01(d), complete paragraph 1 and delete paragraph 2 and Annex 1.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         a Borrowing Base Report delivered pursuant to <U>Section 2.02(a)</U> of the Credit Agreement,
                                         this date should be the Domestic Business Day immediately preceding the proposed borrowing
                                         date related thereto. For a <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Borrowing
Base Report delivered pursuant to <U>Section 5.01(c)</U> of the Credit Agreement, this date should be the last Domestic Business
Day of the immediately preceding calendar week.</FONT></FONT></TD></TR></TABLE>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Annex
1</U>&nbsp;attached hereto is a true and accurate detailed calculation of the Borrowing Base as of the Notice Time,</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
U.S. Dollar Equivalent of the aggregate outstanding principal balance of the Loans <B>[[immediately AFTER giving effect to the
making of the Loans requested in the Notice of Borrowing dated __________<SUP>3</SUP>] or [at the Notice Time<SUP>4</SUP>]]</B>:
$_____________________ (the &ldquo;<U>Applicable Loan Amount</U>&rdquo;), and</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Applicable Borrowing Base <B>[is less than][equals][exceeds]</B> the Applicable Loan
                                         Amount.</FONT></TD></TR></TABLE>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES DYNAMIC CREDIT ALLOCATION
    FUND, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0in; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
use when borrowing.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>4</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
periodic reporting.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
1</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to</B>&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Borrowing
Base Report</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 173pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[This
Annex 1 must be substantially in the following form, or such other form as shall have been agreed to by the Borrower and the Agent]</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 113pt; text-indent: -111.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
    Value of all Eligible Government Securities: </FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Eligible Commercial Paper:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Tier 1 Corporate Debt Securities: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Eligible GSE Securities: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Eligible OECD Member Nation Debt Securities: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Class I Senior Loans: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Tier 2 Corporate Debt Securities: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Tier 3 Corporate Debt Securities: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Value of all
    Class II Senior Loans: </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>


<TR STYLE="vertical-align: top; background-color: White">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90% of A: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>5</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90% of B: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80% of C: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>7</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80% of D: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>8</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80% of E: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>9</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75% of F:</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>10</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70% of G: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>11</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60% of H: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>12</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60% of I: </FONT></TD>
                                                                                                                  <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                  <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
                                                                                                                  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>13</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sum of J plus K plus L plus M plus N plus O plus
P plus Q plus R: </B></FONT></TD>
                                                                                                                                           <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                                           <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<B>________</B></FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; background-color: White">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5% of S:</FONT></TD>
                                                                                                                                    <TD STYLE="text-align: left">&nbsp;</TD>
                                                                                                                                    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
</TR></TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.</FONT></TD><TD STYLE="text-align: justify; width: 86%; padding-left: 0.125in; text-indent: -0.125in; padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List by Issuer the aggregate value (to the extent included
in S) of all Eligible Securities, Eligible Loan Obligations and Eligible Loan Participations of a single Issuer ONLY if such aggregate
value exceeds T:</FONT></TD>
                                                                                                                                    <TD STYLE="text-align: justify; width: 11%; padding-left: -0.125in">&nbsp;</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 3%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Issuer</U></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Aggregate Value</U></FONT></TD>
    <TD STYLE="padding-right: 11pt; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 27%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Issuer]</B></FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____________</FONT></TD>
    <TD STYLE="width: 12%; padding-right: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>minus</U>
    T:</FONT></TD>
    <TD STYLE="width: 8%; text-align: left">$_________</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Issuer]</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>minus</U>
    T:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_________</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_________</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0in; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>5</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (a) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>6</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (a) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>7</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (b) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>8</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (b) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>9</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (b) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>10</SUP>
Clause</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>11</SUP>
Clause</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>12</SUP>
Clause</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>13</SUP></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause (e) of Borrowing Base definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V. </B></FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S minus U:</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: right"><B>$</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>14</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10% of S:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X.</FONT></TD><TD STYLE="text-align: left; width: 86%; padding-left: 10pt; text-indent: -10pt; padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List (by OECD Member Nation) the aggregate value (to
the extent included in S)&nbsp; of all Eligible Securities, Eligible Loan Obligations and Senior Loans of all Issuers (including
Issuers of Eligible OECD Member Nation Debt Securities) located in or formed under the laws of any one Eligible OECD Member Nation
(including each political subdivision thereof) ONLY if such aggregate value exceeds W:</FONT></TD>
                                                                                                                  <TD STYLE="text-align: justify; width: 11%">&nbsp;</TD></TR></TABLE>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 3%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; width: 27%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Issuer</U></FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Aggregate Value</U></FONT></TD>
    <TD STYLE="padding-right: 11pt; text-align: left; width: 10%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 8%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 3%">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 27%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>[OECD
    Member Nation]</B></FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____________</FONT></TD>
    <TD STYLE="width: 12%; padding-right: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>minus</U>
    W:</FONT></TD>
    <TD STYLE="width: 8%; text-align: left">$_________</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>[OECD
    Member Nation]</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>minus</U>
    W:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_________</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_________</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103pt 0pt 30pt; text-indent: -30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103pt 0pt 30pt; text-indent: -30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Y.</B></FONT></TD>
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V minus X: </B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B>________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>15</SUP></B></FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Z.&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% of S:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AA.</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
    the aggregate value (to the extent included in S) of all Eligible Securities, Eligible Loan Obligations and Senior Loans of
    all Issuers (including Issuers of Eligible OECD Member Nation Debt Securities) located in or formed under the laws of any
    Eligible OECD Member Nation (including each political subdivision thereof): </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BB.</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    (if any) by which AA exceeds Z: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CC.</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Y
    minus BB:</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B>________</FONT></TD>
    <TD STYLE="text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>16</SUP></B></FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DD.</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
    of S:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EE. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List the aggregate value (to the extent included
    in S) of Unquoted Assets: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FF. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount (if any) by which EE exceeds DD: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GG.</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CC
    minus FF </B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B>________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>17</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HH.</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%
    of S:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II.&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List the aggregate value (to the extent included
    in S) of Single Rated Assets: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JJ. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount (if any) by which II exceeds HH </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>


<TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KK.</B></FONT></TD><TD STYLE="text-align: justify; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GG
                                         minus JJ</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
                                                                                                                                            <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B>________</FONT></TD>
                                                                                                                                            <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>18</SUP></B></FONT></TD>
</TR></TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LL.10%
of S:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0in; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>14</SUP>
Adjustment referred to in clause (1) of Borrowing Base definition&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>15</SUP>
Adjustment referred to in clause (2) of Borrowing Base definition&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>16</SUP>
Adjustment referred to in clause (3) of Borrowing Base definition&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>17</SUP>
Adjustment referred to in clause (4) of the Borrowing Base definition&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>18</SUP>
Adjustment</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">referred to in clause (5) of the Borrowing Base
definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MM.</FONT></TD><TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
                                         the aggregate value (to the extent included in S) of Eligible Debt Securities issued
                                         by Eligible Corporate Issuers domiciled in, and having their respective principal places
                                         of business in, any single Eligible Nation other than the United States of America </FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
                                                                                                                 <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$________</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NN.&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount (if any) by which MM exceeds LL </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$________</FONT></TD>
    <TD>&nbsp;</TD></TR>


<TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OO.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KK
                                         minus NN </B></FONT></TD>
    <TD>&nbsp;</TD>
                                                                                                                                            <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>$</B>________</FONT></TD>
                                                                                                                                            <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>19</SUP></B></FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; background-color: White">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PP.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%
                                         of S: </FONT></TD>
    <TD>&nbsp;</TD>
                                                                                                                                     <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$________</FONT></TD>
    <TD>&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QQ.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
                                         the aggregate value (to the extent included in S) of Eligible Debt Securities issued
                                         by Eligible Corporate Issuers domiciled in, and having their respective principal places
                                         of business in, any one or more Eligible Nations other than the United States of America</FONT></TD>
    <TD>&nbsp;</TD>
                                                                                                                                     <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD>&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RR.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount (if any) by which
    QQ exceeds PP </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$________</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SS.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OO minus RR (the &ldquo;<U>Borrowing Base</U>&rdquo;):
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>$</B>________</FONT></TD>
    <TD><B><SUP>20</SUP></B></TD></TR>
</TABLE>
<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0in; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>19</SUP>
Adjustment referred to in clause (6) of the Borrowing Base definition</FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>20</SUP>
Adjustment</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">referred to in clause (7) of Borrowing Base
definition</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Annex
A</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREDIT
AGREEMENT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>dated as of January 3, 2013</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>among</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES
DYNAMIC CREDIT ALLOCATION FUND, INC.,</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE
STREET BANK AND TRUST COMPANY,</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
the other lending institutions party hereto</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>and</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE
STREET BANK AND TRUST COMPANY,</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>in its capacity as Agent</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 100pt 0pt 136pt; text-indent: -75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Prepared
by:</I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bryan
Cave Leighton Paisner LLP</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1290
Avenue of the Americas</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10104-3300&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>






<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 71%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; width: 10%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Page</U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE I DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1.01.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1.02.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Terms and Determination</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1.03.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternate Currencies</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1.04.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Split Ratings</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1.05.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rates</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE II THE CREDIT</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.01.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments to Lend</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.02.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Borrowings</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.03.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice to Banks; Funding of Loans</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.04.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Accounts; Notes; Records</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.05.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mandatory Payments; Optional Prepayments</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.06.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Rates</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.07.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.08.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination and Change of Commitments</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.09.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Provisions as to Payments</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.10.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation of Interest and Fees</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.11.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding Tax Exemption</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE III CONDITIONS</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 3.01.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effectiveness</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 3.02.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Borrowings</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE IV REPRESENTATIONS AND WARRANTIES</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.01.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existence and Power; Investment Company</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.02.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorization; Execution and Delivery, Etc.</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.03.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncontravention</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.04.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authorizations; Private Authorization</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.05.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations T, U and X</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.06.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Affiliation with Banks</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.07.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 232.8pt"></P>




<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%; padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    4.08.</FONT></TD>
    <TD STYLE="width: 71%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Information</FONT></TD>
    <TD STYLE="width: 10%; text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.09.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.10.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ERISA</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.11.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.12.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.13.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal Year</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.14.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Disclosure</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.15.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Documents</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.16.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFAC,&nbsp;USA&nbsp;PATRIOT&nbsp;Act,&nbsp;Anti-Corruption&nbsp;&nbsp;and
    Other Regulations</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt">49<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4.17.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title to Assets</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE V COVENANTS</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.01.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.02.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Obligations</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.03.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintenance of Insurance</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.04.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of Business and Maintenance of Existence</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.05.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.06.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inspection of Property, Books and Records</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.07.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indebtedness</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.08.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liens</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.09.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidations, Mergers and Sales of Assets</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.10.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.11.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Investment Policies and Restrictions</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.12.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Affiliation with Banks</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.13.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulated Investment Company</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.14.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Subsidiary</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.15.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ERISA</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.16.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal Year</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.17.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation U</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.18.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Custodian</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.19.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Coverage</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.20.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum Amount</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 231.7pt"></P>




<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%; padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    5.21.</FONT></TD>
    <TD STYLE="width: 71%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    Payments</FONT></TD>
    <TD STYLE="width: 10%; text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.22.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Assurances</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.23.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance&nbsp;&nbsp;with&nbsp;&nbsp;Anti-Terrorism&nbsp;&nbsp;Laws,&nbsp;&nbsp;Money
    Laundering Laws, Etc.</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt">56<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5.24.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Shares Documents</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VI DEFAULTS</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 6.01.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Events of Default</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 6.02.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remedies</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VII THE AGENT</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.01.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment and Authorization</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.02.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Action by Agent</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.03.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultation with Experts</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.04.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability of Agent</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.05.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.06.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit Decision</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.07.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successor Agent</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.08.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agent as Bank</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.09.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution by Agent</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.10.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delinquent Banks</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 7.11.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erroneous Payments</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VIII CHANGE IN CIRCUMSTANCES</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.01.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Costs; Capital Adequacy</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.02.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inability to Determine Rates</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.03.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illegality</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.04.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benchmark Replacement Setting</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.05.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.06.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Replacement Banks</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 8.07.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Law</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE IX MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.01.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.02.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Waivers</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses; Documentary
    Taxes; Indemnification</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 230.5pt"></P>




<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; width: 19%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.04.</FONT></TD>
    <TD STYLE="width: 71%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set Off</FONT></TD>
    <TD STYLE="text-align: right; width: 10%; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.05.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments and Waivers</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.06.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successors and Assigns</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.07.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law; Submission to Jurisdiction</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.08.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WAIVER OF JURY TRIAL</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.09.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential Material</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.10.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USA Patriot Act</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.11.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Rate Limitation</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.12.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.13.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitation on Liability</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.14.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgment Currency</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.15.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
    9.16.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement and
    Consent to Bail-In of Affected Financial Institutions</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt">81</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.17.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement Regarding Any Supported QFCs</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.18.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain ERISA Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibits:</U></B></FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit A -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Note</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit B -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Notice of Borrowing</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit C -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Notice of Conversion</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit D -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Borrowing Base Report</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit E -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Assignment and Acceptance</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit F -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Notice of Repayment</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit G -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Security Agreement</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit H -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Perfection Certificate</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit I -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Opinion of Borrower&rsquo;s Counsel</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit J -</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of
    Compliance Certificate</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Schedules:</U></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1 - </FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addresses for Notices, Lending Offices, Commitment
Amounts and Commitment Percentages</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 2 - </FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing Procedures</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREDIT
AGREEMENT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREDIT
AGREEMENT</B>, dated as of January 3, 2013 by and among Ares Dynamic Credit Allocation Fund, Inc., a Maryland corporation (the
 &ldquo;<U>Borrower</U>&rdquo;), the Banks (as hereinafter defined) party hereto from time to time, and <B>STATE STREET BANK AND
TRUST COMPANY, </B>as agent for the Banks (in such capacity, the &ldquo;<U>Agent</U>&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto hereby agree as follows:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
1.01.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitions</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms, as used herein, have the following meanings:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjusted
Net Assets</U>&rdquo; means, as at any date of determination, an amount equal to (a) the Asset Value of the Total Assets, minus
(b) the sum, without duplication, of (x) the Total Liabilities that are not Senior Securities Representing Indebtedness, plus
(y) the value of all Restricted Payments that have been declared by the Borrower but remain unpaid, plus (z) the Asset Value of
the Liquidity Account. For purposes of calculating the Adjusted Net Assets, (X) Total Liabilities shall not include any liability
to the extent such liability reduced the Asset Value of an asset pursuant to clause (a) of the defined term &ldquo;Asset Value&rdquo;,
and (Y) the amount of any liability included in Total Liabilities shall be equal to the greater of (i) the outstanding amount
of such liability and (ii) the Value of all assets pledged or otherwise segregated to secure such liability. For the purposes
of calculating Adjusted Net Assets, the liability in respect of any derivative or other financial contract shall be equal to the
market value thereof or, if no such market value exists, the net amount, if any, that the Borrower would be obligated to pay to
the relevant counterparty thereto if such financial contract and all transactions thereunder terminated at such time in accordance
therewith on a complete no-fault basis.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjusted
Offered Rate</U>&rdquo; applicable to any Interest Period for a Fixed Rate Loan means a rate per annum equal to the quotient obtained
(rounded upward, if necessary, to the next higher 1/100 of 1%) by dividing (i) the applicable Funding Rate by (ii) 1.00 minus
the applicable Reserve Percentage. The Adjusted Offered Rate shall be adjusted automatically on and as of the effective date of
any change in the Reserve Percentage.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjusted
Term SOFR</U>&rdquo; means, for purposes of any calculation, the rate per annum equal to (a) Term SOFR for such calculation plus
(b) the Term SOFR Adjustment; provided that if Adjusted Term SOFR as so determined shall ever be less than the Floor, then Adjusted
Term SOFR shall be deemed to be the Floor.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adverse
Claim</U>&rdquo; means any Lien or other right, claim, encumbrance or any other type of preferential arrangement in, of or on
any Person&rsquo;s assets or properties (including the segregation thereof or the deposit thereof to satisfy margin or other requirements;
<U>provided</U> that Adverse Claim shall not include any segregation which (i) is required to prevent a security of the Borrower
from constituting a senior security for purposes of the Investment Company Act and (ii) is not a pledge or security interest)
in favor of any other Person other than, in the case of the Borrower, Liens permitted under <U>Section 5.08(a), (b) or (c)</U>.&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affected
Alternate Currency Loan</U>&rdquo; has the meaning set forth in Section 8.02(c) hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affected
Financial Institution</U>&rdquo; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affected
Loan</U>&rdquo; means an Affected Overnight Rate Loan or an Affected Alternate Currency Loan.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affected
Overnight Rate Loan</U>&rdquo; has the meaning set forth in Section 8.02(c) hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, with respect to any Person (the &ldquo;First Person&rdquo;) any other Person that (a) is an &ldquo;Affiliated
Person&rdquo; (within the meaning of the Investment Company Act) of such First Person, (b) is an &ldquo;affiliate&rdquo;
(within the meaning of Section 23A of the Federal Reserve Act, as amended) of such First Person, or (c) is a Control
Affiliate of such First Person.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agent</U>&rdquo;
has the meaning set forth in the preamble to this Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agent
Exchange Rate</U>&rdquo; means, at any time of the determination thereof, the rate reasonably determined by the Agent to be the
rate quoted by State Street as its spot rate for the purchase of one currency with another currency.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Aggregate
Commitment Amount</U>&rdquo; means, as of any date, the aggregate of all Commitment Amounts as of such date. On the Effective
Date, the Aggregate Commitment Amount is $150,000,000.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Currency</U>&rdquo; means Australian Dollars, Euros, <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>and </U></FONT>Pounds Sterling<FONT STYLE="color: red"><STRIKE>,
and Canadian Dollars</STRIKE></FONT>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 42.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Currency Benchmark Replacement</U>&rdquo; means, with respect to any Alternate Currency Loan for any Available Tenor (including
any Overnight Rate Loan), the sum of: (a) the alternate benchmark rate that has been selected by the Agent and the Borrower as
the replacement for the then-current Benchmark for such Alternate Currency Loan and applicable Corresponding Tenor giving due
consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate
by the Relevant Governmental Body or (ii) Applicable Market Convention and (b) the related Benchmark Replacement Adjustment, provided
that if such Alternate Currency Benchmark Replacement would be less than zero, such Alternate Currency Benchmark Replacement will
be deemed to be zero for the purposes of this Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Currency Loan</U>&rdquo; refers to a Loan made in an Alternate Currency.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 19; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Currency Regulatory Body</U>&rdquo; means, with respect to any Alternate Currency, the regulatory body or bodies having jurisdiction
over the administration of any applicable Benchmark for such Alternate Currency.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Amendment
Effective Date</U>&rdquo; means the Amendment Effective Date as such term is defined in Amendment No. 4 hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Amendment
No. <FONT STYLE="color: red"><u><STRIKE>5</STRIKE></u></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><u>11</u></FONT> Effective Date</U>&rdquo;
means the Amendment Effective Date as such term is defined in Amendment No. <FONT STYLE="color: red"><STRIKE>5</STRIKE></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>11
</U></FONT>hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Anti-Corruption
Laws</U>&rdquo; means all laws, rules, and regulations of any jurisdiction applicable to the Borrower from time to time concerning
or relating to bribery or corruption.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Fee Rate</U>&rdquo; means, (a) from the Effective Date to the Amendment No. <FONT STYLE="color: red"><STRIKE>5</STRIKE></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>1</U>1
</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective Date, the applicable rate set forth
from time to time in this Credit Agreement at which the commitment fee accrues, and (b) from and after the Amendment No. <FONT STYLE="color: red"><STRIKE>5</STRIKE></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>11
</U></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective Date, <FONT STYLE="color: red"><STRIKE>0.15%</STRIKE></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>a
rate per annum equal to (i) as of any date upon which the Loan Balance equals or exceeds 80% of the Commitment 0.15% and (ii) as of any
other date, 0.25%</U></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Law</U>&rdquo; means, with respect to any Person, any Law of any Authority, including, without limitation, all Federal and state
banking or securities laws, to which such Person is subject or by which it or any of its property is bound.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Lending Office</U>&rdquo; means, with respect to any Bank, (a) in the case of its Base Rate Loans, its Domestic Lending Office,
and (b) in the case of its Fixed Rate Loans or Overnight Rate Loans, its Designated Lending Office.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Loan Rate</U>&rdquo; means<FONT STYLE="color: red"><STRIKE> 0.95%.</STRIKE></FONT><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>,
(a) from the Effective Date to the Amendment No. 11 Effective Date, the applicable rate set forth from time to time in this Credit
Agreement at which the applicable loan rate accrues, and (b) from and after the Amendment No. 11 Effective Date, a rate per annum
equal to 1.15%.</U></FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Market Convention</U>&rdquo; means, for purposes of and as of any date of determining any Alternate Currency Benchmark Replacement,
Benchmark Replacement Adjustment or U.S. Dollar Benchmark Replacement, any evolving or then-prevailing market convention for determining
a benchmark rate of interest as a replacement for the then current applicable Benchmark for credit facilities governed by the
laws of the United States (or any state thereof) all or a portion of which include a tranche denominated in the currency applicable
to such Benchmark in which tranche more than one money center bank is a syndicate member.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Money Market</U>&rdquo; means any money market applicable to Fixed Rate Loans.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Approved
Borrowing Amount</U>&rdquo; means (a) $1,000,000 (or the U.S. Dollar Equivalent) or an integral multiple of $100,000 (or the U.S.
Dollar Equivalent) in excess thereof, or (b) such lesser amount as shall be equal to the excess of the Aggregate Commitment Amount
over the aggregate outstanding principal balance of all Loans.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Articles
Supplementary</U>&rdquo; means that certain Articles Supplementary, dated on or about July 15, 2021 (as may be amended, restated,
supplemented or modified from time to time), adopted by the Borrower in connection with the Preferred Shares.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Asset
Value</U>&rdquo; means, as of any day of determination in respect of any asset of the Borrower, the Value of such asset computed
by the Borrower in good faith in the manner such Value is required to be computed in accordance with the Pricing Procedures and
Applicable Law, including, without limitation, the Investment Company Act; <U>provided</U>&nbsp;<U>that</U>:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Asset Value of any asset shall be net of the Borrower&rsquo;s liabilities (other than any liability included in Total Liabilities)
relating thereto, including without limitation all of the Borrower&rsquo;s obligations to pay any unpaid portion of the purchase
price thereof, and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
respect to any asset that is not valued daily, the Asset Value of such asset shall be deemed zero for purposes of this definition,
(ii) with respect to any asset the value of which is not based primarily upon the closing price thereof on an exchange, or the
market price therefor determined by one or more pricing services or broker-dealers (other than a pricing service or broker-dealer
that is a Control Affiliate of the Borrower or the Borrower&rsquo;s investment adviser, or that is otherwise not independent),
the Asset Value of such asset shall be the Value thereof as reasonably determined by the Borrower in accordance with the Pricing
Procedures, <U>provided</U>&nbsp;that in the event such asset is a Serial Unquoted Asset, the Asset Value of such asset shall be deemed
zero for purposes of this definition, and (iii) with respect to any asset that is valued higher than either of the following (the
 &ldquo;<U>Base Price</U>&rdquo;): (x) the closing price thereof on an exchange, or (y) the market price therefor determined by
one or more pricing services or broker-dealers (other than a pricing service or broker-dealer that is a Control Affiliate of the
Borrower or the Borrower&rsquo;s investment adviser, or that is otherwise not independent), the Asset Value of such asset shall
be deemed to be the Base Price for purposes of this definition.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Assignee</U>&rdquo;
has the meaning set forth in <U>Section 9.06(c)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Assignment
and Acceptance</U>&rdquo; has the meaning set forth in <U>Section 9.06(c)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Australian
Dollar</U>&rdquo; means the lawful currency of the Commonwealth of Australia.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authority</U>&rdquo;
means any governmental or quasi-governmental authority (including the Financial Industry Regulatory Authority, stock exchanges,
the SEC and any accounting board or authority (whether or not a part of government) which is responsible for the establishment
or interpretation of national or international accounting principles, in each case whether foreign or domestic), whether executive,
legislative, judicial, administrative or other, or any combination thereof, including, without limitation, any Federal, state,
territorial, county, municipal or other government or governmental or quasi-governmental agency, arbitrator, board, body, branch,
bureau, commission, corporation, court, department, instrumentality, master, mediator, panel, referee, system or other political
unit or subdivision or other entity of any of the foregoing, whether domestic or foreign.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authorized
Signatory</U>&rdquo; means any of the President, Chief Executive Officer, Chief Financial Officer, Portfolio Manager, Chief Legal
Officer, General Counsel, the Secretary, or the Treasurer of the Borrower, or some other authorized Person of the Borrower reasonably
acceptable to the Agent, <U>provided</U> that the Agent shall have received a manually signed certificate from the Secretary of
the Borrower bearing a manual specimen signature of each such officer or other Person.</FONT></P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Available
Tenor</U>&rdquo; means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if
such Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the
length of an interest period pursuant to this Agreement or (y) otherwise, any payment period for interest calculated with reference
to such Benchmark (or component thereof) that is or may be used for determining any frequency of making payments of interest calculated
with reference to such Benchmark pursuant to this Agreement, in each case, as of such date and not including, for the avoidance
of doubt, any tenor for such Benchmark that is then-removed from the definition of &ldquo;Interest Period&rdquo; pursuant to Section
8.04(e).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bail
In Action</U>&rdquo; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect
of any liability of an Affected Financial Institution.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bail
In Legislation</U>&rdquo; means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of
the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such
EEA Member Country from time to time which is described in the EU Bail In Legislation Schedule and (b) with respect to the United
Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable
in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions
or their affiliates (other than through liquidation, administration or other insolvency proceedings).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bank</U>&rdquo;
means each of State Street, each lender named on the signature pages hereof, each Assignee which becomes a Bank pursuant to <U>Section
9.06(c)</U> hereof, and their respective successors.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Base
Rate</U>&rdquo; means, as of any day, the highest of (a) the Applicable Loan Rate <U>plus</U> the Federal Funds Effective Rate
as in effect on that day, and (b) the Applicable Loan Rate <U>plus</U> Adjusted Term SOFR, as in effect on that day.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Base
Rate Loans</U>&rdquo; means Dollar Loans bearing interest calculated by reference to the Base Rate.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benefit
Arrangement</U>&rdquo; means at any time an employee benefit plan within the meaning of Section 3(3) of ERISA which is not a Plan
or a Multiemployer Plan and which is maintained or otherwise contributed to by any member of the ERISA Group.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark</U>&rdquo;
means, initially, (x) with respect to any Fixed Rate Loan, the Funding Rate with respect to the currency in which such Fixed Rate
Loan is denominated, (y) with respect to any Base Rate Loan, Adjusted Term SOFR, and (z) with respect to any (i) Euro Overnight
Rate Loan, Enhanced &euro;STR and (ii) Sterling Overnight Rate Loan, Daily Simple SONIA; <U>provided</U>&nbsp;that if a Benchmark Transition
Event and its related Benchmark Replacement Date have occurred with respect to any applicable Funding Rate, Adjusted Term SOFR,
Enhanced &euro;STR, Daily Simple SONIA, as applicable, or the then-current applicable Benchmark, then &ldquo;Benchmark&rdquo;
means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate
pursuant to Section 8.04.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.9pt"></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Replacement</U>&rdquo; means, (x) for Dollar Loans, the U.S. Dollar Benchmark Replacement, and (y) for Alternate Currency Loans,
the Alternate Currency Benchmark Replacement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Replacement Adjustment</U>&rdquo; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark
Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive
or negative value or zero) that has been selected by the Agent in consultation with the Borrower, in a commercially reasonable
manner not inconsistent with similar determinations by the Agent in connection with other substantially similar credit facilities,
giving due consideration to (a) any selection or recommendation of a spread adjustment, or method for calculating or determining
such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant
Governmental Body or (b) any evolving or then-prevailing market convention for determining a spread adjustment, or method for
calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark
Replacement for syndicated credit facilities denominated in the applicable Permitted Currency at such time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Replacement Conforming Changes</U>&rdquo; means, with respect to any Benchmark Replacement, any technical, administrative or operational
changes (including changes to the definition of &ldquo;Base Rate,&rdquo; the definition of &ldquo;Rate Setting Business Day&rdquo;,
the definition of &ldquo;Interest Period,&rdquo; timing and frequency of determining rates and making payments of interest, timing
of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage
provisions, and other technical, administrative, operational matters) that the Agent determines in its reasonable discretion may
be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof
by the Agent in a manner substantially consistent with market practice (or, if the Agent determines in its reasonable discretion
that adoption of any portion of such market practice is not administratively feasible or if the Agent determines that no market
practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Agent determines
is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Replacement Date</U>&rdquo; means a date and time determined by the Agent (in consultation with the Borrower), which date shall
be no later than the earliest to occur of the following events with respect to the then-current Benchmark:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the case of clause (a) or (b) of the definition of &ldquo;Benchmark
Transition Event,&rdquo; the later of (i) the date of the public statement or publication of information referenced therein
and (ii) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof)
permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof);
or&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the case of clause (c) of the definition of &ldquo;Benchmark Transition
Event,&rdquo; the first date on which such Benchmark (or the published component used in the calculation thereof) has been
determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to
be non-representative; provided that such non-representativeness will be determined by reference to the most recent statement
or publication referenced in such clause (c) and even if any Available Tenor of such Benchmark (or such component thereof)
continues to be provided on such date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, the &ldquo;Benchmark Replacement Date&rdquo; will be deemed to have occurred in the case of clause (a)
or (b) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all
then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Transition Event</U>&rdquo; means the occurrence of one or more of the following events with respect to the then-current Benchmark:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component
used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of
such Benchmark (or such component thereof), permanently or indefinitely; <U>provided</U> that, at the time of such statement or
publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such
component thereof);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the
published component used in the calculation thereof), in the case of Dollar Loans, the Federal Reserve Board or the Federal Reserve
Bank of New York, in the case of any Alternate Currency Loans, the applicable Alternate Currency Regulatory Body, an insolvency
official with jurisdiction over the administrator for such Benchmark (or such component thereof), a resolution authority with
jurisdiction over the administrator for such Benchmark (or such component thereof) or a court or an entity with similar insolvency
or resolution authority over the administrator for such Benchmark (or such component thereof), which states that the administrator
of such Benchmark (or such component thereof) has ceased or will cease to provide all Available Tenors of such Benchmark (or such
component thereof) permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor
administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the
published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component
thereof) are not, or as of a specified future date will not be, representative.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, a &ldquo;Benchmark Transition Event&rdquo; will be deemed to have occurred with respect to any Benchmark
if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor
of such Benchmark (or the published component used in the calculation thereof).&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benchmark
Unavailability Period</U>&rdquo; means, with respect to the applicable then<FONT STYLE="color: red"><STRIKE>-</STRIKE></FONT>
current Benchmark, the period (if any) (a) beginning at the time that a Benchmark Replacement Date has occurred with respect to
such Benchmark if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and
under any Loan Document in accordance with Section 8.04 and (b) ending at the time that a Benchmark Replacement has replaced the
then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with <U>Section 8.04</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Block
Default</U>&rdquo; means an Event of Default under <U>Sections 6.01(a)</U>, <U>(g)</U> or <U>(h)</U>, or a Default under <U>Sections
5.19</U> or <U>5.20</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Borrower</U>&rdquo;
has the meaning set forth in the preamble to this Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Borrowing
Base</U>&rdquo; means, at the relevant time of reference thereto, an amount equal to the sum of the following items to the extent
that they are classified as &ldquo;assets&rdquo; on the balance sheet of the Borrower in accordance with Generally Accepted Accounting
Principles:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(a)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(1)
</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90% of the aggregate Asset Value of
(A) all Eligible Government Securities plus (B) all Eligible Commercial Paper;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(b)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(2) </STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80%
of the aggregate Asset Value of (A) all Tier 1 Corporate Debt Securities, plus (B) all Eligible GSE Securities, plus (C) all Eligible
OECD Member Nation Debt Securities;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(c)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: red"><STRIKE>(3) </STRIKE></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">75% of the aggregate Asset Value of all Class I Senior Loans;</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(d)</U></FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: red"><STRIKE>(4) </STRIKE></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">70% of the aggregate Asset Value of all Tier 2 Corporate Debt Securities;</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(e)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(5) </STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60%
of the aggregate Asset Value of (A) all Tier 3 Corporate Debt Securities, plus (B) all Class II Senior Loans;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="color: red; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><STRIKE>(6)
50% of the aggregate Asset Value of (A) all Tier 4 Corporate Debt Securities, plus (B) all Class III Senior Loans; </STRIKE></FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>,
however, that</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(a)&nbsp;</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(1)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> if,
but for this clause (1), in excess of 5% of the Borrowing Base value would be attributable to Eligible Securities, Eligible Loan
Obligations, and Eligible Loan Participations of a single Issuer, the amount of such excess shall not be included in the calculation
of the Borrowing Base;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(b)&nbsp;</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(2)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (2), in excess of 10% of the Borrowing Base value would be attributable to Eligible Securities,
Eligible Loan Obligations and Senior Loans of all Issuers (including Issuers of Eligible OECD Member Nation Debt Securities)
located in or formed under the laws of any one Eligible OECD Member Nation (including each political subdivision thereof),
the amount of such excess shall not be included in the calculation of the Borrowing Base;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(c)&nbsp;</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(3)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (3), in excess of 25% of the Borrowing Base value would be attributable to Eligible Securities,
Eligible Loan Obligations and Senior Loans of all Issuers (including Issuers of Eligible OECD Member Nation Debt Securities)
located in or formed under the laws of any Eligible OECD Member Nation (including any political subdivision thereof), the
amount of such excess shall not be included in the calculation of the Borrowing Base;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(d) </STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(4)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (4), in excess of <FONT STYLE="color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>5</U></FONT>%
of the Borrowing Base value would be attributable to <FONT STYLE="color: red"><STRIKE>Eligible Securities rated, subject to
Section 1.04, CCC+ or lower by S&amp;P or Caa1 or lower by Moody&rsquo;s</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>Unquoted
Assets</U></FONT>, the amount of such excess shall not be included in the calculation of the Borrowing Base;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><STRIKE>(e)
if, but for this clause (5), in excess of 10% of the Borrowing Base value would be attributable to Eligible Securities having
a market value that is less than 50% of the par value thereof, the amount of such excess shall not be included in the calculation
of the Borrowing Base;</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><STRIKE>(f)
if, but for this clause (6), in excess of 5% of the Borrowing Base value would be attributable to Unquoted Assets, the amount
of such excess shall not be included in the calculation of the Borrowing Base;</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(g) </STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>(5)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (<FONT STYLE="color: red"><STRIKE>7</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>5</U></FONT>),
in excess of 20% of the Borrowing Base value would be attributable to Single Rated Assets, the amount of such excess shall
not be included in the calculation of the Borrowing Base;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(h) </STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>(6)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (<FONT STYLE="color: red"><STRIKE>8</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>6</U></FONT>),
in excess of 10% of the Borrowing Base value would be attributable to Eligible Debt Securities issued by Eligible Corporate
Issuers domiciled in, and having their respective principal places of business in, any single Eligible Nation other than the
United States of America, the amount of such excess shall not be included in the calculation of the Borrowing Base;
and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>(i) </STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>(7)</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
if, but for this clause (<FONT STYLE="color: red"><STRIKE>9</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>7</U></FONT>),
in excess of 25% of the Borrowing Base value would be attributable to Eligible Debt Securities issued by Eligible Corporate
Issuers domiciled in, and having their respective principal places of business in, any one or more Eligible Nations other
than the United States of America, the amount of such excess shall not be included in the calculation of the Borrowing
Base.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Borrowing
Base Report</U>&rdquo; means a Borrowing Base Report for the Borrower signed by an Authorized Signatory and in substantially the
form of <U>Exhibit D</U> attached hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Borrowing
Date</U>&rdquo; means the Domestic Business Day or Rate Setting Business Day, as the case may be, on which Loans are advanced
hereunder as specified in a Notice of Borrowing delivered pursuant to <U>Section 2.02(a)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Calculation
Date</U>&rdquo; has the meaning set forth in <U>Section 5.01(e)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.5in"><FONT STYLE="color: Red"><STRIKE>&ldquo;<u>Canadian
Dollar</u>&rdquo; and &ldquo;<u>C$</u>&rdquo; each refers to the lawful currency of Canada.</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>&ldquo;<u>CDOR
Rate</u>&rdquo; means, with respect to any Fixed Rate Loan in Canadian Dollars for any Interest Period, the greater of (a) the Floor
and (b) the rate per annum equal to the average of the annual yield rates applicable to Canadian Dollar banker&rsquo;s acceptances
at or about 10:00 a.m. (Toronto, Ontario time) two Rate Setting Business Days prior to the commencement of such Interest Period
as reported on the &ldquo;CDOR page&rdquo; (or any display substituted therefor) of Bloomberg CDOR01 Index (or such other page
or commercially available source displaying Canadian interbank bid rates for Canadian Dollar bankers&rsquo; acceptances as may
be designed by the Agent from time to time) for a term equivalent to such Interest Period (or if such Interest Period is not equal
to a number of months, for a term equivalent to the number of months closest to such Interest Period), or, in the absence of any
such electronically published rate, the rate therefor determined by the Agent (in accordance with prevailing market practice,
if any).</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Charter
Documents</U>&rdquo; means, collectively, the Borrower&rsquo;s Articles of Incorporation and By-laws and all other organizational
or governing documents of the Borrower, in each case as amended, supplemented or otherwise modified from time to time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
I Loan Obligations</U>&rdquo; means, as of any date, Eligible Loan Obligations having a market value of at least 90% of the par
value thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
I Loan Participations</U>&rdquo; means Eligible Loan Participations in Class I Loan Obligations.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
I Senior Loans</U>&rdquo; means Class I Loan Obligations and Class I Loan Participations, in each case (c) that are free and clear
of any Adverse Claim, (d) in which the Agent has, for the benefit of the Agent and the Banks, a first priority perfected security
interest pursuant to the Security Documents, (e) that are not segregated, and (f) that are permitted to be purchased or held by
the Borrower in accordance with the Prospectus and/or the Investment Policies and Restrictions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
II Loan Obligations</U>&rdquo; means, as of any date, Eligible Loan Obligations having a market value of at least <FONT STYLE="color: red"><STRIKE>50</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>60</U></FONT>%
of the par value thereof, other than Class I Loan Obligations.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
II Loan Participations</U>&rdquo; means Eligible Loan Participations in Class II Loan Obligations.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Class
II Senior Loans</U>&rdquo; means Class II Loan Obligations and Class II Loan Participations, in each case (a) that are free and
clear of any Adverse Claim, (b) in which the Agent has, for the benefit of the Agent and the Banks, a first priority perfected
security interest pursuant to the Security Documents, (c) that are not segregated, and (d) that are permitted to be purchased
or held by the Borrower in accordance with the Prospectus and/or the Investment Policies and Restrictions.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><STRIKE>&ldquo;<u>Class
III Loan Obligations</u>&rdquo; means, as of any date, Eligible Loan Obligations having a market value of at least 30% of the par
value thereof, other than Class I Loan Obligations and Class II Loan Obligations.</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><STRIKE>&ldquo;<u>Class
III Loan Participations</u>&rdquo; means Eligible Loan Participations in Class III Loan Obligations.</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><STRIKE>&ldquo;<u>Class
III Senior Loans</u>&rdquo; means Class III Loan Obligations and Class III Loan Participations, in each case (a) that are free and
clear of any Adverse Claim, (b) in which the Agent has, for the benefit of the Agent and the Banks, a first priority perfected
security interest pursuant to the Security Documents, (c) that are not segregated, and (d) that are permitted to be purchased
or held by the Borrower in accordance with the Prospectus and/or the Investment Policies and Restrictions.</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commitment</U>&rdquo;
means the agreement of each Bank, subject to the terms and conditions of this Agreement, to make Loans to the Borrower hereunder.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commitment
Amount</U>&rdquo; means, with respect to each Bank, the amount set forth opposite the name of such Bank on <U>Schedule 1</U> attached
hereto, as such amount may be changed from time to time pursuant to <U>Section 2.08</U> or <U>9.06(c)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commitment
Percentage</U>&rdquo; means, with respect to each Bank, the percentage set forth opposite the name of such Bank on <U>Schedule
1</U> attached hereto (as the same may be amended pursuant to <U>Section 9.06(h)</U>) as such Bank&rsquo;s percentage of the Aggregate
Commitment Amount of all of the Banks.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Confidential
Material</U>&rdquo; has the meaning set forth in <U>Section 9.09(a)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Control
Affiliate</U>&rdquo; of a Person means (a) any other Person directly or indirectly, owning, controlling or holding, with power
to vote, greater than 50% of the outstanding voting securities of such Person, (b) any other Person greater than 50% of whose
outstanding voting securities are directly or indirectly owned, controlled, or held with power to vote, by such Person, or (c)
any Person directly or indirectly controlling, controlled by, or under common control with, such other Person. For purposes of
this defined term, &ldquo;control&rdquo; means the power to exercise a controlling influence over the management or policies of
a company, and &ldquo;controlling&rdquo; and &ldquo;controlled&rdquo; shall have correlative meanings.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Corresponding
Loan Amount</U>&rdquo; has the meaning assigned to such term in Section 7.11.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Corresponding
Tenor</U>&rdquo; with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest
payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Covered
Person</U>&rdquo; has the meaning set forth in <U>Section 9.03(b)</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Credit
Facility</U>&rdquo; means a syndicated or &ldquo;club&rdquo; credit or loan facility for the purposes of making loans.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Custodian</U>&rdquo;
means State Street Bank and Trust Company.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Custody
Agreement</U>&rdquo; means that certain Master Custodian Agreement, dated as of November 30, 2012, among the Custodian, the Borrower
and certain other investment companies, as the same may be amended, restated, supplemented or otherwise modified from time to
time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Daily
Simple SOFR</U>&rdquo; means, for any day, SOFR, with the conventions for this rate (which may include a lookback) being established
by the Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining
 &ldquo;Daily Simple SOFR&rdquo; for syndicated business loans; <U>provided</U>, that if the Agent decides that any such convention
is not administratively feasible for the Agent, then the Agent may establish another convention in its reasonable discretion.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Daily
Simple SONIA</U>&rdquo; means, for any day, <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>the higher of (a) </u></FONT>SONIA, with the conventions for
this rate (which will include a lookback) being established by the Agent in accordance with the conventions for this rate selected
or recommended by the Relevant Governmental Body for determining &ldquo;Daily Simple SONIA&rdquo; for business loans; provided,
that if the Agent decides that any such convention is not administratively feasible for the Agent, then the Agent may establish
another convention in its reasonable discretion<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u> and (b) the Floor</u></FONT>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Danish
Kroners</U>&rdquo; refers to the lawful currency of the Kingdom of Denmark.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Debt</U>&rdquo;
of any Person means at any date, without duplication, (a) all obligations of such Person for borrowed money or extensions of credit,
(b) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (c) all obligations of
such Person to pay the deferred purchase price of property or services, except trade accounts payable arising in the ordinary
course of business and payable in accordance with customary practices, (d) all obligations of such Person as lessee which are
or should be capitalized in accordance with Generally Accepted Accounting Principles, (e) all Indebtedness of others secured by
a Lien on any asset of such Person, whether or not such Indebtedness is assumed or Guaranteed by such Person, (f) all obligations
of such Person under Guarantees, (g) all obligations to reimburse the issuer in respect of letters of credit or under performance
or surety bonds, and other similar obligations, (h) all obligations of such Person in respect of judgments, (i) all obligations
of such Person in respect of banker&rsquo;s acceptances and under reverse repurchase agreements, (j) all obligations of such Person
in respect of Financial Contracts, and (k) all obligations that are Senior Securities Representing Indebtedness of such Person.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Default</U>&rdquo;
means any condition or event which constitutes an Event of Default or which with the giving of notice or lapse of time or both
would, unless cured or waived, become an Event of Default.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Delinquent
Bank</U>&rdquo; has the meaning set forth in <U>Section 7.10(a)</U> hereof.&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Designated
Lending Office</U>&rdquo; means, initially, the office of each Bank designated as such in <U>Schedule 1</U> hereto; and thereafter
such other office of such Bank, if any, that shall be making or maintaining one or more Fixed Rate Loans or Overnight Rate Loans.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Distressed
Asset</U>&rdquo; means any security or Loan Obligation (i) an obligor or issuer of which is the subject of a bankruptcy, insolvency,
liquidation or other similar proceeding, (ii) which is in default beyond the applicable grace period, if any, as to payment (including
by reason of acceleration) of any principal, interest, dividend or other distribution thereon, (iii) that is rated, subject to
<U>Section 1.04</U>, CCC<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>+</U></FONT> or lower by S&amp;P or <FONT STYLE="color: red"><STRIKE>Caa2</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>Caa1</U></FONT> or lower by Moody&rsquo;s, or (iv) which is otherwise classified by the Borrower or the Investment Adviser (or any
sub-adviser) as &ldquo;distressed&rdquo; or &ldquo;non-performing&rdquo;.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dollar
Loan</U>&rdquo; refers to a Loan made in Dollars.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dollars</U>&rdquo;
or &ldquo;<U>$</U>&rdquo; means dollars in lawful currency of the United States of America.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Domestic
Business Day</U>&rdquo; means any day (other than a Saturday or Sunday) on which (a) commercial banks are open for the purpose
of transacting business in Boston, Massachusetts and New York, New York and (b) the New York Stock Exchange is open.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Domestic
Lending Office</U>&rdquo; means, initially, the office of each Bank designated as such on <U>Schedule 1</U> attached hereto; thereafter
such other office of such Bank, if any, located in the United States that shall be making or maintaining Base Rate Loans.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>&euro;STR</U>&rdquo;
means for any day, a fluctuating rate of interest per annum equal to the greater of (a) the Floor and (b) the rate determined
by the Agent in accordance with its then current practice which may be either by reference to (i) the Bloomberg ESTRON Index
as the Euro Short-Term Rate, administered by the European Central Bank (or any other person which takes over the
administration of such rate) at approximately 11:00 a.m., Frankfurt time or (ii) reference to such other publicly available
service for displaying or otherwise determining the EURO Short-Term Rate as may be selected by the Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EEA
Financial Institution</U>&rdquo; means (a) any credit institution or investment firm established in any EEA Member Country which
is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent
of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country
which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision
with its parent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EEA
Member Country</U>&rdquo; means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EEA
Resolution Authority</U>&rdquo; means any public administrative authority or any person entrusted with public administrative authority
of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the date this Agreement becomes effective in accordance with <U>Section 3.01</U>&nbsp;hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Electronic
Platform</U>&rdquo; means an electronic system for the delivery of information (including, without limitation, documents), such
as IntraLinks On-Demand Workspaces&trade;, that may or may not be provided or administered by the Agent or an Affiliate thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Commercial Paper</U>&rdquo; means a note (a) constituting an Eligible Debt Security, (b) of an Eligible Corporate Issuer, (c)
having a maturity of 270 days or less, (d) rated, subject to <U>Section 1.04</U>, A1 or better by S&amp;P or P1 or better by Moody&rsquo;s,
(e) denominated in an Eligible Currency, and (f) with respect to which there are recognized broker-dealers located in one or more
Eligible Nations that make a market in such note.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Corporate Debt Securities</U>&rdquo; means Eligible Debt Securities (a) issued by an Eligible Corporate Issuer, (b) denominated
in an Eligible Currency, and (c) with respect to which there are recognized broker-dealers located in one or more Eligible Nations
that make a market in such Eligible Debt Securities.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Corporate Issuer</U>&rdquo; means an issuer of debt securities domiciled in, and having its principal place of business in, an
Eligible Nation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Credit Facility</U>&rdquo; means a Credit Facility (a) in which the sum of the aggregate revolving loan commitment amount plus
the aggregate outstanding principal amount of all loans (other than revolving loans) under such Credit Facility on the origination
date of such Credit Facility was at least equal to $100,000,000, and (b) in respect of which <FONT STYLE="color: red"><STRIKE>(1)
</STRIKE></FONT>neither the related administrative agent nor any Control Affiliate thereof (i) is subject to any bankruptcy or
other insolvency proceeding, or (ii) has stated in writing that it will not perform its obligations, if any, under the relevant
Credit Facility documents<FONT STYLE="color: red"><STRIKE>, and (2) the credit rating, subject to <u>Section 1.04</u>, of the related
administrative agent or its Control Affiliate is no less than &ldquo;A-&rdquo; from S&amp;P or &ldquo;A3&rdquo; from Moody&rsquo;s</STRIKE></FONT>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Currency</U>&rdquo; means Dollars, any Alternate Currency, Japanese Yen, Swiss Francs, Norwegian Kroners, Swedish Kronas, or Danish
Kroners.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Debt Securities</U>&rdquo; means Eligible Securities that are debt securities, including, without limitation, corporate bond obligations;
<U>provided</U>&nbsp;<U>that</U> Eligible Debt Securities shall not include any asset that is a direct or indirect participation
or subparticipation interest in or assignment or novation of a loan or other extension of credit that is not a corporate bond
obligation.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
Government Securities</U>&rdquo; means Eligible Debt Securities issued by, and backed by the full faith and credit of, the United
States of America.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Eligible
GSE Securities</U>&rdquo; means Eligible Debt Securities (a) issued by any GSE, and (b) rated, subject to <U>Section 1.04</U>,
BBB- or better by S&amp;P or Baa3 or better by Moody&rsquo;s.&nbsp;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
Loan Obligation</U>&rdquo; means, as of any date, a Loan Obligation (a) of an Eligible Obligor, (b) that is part of an Eligible
Credit Facility, (c) that represents not more than 25% of such Eligible Credit Facility, (d) that is not a Distressed Asset, (e)
denominated, payable and traded in an Eligible Currency in an Eligible Nation, (f) [reserved], (g) which is priced daily by a recognized
independent third-party provider acceptable to the Agent, (h) the interest with respect to which is payable in cash (with no &ldquo;PIK
option&rdquo;) no less frequently than quarterly, (i) which has a scheduled final maturity date no later than the tenth anniversary
after the origination date of such Eligible Credit Facility, (j) which is not by its terms subordinated (pursuant to contractual
provisions) to the prior payment of any other liabilities or any equity interests of such Eligible Obligor or any other the related
obligor thereon, (k) in which the interest of the holder of such Loan Obligation in all collateral security therefor and principal
and interest payments thereunder is no less than pro rata and pari passu with all other lenders in the particular tranche of which
such Loan Obligation is a part, (l) that is permitted to be transferred to any commercial bank, insurance company, investment or
mutual fund or other entity that is an &ldquo;accredited investor&rdquo; (as defined in Regulation D under the Securities Act)
with or without the consent of such Eligible Obligor or the administrative agent under the related Eligible Credit Facility, (m)
in respect of which the related loan documents are not subject to any confidentiality arrangement that would preclude the Agent
from reviewing such loan documents, and (n) in respect of which such Eligible Credit Facility does not allow, without the consent
of the holder of such Loan Obligation, (i) any reduction of the principal amount of such Loan Obligation, or any reduction of the
rate of any interest, or any fees, payable on account of such Loan Obligation, (ii) the postponement of the final maturity date,
or the date of any payment, for any part of such Loan Obligation or any interest or fees payable in respect of such Loan Obligation,
or any reduction of the amount of, or waiver or excuse of, any payment in respect of such Loan Obligation, (iii) changing any provision
of such Eligible Credit Facility in a manner that would alter the pro rata sharing of payments required thereby, (iv) changing
any provision of such Eligible Credit Facility specifying the number or percentage of lenders thereunder required to waive, amend,
supplement or otherwise modify any rights under such Eligible Credit Facility, or (v) releasing all or substantially all of the
collateral, if any, for such Loan Obligation, and (o) in respect of which the related loan documents are not subject to any confidentiality
arrangement (that has not been waived) that would preclude the Agent from reviewing such loan documents.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
Loan Participation</U>&rdquo; means a Loan Participation (a) in an Eligible Loan Obligation, (b) issued or sold by an Eligible
Loan Participation Counterparty, (c) traded in an Eligible Currency in an Eligible Nation, (d) for which recognized broker-dealers
located an Eligible Nation make a market, (e) that is permitted to be transferred to any commercial bank, insurance company, investment
or mutual fund or other entity that is an &ldquo;accredited investor&rdquo; (as defined in Regulation D under the Securities Act)
with or without the consent of such Eligible Loan Participation Counterparty, and (f) in which the Borrower&rsquo;s interest is
not a sub-participation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
Loan Participation Counterparty</U>&rdquo; means a Loan Participation Counterparty (a) which is domiciled in, and has its principal
place of business in, an Eligible Nation<FONT STYLE="color: red"><STRIKE>,</STRIKE></FONT>&nbsp;<FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>or</U></FONT>&nbsp;(b)
in respect of which neither such Loan Participation Counterparty nor any Control Affiliate thereof (1) is subject to any bankruptcy
or other insolvency proceeding, (2) has stated in writing that it will not perform its obligations, if any, under the relevant
Loan Participation or relevant Credit Facility, or (3) is in default of any material obligation under such Loan Participation
or such Credit Facility<FONT STYLE="color: red"><STRIKE>, and (c) the credit rating, subject to <u>Section 1.04</u>, of which (or of
its Control Affiliate) is no less than &ldquo;A-&rdquo; from S&amp;P or &ldquo;A3&rdquo; from Moody&rsquo;s</STRIKE></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 32; Options: NewSection; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Eligible Nation</U>&rdquo; means the United
States of America or any Eligible OECD Member Nation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
Obligor</U>&rdquo; means a for-profit business enterprise which is domiciled in, and has its principal place of business in, an
Eligible Nation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
OECD Member Nation</U>&rdquo; means any OECD Member Nation (other than the United States of America) having a sovereign long-term
debt rating, subject to <U>Section 1.04</U>, in a non-local currency of not less than &ldquo;Baa3&rdquo; by Moody&rsquo;s or &ldquo;BBB-&rdquo;
by S&amp;P.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Eligible
OECD Member Nation Debt Securities</U>&rdquo; means Eligible Debt Securities (a) issued by any Eligible OECD Member Nation, and
(b) rated, subject to <U>Section 1.04</U>, BBB- or better by S&amp;P or Baa3 or better by Moody&rsquo;s.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">&ldquo;<U>Eligible Securities</U>&rdquo; means
securities (and not Loan Obligations or Loan Participations) (a) that are publicly traded or Rule 144A Securities, (b) that
are unrestricted as to sale (Rule 144A Securities that are freely traded among &ldquo;qualified Institutional buyers&rdquo;
(within the meaning of Rule 144A) shall not be deemed to be restricted as to sale solely as a result of the restrictions and
other limitations on transfer and offers to transfer contained in the Securities Act), (c) that are free and clear of any
Adverse Claim, (d) in which the Agent has, for the benefit of the Agent and the Banks, a first priority perfected security
interest pursuant to the Security Documents, (e) that are not the subject of a reverse repurchase agreement, dollar roll,
securities lending transaction or otherwise segregated to satisfy any obligations with respect thereto, and (f) that are
permitted to be purchased or held by the Borrower in accordance with the Prospectus and/or the Investment Policies and
Restrictions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Enhanced
 &euro;STR</U>&rdquo; means, for any day, the sum of (i) &euro;STR and (ii) the EONIA-&euro;STR Spread; provided that if such rate
is less than zero, Enhanced &euro;STR shall be deemed to be zero.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>EONIA-&euro;STR
Spread</U>&rdquo; means, for any day, (a) the percentage rate per annum which is, or remains, published on such day as the &ldquo;EONIA-&euro;STR
spread&rdquo; by the European Central Bank, or (b) if no such rate is, or remains, published on such day, the percentage rate per
annum which was the &ldquo;EONIA-&euro;STR spread&rdquo; most recently published by the European Central Bank.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ERISA</U>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended, or any successor statute.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ERISA
Group</U>&rdquo; means, with respect to the Borrower, the Borrower and all members of a controlled group of corporations and all
trades or businesses (whether or not incorporated) under common control which, together with the Borrower, are treated as a single
employer under Section 414 of the Internal Revenue Code.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>








<!-- Field: Page; Sequence: 33; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Erroneous Payment</U>&rdquo; has the meaning
assigned to such term in <U>Section 7.11</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Erroneous
Payment Return Deficiency</U>&rdquo; has the meaning assigned to such term in <U>Section 7.11</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Erroneous
Payment Subrogation Rights</U>&rdquo; has the meaning assigned to such term in <U>Section 7.11</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>EU Bail-In
Legislation Schedule</U>&rdquo; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor
person), as in effect from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>EURIBOR Loans</U>&rdquo;
means Loans denominated in Euros and bearing interest calculated by reference to the Funding Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Euro Overnight
Rate Loan</U>&rdquo; means a Loan denominated in Euros and bearing interest calculated by reference to the Overnight Interest Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Euros</U>&rdquo; refers to the single currency
of participating member states of the European Union.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Events of Default</U>&rdquo; has the meaning
set forth in <U>Section 6.01</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Excess Percentage</U>&rdquo; means 103%.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC thereunder, as modified
or interpreted by orders of the SEC, or other interpretative releases or letters issued by the SEC or its staff, all as from time
to time in effect, or any successor law, rules or regulations, and any reference to any statutory or regulatory provision shall
be deemed to be a reference to any successor statutory or regulatory provision.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Failure</U>&rdquo; has the meaning set forth
in <U>Section 7.10(b)</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FATCA</U>&rdquo;
means Sections 1471 through 1474 of the Internal Revenue Code, as of the Effective Date (or any amended or successor version that
is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations
thereof (provided such regulations or official interpretations are substantively comparable and not materially more onerous to
comply with).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Fed Funds
Business Day</U>&rdquo; shall mean any day upon which overnight federal funds transactions are conducted.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal
Funds Effective Rate</U>&rdquo; shall mean, for any day, the <FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>higher
of (a) the </U></FONT>rate per annum calculated by the FRBNY, based on such day&rsquo;s overnight federal funds transactions
(as determined in such manner as the FRBNY shall set forth on its public website from time to time), as the federal funds
effective rate (which rate is, in general, published by the FRBNY on the FRBNY Business Day immediately succeeding such day),
provided that if such day is not a Fed Funds Business Day, then the Federal Funds Effective Rate shall be such rate as in
effect on the Fed Funds Business Day immediately preceding such day<FONT STYLE="color: red"><STRIKE>, provided further that
if the Federal Funds Effective Rate as so determined for any day would be less than</STRIKE></FONT>&nbsp;<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>and
(b)</U></FONT> the Floor<FONT STYLE="color: red"><STRIKE>, such rate for such day shall be deemed to be the Floor for all
purposes of this Agreement</STRIKE></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 34; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Financial
Contract Liability</U>&rdquo; means, at any time, the net amount of the liability, if any, that a Person has under each Financial
Contract to which such Person is a party, in each case determined on a mark-to-market basis in accordance with Generally Accepted
Accounting Principles.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Financial
Contracts</U>&rdquo; means option contracts, options on futures contracts, futures contracts, forward contracts, options on foreign
currencies, foreign currency contracts, repurchase agreements, reverse repurchase agreements, mortgage rolls, credit-linked notes,
indexed securities, collateralized debt obligations, firm and standby commitment agreements, securities lending agreements, when-issued
contracts and securities, swap, swaption, floor, cap, or collar agreements, other similar arrangements and other obligations that
would be, but for the segregation of assets thereof, Senior Securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Fixed
Rate Loan</U>&rdquo; means a SOFR Loan or an Alternate Currency Loan (other than an Overnight Rate Loan).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Floor</U>&rdquo; means a rate of interest
equal to 0.0%.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Foreign
Bank</U>&rdquo; means any Bank that is organized under the laws of a jurisdiction other than that in which the Borrower is resident
for tax purposes. For purposes of this definition, the United States, each State thereof and the District of Columbia shall be
deemed to constitute a single jurisdiction.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FRBNY</U>&rdquo;
shall mean the Federal Reserve Bank of New York, or any successor thereto that publishes the Federal Funds Effective Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FRBNY
Business Day</U>&rdquo; shall mean each business day that is not included in the FRBNY&rsquo;s holiday schedule.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Funding Rate</U>&rdquo; means, with respect
to any Fixed Rate Loan for any Interest Period:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the event such Fixed Rate Loan is a SOFR Loan, Adjusted Term SOFR or, in the absence of Adjusted Term SOFR the greater of (i)
the Floor and (ii) the then applicable Benchmark <U>provided</U> that if such Benchmark is an Unadjusted Benchmark Replacement
then the Funding Rate shall include the applicable Benchmark Replacement Adjustment;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the event such Fixed Rate Loan is a EURIBOR Loan, for any Interest Period, the greater of (x) the Floor and (y) the
rate appearing on the Bloomberg &ldquo;EURIBOR01&rdquo; screen displaying the euro interbank offered rate administered by
the European Money Markets Institute (or any other person which takes over the administrative of that rate) at
approximately 11:00 a.m. Frankfurt time two Rate Setting Business Days prior to the commencement of such Interest Period
prior to the commencement of such Interest Period with a term equivalent to such Interest, or, in the absence of any such
electronically published rate, the rate therefor determined by the Agent (in accordance with prevailing market practice, if
any);<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u> and</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>&nbsp;</U></FONT></P>




<!-- Field: Page; Sequence: 35; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; color: red">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; color: red"><STRIKE>(c) in the event such Fixed Rate
Loan is in Canadian Dollars, the CDOR Rate; and</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; color: red">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(c)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: red"><STRIKE>(d) </STRIKE></FONT>in the event such Fixed Rate Loan is in Australian Dollars the
greater of (i) the Floor and (ii), the rate per annum equal to the Bank Bill Swap Reference Bid rate or a successor thereto approved
by the Agent (&ldquo;BBSY&rdquo;) as published by Bloomberg (or such other page or commercially available source providing BBSY
(Bid) quotations as may be designated by the Agent from time to time) at or about 10:30 a.m. (Melbourne, Australia time) two Rate
Setting Business Days prior to the commencement of such Interest Period with a term equivalent to such Interest Period (or if such
Interest Period is not equal to a number of months, with a term equivalent to the number of months closet to such Interest Period),
or, in the absence of any such electronically published rate, the rate therefor determined by the Agent (in accordance with prevailing
market practice, if any).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Generally Accepted Accounting Principles</U>&rdquo;
has the meaning set forth in <U>Section 1.02</U>&nbsp;hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Government</U>&rdquo;
means, with respect to any sovereignty, the government or any agency or instrumentality thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Governmental
Authorizations</U>&rdquo; means all franchises, permits, licenses, approvals, consents and other authorizations of all Authorities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Governmental
Filings</U>&rdquo; means all filings, including franchise and similar tax filings, and the payment of all fees, assessments, interests
and penalties associated with such filing, with all Authorities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GSE</U>&rdquo;
means the Government National Mortgage Association, the Federal National Mortgage Association and the Federal Home Loan Mortgage
Corporation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Guarantee</U>&rdquo;
by any Person means any obligation, contingent or otherwise, of such Person directly or indirectly guaranteeing any Indebtedness
of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise,
of such Person (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness(whether arising
by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay,
or to maintain financial statement conditions or otherwise) or (b) entered into for the purpose of assuring in any other manner
the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or
in part), <U>provided</U> that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course
of business. The term &ldquo;Guarantee&rdquo; used as a verb has a corresponding meaning.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
of any Person means at any date, without duplication, (a) all Debt of such Person, and (b) all Senior Securities issued by such
Person.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>








<!-- Field: Page; Sequence: 36; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Interest
Period</U>&rdquo; means, with respect to each borrowing of Fixed Rate Loans of the same currency, initially the period commencing
on the date of such borrowing and (i) in the case of a SOFR Loan, ending one month thereafter and (ii) in the case of an Alternate
Currency Loan (other than an Overnight Rate Loan) ending one or three months thereafter, as the Borrower may elect in the applicable
Notice of Borrowing, and thereafter, each period commencing on the last day of the next preceding Interest Period applicable to
such borrowing and ending on the last day of one of the periods set forth above, as the Borrower may elect in the applicable Notice
of Conversion, <U>provided</U>&nbsp;<U>that</U>:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Interest Period which would otherwise end on a day which is not a Rate Setting Business Day shall be extended to the next succeeding
Rate Setting Business Day unless such Rate Setting Business Day falls in another calendar month, in which case such Interest Period
shall end on the next preceding Rate Setting Business Day;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Interest Period which begins on the last Rate Setting Business Day of a calendar month (or on a day for which there is no numerically
corresponding day in the calendar month at the end of such Interest Period) shall end on the last Rate Setting Business Day of
a calendar month;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Interest Period which would otherwise end after the Termination Date shall instead end on the Termination Date; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no tenor that has been removed from this definition pursuant to Section 8.04(e) shall be available for specification in such Notice
of Borrowing.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">For purposes
hereof, the date of a Loan initially shall be the date on which such Loan is made and thereafter shall be the effective date of
the most recent conversion or continuation of such Loan.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Internal
Revenue Code</U>&rdquo; means the Internal Revenue Code of 1986, as amended, or any successor statute and the Treasury regulations
promulgated thereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Investment
Adviser</U>&rdquo; means Ares Capital Management II LLC, a limited liability company organized under the laws of Delaware.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Investment
Company Act</U>&rdquo; means the Investment Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder,
as modified or interpreted by orders of the SEC, or other interpretative releases or letters issued by the SEC or its staff, all
as from time to time in effect, or any successor law, rules or regulations, and any reference to any statutory or regulatory provision
shall be deemed to include a reference to any successor statutory or regulatory provision.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Investment
Policies and Restrictions</U>&rdquo; means, with respect to the Borrower, the material provisions of the Prospectus (as delivered
to the Banks on the Effective Date), and other documents dealing with the Borrower&rsquo;s investment objectives, investment policies
and strategies, and investment restrictions, as such objectives, policies, strategies and restrictions may be further amended,
supplemented or otherwise modified in accordance with Applicable Law, including without limitation, the Securities Act, Securities
Exchange Act of 1934, as amended, and the Investment Company Act, all as in effect on the Amendment Effective Date.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 37; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Involuntary
Liquidation Preference</U>&rdquo; has the meaning set forth in the last sentence of Section 18(h) of the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Issuer</U>&rdquo;
means (a) an issuer of securities, (b) an Eligible Obligor, or (c) a Loan Participation Counterparty.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Japanese Yen</U>&rdquo; refers to the lawful
currency of Japan.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Law</U>&rdquo;
means any action, code, consent decree, constitution, decree, directive, enactment, finding, guideline, law, injunction, interpretation,
judgment, order, ordinance, policy statement, proclamation, promulgation, regulation, requirement, rule, rule of law, rule of public
policy, settlement agreement, statute, or writ, of any Authority, or any particular section, part or provision thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Liabilities</U>&rdquo; has the meaning set
forth in <U>Section 7.05</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lien</U>&rdquo;
means, with respect to any asset, any mortgage, lien, pledge, charge, security interest (statutory or other) or encumbrance of
any kind in respect of such asset, or any preference, priority or other security or preferential arrangement of any kind or nature
whatsoever (including, without limitation, any conditional sale or other title retention agreement or any financing lease having
substantially the same economic effect as any of the foregoing) with respect to such asset, including any agreement (other than
this Agreement) preventing a Person from encumbering such asset.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liquidity
Account</U>&rdquo; means all assets of the Borrower which are segregated, delivered to a transfer agent or escrow agent, or otherwise
designated for the payment of the Involuntary Liquidation Preference or redemptions or dividends in connection with the Preferred
Shares whether held in a separate account, or earmarked on its (or the Custodian&rsquo;s) books and records or otherwise in accordance
with the Borrower&rsquo;s (or the Custodian&rsquo;s) normal procedures.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>&ldquo;Loan
Balance&rdquo; means, on any date of determination, an amount equal to the aggregate outstanding principal balance of the Loans.</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Loan
Documents</U>&rdquo; means, collectively, this Agreement, the Notes, the Security Documents, the fee agreement (if any) described
in <U>Section 2.07(b)</U> hereof and any and all other documents and instruments required to be delivered pursuant to this Agreement,
in each case as amended, restated, supplemented or otherwise modified from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Loan
Obligation</U>&rdquo; means a debt obligation other than a security (as defined in the Securities Act).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Loan
Participation</U>&rdquo; means a participation interest (other than a sub-participation interest) in a Loan Obligation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>








<!-- Field: Page; Sequence: 38; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Loan Participation Counterparty</U>&rdquo;
means the seller or issuer of a Loan Participation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>Loans</U>&rdquo; means
loans made or to be made to the Borrower by the Banks pursuant to <U>Section 2.01 </U>hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Managing
Body</U>&rdquo; means (a) with respect to the Borrower, the Board of Directors thereof, and (b) with respect to any other Person,
the board of directors or other similar managing body thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Margin Stock</U>&rdquo; has the meaning
assigned to such term in Regulation U.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; means (a) a material adverse effect on the ability of the Borrower to fully perform its obligations under
this Agreement or any of the other Loan Documents, (b) a material adverse effect on the Agent&rsquo;s right, title and interest,
on behalf of itself and the Banks, in the collateral pledged to it pursuant to the Security Documents, or on the rights and remedies
of the Agent or any Bank under this Agreement or under any of the other Loan Documents, (c) a material adverse effect on the validity
or enforceability of this Agreement or any of the other Loan Documents, or (d) a material adverse effect on the business, financial
position, operations or assets of the Borrower or the Investment Adviser.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Maximum Amount</U>&rdquo; means, as at
any date of determination, an amount equal to the least of:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(a)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: red"><STRIKE>(1) </STRIKE></FONT>the maximum amount of Debt that the Borrower would be permitted to
incur pursuant to Applicable Law, including the Investment Company Act,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(b)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: red"><STRIKE>(2) </STRIKE></FONT>the maximum amount of Debt that the Borrower would be permitted to
incur pursuant to the limitations on borrowings in its Prospectus and the Investment Policies and Restrictions,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(c)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: Red"><STRIKE>(3) </STRIKE></FONT>in the event that the Borrower shall have entered into any agreement(s) with any Authority
limiting the amount of Debt that the Borrower may create, incur, assume or suffer to exist, the maximum amount of Debt that the
Borrower would be permitted to create, incur, assume or suffer to exist pursuant to such agreements, and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>(d)</U></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: red"><STRIKE>(4) </STRIKE></FONT>the maximum amount of Debt that the Borrower would be permitted to
incur without violating Section 5.19 hereof;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">in each case, as in effect at such date of determination.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Moody&rsquo;s</U>&rdquo;
means Moody&rsquo;s Investors Services, Inc., or any successor acceptable to all of the Banks and performing substantially the
same function.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>&ldquo;MSC
Obligations&rdquo; has the meaning assigned to such term in that certain Amendment No. 3 and Consent No. 1, dated as of August
31, 2015, by and among the Borrower, the Banks party thereto and the Agent.</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: blue; border-bottom: Blue 1pt solid">&nbsp;</FONT> </P>






<!-- Field: Page; Sequence: 39; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Multiemployer
Plan</U>&rdquo; means at any time an employee pension benefit plan within the meaning of Section 4001(a)(3) of ERISA to which any
member of the ERISA Group is then making or accruing an obligation to make contributions or has within the preceding five plan
years made contributions, including for these purposes any Person which ceased to be a member of the ERISA Group during such five
year period.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 39pt">&ldquo;<U>Non-Excluded Taxes</U>&rdquo; has the meaning
set forth in <U>Section 2.09(c)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 39pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Norwegian Kroners</U>&rdquo; refers to the
lawful currency of the Kingdom of Norway.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Note(s)</U>&rdquo; has the meaning set forth
in <U>Section 2.04(b)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Notice of Borrowing</U>&rdquo; has the meaning
set forth in <U>Section 2.02(a)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Notice of Conversion</U>&rdquo; has the
meaning set forth in <U>Section 2.02(b)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Notice of Repayment</U>&rdquo; has the meaning
set forth in <U>Section 2.05(g)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Obligations</U>&rdquo;
means all indebtedness, obligations and liabilities of the Borrower to the Banks and the Agent, existing on the date of this Agreement
or arising thereafter, direct or indirect, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or
unsecured, arising or incurred under this Agreement or any of the other Loan Documents or in respect of any of the Loans to the
Borrower or any of the Notes or other instruments at any time evidencing any thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>OECD Member
Nation</U>&rdquo; means a member nation of the Organization for Economic Co-operation and Development.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Overnight
Interest Rate</U>&rdquo; means (a) with respect to any Euro Overnight Rate Loan, as of any day, the Applicable Loan Rate plus Enhanced
 &euro;STR as in effect on such day, and (b) with respect to any Sterling Overnight Rate Loan, as of any day, the Applicable Loan
Rate plus Daily Simple SONIA as in effect on such day.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Overnight Rate Loan</U>&rdquo; means a
Euro Overnight Rate Loan or a Sterling Overnight Rate Loan.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Payment Recipient</U>&rdquo; has the meaning
assigned to such term in Section 7.11.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Patriot Act</U>&rdquo; has the meaning set
forth in <U>Section 9.10</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual, a corporation, a partnership, a limited liability company, an association, a trust (or series thereof) or
any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan</U>&rdquo;
means at any time an employee pension benefit plan (other than a Multiemployer Plan) which is covered by Title IV of ERISA
or subject to the minimum funding standards under Section 412 of the Internal Revenue Code and either (a) is maintained, or
contributed to, by any member of the ERISA Group for employees of any member of the ERISA Group or (b) has at any time within
the preceding five years been maintained, or contributed to, by any Person which was at such time a member of the ERISA Group
for employees of any Person which was at such time a member of the ERISA Group.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 40; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Potential
Delinquent Bank</U>&rdquo; means, at any time a Bank (i) as to which the Agent has notified the Borrower that a Failure has occurred
and is continuing in respect of any financial institution Control Affiliate of such Bank, (ii) as to which the Agent has in good
faith reasonably determined and notified the Borrower that such Lender or a financial institution Control Affiliate thereof has
notified the Agent, or has stated publicly, that it will not comply with its funding obligations under any other loan agreement
or credit agreement or similar financing arrangement or agreement, or (iii) that has, or whose parent company has, a rating for
any class of its long-term senior unsecured debt lower than BBB- by S&amp;P or Baa3 by Moody&rsquo;s. The Agent shall promptly
send to all parties hereto a copy of any notice sent to the Borrower provided in this definition.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Pounds Sterling</U>&rdquo; refers to the
lawful currency of the United Kingdom.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preferred
Shares</U>&rdquo; means, collectively, the Borrower&rsquo;s (i) &ldquo;Series A Mandatory Redeemable Preferred Shares&rdquo; with
liquidation preference of $25.00 per share and to consist of 800,000 shares, (ii) &ldquo;Series B Mandatory Redeemable Preferred
Shares&rdquo; with a liquidation preference of $25.00 per share and to consist of 1,200,000 shares, and (iii) &ldquo;Series C Mandatory
Redeemable Preferred Shares&rdquo; with a liquidation preference of $25.00 per share and to consist of 2,000,000 shares.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preferred
Shares Documents</U>&rdquo; means (i) each Securities Purchase Agreement, (ii) the Articles Supplementary, and (iii) the Borrower&rsquo;s
Charter Documents, in each case (subject to Section 5.24) as amended, supplemented, or otherwise modified from time to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pricing
Procedures</U>&rdquo; means the Borrower&rsquo;s pricing and valuation procedures attached hereto as <U>Schedule 2</U>, as the
same may be amended, restated, supplemented or otherwise modified in accordance with <U>Section 5.04</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Private
Authorizations</U>&rdquo; means all franchises, permits, licenses, approvals, consents and other authorizations of all Persons
(other than any Authority) including, without limitation, those of shareholders and creditors and those with respect to trademarks,
service marks, trade names, copyrights, computer software programs, technical and other know-how.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the Borrower&rsquo;s prospectus dated as of June 15, 2015, as filed with the SEC pursuant to Rule 497 under the Securities
Act, as part of the Borrower&rsquo;s registration statement on Form N-14 (applying the policies stated therein as approved by
the stockholders of the Borrower), as the statements therein may be amended, restated, supplemented or otherwise modified, including
without limitation by means of a filing made pursuant to the Securities Exchange Act of 1934, as amended, a press release or otherwise,
as in effect on the Amendment 3 Effective Date.&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 41; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>Rate Setting Business
Day</U>&rdquo; means any Domestic Business Day that is also a U.S. Securities Business Day, <U>provided</U> that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if such day relates to any interest rate settings as to a Loan denominated in Euros, any fundings, disbursements, settlements and
payments in Euros in respect of any such Loan, or any other dealings in Euros to be carried out pursuant to this Agreement in respect
of any such Loan, Rate Setting Business Day means a Domestic Business Day on which commercial banks are open for international
business (including dealings in Dollar deposits) in Frankfurt and is a TARGET Day;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if such day relates to any interest rate settings as to a Loan denominated in a currency other than Dollars or Euro, Rate Setting
Business Day means any such day on which commercial banks are open for international business (including dealings in Dollar deposits)
in London and dealings in deposits in the relevant currency are conducted by and between banks in the London or other applicable
offshore interbank market for such currency; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if such day relates to any fundings, disbursements, settlements and payments in a currency other than Dollars or Euros in respect
of a Loan denominated in a currency other than Dollars or Euros, or any other dealings in any currency other than Dollars or Euros
to be carried out pursuant to this Agreement in respect of any such Loan (other than any interest rate settings), means any such
day on which banks are open for foreign exchange business in the principal financial center of the country of such currency.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Rate Unavailability Notice</U>&rdquo; has
the meaning set forth in Section 8.02(a) hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Register</U>&rdquo; has the meaning set
forth in <U>Section 9.06(g)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Regulated
Investment Company</U>&rdquo; has the meaning set forth in Subchapter M of the Internal Revenue Code.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Regulation
T</U>&rdquo; means Regulation T of the Board of Governors of the Federal Reserve System, as in effect from time to time, and all
official rulings and interpretations thereunder and thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Regulation
U</U>&rdquo; means Regulation U of the Board of Governors of the Federal Reserve System, as in effect from time to time, and all
official rulings and interpretations thereunder and thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Regulation
X</U>&rdquo; means Regulation X of the Board of Governors of the Federal Reserve System, as in effect from time to time, and all
official rulings and interpretations thereunder and thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Relevant
Governmental Body</U>&rdquo; means (a) with respect to all Loans, the Federal Reserve Board or the Federal Reserve Bank of
New York, or a committee officially endorsed or convened by the Federal Reserve Board or the Federal Reserve Bank of New
York, or any successor thereto, and (b) with respect to any Alternate Currency Loan, the applicable Alternate Currency
Regulatory Body.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 42; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Replacement Bank</U>&rdquo; has the meaning
set forth in <U>Section 8.06</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Representatives</U>&rdquo; has the meaning
set forth in <U>Section 9.09(a)</U> hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Banks</U>&rdquo; means, at any time, Banks holding at least a majority of the aggregate unpaid principal amount of the Loans at
such time or, if no Loans are then outstanding, having at least a majority of the aggregate Commitment Amounts then in effect;
<U>provided</U> that at any time that there are two or fewer Banks, &ldquo;Required Banks&rdquo; means all of the Banks, <U>provided</U>&nbsp;<U>further</U> that for purposes of determining Required Banks, each Delinquent Bank (including, without limitation, its Commitment
Amount and Loans) shall be disregarded for so long as such Bank remains a Delinquent Bank.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Reserve
Percentage</U>&rdquo; means, for any day, that percentage (expressed as a decimal) which is in effect on such day, at which any
lender subject thereto would be required to maintain reserves under Regulation D of the Board of Governors of the Federal Reserve
System (or any successor or similar regulations relating to such reserve requirements) against &ldquo;Eurocurrency Liabilities&rdquo;
(as that term is used in Regulation D), if such liabilities were outstanding.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Resolution
Authority</U>&rdquo; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Restricted
Payment</U>&rdquo; means (a) any dividend or other distribution by the Borrower (whether in cash, securities or other property)
with respect to any shares, units or other equity interests issued by the Borrower, and (b) any payment (whether in cash, securities
or other property), including any sinking fund or similar deposit, by the Borrower on account of the purchase, redemption, retirement,
acquisition, cancellation or termination of any such shares, units or other equity interests.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Revolving
Credit Period</U>&rdquo; means the period from and including the Effective Date to but excluding the Termination Date.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&ldquo;<U>Rule 144A</U>&rdquo; means Rule 144A under
the Securities Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&ldquo;<U>Rule 144A Securities</U>&rdquo; means securities
issued in reliance on Rule 144A.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">&ldquo;<U>S&amp;P</U>&rdquo; means Standard
 &amp; Poor&rsquo;s, a division of The McGraw Hill Companies, Inc., or any successor acceptable to all the Banks and performing
substantially the same function.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&ldquo;<U>Sanctions</U>&rdquo; has the meaning set
forth in Section 4.16(a).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC</U>&rdquo;
means the Securities and Exchange Commission or any other governmental authority of the United States of America at the time administering
the Securities Act, the Investment Company Act or the Exchange Act.&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<!-- Field: Page; Sequence: 43; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations of the SEC thereunder, as modified or
interpreted by orders of the SEC, or other interpretative releases or letters issued by the SEC or its staff, all as from time
to time in effect, or any successor law, rules or regulations, and any reference to any statutory or regulatory provision shall
be deemed to be a reference to any successor statutory or regulatory provision.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Purchase Agreement</U>&rdquo; means that certain Securities Purchase Agreement dated on or about July 15, 2021 (as may be amended,
restated, supplemented or modified from time to time), by and between the Borrower and each of the purchasers listed in the &ldquo;Purchaser
Schedule&rdquo; attached thereto.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Security
Agreement</U>&rdquo; means that certain Security Agreement, dated as of the date hereof, among the Borrower, the Custodian and
the Agent, on behalf of itself and the Banks, as the same may be amended, restated, supplemented or otherwise modified from time
to time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Security
Documents</U>&rdquo; means, collectively, the Security Agreement and all other instruments and documents, including, without limitation,
Uniform Commercial Code financing statements, required to be executed or delivered pursuant to the Security Agreement or under
Applicable Law.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Senior
Loan</U>&rdquo; means a Class I Senior Loan<FONT STYLE="color: red"><STRIKE>,</STRIKE></FONT>&nbsp;<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>or</U></FONT>
a Class II Senior Loan<FONT STYLE="color: red"><STRIKE>, or a Class III Senior Loan</STRIKE></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Senior
Securities Representing Indebtedness</U>&rdquo; has the meaning set forth in the first sentence of Section 18(g) of the Investment
Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Senior
Security</U>&rdquo; has the meaning set forth in the first sentence of Section 18(g) of the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Serial
Unquoted Asset</U>&rdquo; means, as of any date, any asset that for three (3) or more consecutive Domestic Business Days ending
on such date, was an Unquoted Asset.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Single
Rated Asset</U>&rdquo; means any Eligible Commercial Paper, Eligible GSE Security, Eligible OECD Member Nation Debt Security, Tier
1 Corporate Debt Security, Tier 2 Corporate Debt Security, <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>or </U></FONT>Tier 3 <FONT STYLE="color: red"><STRIKE>Corporate
Debt Security, or Tier 4 </STRIKE></FONT>Corporate Debt Security which is not rated by both S&amp;P and Moody&rsquo;s.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>SOFR</U>&rdquo; means a rate equal
to the secured overnight financing rate as administered by the SOFR Administrator.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>SOFR Administrator</U>&rdquo;
means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&ldquo;<U>SOFR Loan</U>&rdquo; means
a Loan denominated in Dollars and bearing interest calculated by reference to Adjusted Term SOFR.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&nbsp;</P>








<!-- Field: Page; Sequence: 44; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SONIA</U>&rdquo;
means for any day, a fluctuating rate of interest per annum equal to the greater of (a) 0.00% and (b) the rate determined by the
Agent in accordance with its then current practice, which may be either by reference to (i) the rate appearing on the Bloomberg
 &ldquo;SONIA&rdquo; screen as the Sterling Overnight Interbank Average Rate, administered by the Bank of England (or any other
person which takes over the administration of such rate) at approximately 11:00 a.m., London time or (ii) such other comparable
publicly available service for displaying or otherwise determining the Sterling Overnight Interbank Average Rate as may be selected
by the Agent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Specified
Materials</U>&rdquo; means, collectively, all materials or information provided by or on behalf of the Borrower, as well as documents
and other written materials relating to the Borrower or any of its Subsidiaries or Control Affiliates or any other materials or
matters relating to the Loan Documents (including, without limitation, any amendment, restatement, supplement or other modification
thereto).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>State
Street</U>&rdquo; means State Street Bank and Trust Company in its capacity as a Bank hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Sterling
Overnight Rate Loan</U>&rdquo; means a Loan denominated in Pounds Sterling and bearing interest calculated by reference to the
Overnight Interest Rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means, with respect to a Person, any corporation or other entity of which securities or other ownership interests having ordinary
voting power to elect a majority of the Managing Body thereof are at the time directly or indirectly owned by such Person.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Swedish Kronas</U>&rdquo; refers to the
lawful currency of the Kingdom of Sweden.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Swiss Francs</U>&rdquo; refers to the lawful
currency of Switzerland.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>TARGET
Day</U>&rdquo; means any day on which TARGET2 (or, if such payment system ceases to be operative, such other payment system, if
any, determined by the Agent to be a suitable replacement) is open for the settlement of payments in Euros.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>TARGET2</U>&rdquo;
means the Trans-European Automated Real-time Gross Settlement Express Transfer payment system which utilizes a single shared platform
and which was launched on November 19, 2007.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&ldquo;<U>Term SOFR</U>&rdquo; means,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
for any calculation with respect to a SOFR Loan, the Term SOFR Reference Rate for a tenor comparable to the applicable
Interest Period on the day (such day, the &ldquo;Periodic Term SOFR Determination Day&rdquo;) that is two (2) U.S. Government
Securities Business Days prior to the first day of such Interest Period, as such rate is published by the Term SOFR
Administrator; provided, however, that if as of 5:00 p.m. (Boston time) on any Periodic Term SOFR Determination Day the Term
SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR Administrator and a Benchmark
Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR
Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities
Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as
such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business
Days prior to such Periodic Term SOFR Determination Day, and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 45; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for any calculation
with respect to any Base Rate Loan on any day, the Term SOFR Reference Rate for a tenor of one month on the day (such day, the
 &ldquo;Base Rate Term SOFR Determination Day&rdquo;) that is two (2) U.S. Government Securities Business Days prior to such day,
as such rate is published by the Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (Boston time) on any Base
Rate Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR
Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will
be the Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government
Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so
long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business
Days prior to such Base Rate Term SOFR Determination Day.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<U>Term SOFR Adjustment</U>&rdquo; means a
percentage equal to 0.10% per annum.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Term
SOFR Administrator</U>&rdquo; means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term
SOFR Reference Rate selected by the Agent in its reasonable discretion).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<U>Term SOFR Reference Rate</U>&rdquo; means
the forward-looking term rate based on SOFR.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Termination
Date</U>&rdquo; means June <FONT STYLE="color: red"><STRIKE>14</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>12</U></FONT>, <FONT STYLE="color: red"><STRIKE>2024</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>2026</U></FONT>,
or such earlier date on which the Commitments terminate or are terminated pursuant to the terms hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&ldquo;<U>Threshold Amount</U>&rdquo; means,
as of any date, the lesser of (i) 5.0% of Total Assets, and (ii) $5,000,000 (or the equivalent amount thereof in any other currency).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Tier
1 Corporate Debt Securities</U>&rdquo; means Eligible Corporate Debt Securities which are rated, subject to <U>Section 1.04</U>,
BBB- or better by S&amp;P or Baa3 or better by Moody&rsquo;s.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Tier
2 Corporate Debt Securities</U>&rdquo; means Eligible Corporate Debt Securities which (1) are rated, subject to <U>Section 1.04</U>,
BB- or better by S&amp;P or Ba3 or better by Moody&rsquo;s, and (2) are not Tier 1 Corporate Debt Securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Tier
3 Corporate Debt Securities</U>&rdquo; means Eligible Corporate Debt Securities which (1) are rated, subject to <U>Section 1.04</U>,
B- or better by S&amp;P or B3 or better by Moody&rsquo;s, and (2) are not Tier 1 Corporate Debt Securities or Tier 2 Corporate
Debt Securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 46; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>&nbsp;</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>&ldquo;<U>Tier
4 Corporate Debt Securities</U>&rdquo; means Eligible Corporate Debt Securities which (1) are issued by an issuer domiciled
in, and having its principal place of business in, the United States of America, (2) are rated, subject to Section 1.04, CCC+ or better by S&amp;P or Caa1 or better by Moody&rsquo;s,
and (3) are not Tier 1 Corporate Debt Securities, Tier 2 Corporate Debt Securities or Tier 3 Corporate Debt Securities.</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Total
Assets</U>&rdquo; means, at any date, all assets of the Borrower which in accordance with Generally Accepted Accounting Principles
would be classified as assets upon a balance sheet of the Borrower prepared as of such date, valued in accordance with the Pricing
Procedures, <U>provided</U>, <U>however</U>, that Total Assets shall not include (a) equipment, (b) securities owned by the Borrower
which are in default (except to the extent that the Borrower is required or permitted to attribute a value thereto pursuant to
the Investment Company Act, the Prospectus and the Investment Policies and Restrictions) or determined to be worthless pursuant
to any policy of the Borrower&rsquo;s Managing Body, and (c) deferred organizational and offering expenses.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Total
Liabilities</U>&rdquo; means, at any date, the sum of all liabilities of the Borrower which in accordance with Generally Accepted
Accounting Principles would be classified as liabilities upon a balance sheet of the Borrower prepared as of such date, <U>plus</U>,
without duplication, the aggregate amount of the Borrower&rsquo;s Debt and Financial Contract Liability, <U>provided</U>, <U>however</U>,
that Total Liabilities shall not include any liquidation preference of any preferred security issued by the Borrower.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>UK
Financial Institution</U>&rdquo; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time
to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA
Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain
credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>UK
Resolution Authority</U>&rdquo; means the Bank of England or any other public administrative authority having responsibility for
the resolution of any UK Financial Institution.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Unadjusted
Benchmark Replacement</U>&rdquo; means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Unquoted
Asset</U>&rdquo; means, as of any date, any asset that is neither (a) valued by any pricing service or broker-dealer that, in
either case, is not a Control Affiliate of the Borrower or the Borrower&rsquo;s investment adviser, nor (b) traded on an exchange.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>U.S.
Dollar Benchmark Replacement</U>&rdquo; means, with respect to any Benchmark Transition Event, the first alternative set forth
in the order below that can be determined by the Agent for the applicable Benchmark Replacement Date:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>the higher of (i) the Floor and (ii) </U></FONT>the sum of (<FONT STYLE="color: red"><STRIKE>i</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>x</U></FONT>)
Daily Simple SOFR and (<FONT STYLE="color: red"><STRIKE>ii</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>y</U></FONT>) 0.10% (10.0
basis points); or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the sum of: (i) the alternate benchmark rate that has been selected by the Agent and the Borrower giving due consideration to
(A) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant
Governmental Body or (B) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to
the then-current Benchmark for Dollar-denominated syndicated credit facilities and (ii) the related Benchmark Replacement Adjustment.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 47; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">If the Benchmark Replacement as
determined pursuant to clause (a) or (b) above would be less than the Floor, the Benchmark Replacement will be deemed to be the
Floor for the purposes of this Agreement and the other Loan Documents.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>U.S. Dollar
Equivalent</U>&rdquo; means, at any time of the determination thereof: (a) with respect to any amount denominated in Dollars, such
amount; and (b) with respect to any amount denominated in any Alternate Currency (the &ldquo;Alternate Currency Amount&rdquo;),
the number of Dollars that may be purchased with the Alternate Currency Amount at such time based on the Exchange Rate, as determined
by the Agent.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>U.S.
Government Securities Business Day</U>&rdquo; means any day except for (a) a Saturday, (b) a Sunday, or (c) a day on which the
Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for
the entire day for purposes of trading in United States government securities</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Valuation
Report</U>&rdquo; means a report by the Borrower, as of the close of business on a particular date, listing each security and other
investment of the Borrower and the value thereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Value</U>&rdquo;
has the meaning assigned to such term in Section 2(a)(41) of the Investment Company Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Write-Down
and Conversion Powers</U>&rdquo; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers
of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down
and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers
of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability
of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that
liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument
is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of
the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><B>SECTION 1.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B> <B>Accounting Terms and Determination</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">Unless otherwise
specified herein, all accounting terms used herein shall be interpreted, all accounting determinations hereunder shall be made
and all financial statements required to be delivered hereunder shall be prepared in accordance with Generally Accepted Accounting
Principles as in effect from time to time in the United States of America (&ldquo;<U>Generally Accepted Accounting Principles</U>&rdquo;),
applied on a basis consistent (except for changes concurred in by the Borrower&rsquo;s independent public accountants) with the
most recent audited financial statements of the Borrower delivered to the Banks hereunder.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 48; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
1.03.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alternate Currencies</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Except
as otherwise expressly provided in this Credit Agreement, each provision of this Credit Agreement shall be subject to such reasonable
changes of construction as the Agent may from time to time specify to be necessary or appropriate to reflect the adoption of any
relevant market conventions or practices relating to any Alternate Currency.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
1.04.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Split Ratings</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">In
each case in which any provision of this Credit Agreement refers to credit ratings by S&amp;P and Moody&rsquo;s and provides that
such provision is subject to this <U>Section 1.04</U>, such provision shall be construed to mean that, in the event there is a
split in the ratings (a) by one rating category (<U>e.g</U>., some thing or some Person is rated CCC+ by S&amp;P and Caa2 by Moody&rsquo;s),
the higher rating will govern, or (b) by more than one rating category, the lower rating will govern.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
1.05.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Rates</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
Agent does not warrant or accept responsibility for, and shall not have any liability with respect to (a) the continuation of,
administration of, submission of, calculation of or any other matter related to the Base Rate, the Term SOFR Reference Rate, Adjusted
Term SOFR, Term SOFR, any other applicable Funding Rate or any component definition thereof or rates referred to in the definition
thereof, or any alternative, successor or replacement rate thereto (including any Benchmark Replacement), including whether the
composition or characteristics of any such alternative, successor or replacement rate (including any Benchmark Replacement) will
be similar to, or produce the same value or economic equivalence of, or have the same volume or liquidity as the Base Rate, the
Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR, any other applicable Funding Rate, or any other Benchmark prior to its
discontinuance or unavailability, or (b) the effect, implementation or composition of any Benchmark Replacement Conforming Changes,
in each case, not constituting gross negligence or wilful misconduct of the Agent. The Agent and its affiliates or other related
entities may engage in transactions that affect the calculation of the Base Rate, the Term SOFR Reference Rate, Adjusted Term
SOFR, Term SOFR, any other applicable Funding Rate, any alternative, successor or replacement rate (including any Benchmark Replacement)
or any relevant adjustments thereto, in each case, in a manner adverse to the Borrower. The Agent may select information sources
or services in its reasonable discretion to ascertain the Base Rate, the Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR,
any other applicable Funding Rate or any other Benchmark, in each case pursuant to the terms of this Agreement, and shall have
no liability to the Borrower, any Bank or any other person or entity for damages of any kind, including direct or indirect, special,
punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at
law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source
or service.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 49; Options: NewSection; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>ARTICLE
II</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>THE
CREDIT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.01.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Commitments to Lend</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Subject
to the terms and conditions set forth in this Agreement, each of the Banks severally agrees to make loans to the Borrower, from
time to time during the Revolving Credit Period up to a maximum aggregate principal amount outstanding at any one time equal to
such Bank&rsquo;s Commitment Amount, <U>provided</U>&nbsp;<U>that</U> the U.S. Dollar Equivalent of the aggregate principal amount of all
Loans outstanding (i) shall not exceed at any time the lesser of (a) the Borrowing Base and (b) the Aggregate Commitment Amount;
and (ii) shall not cause the Borrower to have an aggregate amount of Debt outstanding that is in excess of the Maximum Amount,
in each case in effect at such time. Each borrowing under this Section shall be in an aggregate principal amount equal to an Approved
Borrowing Amount, and shall be made from the several Banks <U>pro</U>&nbsp;<U>rata</U> in accordance with each Bank&rsquo;s Commitment Percentage.
Each Loan shall mature and become due and payable as provided in <U>Section 2.05</U> hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.02.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice of Borrowings</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower shall give the Agent (X) a notice substantially in the form of <U>Exhibit
B</U>&nbsp;attached hereto (a &ldquo;<U>Notice of Borrowing</U>&rdquo;) not later than 12:00 p.m. (Boston time) (or telephonic notice
not later than 12:00 p.m. (Boston time) confirmed in writing substantially in the form of <U>Exhibit B</U> attached hereto not
later than 2:00 p.m. (Boston time)) (i) on the Domestic Business Day of each proposed borrowing of a Base Rate Loan or Overnight
Rate Loan, (ii) on the second Rate Setting Business Day before each proposed borrowing of a SOFR Loan<FONT STYLE="color: Red"><STRIKE>,</STRIKE></FONT>&nbsp;<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>or
a</U></FONT> EURIBOR Loan, <FONT STYLE="color: Red"><STRIKE>or Alternate Currency Loan denominated in Canadian Dollars </STRIKE></FONT>and (iii) on the third Rate Setting Business Day
before each proposed borrowing of an Alternate Currency Loan in Australian Dollars, in each case specifying (1) the date of such
borrowing, which shall be a Domestic Business Day in the case of a Base Rate Loan or Overnight Loan or a Rate Setting Business
Day in the case of a Fixed Rate Loan, (2) whether such borrowing shall be of a Base Rate Loan, an Overnight Rate Loan, a SOFR
Loan, a EURIBOR Loan or an Alternate Currency Loan (other than an Overnight Rate Loan or a EURIBOR Loan) and, in the case of an
Alternate Currency Loan, setting forth the Alternate Currency of such Loan, (3) the aggregate principal amount of such borrowing,
and (4) in the case of a Fixed Rate Loan, the Interest Period therefor (which shall comply with <U>Section 2.02(c)</U> hereof),
and (Y) a certificate signed by an Authorized Signatory stating that no material change has occurred since the date the last Borrowing
Base Report was delivered, not later than 2:00 p.m. (Boston time) on the date of the proposed borrowing of the requested Loan.
Each Notice of Borrowing shall constitute a representation and warranty by the Borrower that the conditions set forth in <U>Section
3.02(c)</U>, <U>(d)</U> and <U>(e)</U> have been satisfied on the date of such notice and will be satisfied on the date of such
borrowing.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 50; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower may elect from time to time to (I) convert any outstanding Base Rate Loan to a SOFR Loan, (II) convert any
outstanding SOFR Loan to a Base Rate Loan, or (III) to roll over any outstanding Fixed Rate Loan upon the expiration of an
Interest Period with respect thereto into a Fixed Rate Loan of the same currency, by giving a notice to the Agent
substantially in the form of <U>Exhibit C</U> attached hereto (a &ldquo;<U>Notice of Conversion</U>&rdquo;) (or telephonic
notice confirmed in a writing substantially in the form of <U>Exhibit C</U> attached hereto), <U>provided</U>&nbsp;<U>that</U>
(i) with respect to any conversion into or rollover of a Fixed Rate Loan, the Notice of Conversion shall be given within the
time period for the giving of a Notice of Borrowing for such Fixed Rate Loan as set forth in <U>Section 2.02(a)</U>, (ii) no
Loan may be converted into or rolled over as a SOFR Loan (1) except in compliance with <U>Section 2.02(c)</U> hereof, or (2)
if an Event of Default has occurred and is continuing (in which case such Loan shall automatically become a Base Rate Loan on
the last day of the first Interest Period relating thereto ending during the continuance of any Event of Default), (iii) a
Fixed Rate Loan may be rolled over as a Fixed Rate Loan only on the last day of the Interest Period applicable thereto, (iv)
a SOFR Loan may be converted into a Base Rate Loan only on the last day of the Interest Period applicable thereto, and (v) if
the Borrower fails to give a timely Notice of Conversion for a Fixed Rate Loan, the Borrower shall be deemed to have elected
to continue such Fixed Rate Loan as a Fixed Rate Loan of the same currency having a one month Interest Period from the last
day of the Interest Period applicable thereto. Conversions to and from SOFR Loans, and all roll overs, shall be in such
amounts and pursuant to such elections so that, after giving effect thereto, the aggregate principal amount of all SOFR Loans
having the same Interest Period shall not be less than the Approved Borrowing Amount. All roll overs of Alternate Currency
Loans in a single currency, shall be in such amounts and pursuant to such elections so that, after giving effect thereto, the
aggregate principal amount of all Alternate Currency Loans of the same currency having the same Interest Period shall not be
less than the Approved Borrowing Amount.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower may not elect an Interest Period for a new Fixed Rate Loan, or continue
or convert a Loan as a Fixed Rate Loan, if immediately after giving effect thereto there would be more than six different Interest
Periods.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.03.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Notice to Banks; Funding of Loans</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon receipt of a Notice of Borrowing or an oral request for a borrowing in accordance
with <U>Section 2.02(a)</U>, the Agent shall promptly notify each Bank of the contents thereof and of such Bank&rsquo;s ratable
share (based on Commitment Percentages) of such borrowing. Upon such notice by the Agent to each Bank, such Notice of Borrowing
or oral request shall no longer be revocable by the Borrower and shall obligate the Borrower to accept the Loans requested from
the Banks on the date of such borrowing.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Not later than 2:00 p.m. (Boston time) on the Borrowing Date of each borrowing, each Bank shall make available its share of such
borrowing, in Federal or other funds immediately available in Boston, to the Agent at its address referred to in <U>Section 9.01</U>.
Unless the Agent determines that any applicable condition specified in <U>ARTICLE III</U> has not been satisfied or waived, the
Agent will make its share of such borrowing and the funds so received from the other Banks available to the Borrower at the Agent&rsquo;s
aforesaid address, on the date of the borrowing. The failure or refusal of any Bank to make available to the Agent as provided
herein its share of any borrowing shall not relieve any other Bank from its several obligations hereunder.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Bank makes a new Loan hereunder on a day on which the Borrower is to repay the principal amount of an outstanding Loan
of the same currency to such Bank, the Bank shall apply the proceeds of its new Loan to make such repayment and only an amount
equal to the difference (if any) between the amount being borrowed and the amount being repaid shall be made available by the
Agent as provided in clause (a) or remitted by the Borrower to the Agent for the account of such Bank as provided in <U>Section
2.09</U> hereof, as the case may be. For purposes of this Section 2.03(c) all such overdue amounts shall be deemed to be the U.S.
Dollar Equivalent thereof determined on the first day that such overdue amounts became due and payable (after giving effect to
any applicable grace period).&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 51; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless the Agent shall have received notice from a Bank prior to any date of a borrowing
that such Bank will not make available to the Agent such Bank&rsquo;s share of such borrowing, the Agent may assume that such
Bank has made such share available to the Agent on such date in accordance with clause (b) of this Section and the Agent may (but
it shall not be required to), in reliance upon such assumption, make available to the Borrower on such date a corresponding amount.
If and to the extent that such Bank shall not have so made such share available to the Agent, such Bank and the Borrower severally
agree to repay to the Agent, within three days after demand by the Agent, such amount together with interest thereon, for each
day from the date such amount is made available to the Borrower until the date such amount is repaid to the Agent, at a rate per
annum equal to the interest rate applicable thereto pursuant to <U>Section 2.06</U> hereof. If such Bank shall repay to the Agent
such amount, such amount so repaid shall constitute such Bank&rsquo;s Loan included in such borrowing for purposes of this Agreement.
The provisions of this <U>Section 2.03(d)</U> shall not relieve any such Bank from any liability to the Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B> <B>Loan Accounts; Notes; Records</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Loans made by each Bank to the Borrower shall be evidenced by one or more loan accounts
or records maintained by such Bank in the ordinary course of business. The Borrower irrevocably authorizes each Bank to make or
cause to be made, at or about the date of each Loan or at the time of receipt of any payment of principal of each Loan, an appropriate
notation on its loan accounts or records, including computer records, reflecting the making of such Loan or (as the case may be)
the receipt of such payment. The outstanding amount of the Loans set forth in any such loan accounts or records, including any
computer records, maintained by a Bank with respect to the Loans made by it shall be <U>prima</U>&nbsp;<U>facie</U> evidence of the principal
amount thereof owing and unpaid to such Bank, but the failure to record, or any error in so recording, any such amount on any
such loan account or record shall not limit or otherwise affect the obligation of the Borrower hereunder or under the other Loan
Documents to make payments of principal of and interest on the Loans when due.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower hereby agrees that if, in the opinion of any Bank, a promissory note or
other evidence of debt is required, appropriate or desirable to reflect or enforce the obligations of the Borrower resulting from
the Loans made, or to be made, by such Bank, then, upon request of such Bank, the Borrower shall promptly execute and deliver
to such Bank, a promissory note (each, as amended, supplemented or otherwise modified, a &ldquo;<U>Note</U>&rdquo; and, collectively,
the &ldquo;<U>Notes</U>&rdquo;) substantially in the form of <U>Exhibit A</U> attached hereto, payable to such Bank in an amount
equal to such Bank&rsquo;s Commitment Amount or, if less, the aggregate unpaid principal amount of such Bank&rsquo;s Loans, plus
interest thereon as provided below, <U>provided</U>, <U>that</U> as a condition to issuing any Note in replacement of a previously
issued Note that has been lost, the Borrower may require an indemnity with respect to lost instruments from such Bank, in form
and substance reasonably satisfactory to the Borrower.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 52; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agent&rsquo;s records with respect to the Loans, the interest rates applicable thereto,
each payment by the Borrower of principal and interest on the Loans and fees, expenses and any other amounts due and payable in
connection with this Agreement and the other Loan Documents shall be <U>prima</U>&nbsp;<U>facie</U> evidence of the amount of the Loans and
the amount of principal and interest paid by the Borrower in respect of the Loans and as to the other information relating to
the Loans and amounts paid and payable by the Borrower hereunder and under the other Loan Documents.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.05.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mandatory Payments; Optional Prepayments</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Loan shall mature, and the principal amount thereof shall be due and payable, on
the Termination Date. The Borrower promises to pay on the Termination Date, and there shall become absolutely due and payable
on the Termination Date, all of the Loans outstanding on such date, together with all accrued and unpaid interest thereon and
other amounts outstanding hereunder.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If at any time the Borrower shall be in default of its obligations under <U>Sections
5.19</U>&nbsp;or&nbsp;<U>5.20</U>&nbsp;(including as a result of market fluctuations of the U.S. Dollar Equivalent of any Alternate Currency
Loan), the Borrower shall immediately prepay the principal amount of one or more Loans (together with accrued interest thereon
and, in the case of Fixed Rate Loans, the amount, if any, payable pursuant to <U>Section 8.05</U>) and/or take such other actions,
in each case to the extent necessary so that immediately after giving effect to such prepayment and such other actions no such
default would exist.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the U.S. Dollar Equivalent of the aggregate principal amount of Loans outstanding exceeds (including as a result of market
fluctuations of the U.S. Dollar Equivalent of any Alternate Currency Loan) (X) on any date, the Excess Percentage of the lesser
of the Borrowing Base or the Aggregate Commitment Amount, or (Y) on the last Domestic Business Day of any calendar month, the
lesser of the Borrowing Base or the Aggregate Commitment Amount, the Borrower shall immediately (1) prepay such principal amount
of one or more Loans (together with accrued interest thereon and, in the case of Fixed Rate Loans, the amount, if any, payable
pursuant to <U>Section 8.05</U>), (2) take such other action, or (3) both, in the amount necessary to eliminate such excess.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If as of any date the U.S. Dollar Equivalent of the aggregate principal amount of Loans outstanding exceeds (excluding to the
extent as a result of market fluctuations of the U.S. Dollar Equivalent of any Alternate Currency Loan) the lesser of the Borrowing
Base or the Aggregate Commitment Amount, the Borrower shall immediately (1) prepay such principal amount of one or more Loans
(together with accrued interest thereon and, in the case of Fixed Rate Loans, the amount, if any, payable pursuant to <U>Section
8.05</U>), (2) take such other action, or (3) both, in the amount necessary to eliminate such excess.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 53; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower may, with notice (in any case, which notice shall not thereafter be revocable by the Borrower) to the Agent no later than
(i) in the case of a prepayment of Base Rate Loans, 11:30 am (Boston time) on the Domestic Business Day of prepayment, or (ii) in the
case of a prepayment of Fixed Rate Loans, at least three Rate Setting Business Days&rsquo; notice prior to the date of prepayment, prepay
any Loans in whole at any time, or from time to time in part in an aggregate principal amount not less than $1,000,000 (or the equivalent
thereof, in the case of a prepayment of an Alternate Currency Loan) or in larger integral multiples of $100,000 (or the equivalent thereof,
in the case of a prepayment of an Alternate Currency Loan), by paying the principal amount to be prepaid (together with accrued interest
thereon to the date of prepayment and, in the case of Fixed Rate Loans, the amount, if any, payable pursuant to <U>Section 8.05</U>).
Each such optional prepayment shall be applied to prepay ratably the Loans of the several Banks included in such borrowing.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Borrower prepays all or any portion of the principal amount of any Fixed Rate Loan on any day other than the last day of
the Interest Period relating thereto, such prepayment shall include the amounts, if any, payable pursuant to <U>Section 8.05</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(g)&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;The Borrower shall give the Agent a notice substantially in the form of <U>Exhibit F</U>&nbsp;attached hereto (a
 &ldquo;<U>Notice of Repayment</U>&rdquo;) on the date of, but prior to, each repayment or prepayment of all or any portion of
any Loan, in each case specifying (1) the date of such repayment or prepayment, (2) whether such repayment or prepayment is of
a Base Rate Loan, an Alternate Currency Loan (and, if so, setting forth the applicable currency and Interest Period), or a SOFR
Loan (and, if a SOFR Loan, the applicable Interest Period), (3) the aggregate principal amount of such prepayment, and (4) the
other information required by such Exhibit. Upon receipt of each Notice of Repayment, the Agent shall promptly notify each Bank
of the contents thereof and of such Bank&rsquo;s ratable share of such prepayment.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(h)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the satisfaction of the conditions set forth in <U>Section 3.02</U>, Loans
prepaid prior to the Termination Date may be reborrowed prior to the Termination Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.06.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest Rates</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Section 2.06(c)</U>, each Base Rate Loan and each Overnight Rate Loan
shall bear interest on the outstanding principal amount thereof, for the period commencing with the date such Loan is made up
to but not including the date such Loan is repaid in full, at a rate per annum equal to the Base Rate for each Base Rate Loan
or the applicable Overnight Interest Rate for each Overnight Rate Loan, in each case as in effect from time to time. Accrued and
unpaid interest on each Base Rate Loan and each Overnight Rate Loan shall be payable in arrears on (i) with respect to interest
accrued during a calendar month, the fifteenth day of the immediately succeeding calendar month, and (ii) with respect to all
accrued and unpaid interest, on the Termination Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Section 2.06(c)</U> and <U>ARTICLE VIII</U>, each Fixed Rate Loan shall
bear interest on the outstanding principal amount thereof, for the period commencing with the date such Fixed Rate Loan is made
or continued through but excluding the last day of the Interest Period applicable thereto, at a rate per annum equal to the sum
of the Applicable Loan Rate <U>plus</U> the Adjusted Offered Rate applicable to such Fixed Rate Loan. Interest on each Fixed Rate
Loan shall be payable on the last day of the Interest Period in effect with respect thereto and on the Termination Date.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 54; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All overdue amounts payable under the Loan Documents (including, without limitation,
any overdue principal of the Loans (whether at stated maturity, by acceleration or otherwise), any overdue interest on the Loans
and any overdue fees) shall bear interest, payable on demand, for each day from and including the date payment thereof was due
to but not including the date of actual payment, at a rate per annum equal to the sum of 2.00% above the Base Rate until such
amount shall be paid in full (after as well as before judgment). Notwithstanding anything to the contrary in this <U>Section 2.06</U>,
upon either (A) notice by the Agent to the Borrower during the continuance of an Event of Default, or (B) the occurrence of an
Event of Default under <U>Section 6.01(g) or (h)</U>, the outstanding principal balance of the Loans shall bear interest at a
rate per annum equal to the greater of (i) 2.00% above the rate of interest otherwise applicable to such Loans pursuant to this
<U>Section 2.06</U> or (ii) 2.00% above the Base Rate. For purposes of this Section 2.06(c) all such overdue amounts shall be
deemed to be the U.S. Dollar Equivalent thereof determined on the first day that such overdue amounts became due and payable (after
giving effect to any applicable grace period).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agent shall determine the interest rate applicable to the Loans hereunder and its
determination thereof shall be conclusive and binding for all purposes in the absence of manifest error.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.07.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fees</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commitment fees accrued through the end of each calendar quarter shall be due and payable
on the 15th day of the immediately succeeding calendar month, and all accrued and unpaid commitment fees shall be due and payable
on the Termination Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On the Effective Date and thereafter on a per annum basis, the Borrower shall pay to the Agent,
for its own account, an administrative agent fee as may have been agreed upon separately between the Borrower and the Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.08.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination and Reduction of Commitments</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Bank&rsquo;s Commitment Amount permanently shall reduce to $0 and each Bank&rsquo;s
Commitment shall terminate on the Termination Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Section 2.05(d)</U> hereof, during the Revolving Credit Period, the Borrower
may, upon at least four (4) Domestic Business Days&rsquo; prior written notice to the Agent, (i) terminate the Commitments at
any time, or (ii) reduce from time to time the Aggregate Commitment Amount by an aggregate amount of $5,000,000 or integral multiples
of $1,000,000 in excess thereof (<U>provided</U> that immediately after giving effect to any such termination and each such reduction,
the U.S. Dollar Equivalent of the aggregate outstanding principal balance of the Loans would not exceed the Aggregate Commitment
Amount), whereupon the Commitment Amounts of each of the Banks shall be reduced <U>pro</U>&nbsp;<U>rata</U> in accordance with their Commitment
Percentage of the amount specified in such notice or, as the case may be, each Bank&rsquo;s Commitment shall be terminated. Promptly
after receiving any notice of the Borrower delivered pursuant to this Section, the Agent will notify the Banks of the substance
thereof. Upon the effective date of any such reduction or termination, the Borrower shall pay to the Agent for the respective
accounts of the Banks the full amount of any facility fee then accrued on the amount of the reduction. No reduction in the Commitment
Amounts or termination of the Commitments may be reinstated.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 55; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.09.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>General Provisions as to Payments</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower shall make each payment of principal and interest on the Loans and of fees hereunder and all other amounts due hereunder
not later than (i) in the event that there is only one Bank (which is also the Agent), 3:00 p.m. (Boston time), and (ii) in all
other events, 12:00 Noon (Boston time)), on the date when due, in Federal or other funds immediately available, to, except as
otherwise expressly provided herein, the Agent at its address referred to in <U>Section 9.01</U>. The Agent shall promptly distribute
to each Bank its appropriate share of each such payment received by the Agent for the account of the Banks. Whenever any payment
of principal of, or interest on, Base Rate Loans or of fees shall be due on a day which is not a Domestic Business Day, the date
for payment thereof shall be extended to the next succeeding Domestic Business Day and interest shall accrue during such extension.
If the date for any payment of principal is extended by operation of law or otherwise, interest thereon shall be payable for such
extended time. All payments by the Borrower hereunder and under any of the other Loan Documents shall be made in Dollars, except
that all payments of principal of, and interest on, each Alternate Currency Loan shall be made in the applicable Alternate Currency.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless the Agent shall have received notice from the Borrower prior to the date on which
any payment is due to the Banks hereunder that the Borrower will not make such payment in full, the Agent may assume that the
Borrower has made such payment in full to the Agent on such date and the Agent may (but it shall not be required to), in reliance
upon such assumption, cause to be distributed to each Bank on such due date an amount equal to the amount then due to such Bank.
If and to the extent that the Borrower shall not have so made such payment, each Bank shall repay to the Agent forthwith on demand
such amount distributed to such Bank together with interest thereon, for each day from the date such amount is distributed to
such Bank until the date such Bank repays such amount to the Agent, at the Federal Funds Rate.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 56; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All payments by the Borrower hereunder and under any of the other Loan Documents shall
be made in Dollars, except that all payments of principal of, and interest on, each Alternate Currency Loan shall be made in the
applicable Alternate Currency, in each case without setoff or counterclaim and free and clear of and without deduction for any
taxes, levies, imposts, duties, charges, fees, deductions, withholdings, compulsory loans, restrictions or conditions of any nature
now or hereafter imposed or levied by any jurisdiction or any political subdivision thereof or taxing or other authority therein
unless the Borrower is required by law (as determined in the good faith discretion of the Borrower or its agent) to make such
deduction or withholding. Subject to Section 2.09(d), if any Non-Excluded Taxes are required to be withheld with respect to any
amount payable by the Borrower hereunder or under any of the other Loan Documents, the Borrower will pay to the Agent, for the
account of the Banks or (as the case may be) the Agent, on the date on which such amount is due and payable hereunder or under
such other Loan Document, such additional amount in Dollars as shall be necessary to enable the Banks or the Agent to receive
the same net amount which the Banks or the Agent would have received on such due date had no such Non-Excluded Taxes been required
to be withheld. For purposes of this Agreement, &ldquo;Non-Excluded Taxes&rdquo; are any taxes, levies, imposts, duties, charges,
fees, deductions or withholdings of any nature now or hereafter imposed or levied by any jurisdiction or any political subdivision
thereof or taxing or other authority therein other than (i) net income taxes (however denominated), franchise taxes (imposed in
lieu of net income taxes), branch profits taxes and any other similar taxes imposed upon the Agent or any Bank (or its Applicable
Lending Office) by the jurisdiction under the laws of which the Agent or Bank (or its Applicable Lending Office) is organized
or in which its principal office is located or through which it holds the Loans or any political subdivision, taxing authority
or other authority thereof or therein, (ii) any taxes imposed as a result of a present or former connection between the Agent
or Bank (or its Applicable Lending Office) and the jurisdiction imposing such tax other than a connection arising solely as a
result of the Agent or Bank (or its Applicable Lending Office) having executed, delivered or performed its obligations or received
payments under, or enforced, this Agreement, (iii) any U.S. Federal withholding taxes imposed under FATCA. The Borrower will deliver
promptly to the Agent certificates or other valid vouchers for all taxes or other charges deducted from or paid with respect to
payments made by the Borrower hereunder or under such other Loan Document. If the Borrower reasonably believes that such Non-Excluded
Taxes were not correctly or reasonably asserted, the applicable Bank will use reasonable efforts to cooperate (at the sole cost
and expense of the Borrower) with the Borrower to obtain a refund of such taxes (which shall be repaid to the Borrower so long
as such efforts would not, in the good faith determination of the Bank, result in any material additional costs, expenses or risks
or be otherwise disadvantageous to it). Any Bank claiming any amounts payable by Borrower pursuant to this Section 2.09(c) agrees
to use reasonable efforts (consistent with its internal policy and legal and regulatory restrictions) to change the jurisdiction
of its Applicable Lending Office if the making of such a change would avoid the need for, or reduce the amount of, any such amounts
payable by the Borrower that may thereafter accrue and would not, in the reasonable judgment of such Bank, be otherwise disadvantageous
to such Bank.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in clause (c) of this Section 2.09,
the Borrower will not be required to make any additional payment to or for the account of any Bank with respect to any Non-Excluded
Taxes under clause (c) (i) by reason of a breach by such Bank of any certification or representation set forth in any form furnished
to the Borrower under Section 2.11, (ii) by reason of such Bank&rsquo;s failure or inability to furnish under Section 2.11 an
original or an extension or renewal of any form required under Section 2.11, or (iii) if such Non-Excluded Taxes are withholding
taxes imposed on amounts payable to such Bank at the time such Bank becomes a party to this Agreement (or designates a new lending
office or changes its place of organization or principal office), except to the extent that such Bank&rsquo;s assignor (if any)
was entitled, at the time of assignment, to receive additional amounts, from the Borrower with respect to such Non-Excluded Taxes
pursuant to clause (c) of this Section 2.09.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 57; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(e)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Agent or a Bank determines, in its reasonable discretion, that it has received
a refund of any taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional
amounts pursuant to clause (c) of this Section 2.10, it shall pay over such refund to the Borrower (but only to the extent of
indemnity payments made, or additional amounts paid, by the Borrower under clause (c) of this Section 2.10), net of all out-of-pocket
expenses of the Agent or such Bank and without interest (other than any interest paid by the relevant governmental authority with
respect to such refund); provided, that the Borrower, upon the request of the Agent or such Bank, agrees to repay the amount paid
over to the Borrower (plus any penalties, interest or other charges imposed by the relevant governmental authority) to the Agent
or such Bank in the event the Agent or such Bank is required to repay such refund to such governmental authority. Each Bank agrees,
that upon the occurrence of any event giving rise to a tax as to which it has been indemnified by the Borrower or with respect
to which the Borrower has paid additional amounts pursuant to clause (c) of this Section 2.10, it will use reasonable efforts
to mitigate the effect of any such event, including by designating another lending office for any Loan affected by such event
and by completing and delivering or filing any tax-related forms which would reduce or eliminate such tax or additional amounts.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(f)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower hereby authorizes and irrevocably directs the Agent, at the Agent&rsquo;s
option at any time upon and following the due date for payment by the Borrower of any amounts under the Loan Documents, and without
any further notice to or consent of the Borrower, to debit any account(s) of the Borrower with the Agent (in any capacity) and
apply amounts so debited toward the payment of any such amounts due and owing under the Loan Documents. Notwithstanding such authorization
and direction, the Borrower hereby further acknowledges and agrees that (a) the Agent shall have no obligation to so debit any
such account(s) and shall have no liability whatsoever to the Borrower for any failure to do so, and (b) the Borrower shall fully
retain the obligation under the Loan Documents to make all payments owing by the Borrower thereunder when due.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.10.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Computation of Interest and Fees</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">All
interest and fees hereunder shall be computed (a) with respect to all Obligations other than Sterling Overnight Rate Loans, on
the basis of a year of 360 days and paid for the actual number of days elapsed, and (b) with respect to all Sterling Overnight
Rate Loans, on the basis of a year of 365 days and paid for the actual number of days elapsed.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
2.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B> <B>Withholding Tax Exemption</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Bank that is not a Foreign Bank shall deliver to the Borrower (with a copy to the
Agent) an original signed, properly completed IRS Form W-9 (or any successor form) certifying that the Bank is not subject to
U.S. backup withholding tax, on or prior to the date on which the Bank becomes a Bank under this Agreement, promptly upon the
obsolescence, expiration, or invalidity of any form previously delivered by the Bank, and from time to time thereafter upon the
request of the Borrower or Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any Foreign Bank that is entitled to an exemption from or reduction of withholding tax
under the law of the jurisdiction in which the Borrower is resident for tax purposes, or any treaty to which such jurisdiction
is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower (with a copy to
the Agent), at the time or times prescribed by Applicable Law or reasonably requested by the Borrower or the Agent, such properly
completed and executed documentation prescribed by Applicable Law as will permit such payments to be made without withholding
or at a reduced rate of withholding. In addition, each Bank, if requested by the Borrower or the Agent, shall deliver such other
documentation prescribed by Applicable Law or reasonably requested by the Borrower or the Agent, including without limitation,
as will enable the Borrower or the Agent to determine whether or not such Bank is subject to backup withholding or information
reporting requirements. Without limiting the generality of the foregoing, in the event that the Borrower is resident for tax purposes
in the United States each Foreign Bank shall deliver to the Borrower and the Agent (in such number of copies as shall be reasonably
requested by the recipient) on or prior to the date on which such Foreign Bank becomes a Bank under this Agreement (and promptly
upon the obsolescence, expiration or invalidity of any form or certificate previously delivered by such Foreign Bank or from time
to time thereafter upon the reasonable request of the Borrower or the Agent), whichever of the following is applicable:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
original signed and duly completed copies of Internal Revenue Service Form W-8BEN claiming eligibility for benefits of an income
tax treaty to which the United States is a party that reduces or eliminates withholding tax;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(ii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;original signed and duly completed copies of Internal Revenue Service Form W-8ECI;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(iii)
 &nbsp;&nbsp;&nbsp;in the case of a Foreign Bank claiming the benefits of the exemption for portfolio interest under
section 881(c) of the Internal Revenue Code, (x) a written certificate that such Foreign Bank is not (A) a &ldquo;bank&rdquo;
within the meaning of section 881(c)(3)(A) of the Internal Revenue Code, (B) a &ldquo;10 percent shareholder&rdquo; of the Borrower
within the meaning of section 871(h)(3)(B) of the Internal Revenue Code, or (C) a &ldquo;controlled foreign corporation&rdquo;
receiving interest from a related person within the meaning of section 881(c)(3)(C) of the Internal Revenue Code and (y) original
signed and duly completed copies of Internal Revenue Service Form W-8BEN; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in United States Federal withholding
tax duly completed together with such supplementary documentation as may be prescribed by Applicable Law to permit the Borrower
to determine the withholding or deduction required to be made.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If a payment made to a Bank under any Loan Document would be subject to U.S. federal withholding tax imposed by FATCA if such
Bank were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b)
or 1472(b) of the Internal Revenue Code, as applicable), such Bank shall deliver to the Borrower and the Agent at the time or
times prescribed by law and at such time or times reasonably requested by the Borrower or the Agent such documentation prescribed
by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation
reasonably requested by the Borrower or the Agent as may be necessary for the Borrower and the Agent to comply with their obligations
under FATCA and to determine that such Bank has complied with such Bank&rsquo;s obligations under FATCA or to determine the amount
to deduct and withhold from such payment. Solely for purposes of this clause (c) of <U>Section 2.11</U> hereof, &ldquo;FATCA&rdquo;
shall include any amendments made to FATCA after the Effective Date.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 59; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>ARTICLE
III</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>CONDITIONS</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 195pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
3.01.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effectiveness</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">This
Agreement shall become effective on the date that each of the following conditions shall have been satisfied, and the obligation
of each Bank to make a Loan on the occasion of the first borrowing hereunder is subject to the satisfaction of the following conditions
(or there waiver in accordance with <U>Section 9.05</U> hereof):</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt
by the Agent of counterparts hereof signed by each of the parties </FONT>hereto;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt by the Agent for the account of each Bank, if requested by such Bank, of a duly executed
Note dated on or before the Effective Date complying with the provisions of <U>Section 2.04</U>;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent of (1) the Security Agreement signed by the Borrower, and (2) (i) a perfection certificate from the Borrower
substantially in the form of <U>Exhibit H</U>&nbsp;attached hereto, (ii) copies of the results of current lien searches (or the equivalent
in the applicable jurisdictions), such results to be in form and substance reasonably satisfactory to the Agent; (iii) authorizations
to file UCC financing statements (or the equivalent in the applicable jurisdictions), with such financing statements to be in
form and substance reasonably satisfactory to the Agent, and (iv) such other documents, instruments and/or agreements the Agent
may reasonably require to perfect its security interest in the Collateral (as defined in the Security Agreement) in the relevant
jurisdictions;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent and Banks of the legal opinion of Sullivan &amp; Cromwell LLP, counsel for the Borrower, in the form attached
hereto as <U>Exhibit I</U>;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent of a certificate, in all respects satisfactory to the Agent and manually signed by an Authorized Signatory,
to the effect set forth in clause (e) and, if the Borrower is submitting a Notice of Borrowing on the Effective Date, clauses
(c) and (d), of <U>Section 3.02</U>, such certificate to be dated the Effective Date and to be in form and substance reasonably
satisfactory to the Agent;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(f)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt by the Agent of a manually signed certificate from the Secretary or Assistant
Secretary of the Borrower in form and substance reasonably satisfactory to the Agent and dated the Effective Date as to the incumbency
of, and bearing manual specimen signatures of, the Authorized Signatories who are authorized to execute and take actions under
the Loan Documents for and on behalf of the Borrower, and certifying and attaching copies of (i) all Charter Documents (other
than those delivered pursuant to <U>Section 3.01(h)</U>), with all amendments, restatements, supplements or other modifications
thereto, (ii) the resolutions of the Borrower&rsquo;s Managing Body authorizing the transactions contemplated hereby, (iii) the
Prospectus and such material as accurately and completely sets forth all Investment Policies and Restrictions not reflected in
the Prospectus, (iv) the investment management agreement between the Borrower and the Investment Adviser as then in effect, along
with any other investment management or submanagement agreements to which the Borrower is a party as then in effect, (v) the Custody
Agreement and (vi) the Borrower&rsquo;s interim financial reports from the inception thereof;&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 60; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(g)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt by the Agent of a legal existence and good standing certificate for the Borrower
from the Secretary of State of Maryland, dated as of a recent date;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(h)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt by the Agent of a copy of the certificate of incorporation of the Borrower,
with all amendments, restatements, supplements or other modifications thereto, certified by the Secretary of State of the State
of Maryland;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent of all documents, opinions and instruments it may reasonably request prior to the execution of this Agreement
relating to compliance with applicable rules and regulations promulgated by the Federal Reserve Board and other governmental and
regulatory authorities, the existence of the Borrower, the authority for and the validity and enforceability of this Agreement
and the Notes, if any, and any other matters relevant hereto, all in form and substance reasonably satisfactory to the Agent;
and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent of payment of all (i) reasonable out-of-pocket expenses (including reasonable fees and disbursements of special
counsel for the Agent) then payable hereunder, and (ii) fees then payable hereunder or under a separate fee letter, if any;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black"><U>provided</U>&nbsp;that this Agreement shall not become effective or be binding on any party hereto unless all of the foregoing conditions are
satisfied not later than ________ __, 2013. The Agent shall promptly notify the Borrower and the Banks of the Effective Date,
and such notice shall be conclusive and binding on all parties hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
3.02.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Borrowings</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
obligation of each Bank to make a Loan on the occasion of any borrowing, including the first borrowing, is subject to the satisfaction
of the following conditions:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receipt by the Agent of a Notice of Borrowing as required by <U>Section 2.02(a)(X)</U>,
along with all documents and information it may reasonably request to establish compliance with applicable rules and regulations
promulgated by the Federal Reserve Board, and receipt by such Bank of all such documents and instruments from the Agent;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
receipt by the Agent of a Borrowing Base Report as required by <U>Section 2.02(a)(Y)</U>;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the fact that, immediately after such borrowing, the aggregate outstanding principal amount of the Loans (i) will not exceed the
lesser of (A) the Borrowing Base and (B) the Aggregate Commitment Amount as in effect on such date; and (ii) will not cause the
aggregate amount of the Borrower&rsquo;s outstanding Debt to exceed the Maximum Amount;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"></P>




<!-- Field: Page; Sequence: 61; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the fact that, immediately before and after such borrowing, no Default shall have occurred
and be continuing;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(e)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the fact that the representations and warranties of the Borrower contained in this Agreement
and the other Loan Documents shall be true on and as of the date of such borrowing and with the same force and effect as if made
on and as of such date (or, if any such representation or warranty is expressly stated to have been made as of a specific date,
as of such specific date);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
in the case of a Loan to be denominated in an Alternate Currency, there shall not have occurred any change in national or international
financial, political or economic conditions or currency exchange rates or exchange controls which in the reasonable opinion of
the Agent or the Required Banks would make it impracticable for such Loan to be denominated in the relevant Alternate Currency;
and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
with respect to that particular Bank only, no change shall have occurred in any law or regulation thereunder or interpretation
thereof (other than a Failure) that in the opinion of that Bank would make it illegal for that Bank to make such Loan.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Each
borrowing hereunder shall be deemed to be a representation and warranty by the Borrower on the date of such borrowing as to the
facts specified in clauses (c), (d) and (e) of this Section.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>ARTICLE
IV</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 118pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
Borrower represents and warrants that:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.01.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Existence and Power; Investment Company</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower is a corporation formed under the laws of the State of Maryland. The Borrower
is duly organized, validly existing and in good standing under the laws of the State of Maryland and has all corporate powers
and all authorizations and approvals required to carry on its business as now conducted. The Borrower is duly qualified to do
business and is in good standing in each jurisdiction in which the nature of its business and properties, including without limitation,
the performance of the Borrower&rsquo;s Obligations, requires such qualification, except where the failure to do so is not reasonably
likely to result in a Material Adverse Effect. Neither the Borrower nor the Investment Adviser is an Affected Financial Institution.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower is a closed-end management investment company registered as such under the Investment
Company Act, and the outstanding shares of each class of its stock (i) have been duly issued and are fully paid and non-assessable,
(ii) have been duly registered under the Securities Act or sold in transactions exempt from registration under the Securities
Act, and (iii) have been sold only in states or other jurisdictions in which all filings required to be made under applicable
state securities laws have been made.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>




<!-- Field: Page; Sequence: 62; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.02.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorization; Execution and Delivery, Etc.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
execution and delivery by the Borrower of, and the performance by the Borrower of its obligations under, this Agreement, each
of the other Loan Documents to which it is a party, and the other instruments, certificates and agreements contemplated hereby
and thereby, are within its corporate powers, and have been duly authorized by all requisite action by the Borrower. This Agreement
and each of the other Loan Documents to which the Borrower is a party, and the other instruments, certificates and agreements
contemplated hereby and thereby, have been duly executed and delivered by the Borrower, and constitute the legal, valid and binding
obligations of the Borrower enforceable against the Borrower in accordance with their respective terms, except as enforceability
may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws affecting
the enforcement of creditors&rsquo; rights generally and by general equitable principles (whether enforcement is sought by proceedings
in equity or at law).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.03.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Noncontravention</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Neither
the execution and delivery by the Borrower of this Agreement, any other Loan Document to which it is a party, or any instrument,
certificate or agreement referred to herein or therein, or contemplated hereby or thereby, nor the consummation of the transactions
herein or therein contemplated, nor compliance with the terms, conditions and provisions hereof or thereof by the Borrower will
(a) conflict with, or result in a breach or violation of, or constitute a default under any of the Charter Documents, (b) conflict
with or contravene (i) any Applicable Law, (ii) any contractual restriction binding on or affecting the Borrower or any of its
assets, or (iii) any order, writ, judgment, award, injunction or decree binding on or affecting the Borrower or any of its assets,
(c) result in a breach or violation of, or constitute a default under, or permit the acceleration of any obligation or liability
in, or but for any requirement for the giving of notice or the passage of time (or both) that would constitute such a conflict
with, breach or violation of, default under, or permit any such acceleration in, any contractual obligation or any agreement or
document to which the Borrower is a party or by which it or any of its properties is bound (or to which any such obligation, agreement
or document relates), or (d) result in any Adverse Claim upon any asset of the Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.04.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governmental Authorizations; Private Authorization</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Other
than the filing of the financing statement in the form attached to the Security Agreement in the office indicated on such financing
statement, the Borrower has obtained all necessary Governmental Authorizations and Private Authorizations, and made all Governmental
Filings necessary for the execution and delivery by the Borrower of, and the performance by the Borrower of its obligations under,
this Agreement and each of the other Loan Documents to which it is a party and the agreements, certificates and instruments contemplated
hereby or thereby, and no Governmental Authorization, Private Authorization or Governmental Filing which has not been obtained
or made, is required to be obtained or made by the Borrower in connection with the execution and delivery by the Borrower of,
or the performance of its obligations under, this Agreement or any of the other Loan Documents.</FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 228pt"></P>




<!-- Field: Page; Sequence: 63; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.05.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulations T, U and X</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
execution, delivery and performance by the Borrower of this Agreement, the Notes and the other Loan Documents to which it is a
party and the transactions contemplated hereunder and thereunder will not (assuming all Federal Reserve Forms referred to in Article
III shall have been executed and delivered by the Borrower and the appropriate Bank for retention in the files of such Bank) violate
or be inconsistent with any provision of Regulation T, Regulation U or Regulation X.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.06.</B> <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Affiliation with Banks</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">So
far as appears from the records of, and to the knowledge of, the Borrower, neither any Bank nor any Affiliate of any Bank is an
Affiliate of the Borrower, and none of the Borrower or any Affiliate of the Borrower is an Affiliate of any Bank or any Affiliate
thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.07.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Subsidiaries</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
Borrower has no Subsidiaries.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.08.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Financial Information</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The financial statement filed by the Borrower with the SEC and included in the Prospectus, together with the notes thereto, presents
fairly, in all material respects, and in conformity with Generally Accepted Accounting Principles the financial position of the
Borrower as of the date specified therein.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since the date of the filing of the financial statement referred to in <U>Section 4.08(a)</U>,
there has been no event or circumstance that has resulted in a Material Adverse Effect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The financial statement of the Borrower filed with the SEC in accordance with this Section
4.08 fairly presents all material contingent liabilities in accordance with Generally Accepted Accounting Principles.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SECTION
4.09.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Litigation</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">There
is no action, suit, proceeding or investigation of any kind pending against, or to the knowledge of the Borrower, threatened against
or affecting, the Borrower before any court or arbitrator or any Authority which (a) would reasonably be expected to have a Material
Adverse Effect, (b) could reasonably be construed as calling into question the validity or enforceability of, or as otherwise
seeking to invalidate, any Loan Document, or (c) might, individually or in the aggregate, materially adversely affect any Loan
Document.&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 64; Value: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.10.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>ERISA</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower is not a member of an ERISA Group and has no liability in respect of any Benefit Arrangement, Plan or Multiemployer
Plan subject to ERISA.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Loan will constitute a &ldquo;prohibited transaction&rdquo; within the meaning of Section 406 of ERISA or Section 4975 of the
Internal Revenue Code for which an exemption is not available, <U>provided</U> that no Lender is a &ldquo;benefit plan investor&rdquo;
within the meaning of Section 3(42) of the ERISA.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.11.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Taxes</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower has elected to be treated and qualifies as a &ldquo;regulated investment company&rdquo; within the meaning of the Internal
Revenue Code. The Borrower has timely filed all material United States Federal income tax returns and all other material tax returns
which are required to be filed by it, if any, and has paid all taxes due pursuant to such returns, if any, or pursuant to any
assessment received by the Borrower, except for any taxes or assessments which are being contested in good faith by appropriate
proceedings and with respect to which adequate reserves have been established in accordance with Generally Accepted Accounting
Principles consistently applied and for which non-payment would not reasonably be expected to have a Material Adverse Effect,
and the charges, accruals and reserves on the books of the Borrower in respect of taxes or other governmental charges, if any,
are, in the opinion of the Borrower, adequate.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower is in compliance with the Investment Company Act and the
Securities Act except where (i) noncompliance therewith would not reasonably be expected to have a Material Adverse Effect,
(ii) the necessity of compliance therewith is being contested in good faith by appropriate proceedings, or (iii) exemptive
relief or no-action relief has been obtained therefrom and remains in effect. The Borrower is in compliance with all other
Applicable Laws, all applicable ordinances, decrees, requirements, orders and judgments of, and all of the terms of any
applicable licenses and permits issued by, any Authority except where the necessity of compliance therewith is being
contested in good faith by appropriate proceedings or exemptive relief has been obtained therefrom and remains in effect or
where non-compliance therewith would not reasonably be expected to have a Material Adverse Effect. The Borrower is in
compliance with all agreements and instruments to which it is a party or is subject or to which any of its properties is
bound, in each case where the non-compliance therewith would not reasonably be expected to have a Material Adverse
Effect. The Borrower is in compliance in all material respects with all of its Investment Policies and
Restrictions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;No Default shall have occurred and be continuing.</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower is not subject to any Applicable Law (other than the Investment Company Act) which limits its ability to incur
indebtedness. The Borrower has not entered into any agreement with any Authority limiting its ability to incur
indebtedness.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 65; Options: NewSection; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Fiscal Year</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower has a fiscal year which is twelve calendar months and, as of the Effective Date, ends on <FONT STYLE="color: red"><STRIKE>October</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u><U>December</U></u></FONT></FONT>
31 of each year.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Full Disclosure</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information heretofore furnished by the Borrower to the Agent and the Banks for purposes of or in connection with this Agreement
or any of the other Loan Documents or any transaction contemplated hereby or thereby was and is true and accurate in all material
respects on the date as of which such information was stated or certified, and such information does not contain, when taken as
a whole, any material misrepresentation or any omission to state therein, in light of the circumstances in which they were made,
matters necessary to make the statements made therein not misleading in any material respect. The Borrower has disclosed to the
Banks in writing all facts which, to the best of the Borrower&rsquo;s knowledge after due inquiry (to the extent the Borrower
can now reasonably foresee), may give rise to the reasonable possibility of a Material Adverse Effect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Offering Documents</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in the Prospectus and each report to stockholders of the Borrower, was, on the date thereof, true, accurate
and complete in all material respects and does not contain any untrue statement of material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made,
not misleading in any material respect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>OFAC, USA PATRIOT Act, Anti-Corruption and Other
Regulations</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Neither the Borrower nor any Subsidiary thereof, nor any director, officer, employee, agent or affiliate of the Borrower or any
Subsidiary thereof is a Person that is, or is owned or controlled by Persons that are (x) the subject or target of any sanctions
administered or enforced by the U.S. Department of the Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<U>OFAC</U>&rdquo;),
the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant
sanctions authority (collectively, &ldquo;<U>Sanctions</U>&rdquo;) or (y) located, organized or resident of a country, region, or
territory that is, or whose government is, the subject of Sanctions (currently Cuba, Iran, North Korea, Sudan and Syria)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower and each Subsidiary thereof have implemented and maintain in effect policies and procedures designed to ensure compliance
by such Borrower and each Subsidiary thereof and their respective directors, officers, employees and agents with Anti-Corruption
Laws and applicable Sanctions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower and each Subsidiary thereof and their respective officers and employees
and, to the knowledge of the Borrower, its directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions
in all material respects.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4.17.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Title to Assets</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower has good and marketable title to all its assets and other property, except where failure to have such title would not
reasonably be expected to have a Material Adverse Effect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COVENANTS</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 196pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower agrees that, so long as any Bank has any Commitment hereunder or any amount payable under the Loan Documents remains
unpaid:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Information</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will deliver to the Agent (along with copies for each of the Banks if such information is not delivered in electronic
format); <U>provided</U> that the Borrower need not deliver any such materials if the information is included in publicly available
filings made with the SEC:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
as soon as available and in any event within 120 days after the end of each fiscal year of the Borrower, a statement of assets
and liabilities of the Borrower, including the portfolio of investments, as of the end of such fiscal year, and the related statements
of operations and changes in net assets of the Borrower for such fiscal year, together with an audit report thereon issued by
Ernst and Young LLP or other independent public accountants of nationally recognized standing;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
as soon as available and in any event within 90 days after the end of the first semi-annual period of each fiscal year of the
Borrower, a statement of assets and liabilities of the Borrower, including the portfolio of investments, as of the end of such
period, and the related statements of operations and changes in net assets of the Borrower for such period, all in reasonable
detail, prepared in accordance with Generally Accepted Accounting Principles, consistently applied, and certified (subject to
the absence of footnotes and normal year-end adjustments) as to fairness of presentation, Generally Accepted Accounting Principles
and consistency by an Authorized Signatory;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
if, as of the close of business on the last Domestic Business Day of each calendar week (each a &ldquo;<U>Calculation Date</U>&rdquo;)
there shall be any Loans outstanding, then as soon as available and in any event not later than the third Domestic Business Day
thereafter, a Borrowing Base Report and a Valuation Report, in each case as at the close of business on such Calculation Date;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
simultaneously with the delivery of each set of financial statements referred to in clauses (a) and (b) above and, without
duplication, each Borrowing Base Report and each Valuation Report delivered pursuant to clause (c) above, and within three
Domestic Business Days after the last day of every calendar month, a certificate substantially in the form of <U>Exhibit
J</U> attached hereto of an Authorized Signatory reasonably acceptable to the Agent stating whether any Event of Default
exists on the date of such certificate and, if any Event of Default </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">then
exists, setting forth the details thereof and the action which the Borrower is taking or proposes to take with respect
thereto;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 67; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;promptly and in any event within (i) one (1) Domestic Business Day after any officer of the Borrower obtains knowledge of any
Default, if such Default is then continuing, a certificate signed by an Authorized Signatory setting forth the details thereof,
and (ii) three (3) Domestic Business Day after such Authorized Signatory obtains knowledge of such Default, a certificate signed
by an Authorized Signatory either (x) advising that such Default no longer exists, or (y) setting forth the action which the Borrower
is taking or proposes to take with respect thereto;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
promptly after the filing thereof with the SEC or the mailing thereof to stockholders of the Borrower, copies of all reports to
shareholders, amendments and supplements to the Borrower&rsquo;s registration statement, the Prospectus, proxy statements, financial
statements and other materials of a financial or otherwise material nature;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
promptly upon any Authorized Signatory becoming aware of any action, suit or proceeding of the type described in <U>Section 4.09</U>,
notice and a description thereof and copies of any filed complaint relating thereto;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
from time to time such additional documents and information as the Agent, at the request of any Bank, may (x) request in order
to comply with &ldquo;know-your-customer&rdquo; and other anti-terrorism, anti-money laundering and similar rules and regulations
and related policies and (y) reasonably request regarding the financial position or business of the Borrower, including without
limitation, listing reports and Valuation Reports; and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
at least five (5) Domestic Business Days prior to the consummation of any repurchase or redemption of shares (including, without
limitation, the Preferred Shares) of the Borrower, written notice of such repurchase or redemption, which written notice shall
contain calculations showing compliance with Sections 5.19 and 5.20 on a pro forma basis.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.02.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment of Obligations</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will duly and punctually pay or cause to be paid the principal and interest on the Loans and all other amounts provided
for in this Agreement and the other Loan Documents. The Borrower will pay and discharge, at or before maturity, all of the Borrower&rsquo;s
lawful obligations and liabilities that, if unpaid, would reasonably be expected to have a Material Adverse Effect, including,
without limitation, tax liabilities, except where the same may be contested in good faith by appropriate proceedings, and will
maintain, in accordance with Generally Accepted Accounting Principles, appropriate reserves for the accrual of any of the same.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Maintenance of Insurance</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will maintain with financially sound and reputable insurance companies, policies with respect to its assets and property
and business of the Borrower against at least such </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">risks
and contingencies (and with no greater risk retentions) and in at least such amounts as are required by the Investment Company
Act; and will furnish to the Banks, upon request, information presented in reasonable detail as to the insurance so carried.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 68; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Conduct of Business and Maintenance of Existence</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower will continue to engage in business of the same general type as now conducted by it as described in its Prospectus
and as provided pursuant to the Investment Policies and Restrictions as in effect on the Effective Date.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower will preserve, renew and keep in full force and effect its existence as a Maryland corporation and its rights, privileges
and franchises necessary in the normal conduct of its business. The Borrower will maintain in full force and effect its registration
as a closed-end management company under the Investment Company Act.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower will not amend, restate, supplement or otherwise modify any of the Charter Documents or the Pricing Procedures
if such amendment, termination, supplement or modification would reasonably be expected to have a Material Adverse Effect.
The Borrower will provide copies to the Agent of all amendments, restatements, supplements, and other modifications of the
Pricing Procedures or any of the Charter Documents, in each case no later than fourteen (14) days thereafter. The Borrower
will comply in all material respects with the Pricing Procedures and the Charter Documents.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower will at all times place and maintain the Collateral (as defined in the Security Agreement) in the custody of the
Custodian.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Compliance with Laws</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will comply in all respects with the Investment Company Act, all other Applicable Laws and the requirements of any Authority
with respect thereto except where (i) non-compliance therewith would not reasonably be expected to have a Material Adverse Effect,
(ii) the necessity of compliance therewith is contested in good faith by appropriate proceedings, or (iii) exemptive relief, no-action
or interpretive relief has been obtained therefrom and remains in effect. The Borrower will file all material federal and other
material tax returns, reports and declarations required by all relevant jurisdictions on or before the due dates for such returns,
reports and declarations and will pay all taxes due pursuant to such returns and other material governmental assessments and charges
as and when they become due (except those that are being contested in good faith by the Borrower and as to which the Borrower
has established appropriate reserves on its books and records).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.06.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;<B>Inspection of Property, Books and Records</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will, or will cause the Custodian (on the Borrower&rsquo;s behalf) to, keep proper books of account and records in
which full, true and correct entries shall be made of all dealings and transactions in relation to its business and
activities in accordance with Applicable Law, including the Investment Company Act, and will (a) if an Event of Default shall
then exist, during normal business hours, or (b) in all other events, upon three (3) Domestic Business Days </FONT>advance
notice and during normal business hours, permit representatives of any Bank, at such Bank&rsquo;s expense, to visit and
inspect any of its offices, to examine and make abstracts from any of its books and records and to discuss its affairs,
finances and accounts with its officers, employees and independent public accountants, with reasonable frequency (not to
exceed 2 times a year, except in during the continuance of an Event of Default).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 69; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.07.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Indebtedness</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not create, assume or suffer to exist any Indebtedness other than:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(i) Debt arising under this Agreement, the Notes and the other Loan Documents, and (ii) Debt in respect of the MSC Obligations;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Debt in favor of the Custodian incurred for purposes of clearing and settling purchases and sales of securities or consisting
of overnight extensions of credit from the Custodian in the ordinary course of business;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Debt in respect of judgments or awards that have been in force for less than the applicable period for taking an appeal so long
as such judgments and awards do not constitute an Event of Default and so long as execution is not levied thereunder and in respect
of which the Borrower (i) shall at the time in good faith be prosecuting an appeal or proceedings for review and in respect of
which a stay of execution shall have been obtained pending such appeal or review or (ii) shall have obtained an unsecured performance
bond, and Debt in respect of such unsecured performance bond;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Debt (other than Debt for borrowed money) arising in connection with portfolio investments and investment techniques arising in
the ordinary course of the Borrower&rsquo;s business to the extent that such Debt is permissible under the Investment Company
Act and consistent with the Borrower&rsquo;s Investment Policies and Restrictions, including, without limitation, any Debt arising
under reverse repurchase agreements and derivative transactions; and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred Shares having an Involuntary Liquidation Preference not to exceed $150,000,000 at any time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>
that in no event shall the Borrower (i) enter into or utilize Financial Contracts other than in the ordinary course of
business for hedging or investment purposes in accordance with its Investment Policies and Restrictions, or (ii) borrow money
or create leverage under any arrangement other than (A) from the Banks hereunder, or (B) from the Custodian to the extent
provided in clause (d) hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.08.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Liens</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not create, assume, incur or suffer to exist any Lien on any of its assets (including the income and profits
thereof) or segregate any of its assets (including the income and profits thereon) to cover any of its obligations, in each
case whether such asset is now owned or hereafter acquired, except (a) Liens of the Agent, on behalf of itself and the Banks,
created by or pursuant to any of the Loan Documents; (b) Liens (other than non-possessory Liens which pursuant to Applicable
Law are, or may be, entitled to take priority (in whole or in part) over prior, perfected, liens and security interests) for
judgments or decrees, taxes, assessments or other governmental charges or levies the payment of which is not at the time
required or is being contested in good faith, (c) Liens in favor of the Custodian granted pursuant to the Custody Agreement
to secure obligations arising thereunder, and (d) Liens created in connection with the Borrower&rsquo;s portfolio
investments, securities lending and investment techniques (and not for the primary purpose of borrowing money), including
repurchase agreements and derivative transactions, in each case under this clause (d) to the extent permitted by the
provisions of the Prospectus and the Investment Policies and Restrictions, <U>provided</U> that (i) the aggregate value of
all of the Borrower&rsquo;s assets subject to any Lien permitted by this clause (d) does not at any time exceed 10% of the
Total Assets.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 70; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.09.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;<B>Consolidations, Mergers and Sales of Assets</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not consolidate or merge with or into any other Person, divide or reorganize its assets into a non-series
corporation or entity, nor will the Borrower sell, lease or otherwise transfer, directly or indirectly, all or any
substantial part of its assets to any other Person (in each case, whether in one transaction or a series of related
transactions), except that the Borrower may sell its assets in the ordinary course of business as described in its
Prospectus. The Borrower will not invest all of its investable assets in any other management investment company or otherwise
employ a master-feeder or fund of funds investment structure or any other multiple investment company structure; <U>provided</U>, <U>however</U>,
for the avoidance of doubt, that nothing in this <U>Section 5.09</U> shall limit the Borrower&rsquo;s ability to invest its
assets as contemplated by the Investment Policies and Restrictions. For the avoidance of doubt, nothing in this <U>Section
5.09</U> shall limit the Borrower&rsquo;s ability to enter into the Agreement and Plan of Reorganization, dated as of July
27, 2015, between the Borrower and Ares Multi-Strategy Credit Fund, Inc., a Maryland corporation, and to receive all of the
assets and liabilities of Ares Multi-Strategy Credit Fund, Inc. pursuant to the terms thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Use of Proceeds</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower shall use the proceeds of each Loan for its general business purposes, including, without limitation the purchase of
investment securities<FONT STYLE="color: Red"><STRIKE> and temporary or emergency purposes</STRIKE></FONT>, <U>provided</U> that
in no event shall (a) the proceeds of any Loan be used for purposes which would violate any provision of any applicable statute,
rule, regulation, order or restriction applicable to the Borrower or Regulation U or (b) the Borrower use the proceeds of any
Loan for anything other than its general corporate or working capital purposes.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.11.</B>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Compliance with Investment Policies and
Restrictions</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will at all times comply with the Investment Policies and Restrictions, and will not make any investment, loan, advance
or extension of credit inconsistent with the Investment Policies and Restrictions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 71; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.12.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<B>Non-Affiliation with Banks</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not at any time become an Affiliate of any Bank or any Affiliate thereof, and the Borrower will use its best efforts
to ensure that none of its Affiliates is or becomes an Affiliate of any Bank or any Affiliate thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.13.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Regulated Investment Company</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will maintain its status as a &ldquo;regulated investment company&rdquo; under the Internal Revenue Code at all times
and will use reasonable best efforts (subject to <U>Section 5.21</U>) to make sufficient distributions to qualify to be taxed
as a &ldquo;regulated investment company&rdquo; pursuant to subchapter M of the Internal Revenue Code.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.14.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;No Subsidiary</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not have at any time any Subsidiary.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.15.</B>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>ERISA</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not become a member of any ERISA Group and will not have any liability in respect of any Benefit Arrangement, Plan
or Multiemployer Plan subject to ERISA.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.16.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fiscal Year</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not change its fiscal year from that set forth in <U>Section 4.13</U> hereof without prior written notice to the
Banks.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.17.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulation U</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not permit more than 25% of the value (as determined by any reasonable method) of the Borrower&rsquo;s assets to
be represented by Margin Stock at any time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.18.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Custodian</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not change the Custodian without the prior written consent of the Required Banks.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Asset Coverage</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower will not at any time permit the aggregate amount of Total Liabilities that are Senior Securities Representing Indebtedness
to exceed 33-1/3% of Adjusted Net Assets.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower will not at any time permit the sum of (a) the aggregate Senior Securities Representing Indebtedness of the Borrower
plus (b) the amount of the Involuntary Liquidation Preference to exceed 50.0% of Adjusted Net Assets.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 72; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.20.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Maximum Amount</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not at any time permit the aggregate amount of its outstanding Debt to exceed the Maximum Amount.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted Payments</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower will not declare or make, or allow to be declared or made, any Restricted Payment, except:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower may declare or make any Restricted Payment payable solely in shares of the common stock of the Borrower,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower may declare or make any Restricted Payment if, immediately before and after giving effect thereto, no Event of Default
shall exist or would occur,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Borrower may declare or make any Restricted Payment if, immediately before and after giving effect thereto no principal of
any Loan shall or would be outstanding,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower may make any Restricted Payment that had been previously declared, if the requirements of clause (b) or clause (c)
would have been satisfied if such Restricted Payment had been made on the date of declaration thereof, and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Borrower may declare and make a one-time Restricted Payment to the extent required in order to qualify as a Regulated Investment
Company or otherwise minimize or eliminate federal or state income taxes payable by the Borrower, provided that immediately before
and after giving effect thereto no Block Default shall exist or would occur.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Further Assurances</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower shall execute and deliver all such documents and instruments, and take all such actions, as the Agent may from time to
time reasonably request with respect to the transactions contemplated hereunder or under any of the other Loan Documents.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compliance with Anti-Terrorism Laws, Money Laundering Laws,
Etc.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower shall not, directly or indirectly, use the proceeds of the Loans, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner thereof or other Person (i) in furtherance of an offer, payment, or promise
to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption
Laws, (ii) to fund any activities or business of or with any Person, or in any country, region, or territory that, at the time
of such funding, is, or whose government is, the subject of Sanctions, or (iii) in any other manner that would result in a violation
of Sanctions by any Person (including any Person participating in the Loans, whether as underwriter, advisor, investor or otherwise).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 73; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Borrower shall maintain in effect and enforce policies and procedures designed to ensure compliance by such Borrower, each
Subsidiary thereof and the respective directors, officers, employees and agents of the Borrower and such Subsidiary with Anti-Corruption
Laws and applicable Sanctions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5.24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Preferred Shares Documents</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower shall not enter into any new Preferred Shares Document, nor amend, amend and restate, supplement, or otherwise modify
any existing Preferred Shares Document in any material respect without the prior written consent of the Agent, which consent shall
not be unreasonably withheld or delayed.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFAULTS</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 202pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
6.01.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Events of Default</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
one or more of the following events (&ldquo;<U>Events of Default</U>&rdquo;) shall have occurred and be continuing:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall fail to pay when due (whether at maturity or any accelerated
date of maturity or any other date fixed for payment or prepayment) (i) any interest on any Loan or any fees or any other
amount payable hereunder or under any of the other Loan Documents within five (5) days of the due date therefor, or (ii) any
principal of any Loan; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Borrower shall fail to observe or perform any covenant contained in Sections 2.05(b), 2.05(c), 5.01(a), (b), (c) or (d), 5.04(b),
5.05, 5.07, 5.08, 5.09, 5.10, 5.13, 5.14, 5.17, 5.18, 5.19, 5.20, 5.21, 5.23, or 5.24; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall fail to observe or perform any covenant or agreement contained in this Agreement or any Loan Document (other
than those covered by clause (a) or (b) of this Section and such failure shall continue unremedied for a period of thirty (30)
Domestic Business Days; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
any representation, warranty, certification or statement made (or deemed made) by the Borrower in this Agreement or any other
Loan Document or in any certificate, financial statement or other document delivered pursuant to this Agreement or any other Loan
Document shall prove to have been incorrect in any material respect when made (or deemed made); or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Borrower shall fail to make any payment in respect of any Debt in an aggregate principal amount in excess of the Threshold
Amount when due and any applicable grace period shall have expired; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
any default or other similar event shall occur with respect to Debt of the Borrower in excess of the Threshold Amount which
(i) results in the acceleration of the maturity of such Debt, (ii) enables the holder of such Debt or any Person acting on
such holder&rsquo;s behalf to </FONT>accelerate the maturity thereof, or (iii) in the case of Debt arising under a Financial
Contract, enables the other party thereto to terminate such Financial Contract; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 74; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall seek the appointment of a trustee, receiver, liquidator, custodian or other similar official for it or any
substantial part of its property, or shall commence a voluntary case or other proceeding seeking liquidation, reorganization or
other relief with respect to itself or any of its debts under any bankruptcy, insolvency or other similar law now or hereafter
in effect or seeking the appointment of a trustee, receiver, liquidator or other similar official for it or any substantial part
of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an
involuntary case or other proceeding commenced against it, or the Borrower shall make a general assignment for the benefit of
creditors, or shall fail generally (or admit in writing its inability) to pay its debts as they become due, or shall take any
action to authorize any of the foregoing; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an involuntary case or other proceeding shall be commenced against the Borrower seeking liquidation, reorganization or other relief
with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the
appointment of a trustee, receiver, liquidator, custodian or other similar official of it, and such involuntary case or other
proceeding shall remain undismissed and unstayed for a period of sixty (60) days; or an order for relief shall be entered against
the Borrower under the federal bankruptcy laws as now or hereafter in effect; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a judgment or order for the payment of money in excess of the Threshold Amount shall be rendered against the Borrower and such
judgment or order shall continue unsatisfied or unstayed for a period of thirty (30) days; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any investment advisory agreement or management agreement which is in effect on the Effective Date for the Borrower shall terminate,
unless immediately replaced by a successor advisory agreement or management with its Investment Adviser or a Control Affiliate
thereof, or the Investment Adviser shall cease to be the investment adviser to the Borrower unless the successor thereto is a
Control Affiliate thereof; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the investment adviser of the Borrower shall (i) consolidate with or merge into any other Person, unless it is the survivor or
such other Person is a Control Affiliate thereof, or (ii) sell or otherwise dispose of all or substantially all of its assets;
or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Agent for any reason shall cease to have a valid and perfected first priority security interest in the Collateral (as defined
in the Security Agreement), free and clear of all Adverse Claims; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower&rsquo;s shares of common stock shall be suspended from trading on the New York Stock Exchange for more than two (2)
consecutive days upon which trading in such shares generally occurs on such exchange, or shall be delisted; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any of the Investment Policies and Restrictions that may not be changed without the approval of stockholders of the Borrower are
changed; and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 75; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
while any principal of any Loan is outstanding, (i) any default or event of default shall occur under the Preferred Shares Documents
or (ii) any other event (excluding any event occurring pursuant to the Preferred Shares Documents in accordance with their terms)
shall occur, in each of the foregoing clauses (i) and (ii), that creates an obligation on the Borrower to mandatorily redeem the
Preferred Shares or gives holders of the Preferred Shares the right to redeem the Preferred Shares or a right to any payment (other
than regular dividends or other similar payments in the ordinary course) in connection with the Preferred Shares, in each case
after giving effect to any cure period; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then,
and in every such event, the Agent shall (i) if requested by Banks constituting Required Banks by notice to the Borrower terminate
the Commitments, and they shall thereupon terminate, and (ii) if requested by Banks constituting Required Banks by notice to the
Borrower declare the Loans (together with accrued interest thereon) to be, and the Loans (together with accrued interest thereon
and all other sums owing under the Loan Documents) shall thereupon become, immediately due and payable without presentment, demand,
protest or other notice of any kind, all of which are hereby waived by the Borrower; <U>provided</U>&nbsp;<U>that</U> in the case of any of
the Events of Default specified in clause (g) or (h) above with respect to the Borrower, automatically without any notice to the
Borrower or any other act by the Agent or any Bank, the Commitments shall thereupon terminate and the Loans (together with accrued
interest thereon and all other sums owing under the Loan Documents) shall become immediately due and payable without presentment,
demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
6.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Remedies</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
remedy herein conferred upon the Banks is intended to be exclusive of any other remedy and each and every remedy shall be cumulative
and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or by statute
or any other provision of law.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VII</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
AGENT</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.01.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Appointment and Authorization</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bank irrevocably appoints and authorizes the Agent to take such action as agent on its behalf and to exercise such powers under
this Agreement, the Notes and the other Loan Documents as are delegated to the Agent by the terms hereof or thereof, together
with all such powers as are reasonably incidental thereto. Any reference to an agent for the Banks in, or in connection with,
any Loan Document shall be a reference to the Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.02.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Action by Agent</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duties and responsibilities of the Agent hereunder are only those expressly set forth herein. The relationship between the
Agent and the Banks is and shall be that of agent and principal only, and nothing contained in this Agreement or any of the
other Loan Documents shall be construed to constitute the Agent as a trustee for any Bank. Without limiting the </FONT>generality
of the foregoing, the Agent shall not be required to take any action with respect to any Default except as expressly provided
in <U>Article VI</U>. The Agent shall be deemed not to have knowledge of any Default unless and until notice describing such
Default is given to the Agent by the Borrower or a Bank.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 76; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.03.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consultation with Experts</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Agent may consult with legal counsel, independent public accountants and other experts selected by it and shall not be liable
for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or
experts. The Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan
Document by or through any one or more sub-agents appointed by the Agent. The Agent and any such sub-agent may perform any and
all of its duties and exercise its rights and powers by or through their respective Covered Persons. The exculpatory provisions
of this Article shall apply to any such sub-agent and to the Covered Persons of the Agent and any such sub-agent, and shall apply
to their respective activities in connection with the credit facilities provided for herein as well as activities as Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.04.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liability of Agent</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Agent nor any of its directors, officers, agents or employees shall be liable to a Bank for any action taken or not taken
by it in connection herewith (i) with the consent or at the request of the Required Banks or (ii) in the absence of its own gross
negligence or willful misconduct. Neither the Agent nor any of its directors, officers, agents or employees shall be responsible
for or have any duty to ascertain, inquire into or verify (a) any statement, warranty or representation made in connection with
this Agreement or any borrowing hereunder; (b) the performance or observance of any of the covenants or agreements of the Borrower;
(c) the satisfaction of any condition specified in <U>Article III</U>, except receipt of items required to be delivered to it;
or (d) the validity, enforceability, effectiveness or genuineness of this Agreement, the Notes, the other Loan Documents or any
other instrument or writing furnished in connection herewith or therewith. The Agent shall not incur any liability by acting in
reliance upon any notice, consent, certificate, statement or other writing (including any electronic message, Internet or intranet
website posting or other distribution) believed by it to be genuine or to be signed by the proper party or parties. In determining
compliance with any condition hereunder to the making of a Loan that by its terms must be fulfilled to the satisfaction of the
Banks, the Agent may presume that such condition is satisfactory to the Banks unless the Agent shall have received notice to the
contrary from a Bank within a reasonable period of time prior to the making of such Loan.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.05.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Indemnification</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bank shall, ratably in accordance with its Commitment Percentage (or, if the Commitments shall have expired or terminated, its
Commitment Percentage as in effect immediately prior to such expiration or termination), indemnify the Agent and its affiliates,
officers, directors and employees (to the extent not reimbursed by the Borrower) for all claims, liabilities, losses, damages,
costs, penalties, actions, judgments and expenses and disbursements </FONT>of any kind or nature whatsoever, including, without
limitation, the reasonable fees and disbursements of counsel (collectively, the &ldquo;<U>Liabilities</U>&rdquo;) that such Person
may suffer or incur in connection with this Agreement or any of the other Loan Documents or any action taken or omitted by such
Person hereunder or thereunder, <U>provided</U>&nbsp;<U>that</U> no Bank shall have any obligation to indemnify any such Person
against any Liabilities that are determined in a final, nonappealable judgment by a court of competent jurisdiction to have resulted
from such Person&rsquo;s gross negligence or willful misconduct, <U>provided</U>, <U>however</U>, that no action taken or not
taken in accordance with the directions of the Required Banks shall be deemed to constitute gross negligence or willful misconduct
for purposes of this Section.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 77; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.06.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit Decision</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bank acknowledges that it has, independently and without reliance upon the Agent or any other Bank, and based on such documents
and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Bank
also acknowledges that it will, independently and without reliance upon the Agent or any other Bank, and based on such documents
and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking any
action under this Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.07.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Successor Agent</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Agent may resign at any time by giving written notice thereof to the Banks and the Borrower. Upon any resignation of the Agent,
the Required Banks shall have the right to appoint a successor Agent with, if no Event of Default has occurred and is continuing,
the prior written consent of the Borrower, which consent shall not be unreasonably withheld or delayed. If no successor Agent
shall have been so appointed by the Required Banks within 30 days after the retiring Agent gives notice of resignation, then the
retiring Agent may, on behalf of the Banks, appoint a successor Agent, which shall be a commercial bank organized or licensed
under the laws of the United States of America or of any State thereof and having a combined capital and surplus of at least $50,000,000.
Upon the acceptance of its appointment as Agent hereunder by a successor Agent, such successor Agent shall thereupon succeed to
and become vested with all the rights and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties
and obligations hereunder. After any retiring Agent&rsquo;s resignation hereunder as Agent, the provisions of this Article shall
inure to its benefit as to any actions taken or omitted to be taken by it while it was Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.08.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agent as Bank</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its individual capacity, State Street and any other Bank that serves as a successor Agent hereunder shall have the same obligations
and the same rights, powers and privileges in respect of its Commitment and the Loans made by it as it would have were it not
also the Agent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.09.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distribution by Agent</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
in the opinion of the Agent the distribution of any amount received by it in such capacity hereunder, under the Notes or
under any of the other Loan Documents might involve it in liability, it may refrain from making such distribution until its
right to make such distribution shall have been adjudicated by a court of competent jurisdiction. If a court of competent
jurisdiction shall adjudge that any amount received and distributed by the Agent is to be repaid, each Person to whom any
such distribution shall have been made shall either repay to the Agent its proportionate share of the amount so adjudged to
be repaid or shall pay over the same in such manner and to such Persons as shall be determined by such court.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 78; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.10.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delinquent Banks</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Notwithstanding anything to the contrary contained in this Agreement or any of the other Loan Documents, any Bank that (i)
willfully does not or (ii) does not as a result of a Failure (as defined below) (A) make available to the Agent its <U>pro</U>&nbsp;<U>rata</U>
share of any Loan, or (B) comply with the provisions of <U>Section 9.04</U> with respect to making dispositions and
arrangements with the other Banks, where such Bank&rsquo;s share of any payment received, whether by setoff or otherwise, is
in excess of its <U>pro</U>&nbsp;<U>rata</U> share of such payments due and payable to all of the Banks, in each case as,
when and to the full extent required by the provisions of this Agreement, or (iii) shall become or such Bank&rsquo;s director
or indirect parent company shall become the subject of a Bail-In Action, shall be deemed delinquent (a &ldquo;<U>Delinquent
Bank</U>&rdquo;) and shall be deemed a Delinquent Bank until such time as such delinquency is satisfied. A Delinquent Bank
shall be deemed to have assigned any and all payments due to it from the Borrower, whether on account of outstanding Loans,
interest, fees or otherwise, to the remaining nondelinquent Banks for application to, and reduction of, their respective <U>pro</U>&nbsp;<U>rata</U>
shares of all outstanding Loans, interest, fees and other amounts. The Delinquent Bank hereby authorizes the Agent to
distribute such payments to the nondelinquent Banks in proportion to their respective <U>pro</U>&nbsp;<U>rata</U> shares of
all outstanding Loans. A Delinquent Bank shall be deemed to have satisfied in full a delinquency when and if, as a result of
application of the assigned payments to all outstanding Loans of the nondelinquent Banks, the Banks&rsquo; respective <U>pro</U>&nbsp;<U>rata</U>
shares of all outstanding Loans have returned to those in effect immediately prior to such delinquency and without giving
effect to the nonpayment causing such delinquency. The provisions of this <U>Section 7.10 </U>shall not affect the rights of
the Borrower against any such Delinquent Bank.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
For purposes of this <U>Section 7.10</U>, a &ldquo;<U>Failure</U>&rdquo; of a Bank shall mean (i) it shall seek the appointment
of a trustee, receiver, liquidator, custodian or other similar official for it or any substantial part of its property, or shall
commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its
debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee,
receiver, liquidator or other similar official for it or any substantial part of its property, or shall consent to any such relief
or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against
it, or (ii) it makes a general assignment for the benefit of creditors, or shall fail generally to pay its debts as they become
due, or shall take any corporate action to authorize any of the foregoing, or (iii) an involuntary case or other proceeding shall
be commenced against it seeking liquidation, reorganization or other relief with respect to it or its debts under any bankruptcy,
insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian
or other similar official of it, or (iv) an order for relief shall be entered against it under the bankruptcy laws as now or hereafter
in effect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 79; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7.11.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Erroneous Payments</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Agent notifies a Bank, or any Person who has received funds on behalf of a Bank (any such Bank or other recipient, a &ldquo;Payment
Recipient&rdquo;) that the Agent has determined in its sole discretion that any funds received by such Payment Recipient from
the Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment
Recipient (whether or not known to such Payment Recipient) (any such funds, whether received as a payment, prepayment or repayment
of principal, interest, fees, distribution or otherwise, individually and collectively, an &ldquo;Erroneous Payment&rdquo;) and
demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property
of the Agent, and such Payment Recipient shall (and shall cause any other Payment Recipient who received such funds on its behalf
to) promptly, but in no event later than two (2) Domestic Business Days thereafter, return to the Agent the amount of any such
Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together
with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received
by such Payment Recipient to the date such amount is repaid to the Agent in same day funds at the greater of the Federal Funds
Rate and a rate determined by the Agent in accordance with banking industry rules on interbank compensation from time to time
in effect. A notice of the Agent to any Payment Recipient under this paragraph shall be conclusive, absent manifest error. If
a Payment Recipient receives any payment, prepayment or repayment of principal, interest, fees, distribution or otherwise and
does not receive a corresponding payment notice or payment advice, such payment, prepayment or repayment shall be presumed to
be in error absent written confirmation from the Agent to the contrary.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank hereby authorizes the Agent to set off, net and apply any and all amounts at any time owing to such Bank under any Loan
Document, or otherwise payable or distributable by the Agent to such Bank from any source, against any amount due to the Agent
under the immediately preceding paragraph or under the indemnification provisions of this Agreement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
For so long as an Erroneous Payment (or portion thereof) has not been returned by any Payment Recipient who received such
Erroneous Payment (or portion thereof) (such unrecovered amount, an &ldquo;Erroneous Payment Return Deficiency&rdquo;) to the
Agent after demand therefor in accordance with the provisions of this Section 7.11, (i) the Agent may elect, in its sole
discretion on written notice to such Bank, that all rights and claims of such Bank with respect to the Loans or other
Obligations owed to it up to the amount of the corresponding Erroneous Payment Return Deficiency in respect of such Erroneous
Payment (the &ldquo;Corresponding Loan Amount&rdquo;) shall immediately vest in the Agent upon such election; after such
election, the Agent (x) may reflect its ownership interest in Loans in a principal amount equal to the Corresponding Loan
Amount in the Register, and (y) upon five (5) Domestic Business Days&rsquo; written notice to such Bank, may sell such Loan
(or portion thereof) in respect of the Corresponding Loan Amount, and upon receipt of the proceeds of such sale, the
Erroneous Payment Return Deficiency owing by such Bank shall be reduced by the net proceeds of the sale of such Loan (or
portion thereof), and the Agent shall retain all other rights, remedies and claims against such Bank, and (ii) each party
hereto agrees that, except to the extent that the Agent has sold such Loan, and irrespective of whether the Agent may be
equitably subrogated, the Agent shall be contractually subrogated to all the rights of such Bank with respect to the
Erroneous Payment Return Deficiency (such rights, the &ldquo;Erroneous Payment Subrogation Rights&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 80; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations
owed by any Borrower, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of
such Erroneous Payment that is, comprised of funds received by the Agent or any of its Affiliates from such Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No Payment Recipient shall assert any right or claim to an Erroneous Payment, and each hereby waives, and is deemed to waive,
any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Agent
for the return of any Erroneous Payment received, including without limitation waiver of any defense based on &ldquo;discharge
for value&rdquo; or any similar doctrine.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each party&rsquo;s obligations, agreements and waivers under this Section 7.11 with respect to
the making of any Erroneous Payment shall survive the resignation or replacement of the Agent, any transfer of rights or
obligations by, or the replacement of, a Bank, the termination of the Commitments and/or the repayment, satisfaction or
discharge of all Obligations (or any portion thereof) under any Loan Document.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary herein or in any other Loan Document, neither the Borrower nor any of its Affiliates
shall have any obligations or liabilities directly or indirectly arising out of this Section 7.11 in respect of any Erroneous
Payment.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VIII</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHANGE
IN CIRCUMSTANCES</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 145pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.01.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Costs; Capital Adequacy</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any new law, rule or regulation, or any change after the date hereof in the interpretation or administration of any Applicable
Law, rule or regulation by any governmental authority, central bank or comparable agency charged with the interpretation or administration
thereof, or compliance by any Bank or its Applicable Lending Office with any request or directive (whether or not having the force
of law) of any such authority, central bank or comparable agency in connection therewith issued, promulgated or enacted after
the date hereof shall:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
subject any Bank (or its Applicable Lending Office) to any tax, duty or other charge with respect to its Loans, its Note or
its Commitment, or shall change the basis of taxation of payments to any Bank (or its Applicable Lending Office) of the
principal of or interest on its Loans or any other amounts due under this Agreement or its Commitment, in each case except
for any tax on, or changes in the rate of tax on the overall net income of, or franchise taxes payable by, such Bank or its
Applicable Lending Office imposed by the </FONT>jurisdiction in which such Bank&rsquo;s principal executive office or
Applicable Lending Office is located; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.4in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 81; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
impose, modify or deem applicable any reserve (including, without limitation, any such requirement imposed by the Board of Governors
of the Federal Reserve System), special deposit, insurance assessment or similar requirement against assets of, deposits with
or for the account of, or credit extended by, any Bank (or its Applicable Lending Office) or shall impose on any Bank (or its
Applicable Lending Office) any other condition affecting its Loans, its Note or its Commitment; or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
impose on any Bank any other conditions or requirements with respect to this Agreement, the other Loan Documents, the Loans or
such Bank&rsquo;s Commitment;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
the result of any of the foregoing is to increase the cost to such Bank (or its Applicable Lending Office) of making, funding,
issuing, renewing, extending or maintaining any Loan or such Bank&rsquo;s Commitment, or to reduce the amount of any sum received
or receivable by such Bank (or its Applicable Lending Office) under this Agreement or under its Note with respect thereto, by
an amount deemed by such Bank to be material, then, promptly upon demand by such Bank (and in any event within thirty (30) days
after demand by such Bank) and delivery to the Borrower of the certificate required by <U>Section 8.01(c)</U> hereof (with a copy
to the Agent), the Borrower shall pay to such Bank the additional amount or amounts as will compensate such Bank for such increased
cost or reduction.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If any Bank shall determine that any change after the date hereof in any existing Applicable Law, rule or regulation or any new
law, rule or regulation regarding liquidity or capital adequacy, or any change therein, or any change after the date hereof in
the interpretation or administration thereof by any governmental authority, central bank or comparable agency charged with the
interpretation or administration thereof, or any new request or directive of general applicability regarding liquidity or capital
adequacy (whether or not having the force of law) of any such authority, central bank or comparable agency issued, promulgated
or enacted after the date hereof, has or would have the effect of reducing the rate of return on capital of such Bank (or its
parent corporation) as a consequence of such Bank&rsquo;s Loans or obligations hereunder to a level below that which such Bank
(or its parent corporation) could have achieved but for such law, change, request or directive (taking into consideration its
policies with respect to liquidity and capital adequacy) by an amount deemed by such Bank to be material, then from time to time,
promptly upon demand by such Bank (with a copy to the Agent) (and in any event within thirty (30) days after demand by such Bank)
the Borrower shall pay to such Bank such additional amount or amounts as will compensate such Bank (or its parent corporation)
for such reduction.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank will promptly notify the Borrower and the Agent of any event of which it has knowledge, occurring after the date
hereof, which will entitle such Bank to compensation pursuant to this Section and will designate a different Applicable
Lending Office if such designation will avoid the need for, or reduce the amount of, such compensation and will not, in the
judgment of such Bank, be otherwise disadvantageous to such Bank. A certificate of any Bank claiming compensation under this
Section and setting forth in reasonable detail the </FONT>additional amount or amounts to be paid to it hereunder and the
calculations used in determining such additional amount or amounts shall be conclusive in the absence of manifest error. In
determining such amount, (i) such Bank may use any reasonable averaging and attribution methods, and (ii) such Bank agrees
that the treatment of the Borrower under this <U>Section 8.01</U> shall, on the whole, be no less favorable to the Borrower
than the treatment afforded by such Bank to other similarly situated borrowers.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 82; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Failure or delay on the part of any Bank to demand compensation pursuant to this <U>Section 8.01</U> shall not constitute a waiver
of such Bank&rsquo;s right to demand such compensation; <I>provided</I> that Borrower shall not be required to compensate a Bank
pursuant to this Section for any increased costs incurred or reductions suffered more than six months prior to the date that such
Bank notifies the Borrower of the change giving rise to such increased costs or reductions and of such Bank&rsquo;s intention
to claim compensation therefor (except that, if the change giving rise to such increased costs or reductions is retroactive, then
the six-month period referred to above shall be extended to include the period of retroactive effect thereof).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.02.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Inability to Determine Rates</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SOFR Loans</U>. Subject to Section 8.04, if, on or prior to the first day of any Interest Period for any SOFR Loan: (i) the
Agent determines (which determination shall be conclusive and binding absent manifest error) that Adjusted Term SOFR cannot be
determined pursuant to the definition thereof, or (ii) the Required Banks determine that for any reason in connection with any
request for a SOFR Loan or a conversion thereto or a continuation thereof that Adjusted Term SOFR for any requested Interest Period
with respect to a proposed SOFR Loan does not adequately and fairly reflect the cost to such Banks of making and maintaining such
Loan, and the Required Banks have provided notice of such determination to the Agent, the Agent will promptly so notify the Borrower
and each Bank. Upon notice thereof by the Agent to the Borrower, any obligation of the Banks to make SOFR Loans, and any right
of the Borrower to continue SOFR Loans or to convert Base Rate Loans to SOFR Loans, shall be suspended (to the extent of the affected
SOFR Loans or affected Interest Periods) until the Agent (with respect to clause (b), at the instruction of the Required Banks)
revokes such notice. Upon receipt of such notice, (i) the Borrower may revoke any pending request for a borrowing of, conversion
to or continuation of SOFR Loans (to the extent of the affected SOFR Loans or affected Interest Periods) or, failing that, the
Borrower will be deemed to have converted any such request into a request for a Borrowing of or conversion to Base Rate Loans
in the amount specified therein and (ii) any outstanding affected SOFR Loans will be deemed to have been converted into Base Rate
Loans at the end of the applicable Interest Period. Upon any such conversion, the Borrower shall also pay accrued interest on
the amount so converted, together with any additional amounts required pursuant to <U>Section 8.05</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Base Rate Loan</U>. Subject to <U>Section 8.04</U>, if the Agent determines (which determination shall be conclusive and binding
absent manifest error) that Adjusted Term SOFR cannot be determined pursuant to the definition thereof on any given day, the interest
rate on Base Rate Loans shall be determined by the Agent without reference to clause (b) of the definition of Base Rate until
the Agent revokes such determination.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 83; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Alternate Currency Loans</U>. If the Agent determines or Required Banks determine (in either case, which determination shall
be conclusive absent manifest error) that, with respect to any existing or requested Overnight Rate Loan (each an &ldquo;<U>Affected
Overnight Rate Loan</U>&rdquo;) or any Fixed Rate Loan denominated in an Alternate Currency requested to be made or continued,
or to be converted from any other Loan (each an &ldquo;<U>Affected Alternate Currency Loan</U>&rdquo;), by reason of one or more
circumstances arising after the date hereof affecting the applicable Overnight Interest Rate (in the case of an Affected Overnight
Rate Loan), or the Funding Rate (in the case of an Affected Fixed Rate Loan), as applicable, adequate and reasonable means do
not exist for ascertaining the rate of interest applicable to such Affected Loan, or that such rate of interest will not adequately
and fairly reflect the cost to the Banks of making, maintaining, converting or continuing such Affected Loan because of (i) any
change since the date hereof in any Applicable Law or governmental rule, regulation, order or directive (whether or not having
the force of law) or in the interpretation or administration thereof or (ii) other circumstances arising after the date hereof
affecting the Banks, the Overnight Interest Rate, or the Funding Rate, as applicable, then the Agent may or, at the request of
Required Banks, shall give notice thereof to the Borrower by telephone or facsimile (each a &ldquo;<U>Rate Unavailability Notice</U>&rdquo;).
Notwithstanding the foregoing, the Agent shall not deliver a Rate Unavailability Notice with respect to any Affected Alternate
Currency Loan if the Agent and the Borrower have selected an Alternate Currency Benchmark Replacement for the applicable Alternate
Currency and the applicable Corresponding Tenor, and instead the interest rate applicable to such Affected Alternate Currency
Loan shall be determined by reference to such Alternate Currency Benchmark Replacement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Benchmark Unavailability Period</U>. Upon the Borrower&rsquo;s receipt of notice of the commencement of a Benchmark Unavailability
Period for a then-current Benchmark:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(i) the Borrower shall be deemed to have converted any request for a borrowing of, conversion to or continuation of EURIBOR
Loans to be made, converted or continued during such Benchmark Unavailability Period, into a request for a borrowing of,
conversion to or continuation of Euro Overnight Rate Loans and (ii) except as set forth in clause </FONT>(i) above, at the
end of the Interest Period applicable to each EURIBOR Loan, the Borrower shall repay such EURIBOR Loan (together with accrued
interest thereon to the date of prepayment) in full,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall be deemed to have revoked any request for a
borrowing of, conversion to or continuation of Fixed Rate Loans (which Fixed Rate Loans would be Alternate Currency Loans
(other than EURIBOR Loans) which would accrue interest based upon such Benchmark) to be made, converted or continued during
such Benchmark Unavailability Period and (ii) at the end of the Interest Period applicable to each Fixed Rate Loan (which
Fixed Rate Loan is an Alternate Currency Loan (other than a EURIBOR Loan) which accrues interest based upon such Benchmark),
the Borrower shall repay such Fixed Rate Loan (together with accrued interest thereon to the date of prepayment) in
full,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Borrower shall be deemed to have converted any request for a borrowing of, conversion to or continuation of Fixed Rate
Loans (which Loans would be Dollar Loans which would accrue interest based upon such Benchmark) to be made, converted or </FONT>continued
during such Benchmark Unavailability Period, into a request for a borrowing of, conversion to or continuation of Base Rate
Loans,</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 84; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Borrower shall not make any further request for a borrowing of, conversion to or continuation of Fixed Rate Loans (which Fixed
Rate Loans would accrue interest based upon such Benchmark) to be made, converted or continued during such Benchmark Unavailability
Period, and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the event that such Benchmark Unavailability Period relates
to</FONT> (i)&nbsp; Base Rate Loans or the Adjusted Term SOFR, LIBOR Rate, then notwithstanding anything to the contrary
herein contained, the Base Rate shall be determined without regard to clause (b) of such defined term, (ii) Sterling
Overnight Rate Loans or Daily Simple SONIA, then notwithstanding anything to the contrary herein contained, the Borrower
shall repay such Sterling Overnight Rate Loans (together with accrued interest thereon to the date of prepayment) in full,
and (iii) Euro Overnight Rate Loans or Enhanced &euro;STR, then notwithstanding anything to the contrary herein contained the
Borrower shall repay such Euro Overnight Rate Loans (together with accrued interest thereon to the date of prepayment) in
full.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.03.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Illegality</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any future Applicable Law, rule, regulation, treaty or directive, or any change in any present or future Applicable Law,
rule, regulation, treaty or directive, or any change in the interpretation or administration of any present or future
Applicable Law, rule, regulation, treaty or directive by any governmental authority, central bank or comparable agency
charged with the interpretation or administration thereof, or compliance by any Bank (or its Designated Lending Office) with
any new directive (whether or not having the force of law) of any such authority, central bank or comparable agency shall
make it unlawful or impossible for any Bank (or its Designated Lending Office) to make, maintain or fund its Fixed Rate Loans
and such Bank shall so notify the Agent, the Agent shall forthwith give notice thereof to the Banks and the Borrower,
whereupon until such Bank notifies the Borrower and the Agent that the circumstances giving rise to such suspension no longer
exist, (a) the commitment of such Bank to make Fixed Rate Loans or convert or roll over Loans as or to Fixed Rate Loans shall
forthwith be suspended, and </FONT>(b) such Bank&rsquo;s Loans then outstanding as Fixed Rate Loans, if any, shall be
converted automatically to Base Rate Loans (at the U.S. Dollar Equivalent thereof) on the last day of the Interest Period
applicable to such Fixed Rate Loans or within such earlier period as may be required by law. Before giving any notice to the
Agent pursuant to this Section, such Bank shall designate a different Designated Lending Office if such designation will
avoid the need for giving such notice and will not, in the judgment of such Bank, be otherwise disadvantageous to such Bank.
If such Bank shall determine that it may not lawfully continue to maintain and fund any of its outstanding Fixed Rate Loans
to maturity and shall so specify in such notice, the Borrower shall immediately prepay in full the then outstanding principal
amount of each such Fixed Rate Loan, together with accrued interest thereon and any amount payable by the Borrower
pursuant to <U>Section 8.05</U>. Concurrently with so prepaying each such Fixed Rate Loan, the Borrower shall borrow a Base
Rate Loan (in the amount of the U.S. Dollar Equivalent thereof) from such Bank (on which interest and principal shall be
payable contemporaneously with the related Fixed Rate Loans of the other Banks), and such Bank shall make such Base Rate
Loan.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 85; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.04.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Benchmark Replacement Setting</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary herein or in any other Loan Document, if a Benchmark Transition Event and its related
Benchmark Replacement Date have occurred with respect to U.S. Dollar Loans prior to any setting of the then-current Benchmark,
then (x) if a Benchmark Replacement is determined in accordance with clause (a) of the definition of &ldquo;U.S. Dollar Benchmark
Replacement&rdquo; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes
hereunder and under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment
to, or further action or consent of any other party to, this Agreement or any other Loan Document and (y) if a Benchmark Replacement
is determined in accordance with clause (b) of the definition of &ldquo;U.S. Dollar Benchmark Replacement&rdquo; for such Benchmark
Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document
in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th) Domestic Business Day after
the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent
of any other party to, this Agreement or any other Loan Document so long as the Agent has not received, by such time, written
notice of objection to such Benchmark Replacement from Banks comprising the Required Banks. If the Benchmark Replacement is Daily
Simple SOFR, all interest payments will be payable on a monthly basis.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Notwithstanding anything to the contrary herein or in any other Loan Document, if a Benchmark Transition Event and its related
Benchmark Replacement Date have occurred with respect to any Alternate Currency Loan prior to any setting of the then-current
Benchmark, then the applicable Alternate Currency Benchmark Replacement will replace such Benchmark for all purposes hereunder
and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th)
Domestic Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to,
or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Agent has not received,
by such time, written notice of objection to such Benchmark Replacement from Banks comprising the Required Banks.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Benchmark Replacement Conforming Changes</U>. In connection with the use, administration, adoption or implementation of a Benchmark
Replacement, the Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding
anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming
Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 86; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Notices;
Standards for Decisions and Determinations</U>. The Agent will promptly notify the Borrower and the Banks of (i)
the implementation of any Benchmark Replacement and (ii) the effectiveness of any Conforming Changes in connection with the
use, </FONT>administration, adoption or implementation of a Benchmark Replacement. The Agent will notify the Borrower of (x)
the removal or reinstatement of any tenor of a Benchmark pursuant to <U>Section 8.04(e)</U> and (y) the commencement of any
Benchmark Unavailability Period. Any determination, decision or election that may be made by the Agent or, if applicable, any
Bank (or group of Banks) pursuant to this <U>Section 8.04</U>, including any determination with respect to a tenor, rate or
adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from
taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole
discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as
expressly required pursuant to this <U>Section 8.04</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Unavailability of Tenor of Benchmark</U>. Notwithstanding anything to the contrary herein or in any other Loan Document, at
any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a
term rate (including the Term SOFR Reference Rate and any other Funding Rate) and either (A) any tenor for such Benchmark is not
displayed on a screen or other information service that publishes such rate from time to time as selected by the Agent in its
reasonable discretion or (B) the regulatory supervisor for the administrator of such Benchmark has provided a public statement
or publication of information announcing that any tenor for such Benchmark is not or will not be representative, then the Agent
may modify the definition of &ldquo;Interest Period&rdquo; (or any similar or analogous definition) for any Benchmark settings
at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to
clause (i) above either (A) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark
Replacement) or (B) is not, or is no longer, subject to an announcement that it is not or will not be representative for a Benchmark
(including a Benchmark Replacement), then the Agent may modify the definition of Interest Period (or any similar or analogous
definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Benchmark Unavailability Period</U>. Upon the Borrower&rsquo;s receipt of notice of the commencement of a Benchmark Unavailability
Period, the Borrower may revoke any pending request for a SOFR Loan of, conversion to, or continuation of SOFR Loans to be made,
converted or continued during any Benchmark Unavailability Period and, failing that, the Borrower will be deemed to have converted
any such request into a request for a borrowing of or conversion to Base Rate Loans. During a Benchmark Unavailability Period
or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of the Base Rate based upon
the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base
Rate.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Effect of Rate Unavailability Notice</U>. Upon the giving of each Rate Unavailability Notice and until such Rate Unavailability
Notice is rescinded by the Agent or Required Banks:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if such notice was given with respect to an Affected Overnight Rate Loan or the applicable Overnight Interest Rate, either
(1) the Borrower shall repay such Affected Overnight Rate Loan (together with accrued interest thereon to the date of
prepayment) </FONT>in full or (2) such Affected Overnight Rate Loan shall be converted into a Dollar Loan (which shall bear
interest based upon the Base Rate) at the Agent Exchange Rate for the purchase of Dollars with the applicable Alternate
Currency, and the Borrower shall indemnify and hold harmless each such Bank in connection with any liability, loss, cost or
expense in connection therewith, and the Borrower shall not request any new Overnight Rate Loan in the applicable Alternate
Currency; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 87; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if such notice was given with respect to an Affected Alternate Currency Loan (other than an Overnight Rate Loan) or the Funding
Rate applicable to Loans denominated in an Alternate Currency, then (i) at the end of the Interest Period applicable to each such
Loan, either (x) the Borrower shall repay such Loan (together with accrued interest thereon to the date of prepayment) in full
or (y) (1) if such Alternate Currency Loan is denominated in Euros, such Alternate Currency Loan shall be deemed to be automatically
and immediately converted into a Euro Overnight Rate Loan (which shall bear interest based upon Enhanced &euro;STR) or (2) if
such Alternate Currency Loan is denominated in an Alternate Currency other than Euros, such Alternate Currency Loan shall be converted
into a Dollar Loan (which shall bear interest based upon the Base Rate) at the Agent Exchange Rate for purchase of Dollars with
such Alternate Currency, and the Borrower shall indemnify and hold harmless each such Bank in connection with any liability, loss,
cost or expense in connection therewith, and (ii) the Borrower shall not request any new Alternate Currency Loan, or to convert
any Loan to, or continue any Loan as, an Alternate Currency Loan which would be an Affected Alternate Currency Loan or bear interest
based upon such Funding Rate.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agent agrees that promptly after it shall have determined, with respect to any Rate Unavailability Notice given by it under
this Section, that the circumstance or circumstances that gave rise to such Rate Unavailability Notice with respect to an Affected
Loan no longer exist, the Agent shall by notice to the Borrower rescind such Rate Unavailability Notice with respect to such Affected
Loan.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.05.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Indemnity</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Borrower agrees to indemnify each Bank and to hold each Bank harmless from and against any loss, cost or expense (including loss
of anticipated profits) that such Bank may sustain or incur as a consequence of (a) default by the Borrower in payment of the
principal amount of or any interest on any Fixed Rate Loans as and when due and payable, including any such loss or expense arising
from interest or fees payable by such Bank to lenders of funds obtained by it in order to maintain its Fixed Rate Loans, (b) default
by the Borrower in making a borrowing or conversion after the Borrower has given (or is deemed to have given) a Notice of Borrowing
or a Notice of Conversion relating thereto in accordance with <U>Section 2.02</U> or (c) the making of any payment of a Fixed
Rate Loan or the making or conversion of any SOFR Loan to a Base Rate Loan on a day that is not the last day of the applicable
Interest Period with respect thereto, including interest or fees payable by such Bank to lenders of funds obtained by it in order
to maintain any such Loans.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 88; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.06.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Replacement Banks</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
(i) the election of any Bank to request reimbursement by the Borrower for amounts due under <U>Sections 2.09 or 8.01</U> (ii)
the suspension of any Bank&rsquo;s obligation to make, convert to or continue Fixed Rate Loans, (iii) any Bank becoming and remaining
a Delinquent Bank for greater than five (5) Domestic Business days, (iv) any Bank becoming a Potential Delinquent Bank and remaining
a Potential Delinquent Bank for greater than ten (10) consecutive Domestic Business Days or (iv) any Bank failing to agree to
any amendment, waiver, or other modification of any Loan Document requested by the Borrower that requires the consent of 100%
of the Banks or each affected Banks, and which has been consented to by the Required Banks, the Borrower may find a replacement
Bank which shall be reasonably satisfactory to the Agent and the Borrower (a &ldquo;<U>Replacement Bank</U>&rdquo;). Each Bank
agrees that, should it be identified for replacement pursuant to this <U>Section 8.06</U>, it will promptly execute and deliver
(against payment to such Bank of all sums owing to it under the Loan Documents, whether or not then due) all documents and instruments
reasonably required by the Borrower to assign such Bank&rsquo;s Loans and Commitment to the applicable Replacement Bank.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8.07.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Change in Law</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt and notwithstanding anything herein to the contrary, for all purposes of this Credit Agreement, (i) the
Dodd Frank Wall Street Reform and Consumer Protection Act and all requests, rules, regulations, guidelines, interpretations or
directives thereunder or issued in connection therewith (whether or not having the force of law) and (ii) all requests, rules,
regulations, guidelines, interpretations or directives promulgated by the Bank for International Settlements, the Basel Committee
on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities (whether
or not having the force of law), in case for this clause (ii) pursuant to Basel III, shall in each case be deemed to be a change
in law regardless of the date enacted, adopted, issued, promulgated or implemented.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IX</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 181pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Notices</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
All notices, requests, consents and other communications to any party hereunder shall be in writing (including facsimile
transmission or similar writing) and shall be given to such party at its address or facsimile number set forth on Schedule 1
attached hereto or by approved electronic communication in accordance with <U>Section 9.01(b)</U>. Each such notice, request,
consent or other communication shall be deemed to have been given when received. </FONT>Notices delivered through electronic
communications, to the extent provided in paragraph (b) below, shall be effective as provided in said paragraph (b).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 89; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Notices made by the Borrower consisting of requests for loans or notices of repayments hereunder or items referred to in <U>Sections
5.01(a), (b), (c), (e)</U> and <U>(f)</U> hereof may be delivered or furnished by e-mail or other electronic communication
(including internet or intranet websites) pursuant to procedures approved by the Agent, unless the Agent, in its discretion,
has previously notified the Borrower otherwise. In furtherance of the foregoing, each </FONT>Bank hereby agrees to notify the
Agent in writing, on or before the date such Bank becomes a party to this Agreement, of such Bank&rsquo;s e-mail address to
which a notice may be sent (and from time to time thereafter to ensure that Agent has on record an effective e-mail address
for such Bank). Each of the Agent and the Borrower may, in its discretion, agree to accept other notices and communications
to it hereunder by electronic communications pursuant to procedures approved by it; <U>provided</U> that approval of such
procedures may be limited to particular notices or communications. None of the Agent, any Bank, nor any of the directors,
officers, employees, agents or Affiliates of the Agent or any Bank shall be liable for any damages arising from the use by
unintended recipients of any information or other materials distributed through telecommunications, electronic or other
information transmission systems in connection with this Agreement or the other Loan Documents or the transactions
contemplated hereby or thereby, <U>provided</U> that such person shall not be released from liability for any such damages
that are determined in a final, nonappealable judgment by a court of competent jurisdiction to have resulted solely from such
Person&rsquo;s gross negligence or wilful misconduct.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Unless the Agent otherwise prescribes, (i) notices and other communications sent to the Agent or any Bank at an e-mail address
thereof shall be deemed to have been given when received, and (ii) if agreed to pursuant to paragraph (b), above, financial information
posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient, at its e-mail
address as described in the foregoing clause (i), of notification that such notice or communication is available and identifying
the website address therefor; <U>provided</U> that, for both clauses (i) and (ii) above, if such notice, email or other communication
is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent
at the opening of business on the next Domestic Business Day for the recipient.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any party hereto may change its address, facsimile number or e-mail address for notices and other communications hereunder by
notice to the other parties hereto.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower hereby acknowledges that: (i) the Agent may make available to the Banks Specified Materials by posting some or all
of the Specified Materials on an Electronic Platform approved by the Borrower; (ii) the distribution of materials and information
through an electronic medium is not necessarily secure and that there are confidentiality and other risks associated with any
such distribution, (iii) the Electronic Platform is provided and used on an &ldquo;As Is,&rdquo; &ldquo;As Available&rdquo; basis;
and (iv) neither the Agent nor any of its Affiliates warrants the accuracy, completeness, timeliness, sufficiency or sequencing
of the Specified Materials posted on the Electronic Platform. The Agent, on behalf of itself and its Affiliates, expressly and
specifically disclaims, with respect to the Electronic Platform, delays in posting or delivery, or problems accessing the specified
materials posted on the electronic platform, and any liability for any losses, costs, expenses or liabilities that may be suffered
or incurred in connection with the Electronic Platform. No representation or warranty of any kind, express, implied or statutory,
including any warranty of merchantability, fitness for a particular purpose, non-infringement of third party rights or freedom
from viruses or other code defects, is made by the Agent or any of its Affiliates in connection with the Electronic Platform.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 90; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank hereby agrees that notice to it in accordance with this <U>Section 9.01</U> specifying that any Specified Materials
have been posted to the Electronic Platform shall, for purposes of this Agreement, constitute effective delivery to such Bank
of such Specified Materials.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank: (i) acknowledges that the Specified Materials, including information furnished to it by the Borrower or the Agent pursuant
to, or in the course of administering, the Loan Documents, may include material, non-public information concerning the Borrowers
or their securities; and (ii) confirms that: (A) it has developed compliance procedures regarding the use of material, non-public
information; and (B) it will handle such material, non-public information in accordance with such procedures and Applicable Laws,
including federal and state securities laws.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.02.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<B>No Waivers</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
failure or delay by the Agent or any Bank in exercising any right, power or privilege hereunder or under any Notes shall operate
as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights
or remedies provided by law.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.03.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<B>Expenses; Documentary Taxes; Indemnification</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower shall promptly pay (i) all reasonable out-of-pocket expenses of the Agent, including reasonable fees and disbursements
of special counsel for the Agent, in connection with the preparation, negotiation and closing of this Agreement and the Loan Documents,
the syndication of and the administration of the facility established hereby, any waiver or consent hereunder or any amendment
hereof or thereof or any waiver of any Default or alleged Default, and any termination hereof or thereof and (ii) if a Default
occurs, all reasonable out-of-pocket expenses incurred by the Agent and each Bank, including reasonable fees and disbursements
of counsel, in connection with such Default and collection, bankruptcy, insolvency and other enforcement proceedings resulting
therefrom. The Borrower shall indemnify each Bank against any transfer taxes, documentary taxes, assessments or charges made by
any governmental authority by reason of the execution and delivery of this Agreement or the Notes.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Borrower agrees to indemnify the Agent, each Bank, and each of their affiliates, officers, directors and employees
(each, a &ldquo;<U>Covered Person</U>&rdquo;) and hold each Covered Person harmless from and against any and all Liabilities
which may be incurred by or asserted or awarded against such Covered Person, in each case arising out of or in connection
with any investigative, administrative or judicial proceeding (whether or not such Covered Person shall be designated a party
thereto) relating to or arising out of this Agreement or the Loan Documents or any actual or proposed use of proceeds of
Loans hereunder, <U>provided</U> that no Covered Person shall have the right to be indemnified hereunder for Liabilities that
are determined in a final, nonappealable judgment by a court of competent jurisdiction to have resulted from such Covered
Person&rsquo;s gross negligence, bad faith or willful misconduct.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 91; Value: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
















<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.04.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Set Off</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the continuance of any Event of Default, any deposits or other sums credited by or due from any of the Banks to the Borrower and
any Collateral (as defined in the Security Agreement) in the possession of any such Bank may be applied to or set off by such
Bank against the payment of the Obligations. Each of the Banks agrees with each other Bank that if such Bank shall receive from
the Borrower whether by voluntary payment, exercise of the right of set off, counterclaim, cross action, or enforcement of a claim
based on the Obligations owing to such Bank by proceedings against the Borrower at law or in equity or by proof thereof in bankruptcy,
reorganization, liquidation, receivership or similar proceedings, or otherwise, and shall retain and apply to the payment of the
Obligations owing to such Bank any amount in excess of its ratable portion of the payments received by all of the Banks with respect
to the Obligations owed to all of the Banks, such Bank will make such disposition and arrangements with the other Banks with respect
to such excess, either by way of distribution, pro tanto assignment of claims, subrogation or otherwise as shall result in each
Bank receiving in respect of the Obligations owing to it its proportionate payment thereof as contemplated by this Agreement;
provided that if all or any part of such excess payment is thereafter recovered from such Bank, such disposition and arrangements
shall be rescinded and the amount restored to the extent of such recovery, but without interest.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.05.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendments and Waivers</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
provision of this Agreement or any of the other Loan Documents may be amended, waived, supplemented or otherwise modified
if, but only if, contained in a written agreement signed by the Borrower and the Required Banks (and, if the rights or duties
of the Agent are affected thereby, by the Agent); <U>provided</U> that no such agreement shall (i) increase the Commitment
Amount of any Bank without the written consent of such Bank, (ii) reduce the principal amount of any Loan, or reduce the rate
of any interest, or reduce any fees, payable under the Loan Documents, without the written consent of each Bank affected
thereby thereof, (iii) postpone the Termination Date or the date of any payment for any Loan or any interest or any fees
payable under the Loan Documents, or reduce the amount of, waive or excuse any such payment, or postpone the stated
termination or expiration of the Aggregate Commitment Amount, without the written consent of each Bank affected thereby, (iv)
change any provision hereof in a manner that would alter the pro rata sharing of payments required hereby or the pro rata
reduction of Commitment Amounts required hereby, without the written consent of each Bank affected thereby, (v) change any of
the provisions of this Section or the definition of the term &ldquo;Required Banks&rdquo; or any other provision hereof
specifying the number or percentage of Banks required to waive, amend, supplement or otherwise modify any rights hereunder,
(vi) change the currency in which Loans are to be made or payment under the Loan Documents is to be made, or add additional
borrowers, in each case without the written consent of each Bank, or (vii) release all or substantially all of the Collateral
(as defined in the Security Agreement) from the liens thereunder (except as may be expressly provided in the applicable
Security Document), without the consent of each Bank, and <U>provided</U> further that no such agreement shall amend, modify
or otherwise affect the rights or duties of the Agent without the prior written consent of the Agent. No delay or omission on
the part of any Bank or any holder hereof in exercising any right hereunder shall operate as a waiver of such right or of any
other rights of such Bank or such </FONT>holder, nor shall any delay, omission or waiver on any one occasion be deemed a bar
or waiver of the same or any other right on any further occasion.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 92; Options: NewSection; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.06.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Successors and Assigns</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and assigns, except that the Borrower may not assign or otherwise transfer any of its rights under this Agreement without the
prior written consent of all of the Banks (and any attempted assignment or transfer by the Borrower without such consent shall
be null and void).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Any Bank may at any time grant to one or more commercial banks (each a &ldquo;<U>Participant</U>&rdquo;) participating
interests in its Commitment or all of its Loans. In the event of any such grant by a Bank of a participating interest to a
Participant, whether or not upon notice to the Borrower and the Agent, such Bank shall remain responsible for the performance
of its obligations hereunder, and the Borrower and the Agent shall continue to deal solely and directly with such Bank in
connection with such Bank&rsquo;s rights and obligations under this Agreement. Any agreement pursuant to which any Bank may
grant such a participating interest shall provide that such Bank shall retain the sole right and responsibility to enforce
the obligations of the Borrower hereunder, including, without limitation, the right to approve any amendment, restatement,
supplement or other modification or waiver of any provision of this Agreement; <U>provided</U> that such participation
agreement may provide that such Bank will not agree to any amendment, restatement, supplement or other modification or waiver
of this Agreement described in clauses (i), (ii), (iii), (iv), (v), (vi) and (vii) of <U>Section 9.05</U> without the consent
of the Participant. The Borrower agrees that each Participant shall, to the extent provided in its participation agreement,
be entitled to the benefits of <U>Article VIII</U> with respect to its participating interest; <U>provided</U> that no
Participant shall be entitled to receive an amount greater than its <U>pro</U>&nbsp;<U>rata</U> share of any amount the selling Bank
would have received hereunder had no participation been sold. An assignment or other transfer which is not permitted by
clause (c) or (d) of this Section shall be given effect for purposes of this Agreement only to the extent of a participating
interest granted in accordance with this <U>Section 9.06(b)</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Subject to <U>Section 9.06(f)</U>, any Bank may at any time assign to one or more financial institutions considered
a &ldquo;bank&rdquo; as defined in the 1940 Act (each an &ldquo;<U>Assignee</U>&rdquo;) all, or a proportionate amount of
at least $5,000,000 of all, of its rights and obligations under this Agreement and the Notes, and such Assignee shall
assume such rights and obligations, pursuant to an Assignment and Acceptance (each an &ldquo;<U>Assignment
and Acceptance</U>&rdquo;) in substantially the form of <U>Exhibit E</U> attached hereto executed by such Assignee and
such transferor Bank, with, if no Event of Default has occurred and is continuing, the written consent of the Borrower,
which consent shall not be unreasonably withheld or delayed, and of the Agent, which consent shall not be unreasonably
withheld or delayed; <U>provided</U> that no such consent of the Borrower or the Agent shall be required if the Assignee is a
Control Affiliate of the transferor Bank. Upon acceptance and recording of an Assignment and Acceptance pursuant to <U>Section
9.06(h)</U>, from and after the effective date specified therein, (A) the assignee thereunder shall be a party hereto and,
to the extent of the interest assigned by such Assignment and Acceptance, have the rights and obligations of a Bank under
this Agreement and (B) the assigning Bank thereunder shall, to </FONT>the extent of the interest assigned by such Assignment
and Acceptance, be released from its obligations under this Agreement (and, in the case of an Assignment and Acceptance
covering all or the remaining portion of an assigning Bank&rsquo;s rights and obligations under this Agreement, such Bank
shall cease to be a party hereto but shall continue to be entitled to the benefits of <U>Section 8.01</U> and <U>Section
9.03</U> hereof, as well as to any fees accrued for its account and not yet paid). Upon the consummation of any assignment
pursuant to <U>Section 9.06(b)</U>, the transferor Bank, the Agent and the Borrower shall make appropriate arrangements so
that, if required, new Notes are issued to the Assignor and the Assignee. In connection with each such assignment, the
transferor Bank shall pay to the Agent an administrative fee for processing such assignment in the amount of $3,500. The
Assignee shall, prior to the date of consent of the Borrower to the assignment deliver to the Borrower and the Agent a
certification as to exemption from deduction or withholding of any United States Federal income taxes in accordance with <U>Section
2.11</U> (and thereafter shall be subject to the requirements thereof).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>






<!-- Field: Page; Sequence: 93; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without notice to or consent of any Person, any Bank may at any time assign all or any portion of its rights under this Agreement,
its Note, and the other Loan Documents to a Federal Reserve Bank. No such assignment shall release the transferor Bank from its
obligations hereunder.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No Assignee, Participant or other transferee of any Bank&rsquo;s rights shall be entitled to receive any greater payment under
<U>Section 8.01</U> than such Bank would have been entitled to receive with respect to the rights transferred, unless such transfer
is made with the Borrower&rsquo;s prior written consent.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No Person may become an Assignee pursuant to clause (c) above if that Person is an Affiliate of the Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agent, acting solely for this purpose as an agent of the Borrower, shall maintain at one of its offices in Boston, Massachusetts
a copy of each Assignment and Acceptance delivered to it and a register for the recordation of the names and addresses of the
Banks, and the Commitment Amounts of, and principal amounts of the Loans owing to, each Bank pursuant to the terms hereof from
time to time (the &ldquo;<U>Register</U>&rdquo;). The entries in the Register shall be conclusive, and the Borrower, the Agent
and the Banks may treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Bank hereunder for
all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the
Borrower and any Bank at any reasonable time and from time to time upon reasonable prior notice.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon its receipt of a duly completed Assignment and Acceptance executed by an assigning Bank and an assignee, an
administrative questionnaire (in such form as supplied by the Agent) completed in respect of the assignee (unless the
assignee shall already be a Bank hereunder), the administrative fee referred to in <U>Section 9.06(c)</U> and, if required,
the written consent of the Borrower and the Agent to such assignment and any applicable tax forms, the Agent shall (i) accept
such Assignment and Acceptance, (ii) record the information contained therein in the Register, and (iii) revise <U>Schedule
1</U> to reflect such Assignment and Acceptance and circulate such revised <U>Schedule 1</U> to the Banks and the Borrower,
which revised <U>Schedule 1</U> </FONT>shall be deemed to be a part hereof and shall be incorporated by reference herein. No
assignment shall be effective unless it has been recorded in the Register as provided in this <U>Section 9.06(h)</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>






<!-- Field: Page; Sequence: 94; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.07.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Governing Law; Submission to Jurisdiction</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and each of the other loan documents are contracts under the laws of the State of New York and shall for all purposes
be construed in accordance with and governed by the laws of State of New York, without regard to conflict of laws principles that
would require the application of the laws of another jurisdiction. The Borrower hereby irrevocably and unconditionally submits,
for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of
America sitting in New York, New York, and any appellate court from any thereof, in any action or proceeding arising out of or
relating to the Loan Documents whether sounding in contract, tort, equity or otherwise, or for recognition or enforcement of any
judgment, and the service of process in any suit being made upon it by mail at the address specified in Section 9.01, and each
of the parties hereto hereby irrevocably and unconditionally agrees that, to the extent permitted by applicable law, all claims
in respect of any such action or proceeding may be heard and determined in such New York State court or, to the extent permitted
by applicable law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.
Nothing in this Credit Agreement shall affect any right that the Agent or any Bank may otherwise have to bring any action or proceeding
relating to this Credit Agreement or the other Loan Documents against the Borrower, or any of its property, in the courts of any
jurisdiction.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.08.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WAIVER OF JURY TRIAL</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
OF THE BORROWER, THE AGENT AND THE BANKS HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. Except to the extent prohibited by law,
the Borrower hereby waives any right it may have to claim or recover in any litigation referred to in the preceding sentence any
special, exemplary, punitive or consequential damages or any damages other than, or in addition to, actual damages. The Borrower
(a) certifies that no representative, agent or attorney of any Bank or the Agent has represented, expressly or otherwise, that
such Bank or the Agent would not, in the event of litigation, seek to enforce the foregoing waivers and (b) acknowledges that
the Agent and the Banks have been induced to enter into this Credit Agreement and the other Loan Documents to which it is a party
by, among other things, the waivers and certifications contained herein.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.09.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Confidential Material</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank agrees that any information, documentation or materials provided by the Borrower or the Borrower&rsquo;s
Affiliates, employees, agents or representatives (&ldquo;<U>Representatives</U>&rdquo;) disclosing the portfolio holdings of
the Borrower or disclosing other non-public information in relation to this Agreement or the other Loan Documents
(&ldquo;<U>Confidential M</U>a<U>terial</U>&rdquo;), whether before or after the date of this Agreement, shall be treated </FONT>confidentially,
using the same degree of care that such Bank uses to protect its own similar material.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">&nbsp;</P>






<!-- Field: Page; Sequence: 95; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Confidential Material may be disclosed to Representatives of each Bank in
connection with the transactions contemplated herein or in connection with managing the relationship of such Bank or its
Affiliates with the Borrower but shall not be disclosed to any third party and may not be used for purposes of buying or
selling securities, including shares issued by the Borrower; <U>provided</U>, <U>however</U>, that the Banks may disclose
Confidential Material to </FONT>(i) the Federal Reserve Board pursuant to applicable rules and regulations promulgated by the
Federal Reserve Board (which, as of the Effective Date, require a filing of a list of all Margin Stock which directly or
indirectly secures a Loan), (ii) the extent required by statute, rule, regulation or judicial process, (iii) counsel for any
of the Banks or the Agent in connection with this Agreement or any of the other Loan Documents, (iv) bank examiners, (v)
auditors, accountants, and service providers for the Banks and their affiliates as long as such auditors, accountants, or
service providers first agree to be bound by the provisions of this <U>Section 9.09</U>, or, or (vi) any Assignee or
Participant (or prospective Assignee or Participant) as long as such Assignee or Participant (or prospective Assignee or
Participant) first agrees to be bound by the provisions of this <U>Section 9.09</U>. Notwithstanding anything to the contrary
contained in this Section, any information that would, but for this sentence, constitute Confidential Material shall cease to
be Confidential Material after the first anniversary of the date such information was first received by the Agent or any
Bank.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bank agrees to promptly provide such information as is reasonably requested by the Borrower in order for the Borrower to monitor
(as required by Applicable Law) whether the Bank&rsquo;s use of Confidential Material complies with this <U>Section 9.09</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.10.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USA Patriot Act</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bank that is subject to the Patriot Act (as hereinafter defined) and the Agent (for itself and not on behalf of any Bank) hereby
notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October
26, 2001)) (the &ldquo;<U>Patriot Act</U>&rdquo;), it is required to obtain, verify and record information that identifies the
Borrower, which information includes the name and address of the Borrower and other information that will allow such Bank or the
Agent, as applicable, to identify the Borrower in accordance with the Patriot Act.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.11.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest Rate Limitation</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges
and other amounts that are treated as interest on such Loan under Applicable Law (collectively the
 &ldquo;<U>charges</U>&rdquo;), shall exceed the maximum lawful rate (the &ldquo;<U>maximum rate</U>&rdquo;) that may be
contracted for, charged, taken, received or reserved by the Bank holding such Loan in accordance with Applicable Law, the
rate of interest payable in respect of such Loan hereunder, together with all of the charges payable in respect thereof,
shall be limited to the maximum rate and, to the extent lawful, the interest and the charges that would have been payable in
respect of such Loan but were not payable as a result of the operation of </FONT>this Section shall be cumulated, and the
interest and the charges payable to such Bank in respect of other Loans or periods shall be increased (but not above the
maximum rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Rate to the date of
repayment, shall have been received by such Bank.<FONT STYLE="color: red"><STRIKE> For the purposes of the Interest Act (Canada),
(i) whenever a rate of interest or fee rate hereunder is calculated on the basis of a year (the &ldquo;deemed year&rdquo;)
that contains fewer days than the actual number of days in the calendar year of calculation, such rate of interest or fee
rate shall be expressed as a yearly rate by multiplying such rate of interest or fee rate by the actual number of days in the
calendar year of calculation and dividing it by the number of days in the deemed year, (ii) the principle of deemed
reinvestment of interest shall not apply to any interest calculation hereunder and (iii) the rates of interest stipulated
herein are intended to be nominal rates and not effective rates or yields.</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: red"><STRIKE>&nbsp;</STRIKE></FONT></P>






<!-- Field: Page; Sequence: 96; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.12.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Survival</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of <U>Sections 7.05, 9.03 and 9.09</U> and <U>ARTICLE VIII</U> shall survive and remain in full force and effect regardless
of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or other termination of
the Commitments or the termination of any Loan Document or any provision thereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.13.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Limitation on Liability</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary contained in the Loan Documents (a) neither any of the members of the Managing Body of the Borrower (collectively,
the &ldquo;Members&rdquo;) nor any shareholders or other equity holders of the Borrower (collectively, the &ldquo;Shareholders&rdquo;)
nor any managers or officers of the Borrower (collectively, the &ldquo;Officers&rdquo;) shall have any personal liability whatsoever
to any of the Banks or the Agent under any of the Loan Documents, (b) the Banks and the Agent shall look solely to the assets
of the Borrower for the payment of any debt, damage, judgment or decree, or for any money that may otherwise become due or payable
to any of them under any of the Loan Documents, and (c) all dealings, undertakings and obligations of the Members and/or the Shareholders
and/or the Officers under the Loan Documents shall be deemed to have been made subject to the foregoing limitations; provided
however that nothing contained herein shall limit, restrict, prevent or otherwise prohibit the Agent or any Bank from pursuing
any claim or cause of action which it may now or hereafter have against any Member or Shareholder or Officer for fraud, misrepresentation
of any material fact or misappropriation of funds or assets.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.14.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Judgment Currency</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
for the purpose of obtaining judgment in any court it is necessary to convert a sum due under the Loan Documents to the Agent
or any Bank (each a &ldquo;<U>Payee</U>&rdquo;) in one currency into another currency, the parties hereto agree, to the fullest
extent that they may effectively do so, that the rate of exchange used shall be that at which, in accordance with normal banking
procedures, such Payee could purchase the first currency with such other currency in the city in which it normally conducts its
foreign exchange operation for the first currency on the day, upon which foreign exchange transactions in such currencies is normally
carried on by banks in such city, which immediately precedes the day on which final judgment is given. The obligation of </FONT>the
Borrower in respect of any sum due from it to a Payee under the Loan Documents shall, notwithstanding any judgment in a currency
(the &ldquo;<U>Judgment Currency</U>&rdquo;) other than that in which such sum is denominated in accordance with the applicable
provisions of the Loan Documents (the &ldquo;<U>Agreement Currency</U>&rdquo;), be discharged only to the extent that on the Domestic
Business Day following receipt by such Payee of any sum adjudged to be so due in the Judgment Currency such Payee may in accordance
with normal banking procedures purchase the Agreement Currency with the Judgment Currency; if the amount of Agreement Currency
so purchased is less than the sum originally due to such Payee in the Agreement Currency, the Borrower agrees notwithstanding
any such judgment to indemnify such Payee against such loss, and if the amount of the Agreement Currency so purchased exceeds
the sum originally due to such Payee, such Payee agrees to remit to the Borrower such excess.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 97; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;<B>Miscellaneous</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. This Agreement and each of the other Loan Documents constitute the entire agreement
and understanding among the parties hereto and supersede any and all prior agreements and understandings, oral or written, relating
to the subject matter hereof. The provisions of this Agreement are severable and if any one clause or provision hereof shall be
held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall affect only
such clause or provision, or part thereof, in such jurisdiction, and shall not in any manner affect such clause or provision in
any other jurisdiction, or any other clause or provision of this Agreement in any jurisdiction.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acknowledgement and Consent to Bail-In of Affected Financial Institutions</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties,
each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the
extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority
and agrees and consents to, and acknowledges and agrees to be bound by:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising
hereunder which may be payable to it by any party hereto that is an Affected Financial Institution; and</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
effects of any Bail-In Action on any such liability, including, if applicable:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a reduction in full or in part or cancellation of any such liability;</FONT></P>






<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a conversion of all, or a portion of, such liability into shares or</FONT> other instruments of ownership in such Affected
Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it,
and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such
liability under this Agreement or any other Loan Document; or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in; text-align: justify">&nbsp;</P>






<!-- Field: Page; Sequence: 98; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of the applicable
Resolution Authority.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.17.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acknowledgement Regarding Any Supported QFCs</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the Loan Documents provide support, through a guarantee or otherwise, for Financial Contracts or any other agreement
or instrument that is a QFC (such support, &ldquo;<U>QFC Credit Support</U>&rdquo; and each such QFC a &ldquo;<U>Supported QFC</U>&rdquo;),
the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation
under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together
with the regulations promulgated thereunder, the &ldquo;<U>U.S. Special Resolution Regimes</U>&rdquo;) in respect of such Supported
QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC
may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the
United States):</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
In the event a Covered Entity that is party to a Supported QFC (each, a &ldquo;<U>Covered Party</U>&rdquo;) becomes subject to
a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support
(and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing
such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would
be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest,
obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event
a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime,
Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be
exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised
under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States
or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of
the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported
QFC or any QFC Credit Support.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this <U>Section 9.17</U>, the following terms have the following </FONT>meanings:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHC
Act Affiliate</U>&rdquo; of a party means an &ldquo;affiliate&rdquo; (as such term is defined under, and interpreted in accordance
with, 12 U.S.C. 1841(k)) of such party.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>






<!-- Field: Page; Sequence: 99; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Covered
Entity</U>&rdquo; means any of the following:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;252.82(b);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;47.3(b); or</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;382.2(b).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Default
Right</U>&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect;
252.81, 47.2 or 382.1, as applicable.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>QFC</U>&rdquo;
has the meaning assigned to the term &ldquo;qualified financial contract&rdquo; in, and shall be interpreted in accordance with,
12 U.S.C. 5390(c)(8)(D).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9.18.</B>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain ERISA Matters</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each Bank (x) represents and warrants, as of the date such Person became a Bank party hereto, to, and (y) covenants, from the
date such Person became a Bank party hereto to the date such Person ceases being a Bank party hereto, for the benefit of the Agent
and not, for the avoidance of doubt, to or for the benefit of any Borrower, that at least one of the following is and will be
true:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such Bank is not using &ldquo;plan assets&rdquo; (within the meaning Section 3(42) of ERISA or otherwise) of one or more Benefit
Plans with respect to such Bank&rsquo;s entrance into, participation in, administration of and performance of the Loans or, the
Commitments or this Agreement,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined
by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance
company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts),
PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption
for certain transactions determined by in-house asset managers), is applicable with respect to such Bank&rsquo;s entrance into,
participation in, administration of and performance of the Loans, the Commitments and this Agreement,</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) such Bank is an investment fund managed by a &ldquo;Qualified Professional Asset Manager&rdquo; (within the meaning of
Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Bank to
enter into, participate in, administer and perform the Loans, the Commitments and this Agreement, (C) the entrance into,
participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the
requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Bank, the
requirements of subsection </FONT>(a) of Part I of PTE 84-14 are satisfied with respect to such Bank&rsquo;s entrance into,
participation in, administration of and performance of the Loans, the Commitments and this Agreement, or</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>






<!-- Field: Page; Sequence: 100; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
such other representation, warranty and covenant as may be agreed in writing between the Agent and such Bank.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Bank or (2) a
Bank has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding
clause (a), such Bank further (x) represents and warrants, as of the date such Person became a Bank party hereto, to, and (y)
covenants, from the date such Person became a Bank party hereto to the date such Person ceases being a Bank party hereto, for
the benefit of, the Agent and not, for the avoidance of doubt, to or for the benefit of any Borrower, that the Agent is not a
fiduciary with respect to the assets of such Bank involved in such Bank&rsquo;s entrance into, participation in, administration
of and performance of the Loans, the Commitments and this Agreement (including in connection with the reservation or exercise
of any rights by the Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this <U>Section 9.16</U>, the following defined terms when used herein have the following meanings:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Benefit
Plan</U>&rdquo; means any of (a) an &ldquo;employee benefit plan&rdquo; (as defined in ERISA) that is subject to Title I of ERISA,
(b) a &ldquo;plan&rdquo; as defined in and subject to Section 4975 of the Internal Revenue Code or (c) any Person whose assets
include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Internal Revenue
Code) the assets of any such &ldquo;employee benefit plan&rdquo; or &ldquo;plan&rdquo;.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>PTE</U>&rdquo;
means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from
time to time.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
page follows.]</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>






<!-- Field: Page; Sequence: 101; Value: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the parties hereto have caused this Agreement to be duly executed by their respective authorized officers
as of the day and year first above written.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARES DYNAMIC CREDIT ALLOCATION
    FUND, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE STREET BANK AND TRUST COMPANY,
    </B>as a Bank and as the Agent</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 221pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 221pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 221pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 248pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund, Inc. &ndash; Credit Agreement</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>






<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>SCHEDULE 1</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Addresses for Notices, Lending Offices, Commitment
Amounts and Commitment Percentages</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><B><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>BORROWER: </U></FONT></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><B><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>ARES DYNAMIC CREDIT ALLOCATION FUND, INC. </U></FONT></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Address for Notices: </U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Ares Dynamic Credit Allocation Fund,
Inc. </U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>2000 Avenue of the Stars,
12th Floor</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Los Angeles, California 90067</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Attn: Scott Lem</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Tel: (310) 201-4129</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Fax: (310) 432-8621&nbsp;</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Email: slem@aresmgmt.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>With a copy to:</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Ares Dynamic Credit Allocation
Fund, Inc.</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>2000 Avenue of the Stars,
12th Floor</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Los Angeles, California
90067</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Attn: General Counsel</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Email: ARCCGeneralCounsel@aresmgmt.com</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Fax: (310) 201-4170</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><U>&nbsp;</U></FONT></P>




<!-- Field: Page; Sequence: 103; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 16pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><B><FONT STYLE="color: Red"><STRIKE><U>BORROWER</U></STRIKE></FONT>:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><B><STRIKE>ARES DYNAMIC CREDIT ALLOCATION FUND,
        INC.</STRIKE></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Address for Notices:</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Ares Dynamic Credit Allocation Fund, Inc.</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>2000 Avenue
of the Stars, 12th Floor</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Los Angeles, California 90067</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Attn: Scott
Lem</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Tel: (310)
201-4129</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Fax: (310)
432-8621</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Email: slem@aresmgmt.com</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>With a copy to:</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Ares Dynamic
Credit Allocation Fund, Inc.</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>2000 Avenue
of the Stars, 12th Floor</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Los Angeles,
California 90067</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Attn: General
Counsel</STRIKE>&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Email: ARCCGeneralCounsel@aresmgmt.com</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><STRIKE>Fax: (310) 201-4170</STRIKE></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red">&nbsp;</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt; color: red"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1pt solid">BANKS:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>COMMITMENT</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMOUNT</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>COMMITMENT</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PERCENTAGE</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: bold; text-align: left">STATE STREET BANK AND TRUST COMPANY</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">212,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">100</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Domestic Lending Office, Designated</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Lending Office
and Office for Notices to the</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Agent for Borrowings and Payments:</B>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">State Street Bank
and Trust Company&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><STRIKE>State
Street Financial Center</STRIKE>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Loan Servicing Unit<FONT STYLE="color: Red"><STRIKE> &ndash;
SFC0310</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><FONT STYLE="color: blue; border-bottom: Blue 1pt solid"><U>M/S
OCB2302</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">One <FONT STYLE="color: red"><STRIKE>Lincoln</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Congress</U></FONT>
Street</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Boston, MA <FONT STYLE="color: red"><STRIKE>02111</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>02114</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Attn: Christopher
Hickey</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Tel: (617) 662-8577&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Fax: (617) 988-6677&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><STRIKE>Email: ais-loanops-csu@statestreet.com</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><I><STRIKE>Alternate Contact</STRIKE></I><STRIKE>:</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Attn: Peter Connolly&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Tel: (617) 662-8588&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><FONT STYLE="font-size: 10pt">Fax:</FONT> <FONT STYLE="font-size: 10pt">(617)</FONT> <FONT STYLE="font-size: 10pt">988-6677</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><STRIKE>Email: ais-loanops-csu@statestreet.com</STRIKE></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><STRIKE>&nbsp;</STRIKE></P>






<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Office for all Other Notices:&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">State Street Bank
and Trust Company&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red; margin-left: 0.25in"><STRIKE>State
Street Financial Center</STRIKE>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Fund Finance<FONT STYLE="color: Red"><STRIKE> &ndash;
SFC0310</STRIKE></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><FONT STYLE="color: red"></FONT> <FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>M/S OCB2302</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">One <FONT STYLE="color: red"><STRIKE>Lincoln</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>Congress
</U></FONT>Street</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Boston, MA <FONT STYLE="color: red"><STRIKE>02111</STRIKE></FONT><FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>02114</U></FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Attn: Charles W.
Reid<FONT STYLE="border-bottom: Blue 1pt solid; color: blue"><u>,</U></FONT> Vice President</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">Tel: (617) 662-0286&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">E-mail: cwreid@statestreet.com</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in">&nbsp;</P>




<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)
<SEQUENCE>13
<FILENAME>tm2416373d4_ex99-xl.htm
<DESCRIPTION>EXHIBIT 99.(L)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xl.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;(l)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><IMG SRC="tm2416373d4_ex99xl-img01.jpg" ALT=""></TD>
    <TD STYLE="text-align: right; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #061E3C">750 E. PRATT STREET SUITE 900
    BALTIMORE, MD 21202</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #061E3C"><B>T</B> 410.244.7400 <B>F
    </B>410.244.7742 www.Venable.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,33,73) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(0,33,73) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">August&nbsp;14, 2024</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2000 Avenue of the Stars, 12<SUP>th</SUP> Floor</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California 90067</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Registration Statement
                                            on Form&nbsp;N-2 (File No.&nbsp;333-279977)</U></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have served as Maryland counsel to Ares Dynamic
Credit Allocation Fund,&nbsp;Inc., a Maryland corporation registered under the Investment Company Act of 1940, as amended (the &ldquo;1940
Act&rdquo;), as a closed-end management investment company (the &ldquo;Company&rdquo;), in connection with certain matters of Maryland
law arising out of the registration of shares of common stock, $0.001 par value per share (the &ldquo;Common Stock&rdquo;), of the Company
having an aggregate offering price of up to $500,000,000 (the &ldquo;Shares&rdquo;), covered by the above-referenced Registration Statement,
and all amendments thereto (the &ldquo;Registration Statement&rdquo;), filed by the Company with the United States Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;). The Shares are to
be issued from time to time pursuant to the Prospectus Supplement and the Distribution Agreement (each as defined herein) in one or more
transactions deemed to be &ldquo;at the market&rdquo; offerings (each, an &ldquo;Offering&rdquo; and, collectively, the &ldquo;Offerings&rdquo;)
under Rule&nbsp;415 of the 1933 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In connection with our representation of the Company,
and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our
satisfaction, of the following documents (hereinafter collectively referred to as the &ldquo;Documents&rdquo;):</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Registration Statement;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
form of prospectus supplement relating to the Shares included in the Registration Statement (the &ldquo;Prospectus Supplement&rdquo;),
substantially in the form transmitted to the Commission under the 1933 Act;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
charter of the Company (the &ldquo;Charter&rdquo;), certified by the State Department of Assessments and Taxation of Maryland (the &ldquo;SDAT&rdquo;);</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Amended and Restated Bylaws of the Company, certified as of the date hereof by an officer of the Company;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
certificate of the SDAT as to the good standing of the Company, dated as of a recent date;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2416373d4_ex99xl-img01.jpg" ALT="">&nbsp;</P>


<P STYLE="border-bottom: rgb(0,33,73) 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;14, 2024</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Page&nbsp;2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Resolutions
adopted by the Board of Directors of the Company (the &ldquo;Board&rdquo;) relating to, among other matters, (a)&nbsp;the sale, issuance
and registration of the Shares and (b)&nbsp;the delegation to (i)&nbsp;certain officers of the Company (the &ldquo;Authorized Officers&rdquo;)
of the power to determine, subject to certain parameters, the offering price of each Share to be sold from time to time pursuant to the
Distribution Agreement and (ii)&nbsp;a Pricing Committee of the Board (the &ldquo;Pricing Committee&rdquo;) of all of the powers of the
Board that may lawfully be delegated to a committee of the Board in connection with the sale and issuance of the Shares (the &ldquo;Resolutions&rdquo;),
certified as of the date hereof by an officer of the Company;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
form of Distribution Agreement (the &ldquo;Distribution Agreement&rdquo;) by and among the Company, Ares Capital Management II LLC, a Delaware limited liability company, and Ares Management Capital Markets
LLC, a Delaware limited liability company;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
certificate executed by an officer of the Company, dated as of the date hereof; and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
other documents and matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions,
limitations and qualifications stated herein.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In expressing the opinion set forth below, we have
assumed the following:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents
to which such party is a signatory, and such party&rsquo;s obligations set forth therein are legal, valid and binding and are enforceable
in accordance with all stated terms.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not
differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted
to us as certified or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records
reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained
in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there
has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2416373d4_ex99xl-img01.jpg" ALT="">&nbsp;</P>


<P STYLE="border-bottom: rgb(0,33,73) 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;14, 2024</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Page&nbsp;3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the issuance of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number
of shares of Common Stock that the Company is then authorized to issue under the Charter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based upon the foregoing, and subject to the assumptions,
limitations and qualifications stated herein, it is our opinion that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is a corporation duly incorporated and existing under and by virtue of the laws of the State of Maryland and is in good standing
with the SDAT.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
issuance of the Shares has been duly authorized and, when and to the extent issued against payment therefor in accordance with the Registration
Statement, the Prospectus Supplement, the Distribution Agreement, the Resolutions and any other actions relating to the Shares taken
by the Board, the Pricing Committee or the Authorized Officers, the Shares will be validly issued, fully paid and nonassessable.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The foregoing opinion is limited to the laws of
the State of Maryland and we do not express any opinion herein concerning federal law or the laws of any other state. We express no opinion
as to the applicability or effect of federal or state securities laws, including the securities laws of the State of Maryland or the
1940 Act, federal or state laws regarding fraudulent transfers or the laws, codes or regulations of any municipality or other local jurisdiction.
To the extent that any matter as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than
the State of Maryland, we do not express any opinion on such matter. The opinion expressed herein is subject to the effect of any judicial
decision which may permit the introduction of parol evidence to modify the terms or the interpretation of agreements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion expressed herein is limited to the matters
specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to
supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion
expressed herein after the date hereof.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="tm2416373d4_ex99xl-img01.jpg" ALT="">&nbsp;</P>


<P STYLE="border-bottom: rgb(0,33,73) 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ares Dynamic Credit Allocation Fund,&nbsp;Inc.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;14, 2024</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Page&nbsp;4</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This opinion is being furnished to you for submission
to the Commission as an exhibit to the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Registration
Statement and the said incorporation by reference and to the use of the name of our firm therein. In giving this consent, we do not admit
that we are within the category of persons whose consent is required by Section&nbsp;7 of the 1933 Act.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 55%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Venable LLP</FONT></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(N)
<SEQUENCE>14
<FILENAME>tm2416373d4_ex99-xn.htm
<DESCRIPTION>EXHIBIT 99.(N)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xn.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0; text-align: right"><FONT STYLE="text-transform: none"><B>Exhibit (n)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Consent of Independent Registered Public Accounting Firm</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the references to our firm under
the captions &ldquo;Financial Highlights&rdquo; and &ldquo;Independent Registered Public Accounting Firm&rdquo; in the Prospectus and
 &ldquo;Independent Registered Public Accounting Firm&rdquo; and &ldquo;Financial Statements&rdquo; in the Statement of Additional Information,
each dated August 14, 2024, and each included in this Registration Statement (Form N-2) of Ares Dynamic Credit Allocation Fund, Inc. (the
 &ldquo;Registration Statement&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the incorporation by reference
of our report dated February 28, 2024, with respect to the financial statements and financial highlights of Ares Dynamic Credit Allocation
Fund, Inc. included in the Annual Report to Shareholders (Form N-CSR) for the year ended December 31, 2023, into this Registration Statement,
filed with the Securities and Exchange Commission.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Ernst &amp; Young LLP</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Los Angeles, California</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">August 14, 2024</P>


<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>15
<FILENAME>tm2416373d4_ex99-xs.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xs.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="text-align: right; margin: 0"><B><I>Exhibit (s)</I></B></P>


<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Tables</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM N-2/A</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>ARES DYNAMIC CREDIT
ALLOCATION FUND, INC.</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered and Carry Forward
Securities</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
Type</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
Class<BR>
Title</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
Calculation<BR>
or Carry<BR>
Forward<BR>
Rule</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
Registered</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
Maximum<BR>
Offering<BR>
Price Per<BR>
Unit</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR>
Aggregate<BR>
Offering<BR>
 Price</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
Rate</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of<BR>
Registration<BR>
Fee</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
Forward<BR>
Form<BR>
Type</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
Forward<BR>
File<BR>
Number</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
Forward<BR>
Initial<BR>
effective<BR>
date</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing Fee<BR>
Previously<BR>
Paid In<BR>
Connection<BR>
with<BR>
Unsold<BR>
Securities<BR>
to be<BR>
Carried<BR>
Forward</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="48" STYLE="border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newly Registered Securities</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Fees to Be<BR>
Paid</P></TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(o)</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$499,000,000</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$147.60</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$73,652.40(1)</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 0%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt; width: 0%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; padding-bottom: 12pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights to<BR>
Purchase Shares of <BR>
Common Stock(2)</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Fees<BR>
Previously<BR>
Paid</P></TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(o)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000,000</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$147.60</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$147.60(3)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding-bottom: 12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights to<BR>
Purchase<BR>
Common Stock(2)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="48" STYLE="border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry Forward Securities</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Carry<BR>
Forward<BR>
Securities</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="16" STYLE="vertical-align: top; border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: right; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Offering Amounts</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500,000,000</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$73,800.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="16" STYLE="vertical-align: top; border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: right; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fees Previously Paid</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$147.60</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="16" STYLE="vertical-align: top; border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: right; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fee Offsets</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="16" STYLE="vertical-align: top; border-left: black 1pt solid; border-bottom: black 1pt solid; padding-left: 12pt; text-align: right; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Fee Due</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$73,652.40</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount represents $147.60 previously paid to register $1,000,000 of common stock, plus $73,652.40 to register the additional $499,000,000 of common stock registered hereby.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No separate consideration will be received by the Registrant. Any shares issued pursuant to an offering of rights to purchase shares of common stock, including any shares issued pursuant to an over-subscription privilege or a secondary over-subscription privilege, will be shares registered under this Registration Statement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant previously paid $</FONT><FONT STYLE="font-size: 10pt">147.60 in connection with the filing of the Registrant&rsquo;s Registration Statement on Form N-2 (File No. 333-279977) with the Securities and Exchange Commission on June 4, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0"></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(T)
<SEQUENCE>16
<FILENAME>tm2416373d4_ex99-xt.htm
<DESCRIPTION>EXHIBIT 99.(T)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2416373d4_ex99-xt.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-4/tm2416373-4_n2aseq1/users" -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit (t)</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KNOW ALL PERSONS BY THESE PRESENT that the undersigned
officers and directors of Ares Dynamic Credit Allocation Fund, Inc. (the &ldquo;Fund&rdquo;), a Maryland Corporation, hereby appoints
Ian Fitzgerald, Scott Lem, Lisa Morgan and David A. Sachs (with full power to act alone) his/her true and lawful <FONT STYLE="background-color: white">attorney-in-fact&nbsp;and
agent, for him/her and on his/her behalf and in his/her name, place and stead, in any and all capacities, to sign, execute and file the
Fund&rsquo;s Registration Statements on Form&nbsp;N-2&nbsp;under the Securities Act of 1933 and the Investment Company Act of 1940 registering
securities of the Fund, including any&nbsp;pre-effective&nbsp;and post-effective amendments thereto, with all exhibits, and any and all
other documents required to be filed with any regulatory authority, federal or state, relating to the registration thereof, or the issuance
of securities thereof, without limitation, granting unto said attorneys, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the premises in order to effectuate the same as fully to
all intents and purposes as he/she might or could do if personally present, hereby ratifying and confirming all that said&nbsp;attorneys-in-fact&nbsp;and
agents, or any of them, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall remain in full force and effect
until revoked in writing.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the undersigned officers and directors of the Fund
have executed this Power of Attorney in one or more counterparts, by hand, via facsimile, email or other means.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature </FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Seth J. Brufsky</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and President and Chief Executive Officer</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Scott Lem</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasurer </FONT></TD>
    </TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Lem</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">(Principal Financial and Accounting <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer)</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David A. Sachs</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David A. Sachs</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    </TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Elaine Orr</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine Orr</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    </TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John J. Shaw</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">John J. Shaw</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Bruce H. Spector</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Bruce H. Spector</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>18
<FILENAME>ck0001515324-20240814.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:ck0001515324="http://www.www.arespublicfunds.com/20240814" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" targetNamespace="http://www.www.arespublicfunds.com/20240814" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/Cover" id="Cover">
        <link:definition>0000 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/FinancialHighlights" id="FinancialHighlights">
        <link:definition>0000 - Disclosure - Senior Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/FeeTable" id="FeeTable">
        <link:definition>0000 - Disclosure - Summary of Fees &amp; Expenses And Example Table</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/GeneralDescriptionOfRegistrant" id="GeneralDescriptionOfRegistrant">
        <link:definition>0000 - Disclosure - General Description of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/CapitalStockLongTermDebtAndOtherSecurities" id="CapitalStockLongTermDebtAndOtherSecurities">
        <link:definition>0000 - Disclosure - Capital Stock Long Term Debt And Other Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240814_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240814_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240814_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" id="ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AffiliatedTransactionsRestrictionsMember" id="ck0001515324_AffiliatedTransactionsRestrictionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AntiTakeoverProvisionsRiskMember" id="ck0001515324_AntiTakeoverProvisionsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AssetAllocationRiskMember" id="ck0001515324_AssetAllocationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankLoanRiskMember" id="ck0001515324_BankLoanRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankObligationsMember" id="ck0001515324_BankObligationsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingMember" id="ck0001515324_BorrowingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertificatesOfDepositRiskMember" id="ck0001515324_CertificatesOfDepositRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CollateralizedLoanObligationRiskMember" id="ck0001515324_CollateralizedLoanObligationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommercialMortgageBackedSecuritiesRiskMember" id="ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommercialPaperRiskMember" id="ck0001515324_CommercialPaperRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommodityRelatedInvestmentsRiskMember" id="ck0001515324_CommodityRelatedInvestmentsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonStocksMember" id="ck0001515324_CommonStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConcentrationRiskMember" id="ck0001515324_ConcentrationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConstructionAndDevelopmentRiskMember" id="ck0001515324_ConstructionAndDevelopmentRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleSecuritiesMember" id="ck0001515324_ConvertibleSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleSecuritiesRiskMember" id="ck0001515324_ConvertibleSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateBondsRiskMember" id="ck0001515324_CorporateBondsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateLoansRiskMember" id="ck0001515324_CorporateLoansRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CounterpartyRiskMember" id="ck0001515324_CounterpartyRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditDefaultSwapsMember" id="ck0001515324_CreditDefaultSwapsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditFacilityMember" id="ck0001515324_CreditFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditRisksMember" id="ck0001515324_CreditRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrencyFuturesAndOptionsThereonMember" id="ck0001515324_CurrencyFuturesAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtObligationsOfNonUsGovernmentsMember" id="ck0001515324_DebtObligationsOfNonUsGovernmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" id="ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativesRiskMember" id="ck0001515324_DerivativesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DistressedSecuritiesRiskMember" id="ck0001515324_DistressedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DoddFrankActRiskMember" id="ck0001515324_DoddFrankActRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmergingMarketsRiskMember" id="ck0001515324_EmergingMarketsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmergingMarketsSecuritiesMember" id="ck0001515324_EmergingMarketsSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EnvironmentalRiskMember" id="ck0001515324_EnvironmentalRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquitySecuritiesAndRelatedInvestmentsMember" id="ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" id="ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventLinkedBondsMember" id="ck0001515324_EventLinkedBondsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventLinkedSwapsMember" id="ck0001515324_EventLinkedSwapsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventRiskMember" id="ck0001515324_EventRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedNoteRiskMember" id="ck0001515324_ExchangeTradedNoteRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedNotesMember" id="ck0001515324_ExchangeTradedNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedProductRiskMember" id="ck0001515324_ExchangeTradedProductRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedProductsMember" id="ck0001515324_ExchangeTradedProductsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExclusionFromDefinitionOfCommodityPoolOperatorMember" id="ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FloatingRateLoansMember" id="ck0001515324_FloatingRateLoansMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignCurrencyRiskMember" id="ck0001515324_ForeignCurrencyRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignSecuritiesMember" id="ck0001515324_ForeignSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignSecuritiesRiskMember" id="ck0001515324_ForeignSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForwardCurrencyExchangeContractsMember" id="ck0001515324_ForwardCurrencyExchangeContractsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FuturesContractsAndOptionsOnFuturesMember" id="ck0001515324_FuturesContractsAndOptionsOnFuturesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralRiskOfInvestingInFundMember" id="ck0001515324_GeneralRiskOfInvestingInFundMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GoldAndOtherPreciousMetalsRiskMember" id="ck0001515324_GoldAndOtherPreciousMetalsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentInterventionInFinancialMarketsMember" id="ck0001515324_GovernmentInterventionInFinancialMarketsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedMortgagePassThroughSecuritiesMember" id="ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighYieldJunkSecuritiesRiskMember" id="ck0001515324_HighYieldJunkSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HybridInstrumentsMember" id="ck0001515324_HybridInstrumentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IlliquidAndRestrictedSecuritiesRiskMember" id="ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeAndDistributionRiskMember" id="ck0001515324_IncomeAndDistributionRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InfectiousIllnessRiskMember" id="ck0001515324_InfectiousIllnessRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InflationInterestRateAndBondMarketRiskMember" id="ck0001515324_InflationInterestRateAndBondMarketRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InflationLinkedFixedIncomeSecuritiesMember" id="ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InfrastructureRiskMember" id="ck0001515324_InfrastructureRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestRateFuturesContractsAndOptionsThereonMember" id="ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InverseFloatingRateSecuritiesMember" id="ck0001515324_InverseFloatingRateSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentGradeCorporateSecuritiesMember" id="ck0001515324_InvestmentGradeCorporateSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentGradeSecuritiesRiskMember" id="ck0001515324_InvestmentGradeSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentsInDifferentPartsOfCapitalStructureMember" id="ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" id="ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeverageRiskMember" id="ck0001515324_LeverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LimitedPartnershipsMember" id="ck0001515324_LimitedPartnershipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiquidityRiskMember" id="ck0001515324_LiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoansOfPortfolioSecuritiesMember" id="ck0001515324_LoansOfPortfolioSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementRiskMember" id="ck0001515324_ManagementRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketDiscountRiskMember" id="ck0001515324_MarketDiscountRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MasterLimitedPartnershipsMember" id="ck0001515324_MasterLimitedPartnershipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MasterLimitedPartnershipsRiskMember" id="ck0001515324_MasterLimitedPartnershipsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MortgageAndAssetBackedSecuritiesMember" id="ck0001515324_MortgageAndAssetBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" id="ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NaturalResourcesRiskMember" id="ck0001515324_NaturalResourcesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsMember" id="ck0001515324_OptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsOnForeignCurrenciesMember" id="ck0001515324_OptionsOnForeignCurrenciesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsOnSecuritiesIndicesMember" id="ck0001515324_OptionsOnSecuritiesIndicesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" id="ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OverCounterTradingRiskMember" id="ck0001515324_OverCounterTradingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PortfolioTurnoverRiskMember" id="ck0001515324_PortfolioTurnoverRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PotentialConflictsOfInterestRiskMember" id="ck0001515324_PotentialConflictsOfInterestRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredSecuritiesRiskMember" id="ck0001515324_PreferredSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredStocksMember" id="ck0001515324_PreferredStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaymentOrCallRiskMember" id="ck0001515324_PrepaymentOrCallRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyLiquidityRiskMember" id="ck0001515324_PrivateCompanyLiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyManagementRiskMember" id="ck0001515324_PrivateCompanyManagementRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyValuationRiskMember" id="ck0001515324_PrivateCompanyValuationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateInvestmentRiskMember" id="ck0001515324_PrivateInvestmentRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateInvestmentTrustsMember" id="ck0001515324_RealEstateInvestmentTrustsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateInvestmentTrustsRiskMember" id="ck0001515324_RealEstateInvestmentTrustsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateMarketRiskMember" id="ck0001515324_RealEstateMarketRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecentMarketEconomicAndSocialDevelopmentsRiskMember" id="ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepurchaseAgreementsRiskMember" id="ck0001515324_RepurchaseAgreementsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResidentialMortgageBackedSecuritiesRiskMember" id="ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReturnOfCapitalRiskMember" id="ck0001515324_ReturnOfCapitalRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReverseRepurchaseAgreementsRiskMember" id="ck0001515324_ReverseRepurchaseAgreementsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithLongTermObjectiveMember" id="ck0001515324_RisksAssociatedWithLongTermObjectiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" id="ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" id="ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" id="ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksOfCurrencyTransactionsMember" id="ck0001515324_RisksOfCurrencyTransactionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" id="ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksRelatingToRussiaInvasionOfUkraineMember" id="ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SectorFocusRiskMember" id="ck0001515324_SectorFocusRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesIndexFuturesContractsAndOptionsThereonMember" id="ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesLendingRiskMember" id="ck0001515324_SecuritiesLendingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortSalesRiskMember" id="ck0001515324_ShortSalesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermDebtObligationsRiskMember" id="ck0001515324_ShortTermDebtObligationsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" id="ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialRisksRelatedToCyberSecurityMember" id="ck0001515324_SpecialRisksRelatedToCyberSecurityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StapledSecuritiesRiskMember" id="ck0001515324_StapledSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrippedMortgageBackedSecuritiesMember" id="ck0001515324_StrippedMortgageBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrippedSecuritiesRiskMember" id="ck0001515324_StrippedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StructuredNotesMember" id="ck0001515324_StructuredNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StructuredSecuritiesMember" id="ck0001515324_StructuredSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubordinatedSecuritiesMember" id="ck0001515324_SubordinatedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubscriptionRightsMember" id="ck0001515324_SubscriptionRightsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SwapAgreementsAndOptionsOnSwapAgreementsMember" id="ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SystemicRiskMember" id="ck0001515324_SystemicRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TemporaryDefensiveStrategiesRiskMember" id="ck0001515324_TemporaryDefensiveStrategiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrackingRiskMember" id="ck0001515324_TrackingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnratedSecuritiesRiskMember" id="ck0001515324_UnratedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsGovernmentSecuritiesMember" id="ck0001515324_UsGovernmentSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsGovernmentSecuritiesRiskMember" id="ck0001515324_UsGovernmentSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValuationRiskMember" id="ck0001515324_ValuationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VariableAndFloatingRateDemandAndMasterDemandNotesMember" id="ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VariableAndFloatingRateSecuritiesRiskMember" id="ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsAndRightsMember" id="ck0001515324_WarrantsAndRightsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ZeroCouponAndPaymentInKindSecuritiesMember" id="ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>ck0001515324-20240814_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_PreferredStocksMember_1" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_CommonStocksMember_2" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_SubscriptionRightsMember_7" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001515324_CreditFacilityMember_1" order="1" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MarketDiscountRiskMember_5" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateMarketRiskMember_6" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfrastructureRiskMember_7" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_NaturalResourcesRiskMember_8" order="5" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SectorFocusRiskMember_9" order="6" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConcentrationRiskMember_10" order="7" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11" order="8" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DistressedSecuritiesRiskMember_12" order="9" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14" order="11" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15" order="12" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16" order="13" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrepaymentOrCallRiskMember_17" order="14" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18" order="15" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19" order="16" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateBondsRiskMember_20" order="17" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditRisksMember_21" order="18" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankLoanRiskMember_22" order="19" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LeverageRiskMember_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PreferredSecuritiesRiskMember_24" order="21" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25" order="22" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfectiousIllnessRiskMember_26" order="23" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27" order="24" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesRiskMember_28" order="25" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsRiskMember_29" order="26" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignCurrencyRiskMember_30" order="27" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31" order="28" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DerivativesRiskMember_32" order="29" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CounterpartyRiskMember_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LiquidityRiskMember_34" order="31" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortSalesRiskMember_35" order="32" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesLendingRiskMember_36" order="33" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RepurchaseAgreementsRiskMember_37" order="34" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38" order="35" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39" order="36" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateLoansRiskMember_40" order="37" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41" order="38" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42" order="39" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ManagementRiskMember_43" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44" order="41" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45" order="42" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UnratedSecuritiesRiskMember_46" order="43" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ValuationRiskMember_47" order="44" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48" order="45" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductRiskMember_49" order="46" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNoteRiskMember_50" order="47" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PortfolioTurnoverRiskMember_51" order="48" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52" order="49" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReturnOfCapitalRiskMember_53" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StapledSecuritiesRiskMember_54" order="51" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55" order="52" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56" order="53" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IncomeAndDistributionRiskMember_57" order="54" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58" order="55" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59" order="56" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60" order="57" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DoddFrankActRiskMember_61" order="58" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TrackingRiskMember_62" order="59" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OverCounterTradingRiskMember_63" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsMember_64" order="61" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65" order="62" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66" order="63" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67" order="64" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68" order="65" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69" order="66" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70" order="67" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71" order="68" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72" order="69" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74" order="71" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75" order="72" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76" order="73" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditDefaultSwapsMember_77" order="74" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78" order="75" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79" order="76" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedBondsMember_80" order="77" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedSwapsMember_81" order="78" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesMember_82" order="79" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductsMember_83" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84" order="81" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_WarrantsAndRightsMember_85" order="82" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BorrowingMember_86" order="83" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87" order="84" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesMember_88" order="85" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89" order="86" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90" order="87" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91" order="88" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankObligationsMember_92" order="89" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialPaperRiskMember_93" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CertificatesOfDepositRiskMember_94" order="91" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95" order="92" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LimitedPartnershipsMember_96" order="93" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsMember_97" order="94" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98" order="95" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesMember_99" order="96" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsSecuritiesMember_100" order="97" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredNotesMember_101" order="98" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredSecuritiesMember_102" order="99" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SubordinatedSecuritiesMember_104" order="101" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FloatingRateLoansMember_105" order="102" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106" order="103" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107" order="104" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedSecuritiesRiskMember_108" order="105" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109" order="106" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110" order="107" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111" order="108" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HybridInstrumentsMember_112" order="109" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsMember_113" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114" order="111" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EnvironmentalRiskMember_115" order="112" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNotesMember_116" order="113" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117" order="114" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118" order="115" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119" order="116" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120" order="117" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateInvestmentRiskMember_121" order="118" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyManagementRiskMember_122" order="119" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyValuationRiskMember_124" order="121" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125" order="122" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126" order="123" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127" order="124" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SystemicRiskMember_128" order="125" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventRiskMember_129" order="126" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AssetAllocationRiskMember_130" order="127" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131" order="128" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>ck0001515324-20240814_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_131"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_132"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_133"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_134"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_135"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_136"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_137"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_138"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_139"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_140"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_141"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_142"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_143"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_144"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_145"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_146"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_147"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_148"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_149"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_150"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_151"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_152"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_153"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_154"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_155"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_156"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_157"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_158"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_159"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_160"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_161"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_162"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_163"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_164"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_165"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_166"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_167"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_168"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_169"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_170"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_171"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_172"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_173"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_174"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_175"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_176"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_177"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_178"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_179"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_180"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_181"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_182"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_183"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_184"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_185"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_186"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_187"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_188"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_189"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_190"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_191"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_192"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_193"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_194"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_195"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_196"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_197"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_198"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_199"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_200"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_201"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_202"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_203"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_204"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_205"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_206"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_207"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_208"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_209"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_210"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_211"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_212"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_213"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_214"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_215"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_216"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_217"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_218"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_219"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_220"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_221"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_222"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_223"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_224"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_225"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_226"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_227"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_228"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_229"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_230"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_231"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_232"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_233"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_234"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_235"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_236"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_237"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_238"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_239"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_240"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_241"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_242"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_243"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_244"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_245"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_246"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_247"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_248"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_249"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_250"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_251"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_252"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_253"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_254"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_255"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_256"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_257"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_258"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_259"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_260"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_261"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_262"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_263"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_264"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_265"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_266"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_267"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_268"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_269"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_270"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_271"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_272"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_273"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_274"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_275"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_276"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_277"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_278"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_279"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_280"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_281"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_282"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_283"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_284"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_285"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_286"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_287"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_288"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_289"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_290"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_291"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_292"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_293"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_294"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_295"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_296"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_297"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_298"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_299"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_300"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_301"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_302"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_303"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_304"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_305"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_306"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_307"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_308"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_309"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_310"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_311"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_312"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_313"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_314"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_315"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_316"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_317"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_318"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_319"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_320"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_321"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_322"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_323"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_324"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_325"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_326"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_327"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_328"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_329"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_330"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_331"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_332"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_333"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_334"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_335"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_336"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_337"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_338"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_339"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_340"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_341"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_342"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_343"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_344"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_345"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_346"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_347"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_350"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_0" xml:lang="en-US">Additional Risks of Foreign Options, Futures Contracts, Options on Futures Contracts and Forward Contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1" xml:lang="en-US">Additional Risks Of Foreign Options, Futures Contracts, Options On Futures Contracts And Forward Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2" xml:lang="en-US">It represents additional risks of foreign options, futures contracts, options on futures contracts and forward contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_0" xml:lang="en-US">It represents risk of affiliated transactions restrictions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_1" xml:lang="en-US">Affiliated Transactions Restrictions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_0" xml:lang="en-US">Anti Takeover Provisions Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_1" xml:lang="en-US">Anti-Takeover Provisions Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_2" xml:lang="en-US">It represents as a anti-takeover provisions risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_0" xml:lang="en-US">Asset Allocation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_1" xml:lang="en-US">It represents as a asset allocation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_2" xml:lang="en-US">Asset Allocation Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_BankLoanRiskMember_0" xml:lang="en-US">Bank Loan Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BankLoanRiskMember_1" xml:lang="en-US">It represents as a bank loan risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BankLoanRiskMember_2" xml:lang="en-US">Bank Loan Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BankObligationsMember_0" xml:lang="en-US">Bank Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BankObligationsMember_1" xml:lang="en-US">It represents risk of bank obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BorrowingMember_0" xml:lang="en-US">Borrowing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BorrowingMember_1" xml:lang="en-US">It represents risk of borrowing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CertificatesOfDepositRiskMember_0" xml:lang="en-US">This member stands for risk of certificates of deposit risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CertificatesOfDepositRiskMember_1" xml:lang="en-US">Certificates Of Deposit Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_0" xml:lang="en-US">Collateralized Loan Obligation ("CLO") Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_1" xml:lang="en-US">Collateralized Loan Obligation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_2" xml:lang="en-US">Collateralized Loan Obligation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_0" xml:lang="en-US">Commercial Mortgage Backed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_1" xml:lang="en-US">It represents as a commercial mortgage backed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_2" xml:lang="en-US">Commercial Mortgage Backed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_0" xml:lang="en-US">It represents as a commercial paper risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_1" xml:lang="en-US">Commercial Paper Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_2" xml:lang="en-US">Commercial Paper Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_0" xml:lang="en-US">Commodity-Related Investments Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_1" xml:lang="en-US">It represents as a commodity related investments risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_2" xml:lang="en-US">Commodity Related Investments Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommonStocksMember_0" xml:lang="en-US">Common Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommonStocksMember_1" xml:lang="en-US">Common Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConcentrationRiskMember_0" xml:lang="en-US">Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConcentrationRiskMember_1" xml:lang="en-US">Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ConcentrationRiskMember_2" xml:lang="en-US">Concentration Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_0" xml:lang="en-US">It represents as a construction and development risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_1" xml:lang="en-US">Construction and Development Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_2" xml:lang="en-US">Construction And Development Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConvertibleSecuritiesMember_0" xml:lang="en-US">Convertible Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConvertibleSecuritiesMember_1" xml:lang="en-US">It represents risk of convertible securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_0" xml:lang="en-US">It represents as a convertible securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_1" xml:lang="en-US">Convertible Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_2" xml:lang="en-US">Convertible Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_0" xml:lang="en-US">Corporate Bonds Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_1" xml:lang="en-US">Corporate Bonds Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_2" xml:lang="en-US">Corporate Bonds Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_0" xml:lang="en-US">Corporate Loans Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_1" xml:lang="en-US">Corporate Loans Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_2" xml:lang="en-US">Corporate Loans Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CounterpartyRiskMember_0" xml:lang="en-US">Counterparty Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CounterpartyRiskMember_1" xml:lang="en-US">It represents as a counterparty risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CounterpartyRiskMember_2" xml:lang="en-US">Counterparty Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_0" xml:lang="en-US">It represents credit default swaps.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_1" xml:lang="en-US">Credit Default Swaps [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_2" xml:lang="en-US">Credit Default Swaps</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditFacilityMember_0" xml:lang="en-US">Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditFacilityMember_1" xml:lang="en-US">Represent information about the credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditRisksMember_0" xml:lang="en-US">This member stands for represents as a credit risks.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CreditRisksMember_1" xml:lang="en-US">Credit Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditRisksMember_2" xml:lang="en-US">Credit Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_0" xml:lang="en-US">Currency Futures And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_1" xml:lang="en-US">Currency Futures and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_2" xml:lang="en-US">It represents currency futures and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_0" xml:lang="en-US">It represents risk of debt obligations of non-U.S. governments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_1" xml:lang="en-US">Debt Obligations of Non-U.S. Governments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_2" xml:lang="en-US">Debt Obligations Of Non Us Governments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_0" xml:lang="en-US">It represents risk of debt securities issued by real estate investment trusts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_1" xml:lang="en-US">Debt Securities Issued By Real Estate Investment Trusts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DerivativesRiskMember_0" xml:lang="en-US">Derivatives Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DerivativesRiskMember_1" xml:lang="en-US">It represents derivatives Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DerivativesRiskMember_2" xml:lang="en-US">Derivatives Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_0" xml:lang="en-US">It represents as a distressed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_1" xml:lang="en-US">Distressed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_2" xml:lang="en-US">Distressed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_0" xml:lang="en-US">Dodd-Frank Act Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_1" xml:lang="en-US">It represents dodd frank act risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_2" xml:lang="en-US">Dodd Frank Act Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_0" xml:lang="en-US">Emerging Markets Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_1" xml:lang="en-US">It represents as a emerging markets risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_2" xml:lang="en-US">Emerging Markets Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EmergingMarketsSecuritiesMember_0" xml:lang="en-US">Emerging Markets Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EmergingMarketsSecuritiesMember_1" xml:lang="en-US">It represents risk of eerging markets securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EnvironmentalRiskMember_0" xml:lang="en-US">It represents risk of environmental risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EnvironmentalRiskMember_1" xml:lang="en-US">Environmental Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_0" xml:lang="en-US">Equity Securities And Related Investments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_1" xml:lang="en-US">It represents risk of equity securities and related investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_0" xml:lang="en-US">It represents risk of eurodollar instruments and samurai and yankee bonds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_1" xml:lang="en-US">Eurodollar Instruments And Samurai And Yankee Bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventLinkedBondsMember_0" xml:lang="en-US">Event Linked Bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventLinkedBondsMember_1" xml:lang="en-US">It represents risk of event linked bonds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventLinkedSwapsMember_0" xml:lang="en-US">Event Linked Swaps [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventLinkedSwapsMember_1" xml:lang="en-US">It represents risk of event linked swaps.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventRiskMember_0" xml:lang="en-US">Event Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_EventRiskMember_1" xml:lang="en-US">Event Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventRiskMember_2" xml:lang="en-US">It represents as a event risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_0" xml:lang="en-US">Exchange Traded Note Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_1" xml:lang="en-US">Exchange Traded Note Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_2" xml:lang="en-US">Exchange Traded Note Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedNotesMember_0" xml:lang="en-US">Exchange Traded Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedNotesMember_1" xml:lang="en-US">It represents risk of exchange-traded notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_0" xml:lang="en-US">Exchange Traded Product Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_1" xml:lang="en-US">Exchange Traded Product Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_2" xml:lang="en-US">It represents Exchange-Traded Product Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedProductsMember_0" xml:lang="en-US">Exchange Traded Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedProductsMember_1" xml:lang="en-US">It represents risk of exchange-traded products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_0" xml:lang="en-US">Exclusion from Definition of Commodity Pool Operator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_1" xml:lang="en-US">It represents exclusion from definition of commodity pool operator.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_2" xml:lang="en-US">Exclusion From Definition Of Commodity Pool Operator [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_FloatingRateLoansMember_0" xml:lang="en-US">It represents risk of floating rate loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_FloatingRateLoansMember_1" xml:lang="en-US">Floating Rate Loans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_0" xml:lang="en-US">It represents as a foreign currency risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_1" xml:lang="en-US">Foreign Currency Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_2" xml:lang="en-US">Foreign Currency Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignSecuritiesMember_0" xml:lang="en-US">It represents risk of foreign securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignSecuritiesMember_1" xml:lang="en-US">Foreign Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_0" xml:lang="en-US">It represents as a foreign securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_1" xml:lang="en-US">Foreign Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_2" xml:lang="en-US">Foreign Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_0" xml:lang="en-US">Forward Currency Exchange Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_1" xml:lang="en-US">Forward Currency Exchange Contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_2" xml:lang="en-US">It represents forward currency exchange contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_0" xml:lang="en-US">Futures Contracts And Options On Futures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_1" xml:lang="en-US">It represents futures contracts and options on future.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_2" xml:lang="en-US">Futures Contracts and Options on Futures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_0" xml:lang="en-US">General Risk Of Investing In Fund [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_1" xml:lang="en-US">General Risks of Investing in the Fund</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_2" xml:lang="en-US">It represents general risks of investing in the fund.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_0" xml:lang="en-US">Gold and Other Precious Metals Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_1" xml:lang="en-US">It represents as a gold and other precious metals risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_2" xml:lang="en-US">Gold And Other Precious Metals Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_0" xml:lang="en-US">Government Intervention In Financial Markets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_1" xml:lang="en-US">It represents risk of government intervention in financial markets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_0" xml:lang="en-US">Guaranteed Mortgage Pass Through Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_1" xml:lang="en-US">It represents risk of guaranteed mortgage pass-through securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_0" xml:lang="en-US">It represents as a high yield ("Junk") securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_1" xml:lang="en-US">High Yield Junk Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_2" xml:lang="en-US">High Yield ("Junk") Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_HybridInstrumentsMember_0" xml:lang="en-US">It represents risk of hybrid instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_HybridInstrumentsMember_1" xml:lang="en-US">Hybrid Instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_0" xml:lang="en-US">It represents as a Illiquid and restricted securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_1" xml:lang="en-US">Illiquid And Restricted Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_2" xml:lang="en-US">Illiquid and Restricted Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_0" xml:lang="en-US">Income and Distribution Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_1" xml:lang="en-US">It represents as a income and distribution risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_2" xml:lang="en-US">Income And Distribution Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_0" xml:lang="en-US">Infectious Illness Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_1" xml:lang="en-US">Infectious Illness Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_2" xml:lang="en-US">It represents infectious illness risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_0" xml:lang="en-US">It represents as a inflation, interest rate and bond market risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_1" xml:lang="en-US">Inflation Interest Rate And Bond Market Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_2" xml:lang="en-US">Inflation, Interest Rate and Bond Market Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_0" xml:lang="en-US">Inflation Linked Fixed Income Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_1" xml:lang="en-US">It represents risk of inflation-linked fixed-income securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InfrastructureRiskMember_0" xml:lang="en-US">Infrastructure Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InfrastructureRiskMember_1" xml:lang="en-US">Infrastructure Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InfrastructureRiskMember_2" xml:lang="en-US">Infrastructure Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_0" xml:lang="en-US">Interest Rate Futures Contracts and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_1" xml:lang="en-US">Interest Rate Futures Contracts And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_2" xml:lang="en-US">It represents interest rate futures contracts and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InverseFloatingRateSecuritiesMember_0" xml:lang="en-US">Inverse Floating Rate Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InverseFloatingRateSecuritiesMember_1" xml:lang="en-US">It represents risk of inverse floating rate securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_0" xml:lang="en-US">It represents risk of investment grade corporate securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_1" xml:lang="en-US">Investment Grade Corporate Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_0" xml:lang="en-US">Investment Grade Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_1" xml:lang="en-US">Investment Grade Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_2" xml:lang="en-US">Investment Grade Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_0" xml:lang="en-US">Investments In Different Parts Of Capital Structure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_1" xml:lang="en-US">It represents risk of investments in different parts of capital structure.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_0" xml:lang="en-US">Investments Where Other Funds Hold Related Investments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_1" xml:lang="en-US">It represents risk of investments where other funds hold related investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_LeverageRiskMember_0" xml:lang="en-US">Leverage Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LeverageRiskMember_1" xml:lang="en-US">Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LeverageRiskMember_2" xml:lang="en-US">Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LimitedPartnershipsMember_0" xml:lang="en-US">Limited Partnerships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LimitedPartnershipsMember_1" xml:lang="en-US">It represents risk of limited partnerships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LiquidityRiskMember_0" xml:lang="en-US">Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LiquidityRiskMember_1" xml:lang="en-US">It represents as a liquidity risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_LiquidityRiskMember_2" xml:lang="en-US">Liquidity Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_0" xml:lang="en-US">Loans Of Portfolio Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_1" xml:lang="en-US">It represents risk of loans of portfolio securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ManagementRiskMember_0" xml:lang="en-US">Management Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ManagementRiskMember_1" xml:lang="en-US">Management Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ManagementRiskMember_2" xml:lang="en-US">It represents as a management risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_0" xml:lang="en-US">Market Discount Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_1" xml:lang="en-US">It represents as a market discount risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_2" xml:lang="en-US">Market Discount Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsMember_0" xml:lang="en-US">Master Limited Partnerships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsMember_1" xml:lang="en-US">It represents risk of master limited partnerships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_0" xml:lang="en-US">MLP Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_1" xml:lang="en-US">It represents as a master limited partnerships risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_2" xml:lang="en-US">Master Limited Partnerships Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_0" xml:lang="en-US">Mortgage And Asset Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_1" xml:lang="en-US">It represents as a mortgage and asset-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_2" xml:lang="en-US">Mortgage and Asset-Backed Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_0" xml:lang="en-US">Multiple Class Pass Through Securities And Collateralized Mortgage Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_1" xml:lang="en-US">It represents risk of multiple-class pass-through securities and collateralized mortgage obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_0" xml:lang="en-US">Natural Resources Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_1" xml:lang="en-US">Natural Resources Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_2" xml:lang="en-US">Natural Resources Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_OptionsMember_0" xml:lang="en-US">Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsMember_1" xml:lang="en-US">Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsMember_2" xml:lang="en-US">It represents options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_0" xml:lang="en-US">It represents options on foreign currencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_1" xml:lang="en-US">Options on Foreign Currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_2" xml:lang="en-US">Options On Foreign Currencies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_0" xml:lang="en-US">Options On Securities Indices [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_1" xml:lang="en-US">It represents options on securities indice.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_2" xml:lang="en-US">Options on Securities Indices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_0" xml:lang="en-US">It represents risk of other risk factors associated with mortgage-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_1" xml:lang="en-US">Other Risk Factors Associated With Mortgage Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_0" xml:lang="en-US">Over Counter Trading Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_1" xml:lang="en-US">Over Counter Trading Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_2" xml:lang="en-US">Over-the-Counter Trading Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_0" xml:lang="en-US">It represents as a portfolio turnover risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_1" xml:lang="en-US">Portfolio Turnover Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_2" xml:lang="en-US">Portfolio Turnover Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_0" xml:lang="en-US">It represents as a potential conflicts of interest risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_1" xml:lang="en-US">Potential Conflicts Of Interest Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_2" xml:lang="en-US">Potential Conflicts of Interest Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_0" xml:lang="en-US">Preferred Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_1" xml:lang="en-US">Preferred Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_2" xml:lang="en-US">This member stands for Preferred Securities Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PreferredStocksMember_0" xml:lang="en-US">Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PreferredStocksMember_1" xml:lang="en-US">Preferred Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PreferredStocksMember_2" xml:lang="en-US">Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_0" xml:lang="en-US">Prepayment or Call Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_1" xml:lang="en-US">Prepayment Or Call Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_2" xml:lang="en-US">It represents as a prepayment or call risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_0" xml:lang="en-US">Private Company Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_1" xml:lang="en-US">It represents risk of private xompany liquidity risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyManagementRiskMember_0" xml:lang="en-US">It represents risk of private company management risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyManagementRiskMember_1" xml:lang="en-US">Private Company Management Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyValuationRiskMember_0" xml:lang="en-US">Private Company Valuation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyValuationRiskMember_1" xml:lang="en-US">It represents risk of private company valuation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateInvestmentRiskMember_0" xml:lang="en-US">Private Investment Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateInvestmentRiskMember_1" xml:lang="en-US">It represents risk of private investment risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsMember_0" xml:lang="en-US">Real Estate Investment Trusts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsMember_1" xml:lang="en-US">It represents risk of real estate investment trusts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_0" xml:lang="en-US">REIT Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_1" xml:lang="en-US">This member stands for real estate investment trusts risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_2" xml:lang="en-US">Real Estate Investment Trusts Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_0" xml:lang="en-US">It represents as a real estate market risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_1" xml:lang="en-US">Real Estate Market Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_2" xml:lang="en-US">Real Estate Market Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_0" xml:lang="en-US">It represents as a risks of recent market, economic and social developments risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_1" xml:lang="en-US">Recent Market Economic And Social Developments Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_0" xml:lang="en-US">It represents as a repurchase agreements risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_1" xml:lang="en-US">Repurchase Agreements Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_2" xml:lang="en-US">Repurchase Agreements Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_0" xml:lang="en-US">Residential Mortgage Backed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_1" xml:lang="en-US">Residential Mortgage Backed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_2" xml:lang="en-US">It represents as a residential mortgage backed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_0" xml:lang="en-US">Return Of Capital Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_1" xml:lang="en-US">It represents as a return of capital risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_2" xml:lang="en-US">Return of Capital Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_0" xml:lang="en-US">Reverse Repurchase Agreements Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_1" xml:lang="en-US">Reverse Repurchase Agreements Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_2" xml:lang="en-US">It represents as a reverse repurchase agreements risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_0" xml:lang="en-US">Risks Associated With Long Term Objective Not a Complete Investment Program</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_1" xml:lang="en-US">Risks Associated With Long Term Objective [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_2" xml:lang="en-US">Risks Associated With Long Term Objective [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_0" xml:lang="en-US">It represents risk of risks associated with long term objective not a complete investment program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_1" xml:lang="en-US">Risks Associated With Long Term Objective Not Complete Investment Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_0" xml:lang="en-US">Risks Associated With Position Limits Applicable To Derivatives [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_1" xml:lang="en-US">Risks Associated with Position Limits Applicable to Derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_2" xml:lang="en-US">It represents as a risks associated with position limits applicable to derivatives.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_0" xml:lang="en-US">It represents as a risks associated with status as a regulated investment company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_1" xml:lang="en-US">Risks Associated With Status Regulated Investment Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_2" xml:lang="en-US">Risks Associated With Status as a Regulated Investment Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_0" xml:lang="en-US">Risks Of Currency Transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_1" xml:lang="en-US">Risks of Currency Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_2" xml:lang="en-US">It represents risks of currency transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_0" xml:lang="en-US">Risks Related To Funds Clearing Broker And Central Clearing Counterparty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_1" xml:lang="en-US">Risks Related to Funds Clearing Broker and Central Clearing Counterparty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_2" xml:lang="en-US">Risks Related to Fund's Clearing Broker and Central Clearing Counterparty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_0" xml:lang="en-US">It represents risk of risks relating to Russia's invasion of Ukraine.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_1" xml:lang="en-US">Risks Relating To Russia Invasion Of Ukraine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_SectorFocusRiskMember_0" xml:lang="en-US">Sector Focus Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SectorFocusRiskMember_1" xml:lang="en-US">Sector Focus Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SectorFocusRiskMember_2" xml:lang="en-US">It represents as a sector focus risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_0" xml:lang="en-US">Securities Index Futures Contracts and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_1" xml:lang="en-US">Securities Index Futures Contracts And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_2" xml:lang="en-US">It represents securities index futures contracts and options thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_0" xml:lang="en-US">Securities Lending Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_1" xml:lang="en-US">It represents as a securities lending risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_2" xml:lang="en-US">Securities Lending Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ShortSalesRiskMember_0" xml:lang="en-US">Short Sales Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ShortSalesRiskMember_1" xml:lang="en-US">Short Sales Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ShortSalesRiskMember_2" xml:lang="en-US">It represents as a short sales risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_0" xml:lang="en-US">Short-term Debt Obligations Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_1" xml:lang="en-US">It represents as a short term debt obligations risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_2" xml:lang="en-US">Short Term Debt Obligations Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_0" xml:lang="en-US">Special Risk Considerations Relating to Futures and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_1" xml:lang="en-US">Special Risk Considerations Relating To Futures And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_2" xml:lang="en-US">It represents special risk considerations relating to futures and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_0" xml:lang="en-US">It represents risk of special risks related to cyber security.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_1" xml:lang="en-US">Special Risks Related To Cyber Security [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_0" xml:lang="en-US">It represents as a stapled Securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_1" xml:lang="en-US">Stapled Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_2" xml:lang="en-US">Stapled Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_0" xml:lang="en-US">Stripped Mortgage Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_1" xml:lang="en-US">It represents risk of stripped mortgage-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_0" xml:lang="en-US">It represents as a stripped securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_1" xml:lang="en-US">Stripped Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_2" xml:lang="en-US">Stripped Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StructuredNotesMember_0" xml:lang="en-US">Structured Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StructuredNotesMember_1" xml:lang="en-US">It represents risk of structured notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StructuredSecuritiesMember_0" xml:lang="en-US">It represents risk of structured securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StructuredSecuritiesMember_1" xml:lang="en-US">Structured Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SubordinatedSecuritiesMember_0" xml:lang="en-US">Subordinated Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SubordinatedSecuritiesMember_1" xml:lang="en-US">It represents risk of subordinated securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SubscriptionRightsMember_0" xml:lang="en-US">Subscription Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SubscriptionRightsMember_1" xml:lang="en-US">Subscription Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_0" xml:lang="en-US">Swap Agreements And Options On Swap Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_1" xml:lang="en-US">Swap Agreements and Options on Swap Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_2" xml:lang="en-US">It represents swap agreements and options on swap agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SystemicRiskMember_0" xml:lang="en-US">It represents as a systemic risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SystemicRiskMember_1" xml:lang="en-US">Systemic Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SystemicRiskMember_2" xml:lang="en-US">Systemic Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_0" xml:lang="en-US">It represents temporary defensive strategies risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_1" xml:lang="en-US">Temporary Defensive Strategies Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_2" xml:lang="en-US">Temporary Defensive Strategies Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_TrackingRiskMember_0" xml:lang="en-US">Tracking Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_TrackingRiskMember_1" xml:lang="en-US">Tracking Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_TrackingRiskMember_2" xml:lang="en-US">Tracking Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_0" xml:lang="en-US">Unrated Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_1" xml:lang="en-US">Unrated Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_2" xml:lang="en-US">Unrated Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_0" xml:lang="en-US">Us Government Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_1" xml:lang="en-US">U.S. Government Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_2" xml:lang="en-US">It represents risk of U.S. Government Securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_0" xml:lang="en-US">It represents as a U.S. government securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_1" xml:lang="en-US">U.S. Government Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_2" xml:lang="en-US">Us Government Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ValuationRiskMember_0" xml:lang="en-US">Valuation Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ValuationRiskMember_1" xml:lang="en-US">It represents as a valuation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ValuationRiskMember_2" xml:lang="en-US">Valuation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_0" xml:lang="en-US">It represents risk of variable and floating rate demand and master demand notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_1" xml:lang="en-US">Variable And Floating Rate Demand And Master Demand Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_0" xml:lang="en-US">It represents as a variable and floating rate securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_1" xml:lang="en-US">Variable And Floating Rate Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_2" xml:lang="en-US">Variable and Floating Rate Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_WarrantsAndRightsMember_0" xml:lang="en-US">Warrants And Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_WarrantsAndRightsMember_1" xml:lang="en-US">It represents risk of warrants and rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_0" xml:lang="en-US">It represents risk of zero coupon and payment in-kind securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_1" xml:lang="en-US">Zero Coupon And Payment In Kind Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain_0" xml:lang="en-US">Class of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_0" xml:lang="en-US">Debt Instrument Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_3" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_4" xlink:to="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_5" xlink:to="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_6" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_7" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_8" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_9" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_10" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_11" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_12" xlink:to="lab_ck0001515324_BankLoanRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_13" xlink:to="lab_ck0001515324_BankLoanRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_14" xlink:to="lab_ck0001515324_BankLoanRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankObligationsMember_15" xlink:to="lab_ck0001515324_BankObligationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankObligationsMember_16" xlink:to="lab_ck0001515324_BankObligationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BorrowingMember_17" xlink:to="lab_ck0001515324_BorrowingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BorrowingMember_18" xlink:to="lab_ck0001515324_BorrowingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CertificatesOfDepositRiskMember_19" xlink:to="lab_ck0001515324_CertificatesOfDepositRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CertificatesOfDepositRiskMember_20" xlink:to="lab_ck0001515324_CertificatesOfDepositRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_21" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_22" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_23" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_24" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_25" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_26" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_27" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_28" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_29" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_30" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_31" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_32" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommonStocksMember_33" xlink:to="lab_ck0001515324_CommonStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommonStocksMember_34" xlink:to="lab_ck0001515324_CommonStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_35" xlink:to="lab_ck0001515324_ConcentrationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_36" xlink:to="lab_ck0001515324_ConcentrationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_37" xlink:to="lab_ck0001515324_ConcentrationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_38" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_39" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_40" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesMember_41" xlink:to="lab_ck0001515324_ConvertibleSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesMember_42" xlink:to="lab_ck0001515324_ConvertibleSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_43" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_44" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_45" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_46" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_47" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_48" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_49" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_50" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_51" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_52" xlink:to="lab_ck0001515324_CounterpartyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_53" xlink:to="lab_ck0001515324_CounterpartyRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_54" xlink:to="lab_ck0001515324_CounterpartyRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_55" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_56" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_57" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditFacilityMember_58" xlink:to="lab_ck0001515324_CreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditFacilityMember_59" xlink:to="lab_ck0001515324_CreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_60" xlink:to="lab_ck0001515324_CreditRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_61" xlink:to="lab_ck0001515324_CreditRisksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_62" xlink:to="lab_ck0001515324_CreditRisksMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_63" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_64" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_65" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_66" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_67" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_68" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_69" xlink:to="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_70" xlink:to="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_71" xlink:to="lab_ck0001515324_DerivativesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_72" xlink:to="lab_ck0001515324_DerivativesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_73" xlink:to="lab_ck0001515324_DerivativesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_74" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_75" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_76" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_77" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_78" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_79" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_80" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_81" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_82" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsSecuritiesMember_83" xlink:to="lab_ck0001515324_EmergingMarketsSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsSecuritiesMember_84" xlink:to="lab_ck0001515324_EmergingMarketsSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EnvironmentalRiskMember_85" xlink:to="lab_ck0001515324_EnvironmentalRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EnvironmentalRiskMember_86" xlink:to="lab_ck0001515324_EnvironmentalRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_87" xlink:to="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_88" xlink:to="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_89" xlink:to="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_90" xlink:to="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedBondsMember_91" xlink:to="lab_ck0001515324_EventLinkedBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedBondsMember_92" xlink:to="lab_ck0001515324_EventLinkedBondsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedSwapsMember_93" xlink:to="lab_ck0001515324_EventLinkedSwapsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedSwapsMember_94" xlink:to="lab_ck0001515324_EventLinkedSwapsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_95" xlink:to="lab_ck0001515324_EventRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_96" xlink:to="lab_ck0001515324_EventRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_97" xlink:to="lab_ck0001515324_EventRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_98" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_99" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_100" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNotesMember_101" xlink:to="lab_ck0001515324_ExchangeTradedNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNotesMember_102" xlink:to="lab_ck0001515324_ExchangeTradedNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_103" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_104" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_105" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductsMember_106" xlink:to="lab_ck0001515324_ExchangeTradedProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductsMember_107" xlink:to="lab_ck0001515324_ExchangeTradedProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_108" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_109" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_110" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FloatingRateLoansMember_111" xlink:to="lab_ck0001515324_FloatingRateLoansMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FloatingRateLoansMember_112" xlink:to="lab_ck0001515324_FloatingRateLoansMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_113" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_114" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_115" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesMember_116" xlink:to="lab_ck0001515324_ForeignSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesMember_117" xlink:to="lab_ck0001515324_ForeignSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_118" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_119" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_120" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_121" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_122" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_123" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_124" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_125" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_126" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_127" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_128" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_129" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_130" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_131" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_132" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_133" xlink:to="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_134" xlink:to="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_135" xlink:to="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_136" xlink:to="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_137" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_138" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_139" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HybridInstrumentsMember_140" xlink:to="lab_ck0001515324_HybridInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HybridInstrumentsMember_141" xlink:to="lab_ck0001515324_HybridInstrumentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_142" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_143" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_144" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_145" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_146" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_147" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_148" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_149" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_150" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_151" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_152" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_153" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_154" xlink:to="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_155" xlink:to="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_156" xlink:to="lab_ck0001515324_InfrastructureRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_157" xlink:to="lab_ck0001515324_InfrastructureRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_158" xlink:to="lab_ck0001515324_InfrastructureRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_159" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_160" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_161" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InverseFloatingRateSecuritiesMember_162" xlink:to="lab_ck0001515324_InverseFloatingRateSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InverseFloatingRateSecuritiesMember_163" xlink:to="lab_ck0001515324_InverseFloatingRateSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_164" xlink:to="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_165" xlink:to="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_166" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_167" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_168" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_169" xlink:to="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_170" xlink:to="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_171" xlink:to="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_172" xlink:to="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_173" xlink:to="lab_ck0001515324_LeverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_174" xlink:to="lab_ck0001515324_LeverageRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_175" xlink:to="lab_ck0001515324_LeverageRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LimitedPartnershipsMember_176" xlink:to="lab_ck0001515324_LimitedPartnershipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LimitedPartnershipsMember_177" xlink:to="lab_ck0001515324_LimitedPartnershipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_178" xlink:to="lab_ck0001515324_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_179" xlink:to="lab_ck0001515324_LiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_180" xlink:to="lab_ck0001515324_LiquidityRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_181" xlink:to="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_182" xlink:to="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_183" xlink:to="lab_ck0001515324_ManagementRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_184" xlink:to="lab_ck0001515324_ManagementRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_185" xlink:to="lab_ck0001515324_ManagementRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_186" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_187" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_188" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsMember_189" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsMember_190" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_191" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_192" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_193" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_194" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_195" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_196" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_197" xlink:to="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_198" xlink:to="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_199" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_200" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_201" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_202" xlink:to="lab_ck0001515324_OptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_203" xlink:to="lab_ck0001515324_OptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_204" xlink:to="lab_ck0001515324_OptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_205" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_206" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_207" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_208" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_209" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_210" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_211" xlink:to="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_212" xlink:to="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_213" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_214" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_215" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_216" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_217" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_218" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_219" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_220" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_221" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_222" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_223" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_224" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_225" xlink:to="lab_ck0001515324_PreferredStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_226" xlink:to="lab_ck0001515324_PreferredStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_227" xlink:to="lab_ck0001515324_PreferredStocksMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_228" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_229" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_230" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_231" xlink:to="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_232" xlink:to="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyManagementRiskMember_233" xlink:to="lab_ck0001515324_PrivateCompanyManagementRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyManagementRiskMember_234" xlink:to="lab_ck0001515324_PrivateCompanyManagementRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyValuationRiskMember_235" xlink:to="lab_ck0001515324_PrivateCompanyValuationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyValuationRiskMember_236" xlink:to="lab_ck0001515324_PrivateCompanyValuationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateInvestmentRiskMember_237" xlink:to="lab_ck0001515324_PrivateInvestmentRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateInvestmentRiskMember_238" xlink:to="lab_ck0001515324_PrivateInvestmentRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsMember_239" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsMember_240" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_241" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_242" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_243" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_244" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_245" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_246" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_247" xlink:to="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_248" xlink:to="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_249" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_250" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_251" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_252" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_253" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_254" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_255" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_256" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_257" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_258" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_259" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_260" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_261" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_262" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_263" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_264" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_265" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_266" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_267" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_268" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_269" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_270" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_271" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_272" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_273" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_274" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_275" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_276" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_277" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_278" xlink:to="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_279" xlink:to="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_280" xlink:to="lab_ck0001515324_SectorFocusRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_281" xlink:to="lab_ck0001515324_SectorFocusRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_282" xlink:to="lab_ck0001515324_SectorFocusRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_283" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_284" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_285" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_286" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_287" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_288" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_289" xlink:to="lab_ck0001515324_ShortSalesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_290" xlink:to="lab_ck0001515324_ShortSalesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_291" xlink:to="lab_ck0001515324_ShortSalesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_292" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_293" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_294" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_295" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_296" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_297" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_298" xlink:to="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_299" xlink:to="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_300" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_301" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_302" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_303" xlink:to="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_304" xlink:to="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_305" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_306" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_307" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredNotesMember_308" xlink:to="lab_ck0001515324_StructuredNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredNotesMember_309" xlink:to="lab_ck0001515324_StructuredNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredSecuritiesMember_310" xlink:to="lab_ck0001515324_StructuredSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredSecuritiesMember_311" xlink:to="lab_ck0001515324_StructuredSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubordinatedSecuritiesMember_312" xlink:to="lab_ck0001515324_SubordinatedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubordinatedSecuritiesMember_313" xlink:to="lab_ck0001515324_SubordinatedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubscriptionRightsMember_314" xlink:to="lab_ck0001515324_SubscriptionRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubscriptionRightsMember_315" xlink:to="lab_ck0001515324_SubscriptionRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_316" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_317" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_318" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_319" xlink:to="lab_ck0001515324_SystemicRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_320" xlink:to="lab_ck0001515324_SystemicRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_321" xlink:to="lab_ck0001515324_SystemicRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_322" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_323" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_324" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_325" xlink:to="lab_ck0001515324_TrackingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_326" xlink:to="lab_ck0001515324_TrackingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_327" xlink:to="lab_ck0001515324_TrackingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_328" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_329" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_330" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_331" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_332" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_333" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_334" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_335" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_336" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_337" xlink:to="lab_ck0001515324_ValuationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_338" xlink:to="lab_ck0001515324_ValuationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_339" xlink:to="lab_ck0001515324_ValuationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_340" xlink:to="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_341" xlink:to="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_342" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_343" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_344" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_WarrantsAndRightsMember_345" xlink:to="lab_ck0001515324_WarrantsAndRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_WarrantsAndRightsMember_346" xlink:to="lab_ck0001515324_WarrantsAndRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_347" xlink:to="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_348" xlink:to="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_349" xlink:to="lab_us-gaap_ClassOfStockDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_350" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>ck0001515324-20240814_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240814.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_PreferredStocksMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_CommonStocksMember_2" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_SubscriptionRightsMember_7" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001515324_CreditFacilityMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MarketDiscountRiskMember_5" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateMarketRiskMember_6" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfrastructureRiskMember_7" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_NaturalResourcesRiskMember_8" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SectorFocusRiskMember_9" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConcentrationRiskMember_10" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DistressedSecuritiesRiskMember_12" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrepaymentOrCallRiskMember_17" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateBondsRiskMember_20" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditRisksMember_21" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankLoanRiskMember_22" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LeverageRiskMember_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PreferredSecuritiesRiskMember_24" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfectiousIllnessRiskMember_26" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesRiskMember_28" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsRiskMember_29" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignCurrencyRiskMember_30" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DerivativesRiskMember_32" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CounterpartyRiskMember_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LiquidityRiskMember_34" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortSalesRiskMember_35" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesLendingRiskMember_36" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RepurchaseAgreementsRiskMember_37" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateLoansRiskMember_40" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41" order="38" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42" order="39" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ManagementRiskMember_43" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44" order="41" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45" order="42" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UnratedSecuritiesRiskMember_46" order="43" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ValuationRiskMember_47" order="44" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48" order="45" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductRiskMember_49" order="46" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNoteRiskMember_50" order="47" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PortfolioTurnoverRiskMember_51" order="48" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52" order="49" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReturnOfCapitalRiskMember_53" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StapledSecuritiesRiskMember_54" order="51" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55" order="52" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56" order="53" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IncomeAndDistributionRiskMember_57" order="54" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58" order="55" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59" order="56" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60" order="57" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DoddFrankActRiskMember_61" order="58" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TrackingRiskMember_62" order="59" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OverCounterTradingRiskMember_63" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsMember_64" order="61" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65" order="62" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66" order="63" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67" order="64" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68" order="65" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69" order="66" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70" order="67" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71" order="68" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72" order="69" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74" order="71" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75" order="72" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76" order="73" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditDefaultSwapsMember_77" order="74" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78" order="75" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79" order="76" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedBondsMember_80" order="77" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedSwapsMember_81" order="78" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesMember_82" order="79" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductsMember_83" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84" order="81" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_WarrantsAndRightsMember_85" order="82" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BorrowingMember_86" order="83" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87" order="84" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesMember_88" order="85" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89" order="86" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90" order="87" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91" order="88" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankObligationsMember_92" order="89" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialPaperRiskMember_93" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CertificatesOfDepositRiskMember_94" order="91" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95" order="92" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LimitedPartnershipsMember_96" order="93" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsMember_97" order="94" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98" order="95" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesMember_99" order="96" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsSecuritiesMember_100" order="97" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredNotesMember_101" order="98" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredSecuritiesMember_102" order="99" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SubordinatedSecuritiesMember_104" order="101" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FloatingRateLoansMember_105" order="102" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106" order="103" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107" order="104" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedSecuritiesRiskMember_108" order="105" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109" order="106" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110" order="107" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111" order="108" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HybridInstrumentsMember_112" order="109" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsMember_113" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114" order="111" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EnvironmentalRiskMember_115" order="112" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNotesMember_116" order="113" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117" order="114" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118" order="115" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119" order="116" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120" order="117" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateInvestmentRiskMember_121" order="118" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyManagementRiskMember_122" order="119" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyValuationRiskMember_124" order="121" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125" order="122" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126" order="123" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127" order="124" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SystemicRiskMember_128" order="125" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventRiskMember_129" order="126" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AssetAllocationRiskMember_130" order="127" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131" order="128" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  7 4P# 2(  A$! Q$!_\0
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MZW5?W=J&4& M_?*C!)/=.,<5Z[X<U+6M4>ZDO[:PBM(IY((GMY'=I=C;=W(
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MMRTUHUXMQ]I8 1A]N"NS[W?KCWJ&+QAJ-QX\O?"D6EVOGVMJ+O[0]TP5D+
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M2Q8JF5SQ[XHHH Z>7_A(KGQ!;W+:=;Q:?;6\HV"[S)-(Q4#C;@  -W/6N?\
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HS"1YFWCT7CIG/:NSL[&UTZ PV<"0QEV<A!C<S')8^I)Y)-%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2416373d4_ex99-xkx6img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2416373d4_ex99-xkx6img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (  J # 2(  A$! Q$!_\0
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ML;.+G[)^T'X'N?LF/MGV:]U2]%KG_GH8K=L '/*@\=1BNZ\2VECJ'[1GP_\
MMEFMP;7X>^);JT,X!P7G6-A@Y&[YB&)!P<GM7MDOA+PW*/W_ (<T6Y'4;M'T
MD?AED!ZBNJV$H1BY<T=$VE)))N^FJ;NK:Z[Z:ZG._K2?3?2_](^6Y?\ @H-^
MQO!\TOQ]\%*OVG[)YY_MDD/UVDC0MF<\8!V<Y\S'-5IO^"A_[&,$H@N/VA/
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MK6Y^,7PW5@I[$'Q-_CZ$#G$__#8_[(_[O_C)_P#9X_>CY/\ B]GPT[?]S/\
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M'[4/[/-Q;VN[[7<K\:_AJ5L_EZNP\1$+GMN(R<#GI3C^UO\ LM?:6A_X:6^
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MXV?!W3E(%PSWGQ)\&6)VCSL,2^NC=\NC:N#ABN=(F5LK"6,(_:4_9VD>R/\
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MH^"A86C;_P"RPKO_ ,) JQIORN"%4,>6$A4UG_\ #)?[+F_SO^&9O@%Y^/\
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M/!C1?BXU\J/HS9]NF:T'[1W[/5Q=?8H_C=\(GO\ .GNUD_Q$\'"_SJR_VEI
M"?V^'*S1L9(4 83@%XR$QNRO^&2OV5O^C;/@#_Q]?;/^20_#G_D(>O\ R+?^
ML_VOO^]6/^&4OV8O^C;?@+_X:#X=?_,Y1_LOF_5Q7Z/]/Q"^)[HTH?VBO@)*
M+<Q?&?X4-)=ZN-%M<?$'P@WVO63I8UD:-$W]OX?6AH0%P8VDWB(>808B$-S_
M (:$^ ZVT]W_ ,+I^$YM[;/VFY'Q%\&F)=H)Y<:\50XZ!FRW10>E8$/[*'[+
MT(E\C]F[X"6_G=3;?!_X<(6XP2<>&U5SQD[@P^AHE_92_9>E!$O[-WP))GX;
M=\'_ (;D].02?#I)X'?<?IV/]E\^G\K[?UZ_(/\ :O+_ (;^OZL;W_#0GP&\
MKS_^%U?"7[-M_P"/S_A9/@O[#],_\)!MSV^O.ZLV?]I7]G.TQ]L^.WP=M=UZ
M-(/VKXH^#%QJC?\ ,+.[7O\ 7CO&>1W')K,F_9*_9>ED\Z?]F[X"7,PN?M/V
MJY^#_P .&8''WM__  C9?('<C.?F+9J:']E#]E^UB$-M^SI\"K;_ $<6O^C?
M"#X<)\H7IC_A&P2.^TC8>I3.#1_LJ[O_ ,!^_P#KMYA_M7E^)>D_:,^ ,=M<
MWTGQM^%5O8V6/ME[)\0?"":=;.NK:WH@+2S:VB*3K>C:U"7#$>9HMS =LELX
M$A_:+_9Z\^ZC'QP^$'GVQ6WN\?$GP8/LK@1E1(#KX,9 U.,9XQO9<@X SO\
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M!MWC7[0?AUXZOLJ!@NFL^'(D<C/)B76-90DX/_$ZP.@S]!]G^H_F:,9OEO\
MUZ7YUOT_K:[PVR]5^:):***YC<**8_0?7^AKP34/V@O!%G,8)= ^-R8&<V?[
M,O[26IY]"7T7X9RCGMG../K0![]17@$7[1'@:4SC_A'OCF# <$']F3]I($G
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MD8E_L/XQ\C@']G/X_AOP'_"M\D?B/U%/_P"%[>#/^@#\8_\ Q'KX_?\ SMZ
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MW6?&&E:9\0O'MCJVL^$/"UY<J-3U[3=!Q_;,FCJ2N]81@L-ZDA6V+G:!Y_\
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MJ+@];*47%VVO9I.S]#;#8G"XE-X62DK:M+K]_P"I& N,DGZ#K06R %X'\_\
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MJS#]00<C/2OGL52^J8J>%ZP<DW_AM?J^]CW<,V\.GZ_H+11161U%9_N#Z?\
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M2>!O#]EX<U1O$GC+2]=;11X<U;1=%(\S7CXK?2PT05E\UI"HSR#SW[<GPO\
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M"D:-?$/@Y/"2^+&0:+(T<BS(N_Z _8G\2_%BXO\ XA> ];_X6EXJ^"?PYM_
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MS?#9 L&T\(TFDEK'I:*[;V2L^GE?7\=_"'P:^(4W_!(2Y^#]CX,US3OB1-\
MO$MC:^!O$'A_4M.\2IJ\NHZ_K<>BR:'KN)5U]]X$:39+3NKJ-OED=;H_Q-O/
MC1^T/^R'K/AWX3?M >'M$^'WAOXGGQ[JWC_X+?$OX=Z!X0\2^(OAQHB0>#-;
M7QYX;@F?7HS*3'XAA\SPE)L>&V\;W-RZI)^KH2%-JD#)(!X_KTXXQR.2>*;]
MFA4LQ7UVGCN>>W&?Y]:/]8\9SYI)QA[2M4XJJN+YM)\5T72J--;\D9-0YK7O
M[W1G/_8*_P"$OWM*2@I:+51:DM>UU=]]$?BKX^^%_CO4?^"?GQ\\,+\+O%>J
M^-M9_:8\>^(QX'LO FM:CJVM>;^V:VO)KNCZ.-#7Q#XA\,S>'%3Q+'XC%O))
M)X0"RHVR%C']BZIX-U:']O+X6^*K/PQJ2^%8/V6?BMX5U#Q/:^'M:&A66J?\
M+(^%&K^']%.O(?["T:22WM]?>+P\^;B>./S@<)M7[L,4&!\N<$8'OVSQ_C3R
MJ ^IYYXXSUX/7/?D>E14SW%UHSA&--0G_K-+E3DE'_6:C0I/EWM&$<-2<%>[
M4$IM[OKPV3X3"6\K.^C?NRE/R_F=]$_4_(;]L+X)^(_C'^W)^QY8V=W\8O"?
MAC_A7_[11U?XC_"/^U=!U7P7(-(\-NOG^.5T2=? +^*9<:!&%E5O%Z-%&BAH
MU+=1\9?V3? WPQ_9M\(?!?X6^!_$WBO1+[]I7X#>*O'T5P=:\?>*?%<>M_&G
MP,/''C?QIJNLF:1EFT"*8>,CY,?A/PGX-C:(1>$? T!2+]3,094;?O=/ZD<?
MER/UJ8A<-R?E]<=.,_Y^E=*XGS/#_P!CSC)I9'3BJ:C:.L77DIIJ*FY*5>3B
MW.2A9.,8N[>3X>P?_"RG_P SUWFWVM%6[?9OHM3\\?VB?"?BK5/VO?V -;\/
M>&-<O_"W@S5_VBW\7ZMI7AR_U/P]X9C\0?!N30O#AUK68=L6@)<:^%@MF<HT
MS(P958$MY#^RG\2KCX,>'(?V;?''PD^.EW\78?CSX]_MW4=*^#/C6\\#>)]#
M\=?&3Q!KVB?&:/XIP,GPUN/ /AKP]KV@IXN#^,8_%]I_8<_A0^#FD@M;.?\
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M]3\&_LS6NC>(+NR!%[9Q^#/'AU;3-&U=2'EC@N"K3*K#;*4)&,%/O;R;=@.
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MIPUBK.K6Y6ZM1MW;E+EIW>S:;MJ=N79<LK_M6S?O-M7V2Z+_  V;T^1^3?[
M'QW^'?@[]FZ]\%:]'X^\/^+/@[HWQA^)'C[P]XN^%?Q+\%:EI_A35OC)X_\
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M=O;!<HN1SU XX^I_^O[TEQ%;E09$# XZ!1D8/7(_/ P1W-;ULUBZLL*LM?\
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MNR'6- 4ZUX'TDZ_%X<T;P\D?]MPK-,OC&62.-&<>#7+$_0_P,_9L_;^^'/\
MP2^^/G[,UW\/=1T_XK:OXAET;X5:6OB_X;:FEAX#\;_\(VWCG=X@'Q$*+N0^
M.9(BTJ>,Y?&'B R1+,F9(OS#^%/_  1)_;6\9>-_#.D_$?P!IOPH\%7&K!O&
M'B>X\>^"_$DFA:4Y9=9&B:#H'B;Q8NN^(9'1D1Y"D6Y2"ZA6(65X?)\-C)/'
M232EIRO2UDTW9N[U]-%97.?,L3G#PG^Q+7J^KZ?U^=C^F/\ X):?%#XE?&']
MBKX4?$3XNZS>Z_X]\37'CB\U?5=0L!IKWI7QKKT<9\I4VB-(TVH><*A0*%0
M?H@PW#'3G_&O#/@+\%_!?P ^%O@[X/\ P^T^>V\'>#+5[+2AJ=XVI:G>F24:
MMJ&KZO(8D$VM2Z[)/)+)\S)(Q9-G")[F6QGN!G]-H_F37SN+<:V)E.UE=RMH
MM]M$E;:]CW<+=8>/?_AAU%%%0=1"_P!X_A_(5\J?LPW'VC5/VGE,WG?9OVH_
M'=MD_P .SP?\/#M/4'[V.IZ?G]4U\M_LTPS0:C^TM)-;R0&Y_::\<W< 9@#=
M1OX/^'ZAP./E)1@,X&Y,_P )JJ7^ZYEV4J:Z='/Y[7T1E%W?HE^"19US4ID_
M:N^'.D06!-M=?!;XFZW=:O\ \2W);1/&?P]T==(R=LOW]>#DAOE VE@P?'T]
MV?ZC^9KY3\2PF7]KOX1F> 7!M_@W\4C92@*?LA;7?A^-:8XP?W8.@P8;G&M#
M^$BOJSL_U'\S6V,WR[_KTNG2];[_ /+8G#=/5?H2T445SFX4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !117$>-_'7A+X;^%]=\;>.O$&F^%/!_AJS_ +0UGQ!J
M]T+#3-/T]0,R.Y^7*\*#C)) 48&  =O17">"O&'ASQ_X:T[Q?X8OGU/0=6R+
M&^:RU32Q*PD.FD#2]7CBEC17#*=Z*&QD([$LW=T %%%>>Z#\0?"GB'Q1XW\$
MZ+K=I?\ B7X<WVD67B[2U4*VAR>(](77M$63C_EKH;AP5X+;MY'\0!Z%117F
M/B?XH> /!GBOP#X)\4>+]#T7Q;\5]3UC1/AUH.J7JIJ'B_4] T4Z[KNDZ(%1
MC)-;Z!;_ -MO'O5A&KNQ(*(0#TZBO-/#'Q#\$>,]>\<>%?"OBC1O$.N_#'7-
M-\+^/M,TO4(K[4O"/B;5]"T?Q)%HVNQ0!6TC6SX9UW0O$!A=M_D:VK,@96>I
M_$_C[PSX0U[X?^'_ !#JUIINJ_$[Q/?^#? MLWW];\4Q>"_$WCR31HP%.YW\
M->"/&7B!B2H,.@R'>6&QP#T2BN>U75[#0]+O=;U:]T_2]*TVUO;[4]2U*\BL
M--L=/C1I&U'4VE\M%39"26?8H#.=R9PN)H/C?P]XLNM;L?#NI6VJS>&[_2M/
MUK[)ME^P7NMZ)H?B/1D=)!C$OAS7M(U_"YQ%*A!!!% '>445Y!X)^,OPN^(7
MB#QGX1\%?$#POXK\3?#K5O[(\>:#H>L17VI>$M5.MZ[H#:5K<0C5X''B'P]K
M>@F.1%*RZ1*KA64A #U^BBN6T;Q!H>N7/B*PTJ\M;J?PMKG_  C7B (JA;#5
MGT70?$!TI\D*7_L+7='D)7 PZEEW= #J:*BEE$49D/(&#^=>,_"3X_?![XZZ
M-<Z[\(?B3X,^(^BV']F"ZU3P9K$7B#38_P"VMS:.3-!@?OE3S.#D;#RO(4 ]
MKHHKY_\ #O[1'P,\:>-M=^'7@[XP_#+Q3\0O"MUJEEXD\#^&?'.@ZOXJT'4=
M%FM-)\0IK6BZ+K#7'G>%3J^D)XOA>,?\(K(R)=&*XDA\D ^@**X/3?&GA76/
M%WBCP/I^JVESXG\'67A76?$FE*L;/HNG^.&UP>'I9-R@,?$/]@:UY9#,^%(/
M. 6?$#XA>$?A5X&\7_$[Q[K=EX;\#> O#NL>,/%_B#4V\O3]%\,^']*EUK6=
M6<CGRX((V=^68D?(K%=I ._HKACXR\-CP]IWC$Z[I</A;5+72+RQUNYNTL-+
MNUU]K8Z#()9$7_D8&UC37B!0[O,0,OF%5-[P]K>D^(;>>_T75+&_MK;5M9T2
MYGL;A)4&J^'=>N/#^NZ9)(J1MYV@^(-*U;0)(BF%>!X]S,27 .KHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH 9L'J?T_PI]%% !1110 4444 0O\ >/X?
MR%?-/[/5]+=:E^T.+J">VO+7]HCQ5:2M<D W<:>#?  T1USEMI\.G10.Y*]R
M#7TE+]QO]T?R%?,'[/4N=>_:.P8/)'[1?BS$HV#?CP9\/23\V#\N/)R. -'.
M1\P*W25\)F7DZ;^YSVZ7UTN]K];&75>D?R(/$H_XRZ^#-P1"N?@K\=K4V9N%
M5\?\)G\'W75]JC&$3$/0L!KA!)89/U7V?ZC^9KY;\20@?M=_"&9IALN?@9\<
M;2&VS]\+XS^#<NLMZX$HT,8[XS[U]2=G^H_F:UQEN;+O^O2_]*K?\'Y=;DX;
M9>OZHEIFP;]W^/U_GS^E/HKG-PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OC/
M]N#Q#\-O#_[+/QCO_C ?!\OPUU;PY%H_B>U^(GCGQ?\ "GPWJ&DZ]J^D:*VB
MGQW\._#'B[XD^'/$4[ZP(O!K^$O"USXK'B^*W2T2&69)XOLRO-_B3XUA^&_@
MO7_&DGA;Q=XU.@V(O!X7\ Z,WB7Q/?[!TT71%>,R.<$\,.,DYP-P!_*1\-_C
M/\ )_C]X ^+/Q@_X*#? KXFVVA/\"+W1?$VK_%35['QM\)=(^$_QJ\>^/=%\
M&:-\4?'W[%?BI_'S^,?@MKG@KPM\:RGC#]G#QIXR\::%XC\%?$$[O%WA#Q;X
M*\ZLM5_9>L[_ ,5>'?B1^T!_P31^-NO^(/A;^T5X!\1_%7QQ\8?&&EZG\1_B
MA\<_C/KFO:%^UEK9C_9O\6GP_P#$+PGX>0^&G_X17XQR?\(;X-?PXO@/QWX.
M^'Y\%(/Z(/@1_P %)OV?/CW\1].^&^GZ?XJ^%MUXQ^%OPQ^+?PKU#XV6/A#X
M;M\:/"GQ:UCXN:-X-?X6:!KGBB/Q7XADFT'X4Z]XH/E^$V;_ (1!XYV\Q@RU
M]I^'?BE\,/%WB+Q?X5\+_$+P7XL\3^!M0_LWQYX<\.^*-#U[Q%X'U1T/_$G\
M:Z)H,T]QX<>- Y1/$@@8G<3N4!QO]9\_Q_X*.?ZMY?A_]J?S4_%'7?V.-:M_
M'.J_#_\ ;P_8U\/_ !F^(WB3]H3PS=_'F#XXMIGC>^\"?%3]C;7_ (3^"-'\
M<>-/#T<BKH$7QF/@;XK>,?#" ^#/",JCQKX&:#QW''+7@7Q>\4?LP>._A/\
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M_P#!O[87_!/#XM?!7X=?M-:5XSL?@3\5_P!MCX:^'O#7Q)^#NA?L6^!OV:_
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M> =;DT+7M%UK6"ZQZ$_AK7]&,,GGL%CE1957")(< /;:*X"/XA>!1J.D:/\
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M]G#X[AK=AB_+/\2O@!)N3G!C_P").%'/4-Z9KZZ[/]1_,U\>^)YH$_;=^"\
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M -E3]JGXG_M!ZQXD@\5_ *_^%_@EM)U3Q+\-_$]W\2?AQXFU?7].T'XD>(/
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M\2QR^$_%'Q"\%^)7\,VS>&(O&<7AGQ-X'N9X/ _BHP1]MXH_8@OO%_Q^\/\
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M7@'G6<YQDV;2SK.WG\HU(6F];*TDUYW22L7****\@_H **** "BBB@ HHHH
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M!-<^%G@O7<RKXE\0^(?!G[1?P-\$?%3P8Z[HG4>*/^$T>=P8_&.VG?\ 7^M
M/I[X^>-/V2/A1XU\3_%?XGVW@K7/C/\ #?X-P^/++PW>WFE:Y\28/A_X#U?Q
MYXAT;7? '@O6]8"3:ZFN_P#";-#XD\,1)XL:X#VKW(7RTB[_ %KX:?LU^*]#
M>_N+#X5G1/B#XT\-:C?ZWH<NDZ''X[\2:'XYT?QQI>DZIX@T::'_ (3:6?Q-
MX/0^+O#-U/<Q^+[6VFM_%=M);_:?,^=OVJ/V/_&'QP\<>/=6\%:A\+-.T'XK
M_LO^/OV</'T?C3PSJU]XETA=<.OZMHNM:'K>E8+VWB3_ (2*+P_X[\.>(63S
M/!T:^2TF]K>7QGXQ?\$SM=\<QZE:V-S\+O$?A.\^)_[36KV7PF\17GQ/\#^"
M=-\"_M&^#O VBL?[<^$GB;PEX@;Q!X5U[P4QD\+HD7A+QAX*\<^*/ K/X4+0
M>,K<TTU _5"ZTCP*GB*VBO++PH_B/Q%=ZMK=M;7EKHR^(=;:'14\/:SJD:&,
MOK9_X1LZ7X?F=D\V+PLB6TEPR1I$G!^(]#_9ZUJ,^(/$VA_!_P 0S^ -'.A+
M?:KHWA#4SX4T[70=VA@W$3/HD?B48V:$QC2X<C]TP.6^+OCG^PA-\4?VL_A]
M\>WL_!/BK0O"P_9U^QZ?X_\ $'QDM/$GPXU/]G;XI>.O'F@>(_ G_"O_ (B^
M%_#OB/Q!XCD\="%U^*3O%:#2"US%XSMO%OBSPDGS%XB_X)0^+]*\4? KQE\.
MIOV?&UKX7>#_ (P:5XP\)_$'P?JVH> _BQXD^*^N?%I=%UWQUH^@^'8UUY?!
M_P#PM1_%SI*YDF\817/V9?"K>)YO%T1IW_JVP'ZM:-XB^ 7Q5^#?@KXN^(](
M\%1_#OXG>&O GQ.TR\^)&D^$-.7'B+0]&U[P5+K2:V\VA0>(!HFJ:9# AF9X
MI$,,4GRA5\ST3Q5^SMJG[8?BWP3H'PW3Q!\?M,\&^&_B9XT^*']C:-J6G^ 4
MDT=/ GAS16U[6O$TOB7P_P"*O$OAC=%+%X,\)-%-X1)?QO.B *?)?$7[)'Q)
M;X7_ +#'A[PY/\&_'WB#]E+PUH_ACQ;X=^,&BZ]=?#?QXL/P8?X5ZSK.B.D?
MB:X\,>(\AX_"/B*[\)^+?)\(^(/$]K)&!< 3]K^R[^QY:? ;2=8TG4-7T/4]
M2U+X#_ OX*GQOX3TAO#OC?S?A-\-#\/=?U@:[&&316\22IH_B3PC&DV;9E/F
MKDQFL0/7X?%7[.&N_$^R\ OIWPYN?%OP<\.^ ];\*:M>Z5X1.G^$E\?:SX\\
M#Z#HG@+6'B=M"\1/-\$=;BE\,>&_L[Q1:!X=8! $"]7JGPI_9YU6Q;PUJGPW
M^#NH6%WXOU'6/[!NO!G@Z_L+SQ__ &-LUK61H8BDCD\3G1,>;((SXE6WS([-
M""9/P\^(W_!(SXZ?$#P/XP\$65U^R3X7TCQ3^S+X _9C%IX1\ >,O#&E>(-1
M\$>$/'OAMOC;XUFT7P['X@;7U'CC79O^%5B7_A#Y;=?"_@WQKXT\<)X6@,WZ
M"?"S]D'4O#W[:.L?%GQ%:?VIX \%_"'P#KWPY%[<;]-C_:@\<^#4^!GQR\9Z
M,@"^5(OP4^"'PI\,0AP)%/CWXERE7_X2MZ /1]<^(_[#5]\1/C9X=UCP]\)=
M5^('P;U[X97/QMENOA*-1U70_$7CH>'6^'\^JZR?"\B^*-;;^W=$$S^&IO$\
MW@HZUX=?QF?"Z30>;M_$?XY?L=7_ ,=/ /[/'Q<O? >L_'#4KS47^'/@[QC\
M-]8U?.IKHVB:_,-"UW7O#,WAK1?$$GATZ'*OD^)[>XD4HFW>#"GQ;XA_X)L_
M$Z31;KQ'H/QDTV#XK>/;KXY>)OBDWB'2=-U/X::AX\^+'CCP/\6M&UC1H_#O
MA/PI\3-:T'PG\0_A/\+O"\"^*_&);PG\'QXDM/!7V65H!(OQ,_X)_P#QQ^,7
MQB\6?M-:QXL^#_P\^,&J>!O$VG>!K6QNO%?Q"\-^ /B)X-U_]F3QW\"=5DUS
M6O#/@[Q!XBT/PQ\3?@EXV\2>,Q!_PB*W'@WQ)#X*B\$RI<>+I9-M._Y@?96C
M_%_]E3PQ\(?VA_%GP[T+PI=> /V7/&'Q#OOC/HO@#X=06*:/\4_@?H^B^/O'
MD.B^'VT+PQH6N^//#;0Z-<IX@AD'E^*88D%Q#+ 8H??$@^$<2:YXY%K\/M,B
M\<W>EZ%XG\6!]%TUO'S:2CZ#I&BZ_K4AC&OK;[]4\-1>'O$,UPV3<6L<<2KB
M3XM\#?L-ZMX#_9?_ &O?V<K'Q5HMRW[0?AS5?#/A/Q%JT.MZG]@35_V1_A'^
MS9_;'CUSM76?$7B;Q+\,M9\7^-3X:V@CQ#^Z5G<,/EWX@?\ !-;XJ^,_#?CO
M0M&\,_LU^$?"WQ*U#QW:7?PA\,W.J>&? OA&#7?V8? ?P,\%>-=%\8Z!\&8/
M%Z>(D\0Z#KFO>-_"?A:+P=X4\7>$Y/"?@B;QC)'X.G;QB:=P/T,^$MG^R9XM
M7P_K?@_X9?"/PKJ_A'XJ_%_P7X"MKOP)\/?#GB;2_''PH\<Z[\)/'VI^!D1/
M.#C6? [E+OPQ*7E\+'PR9(X(O)A7T'4? G[+^K#XAZIJW@SX%Z@?$UFZ_%#4
MM5\._#R^'B+26UE"C^/9C;JVN:%'KFBC!\4/)']HT.123) '3\RO#G_!.KXO
MZ5X_\)^*-8U3X1:YH_A[X\6'QGMKNQU/6?#NM>"RG[<?Q?\ VG-<.BV__"M9
M9_B#+XM\,^-] \++;^*?%'A3PIX*?1?$:>!;4-XMD\8IROA?_@EOXW\$^*?@
M=\2=&T3]GCQIX@^&7QU_;+^+WC?PIXCTS6_#_A?XUK^T;\:=:\=_"S2?'&O1
M_#GQ?XB?Q!\)/#WB(&+Q/XK\*^,)/#/C#PWX>FT];F!4G\(&G<#]C&\'?!RZ
MF\&>"G\.?#JZE\(6NG^)_ 'A.;2O"\C>$=-THOI>D:]X)T0[F\/1VY+6]OK_
M (<M[<0^6($EB#Q1#Y]L;K]B?4;/5O@QX?T'X":SX>MOB7K'ACQG\./"?PUT
M+Q/X*\'_ !1\$>"/^$WU8?$W1_#_ (8F\,?#_P 0>$_#^A"27Q-XU'A-8II_
M"W@TW/\ PF/B+P?9W'@'P,_8>\1_#;]HIOB_XO\ !?P=U&^_X2N/XB:=XU\!
M>//B9X(U#P+K#_LS^'_@%K7@C1/@E%X9G\,Z_P##M)M%UA?!TOBCXN3I;>"G
M\*R/X&/CKPD/&;>#?&[_ ()=^-OB'/\ M5:9H[_ K3(/C_\ %+XZ?$GPC\1#
MH^KV'Q+\/:?^T=^PO\6_V3-;\#:]!'X?9?[!\+?$;Q[H_P 4I;BU\4R0^,8=
M8\6RW'@Z+QK!$WC'$#]88_A5\!+CQ5X>U_3_ (=?"J;Q?X5T7^PO"&O6OASP
M</%'A;1] CDT<:5X=UA+>/Q#X?T;PZ=8\AD\/SVT=L^NQJFSSP)X_@Y\)?@]
M\&/!7ACP=\+]&\.:-HUOX2\*^#M)U:S32AXB\7:7X%\/6V@Z#)K&N!E?QMK:
MZ)'('\03/.[AY&=]F0OX^_$W_@CK+XA\-W-A\*[CX+?"/QE=_$ W@^(7A'PU
MJOAOQ3H'@.7_ ()R^(/V3-9T+0M:\.^'$\3[1\9=>_X6BOAD^+_^$+^SQ&:5
M_P#A.R9&]I^%O["'CSX<?%KX(?$3PK\/O@QX NO 7C+Q/K'C'5;'XU_$WXL:
MI?>'?'.6\<>']%\$^/\ X*^#_"\;>+O["T'Q0/%7A=O!?BWP=XSE\1CS/&B3
M>+QXUVT[O^OZ\P/L_7O'G[.OP^UG6O =UX'FCE^$GAOPK=QZ5X-^"^L>-!H.
ME?'37/&NAZ)X.\.^&_AQX:\5>(V?Q4_@#6Y/%^@^&/")FB\*'P[)XR,=K*GF
M<O\ !SQW^QC\5-?\8_%'X6Z)\*#XC^#7ASP+:W?Q(LO!'A+3?$6C?#'7_A?X
M?\<^"]4T+5SH\7B#0_A\_A35SX6A,BP0Q7'@7Q1X3,/F^%)0OGWQ2^%?[5__
M  E_[5/_  SY-X+\-:S\8[WX&WOAOXF>/]:ETW3- \,GP;K_ (#^*NB>#/\
MA'?#_C#Q'HGQ'\(KX(T3Q/X-\5>+_",O@PS>/O#4L?\ PF*^#I?!R>??L_\
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MQXE\6VUKXQO]=\%^,Y&\:)>VT'8>.IOV7?@A:_ CP)X@^&7PZTNQUSXU:/X
M^"OA_P .^ /![Z9X1^*6MZ'X\\>Z3J^BZ4D(M? KC0O!&O\ B(^)8%C==C,,
M%L1_FG\"_P#@F+\6?A'XTTGQ;X@T_P#9T^+%E:W?@/[7\/O%MWXN3P/8#0_V
M,OV9?V96^**:%)\./%P\1?$3P9XC^"'C5_!RE?![^+_!?Q#\1I+XT\&3,T0X
MKQ#_ ,$M_P!HOQ!\4[CXJ:\W[*OBZ4_'CP'\6O$G@K5%UO1? _Q?A\#?$?\
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M+WOB=='>30%UXZ-FZ31GU;"7+ 91 [1/$PWAK<Y<3_NS^7Y2/R4E\'W/QO\
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M^-/!'C)OLCXA^*O&_P 3O^"6?[;NFC0?"-S!H/P/_:U^#?PMN/@W\-]5\%>
M?'W@K0/AEKOAWP-K7PQ^%\WB;QE*GAUT9?#5O!8>*O$\*MX;NCX/DE6Y@BH
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M_;6T+]FS^P_'7@X^*?%WAS0_B$WAUS_PF=OX1\7F&+QBLJ^!_P!W-!'7T-X
M_95_8CU7P7HNO_#K]F#]FBT\$>.]!\(>)+"+1?@7\.O#FD:_I$A\/>//",DF
MDQ>&HD=$UK0O!GB2VCEAB,5QX=\,R[I)?#%KY7KWBSPA\(='\%^++[QCX/\
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M;QT9=QP[X7M][5O2WEWZ_,>OF?G[??\ !33Q#8>-]4\-W_P?NM/\3^!=0O\
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MIXP^$?C7PS!\"=)^/!^(^KZ0FM>)=,TSQ-^S;X+\/>._BE)'K=Q\./#7A/\
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M!OB3XKO=/U1U;X5?M#^!/V;_ (WZY%X,31IH_#TD/Q$\=E?!'BKQ&OC+P?\
M\(=X=U_QYXV\%Q106W@;Q?\ M9I\4\-G;B]F^TW(M<7-UT#'AC]!RWY9YKYL
MUK]DW]F_5/%LOQ N/@/\,KKQR?&FC>/)O%,'AW2H-<7QKHOB30O&47B!=8-K
MYT>N2>)O#^A^*+F=4@'BWQ/H&A7/B^>1X(Y*^IZ#H"BBB@"%_N?\!7^35\K?
MLQR[M2_:=CQ /L_[4GCI2L';/@WX?'YU'1\\$>H([5]4O]S_ ("O\FKY2_9?
M_P"/_P#:9_[.G\>_^H9\/ZK#_P"Z_P#@/_I3_2Z^9S?\Q/\ VZOR*^KS8_;C
M\ 0_N<?\,Q?%+@XWX/Q/^$9QZY_N_A7UW7R%JLV/VY/ $'K^RU\4S_Q\$9_X
MNE\(^J Y/^]U)PU?7M57V7^#_,=#;^O(****S.@**** &I]T?C_,UPOBN/Q1
M<:!JL/A&_P!#TOQ/<:;J!\.:MK^BZMXD\.V.IA VE-K>@:)XA\*3:WHOS2^;
M#_PEWAF21!&$FBDED>+ND^Z/Q_F:\Y^(G@FS\?\ @GQEX'OM7\0:)8^,O#NK
M^&;S6/"VJOI/BBPCUK2SHK:IH6M!4.CZY##,RV\R;D#X=D8LX+6_R.;$;?+_
M #/R[US]J/\ :LU+XA:U\'?A#XN_9D_: ^*_AF..S\>^$O!GP:^).G>%OAFT
MS!?)^*7Q0UGXYR^%= GWQZR?^$816\:NVCA(/!DADE1?TX^&]EXBL? /@W3?
M$5GX1T_Q)8>%_#-EX@L_ =I=:;X-L=7728EUM?!T$JB:+PU%(\L?AA)5$L2*
MJ3;2CI'\F^"/V#=,^&7AS3?!_P /OVE_VE? 7A?2<_8O#_AW5O@YING+GKM4
M_!-S@XYPW0#C/3[-\(Z+<:%X:TG1+S6=<\176CZ3I]A<:_XBDTV77M;DBA16
MU;5FTFWA4ZNR1MNECACCDD+.J,SR,-Y6V75]-5KV?7U?6YX62X?-_P#>\YW[
M)W77;1-^;?W6LW\.?MSZ3\3?^$6\.^.]%^.'P@^$_P ,?AOXP^&OC3Q,WQ*\
M'Z]J5D-8\.?$_0=<T76#XT\/_$7PJ?LL1&BQGX;2^%U'C&X>.U_X3*-I$C7S
M+]F[XTZ'\<?C]X:OKK]LOX-?&76?"7A3QR?#WP\^$/PD\8?#L7XU<^'H];UK
M6=;U[XH>-5UM?#20HH\,PA7C$PN)0LZ2;?KG]J+1O!-YX"\/7_COQ_X,^&OA
M_P )?$_X8^/I_$GQ)U;1=,\$C_A"_'&AZTFE:ZVMZSX:B=_$$BQ16B&[VQ^*
MIM#EE$HMUW_$W[+>C>"8/VFY-/\ A]^T;^S1X]^'/A?3_C)K7P[\/?#3QUH?
MB/XUW^F?&WQO#\0-<\.^.1HGB*<-\.OAGK]PR>"Y;:"=1'K?AY))K>XAC Z%
MKA)>OI;:W]/0\G,?K>&XBREK6,MU=_?922>^[3V7\Q%_P6@BFF_9K\!""W^T
MG_A=GA<_9L?>'_"&_$#OP1MZ<COTK^96>RGFEN)['_CX_P"/WT_R?\_7^F[_
M (+,1>=^SG\/1YKJ!\:M$YMNISX(^('3J.,8;K\V:_F@$T_VK_7_ &:X^V?;
M?Z\<]<=*^AR7#?6\';R_2_Z[?(_ESQU5N.XK^['\8+N<OYT\T5QY!MO]%L_?
M_P"OSSTK2^QS\P?8?M/^A_;N;/!_LO\ #KW(K7FLOW5Q/_HWV>U_M2]XSW^O
M3_F!\'_&J\T,_FW'[C[3_P @O_1/^0;C_/\ CGOGO^K>7X?_ &I^+&?#-?11
M>?/ ;;_2^UG_ %/^1089_?[/]C_T/WS]>_OGK^FA]B_?6\%C]IMK<?\ +I:>
MW'^?\FK'DP>;_J+?_CS/_'V1_CV_SG%'U;R_#_[4Z#U#X#V?_%Z?@O\ O_\
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MON\>A_3_ !HWCT/Z?XT'0?AC\&O^";>M6WP4_9@^"'Q6^&?PZT_P]\%?BO\
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MD\*1>+[O2)/%,T\4T=O%)^S=%:_6)::K3;7RMKK^5M=3<_G=^*/[ 7[;NO\
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M-LM2\DBO_;<PD#R*B>U>5#Z?H?\ "K%% !1110 4444 %%%% !1110 4444
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M?P7]J:.+_A!I_%ZLT<@<Y^-7PQ^%G[3NE?M#?%/XRZEX(_:6\+>$O%?[<_\
MP4#\/Z+JFB^!/B2GC?Q=X$\;?!G^V_@CH?C71"Q0?LK^)O$*32>"/B5_PB1E
M\&?&6#P^J>-O!Y\4R%>Q\!_#;XOZ9\*_$<'PH\$?MBZ'\ O$?[.G[$VA?M*_
M#WQ#X9^/G@KQ.?'N@_&3P/HG[5A_9S^%GCU_"OQ-\/>(F_9MB\>-XWD_9\\(
MH/&WC+_A&$\!CQ?X_;RZ_<OX9_M,?"+XJ_"C6?C+I7BM?#7@3PNNK)XNUKQY
M;'P/IW@R/1=$T3Q!KTFOS>(&CT18/#NAZM%)-XDBN'\*>=N'VN5%+#0U+]J#
M]FS0/#7A'Q5XA^/OP:T/PO\ $6XU2S\!>*=7^*/@W2?#_CK4M(U9=#U>W\%Z
MQ<>(4M_$4L>M.J.GATS%'(\PJQYVN^W]?U_PP'Y\>*_"&F_#WX?3_M!_L4:%
M\9_"WC WFD_";P[X*^)WP@_:JTS3O#W@7Q'X@\/:]\5=6\$_!'7/@GXM^(WP
M^\0>*(_!F@/'XG\5?"67X//XN\/J6'A&7Q?XR\;3>D^+OC'^TY?_ !-_9GT;
MPQX>^)&B?#WXI?"'2+[XB>'U^!?C@_$GP)\3?''A'Q%-;:Q\4/&IT!_@3X>\
M/^$VT<)XV\*Q?&#P=XS\(^,UCC5/&,7BWP/!%]<2?M1_LVVFB:?K]W^T'\$(
M=#U/1_"?B'3/$%S\7/!"Z+JGA3Q[KFK:!X*\0Z5K4GB%8+G0/%GB#0M8\+^$
M/$<4BQ>+_%&B7-GITEQ<6S!N3TO]M+]E;6];\>Z%9?'OX73R?#7PMX2\7^,=
M3N_&VC67AFR\*^--&T;Q#X,\7:1XBFGC\.Z]X;O8=?T(Q^)_#[36\4FM>'8I
M)7EG@63$#\O?V3OCU^W[IWA_]G+P-XL\-?%;QOXH@/PK\!>-/"?QF_9R^)G@
MK5M=\"Q?LR>'_$/Q0^)_C7]HGQ#GPPOQ"\(_&N*7X:(?%3(/&,J-*J^,Y/&/
MA'QN.(\7_$#]L;Q'\5/V(?CI!X8^+OBKQ?H?PX^/.B_M ZHW[(OQD\#:9\#%
M\;ZM^R)-X]T7P5X&\0^&E_X6_P"(?"0'CL_!:-?&$J>-8/#WBAO W_"Y?'/A
M1_!'C']T+#XW_!_4=;\#:!8?$[P+J'B#XGZ!_P )A\.=)L_%FEZAJ/Q \+G2
M!K1U[P1"C&3Q)H/_  CR1^)/M/AOS8A GVA6,+L[^82?MG?LJ1>&+GQCJ_[0
M?P>T#P]:_$KQI\)KG6/&/Q#\)^$+-/'_ (!UO7=$\3>$!'XEU[0 /$,2>&M:
MNH%"EKCPLD?C,9\'RQS2;7?;^G\OZ_(/D3]IGQ7^UO\ #[X_?$[Q+\(M4^)U
M_IFN? K]F.P^%GAU/@IXS^-GP@TWQ1)^T+X^T/XY:MKFB^'V\*8\2^%/AOKW
MA[Q1)''XT\)^+_&/A &.)W7P:C5YQXG_ &C/VX_#7Q;^*7P[T'PIX[\4>%O"
MWAS3M$C^)-[^RC\2]373M2T?XT?LU^'O$'Q)\'Z%X'\/Q_#SX@8^#'Q/^-7Q
M,\(^#/"WQ8\:^-/%]U\*+=1X$\(M;2>$/%/ZG^./CI\%OA?=^&-/^)/Q8^&W
MP_N_'%Y+9>![7QEXZ\)>'-0\7:A'_8\0@\/?V[X@B.O3I)K.ADI;I*4_MWPZ
MCJCS0M(SP/\ '+X,_%;5_&'A[X8_%GX9>/\ Q#\/[Y['QWX=\$^-O"WB[5O!
M^H'4M9T0CQ;HF@ZW-/X?F.M:)K<'EZ]Y;-)HETJ*MU#(8DGIL!^+WPA^(_[:
M_P +/"'P<\+^!O#MY8:%XX^/7[8_Q \7^*?C3\ ?C[I?B7QVOB']M'Q!K/@?
M2)? ?P^^#'BKQ'\(T\4_!7QQK_Q2 \8>#O")4Q^&C#XU/@CPAXR5OLNS^.G[
M1MBW[=T>L>%?B'XBF^$NDZOK_P ";OP;\ ?&]AIFMDR^/],T3P5X+T;X@:#X
M4\1_%WX@PRZ!H?\ PFG_  BK^,_ GBU->\,^,/AWXX2'QBO@?P=]/ZK^V#^R
M?HVCWWB#5_VH?V>=/T+2[W3-*N_$&I_&GX;6&C:=J.M_VVFAZ-JVN2>(3;6\
M_B)_!7C.2W1T<SKX7\4M$I?PQ>-%U5M^T-\"KOQ;H'@"U^,_PNN?'/BVUTS5
M/"O@F/XB>#H_%/B'2=8THZWI.J:-X>DUA/$>LP3^'D/B!9X()!-9E;J!W1H6
MIW?8#\V_V7?B-^UEX^^/7P<\9?&K6_B-;>!?&?PN_:*T.#2=*^!OQ.\*_#?4
M]6\!?&M-+^%?BOQQ+X[\,^%IO &O>,?AQJ/_  E'A+Q%XH\%_"(>.X?#CKX'
MC:+Q8_@L>&Z/^W?^UC\1_ G[4_BSX.K;^+O&/A\QWW[./P^M_@7XV\2GQ[X6
MB_;-\1?"36?&G@HZ"S#XR?#I/@OHW@B3QKXG\+^,"O@KQSX@\3SX\&^"AX+>
MOV#U7]IC]G32]%OO$&L?M!?!;3O#5IX;\#^,+[7+CXI^"-/TVR\*_%8SQ_"K
MQ4^M'7U@3P[\3FT?68/ OB12@\8R0O\ \(=+<-$QKY?^$7Q7_89^'WCSXGV'
MPN\+_"3X,6^FW>E67BCXKZ);?![P-\-_%6G#P;\(OBQI&K>'?$F@Z\DGB'PS
M(/VC/!<:7*16_A+_ (2\^*)(F1Y4F\5'R ^3O'O[1/\ P4 \ ?$7QYH5W!#K
M'A/P-J]OX$O+#1?V=OC3K_CF[\+ZKI7P_P!(\/?'OP_KGAOX:>(OAH+;Q)XF
M/C7Q%XXC;XL^+/\ A$O O_"31^#_  #XU\>_"B;P1XU\M\"_M._\%%KGP;XP
M^+GQ \'^.?"GB[5?A#\"]-'A_5OV<?CWIGPT\":;H/[4?QZ^'_Q<^,0T0>'/
M%WB<_$1O@]H/@7XES>$CX1_X3-O"'CWPMXUD\"GP)X1VC]I/#G[3O[.OC77+
M7P]X-^/OP9\5>(+SPY_PFEIH7A_XH>#?$.KW'@B#3=%UX^,UT?1?$,TLOAJ7
MP]X@T3Q%%XF2-;06FOZ#-YICG@63EOAE^V)^SI\8?^%NZWX"^*'@KQ%X'^"$
M&EWWCCXK:-XY\'ZG\(O[,US03K]QJC>.M(\12^'/*\*Z!;B;QJ=>%H?"96,/
MO0&60N^W]?<!\W? ?XD?MB?$'XJ_!WPQXTE\.:#\-X/A#X[^('Q*\5Z3\%_B
M_9:?X\\3Z1\9-?\ !/@3PIHOC;XA:!\*9? 'B.7X?_V1XH\;^&;GP6)I[E)9
M? :2> 29Y/BW69_VRH/%3:WX=\1?&G5?'_PH^+W_  48U"VNM>_9N^)?B'3K
M'PHH\=>-O@9X.\$:YKF/#7C_ ,-_%+PSHG@)/!<OA,^,5@C">!F=/'*C'ZJ>
M(OVZ/V.=!\.:GXJNOVH?@5+8Z;X8\7>*#;Z1\5/!?B#5-0\.>!EU_P#X336M
M#T+0]<G\1>(D\+1^"?&ZW'_",V]R5;P]X@VI)+;L4]/\._M _ SQ/KWA?PGX
M;^,'POUSQ1XY\,Q^,O _A?3/B+X1U'Q5XO\  _ER >-?#VAQZ\VOZ_X:QI&K
MAO$\$+6ZMHMWAF>"0,KOL!^27B']LC]OM?'5OH/A3X ^++>\O?V;)/$WB+2O
M$7[.'Q+U'3/"7QA/[-.@_%[1CX?UCP]XD5=?\-O\2_$.L_"^7PUXI\6^#?&M
MQXS\/^(/ _@GP7*?!WB[QL/NCPEKOQ4\4? ?X]:/\;-1^(&G:KX-\>_%#X;V
M'CWX4_#GQOX8\<>*_ ND)''H_C/P+X,\.KXL\43:^4UNXT!O$/PPCE:>\T/[
M3X&>)HH7C]4\<?M7_L\?#?2/C?=Z_P#%[X;:CKG[.7@?4_B)\8?!?A_QOX,U
M3QYX%\-:#H[^('D\1>"$\1+KWAXWD1@_X1:+Q#':Q23Z_HBQR,)PT?$_$O\
M;D^"OP7^&_P_^(WQ%M_%FCZ5\0_!7B7XB6>EZ3I^C_$/4-/\#>!=$T+7?'.N
MZQK7P]\1>,/">N-X6T#6])=_^$/\8>,G\8%Q_P (&/&2M&3D!^"W[/UC^T1)
MH7[%UYJ5A^UQH_[5O@#PW^Q#X0\"^&_'?AGX]^'?#.G>&H_BEKNB_M_2^./
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MXMZ#X\\#ZYI7[!7[2&MW'A?QYX7\3_\ "/#1]9U+4]0U3^VM _ZIO_Q4&?\
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M!'>OPOATV#[5<>1/<W-QD?;/M=G_ &E]@_$_Y[8[']X?^"C5G]M^$G@F//\
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M)\3>#_%:1^#=#\5B*(2 9Y[]GC]KSP[H/[-'A+XA_M@_&/X0_##7U^,GQV^
M%SXX\>^,O"'PM\,^.O'/P3^-WQ>^%&E+H;^(I_"F@-XA\7>'OA9)XG7PKX9Q
M;P@>(%@B\FU85\^?O)^B],WCT/Z?XU\N>!?VP_V4OB7IOCC6_AE^TS\ _B?I
MGP\\,-XU\?WWP^^+G@OQS!X3\-K_ &QNUW7V\-^(?$@T/0W71-8".RC @D5
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M%)_#WA[X/>,=.T30_P#A0OQ&\4>+O"?Q<^,W@#X%Z3J>B:%\(OCCXU;2-?\
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MT)AH6AHVPQZ!X;>5K:W0;@$CB"'=^[KIQ2W?K^O^?]=?DN'<3O@[/1MW;O\
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MUWX9^-="\>>)OA3\5/@[K7B/4? OQ!\)Z3X1UZ\L-)\=Z&?#GCWPGK6A^/\
MPSXK\.:[X=\4:!)$SPHENL7BO0O#.HQ3,WA=(&Z/]G3X&^'/V=/@[X/^$/AK
M6/$/B"T\.W7BS6;_ ,3^+;O3[SQ-XK\6>._&.O\ Q \<>,]:?2;>UT%M?\8>
M/O&.L^)Y"MLJA]8<>7NC<+D_M#:'\:;[PWINI_";X_?#CX!Q>&CJ>L^.=?\
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MQ3&8F$H2#5Y9TV$E9H3W9VA^@**#H/F_7OV>O!OBOQS\9/&/B2YU'5;?XY?
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M44>$C:S0>+/T)HH **** "BBB@ HHHH **** "BBB@ K@?'O_(!L_P!^+?\
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M_P#@H[\?+6_M;4;+Q?#FMNS C.=&4_&A?+/H-SC&/F!(%6A_P;[>*R;#S_\
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MD' ZCH*6;_@A/^V7=Q>1<?\ !9W]I&XMAUM/^$:^,P'XD?MK8_6ERK^;\/\
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M?AWKE]\-O@EIWP:^(GB?6OA5L\9_$GPWH>C^)-$U?0FT,:^WP2\->'O&>O\
MC=O%+'PGX)\(>-/!$-MXH\'>"_&/BCP9XSDB\(AT'VSX!^-GPL^)^G>!]1\%
M>/?#VM/\1? 6E?%;P3I9NSIWB/Q#X"U^,/I'C*W\':V;/Q.OA^0-\ET;>*,2
M*8CLDVHGG=S^UK\"_P#A:'A7X76GCG0=6U7Q+X?^._B9-4T/5=&U+P;H9_9P
MUGP#H'Q6TSQKKD<TG_".ZWX5\0>/=$C:">*&6/$DDP7: WYW?L_?\$M_$GPO
MU+P-<ZS\0OA/:?\ "">+_ _BBT\5_"[X.ZYX#^+][_P@'[,C?LS:)HI\<_\
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MOQ3\0E_:3_:=\-_'3P.-;UI8/,UX>#O#VA'PY*MS'(8Y)&7P88K7B+POQ?\
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M\GB_X:KXE^% T36/%_@:#PPB7/CCQE,D7CGQEX0\&^*_'-MXM /T5^'/QE\
M?%_4_B+9_#?6[?Q$GPO\:1^ /$VOZ7)_:'AQ?&D.C:1K6LZ)HVMPW<::WJWA
MB#6M'C\4HB[;2=_^$7EA:[%P8NC\&_$_P!XVTCP1KOA[Q;HVIZ?\2_#:>+/
MF^XDTS4/%7AEX8=376M$T;61!KLD:QZMI<DP>/, EBD,=NOEA_CC]CC]D3QC
M^S#J7QL\+:K\1H?&?P3\8^)M1O?A%X&N4UXGP?IVN>-_'_CCQ"NN1^(_$'BG
MPX^N,/&^C^%EF\+Q1IXV3P#'\0/' /CSQ?XP9?DCPI_P3#^(WA[2OAOX/M-1
M_9TMM!\+^#?AA\/;WQ^_PIUF^^)?@#3OV;_C/K7C[P'\2_@D2&\->'_B)\6/
M#NO[/',D*^$X? WC?P[X>\;>!V\8M$0-;+N!^I_C;]H3X7?#GQYX8^'/C3Q'
M<:1XA\1>'/%7B^SO+S1-7'@W3O#/@;0M:\0:]JVO^.WC7PKX<QH6A:[<!O$W
MB2V$T6@ZPZILBS/Y1I7[=/[.^K_"3XG?&:#7/%NG^#O@[;^';KQA9:W\/?&G
MAOQRL7C?2M#USP$=#\$:]X>M_$NN?\+037?#Z^!UBB+>*I==6.-RR(S>:?MM
M_LP_%/\ :FUKP'X+TN[\!Z=\%+OPU\4/!7Q7EU/Q+XQ\-_$L^&/C?\,_%'PA
M\;2^!3HGACQ+X7/B7PUX:\9_\)-X*;Q: G_"8I$=P@C$Q\%U+_@FO\0_BMX
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M?"WP7\//$7PS\1?$O0OACH'[/^OZ#HWC+0-:_:>\2>+AX>\->)_C5HFA^$O
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M .PVOW\.GX@>!?"GC-M!.KA1J@T8^(=$NAI#3JB1RO"R27$:+',6(\L;>D^
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MOAR@#TRBF1_<7Z4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M31/%O[/FO_#KQ!)\;E/BG0]"E;X@>&?C[X-1K61(6\%^,A%&B3!T'Z8T444
M%%%% !1110 4444 %%%% !7G7Q&BFFT.R$,VT_\ "9?##GUQ\2O#>3T[9 Z_
MPFO1:\]^(TGEZ'9]?^1R^&(XM7N^OQ(\-CE5Y^C'E#\R_-B@#OX_N+]*?3(_
MN+]*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5
MD^ZO^>[5\E?LH?\ 'K^T5_J?^3L?C-]W_L+Z)^OI_M;:^M)ON#Z'_P!FKY#_
M &.Y89=(_:$\F'R/^,L_VB0?E R?^$T8%L#N3SCMCWJJ<;8/,GO[]/\ .?GY
M&"5L7_VY^O\ P"W<_P#)[V@=L_LM>+>>/].Q\4O GX?+T[]/0FOKRODV]_Y/
M;\/?]FP^)_\ U9WAZOK*KKZI?X'^O]?\"PJ&S_KL%%%%9'0%%%% !7SG^TIX
M/\>>.O@I\1?#7PMTGX8:U\0-4T^Q;PCI/QA\./XF^&U_J^D:W#K*_P#"2:(@
MS,JA";:5U58?$26SRA%7>OT97D/Q>T?XD>(/AKXGTKX1>.-.^&?Q&N;-1X7\
M::WX;B\9Z5H>IC4$ ;5- FF6/6(L!XA"7R"Q8MM)) /Q#\)_$#XS:]\3OV<O
MV?O$?[5?Q8^ ?CCXF>*O'?AGXL?L_P#A/X%? 7X#ZKX"LM$^&/Q$\=:/XU\$
M:CX@^&WQ73Q!X;\3^(/!'A_PNGBWP?XX\9>$IT\2W$ 6'QTH/A3]]M&M)M+T
MK3K*6\O]4FM;.QLWU+42KZG>NB[6U/5<+%\[,K,P8 AA(#@ME?P4\=?M0>./
M$MQ<? /X^^"?V4/^"A6HV^LZ3:6?AS]D?6OC$WQT\'ZH-&UO/B_7-#T#X;^,
MO"WP_P#$+",JWBI?C#\'SX+\R1HY 65Q^[/@V-H_"'ABWDAUNQ*Z!IJFV\2W
M37WB2R;^S$#+K6JEY=^NH'V7<ID/SK+A%!")OB-GTWV^?DG]^IY^&^S\OT/S
MY_:N^)GAV6.QU+QA_P +-^ GB[X(_M&:3:? CXJW?PBUSXV>&_'?BA_@OX@U
M_6]8TGP)X :?Q-XA^'K_  YUWXL>%_'5SYG@]O"']@>)PWC;PB8Q(<7]E#QU
M%\=OVA?$GQ3\0?'?]G/QO\0? OP3D^&0^'OP1M_&?AOQ,FG:]XQT+7M<\:^.
M?!/Q#\12^(_#D,7B/0_^$:\%!X9XPNN>)D7Q=/(ZQ-1_;G\*_M%6_P 3O@7\
M5/ O[4_[.OPL\$>&OB+IB^'_ (9?M&>$M,T[PZ?B<WPR^,'AY=<T+QY;_$?P
M;XGUZ?Q;X9US6_#+?"^U),1*>.897B\'^+?"'C/VG]GVW_;)\1?$32O''[08
M_9UTCP/9?"/4-)@G^ 7C#QAXVTSXD>/?$/C'P_K>C^,=+C\8_#OPAXA\!^'?
M"WAG2)?#Q\,_\)GXWMO%MQKYNR<6T:H?\PB]'^7I^ORZA_S%_P!=SX9_X+I:
MQ!IOP:^",'VBQMY[CXJZG<K]OM-1883P5K^67R/NG)PRO@@@8"C-?S$#Q)_I
M=OY\]S;&U.;S_0_^/#_B=<_]C!Z=<]Z_=7_@XC\7_'+0+#]G'0_"]K\.G^%-
MY?\ BC7;VZ\2+J@\2IX]T5$T0JIAURW#>'&\.:^979D9S+)(I<JJA?Y>H?$G
MQIF_X_M*\$^MYQK/'M_R,G'3_(K[GAO$_P#"/ZMOYMW/E\\PU\:?5$/B2;S;
M>#S_ /CZR?LGVS_.*(/$GE3>1_X&=],L ?;_ #]*^9_^$Q^+0BN/^*<\$=?^
M@Q_9OV_MZ#M_;G^3Q7_X3#XT^5Y']A^ +FW[VGVP_P!I_P#J2?RZYZ#K7L?6
M?/\ '_[8\?ZMY?A_]J?5$/BK_D'G_F'VO^AV=I]C_P _0^OIZV)O%4\PU#]_
M]IM^EG]DO,=O8_A]:^3X?%7QBANK?R-#\ 7/^B?Z9]DO/^)9C_PI/Y_IUHA\
M;?%3[5<?\4YX2N<6?V+_ (_-9_ST[^U='UGS_'_[8/JWE^'_ -J?IC^S?KU]
M_P -(_L[SV]]<VW_ !?CX-V5G:?;.?\ DIV@?C_R+G^1Q7]YHZC_ ('_ .A"
MO\V'X#^+_P!H6'XW?!C_ (0#P/X U+QQ:_&#X7WO@^TU:\UD>&;_ ,4?\)IX
M?_L+^W/^$?S_ ,4[CWK^L;_A;O\ P<"^9;C_ (96_84P,_:O^*[\883/)"C_
M (77CC@\@Y[YQ7QO%ZOCH/M&6G75H^OX<_W-^J_4_=JBOPI'Q>_X. O+@(_9
M3_84,R7Q)4_$CQ<4N].VZZ"1_P 7'^5EQHI&6ZR.6SE<0P_&;_@O\(OW_P"R
M3^P^)@"/M ^(NL[?R_X743QTQTKY$^A/W<HK\)%^,O\ P7]:XN8)OV1_V'C;
M-G[)=VWQ2UL&Q &/F#_$?)]/F&<<?1W_  NS_@O?"_D3_L=?L7W"E?\ CZM?
MBGK( U+&<;3\1^!CC;VZ$<4 ?MUI^BZ/HYOY=,TW3M/;4[MM7U-[6TCL6O=3
M< RZEJ+*$9Y&,*Y:4,^5SDX.-^OPDB^-G_!?[[ )YOV//V*+BX^S#BU^(^L
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M)XM\(#Q:R>$Y)O#\:RY00M'\G_L0?!CP;X5_:@^,'Q3^$/[&GC_]DGX;^)O
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MU;7R'<03R?MOZ1./(^SVW[+>LGD$D%OBGH9/OCT[;<$^I^O*=?I_@_S_ $_
MFAM\OTB%%%%9G2%%%% !7!^,(?%5WX<UV/P9?:-I/B]=,OW\-ZOXJTO6-3\.
M6GB$)C2%US0=%UOPK-KNA!V FBC\4V<N2 LXDR!WE>?>/[_Q=8^"O%6I> M$
MT_Q1XVLM U2\\'^%M5U7_A'M-U_Q)%II;0='UG7&C?\ L2&YUDQQR3@@QHQ<
M,KJS( ?ESX;T/]N>S^'-WIWCO]EOX#?&KQ9!XR^,VH>$_&_C#XX2ZWXX\(G6
MOB/XWU[P/K3>"OB)\,?$_AM?#\(_L!/!GA?PO\8V:+PBOA^TE_X0N6W>&W_5
MOPP-;?P]H0\5QZ?#XI_LK3#XB&E$FP7Q(^DC^V1I#-\Y19C,(6Y'DYP6(8G\
MP? O[8G[1?AWX1:_<?&']D#]J0?%>SO_ (HOHNI^'?AQH_Q&\!WNJ/XPU^+P
M/H/E_#OQ-'\2I?#/A13I/AG_ (2:Z\&>%1XT\):&OCX8_P"$FB1?T^\+W^JZ
MEX<T#4M>TUM%UC4M(TN]UC1VP[:?JTNF(^J:403TMY%9$W=0A)R0*VQ%[RVZ
M[?/S.;#[+^NQ^7'[=G[/W[*=[>?#[5_$O[)>B_%/XW_%CXI'1?#E_P#"'5=!
M^"_[0NN:I'X/UK6]:US0_'27?A.37D\/^%]"EF\6)XO\8^&?"21;9;ZY29EM
M79^P7H_AGPS\2OBM\/\ P[K_ /P4%T/4_#?@[POJVJ_![]LGQ'I7C'PYX0TC
MQ#JA@T+6O!/B!+GQ1<./$TG@SQ#H"O:^-_$WA,+X?\2K;D3KNEO_ +6FH?'2
M3X@7T'Q%^&/BJ;]GSPMXF\+^._@K^TK^RC?CQ7^T'^SMXJ3PC+X:US6?'/P8
M\0>&_%K_ !!TF:X\0>-(YQ\+/"OCG=\'M9DA\<^!GF$T[>I_LJ>#X_&OC*V_
M:8C_ &N-,_:IM+GX:GX2:%K'AWPI\.?#.G:;*=<AUSQNFJ?\*]A4W/B"3Q#H
MVDX\,^)V23P5*GB&'R=\S^0_^83Y?+;[OZTN8?\ ,9_7<_,O_@XFF$7PS_9A
MB T_!^)'CO&_^S!JPQX*&P:)Y_((C\O>HZ3GP]O_ 'A>OY1Q#_X$77-Y]KY^
MW\8YS^F>E?UA?\'$4T ^%O[,6)8A?#XE>/;M?.X4Z8O@O][D< $3G2%QUR,D
M9)K^47R?.Q!Y^;COU.I_YX_3%?H_#/\ R)NWOS_-Z_,^0XD_WQ>G^08\Z*X\
M_P!!G%GS_7\.*KWG[F+_ )]O^GN[ TWIGD]S1Y,_^H^GVS/_ "X?D/;CI]*T
M(?W-U<6__P#-,?T..^?KUY^B/&*\/[B.X@\BY_T7G_2[W61]@SG\L_@*L0_\
M>EOY'^DV_?\ T,=QW_SS]35>:\@A_?SX%Q=?\>?X_P#U_P#/%$,,\T1\_P#X
M^/\ GSN[S]/\.I'7Z 'TC^RO^Y_:O_9?\^#[-_QDA\![VSZZ;_S4[0.@[=O7
MKGM7^B['T8_3]"/\:_SF?V2S_P 94_LS^1!]I_XR0^!'^B6G3_DIW@'_ #^M
M?Z-"_=_[Y_D?\!7Y_P ;X>V)ROR@W]SM^I]CPW\%1=TE][9Y3\:[KX4V?PC^
M)$_QNO?#FG?!]?!WB4_$FZ\6WJV/A=? QT>X3Q&=;ER$_L==#:873*22N%V[
MF-?DY^P#\7?V1]*U7]KG]HWX=_%+]GSX5?!+QWXE^ EAH'PN\*^+_AEX;?X;
M^%M!T4_"CP/\4/BOX'\.:[]G^$'B3]HCQ)K.SP9X5\516WC!?!.B?#3_ (38
M6_CT^+? _@W]G-?T/1O$NC:EH?B+2]-UK0]5@-EJFDZI8KJ6G7]A( YCU/3)
MD$3J2@R&0@$(Q 4;4\E\+_L\_ /P/%KR>"O@C\'_  3%XE;2[KQ*GA7X;>#/
M"Z>(3H4PU705UJ/0-"B77V\/2;6M6G>55)^4\D'X\^G/R<^&&C_"S]GS]LC0
M+S09?V2OVC?%7[6O[7_[36L:-XP\$V>D7O[4OP7G?2?'VN>-L:VDWBR7Q%\.
M?A9-X'UGX6^.+?[1X/\ ^$/\8^(D@W$R/X+;]./%_C7]K_3_ !)K=EX!^ G[
M/_BSPA:HK>'/$'B3]J?XB>"O%.I#;@'Q!X)M_P!DKQA;^'B<[L6WC+Q<.AY'
M3U#P_P#"+X6>$/%VN>/?#GPU\!^'_''BDM=>(O&^C>#]$T_Q3K;HIW+KVNI&
MGB+6FY!7S9#D[0=I.VNGU/Q3X<TC5M&T+4=:TG3-7\37>HV_A[1[_5-/L=4\
M02:7&=3U4:#I;GS=8DBC7?="-#)$CF24Q^87E /QR_X*9>"]-N]4TCXR?&2X
M_9C\3?"3P9^RO\== \1?!;]HGX@_\(1%X)\2^(=9^'LLOQ_^%NL'X;_%F7QQ
MXF\+C2M$^%ZQS>$/!-W'<>.?#S^"?& \9^+(/!=[Y_J?@3XF?'7_ ()R?LG_
M +,WQ3^)?@/1/VGO ]A^QQXS^-WP3_:-^(Q\%ZC\3/#<?C5M!T+X+?''RX_&
M/BD-^T$G@37O"C-+X2\6KXT\::!XBBC$CL0G[6>,_A/\-/B)J/AG5O'OPZ\"
M>--5\'7AU?PCJ?BKPGHWB"_\*ZHPC)U;06UN*>309R=*TM_.LS%(9(%C=B5,
MBY_BOX/_  L^(<7B"V^(?PQ\ ^-K?Q5;>&['Q?IOBGP5H_B73?%-AX'N9-5\
M-)KT.NZ%.OB#_A$]7UG6IO"H9'BMGU:XFAB,KSB$.<_G!\#_  Z@\:^))?BU
M+9?L@V?[._PG_:__ &U?'/A']E7XK?M#NG[._COPK;_!_P"#W@CQU\2?A;K'
MB#X+Q^&M>T#X!_M%Z+\6/$LFSX-GP5X-\7^/?%*>"_'&U8O&'C3.^ 7P:_:"
MT_X/?L!?&)M6\'ZI\?==T;3?"_[.7@CQSX;UCQOXCT'X7?"?6_VO-<^%GC)O
MBKX?\2>$?$G_  IA?V<_VBO!*^.@?!Y\:>,SX!^&7@5L>//BW_Q1O]'^O?L\
M? /Q/X>\,>#?%?P4^$7B7P;X'+/X/\*Z_P##CP;JGACPCA<NF@Z#+H!T#0!T
M*BV@0=U4$DGO)?"?A^[U_3_&%QHFB3^(]+TC6=%T?Q!+I6E'Q!8:5KMSH;ZW
MI>DZJ81-'I/B,Z!H(NHEFA6;^Q]$,ZRFWC$6_P!9\_Q_X/WB^K+LOZ^1^5'[
M$_[2VE>'_P!C/XH^++CP3>:))\&OAE_PT;JWB'4?$<WB35OB2GQ?^&J?M&_\
M)QXW@@\+>&6\#_$+Q,?$>L'QW\+?#B^,K'P*Q'A3P9XX\7):QM%^:'B7Q=^S
M;^R5\)?V0?'O[+5[\ O$?[4O[.7[./CGXU?M9>+?@S!\.?$6J^(/#$?[,^OZ
M'CXYZU\/5C_X2!/BQ^UAXV^%'_"%KXK=_&,Z-XK\:>!U:'PEXS$G]+VE_"#X
M7:+X:\7^%-$^&?@#2O#'CJZ\1ZEXWT+3/".A6/AWQMJGB?S1X@F\9:''9F#Q
M#)XDMYY;?Q4_B-9C?*3#</('\Q<32/V;?V?-#\-:_P"!-#^!'P>T3P3XELUL
M_$OA'2/A9X,TOPSX@TW'RZ5KFA1Z"WAW7(2QPZSQL,[?E&TLV S\E_ /[4OQ
M!^%7Q6_9R^!^L^+_ (>:=X*U3X+O9^'O!/[,W@3X=7_AG4OC-^SK\&A\6OVK
M_AK\5=%D\3Q^)/@+XAA&MZ%_P@GA;PEX1<P1:X(O&NWY(ST-A^UK\;[WX<_L
MX^)(OVD/A#K/Q/\ VQ-1^!6GV'@+2_!_A&\\._LV:7^T3)K>OZ+XUT0'Q%!X
MK\?1^%]#\!^.OA=X'7Q4KVWC[XPQ++NDM_"_C#P4WZP:3\%OA#H/CG5OB9HG
MPL^'&B?$W7K,6/B+XA:-X$\)6'C;Q%IZA5;2]=\91:$/$NNP;M-!:*>Y;]VL
M;!<QHXYH?LO_ +-5EX<\4^"H?V>?@=:^#OB#=R:OX[\+6OPC\&1^&/&&KJC9
MU/QEHD>@#0O$4N"2LGB.&9L@[7+#"[77]=?Z_KS#\U/ W[<_B_PM\9I/#GQ+
M^,/@;4O@!X8^+G[3BW7Q^\16GA'PSH_C?X-?!#X+_  >(&75M$$/A=?$OA']
MJSXW:U\+C_PBZ"3Q<OP_\5".*.3PS<+/\H+_ ,%$_P!L#Q]X(\4>(? 'CGX:
M>'!\-/V'_"_[57B.ZO/AYINK:CXL\>_M(_%#Q'<?LI?##0]#_P"$F8>'/#;?
M#S1/!?A?QUXJ; D7Q!XFMV/@_P ;K%XN\%_O?>?L]? 2[TWP/H=[\#/A!=Z+
M\, Q^&FCW/PT\&OIGPY94W'_ (072?[!\KPR#]Q1X;\C<W /4B]'\$/@U#%?
MQ0_"[X=6MGJMGX*L-6L[?P)X2^PZUIOPO=6^%<&M(WAT&>+X7/&@\#1.7C\'
M;(6LC$(X2F('Q#^RT_CGQC^V5^W9X[U+XRWOBWP9X&\=>!/V;]&\%OX;TO3M
M,TX^!/ACX>^+FW277?+&WA?Q!^T;XA\,-<OE?&$BYE8R>%$63]0J\ST[X9_#
M[P_XT\3?$+1?!'@_2/'_ (VL]-LO%GC32O#.D6'C'Q9IF@@+HD.OZ_$AU_74
M\.I)F".\N7"F2-88T*H@],H.@**** "BBO&OCI\6]/\ @3\*_&_Q8U7PQX\\
M;Z?X&T&76KKPO\,O#DGC'QQK*QY"Q:%H,<BM<2$JW&^--HD<D^4J2 'LM%<%
MX"\7V?C?P7X1\:6VD>(_#L'B_P /:3XAM/#_ (LTJ30?%>C)K&EV^KKI6OZ)
M*7?1]>@CF1+_ $-Y7:WECEW[RC =[0 45^8'[:7[5/Q3^$/C+PG\,_@_X<FU
MCQ3XMT;P-?W>H6>C^$_$FH^$&\?_ +3'P ^!&C:R/^$D^(G@[P]+&/#OCGQT
M(X?%:QP?\)K_ ,(IGQ:O@N#Q>8>H_:<_;*M/V?/C]^R;\'[J?PG'9?&SQ??:
M-X\O?$6JC3-5T32]<UKP_P#"OP%_PAL<FO0/_P )!XK^,WCO04:-X?%4B>#M
M!\6E8X94BE4 _1>BOP'\ _\ !3#]H?Q1\=_CI\-KOP9\*]4T#X6_%S]NKP#-
M:Z)X*^)&@>(-%\"_LI^"]'U[P3\1=8\>^)/$0^'7C_Q'XF\4:]H/PU\<_#CP
MA!97/A!M?M?'HN'\"I-%'ZI!^WY\>=!U35?@IXQ\-_"+4?C;XQ^'7[)WC_X*
M_$+PU9>,M,^&]]'^U;\3G^$L>B_%+X8ZWXF\2>*/#7_"I_$4>J>)F1/BV_\
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M+QCX>;^QO$%WXJ\.:OX=9G0R?$SPCX)\*^,)-$\1?\*^\7>-#X8NFBY'1?\
M@H1\+-4L?@9K^K> OB=X2\+?M&>(?"NC?"W7?%\_PAT*;7;#QWJO@K0?!GBN
M+P7<?$R+XDZYX>\4^*?'OA_PU;7'A'P;XJ/EG_A,G@A^'\:^-F /T+HK\S/&
M_P#P4[^ ?@#Q?J7AGQ%X8^+%O<#Q+\3? 7A/6[K2/!GA[PQ\1?'/PF^)N@?"
MCQSX/\/>,_$7Q!\+^'] ;PSXI\8Z!$?$GQ4G\$>!=FL)+#XV6Y5UDZ7X-?\
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M^"IGQ<U72[GQ5XT\*?!_X3V_@Z34M>\8>"-7DUSXCZEXLTQ/BCH>B?\ "L/
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MB#0_#Z^'#+X?'AWQ5#N9CX?\8ATGN+OPCX16OU7I:VO?;[_T%_S%>=C\K_\
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MB^#'[7 \>Z"OC77OC;\5_%&N^'D^,NB?LNQ1^)U;X/\ @GQ>2K^ _ O@_P
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MH:\DC&XT&'XC:OXD\82?"Q%?P9XR\82^&&\:&YM?"<7A.?;1=OZU.<]Y\/\
MQ@\7>'/V=/$WQ[^-G@^U\$ZGH?A'QW\3]<^'UA?IJ6H^%/ ^@1ZWKVB>$M?U
M.25MOCZ+PUHL$7C1T<^%HO&/_"06\0^R(C'XH^&G[?'QML?"'[-'Q;_:8^'_
M ,)_ OPT_::^"OCSXN:(_@GQ=XS?QK\-'\%?!;7/CR=(\<Z!KOAX)XB\/'X<
MZ%KJ2^*_"VVX3Q<_AY5\$Q17(D?N/AS_ ,$[)O /[(O[0_[*^D_%2UTE/V@/
M#A\&7WBSPO\ #)/#OAOPAIK_  9\!? B76-#^%\7BF8/XC\4>&_!0\2>._$7
M_"7A?%OCS7/$GC6/_A%()8O"EO>^+/[!7C3XZ^#]>T+XA?'+3E\0_P#"I/B!
M\!_AE:>%?A2?#'P@^$O@7XIZ"? 7CGQIH?PLE^)'BOQ1X@^,1^'BZUX6\#^+
MO%GQ<D\(>#H==5X/ $D$OC#PIXN6FO\ 6@'MGPL_:HT[QA<^'_!&IZ3XCU;Q
M]H7A7P"_QQ\8>$_ >MZ9\)?ACXZ\:_"_0_BU)HVL:OXBUN<Z.9?#>LZ!KK1J
M?%3^#;/Q)X:/C*YMI?$\!DP=$_;_ /@OK_P^TWXGZ?H'QM@\&^*/^$77X5ZI
M<? ?XG _'%_',DB^#/\ A4^D#PXWB+Q,?$RA?$,2-:P,/!J2>.Y'_P"$#<^+
MU\M\8_\ !/\ UOQ_\9/%GQ.U_P",>B^'M \5?"[XP?".\\._![X;:Q\-?$WC
M#P5\4O!W_"":%#\;/&4GQ*\6^%OBW=?"CP^B?\(%XCE^%'@Z6&70?#18LUL1
M)K?\,B_'V?PG^S_I,_[0WPP;QI^S#XP\+>*_@_>VG[,>MZ7\+!HVB_!OX@?
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M;7->FUG5RL<.D0QM)H/AT>9A9O&'B'POX1B\RX\26JR@'T!17P/9_P#!0/\
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MP?7(Y]L=\5I3_P!SS+_%#\ZC[/JK?J8?\Q?_ &Y^IOAO^,RA$HN1_P 8S$P
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MK!(Z^8J%64[1^>_P!_9Q_:<^'OBO]H_]I#5?AK^S'\%OC#X_^!7ACX2?#?\
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M=:'X ^&?B[PYIW@CP'XK\?7FJ_$[XAZ/\4-$7XI^-_$?P_\  IT3P)H7P/\
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M+H_B?2_%GAK0M(9T\%Z+X&/[.O@_PUX!@F\2C1O%$7BCX32?!OQ:?&*/XO\
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M8C<EV& 2SLY9O3:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO,O$-OK"^.O E[:W
MNM_V05\26>L:9:6Z_P!@,QTN5K?5-;8E""DS!+4,Y#2-M4[@Q8 ]-HHHH **
M** *LGW5_P ]VKY6_9,2"X\ _$"X2*XMI+G]H[]IQ[E+N\_M%S-#\;?'NDD^
M9G[A$280@#Y6).#Q]4R?=7_/=J^4OV2+W[7X$^(.+B"?^S_VB_VC+!FM+33K
M!ML?QE\4M_Q,8HLK]I!.7>,K*T>Q<,5B JC_ +GF?_7RG^50YX_[U_V[^J+D
M//[8M_QC'[-VD\?+_IG_ !<[7^<_=_=]?^X[QD]?J/SH?^>W_CQ_PKQ7XB_L
M]_ _XNZGIVM?%#X5^"/'VL:1:RV>D:IXJ\/:1JVHV5@VZ1TTF5XG>-2[A@?E
M89&!@!#P:_L0_LB"$P_\,W_!R&'IBT\!:+8 9[_NXU;\Q_\ 7MV=M_E;]5_7
MY!]3>?[?I_\ 7H\_V_3_ .O7RS%^PW^Q_#)#-!^S=\'%: G85\"Z(2IY!VY@
MV_\ ?2O3U_8B_9+B_P!5^SQ\+!]/"&D'G_@2+_GO1_LW=?\ @"_^2)_VG^Z?
M4/F+_=_G_P#%4>8O]W^?_P 57RDO[#'['<4?DP?LW?!R ;_M&(/ >BIE@>H"
MPCYCSWVGL.U3?\,2?LC[\?\ #.'PE"?WO^$.TDG'^C_],^?^01I'I_JDSC]Y
MC+YCMBNR^X^I_.'_ #T_1?\ XFCSA_ST_1?_ (FOE:+]AS]D.&'R%_9\^&XA
M ^Z?#B\_7/;Z&C_AAS]D+]__ ,8]_#;_ $K_ (^O^*<7YSC/\\9QC^=:_P"S
M=_\ R6/_ ,D%L5VB?5?G^WZ?_7H\_P!OT_\ KU\PI^Q5^RS"/W/P2\#PDVGV
M0;-/880]OOGG_:[\_+SFH_\ ABK]ELQ"'_A2?A"=<<_:5U0$_P# FG8?D!]*
M/]F[K_P!?_)B_P!J_NGU%Y_M^G_UZ//]OT_^O7R_+^Q=^S!*<GX/^'B>TYN]
M:*_7C7%<X.?_ *_=\O[&O[-$MM<6Q^$FAFWNO^/JV^W:V=W^]C7E1?7Y2:/]
MF[K_ , 7_P D'^U?W3Z;\X?\]/T7_P")IWG^WZ?_ %Z^8O\ AC7]F/RO)_X5
M%H/D==OV_6]OIG=_;N[_ #ZU)-^QU^SA/_KOAK;M_IQU'_D8?%XQJ7_01X\2
M<./4_-ZT?[-W_P#)%_\ )!;%=E]Q],^?[?I_]>CS_;]/_KU\V_\ #'_[.GE?
M9_\ A7-O]GQG[-_PD?C#'Y?\))C./;%)-^R!^SI<2>=-X ,[?[7BWQH1Z?\
M0R+[<9_H*7^S=_\ R1?_ "86Q79?<?2?G^WZ?_7IOG#_ )Z?HO\ \37S4?V/
M/V<]MN!\.^;1C<VUO_PEOC,!7Q@'!\2$8W$#))4'&<][G_#)7[/GE30_\($?
ML]Q]_'BWQGAN@X_XJ3@#&1M_'TI_[-W_ /)(_P#R86Q7]T^B_/\ ;]/_ *]'
MG^WZ?_7KYTF_9'^ ,P_?^![F?V;Q=XT_KXD7OW!S4*?LC_L^P1^5#X'O;=1<
MB[(M_&/Q#&9,_>+)XFR"V,$ [1CA:/\ 9NZ_\ 7_ ,F'^U?W3Z1\_P!OT_\
MKTWSA_ST_1?_ (FOG3_ADCX ^7Y/_"$ZCL]/^$\^(^.G7=_PE&<_C_A52?\
M9'^ $[VXG\"ZC.EJ?]%9O'GQ))1<3\\>*#WUG53R#D2-C&#Y9_LW?_R6/_R8
M[8KM$^F//]OT_P#KT>?[?I_]>OF;_AD7]GS_ $[/@F^_T\?O_P#BO/B5Q^[W
M#;_Q5'_$H&2#^YV_+GOD58O?V1_@-J3B:7PEK*M]J%V6@^(GQ+LBTG]XK#XI
M3KU*@*/0BC_9NZ_\ 7_R8K8K^Z?2/G^WZ?\ UZ//]OT_^O7S/+^R%^S_ #20
M3'PAK*M;*;5?L_Q$^)0"KD#:P7Q4"=IZDD8[DU)_PQ_\ /\ H4-:_P##B?$K
M_P":NC_9NZ_\ 7_R86Q7:)]*>?[?I_\ 7H\_V_3_ .O7S3+^QW^S]+%Y#>#]
M9\G'W1\1OB4#^1\6'^=5T_8X^ %N\TT'ACQ-$UQ<B[<V_P 5?C"A9QCYSL^(
M*KG'=%5,'A.F#_9NZ_\  %_\F'^U?W3Z>\_V_3_Z]'G^WZ?_ %Z^9/\ ACKX
M!^;YW_".>,]W7_DL7QES_P"K$Z_A^%53^Q[\ S)8R_V%XW"Z9=&YLK=?C-\9
MO[.28RC5=RZ4WQ%-L6$N6$;0$[OF*&+@'^S=U_X O_D@MBO[I]2^?[?I_P#7
MH\_V_3_Z]?+)_8O_ &?!'!"/#OC8+;7/VQ1_PNCXSY$F2<G_ (N+G!X!SQ@?
M7)!^Q9^SU:>1Y/AOQN/LWW"/C1\:?S.?B(!U^;].]'^S=U_X O\ Y,/]J_NG
MU-Y_M^G_ ->CS_;]/_KU\KR_L<? "=KA9M&^()-U_HEW_P 7W^/(W#<-7(S_
M ,+(''F_.2-IS@ [?DJ;_AC/X!>;<3_V)X_\^ZQ]K;_A?/Q[^?\ $?$COZ@+
MQ[4?[-W7_@"_^3"V*[(^H/,7^[_/_P"*H\Q?[O\ /_XJOE&+]BSX!1?=L?BQ
M^/[2'[21Q]/^+GK_ )S2S?L5_L^22W$S:7\1\W=E]@NC_P - _'Y0;#D[>?B
M4>,C/4#K\U'^S=U_X O_ ),TO+O+\3ZM\Q?[O\__ (JI<IZ'_/XU\J2?L;_
MK[+=6Z6GQ/M7G7YKNS_: ^/UGJ0)/7^U8_B6)L^F&XR<ACR&C]C+X%)':Q+%
M\9-MI_QZ ?M-_M,XM/<;OC'N.#UV,<_K0U#T]+F=L5_=/J_>/0_I_C1O'H?T
M_P :^3!^Q1^S_NN<Z7\3?+NQFYM/^&@OC_\ 86('.5_X64!^*\]> *27]BOX
M"SJ-FG_%.VQCFV_:0_:1L#Z]$^)Z_H/;M611]7^?[?I_]>I=X]#^G^-?*/\
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MOEW_ (9,\#^=!-_PLS]IG_1AG[-_PU/\?B#D=&_XN./KR3GIFD_X9&\ ?O\
M_BXW[4/^D#G/[6G[2G'&/^BE#:.HY[<<<&BV&_F_!=_7M_5@_P!K\OR_R/JC
M>/0_I_C1O'H?T_QKY<F_9.\!3R^</B-^TU;L ?\ 1K7]J[]H-$Z],'XD'_T/
MZGM47_#)'@7_ **;^U+_ .)8_M __/&HM'M+\1GU1O'H?T_QJ+S8?7]3_C7R
MPW[)7@FWA_<?$O\ :B@;/(_X:Q_:!U(#_@6N?$6<$GT..G-)_P ,E>$M^?\
MA:W[4OU_X:G^.V/_ %+<?^/=/:FE%;-_>!]6[QZ']/\ &HO-A]?U/^-?++?L
MF^$S#^\^+G[4$O7)?]ICXRV8.>>D?BE"/H:3_AE'PAY7D?\ "TOVH\X_UW_#
M3OQX\S/U_P"$LVXSV].<YYH2BMFU\V@/JK*>A_S^-&4]#_G\:^6#^R9X0\V"
M4_%O]J'-N#MS^TS\9,8_VA_PE&6SWP5[^^8/^&1_!_\ T5_]J?\ \2;^,O\
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H^K23ZWK4Q99"DL1\H,Y,98.Z^K-7U:CI;:REUOUOM;H*UL5\K'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2416373d4_ex99xl-img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2416373d4_ex99xl-img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ .(# 2(  A$! Q$!_\0
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MXC_X)N_L#>*]-NM&U7]DCX$Z=;WUE;V,E]X:\ :/X/\ $-O!'-<3)<Z)XO\
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M?B5^Q9\$]9_X7]^U!^T[IEIX(\+_  D^"4$GQ6\4Z9X;M_$>CW/BSQ'XHL?
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M)I^M_M3>"_V;?V/]+6*>33]6M;#]I ^"?A;\2M2\.3;)I!JG@+X.ZY\2_B7
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MQ/IVFP6JK;1:?9:K;V:6X6$0F-50>PB.,<A%'KQUSSSZ\\_7F@QH1C8N/3
M_(5E/$8FHXN=>;]FN6G%R<H12BHQ?*_=4ERQ?NQ2NAT\-1I-J$$XS<G.4DG5
M;DVW:=KM>])*\KI=3\8O@]_P04_X)F_L^_$:#XN_ WX8?&7X4?$R"VUJU7Q_
MX&_;!_:[T+Q5-9^(XUC\06=[JUK\:UGU&SUID2ZU.TU!KFWN]0CCU.:)M1BC
MND^D/'W_  39_9Y^*7AN_P#"'CWX@_MH>)?"VL6LECK'AVY_X*"?MN6>DZS9
M3%6ELM6L]+^/%C%J=I)L&^WOEGA.W&VOT-$: 8"@ = .GY4"*-<811@Y& .N
M,9^N./I6U3'8VO5H5\1BZ]:M0I*G&<W&3O'5-2E&4THN[C&[2;;5F32P>&H4
MZU.E3Y8U:WM>7:&K3<9)/KJG:U[ZW/RB_9@_X(N_\$[?V-O&_CSXD_LU?"+Q
M[\,/B'\2/A?XG^#OBSQMIW[1O[1VJ^*)/ 7C'7O"/B;Q#9:+KOB'XJZIJ/A?
M6[K7O GA?4+?Q;X6N=(\7:;/I[-INMV8N[SS_/O%?_! [_@F5XW^,$W[0/BS
MX5?&?6_CC-XJTCQPWQ<O?VPOVOAX]7Q?H#VTF@^([7Q)#\<$U*SU?0GL[9M)
MO+66WFT_RQ]F:,,P/[/E%.<@'/7/>D\N/.=B@XQD#''I]*U6;9KSSKO'XA8F
MI%4ZM:,WS3I17+&G*32DXQBDDFW'31=R6#PDH*A]5HQH1?/"*C[T*KES3E&Z
MY8\UY7Y4F^9MZL^'=2_8+^$NKV<^GWOQ=_;;2WN8A!*VG?\ !0+]M71[KRP6
M;]U?Z/\ '*QO[>0[B&FM[F.9TPCR%%51\[?L_P#_  1&_P"";7[,O[1GAW]K
M#X1_!;QG8?M">%+OQ#J&C?$SQ?\ M%?M'?$K5EO_ !9X9U_P?X@O=3T[XC?%
MCQ/HOB"[U'P[XHU_3_M/B'2=3DM'U&2_L)+;48K6[A_6ORT_NBCRH^NP9]<5
M%+'XVC"K2I8JK3I5X2C6A#D@JBEI:?+"/-&S:<9.UG9:-HT>'P\HQ4X2DX6Y
M7S:JU^K;?;5._P [6^=_VB?V7O@M^U9X#TGX;_'+PUK7B'PIH/CGP=\2M"B\
M+?$;XF_"C7M#\=_#S4CJ_@KQ/HWC/X2^,? _C32=1\.ZH5U"P:P\06\(O(X9
MY8I9+>!H_GW7?^"8W[(WB[X=>)/A1XSTS]H;X@^!O%OB+P/XIU33_B3^W!^V
M_P#$?5;'Q+\-O$'_  DW@S6O"7B[QQ^T3KWC#P%J&D:\!J#S^!=>\.MJKI%#
MK/\ :%K%' OZ%&-#U4'ZT"- ,!0!G. .,]<_F>?7O7/"MB*23A7JRG&3E!SF
MTHRDK2DN2S4G%)76KLKLBIA</4@XN'O/D]YJ+TA/GMK%MIOH[I-MVU=_AG1/
M^">?[+^CZ5JNAW-C\=_'.D:MXD^&GBV\T_XP_MC?MB?'.U@\2_"+X@:1\4?
M&MZ1%\9?CQXZ70-0T?QQH6E:S?3Z%_9S^)8+0:)XI_MK0)[G2YOMO[);O,)V
M5FD$GF@M)(P#! @V@N455"[P@4(LK/,JB:221K8BC&<(HSUP.O?FEV+Z?J?\
M:4ZDZB493FZ<;\D>=NSG9U&[Z+FDD_=M>WO7:1JJ5%3G.,$G)0Z*ZY(N*V7F
G[=NEA,#^^?\ OH44NQ?3]3_C17/["EV?_@3_ /DC33S_  _S/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>33
<FILENAME>0001104659-24-089766-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-089766-xbrl.zip
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MR7W.E87' Y7  WPG>53I_UX;ZVOC/5?<,'G,;6Q$CCD8IU=\)FQAF"KJ.NK
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M]DL^\.!QO14=0X53*:R+$^!@FI(3&&62A[DCKQWP"28>A;$N3BPT#%[HX+L
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MX5&6Y@/RL^^?I]D_/$^S?\0QNRAH>92F[>S)P5Z=X.S]<S'TS>MG8RD.0_A
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M[!$25KPN*Y[UEY]=S-<("E.QHC6"J5BQ&L%4K+A;YR-YZJAIH41 P(JM>X2
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M\4@Q<S_&(\7"%95GH&1)(E3)<PB\+;OGU6TDVS8L/K4  1TI0CX'Z$C1]CE
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MDS;!WR;?MDV@_7Z+-O%\?*$& \U?'O9RG-IA^K5FM'+4ZHT.PV& ^8AJ?O6
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M0*S3-COU-!NU]RZT7=KINM>$DF-:!4'E1:'F ?\;X4Q>(C_*DM,TK\_.7(F
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M:6:\$Z!FHN.D+ !/=4$.$" G9<\+.4"#7)0%X^WG3-Z$.F7?Y+52&2DV)_I
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M]%S(_OEWXC_$_]^2@O[Y?P!02P,$%     @ _9 .62&<$!R$$@  3_@  !T
M  !C:S P,#$U,34S,C0M,C R-# X,31?<')E+GAM;.5=6U<;.;9^[U_!X3P3
M?.%B]^KT+"XA888$%I!)][QHR679Z% N5:NJ",RO/UNR2R7CND@F>V9UZR4Q
M4%O:]5G2_B1MZ?OE;\^+>.>)R8R+Y/UN_UUO=X<ED9CR9/Y^M\AG>Z/=O_WZ
MTR\Q3QY_5O],:,9VP";)WN\^Y'GZ\_[^]^_?WSU/9/Q.R/G^H-<;[I</[BZ?
MU(8>CS]G?.WI[\/RV?[^;Y^O[J('MJ![/,ERFD25U48M*[O^>#S>UW^%1S/^
M<Z;MKT1$<_W2G7[M-#ZA?MHK']M3O]KK#_:&_7?/V73WUY]V=G[YG[V]G<LO
M]Q\^7OZV,WG9^?#OO=].;Z]V]O;T7S6L4L3LELUVU/]?;R^-0[JJC$7OYN)I
M/V*S??7 _I<!O(6VRU]2]GXWXXLT9N7O'B2;+0O(ZDH8] 9#]6%/?5!._B\4
MMU^YDDJ6L237P%S!+]9J8L\Y2Z9L6M:EW.EV5A6NBA?16F&Q@E_(%K]G-)MH
MI(ML;TYING2>Q7E6_J9ZB]4OR%E,L^QZ=I>+Z/%<+"A/R@IB.F&QKI8T/TQZ
M2S!<_8T>>] F#_N'P\&!<N:@-^H?:(?LOY ;>)A)R::ZJNPS6TR8K'&LVXCT
M41P\$XN%2'R\V[0@ Q37[HI)%DF>JA9YR^</N:.#37;DV,_--S?)<S;)+V&H
MDL4">M87NF"=#;/)!*EYGD$CX_D%C7C,\Q?'[[_&QK=Q>HQ2\ ,YB>-;GK4U
MT(V'D #[R!(FJ:[H>G:9/+$LAW!YF5P4R=0-ONX2R &*ZY^I?&3Y.<\B422Y
MJM_-X28[<HCBYBVC\0<([SE;5NSN:+,E.4)Q]3*92:KZ:I07DKD[VF3G.T Y
MNOF%0C70XE@F"AFQS-W19DLRPAGR602F%R(J/+RL-2)CI' )M#/))5T&%U<7
M&\Q('V>4^@11[W?.XNG?B^01X"DDS[G/%]]9 .GCT!$89G(@HAEPGRW<;K<F
M?1R><B;B& 8=Z"C\WVQZ)6AR/8GYW+N)N)1"^D.<X"!D/J=S=I),3P"__)1&
MCS:*CJ'"J132QPEP,$SQ*?0R3N/2D=<.^ 03C\)('R<6*JK-9/1#7LBG+-+'
M"9@PL4GIBV*VU_*,+OF:\Y2HP9+T<:(F!.E8=[[+!'HEL+1;Z)W0L$\%\#1/
M9N)3%NGCA-9_4LGI)%;57L2"*M*IO-BF*7D41?I8<5BF L(I4Q!Z]8)Z.S+
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M;=6+$[G^,E1&97WP<4WR8E,.9/7$?DH5M]R+'GALU#)F4BR6SK;J3Y25B]H
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MBT7Y; :_J__^/B\/^*?S'/\MGND!GSZW?_Y_V4%4QO_:?U:7<5$^"9X^A47
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M52=3II4%?1AGDSCXT\&+75CU LZ=IAK"CJ@MV0\/'N:FO-[XIB#5P,:HG3G
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M,)7]I3>?C ;]W0FZ3SD[B AMDA2@+*,N/8E+UQ:0+,C[S1W7K34[W"8(<(+
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M[NSVJ.L?UIP^_NY:*2S7.,+"TDTWGK3O/_Q3SI;M(9D"$)U;MD#))@&:0K=
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M[MQ K%'376VFH$S2PG#+Z&7KNXV,3PAWI=E!H)D#ZS\1N&97L)::86L,)>O
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M$"6B'#$K114*^XMF448ATXK+JN"=AL'VX4)08QL=OP[=EAFAVU>5;H/P5;_
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M>AP#8Z"AH< R#$B&54-GX#*:.02]P!:M7/Y>= NC=&G(*3^Z1:A[-AGK%O1
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M#BO:H&M,/3*VSR'977AHEP-J3P^ZGKGPGK-]4FI_(..#SE><1UGR;XFLJGP
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M<!OYELCWX3;R_=!MO1NT3+L3R.>WLQ#K_MH"([05J=M2'!U=J@$,::M,KMP
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M5(?&&ZVQ/>+]%W@/C.'\Y3XR' WXB#B!^22>$L816J.,[OA+1#T%R,URALA
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MZ_,+T.6X.&:.@".$C 'Z4!*1@GH,BRSRE''3$OU[2M)"_5$Z)W'!F#Q!<Q8
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MQ+F__8KCW/?[%M\M5V58&0$*Z--[K.P=%\%T$178Z[R.@S_M[NWMVUBB7LR
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M73:C,0@@Z87/6ZBE;8_+\I[SS+ND65\KQ>=WU,OSIA/TWHJV7]H3W^J'U]F
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MFQ ^>_WKR3]_Q!_^=O;+NQ__/U!+ P04    " #]D Y95%7J"W@/  "D00
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MY:M*<9?BP\M@E2O\'@2Y&P1,I:G4J,F\-:#5*0:PPTS-UM7CGYY@M8'>LZI
MA6.@X(6CUH+P(- OT<#H2R6GA(_<$$@(E(H$3TVJ9D6E0=732'ZPRWDU(E,;
MK?08_5;DJS)_L[8I"@BH7F;EC$^EK&!-[$7NO>YG4 KQ$VN'@Z:L_,?+;DQ
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MQ VM/WIS7J L\/1HM/](:O9[0"R@ P+?FQL!2#R0 JKH7!H:^P0Y&5A@L+3
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M>K+,=4E.'1M+@GI$^/O'ZS]8['UI:94F0!!1@'80B*-W4AJ]+7T:I0 Z_-I
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MP:AP_5J;T>_QVVVL8-GJL[]D-LL6,T#$2V9;+R3B@Z\ZT"P=;M0]XG$WU]/
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M_#Q:D1)0+"6E[O4ZIZP&#Q4 5A745S8[/$C+U84N[?@<KZP]Z*7J0U]1PD:
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M/:KG[ED_K?^PNGR0_1[R0O/0PJN-X[@E=?KEL@N3)'?%-SVPO[O&_EY<S8&
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M84:Q/S&HVW*%JGQO^TFB".9*,0DIY>.Q@KUT&?'<H<I(5%)W4&_..XET.;E
MAS7.NH^ ,MD8V6'Q@79H-ZT_+D.P77D$#MR6;(R]E6&:</;DNHAU2^ K<*FL
M/<_$KPO<E?XJ3N/ J?(:.A@N3CR@^'%8LV>%7-?443G<P'6I-!I!G_@@EL(A
M&'*-'-<9RPS)M.Q]F1 # :P'>8<F,M%/7B!^Y[ML3*7R'[,FJ\$YHZX+SI_R
M-8_K?-<W<&N9B)*2? GO2R?!L("M0)UC!]DW!0">!CS5)0KAMTFO*='H\'T9
MW(M"R^%$,]-V2Y/UD?(G%]P2_/@7FG4CK=J4SH3K:_9.=:V17DKS1_-X,<3L
MN8X52:1>CSX>OI$\4R@5B#>%ZHWG3^MQ.0!(-4+D@H4'5.FW8#@_[ )%'2_5
MP&/;\JA^+J< T:4UE-OH!'\>T,1?8-^O4#C*VM2 ^I, \.^J);@[=%@JY6WG
MBX?-_!*;N61UHME,$R\6!!,Z 277;C@&1G!4YF0^A@=6-[M"9PGCS>3!* (X
MYT?;Y,EE@("?; 9@D+3IYXR@,@8H-C!?XS2&7Q>$9E&1G8#E,,EL(Y<9,11C
M3D)FY[> -&UZ"=,E=6SV@XX3#.%OIQ57<F)X 6T\H0/DG$%;9V3R\RW%]K9Y
MSG?)UO/\G@5LG]_C@.T]5*1+%C/V*-)Q3M[ F (;<BN.LU&1AHE_HX><*X23
M*%A)8?[&4H!TJ -(O0TOMHKTG ,9UN&@\ Z^S%4'8F2D4Q*,#W U@.!)"^@!
M$<(#OU3PEPJ6MR0U^K8:S4F3AT6##U?YM^!W?Z=R],;UG)J+U<FAS6]3(3V#
M-'RKO,'&F<TI7,,/&_E-><"C86_-$W$)UOA2G@1TKLZJXHPAB"Y8HO  G!L!
M!874"2YTH1I8=^, (9_%960)ZVL1MH3%# @>64*$6$&C:Y8D2R"L%;*C+T.7
MD'P-M@082]%4?9P)[G![Z[4L.X*_R,T#$<+JS_L52N3L[MWOXMSO7R:6).S^
M"F63*HO45RMY-143*XL,M0P[T0]ED"$4Y,7*H"#[KB"/DG)$W; (!$)-+EJ2
M-DH?")*OB=002"D;" G5P_C?J[,I^ :;2FP%A[^^YN=C;?()GIZ!/$82K<GB
M/.O SY\BVC>M:T9S<*YYTH408E(07NHOO*D;])>C2VK%]6W]A1)MI!32%A>R
M"8%1I1HL%?A6B$=!%Z]M?,"A9+5,^(T!KQ[6M9^HP[V0BA 8'F,P !2/5P6*
MEG')KV\1G>-JAV+%D$I%F:7NUAK=]V*$'U;8(YPR>[1CI-3WF:X73FH\NW[9
MN;>I0D[.Q8HUHWW#T>Q=7^MI$,[EOATB1I5.A^'[15A/(T>?HQ13S!M%F/?O
MNU#]N#*A.LJDW]C85D5>"AE<QOQ8KM)JX,!27I4E8A8:.[)HC25WA!I'7N2S
M5 _8Y.5K)_8@R6V;) (:R51^R*=",SGH3(?77R)777C2TKZE@Q=84+SS@ZVE
MC./,#+]N!QI_77+G$,JP)+?S^IK'Z!PR,Q.*Q.*S5D3SVLNCK!;EVD3*<A26
M9%.FJ=%(WQV_D3O0HV(.:& WOQ+],BE:-+6ZM+!JRZW9'E[QYJP)TI6:EYU0
MK)=Y [SJ_= '-8ZGK5(;P*'!*"(V,Y%03Q=?4S,K!&WV0DP@0QQ+]WBR8:HB
MEHFT*##)+E*]G)VENI<ZX]&G2\"94LC$]]^A(YUX(Y8LRO]'+NI+WE?;<I_M
M/'_^W)'_SH<-I8A:%!+^J)S$\/I$B;1"OY")^.B@0T0L?!<@@C,PUE,B$*QF
M>:E8 4'/3B;6VH-G^(<*?TF*+"M-!*VK@$FFEF?NX!BAA<5-M,EH=R86FXM<
M*-^N).7%/<MPOKC'&<Y[;E;N[GP!]\1JUEZ/U3,X.PA=L&#*;)(CM372KVC0
M&'-E^/A8Q:DQB-7B!\Y.QVCS34/[(>FSLL#M%C2N(IAV34(Q:-?Q[_U*:;SE
M6E7H[$-H7"7*0_G)5RP_Z8>WH@UB*7D9Z[I(.%R^)_(9\+Q.)$**;"SX)R6A
M^&/W4$0* X+ZB-Y*@$V+O>*3U0:X\IZ"*<P@$U'2\$+WE8O.3 :)P*EAAK\P
M!>S,A#+R8DW!2'SW[:L&BK]_X5\>W:O0 6$VNKO1$3"?%JB>B(&?^8W3$73+
M]'SYH.1R)1':3)H6P+_!VO+3#S8?HL;H/PINKJ"PWBIPE/=&/;IY$,MO 3[N
MBJ5IJZ'AR#<5T+[:U;B 6O!IGPX,Y%/+IOUNGW!Z!&%+"R?^6Z84_X8ZB=;E
MS<:-+1L<Q$Z0:W'9>X*N,,8[E0#D_Z*H1DWP1Z]B45))P$AWU+;B6Y4L8Z^;
M/7%!3-&344! $T#0+?N:>=%Z;>\#?[TK>PN,5F-S2&M:'!&.AJ(>YD4LM,6%
M>^.D3N<@6J[A?;S+?8S&C%W_B4O<<9!GPFV:Y0\L8'F=P&$NJHLL^VK,AU'/
MZF9^VFI<LMT;N&1_@+-4-Z?Y#)P25Z''VO X_9Q\D.#8I1%_Z>!#WA<]4''_
MC/23*1X\F>3C]"PW0?H"@?AC;F5L6UD@IM^%("-11:\U"!&8V#!H+]=4C'C)
M9 7<24);E'BC./75VUYK(HTMW,-N>=II6<S^#_<LHO7#/8YHW<$@U-Y-J%#J
MZG/ >D(9JR_+T3?P2/H6?9PX^J+^]: S/OS0Y91Y@V24SAM3H 0S 3,XZ+G&
M]7HV:L\]>^CJ#6J.!TG>*?)&'UY]V=&]$.75(GZ")!:%4#8WN7>\7XK\ F0(
M[Q*5N0")++G,G).X;)3R%U5M%K)TCC6MGUT+V4C/OM(/<4.YH,Q5/N(J]2E2
M7N1I(=<:VW3$XJ$S)\$:WO([XLL?WVMS^A/?INDVR #UCVJ=G5SU4/M_^6-.
MQ3?+G_-5<7&2-3+-6RO1EA(EI(I >RNP=O !)@NK*>@NZS+9H2H7@$;K#"M%
M'1"PJF>?9SEGVFF:=7YRVLE8MX9#C[YA3A:::Y^S>I1SJ G?S)4&B'V5C+"?
M5%Y?NZQK@B40YL'3E+HIY][\\B6/W[1%-614!E@Z])R8V=,6G&HV4A<<-<ZU
MBWP2HZ=W(?31P_?0YG?D)ND1FSX9T5S>5YK7^6F%K#"1 ><8#IF#.-"N6,<2
MBVDO*&[M_,--V+!/ABVD;^YQ?\7SO3EP@5XF%@P39Z(6,8*P9GR5:MH"Z5.!
MHDO7>W4N7"=A!\"8TU$[8"2KG$X[D,:#SZKXN'3@L$0L_L+G#2?,VWD*5Q9Y
M[ 9WR6U&XZ.QXX!57U]S9"G^PV6_FRBB2_0J8E.,'(7+2"/P5XR5()C'IXI:
M!E$!=@C$30J>(:@?4,J8*L$"&DO8-$XO&E=G1#81\>>6BLW26Q[\5/K)M&3
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MNT06*4/GK93$(N.+#IO3_9-Y,8'MXPH-&*AJ(K]4KS7*3';_;@<,$T"-XP5
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M,Q&L.S4A;?Y0-IU5->9D@Z#F6-!J9]E#0.;+.>F?EU=\+F3;F!VYB 5D4#N
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M RSM@AXO"]F?8FYM/(RXG&M J%C6UPS\)J(-=#78.U=T[_!E88^C'RV""5E
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M2+)A0I$!G@*+0I&EM"Y3SOD5>7:F%*=^H2U%$#TNXD&:%C8NK[1<P2B<V-A
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MO7_=W0S_'MWFWS'#:I$22)',R%IS&37"*NGZO*$G7Z@21P_#:(SVG&+))CY
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MMDC/&T)1$M*]FDZK\CP#&XY"V=Y0;_FF+QT8?G[? L//'P+#=TFW[-U MWQ
MJ).*238+-<H<&\]G8W/_&EP2NP=RBY*Q8NN+J+0OIV(U\X9%?'ZNRT2$B34D
M\^O<[VPJ7\2SG9R*N^4ZZ<L+RY,;",L^U:*&8$R\"3PQP;"V$.+9ZE5PG%S-
MAK%/3:$%[IT!9PG)7)1;QR9*H\@&X@OJ>53HC^'K[[TH/%VTW7V]4$$,#HVI
M0!$;Q.B.QSES?Z&?(9:%IT@.XQ67W 4TF@P*_!'N6+&( ;2C, 8]Y/^DB1*#
MMU"F4*[GQ1P3:/_(Y&Q-W$*70ZJW#!=0\C<&+DT9N#'&D%K%9.%PS$(' 7M;
M&K?9<Y&3_?+"L 6Y(7(-L%MZ-2YK^E%$V222W%%DM)+SI%RD%?;HL_2-0TR%
MWZ3>T09?811<'@R.LM3>NT,X@9ND9O(H9@5QO"*6^,5G)?$U^B]8240HRK?5
MB(,\H(S>5\%&]@V/F_LIFFCCDQL<6X+:@RP?NSYCW!%#6DG5Z().C^S:?5<O
MSVYRT]@=8Q+'CC8)HB_,DHWL7-+7RK)SF1A5YR1C*7"1F]JS?03DCO//R;[(
M/@6O:\;18/PWS#S4&3E)CN"X45%MUQV+,3/&',IM/KPB%/*D QBT:5\.%(:E
MO: &N2.LWTW81'DD@L)#&MC>7@N6Q8N%"\[)SW\-L2&E=!"@3!C.B-4Q%IGF
MK@FH.EO6J5Q85$DA]4QXAE+WH'-* W0:J":AA+U87V,(WW=SU(X.WAP?_O'>
MSO#YU0_/<H<U.&/NUESBH)&06/P^1J!5LAFD3X+2TCXV>O#<MJJS!VZ(.7PA
M0$5R*6UX*CL.P4H.97C6+SN5R94/96>5@G.HLM.N"]YW(^77O%!>W.!".28V
M S9Y/!'?IT#O)$-J6D'2Y+;?O.3MV.J0O!WS=&B3<Y&&Q5WNWC).TEF@Z&F+
M%359*\U\^+>E9P@[.8:!NLY]G*3#ZHQXG"F[-T=T)S?2RKO(- 2?&D==C#[S
MK9Z>?%9=4-43L[ZRF'NT@YPZLJ77@H?EY-9E&Z'@RMYN4"F"&Y\Y7<@BI^"Z
MTH!PB;%4%JJRQ.>[!$F+AV*Z<IGJ'3;O[=0-)9P&BL%@9 44ZLNL :N.:9:&
MR6NR['$.AJ ]V,#&+ZE@?FQ,VE!VAALFLOE%NS&\<)>U=T]S#T7GWS.7/L%U
MD$U 2NO'S!5X F?BOPU^IV%:?,3U?(9#PO3A3$.. .2Q_"+'L+<N8TK8MG!;
MHYY-/ZL"<P3TF$;REJ6*J6PIU<M,K["-8O(X_P39#FF8K?(UUM>LLT%Z %T-
M J"S"22\CAVN5H/J9BFWP\#^/1GWLG<X!Z89QR<:%EJASG<O8_NK]VUC"V+W
M#C4E O)VCM2,E,//3M)"6A,,DF'."TX*J:1L%S>D<0\F@'IF%Q9VA2A666J[
M2LGU1B#295UI:,H/:_9215';/V,_>=B&UC%Y"..F2[?7*H=G4WBV& +)H3MD
ME6IOOP93V**<PHO[EE-X<8]S"O?=</OA1GUIIE4+MML^H4IP FS:@_<"IM1\
M&N0KPOO/10PY[,>1&^O0.F] % B_+NE[&YOCMQYJ_>6W],<;;.E[IM_Q<PC[
MJN5,[M,U1?K+2 &>M)/)S[)212T$5N_@@DC8EM6-C>$*UM-NN@V%(D Z[.XL
M@)82^7J*3JMPW8"'B,WSL27/SJB--,4W4=2R(D,*)^XH6]//HVIFB2[M(%H.
M,S,_'%W(XW&=-<*4KPPZ]WN).@\S=F!MCY@+*2'O!,&_L/P>[[_^[2!Y<_#;
M;T<?]M\<OO_E7X]V'M'/'_;?OC4_7_FUY_FX/<6/[OS#7GTC6":04+@<S+\>
MD4[_^?BC><$98H9&:6'. UP<CXS>/WYK/B4/W]OY1^Q03-)I7ES\=-D(@UOV
MT:MC5R+_DPC[SX^/W_:^_H?5OO[_?2_4[#B _T\/ /[S\6H+9;=9#W^%8]W;
MV=E)]N$HSRT*^ZA-L6'/[M[/1W]^>-6>_OP8_S=Y5U15?;LG\UL%ET9Y F<<
M/O1F/_EQ9^?YB]L]Y'U,FJ+._2EYBX&+(OD5]/_M'O,Q+/#LM"KA%QM/=G<V
MD0%GZRDHB-L_;-3]_JA?](SZ,:G35P^J^HNK:B]^\BWT]='Q_O$!/.GCP<%Q
M\GK__?].]M^_38X__GETG+SYX_</^^__?;LE&Y1X\J9(,1 /YM91"S9W>[M'
M;"LK]I.=O=W=6ZXYE)+^/1^=IJ"EWU48T+G=PU9Z^OGNBZWGS_>V?MQY\>/M
M'S1K:3/FW1^_B8[^4EU1T958UN>B6![F6Q4&PH4L,;WE$!0N :!<H2*C\+)4
MG?BL:A,$:EC7BCC8N/IA5C6MM#_33UY?DRC>.0SM8FL"OI@X9/PUI/I.VQ%1
M?X??-8Z8IBZ"4>BO8#Y$T:#.VP;S>%$/<'TM;V/P$+<TMF6KS+R$K1 @$H^5
M7W3!U6IQ-Y-:5I4CVW9<3X=6 @LC<5J>8RFL07I=55&)*8\4 /AV<B!M9QU/
MBQ"EG3-(9H9E0M;I1%K:-IW.))0_F[<2F):R%A]_/BKF1 1H6ML2Q2_O[;T/
MI>SN7+'CN*7^;2Z%80ZI,>UHWO+A;+(S0EPI^N!F8'.9G KJQ3I5=0[+@@D#
M4R(G"3+W+$Y=(#7-"1.T6PB8Y!T(*F RAT0J\X"7LG)PA1H1Y#2@O61Z<%\.
M#B<A=*Y>7"?E-X7F#<]+20O-RR(]1U9Y9# L56*(\3NFK_6 LTF82/,22*Z=
M."L=TR.@@Q,4.C@<^;GP8E"9%2<.\^DLQ9#?+9>2I6M*?KAO^9\?[G'^YRXJ
MHRL4E="E5$[P9D?*L(X^.NXPU9AD#!H:7+LL)!M92EEJ^RRF4]-T^0ZN.[S@
M[W*(.T*<BC7N-6,(,%5M[2"J_S3(\X8A0/JEO:]+#>LM3\*J3=5LVV?'E<]5
M!1J9MBNY:<!$?38Q8R%=-ME2]$C<.DRL"FD.IJUL0.9U#M$,A=W.\Q[&WG A
M2+4&MH8IJH8O?:(B.LWK,4^&DVNV(7'B?=%/K#/<UBVA:D7!C+Y$&S#"O36-
M>M;7R/JUB\U+)<7G HN+?6^@"4H-KV:JR(W#H@+=L(('@^<%45GPY^(".1EJ
MLM:]_(E")9IZE7EC:ZW[Q"641WE*M/M4L"U>GPM#@^SVE. ->-TJ@ /V/W-X
MDH%@R 0@ 3;;'&YI).I,30DY=12;55F9#I(1R%VAOW*&]M\T%3(PO[<RO:7A
MMA<P3:^(HP.Z")IC.%9#7I,FRSX)7M)('\%UK-?$B'PJ4NLI$>('.09$1F#9
M+3%$'.9;GN#.2\4NC5N!%M!V\KYJ\0>+08+U;HE@FG."MO\GUS;4G>Y4!C7D
MVK?1R622#&;8:(B[FB5:P=2P(0_!@;10"9_'J,BYW8B%52.K2H1]N2H]E@\0
MQK3)I9D)<4A$*"M-)Q1ZA_?V5%5J(2 WG\"('5S-T-9UQG'+3;6O<(=>H=:.
MD X@PV,.P9#!;(%FBVHRK2\V.LW&<THWI0162/&PG^9#9F]AX"D!D-.V!>4X
MM2@^6\-B;V=[B_" D&S4J,/3"GP[9+/-1P/^"4MW\(=I/D*NF&(J_X1%01(Q
MT#9Y2LV#]7>3/J4B;(.!M5 4CS,"(RJ[(34U4;5:-U7)-*8>,'@E(=6JB3L(
M$M#XLGBNLF)B=.K?<*JHUPP5#>'0F[9F;:A4*UU6-'CX&"H2_XF$ R<\HPW9
M!)_O#OL\E7HD9678#N$GQ /9I<8>, K0KD8&GEI](A?=)!W1TA+68#*OZ?W>
M.PTB-K)^2*:%C=3Z%_+A<"^LGHP<;G,AKJ_]\HMWH \L1&D9E"W60%09<YYG
MY0FZ*MP850#"5)Q99FURDD[A;E$T4@-'/24L?$0R3ATS+ ^5W[CIR9/MO8W:
M$5J_DXJ]CQD%?!,WJ^277Y*-W;WDS;N/"7QM,]D(>GNH#W9:D*RO==8 NX25
MJ5517%]A%L!=X=X*]$^=H.DA/MX;$T?!!.V<-V88%DY#KY8IP>:T=4Z1"47?
MW5G?9+GEO7#+ZPO)@-#M<#9)B3O#;YRE!9D(MGXTWO0SY*=2#1(MLK^B3FQL
MX7A6ZL/Y-N6+?870[FR_3=LT^0!N0SKR/%_YA ]*)!+Y?#HKW/6-(3'J*NJ:
MVVC[RS94!5& ZW/*LHBF)\+TO3X@]J-3L&KG4B?5I!.0*[B,)39/2+C RU7P
M:=,O!4]9G:$]FB$&)X,A5Q?4NY$[D50UG<W'5+&,<+JZ22)]?<60Q\*G%JFF
M!G:Z>'_)K9\UOGBF(_EM7Z=>717<[>Q@*?WA4>)LPWOE],;F+R?7N,-42P%>
M*S=>,E43MNZXQ+CUQB2OF];V9<)])$H\^B->N?1G^LG[V^; I%!,KH;RHDDY
MQU9."7+P40. I*G($K%;RA\88&%#,D8?M<;*HA&V77!_&VU**37',B;2R!"#
M &/WJ3$\(0.=0@UCP*7,V^ #V2:,']3OB-H<&6XZ&2+Z<Y--)4?^J]RG9FG3
MG(/*9;$XIP; ,^0,:66#F3Z1'^1X.@P3'G<.(<T$[O_0;W.B0Q'J\2GUU$T5
MW+.H3L ?XB:0\M;XKLI[N\Z?_[) BI"T-10C+Z"-GIKGCR;&H>>P.F8?A]*Z
MA&":W2"'[\VB;.'GI'I^P!M.;GI!70Y/J%1%@+)XY:E7<<V[?;"XL89_@%]]
MRU7_TB'V'^];B/W'AQ#[G;(PKE#<#5;&;Q66_R^N?PCJM:4>BN_KQBMHEN?J
M<F4I)BNJM%3ER@$1\JGIY2L&\G)5%3CV;C&%1"(LW8CWAD[_H6[O(>PD+;PP
MIOT0,4)ETD\/G]CP"*6)4I<,QN?9MR_'A[K"UB^EO>ZGV%^AC!O3W,X*75][
MXW=G/A!N8^\,'!V\23[.BTQ>^'2XM6=BYPT1V)I.X]3[7/'HNB;"EHJ7R .F
M9-G:AM+2QAJ4*W8P1T+@IIGC1\@4[3P-;;YFH&LUI.TZN7 8S8'+=R)1I_.R
M^R Z0F0QX&L,#3';\L0\S:TQ&>H3/(O[,W[&<$)#AL;?G%!WT7;;/3OW0LZD
M2NCBXWYJ8/Q?./.[GDOV7[532$HX98VJMZ),QQCW*K/Q+[3\3$UK2 H;,B9X
M5#^XBG81!X:SJ":D4<YFH=L5/,RN^OY<""?L@KHZT7/,_AW:#E%@C!?AJ,3<
M*ROKW8?$8V+IR=AQ7_RE3'H&MN2;+URA-Q8;F= /J$TP0Z3U9N>C9 W:H9OO
M$U=*F*K0F271@+4]/<13G>FN7<BHP8D4/VO3(T=8QE1WNC&<J^YTNF*7^7[9
M4.?V\(YEQ/L".W@!'13L0&NXSJF4ST[#Q% :/C6=W9 "*0P6G=AW^.X>1:'$
M;S-M:FP>UZ4@^QK);V/+<03LF2,AS#7V9-BED-5EAYC.*RD9VF_*XI:V.D81
MYS?)72#">?3JWP='23] ]R^8(.E%>/?_W'W^PTM1Z@F/1/_WV%<^R+)O%,N8
M3QRO=W0W%VJ2VTX12?_=S<ME;NJM7;RHW_^Q])KO[9@U#^YC?^DU(97TW[PK
MR[_ 8WRR<\\\QB<[]]ACO-VG/"8*2YO<F',!RYEZK\#%C,1')QD;R:]?V?J%
MKS+]J(Y:(:/]]6H[Y!=]BW<(:NVOO"6PV%\,C]<K]WJ%-2:#Q.['ZU>:5$I2
MX-@KO&'ZE+&QKFQ-!KO=&N"-;K&U5X242!JV$!^/TM*:>.\L$_:;)L-8ML_E
M3)%L\+.1/&I+$A2W_(ZD73S8?_-K\L>[Y/C7@^3@_?'A\>'!$6_C:M]S='"<
MO/OCXS&\['VR_^'#P?NWA_]/LI_\>O#QX/B/E;_Q3E=PKK)N[Z*G0//-'[@0
M[__U:,_.^M(;>66C>MP\-M73__=VIX"Z4T4Z0VK$\L3=DOHVO%917%"?^N0?
MCZ)E<L''GJVTBI7LC&6J9Y_NK?2]5UAX,^^=?]QPO;]X$2(VWXDO9L>:$ANQ
M:R&N<I&EN4N"=4A-5@R2-Z=Y-DE^(SCJ'YP)INOG*!MAHY_ZPL"45S<&NQS*
ME$GD_WV315EA@2^&*=]>P"6>CY(WG)S=+S"S1\$D=*8&+'*'):;JPH4(1"0J
MV[>Z6)7OU&7JX+_SB_4R%?2EM7CO!;O4I6KG^72UH\(+UE:^;\.73K*Z^4JJ
M_FO<D"M\R7++=&O69.%-M[*W')"WA![/?V)M\P=0MP1@N<+:?!WU&0L%7?4U
MEP2-?N8I'[[ZC_]87[/A @H0V?C_[RG6[ZN$@4,4_L=_,)+S:\83OC!HY,E7
M"OPM$_WZW@)N7RM&]OJ5<\)7;"3TOG'E?OX*XG]\<G66Q![=;Q,+O/8CKVH3
MW^[9+*F)GKQ,_IA11N0G?+3 *+Y>7F*YN5T[8;$_FUTK9[';F[)X4* K4V='
M;WX]>/LG.#]O'Q3H]Z! EV\*<X0%GFF1',V'6W;>N@#QMD_U?55FWRZ#_#2N
MM']#]/_WHKG??FF]_=73OO8CD=U^_/J/M_]&7^_QK\>___;J_P=02P,$%
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MVOW!:??*:__>[7?^]-K]$V_0O?JCU^G"1U?=[GFW/_S9SNFO(LO#R4(^#.-
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M*4T:QM(%L:RH!:S_AJXW-)]24AVVLP .H2%_[T>+\@@LR@9T;F#_ ERYKAK
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ME$P5=A@"KIYMA8IKO?2V&,/J5/5M1:A4&'U61238;3:[@9:' &RTOE>X^IW
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M\YR<?Y_&44&N,YG_/>FENCYP>7AT+4I377S0#L<K@9>/0G8G,KR>JQO(Z&5
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MC[ OC;6\C/=7;MY'WH#Q5 4% 7A0(T=0'=G)R[DNK?+P7L/1)9J&03U)E<2
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M^",QDF$*1XTI='/0Y%[OX]N<)-K/7/J7+'>=2SPZ.,"X,L*Y@B;'2VUYA\_
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M#M6B,.O_^UQBV5AZ?X.E82#J9!'#S\=>AP,*[0C=S^3AIL.S==4_.P,#H^_
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M7L]?>1=SRJ]]Z9UA7<DW\7JMR^ESEY=U_^W%R9_DH7TW/#][\_\!4$L#!!0
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MM4S>8N#:;;Q:@B1$ 3C[ON/YP#S%I ;E#YD",(E)D5_H/C)DR]X=/\>O$C^
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M=I/?'/^U@%V-PH YC_K#EPS?GA>?\?]^WZ6GG0%&.\.4][J8XA#F&OU^J["
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MIC8N$Z_6M_>VMJE'^G7'MF@;*G';N>-C@^G0*^5#Q_H:S,@+] ^A[8I%J/3
M)19!BMV=7P$_<)FY]2(7<7F,*9# %,8[9V98OVQNS_8PASP"QDAU%NK 32M
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M.6Y8GF,V+Z\ZQ;3!S:3!8,A[P1&BLR@FV,59#O,2O7Z%^4[:&K1X.M+W ,T
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M$=Y8N&(",]]P)$V29>#1F!J;R]=A3,%@\/@U?I8/[?BW]S>L$>Z^MQ2QZI$
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MW&O"BYQNF P_2@*QI6V(S9'-X''Z.%K]HIG*G'%><7((PH?VWK64^TH1&:/
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M#79TN/?Z<!($!]6U3L=C#!$ZV>NRI&C"<S<9U'$\L7*&\Q,?GGS"_^$$?UO
MZR_@\"H+:$/$;?7B-I?A1O)9'W/;E^C[W5Q'N;T:\W[W%R5</TK>@@(#E0.G
M0B5*D^9/HQ6C-70RN\5W??+HT:-D#\Z<N4F6/F[3&JX \T9>K/,P]P9>6SNY
M(D)7ZU[RKJBJ>IVS=N_U^PIL__(T*_#+;_>2'Q\]>O[]FIZUU[;P\=LS##B]
M)ZCL R=.;;I=[^2TLVV@JEP($JQ9,)G7)=>*^"4' 2^-F]SKZ)JPKD;8V49(
MT,"0U8:[0/XN++))NXJUNC;ZJI^0(*"D[-GWZ85B,7%O]Y2^*_F9PK<D6*T3
M4AE'FEL.)$?<D@8?MU)2H?U #;R-S1"0=E;+4+2Y %U*MZCGQ>WEGL7\P!L^
MS/]U?/C3T=[)KY\.DH][/QTD[SZ\?__AM^-_;[8@K^S+/_W:?/FGWWSY=?OR
MAT=@99\<'1P?)[_]?/#IX,.[6 (,GSH*"V)N@H\@&VU$+B*H,&0!DRI/ZJ>C
MB8]K5C:KN14J)KP/1E51I+,&)$5_>IFHH8^.!ZWV$C>!)>B>"@4:[TL-+1VT
M6%KP?7-E\O8##O3H[_>>7-G?B=F?GOW\Z> XV?_OH[U?#M\F;S\=[!^>)'N@
M'M_NG1Q^.$K>_7JTK^;ST=L'+]SQD3/RYYB%[F.O]W)ZGYL;MW/':PTI\$._
M0\F]_A)<>6?J8R]]ZIO%BZ6/7'XZ7<5DD"$]PS$];!XF^VD)RCKYQX/D9[##
M_B.2?</23 ?FK3PIG+O_G'*XX1<[P43"FYK#2USLG[@K!^4,$#MJQ#VETQ-<
MEIJR:K]IX3NFA3=SO@^/]@]^.3H\.3CX=J[?.8E:=4@W=7#R87F<M6>H[M_4
M\TGS>?%G4/4W>5I>HND[L_<G.R]O\8$?ZZS!'#&F?>(3\X#9)L&M-*!N;(*]
M\,D&N>771E&6S]3?_@;#.7Q];")\'TV$#SQX$47%?$V*D/'B7ST\?)W\[6\W
M'P+X3T)FSVX'*//0HJ\8FKH%C/?5F]<'__7SX9O#$Q[&WJN';VY+6F_A]?;>
MO3O\] MC,GM'^\FO8+I].MG[OX='/R4G'Y)/!Q_W_CLY^*^/!T?'!\?)WOX_
M]X[>'NQO^FX]J5YTB@NY?00"A_NV(>$DP3AO<H4P[V:_^*<L>/$].+#JJ4WE
M_-761VWZN[Q/Q[DPU8$GRYQY:\[S60_FS6&Y_H7 3*9A9HJ7QHAXN\PW5)B!
M6558E--[GE*"U-C!QO\'_]/<K?_Q_ALD3Q[QOU+WH\V^([MA>ZM_.V#)G\8!
M7?J.9 <'\-=BC&P6>,U?:_IQUW(24HZ<)/B[')/.A<&K.M4U]G;N/$F59Y).
MO8K-&&--A(<=%/V_]K-F5.<S0XYL*(K^C5K?&YS]FPYFPY5#CVQ2#YYY8SC6
M:8&H28EAN!EG$R+ZI'CR]I9II3W-TI(J2:4<-C,]+WJ%]$[.$4E4T#[.9S0T
MO7BVMZ:+;NL@SLVT#7M2K*;"O2H5OMP4MN'T<OCF-.N0>ST N=8Z/=(D"3SH
MM*JH3SQ([U!JG<^07C[EFIR67S0OFVJ2$M/:(=':Y.5Y59RSKD"IM[P__T[^
MA<4][.2PS'N,(E)-*)\A7P@-GGJ%-)BVBO.!K#JFW,O.DZJ-9.>Q)K5R9BI.
M V_!8:JO@X4$7$:-!$'P;L.,)G2<-V=5F37M8I#L/ GN(RS?7,*.-?W5S+2V
MQU(E(>"!ET 6 ;@#?X/I\HGK9R3GS<Y3[8=3VBP5J0< !3&ETJ>9?36B'RDK
MIT<6<@7-F1V*EN9<&0R81\U=<EEQ7)EY6:07DWEQ-[<)Z51TGK4/L[34B.C?
MX<+I.C"A/&'372P%\[2&]6F$#2F99):PELZX:)>-:;2[1K!770V^Q^,:6[9Y
M<ZRHJ.J.LVP,^23&VAN*NJ0GFZX;F? B&-%/RX@4@/)@,9@B7052_L@F@M\Q
M"]K97Q$U1'*K%=1X%TSRYMI<&+"WM4R-[H5D8<&I+U07O.N$ R.V[^AZW7F'
M$8I]>+5K[SV\M[_U<!\MWWMFK=*Q*T7Q[4?R&$R\N_&8/!OTI'!(4P<+>CMI
M^\EBZ]3MXJ\J258P25*=%A?<SPWDHFGF_)Z\IHV>F.Y"VG[PK&;!=S^M\"\3
M+IMJ*#UB>XNR\AP9VW"MX9+11M) [#HZJ1]2P&5M9Y9,UWBNA-*]U]CU3=X-
MGZ1-33*Y?H0>GQ:-*?R1F+]@Z[<7T(^&5385\+T>=OG=-^QR,]/J7!B0:'57
M34\],%VR_HF^=E5N7F;J]6,3;Y M7"+-[PXEK6SOIT\'![\<')U@0O0M(K4W
MZY/_?'B<]+Y9LJ/V:XB&@-.C+6,IJYO+[O*26!O55GGZ"&Q .2>/JG,A;GWR
MZ/&35<"@)="HBP4A8>ZJ8- _JK,28Y?'9^F%>3>7$O4.HRMDV^P=#Y;QQ8:,
M9S!WZ--0(Q8B5V]\CG3WXC5;'NN=E [5FS"7"-(B? ]L.&]O-?.<P09K^C>F
MT01-D'5B8H2Z[&+\2:>27@N[-H_G(].6S>L3 Q-(1/U,M\$TTSWL_0X#&_X!
MM8PTF]1>G4*WI(Y]IEX/H\!-:QUSJ@BZI/^E$A>ICQ1;Z8%UA879R6DHY/%/
MP1CN]$JZR?!43>5EOH^S)J]U/;74EFG0+<4OE^$P^>)2 G==N#LI^T<??H.K
M<-K>??ATH*A,%WZB5L74Q$5##]A;M4Q++E&2WK_:8-3(?D!".JX4#-*K'0KD
MM)&V,\V&QZ?6T _FP1HI8;$=#,8><H+)A7_F'6H&I:;J4+S<F058=WL8MJ-,
M@V]M62_F%$*-*7*+)B/SC1%_PV_0,D(]3D>L(6+@#CP(M.]KG^1$,H (8XO2
M=W/S^JH6.!)[-L"2<IS@L,VFR?.=3( _;&8W.LO&\R)+'C_;PP=\RD[G!>]J
M_&2'.TCI3;0_B1#P)#G>KRJ]SQJ]8T6]!Z:[A.W-BU,"E*47'=4W@LN$M:VP
MI =?9'+V1F16//[QZ3,^:I'C""YS#5OWR]; 5:YXH0@R\\JMZTLWJB3DI@0M
M8E6GPW/J-J8W_>B9CC5&+2B4J)VU[V4>X57&E4&6X^Y";V_12ALV$IQ8>6U&
M>.6%J<LP/1W;#%%KQ8;76W1&DSQ^NC,V=QG#:II?1>S<>=R57@S#;(0](GB!
MY,&,*(\0):\NRJQVAZ !2WCP)UAST51/Q_>?FGYEP8,&8OX4"Y?/']F9D??$
MBH37U-HT5<#]\?B[OQB./7D5&/20QG%>T5=FL'2U]A5W=IDQ4E$D[L-J4E](
MO,)YLDOURZW(TAE*15IPAR,0@2P%UZ*]J.X3CXKQ^+@YA_DUG@9C)-.5:?JJ
M"C,1"5)D,,FG(#TYB 2UZ';:HA$A*,F#O%':*C^E=MA )S\]91Y(I$%^Z;<E
MJD4:J95U77U9D%K*L*5'57O[)[5$-VF\UP)Z#6G!&HK:(PRD"\@$M@MLKJ C
M ZQG59^F9?Z__#F%)FF.V;R\ZA33!C>3ANS&#3-_-5I8:H@7H]>O,-])6X,6
MYS"R"<2Z3&-$KT9]2&&.TM\K$*:%8>DSPZPSVO0OA=+';'/;ZW'@7+_TI9'<
MCWEGQSEHK'E:-,G.GH:;SJKD I?8]!BG2=&='YPK,)8W]D)0\UDA?H.P#(@D
MHVJ=:DMKC"6&W_/VF-<]$$,_NL2&O"#5: .,!'8NRT__VMM^Z?Z")]VW39:]
MK/^.PBH7?R\<-JB>\[R:8U>.IC(OL>$HR<I8]/,X%GT9MK\*5KT96/3=0Z&O
M9L<.;]B.U92:[2W.J='CGLU88IJ27!LT1Z634\JG")W1:OB9QCVK=\I:TJ;0
MZ73XU;?',KE*E(#4 W<^2/;H% 2;W(<E/$-6V[>.\GHTGW*/HB8Q/:LCF*$,
MQ7^P.>DX>TDQ0!^2BAC%PVP)8/O"VL&YU\E P%K)9^#T*J\IYHWWMC1I$9=)
M1J1%Y?963#*B(F"R5HR]TC4&?!,7+@?["AF9Q<HCJ;E 6SAN9W>8@TR*"8-^
M.#M**BL$@(TZK$7O75T#(.B 29[.9:@Q@Z8H,BYI6@>W1B)"Z\>-YX+=#9C_
ML-/"RJ:[3%"5P+[KW8TY=1''T'P^0\"*K +C^=0YI_>9WH:-RK 1FG70';L@
MTNT?+#?6!(X/EGT,(+",H@)5G\@_7N(1 S+PA"^?-%@J/UO'),CL$<PB&[ER
MW(5H'R*%=31K6?G-?16V^8M['^FR7B"1X8K1740%;G*9?7.[:SR,R;2PD+ID
M93&CC-.-89T\\?_1?77]IF#9#3<%4SC-2\DT>&7)T2<\LMV443PTYNW]:G)_
M!NX=+&-_$BD%J)#3EY!_)#FD[D/Z.7G45 2@G]"5$BVIB008;!4BJ)U0(TZX
MXCPK3#!E "< =2>A U'N 0=I:0B E?U<GPA^W0RS*Q&+K4_Q#D*0.S!LN\9V
MX4=.,HQR% APM-3!#(/RA9BX9#BVZ1=4&%.$R<<(AKH-U?QS3W(BI;6S:<A"
MS,)J8<S2Q91RO!4_\_JL;6\=?#H\WH,I&)')2,_FME5E6K1:Q6/-VW'>4#8E
MWQ/-A4Y&;R12""YN0PDMF&$[SB99R<FV1"-<$VB*IZQ\2U+'\5L#Z>2=GZ9\
M,5?;4(A1+E6S+]&US8,VO^88;D63IXYF?V!UM!1)I$53R=&<1?*5>^*@TBJ;
MUX8R/K'-F=\M.[FDL8R)><VG*!^,("ZD[Y(EK<8HK9NERG8D:#OLI(48,IK[
M(&8@+-I;2_@A>8SZ(9HH:..<I\7FUW=<:EU,;O;8P4TWR^@9VUM"PQ*:%D5Z
M@>?,=, =7]GN9S?6_DE[\Y .RKE5.N922Q(Q?-M-N,'KJ(PGRVG)<IB.DF,F
MA%[/$,F:X&F(O&D-Q?DQF=AH13)7#;SM>#RNB>Z']5%^)$_=35^7$; #26;1
M#HL1@I*D2<^,3=16YH5@<XR8WM)]3$SY)&R4\4US\UW55"8F%)I9>GVS.R"K
MVKH&3M,'M>.JVC7#R?^U:B(P\H(L_93S&FC_A8/ !>^:>=BW23CD'R1'58MS
M9"("7D(X;W:*M70%+@GDS>T)QFJ)%#L[]6#*#IS8B.VO12=,.4X%\ 3E.N&.
MNRDUS0 WHV7<$_'(%%Q,4DL4 :304FIH0/%RZPZ6?O1$Q*17O#!X+^52Y&-E
M^-(@J+%4'TJ1C)]4&ZZ>5H9'OW^9?* JQ>8%WEJB:U\97>>WSALWZ)KU'HHQ
MVN/57+C3FSU+.P6W?(*B9D"8 U:US4J,D,_8+N14M^FLR%I3:LG)98,DK8=Y
MJX 96*APU$B5TPP-1]!+5<&)T],,H\1Y,_5L2+PL+Q'904+E,6BBO*'[8:S\
M+&.+4AI=FOY!ICA,DP*&M7'FS>',VBM$GZT92D"#)A6@C3""XZ9PN@U*@SW2
MT'2PS4OG$U">Z.I0IMWNP-13A2_!XS&O"Q_L4)O;@O_ /^]*UH<'05DCEI G
MM%^I@_PH0V<"%'9T=?@LY#T9"8\-M%&4G0?MP$NU9Y*CZ'>/ZLGDPE:_'FQK
MW,B%EHHU4JHI?5B:''PC%H9T@6' L9@$HWE!\;E,URZ7N*NV=/1* KEQL+F7
MZR=(]T1,74-1=1V+S3ZPKL>)OKZFMHRK!DFGTM^V ]3WI@(_2'ZV23811G6R
MH<BS)GG/72._&A:B(0*GV\U>X#YVG(2[)%?9 9U[N-W]]G@&29[24 @>QV)'
MS>>W.1Z>:B*NA,5NN$\V3O)B9Y-_AOV!T\J3T+5UUA-&3M.X4]:#%]/D5P^\
M/%T#'K15-_1@"GXI(X!SQ%@;^839N.A:]&N5**817Y94;>@]T*G$IL#<5U':
M^P1I##1NFQ]'Z 6FCY HP[^Q1#8< FC;LG)2$;V'.NVI\)$Z@ EH;HQRB%,D
MH1-X.+HAVK/8F2K;F&N8"B9FRU7(8VXN>S_N=BG^A=_&O#/YOD"9)2;/*PK<
M\%+(S3M(-&_51M/H.D!TYQ >CW,Y\D.OTUW>[2U?-=]_]O@'--S<C#RS&)9/
MUD(-[[%HQTD9^^6GM^\WMV1GK2KD9A*JU]3>3ECVX) 4=WY[:V*=;)4-;04_
M\/E*(F=4R'$2BXH2HD69KFJ<,\HZD"(UZJ@N&7P>Q.FDX0>JT8.QI1,P?N'W
M^?B4T)R!Q9PQ=EXJ]#S%ML(83,UIB\+^8D*IELL"\!Y&T1I. ^:<,.:ARS;A
MG^S>46_F:)C!X"?+:EZVMQS@2&S</NJ(U('@0@H#7Q==B4+"&P+'R%?CD,CS
M2T@DDEX."=!UYC1R%_3&N21&O30N8!XIET27HL8Y-%8AE3CC7 3"PNX\BXNG
MC-;6O>BML)F]Q_.O<?:/IXFPRZ\/?T8:\D;:_#H0LW\./]_M+K%G23N\8=\J
M2?B?P'QPT&GL4!J WRC^Z.5? FD$Q568S3U&%9X)QQ1J;MB9]*$!R\.';6]1
MUV6;>3.9UTZ$:B A/4Q]*CQG:L/+W6XMMW+YRO[A]4FNLCQB;X-IGC?B$704
M/G&7R7'@GA(2?7*>3(%T L-Z3X^@CVE0J,,4:21D$G7PF>V6F4*81K_9$K9R
MG.&'KRRD\*T!V%U,Y5L:5K7L;LEE!Y>#Q[NJ@>WR( C><RE&O+F;8NAV;V]%
M4V>4#Q7APL+D# H0T^W':!"6>7M6U;!/R!GQ*W*?Q- !SV(W)6Q&A^UA<+O(
M!-5P<PG@PC<+[-XXX*0A#8R(NO?*:5S65:J<.67$@'PG?C$M88'+G2(@B[^:
MFI[4B=%[95A.Y9++DA:6A65?,+S<4,4403,V>'#W[?+G:[/+,17N_H>:(Q$W
M:),/*!, \^S0_\+EG-58T0:>.SBC8$1P4&T^P]R,F>3/=3Q;E'Z*HW!#>ZH>
MXTI+O#-;\I)Q/:!H#1T\W;P+[Z9NK$CS/JF:GRP)MP+AFTL@"G>"?"Q8\4'S
M;K(Q)'#F6XZN4C TBK2K62%& ,CQKEMR0!CD3V_?#SI+3:N[O14L[\ 6BI##
M'ZOU\ >%E Y:%"QGA2G[U=)5;^B;;^)U9.'2&-W-N157D8Y)FM==I,U=GG#S
MPN*>YS '4D?-R%.1P7F/,2]WNW:L>C=PDN]BVAOF%;=:/F;3G!3-\6#XB* .
MNU+JG[2:66?\)_5WF/.6<FRY?GL9TM6[44;+=XG5@+0>G1PX1WG"DM'>P%"B
MX&E.&#2\,DS;"]RORQ,:S XUA4DZ -MOW$R9HG=>,=B8J-J''KW )5-CM[^6
M1<'0=<???:/@^W49!1T>?A1>5U.F7J3[-RZ+@7\*+LCZB*F39 4>ST>P=LUD
MSB'03G;CJJ8$ANPZ!8.&2,I<.PCLZ5#_$%K%Z;%>O ,?UPEP2-#")H7N8)F.
M#:8*285\0U-%\W(WW!TI&ZJ-F8N!HA]36'C.AS>W':CT4R8[P]=AY* /TQPZ
M3DC&--M_.,ZQO;5JH(/R?W"1,* 4:'U4QA<L'W8:3!VIJTGF;7>N)&@=FRSF
M3D8$4KDX\ X."P*\_U(NYF  _9$H=R+<7%-_2][,I/<'E]#XZ427LA0SC0RE
MFKRI?5%,>2,61XZ"IV$E#:I_)KA&\2=([D$2HUT*HL??X]7]10EL!A@+G H.
MHN,SZY &A\HX;S#BA>#A!8>AK!H ;X_ 2!""GHI>5]0D5L7BLF2J-OQ46!G(
M^_$K _*>?0/R;M7V^&%=MH=0ZY.-;'2HD[E@\_O6G;0 KD)@ "Q/6K"*D!$)
M.OI13144=ZX7QC.*@!)FR%@'-J7B5/&)E-TS-,D-N#DPX&=0)!GMFL'GBQS@
M/B[2/5G$KW/KWHY)3RO::H#7QBIAFC6\&@T9,.O'Z:)Q2,:TT-"K_\?<6:IL
MU H?\TO#Q&B8F:R>>>SIG<PSZPL: B7\/@V#@UF8_%TUN:Y%:(G@P2AD$[E8
M(%3,7TV,B>;,-=P,6VH[0*GK>Z)-HL)ABD4KL!1-DH?46YJ!F+4SU :<NY?7
M8\,6VK.. YOY)],3(8B%*R8P\PW'TB1=!AZ-1!6Y?!W&% P&SU_C:/G8CG][
M?\,:X>Y[2Q&K'@DP.)_:3K W$.!%&? PG!Z3*G6,.2Z$HMQSW)JC#%/X4#!&
MS).1"_47)9:C]*9.&S?OMJ2A(N\8[]'D00XNX@#;#4P4U ZQ@C$OK3V, A3I
M!2<S=6EC#0R!: >%$,P+D<Z05AI+]<& S;(ACEK<.;,)D.8-"18YA,Q\XZ"\
M#[Z<Y<.\-8TS?WTMOC^M-E_9Z*XR3!EL3-L2M*23G"GS1_M;ME>F5/>T-9'R
M8N !CEP6:]NVH.ZV-KGV;_&EUBV/O5H#%RI$%GX'!2M5DU.=03>_JT\@SH15
MPBQ?5YCY002<Z#=)4XNQ2Z'RQG3\Z@=.OH_P&Y#=WU1)44EG&B?4$K1$.Z2"
MD2F7'A+)S/:68<Y\]JB7.;-[G<^AR>FL5G.YEH Y99RQ&*XV<@,GJJL5T5<6
MOG'NJF?G 2^L&NZXU!I+2A.OL#IV<-M]Y::[!>XDG2;-G,H^))VQJ!J22:$V
M]QO'E;3-T8,Q1YV;Y^;S\J0)#*6>3PUKI4=V8OD?!UIN&52.2JZ':HIJEI=<
M0R5(H>"Z YM0C:ZD@K,PZG&.?J[)QZ9^<3 7B+K,F)B "F111N^WF*UXOP6K
M7BNK=@=F9]2"&NA4A!EXKBMNM]E%SC,\J:3H@G>',:5B\/*#Y*0+&5VF*,:5
M])_#]F3\3EJ?U.-7DM_NJXU!<+@: ;F&LXYIZJYB-[I5CH; <?_!>1B>" J/
M2O@V<8I:EIN,J2O8<(9F,[R-M8,GL))T3%=1' D-L9(H796MBLO0U?!(.WVV
M7.8PW!P.:2Z9+$AH8'8J5Z15F^[4K^!N_7A+4"\CK7L1*B+2HK])$3Q(Q >R
MK3]:Y/,/ ;Q=V-:#VW(Y@!>43'YEKT^1W L[?*? LODL;%V&\$/Y#3S,U?@3
M6O1GLQ,,9Z!/)##0O@D=$KO<(X[JAW,-*U2' ,?;$"[HZR;)WS;PNRZOSP#]
MCN<76LHW[@ ^ )UY%:<DN8I/LN$::568\<FCKPQF_.X;S+@>_C,_H^W1NHX[
MVMYC,+\YIKD? G('/N86RX?:[)V[[BX3WC]@.5=#*NL(M;&-CSE-W/O..7#E
MIKGQ*AGK,$Z(' -NN6,KC<NYPEJ.'M+>XVHTQR<YMHR0%VC^0]ZX*KNO=%0B
MMLXW+4SCL='H$6,.>G >Q(AQD:(@*ZKC@CB/GI+M2Q/B1C4E)8GF(H)V,L8C
MO+WXP4YCZH0]2PHC9(V7CY='HXV@>%U0DST,H;'U<CLX*=\[I95#%T?I/5Q@
M<M-DEY+_'.(YB0&:Z[O'/&'=N: [AC5?22!"UY#R?>1NV;@S[7=R)]\8S[;W
MSZ\S-/B"/1=8A3%\<C:OFWG*RC)0X;92?5B=4S\!+_PQP)QLQTT%4]<#  >=
MG*.(E'HA$D$B@T;.&I 0]]NZZ2DVRW69G=/MK;X.*E[3E('.RTKHB:HU$E9.
MBITM+!NL$[HFXD>$5#N5*NH]! ]TP#!*L[8.2:#*XMG4W63S:'%XMKOS9-<F
MN'F99T(.+7U)_,JZ>>FH3[S[&=@EVG'"F77;M@89\]Q9QQL%,V\Z2WAO0H"]
M <),"P=%PXAJA3T)ZH(2Q<02I&8VF8SVVK24]^&3#@=!V?M]SQS/\5RQ.+T6
MU!K@FH?LC E5;4$BP0I_>XLT?B]V9YID2,U6*!4&^P^EXH:6/2I278&]@E0,
M:/^O;TN%L2\0P;=V#IM*@FS2$F2UQB<#?7.O(,(CE3F<2&UWXY@,XTM2IB/9
MS1HU\]]BE7@K&T6NVGW0O<6HPN1/- 5(XQ)PS!FI \E,9<968HV!IWTV@5@_
MGGU5?=VQ@QP;#T9 P+L$8YQV!+$QB1UA85*!"?0<0\O$-PTMJQ4/71GF44K!
M+CK/B^P4Q<%GA*UAE].&(OL+K:.B0BS?"<JL;E_V&9><[.=/K:8$=H+,IGHF
MI@CH@!5Z3_>@'A54U8Z;V^B2>((7G.+#W0?)GAL[Z\&,,,A7&5FB,BF1IB4+
MYPA3^,I&O(=(Z^SA1CMY+6)&S&72E<>[FO.\KBR!N[9G9)2, O^(6]TW,NNI
MY!L*_]G=,"P%,_E]#J?09+%N\GW?;S0=U<182Q=A/H5A[\Z<M./X"<'G9DY>
M#7:XV/BF2/VXQ^/UX1Y9,Y\R@RC+^(%A55)J!@M]-M^ #O^?PQ*3P3ZKE[O\
MW%L];\LJ1R(<7OVLU=J)&2UK-R:Z'&^(TRK[# !GU-AQ*%PP2WUR"FV&9:M]
MSF \N3_4N(;[:SBOQUDI1,059_R-BBRMA=F_/(?CB/B$!7P?D/N$Y5V8G,\3
M,[/"'^/F(0N/9UHB[O[Z,JU>+;6Z_OWNY":Y?NN'X0VW?NB>"I&<<2?1ALN&
MER22M]K6&>1$*:(&7!(U<#B@F(P4A,>K0DUF(%GX@%>'K\NJJ)A1$<^;.GOU
M\/!UE_U^()NU7DA5#!=?L;@.!2+1Z),=S[C*V-0<4<JI]"Q3$0TW\S@?,_/)
M-,MLDRKP#MMX I'-]Q&<-+)G-UQNZ?]/GGROC?-6B$0]_LHB4<^_VDB4*QRW
M95:LS0Y./I?5!1S3IYDT@A+B:L[1FH#[2,$J3#$:M0._9^"UVAI&KKY*FSJL
MG[V5WH:1#G9!:T/IKW>5WH8>%)5/9_.V PY-@K(GM07\9!:N<>V:5G'2C[N@
M;?^H;1!0DJR9U/(3UGGER/SLI0!]\UL"OV6RO66;N =V;=XP=+@LAC/L,]MC
M+@?NJV5(9KR7E-N()=X"#^^+,<UBT3O@)OD!-_R/ME#1?X ^H:RZ13B7^&MA
ME?H5YHP*-MQ)$Y3V^2,7I.U)C5)#KS<2NI.?=XM'.N0)C=B.O1/WO3=QW<$&
MD')O(E<8/-3DRP%7C:PP5G=X5M4VED"HVP@(A[ "E9')"M=,=C,E\9<,MXHM
MI\!KK@K@]U=KNTYZ6OKT>E*8XT3JF>-!<X,%$\841]HQRMK,\RT4>=K\2WAX
M\"3-*#O!9^&)YU$&&R-**1'O:/0 ]I\TV<C/8=]VIF"0>%-H'EG->$"4!9%E
MGVD*+C1L99MX2(FON#Q:LX/Y\]C!2+_(1[F1*9RNM]5TFM64<KSGW.[3' 3(
MBW3M8;GY"![O?FVO:2JXMC>0 O>F.CP*7ZC3BN_!UD/ GUCWOIU(Y>,?1%'8
M8@:"NFG%([V1N7OE&5=M;&\9(\4,3-D2=&C^[(3%[(^?P+$48W"W!2RF,Y4&
M%:R%A>'\!5NN[B.CG&LNC1H.P^OH='G)R@%W&TE=&G4% CB<I;G'C;M3J,YH
MQR:KGPK'&/KXVL2*+B 54J.([,H+TLNIGN*(L5T^3I9QX"R8#C!4J *BMW\5
M[3"6>)/L&@A+1%+NIK&SGAR6PY); ]&LX0:?><"1N[]T0XPOW0%+E+> KTHW
ML-3RB:O)@6'D0=HJ36^/HK,K@Z3GD40H2D +K+,5-7ELB"&_A\XF5@A</OFP
M&Z\YY^*WN1VV_7(_FIR)>+FF7JK75OM!VL5[$SV'*2H,X6W<8O[#D>YDAP.4
MDBF!?8%LDPEIIV0MSNS+63JG+!!XM2*=-=EX-]0QIH0":ZO0_)(L1 YH5U26
M::I&!UK]BL6P$LU.FR:K6_+PQ7:XT7UDCXR9IN!*QU@G,M75[7B6<Y'C>5KD
MF'21EZ8Z6TX,4QDEV:1M/IL7MH@C<:C);,^ICMXF8U*&J%;BD.K(T+3 %1+#
MP#]+[I2C?]/A@-$ZPP'HNX9V^!_PQ5;P7Y=GX70+.8UX1))A;F(/A<D83T 9
M#QLZ#1*DQ3&%*4'USH12F*0=Q(1Q0[(UW?81P5?\')1I^CF+UO_89[('Q7=
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MF-".JYS):R(JU%M!\U(HIH!TWO0\IH4P#]*Y-H>Y;P!3+S)J.#*P"3K1@(5
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M=C+^I%-)KX6-E,?SD>F4YK5N@0DD[GQFP&#FYQY"?8<4#?^ >D;Z/VK[3&%
M4M<^4[^'<>"FM:XY%>E<TI)2N8342XJM], ZPT*VY/3X\2BA8 QW>B7=_'0J
M</*2T<=9D]>ZGEK]RLSDEG67*V.8#W$II[HNW)V4_:,/O\%5.&WO/GPZ4%RF
M"T!1]V#JJZ+!!VQW6J8E5PU).U[M^6ED/^ %'5<*!^G5#BMQVD@GF&;#(U1K
M:-'R8(TLK=BA!:,/.0'E0@GS#C6#LD5U6%?NS *LNV,+VU&=MO9B3B'8F"+=
M9S(RWQCQ-_R>*2/4XW3$&FX$;HJ#4/N^MBY.) &(4+8HHS;WDZ]J 22QC0(L
M*4<*#MMLFCS?R03ZP_YRH[-L/"^RY/&S/7S I^QT7O"NQD]VN*F3WD1;A@@G
M3I+C_:K2^ZS1.U;4#F"Z2^C>O#@E2%G:PU')(3A-6&X*2WKP129G;T1FQ>,?
MGS[CHQ9IA^ RU[1UOVQ-7*5O%]8>,Z_<3;YTXTK"-TK@(A9:.M2C;J]XTR*>
M&5)C;'_"4MI9^UXR$%YE7!DD'NXN]/86K;0A",&)E==FC%=>F!K_TM.Q\P]U
M.VQXO45G-,GCISMC<Y<QK*;Y5<3.G<==:8\PS$;8MH$72![,F/((<?+JHLQJ
M=P@:LH0'?X(U%TWU='S_J6DA%CQH(.9/L7 I]I$P&:E(K$AX?:9-GP/<'X^_
M^XNAO9-7@4$/:1SG%7UE!DM7:ZMO9Y<9(Q5%XCZL)K5JQ"N<)[OLN]P=+)VA
M5*0%-QT"$<A2<"W:B^H^49L8GX_[99A?XXDP1C)=F::OJC 3MQ_%!I-\"M*3
M@TA0UVRG4QEQ=)(\R!NEK5)&:M,+=//34Z9F1&;BEWZGH%JDD;I+U]67!:FE
M#+ML5+6W?U++/9/&VQ^@UY 6K*&H8\% &G-,8+O Y@J:),!Z5O5I6N;_RY]3
M<)+FF,W+JTXQ;7 S:4@XW# 95Z.UGH8+,7K]"O.=M#5H<0XDFU"L2_Y%C&?4
M&A3F*/V] F%:&.(\,\PZHTW_4EAVS#:W[1<'SO5+7QKY]I@*=IR#QIJG!3CU
M>QIP.JN2"UQBT_:;)D5W?G"NP%C>V M!S6>%^ U2^"^2C*IUJEVF,9H8?L_;
M8UY#/PS^Z!(;/H%4XPTP$MBY+#_]:V];F/L+GG3?-EGVLOX["M%;_+UPV*!Z
MSO-JCHTRFLJ\Q(:C)"NCT8__[&CTW<.AKV;'#F_8CM6DFNTMSJK1XY[-6")_
MDFP;-$?_?_:^M;>-(]OVNP#]AT: .9 .VHY?<1)[QH!B*XG.=6S#<F[.P6!P
MT"2;4D](-M%-2M']];?VLW955U.4+"I4K'R(;8GL1SUV[<?::[&X4D&G")[1
MXOBIEL[ZXE4KE .-^. 7KUBE:"6$(/6D.Q]F!W@*.I\\3$L$CJPHJ@ZK9KB<
MDFQ0FZF,=")GR(\2WEA/.L(O20XP3$DEG.)!N2)A^\+[P54@+L#)6D8T$, J
MT*F\<;E)!49<MC(2JI&[.ZF5D5P"BEM1?Z7K#(0NKONZ\Z^ ))F]/%PUY^ +
MI_WL#IF/@DPHZ0>C(SROS,G72L ZZ;VJ=0 B44J,="[+&E/2%):,Y3'KY*V!
M&]#'<:,EY^YRHB3LJ$IYP,L83(G;=[V[L4)A;RC.5W-(6*%7H)%/4Q' 3^4&
M6UG#NF@VP4!LDTBW?[#<F"X;'2QOH(! :Q0,J,1$X?&2KAB@@\<4]FC!"OZ[
M#TPB; _G+,JA7<?=%.W7P"J=Q"T+Y7AHPK9_<A\ @]4+X!9<L[X+68&;G.;0
MW>XZ#R-T+7Q*G7%91/)B!!(V2=W^I^ZKZ^MTE3>LTR7IM "4J?G*&56?X,BV
MH%$X-):+!_7XP=R%=VX:^V&D6* "FEW,_ /O( H"R<\QHL8V /D)?I.K)0WR
M\CI?!3ECQZB-Z;YQ5DZTF)*[$P %0_! Y&NX@W2FG+Q"2"YW=''='/"5D(MM
M3N *S%F;*P&N^BYTRW$)58X))#@6*"H&9?D)N[CH."Z*/\!@3"%-/H)DJ-4X
M"\\]1D6RVK)JI"#9KW@8+&??:OXLD#[;W3G\>'1\X(9@B"XCWIN4I&;%9"%]
M/-Z]'54MXBGIFN N=#"]B4JA"W%;A+0 QG94CLL9P6V1V;?!I"F<LOPI!H_#
MIW(6UZY."OHR]=M@B9&_*FY?)G-;1<J[>@POV)(7QK(_]#::VR2*25OST5PF
M$,L]=5!6KZ:Y0<PG*(^% M;9)5HO6O-:3F%]4 ;Q@J60/(\T5&DM3I7\2&?M
M0-P*<LC@[KMEYA:+R%TQ92,]H_P07!3P<<Z*R?9W>%SJ78QO]MB!33<O\1Z[
M.TR,$KL6D^(<SIEI3B*LY/=3&.M_)7(Y:(,J4B\'-#7#B-VG+>0&OH>-/&6%
M4U:YX9A1S02SUW/(9(WA- 0JLQ;K_  G5JN([JJFMTW$8UWTL*P/ZX>1ZA;
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MO;N31,\(*2JD"R<*&^1$3%<E43,LR\5IW;A]@L%(V)3[))4="#QV[6)3&W8
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MC"%1953,_H78<EB]A=%R"RZ+%BKQCFFAIB#E8#,.;KLY%P6L0ZIG+$"VQU6
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MQEG:YX]LDK8'&B6.7F\E=*\ZZS:/=,@36O8=>P?NVV#@N@\;I91[@5QQ\5#
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M+%WD;CH%F\F(_$;P..UW/W=CA[G2D.K-:&&NE2;Q;.&)0U#BKDC3EZ1?=W<
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M/#,R=1&\#SO7H#&2\FD<_A&#-!Y[T7NQ3UY<[6F<8^D?YQ(UDTB&0^Z!H P
M<46ZDW2_%%2"%X%TLCX,.F_IEC+3$><$'3RID:2FPNAM;4?5PCFE=4.+%SPU
M>EXTS>#:S>$;D)QI+O0Z4-Q!X8\2;D*'JOXF)"T+YLP%Z)@N'=2SD8=[4+9V
M@?+=;5A\0!!(4\(%#3^:.R9$<960O%I106T%P:5@30'HO/%^1 NA-Y*QUL,\
M=(!1BPP%1W(/T$D6+#AER]>15"[A]5(WWG(?8(UBQ)-'FRI&' .FE4,I+9T&
M;=&<\^Z7;_$1/)+<49&KFK'T3#6AP".F"(E*I6YG%HNVAJ=YD2E-'RP!O(Y[
MNIRI7##JLCHV% 9*TV0YY>VT\I%](L#O'<_DYF(JL.%053%]N3PC%  [NUS,
M3S'8CTD=_5T@CC?&2'3DM-W\"J,E.&<$J"W:<C*&K,PEW]I/H]H&PI1*VDCN
MT"O(N1864!,"P6@&DD')>BZ:;M_./BG.7V:>Z2Y\[7 U&1I^;/= \<MIIU,V
M@)E#MSA&&77$?,!V@[AEJ5K$?.F,?%:<V<+D0,(C]R5E2(5JLZ=\S6G//%%_
MCTF_/V>I93>RTG9WKK+4\L1:N_Q;^WXF(<Q=-$L 6=6<P<+YH#E [(.9!&<=
MJS&3FM/Z^PN8Z\<;ZU6#F[H%/P$Z?TQ=N<7K,7O!FA#7ACK#$7+@?&:8N2EH
M>0W-!7@5(D>$)S-%"PT "A'V]MN4UA(FTJH3U'P#A0O*=$*&$@$E]0GE1S2I
MR7Q0^!ARPF/T;U0IW\]*U1Z3Y\L@]^6+X(1L%=#!^:ES */#H!+=#,/Z8+H)
MD.6A&N%>TE:0],[Z"RS&#:F*__KJ9Y*NHN6'ON(I_\3+OHG]2AW"0!S@IM"Y
M:2Q;X9;(63FK:"9F$WL2A2PZ= C(<L(EDJ)X(1U5#]UFR\0\+!3P_ 4F>&/Z
M [_4H[#F\QOZ]VQNWD$,Y,Y?#K&G]L,(?F(^F%4>H]9\B/+'VBK!LKA-/Z@7
MI^G3FAZ#P@ZM*URN.-AQ.^J$E2KBZZ(Q,Y=EOB#) Z.C#.NT=:?[I&CVW3_D
MLFC1^'+!+;C4@P O_/66K\>U$Y9/OK2$Y9/[A.7MFKT-D?4!2Q\ SOA8.Z##
M!WZ@LAY4?W/O,+(%-L N+&=L 6W#@N4J%ZL62*/Y4\V+=(Z6$^&;J@PFASN<
M6/RLD&8FYL7G<S3PDS#K!3DR@)T*EJY)/7-'*)2*6= %JRVC%YIJD5ZKJ'SL
M D940'//, 3N*=1[P\Z.$W"RX,GA(X3O@^P4K,4YY \K?Q]GK9N1+VVM$DBJ
M%N3M973C%YLUGY\.?GA[F+T^?/OVP\&;-T?O?OK'5X^^PG\??SAX+?_^[>C-
MIY__\=7C1X_^]M5UG^$2&_7W3Q_ERF<PS"XD$%OGOOC5*WC6-_*)\VJT.'4W
MQZ3_UY_>O.K^SJ/2X@]8,_KO90N:#E^].AI'Q4$)K8O1"$J$!KW.4PHN/.G)
M@(VC@>4SG.[X]:>/\#\8X/L)O/X$#JXR@;Y$O*A?W.8TW B>]3$)OR3?[^8T
MY0X:P/V^N9BY[P^SU\Z .9/C3H6:C2:.GU0KAAO0,KO%=WWRZ-&C[,"=.4L%
M2Q\OBL9]P[DW_&*=F]D+!,)V_(T$7ZW]RH^3NFXV.6I?O7I;.]]_=E).X,.O
M#[+O'SUZ_NV&[G6P6+@?OSZ%@M-;3)6])^#4MOOU!M-.OH&8<B9(\&[!>-G,
MJ%<D;#F(>&DLN-?8FKBOANG9AD#00"FK+0^!PETX*<>+=;S5C=%7_00$ 3-$
MS[XMSB47DXYV3_"SC,]DOB7.U9J2RB@A;YDS1MRS!A\ON*5"%$$UO0UJ", [
M*VTHHBZ 7\5+-,O)-F+/KATQ_O/XZ*=W!Y]^_7B8?3CXZ3#[\?W;M^]_._[7
MUKWA]6+YIU]:+/_T/I;?="Q_],YYV9_>'1X?9[_]?/CQ\/V/*0 ,G3J2%@1L
M0IA!5FN$(:(S8< "QEV>**@CP,<-&YOUP@I9)K0/AO5D4LQ;MU+D;R\S<?0A
M\,#97A$FT KZ2A8%..\K'2UY:/:TW.?UF]GK]_"@[_[QU9,KQSLI_S/PGS\>
M'F=O_N?=P2]'K[/7'P_?''W*#IQY?'WPZ>C]N^S'7]^]$??YW>N'+^SS83#R
MUQB%[FVO]W)RG9M[;G/%:SU2%(=^ ROW^E-PY9TIM[WTKC]<O%AYR]6G$P5+
M5WJD9_!,7[=?9V^*F3/6V7\]S'YV?MB?LK)O>#73@7DKMXH'[\^S#C?\8I\
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M,@6<2V;P V&Q4FO&2%_>T)JYPLJ(1-%V=\*5D5P""G%1YZ7K&81NK_NZ<[:
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M"C;2%2-N<T.4U99;T5NEG_8+/#S19/X0S)--ZUFY / 9MX %U,X=< F<RZ
M39$F1!TY2Y) #]_(S1O^J)K.H>K"N60"$%3@M3!E#\M.(Z,L0<+L0^$<\S/
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MR.\YY#-H[ZE(:<X\AIH[/)VEF")CPMR_&K+!S6HCM@O\H$MBA,6I.1/>,Z)
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MQ\6@[,_@5LYY8N8%@53DM3XCVKI-N:ZL/NGR0!X?D1QIUK$ +7OVFMH15XU
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MA5#<'.N955EDE+2TY/*ZJM:<3^RP:9O0:!Z9M3QE:5F_6Y$8(<FW\RQ]%!X
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MMOPJBXT$)B:@'Q(?@7I7+92"0F-_?7Y$NW/5!=7*-KN/-K09#O'!4@>((T=
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M@YC?&M<8(?IH#K$;ESG]4MH'_E<LR-@F(!JWC+_<X:P"MR1.<&$>J"AYQ]&
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M#:!:P34:YI0RT=^@6-7R!M,L@V4MII3#F$MHZAH @R:+U&.D<(RIDW)6(XT
MKN!. BL="E6#[,(,&DP$U4SL4A^ =E9-)-:<Z\<GI:Y1VS&'_0'?3$K]Q2-+
MJ;]X2JD_3$3R:2#>S7$^(>I07YXC4SZ%MB3[%#FK8B=4TGY ;?,)U0GA/7QJ
MI?KW:'8[C7-+\EN-LPL%.(7]Q26]XY0CFF?$S[F"AVNKQ*[+'@T;7!0!(%F%
MUPQ3OH7#$EE&-9ORQU_KO+_+-T@^4V-]^![(75%PP,\O!1OIT@&WN2'*:LVM
MZ+W23[L%[I]H\OX0S).,RR*; OB,6\ \:N<&N 3.95" ID@3HHX.2Y) #]_
MO#?\53Z>0-6%<\D$(,C!:V'*'I:=1D99@H3I0>$[YC' Q6DWZL"FJC*!P4'6
M^;NDBS5MT*?B)H'0-;57]X2]X>K2N-%$-8BR5%[\9U:0-PM9VFPHFP^<7'#%
M99'BEA(R(4D6@Q4AB!]VY4'3)^;$+)T&D6JC/0F>BSWJ].:CN4+!Q4J.;&X@
M'$+N@1@,P&P%TI]TO[;68=4N')'ODA<=T&O0AN:A&X]6S21U3 9/J[MXIL:E
M+"M:O.!GT7C1OX!B 'P!$B35W%X&BC6H;I+!/<A8V7^Q[XSJ%-Y+,U$R=027
MQ<"!.RCE.D69\SHH(&",#!=4C%W&U1'-6\+V=L18HAR H%"P+ #^?8KW(PH,
M>R.9:VLE??<5I=I05B5:=$ALS8'3KGP92<<2.B]VWP=I6[TTP\N=51443@#&
MRG&0+95Z+=^<M_8)^.+A-]*N$4@Y+UA@)Q]1U!"RH02E4;,QTVE=PFC>)I"?
MM%E O(X978=9:S!D@CYFN1;%<-*GEXUY-RT<LHOBG;USW&(F( (3#I41D:HP
M ^4W0M&KL<OIY!PC]9"$T-V%.\3$%HG*GFVEO\9L"=89X6C3.AL-(:5RQ;>V
MXQBVGK#'DA"4.?-2<EJ$&56YEC";B3>0F#@4FC_7JC]*+]\ED$PBUC7_L?W5
MI(0)L $$14''C>9,#VH.G?#HO95!X9=ZU9EOERH^S$"?,5I/0&53E<#P3]QW
ME*7LRPJ,:F%)ZC&F%#@-LN"W66K)G:PTD(U8?JEU(FOMZF]M*^X ,Q'3:@9H
MEY+33_@^!&SNOP1C'?,A$\W3^OL&S/6+59GK [BI6? C$$C O)-9O X\Y:T)
M\6RH&1E1 \9EAC<W!L&ROKH KT+DO[#TFF2A 00AVNINF]):PBQ8?H8"=Z#Y
M06E*8<*<EF<4=]J,)%-?X3#DA,>H2NER'A69%5B3\260N'*%;(*Q"G#@\MSX
M?\%AD(N2B)*L4,T#R&"1#W OV6Z0^,[Z!A;CRU4MQE]);8F6'_J*Y_P;VV=C
M[5>;%)]YA<9-8R$0LT0NLB*G-U&,]$GD,P31(2#+"9=(C+X&;8T":K-E4FYN
M.5SS%[QT^O+E(TM?OGQ*7]ZK%7FU*BOR6SGPJX*_8Q#)9]HA!-K&R>,TSEA_
M&%%R3*BT*"RQ54'BS-('HN++,J_[/.X2TC HMK65IXAX9^L V&J5D:,P#:^+
M)Z:Z+!-N21(7HS$PAK5Q(4=IM6U^D,OBL<F7\V[!Q4!$ N(_K[G16V8]?K^J
M]7B(D#$^U+K,K]Z'H7*%CDIGYAD&NC8&Z(%9P4M3X\8U=[8L-T\JSIUI3F-R
M,!L)DU:N4#'<S$2NT#FF)U/I$)K(*>IY29CR@@09X$8%#5?%QMS0N:02 ?09
MV_;0N4VT2%M54/DUX2*2W9DQ](%5"_7O$&!_!BX6C!P^0@@]2$V!;9Q \C!W
M]S';J!JX@L$BR:I\2KY>0C=^N]IU?=K]\&D_V=W_].ES=V_OX/#CWY[M/,.?
M3SYW=^7GWP_V3G_]V[,7.SM_>7;3,5QU8IX>RY4O8)I-0" GK_GBL_<PUCWY
MQ&4^F)Z#AX#??'ZZ][[YCZ]>H9H#D/;[_ZX/]?_,:E :>/;^8!B47"2P3@<#
M*+PHK#J_4G#@26$'SER:6#:N=,?GI\?P/YC@IQ=X\Q?8N\X+=(6W:?E6O89E
MQF;GENX6_+CPYOJC<#]RF?Z<_U;]K#=?Q,T%A&"VMW Z-E>4[WW;VW>A+W)O
M7J3CO)_L&NMK[*4YTDJV^/3R#XK^G?@#=S+B%V]V=I*N.?=F%G)],DVA*G(R
M,Z8F>?']SL[:#/93:=R]XBP;P>5WN\E/.SL__+@VH^M.I^;'W7.H?'W"I-T1
MX:_4"-=C$Z[<[M_^D@JU3[Z3''7$%J'<IN&L*J@9QF^J"'A\-/Q8V>*P<XB9
MSOK 5D$)O8?AN_N+<1F'_O6J'/J/P)=08.'Z4WHIR:IXI':&GV7T*5-4<3);
MU9P&D6[T#@/9'67TR93[1D2$5I5IB758>FU$:0*_BI>H9J-U1-;=.,7SSY.#
MCX?=TR_'^\GG[L?]Y)>C3Y^.?C_YU]H]X<V2;Z\>6?+MU5/R;<7)CH-#$X:<
M'NZ?G"2__[I_O'_T2Q0>A,>.)+0 _>$GV*TMPAC:&#"@3>,^5I16$KS=^IF:
M]HVX7!#G;[Q^.1JED]HL._G;NX0C)PSS<.DL" 9H.3Z3%09>4Z/+S&U'-P/<
M(F8^;[^9[![!0 __]NSEM:/+6 .>OFWW>/\DV?O'8?>W@]UD]WA_[^ TZ1I+
MN]L]/3@Z3'[Y<K@GP*K#W>_>ZO%9+_#AST+SMD\/%SY<D#YX#7O@YL][[=TM
MM[WRKA_F;Q?>\JJ#]=I#^O[J,3VOG],X#E(30^?3_SL#08_!G[G@[GB1T8%_
M+[?Z9N?P%)"BBQ?O7=U*L<!F_8I0T7#:?R2I&<2*U-GHR2(^/=Q:/=S!X=[^
M;X<'I_O[3Z[(T\/=S</=E4.PM!.P/P**V.2HJKZAPPL=@'NYTS<Y?73VW^,-
M][C9>LTVXYW%M91LC\SH&CSD?5F<W>='-(YK5/4>Y41AI9!&0N7"1SD+4$GE
M]=(LIS[2.?E4UCPES:IM;$)L87+MDZ*+JA/?OTN.)@A+>PN7YK*;+5F\>!0E
MBZ>*Q9]2^/OYP_O]O_]Z\.'@E(;1_?GYA_7C3+OQXW5_^>7@^#?*KG</]Y(O
M)J(]/NW^S\'AQ^3T*#G>_]S]1[+_]\_[AR?[)TEW[W^[A[O[>VOW_,$E3\NW
MV,Z!RDMP;NPY6>+A4NZ'=&_?#;)HE<]Z#$9C.,RKL4.@?W&]P^L^_$_I(&<B
MUH]FX2).?L4HV-44/ F1T?XB .?;RVQC+[;^:V8V;%H$S#$TK!X$9&.N)#I
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M7SKNEAAGZ97*]D(E8Y6Q)& ;$3A$V*#5YKLP#UF0 I@ID" Y? GONF8;SLT
M!44V4V$DLPAWW<Y#"V+\%[\>")#M193F,Q#F&3P/JH!>,E ^CA\B.88\#3F.
M%3I&F#*]&<%\0/K S\:+%A!VD*GK2-THWC(YQY'UEV8S>5? ,, ?XBY?*37'
MN9&:T+"A48)[KFB;@/L9C6FL$E!;BEP?5)2!#A61MR2=!KQ.7K%O$WR+J_3E
M[S-O0@?LJTC%X3-Q#H;5<_CY'Z4"XH.WDE>4O+XGO?=5URC?L,.CABOV"WXV
M!F$#%&@^>QE+,/\/8>@\C:,0AE]VM>+-=*M\\1#&7!Y]G"EYM3=6<%PPPSG-
MV)_1+PT3PEG><T1O5Q[BMK!_>,L2[\\2Q[NW2;U836%P9(=I0H8=T%[./&.*
M@F[5?:U>TV]X\7[\ YLX&89Z89F@_]-3&MF3!R;CI4S@8J @@Z,!V6*M+CR.
MOV<Y6H*Y]@2RGFK?X3FOIBS[9+S0BB@,6"S< 0=60**#%3\O8YF)L<Q!G]E)
M4B"A'(F%N%8!-@N(C03(",P5E<6+W2U=;(@NPC4N\F4*AZ@DW-F%@D.2J/5,
M0>= 70:(8Z84RLO\/H0 .@"[@WPE*9B#'0^69Y1JYV?&3@&T7=&HB3&NIK8\
M85-GK]8]^Z7K?Z/&>03L@YP18,.2IXJXNOF&:($^825,AU+&J-,ZY3A'OX\.
M., E9[]&K(W=T*F-@?%I>FJ@IU&W?&&"/ 5^FJ&74C:(%.T,T9H\_:FMIO'"
M_0B^GLV1\< <:1GXMF"L@(3A0.6UC&+4;#T.R,$,&OF6):\U. G) BB%-%3X
M[Y;D-T3RTUM)WEKK*LE+,%& %D4Y1V]W[AMUR]<@8Z=DK-"[B=2 KADZ.:1J
MPC=LCW!#1WBQ!M<R9CI>VA88)]."XDB2 L%92'_D:E)F*(O@QP68[:R>-BD[
MYIC),9N3A4LW?HQ>MB@)@6HR?(V$ETPJ]G,PAKN?I(4-NP,5E;E"ZSM1Q4V:
M71F/^S3*U W06VX#I#B-&$FO (.HF&!4@"U^&"V:H!6/WC]4D^"EQ.OT*_EW
M%/'*!"A0T1R= EOZVQ#]7:Y!?T1;I!R-P4+>*^?$2I@:"<C$_Q$Y:$5*ATE8
M=!B?"I()*<>WREYTR%@'B'UT)]KE0XF20(HPFI*R!NH74CO)EAMT*E<%-@AB
ME/7:_[(3N7< )V,6QKZ;"2CB8W0H 1DJ=-$H4-IC1KZ >$S2&>XU?*#])Q.9
M*\14$(GBCVCEH"'F6Y+<$$E&ZUGC0"S**39X-@P^\,),C92F#Q(..R%,2QCE
M$IV.2-],M?P5D<>EC-&1EHD<!B>8#=EOY&)$.LP#:R8LC<X\BPG15]GJ,]H2
MSH8(Y_=[R%*.$T<3 :*(>!H)'JTIK::='#0H+:%4BTEDZ<=ABD:$2"1HO"$(
MPDEA95T:7P/)W*I\D6F 3F5@L7&47.5& UOY"!BE$P/MXB#IUJK<&$U=+4=+
M?'L(KCJY$MB\N85L6+G1\@BT+ +L::9 #\-YISK>@0_"Z6M\CXU+V'>0_>AB
M&4MV:6$\#C/-XJKN*>MW,@ZJ,B'_5 :B+TW #D3/%ODXV6A=\:X9\-_ ^;2^
ME1/KFT05CIZ+LSGIT,_PM4-6J)^+]S(N\>MO$G3 !>[ET?\I7F45E6T T&O=
MCCU_K6:5S\5H,8=WMS,YCB;/11_X%>]$/\7U'54"#.8I_&9O&_OX<1A<O)X/
MP3"_1"$/DF AFJ Q6)N7Z']'AH4&I0L*>Q'DO!Q/8@E6 + ;I77QXC)+RXM+
M 3QV*ZXV=)JS^YVF$P690G=UQ3$$AS:#R4?_AZ?,?CTKV= Y<!T1V I4$W/0
MGGC0\,7MJ6[B5)-E)<3SS^8&42CS*C#51B.T4W8F%\O.V)J;6NQ,TCA6Y)&)
M%RVQ(^NW-=EM!55PI0%@U5(LO@=M@/^7MUGO$LCC)+V)57BA?50&JX9:>43)
M,^@#DV5QF<+E '7,@W@B-K6B'Z(/Y(H_]T$K:=+DR]?NNDJ:@3YDBAAZKA W
MA$5+!DU& N<]N(0+,F:G45P-<0V[G9JC!"?<X/XW0!88ZB:+2(.MN/K3+$"/
MH UU: 1HP@J4&] '$&FN88&Q]N&O!G[]KCG&7=SBD<-K=L[>GI_VVOU.%Q8S
M>H/(7/'J7?]$4\=0O#Y[WQWT8<'BY*SS#G&=#.EKG\-S'=JET_:'?=%+R!X%
M*BC0HP&GAR3GI=DLG6<CD(_"GP@P6X'U1)("^U5;S>3"]D2*B4[%,85L83@8
MO:5!V;,Y<#!\$;N:T2R!EVB*G]K4D@ 3F4SX+2O![C'D'NJP/0^+E*\8_DTL
M ,;DVP W .X3P<"F"F'-<8LO%SL#0>N%TQ.QO#$VOWWG%I[ZY;3]V-%V]U^=
MTW?#WOO>Z"-CD:T8A./VP,;Z$#-%7%MC^3AN22D%.0BZ"D+98!S3Z11>E\&J
M%1!7NE!&'$R1?6(H(P"!ZK"-C&N/@+T:,L8(2\UJQ@0UFA#);SMEF ^1UY9(
M-D D3];#, ^ZYX/N$%A>>]0[ZS/?^] >#-K]&IQY>R0;!Q[KJV8U(KY9-S++
M* &$5"VG[!24[YJ.=5((,F-GAOIYI;!2G8"5>[A;=)U%J(J%G!JG955043I0
MB\)[+K73JRK!ZE&DW(<J8\)J%<V\K%@1,$1<I"E&N22GL="/7O7Z0&)&0+H<
M&/+A:2C*YRS8K5/<8YVH0JKI%&VYL,RL?U+!6Y:D^O9>;!Q]:DV0JL5!^0\N
MU$4)WY[2[5D%7F3+QB: !%M,9JCZ.[U>&S#%PD/J<_V,S_\_?'NNXNF>UGM2
M]!-E1D$R ^[2?9YPL(6%K?,GM&P\@TP5&U6#+_(RGW-B. 'WK^'&A=JR<E>B
M]:5KT!>*-DM?)T3T\YPQ"0E45G*_3Y0*R8RB;=4I!=&%]L'C]J/!#0RNC%GC
MQ:TG52!7M&!:5"4V#=]]Z?2KIY]Q\$%H("SENB=%EL:>EJ2I0O]$$Q%PY8B,
M5]_W[QZ 69MIP^?>XT7ZI0LP^6-F RDZ;R,3?KZY##&^BJ DR3R+*$GG5'\>
MH_].W!9K!3$>_5SQBD?;>,7/("TGGZ]%$B<$=AZ%Q$@BAF7 @X3A-F552@J\
MKZHK,T]OC$_ B+/ T[7(<!S'6@KD-H.\X@[Q>'Y-S<0)C#&E/2PU!LE,U[D;
MP1[]I":EP3:%*@8+%N1H %('AQ\K4!>F)E<=UEB4B/BDKZ)$9]"'L&R8\$21
M)\/-N,DS0[EE-O_=X_R<(X=S(=^@F\PB6/8!Z5H5DS+34'LVBOW-XFQOX7+@
MC:/F-F\A^8/0M'>+)74<P_(P#1+=H9I*%,)T&BU:D/DU)?BEDY(\12WK\@3"
MXH^<1]VE]DM=@ (!<8NE;RD?G80J"24XL #^,+ZD!=LA+7(^:0&:>6XBW\$$
M0T<D=TF^IF56&%E] 79"EN $90P#AC07&<ZB1.M!"*>\@'U> $E=XY'_#NI\
M'D:D=03X-+QZJ\%_D[03ZW%H"C!4=7STC9H"3:$B99>JY(#*!E^E2)D>\&.;
M_/Y5TTC6"@@E*M+Q&>/@2W04A^I3T+T$?HH)\,AX36Z@%V9M$4M)S'=>$H4D
MJ!B]!]BG_-3R7^6X!AI9QC.OS0S_MON^3:8RY'W(#BUW3V\2-S7X=@+,Q0?B
M%B9!FY\GC1RS(?.(_. <Y*(D8_TRGWJK=I'Q4L@HE_$2,Z\HYUPJ8DO8WR19
MA-&1G^.78]FK:]B@>L+1FYAD$BH<_%>+"!.4@BS4XK,A-,A9#'Y")3G7.*&]
M[H0KG.S7I=R0_*9*Z<!F;;Q[>NJW=/<-,UQ62D9D-U2 -+<U@!#ZW9S Y -O
M,> #G,C8^'X$T8A<)%Y3ID&7GYBHZ)J**D[2N7'6+!<6VY+&EP=I?EDO2'/>
M';PZ&[RE$/;9*U>+=3AJ]T_:@Y/A]BPV'IVY\YIJ?W13>,$*AY+J_N1<F\O5
M;G)Y9?H^TUT#X5$8!@_J[53E.8@$&9M,';C",%J.PB(.;BY3NMV657#FZA\E
M3'4:::L8IDFQ(M27>9YDZDNJT%F=\G*"4,W^13FRA$P(?-B+C2[Y"7>5? +@
M.-7J;[@"$H"@[415%$2%IVGMSU/U+-Z!'@L\ _I'<EX^_KF<EX^WSLN?@<FN
M4VBF9JKIBKJ./3A/8!-$I450:^LP, :KCX,R+,MCC$,/0NJ"+4$E#62K&']U
M3S:?.0$HFY.Q"4J/*:M3$[0#05!B\N)UE"&Z'HP<.%(LC(C0WG$Z&\._1UGZ
M.SP#5(,X 9OF"#;3;%K&["!%AR>!?H-)2CE./GGX\I(+=%LGY98:_A0?(E.*
MKU[<:@WQSUEY\7,1;ZL#L3W9K^917./TJOF@BNL4 B.VG%I?3^TGTY&-RM5L
M.7>?!LM2*7XC4!HT78.\T(5G7&8/%= R308T"Z@5M;$SW<J(K^*TJ]*..<25
M=$/6QNVDQ6]"]UF43-'K!A1S':4QI3;/HIS0+_,,H:Z4QQ#E(&$"KK-<<$C/
M%%]OD<.$'#7Z4W3E90K^@A=<R\G">'&L]$%7#B6:E&05XH**A0EVD</NN7CQ
MSN2[4)<03KANF2I*;OX-#FE\B\F<;>&97>7LCVP:U18PVJHY7]/_=S\2]@NW
M4N4-G9>D@P@$P,I-K7A='<OU_F!_0<YEI8T? 6@%(RJ&W"D=&NC$"[G&\L8?
M=[ENK?]C0]J(]M\7'_1OYYGZ'9Z>6.&*UAFE2K8J89C Y__DF> YZS3OVRI&
M$*:N'.>3+!KK]6( *89S(Z^FJZ1#;  !@UJYY^*YE!L1<DPZ6+6@+?U_L9/S
MUTTAT4WBSO90-H]%']E0$X=U21/R08@K$;CZ1W?C;ZO 6]^79S%$542LRZY;
M8@$;1,HV0EV#6Z&NGPUKO0\N%5&P)A_R%J"IYVGE6;&TU\"I.C@T;]C*):AH
M';\5-.&W?B0WZY.?R\WZ9.MF_1FX^[B!NZ_$-*059O]Y>%'3XE Y?.@7IU+8
M](P_"U[ZY<D@'CI5?'5T:FM]>&I#BO(R/#6H;_9*>"KAJ6:N(A3E3 %UY5H:
M+L.:4,#?@EL55=QJ\$6X5>?R;T:N^M\O8U>%CUT-_GSLJL"G@RUV=1/FR3_7
M,T^PBD"W/R3C9+OMFS= VGFE!YP%$0R]['"_RK9SN3:S?U>_AZT6N? QI2[I
M?*K8"9P$,DG0'R9G""[%(KOP!SQB9>'!_N'1W\3.X9$8S_-=P^(D[ BJ*?+B
M FN9%%B@&$NG7J-"V5B"D_MBAJ*= Q/-A=]R+TK(L^BUGO6::"*C;3,^=>&)
ML[$J;E":56K=X!^Z(^.NKG;C-:(R56S(+Q-E>2':28(R@4M:L>UA?EQ%AL F
M'. F'&QV$^P40W+*SZAQ40%VB]<847<8J4_77TRF9J8B1V.V;DN_1"E-3B!'
MLU*C9>8R"FWB'\:+V%_68F9K/^6:F>Z)U'LBE M3L-!V+M4+KK=RPD,DVLOY
M-3Z2IG3%$1I)(5A!"K5VC_;JO%+J3ZA*]..S+T_#[M5)#0_6M'DC#<(5,/(;
MJ Y-B9?#0W@=WK-&UJ6KGSXZ0!*S& :_C1Q>G,!7XXE7[F7H$L:B9IY6YM.%
MB9U;.EYUE>L75K/G,B'JU9=BCN!1VPNF/KTMW7VYMO+4U7XY[;WML;,4G:.G
MO?;+WFEO]-%O0>A7'-(A(DSF\Z)#F&N#;K-91&A#JHNEOU)9AM],00<*+SCY
MV7V)M;Z#O*0RY%7F]26UKE;(<O5IHN!,)(VZ ED?L"\.>3^70X<U(ZX#%C95
M,N>6(F,9BJG$*<&S%QF^+5$7<"1L[23U G]H)QB14%L FB%AJ3V01GK!5*ZP
MBFP01CE7-O/65GFH<:6F])FM^JX-H<H[M*>Q-M-J635$P+!I#T.A+].5U'#5
M@/S6A.8ZR^LT"LT2P[0<%RW'HI[@_'[9%3M.Q.AIG5!/0-S[3IJ$Y:3XKHO@
M5?UQU@*HN\@IAA:J60+?ME"%4PDCZ"_3F'I2S*B@,&\1V^44U>7X%@)XM;<W
M=_?4UKB>*9GHJ)[>?U[MX1-W>ZC7!=)2FZM.'CY]]*A%/>=G[/:N53%<.K:>
MGC[BA<\Y5%CM#2TOL)EMP9Q"5P";Q#)"/P/&O).0:J^P"SG2,&(L3H"U6(*=
M:NC20NH8SV'L=A0]9;&73O?FZ>1*H2L@9YB>ES/%J5Z\QU87K,T$?U&?"YKK
MZXY+.3,P;)J@5"QA";'QA=2Y&OGN\;1VJXFO#1M*<0)Z32#!@*>5E'1<MN^F
MWQ^[#C1;P1&Q!TF:Q L3 -!-.AW$^K93"OQ3@OW@2HXP.>5-S=0*&TNLUUW.
M+7-<ONQ_V?;<:SG_?_FYG/^_;)W_/[B*>'BPEHZ(T?3VR?O>L#N@6+N-KL.2
M7#:O-F-M/B\)0-/ ;RU=,EA+EQ2^+GGOJJE5R.=J!:L55%7)C>B,U IZ'461
MUJQ5Q<"HBJ*B*K*W^//51'M$3E%<VI^ZJA@X55&L4A6=ZD!O_['TO0?UBF,-
MBIU85NSP%,WUJ/8R]#*LHLS+3V!;I9J/<+MBZ%_!Z@VL:XK!YVB*XDY-D4:[
MCYX8W%M/%%]/3PSNH2>N/6Z3GHBLS,^KJ]%%H"WCNY1)SO:%N:S:=J=-BMNU
M2>NUKMJ)09UG.#Y1"_2U;C,IJWS"UMYF#EAG5<YY7)L+<-68L'^I7[JX 8R8
M>W4>>"I?I/]6K93U]=]FUK>MS_U92LKA>F&W47?P%E1:^-]>?QM[^XK@O^:
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MSGGFY021!NI5XMTY-'7>B!V,U21%63TOQW#;$99X+:.8-G3'JU\!-+02L4)
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MGV6W/GQY=O(1*/WAF]';T^/_!U!+ P04    " #]D Y9RX%RM54)  "!+P
M&0   '1M,C0Q-C,W,V0T7V5X.3DM>&MX-BYH=&WM6GMOXCH6_[]2OX.7U52M
MQ+N=WCLM19L"G6%%H8)TJM%J=66" 4^3.&,[I>RGWW/L!$(OT\=>VJ72%!42
MQ_9Y^G?.L5/[XEYVZKL[M2\MIPF_!/]J;MOMM.JUDOV%IZ7D<>V\U_Q&!NZW
M3NLL-Q:A/B&5<J2)RP.F2)?-2%\$-,S;ACP9,,G'N7KM;X4".:=AR.0%]]E9
M3@?5H\KQX6^'HZ,_V/VG3X7[V_OCXE0'.2"_['A%]?0L5Z)1I$ICN$^_OP>J
M:J\F G]E:3%AX2A[_4=8I8K]J)1BQ:3*D4(!A  QKE(9 BHG/#PAY5Q]+QRJ
MZ+16NC)=LIV>*^@I64P'7<NG1+-[7: ^GT"3Y).I!E6<UVOM>NM^RH=<6Y+[
MMP?[QP>U4ALT#D\WQ\"KR^2Q4#-IA'(N6]TF_+O$[9%V]VMKX/;Z9'!]==7K
MNV30ZG]M-UH#XGSNMUK8[;V)^CU6FH_G22,/1PPG+1<_\C!7=Z=<$2=@X0C^
M-=&"M,,[IK20NSN#.(J$U$CBCGM W9E(QK!?GHRH9B-"%1%CHG&.BM+0.,?[
M?](PIG*>)]5RM4SVS>,]?_0C%J>UZ_J"6*UT7=^3IOD@CY3UE&HPC-24A_\#
M&UUQQX(ADU:=AV6D7ZF2?7A*D29T',XMLTN!:6B&3YED= P>D7;-$PGDS>Q"
M$J&APXPKMKL3B!$?<^P ;5FQ4J96Q0)BQM-@'AZ"C, !DAPR/6,L) Y0(<UY
M2 /ND0;TXIHXOB\\JKD(R44<CO)6GG;HY0DEGB\4&Q6 Q]T=;E1DQ/!$$-%P
M#DQ/N++D8"B(@TRVE_T:23_'TZBRRJ<C4%-&0?NK0N%S[)N5R? OY(2&_#\,
MN,#1Y!+L[>.#AI!@+,O]@\E0F%7EX( FL"8I:="(:^IG>%6DTVF@R$WFTQF5
MC/@\X&@0G],A][F>+\1&2A !EK3LK%EJQ90$<@U+00:* +2.C.G!WY"74( /
MLS$/H5E-J>^3*;UC1H<! WG#B2**:3(&=YR"/<V3A>&+6P<*ST2!E'9!B\C0
M7S0,A=8B,&T E1<]P,@,$X4QN*T_/WF*#=-7@=XMU[FZ ZK"R>I[?_^]>OCI
M=*,_+KH"^EK6O6#M3A%B GK+%A!#4Q10%GTRMC1K H8G[: R;%S:WCI-QN+I
MYY?E'[7\^9M;'H%CQGT?%B]:TQ.A2@(=&C;C @^-2Z)8JIB:OA:J5#S\SCQ[
MCX,MB. 3F!60&S O,PWB\X-HL[W^\N+TH8+)0[=W Q-]:?5;%[U^*X^(B/KE
M$'A,!-C=,=D!(Y%D 43/9$TAG,8Z!K3W(&2'%+5O=6Y#,,R!ZY-9.YK82R9"
MV-L[ZL=TZ+-52M8@DGF,1SHQUGC,/<Y";V[8F$VY-S7>@*0P#'NWH9CY;#1)
M@WE$I>;,\@+^01$,$ C& B+R3)UL';X_;;5-KMU*\346;?*3P *$;DQ16*B,
M63& %R$#A%4'=U9EO^_3 WN5.-<2M&&MC9C/M$FV"-<F]^)@3)MT21;YU(.'
M,PZK'(=:RP(TO$?;KEN1F[,V:OEI>SEJ=\?+& RASVAVD:QCSHL (.YXDH$G
MP)SFIWPEH<>Q!L)M_A5!10$SI%@.Z)I,.X:EZ5'?B_VD MC=29<IV:\D#A+$
MON:1/[<Q'+%D;&H4Y_J2#"GDJQZ N-'+?C498APJBGSN&9!)Q"!]H$+VG4'_
M@(A8^P:<P,56BF$'IM_=>8#XQ,4)!WWKFQ@QS-@AQ=13V QRQ S2('-<>2(&
M3P8M&LR, VQV^LW&GE28QT* T<*[A:?(EH346'-,485Q]RX$'T=!"-K=^0HX
M">BEL[(S"A ("L@#.L(5ZM":AWJ>C!.\C2@?I;FM@O@(GHB;&GD"6"V7K1'X
MC<B,$)D1J&/ 39.4.Z,[0'ZY8#]3M%!\).3<, +Z,?,,YTL?L"YB>%TWC"X6
M_H-*8^%\%XRMU !;M\K7+NLWSLFJKX+KN/660GI7:#2'07.R N;5CV0=BJ?E
MJ$HV!;!#@@&AF0O\ 9 FL)B# ]9%Z6W.L>RWS<'7QNWV> E\N#NRY1%J*4^N
M_GA)_TI$CXZ.R W0(1TL\08:O G"R2#FFEEA*[^5RZ]$NP&Y)9V(=*<&BPT!
M3GE<AL_[,=OF$.6&8_E#(46/YH0%E$.631(X $\F  D^FU#_'R/C*9YUE"(D
M$@@1VZVQ7)8_/!RXX,P?G9 K.F&G,.)'#"4':L+NV)M#B6;[Z^JNO<7V2G4-
MN!]CVU!(B'R+MG-(6V])!<@KX?,1L/#G4P#4^U+86@EHKB$_E(S>%H8,P!-X
MC S/69:.UW"$;+Z49$8Q)=1,>GRQG39]$HPQB6/C,48N*%B96FY[+S(]*/=5
M9H<@288T5V-JXMTB_TKBW:+TR&X>1%C!FG1^NQ?!J]>:AV]5:\:X.8^%OTIJ
MS0<'(@&DLD/< &1>G-25N.$<QGC2@+;D:"Z ?]S,6$YF-XR,O3/-9F<!QMC:
M9HB9/Z0\HS0)!Q^1')1,?=P[ F2,;4TTC"'I]5<)I%-IB':0>8L),]LD=F;<
M&M%< \-V+%'@9SXF3>FDVY<)/^>LKEW_UP!:J(XE,^!E"2>97_'?]B!RFP5[
M;O2H_HH>[R9Z_"R![Y*;MMMM#0;D!K=(>Q=K=QG-"5,*+P^W#[+GL>3GYZ"+
M<UAF#D3)F$N5/:V@0ZC=7WG)N\YYIT4:K4YG<.4TVMW/9[ERSMQ?.<UF>O]B
MLC,^TE/L6OZP<&P/UCN-%+A@>I4SGE-S^RF!.R8-**=6L=Z82QW,;9)&#QGM
MGN6J&SW9ZK<&I/FMZURV&Z31;S7;+G$ZG5[#<=N]+KFX[C;3*J';2.-0R6TN
M&5MH%B[AJ__7),M,MD$*2<?$-A\_;/2$:'ZR5B\+#'H4W!8.<X1<64'?_GL]
MYZFZRA]R?]D$&U1XEP9P_:0O;LY]-LB[R[7/UOO+"W@O&>RJ_\+%U\/%9FO@
M]AW2<*[:KM-)WK+"EZD&=DOH%Q"^*A"65"FM?;+\F;Q%2QHJW$P](:$(P66:
M(N AOHY4M#0O(6%AX$]2/,K/.X2W%RGC*3ULD]"/X6*CU?N_@^);E5&'O\JH
M;2ZC_ESD/_?PJWWYF0SZC9^\CLV#2;E<*7Z/)CG(OMVS7&[MML"SWJ#.='J>
MSQV=DEYDMO-.2(="';8U+O@<?WA,)R5\A=Z^4X^OWO\74$L#!!0    ( /V0
M#EE$!(BVG(\! %/W#  9    =&TR-#$V,S<S9#1?97@Y.2UX:W@X+FAT;>Q]
M:5,;2=;N=T7H/^3MZ.Z N#)&+%[:'D?((-QT8V!8IM^^'1-OI*I24.-2E;H6
ML.;7W[-DUJ82")!0291GV@:I*M>3)\_ZG(^_7GP]^M1L?/RUV]F'?P7^^7AQ
M>''4_?3Q-?\+W[[67W_\?++_ISB_^/.H^X\?^KX7_2+:F\-(7#@#%8IC=2O.
M_('T6OQ!2YRKP.G_\.GC_WGU2GR6GJ>" \=5__@A&FSMM-]LO]VV=_Y7?7__
M_M7W;]_?;5Q'@Q^@^_3!4QE=_^.'UW(X#%_WX7?S]W\&X1;_=.7CO\'KI,%7
M.]F?_]?;DJ'ZN_TZ#E40_B!>O8))P#1.S1P&,KARO%_$Y@<1J>_1*^DZ5_!K
MX%Q=1S]\^MGKA<,/'U^?TEO3O_?Q\Z?N]VNGYT1B[=OZVKOUCZ\_?[JSF;OZ
MFG:=/XBD.7ATD_[>?KLSC,K'>'!R?)'MXE5?#AQW],M]G="SH?-?Q6/2LU56
M'#F^UVS\"Q8:?N 98Q^E$W_RG&8Y ;/T,QOMJ\@?THCS*V\I+U)!\E#/CR)_
M0,_->#LZ7[O'^_#?1;-Q?+(AVFUQ<2+VSKK[AQ>B\^6LV\7OYKA#[]\]\P9E
M5_D_<1@Y_1$W\X@9Z#US/%OA^YL;NXXWR\F,;4Y+V#)2MI"A\/NB,PP<5[2W
M6F)K<VM'K$773BA^=NV_8__#Q\M/G8'R;/@O^OCZ\M// 7V\WA*1+Z)K)?8"
M90/3Z5P%2N%#^:9_DUXL@Y'8QK;;VZUFHS<2TH.O![YW)3IGW7.Q_^=QY^OA
M7D(M1T<G>YV+PY-C<7!YO-\2A\=[&RTAQ5=HR,5W+3\8^H'$PX^#59FQ?O:#
MP+]506&H\ RP^&]ALS&4033"#P(5^2T:ROE%YZ(+?P.17HC/G>/?1>=X7UR<
M79Y?B+V3KZ>=XS];.!UY!=.#Q0W2]L2:XXDPMJZ%)8?2<J(1=Y99O*OBPC4;
MV!:N*:P2K$:RO.+8A[TIVYI=O7J%9[?RSYY8D=]3@:!];.\4G]ZFR>[Y7@B?
M "&4=!9? 2&+[38UL%ML8"?_]+D:1FJ '6YOT@MOBB_LWC6^=[ 0^<??W/7X
M^V+C;PN$%GM*O",*WBP^^J[XJ#N"UYL->+9=?/9]_ME]9?$<M_ATM)ED"GNV
M63(6W !X84NLP8=($R'L.1S[D>@IT8\#)$$@!::#%A#1<.C2 8)F@,1\_/[6
M">$5WW;Z#GS:#_R!B."DT]&#?XNT5CR*6;+;F#W?G3?76KD[$K;HK+MW>-$Y
M.L>MF>-MN+6Y75^'$R=SN %:!\^(_^Y*X.!  W"\KF4DX/:S5=_QX,P!>R^[
MY(@)>'XD\!Z!9\SCU_JL#Y3T'+C?9&@%3@^^T!<.\ONR]IJ-VVOE"5 9;-UD
M?5Z+XRX2UYQI!(GD N]Y+5' 'H=. &U(CV]OH@/@]J7T$0]]IARDJE"PU.+!
M,R"SA(9JX)-((MWPI2)=5TL5U_)&@;@!C=G-AB&=AS4Y/_IYWGU8*<;3L4!T
MM8$QN",0/WB[0L=66I;5Q'2F0)"4+F\Q?F#Y-\J37@0M9W:<2,80G"$ V0?J
M$*$B.36Z9L+J&WE"7/F^31_=2#>6/5<U&[DAL$01@-#C#)G)25O]'4MKA(.[
MO7: 3\I 46<HR%O?//_65?85TC"^BN*UHW@T0+,T/I2*^K[K^K?A+S57>ZYQ
MMXN7W$/_/@"J&<:@:84J9-*$>S$1?'F[>5OQIF.F1(PK_X6^"D-1O.%6D19F
MR8SX;YS"W*>5:JNVC5?.!72741YH#T-A7<M 6K#1(8A%MF.1QH,CB^'F&AE1
M2:LY:$\56AI*B4%]EP-0<WX1N<'W@"FJ(!&\/[LQJ$\P^=!W'?L#\#S7#WX1
M/?@89AU_LOV8.%<,ZQ&X)'=%>L!Z:^9P^3WC;LR)X2R"GK[*X!L2U!V:J28N
MON>&(W,)=K\[<'R 9,9%[R@"<5VS$;QC@"L!M7T7G=7>]F7G+>=1X%C?E/?L
M[$7S#Z CF-CYQ=GA[]U/83(89AWZXQ?!/Y9)8M[:X-$_29*YN).?K#F>Y<8H
ME8MSY"NQ"[</R;[&H;;?$KTX NHRSRFT%[!$G;R2>6$=+0A&1&8#']"9#QJD
MJR*6C\QA$'@66- '3F:SO$^W,'W30K*GWBP9DB"=B/;F0#"++9E6EHN.<V"R
M:(>^2 R0!;.UMD^_#),BC1T=Q@>.<NU?Q*F\4A^@D;]CY5GX,GMQR5&]?_BO
MO"N5K8KM+30K%DR(;_"S,>D&M*94O('9G9:U]P KY?2']P>:\\?7,(>2Z0QA
MUJ]Z@9+?7O44T!A,7+JW<A3F[:=ORB<Z/A%M0DV]S+F.,\O]&M?;.,J?3D7M
M-TA*U;58+.6LMC>>PH'Y[V8CX:C([B:SY#'V21PR4&%$0H'F?$"B Q07TT99
M(IP]7UI-BEK,9'9F0DBG("M>!7)X'0)SCJX#/[ZZ%MOC9@H17J-9%4WU/254
MOZ^LR+E1(O8BQ]7W>+\@169L;-!4*",G)/\;W:CHYT/;71](<M02OJ>M8NP$
M3M_D?LD>TG>"$+N'VSYMK*>PJT#U51 HNOVU!5<+M27N=]$UPV\V]F$8V;MX
M?L:4BI'Z<FI!:W+]:?1.8N%52M!$6&2GO4D\PUEG!?)+HFYT* CED*RZYJP+
M"40:HR2!EMJ2\Z(HK I]T![0*/35AX>:#2)OBIUHH7=ZS8&F;@,GBH"HU8UC
MHYRDJ1MT.#\8F? 0'O0:'Q+T?K.T#;*LB )0^P9.B+%;Z!@#Z=B* M]S+'@0
M3B<,3HH0=AK%9_Q71G& )F80%L8&OLZN.YIS.EARR"53NF?NRVUS6=&#TWON
M@X/&!;8X,.F!X!W 8I$](GW^7%D@:F!DD[X^3 ,F$@0^R\:W)*Q;(.>FXXF\
M'@8$4LT0O@KA!QGZGNQASY,.4HO.,(]HQ YF_'[M^SH] V<K'O3@+([HT,HX
MNO8#6$U;#%40XK54&*T^&V3 S_,!'.':2"]^\GJF1=17K2C')G)-&_^6A_/&
M:Q)XT(2 L40!;]%3/NC:KC-P(NV2HC?U,E&WWD@<^Y%C$1O@_O#E9@/9$H^8
MC80TKR!6Z#=#PY!>>0M>P;8L?^BP;P-:]]V8;VX;PX.D[0\CCL_*3NKG(,3K
M-@2MVY-7I%A_]FUX?#@,_)L)RT@^6^1UTN(>T$FK8#Q$*"SHMH@6$A\;TVH/
M=U3T8_@19%V+!\\RC&!?\&020TIQ\K1"#+)T-GO7P!"!&O9]H!]%CL;3P*<%
MC^%G$KN-NUO:+.)(%W<897"]38&Z GE>NS*35[ EQ\+NH45+V<#!0]SQ&Q#F
MJ<D!KJ2V["8*0$]%MR@OC=UI-.?#].V.?>.$>.HHM@W8&NY&JDC0:6?A3WGB
M(<%6H8,W6BZ2"V\^%OU"C!Q\&(6E%U,2/) =!XZ"^[9T7"/T910=LOWP\4)Z
M*VS>%#LE<AL% WP-W4W:KW1BLC UX"CYN27<;^"#A(M<%7I^\'CN&DL(?<(:
MP:KT7+5>W]#5F]::-=<;6@H/AG*@,$+!%6<*#CM\?8"J_\&9N'S5;E%X0R+K
MMIA_)S(?,' \X)-N*0[#($L"TG88]X#ZRF19.KK8P6K3X*QF\+Q:XYK]2!J\
ME_H\$0]!Z,.X;Z5:2?"WM$B32!@[4QY*='C+T%<8-N,BY?S8?K_=>KNSL[&S
MLWHKOZI,3<V5J1$SL8VPI;6!Y$8T)B!^WP](X"4]/M?6WS$(06P-)0\#TAK=
MU*-F@T1F;4+"$*U7(S\.7EDH'PU0=&"_*_;+7BSI1<XKD  #$.[#08M_'_B>
M&@E74IP%R0/((4$P=R7<V+&K0FV6O8I=F<:D!8H$VV9CZ,.]C>)/>H,;9<:P
M7QK#[ _%<Y#(G(YR^_TNMSZS9BO@/]OZ($Z&1"&_8&?GK!)^$/^2;HQ?KXY[
M+;,(9OH?Q,5H"+/L!++G6!_$,2@ O$3'/DY\*^<*,V_A-R_!6;?]ON!:*1S8
MR3FJ2WJS]->?&,W ?^<TX\R],)2.K>U*VIS$&JFY;5#AC:-7?O_5T+>^*9)K
MF&^K[T/E8:PG6I'(*:&-']J$.VZE:3:R9IK)';KJ"D2AI"/;"7MQ$.JX91"A
M4)8*E9NS=*V+O/D(S238[>R=>_=1X'(*2UO/-:G=F?CS<ID6:W(=J:G?=TRB
M@[2!SE@JNH'UL9V(LTB51X8Q8*PN?F3$\2,?Y'!CS$*R8JN:0YYEJ5T#)N4"
M+:78N-^#A==R#.5<D-R3AMD71B(CLL4Z$?D8/(SNZ>/Y,19*DO'2-MF@ZO ;
MJ5,2]-3 <D(RK8PPN,?O]TEA[?<QTJ>\+;9VK?76<0"!&@8J3.3(6QD$F"I
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MC#V>@9E2. IAR5K&3DGN23[K"2H,,"LCL\%3Y!RG*'@TH&LVD+$*NO(V$P5
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M:LFTAYXQ7T4^:+Z1"@:.I\29C"KG[WNS"O%4[Q9=J?30==65Q!VOVO:N0I&
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M:#VFTK=(A2G!V\H%WHV0/L,X"&-*]_>S0#-;&YM;.K]:L(WT1;+(>T.*WKS
MD*+W=4C1DZCVF6*/%LP<][*ND2)[O!-P)L.&=A'62"V$#2WSK9A-9[HW_T@_
M?)95<,PVQK"-GK0=C*%G1/J/K^-D%U'NR3SY8_8[BH(EZ)@$_,65M_W8%99!
MD(<;B5J7&PMP-M1>A!GJ_!DBV#\Y:S;.Z+C']Z$@HF9XX'P'*81D(0H%@_-O
M2$[70 @92@^>/<3K#4M#,\XBZX-7<*68 KR2B^0>N#YAOFN(/T(UP@Z&A+CG
MQ8,\;)$$20BO"),Z!T_ ER.\/>B], ?5Z!?')WK2^Z8"$Z"!$$1J&*%@%L(8
MN%9 SX\C6+]?-C>%W!ALB+4+/X"%]5OBQ(LD3(;0EF"HM_YDN3!$71NU$QZV
MA=@LGH8E-.IP88E@  17"*R5"]=%:44SW"J!M[+9I36]S+83@BH_8GW&B>+(
M5".&?:#JB9]A?3$.[DI@&YMMZ-56WU,X<#8O8M-4 \%*0&1 +9()+'+HQP&(
M#;HWG&RRL [. I=5]!RS!WT*C2E;^5 O?7;E40X&R9D*&-HJ5>&BI&9Y/_ '
M&N_1K#[1F< ZA4@@SHUT%0O&94M+TW7*EYWK#VATK&8#25T V?683 >P\]=P
M'"9VAX,L/BXL%U$D)PYG'<']DB(?LA>:&ENPHQJG4[EP[H#L,$01=B)%G<8%
M;J7'Q.SUG>7>BT!;PT#ASN(VZD",82 MU#Q:#+_MC=87P>>KHTNLU!13,>]:
M F\)4#Q@!-.P!%H.[@R7S87NJ)6SKB1<LX,9>"[;^PX]2ULDJ6X*L/'/HU<4
ME$L54%U7<Q@_N +Q\;_T&)XS(-DK K<B%=>,IP@3Q[$8*)Z0?@V, O0;6"@*
MV -&3PR5"Z!0-[<.:N&^K0L7%-G&B]2+5VJ**2UCDGNS<3@6E%Z&EIA$B-O$
M/2<'M&O#>2% #5^.A*LD</#WN="T9B,7FU;3U[)/<0)]Y9..QXV'=Z8HHYBL
MD9>*!%<3S+)/<9Q@L@DQXY0RB1+HNLQ]F:>BPDV(-;09^SQ0<,\I1>_#I2RY
M>@G5Q;+A?H5GH55GT!*8I. 8PW0J(%Y++=X29JOR5-])T%KY"6R9+F60X)&;
MZH+JI. @DCZH:GV0&.#"#=EU.4+'J)9XLS9K;$1[-T<)BCJTN*8RDT%9/%0:
M$<5F?^9:/_, UB-SHH@KRV"M;U!-8!(L!5RC(M@;<<[N76"S^/UIX)-^&]/J
MO]9K<.C=P,!)4SOU095$1RP.X@P^#;A(77UNEWZ*8^?VV26)>R,7=F>:8/-F
MLS3#IB2^/A-Q5-];JSK%2?0_(TFG)IG5FV()R4PEZ]PM[$PE[<@2::?9('%'
M3)!V>O.6=IH-(^Z(ATD[UGW2CCV-M$,F%"WNW NM_T1IYR50]R.#"MZ^P*""
M]F8=5? $LGUA#LUYY_-E')KF7BJ3Y<<\G+.4Y;?OL@I.)5&77(EYX:FJWIB:
MFI^)FHN2>?Q(R;RFKNI2US,&?Z34E1?BBV0UF6QR+*L6XZLOQE?WF-='^[&J
MN#\ NL)]SQ4)3$/:I2G^A\>#CB*>B"S>#3V&P2-,,9;OV4Z"K9LO(-C"QP?R
MF]*![?KEA&23T/;:V+/L4RRAL&:C0_E<4]1,SA!:)@\LC1SVAT,_=#A^27B2
MBQ=R@6*,)/,YL!B3;F(0:-JY-!S.H*#2AB&_HYOG[ L!?-6[*HO^N"-_XEVF
MD.K[C<TWNDS02TZG6*DIEE+SJ0K08"*ORBILWD/1P^3=QU)UL]$NRRX#(8D9
M=XCO:Y+604^3")@HELL&KR>' KM,(K8RPTVD)"VM-!OIFHA.DK!)D5O]5(2J
MS\"R3S%S!KR^@[TX&(CW%2.RX:?'I'P X;U?4.99O?N/W_TH\&'C._V^XSJ%
M9!\JIP",,83=92$2E39*"R<;EO[*=@(@ 9=R(V',^K>6\&^17C"(E#JA$&/4
M;WS7IL\Y_!AE18JTOO'1\&:R HK0;WX<88XN8;;"DTR(26Z\8:T\(M84Q\99
MUO3MM1]BL/N=K:/.5CY)G".J>&:*^+-1X=+IB61VO5%^G/ L2!>8\3"Z>S6S
MBYCM#EJD5CB'% /VH0G]-8V@E8WLYRXVQ &\ =?'$ /3J=8L2?8V*,X8,H[B
M?\LD&^BVQM-CDYFI[Y@C@ &YN9UVO+[+G@",[&4.(CVX=%C_" AUUW+T /#=
MP1"6H95-3LJT5Y*ZE*Z"^9+!!*[E#299!('"++:;A'/5U];23S'#N *4QWPZ
MLLT&F9O&%9+BU875RBFAQ.1B4 X'7&/F#GN[T6[7M]:2;?Z%\OP@N^UEZ6J=
M)'V)'L_X?=(<L990#O%)3.[!AS(XX9R><'4=K5->F)?8!YN-H1P13QMR"I%Q
M$ V'@?_=&<"5PZ 2+,2[RKN"T:W93H@B=T"-)[ K-HCXTL8%Q193^;TP^IJ1
M+?L4,[1,< ZD@,+=_$C!>UL7"W_)-HI[HS/>O<3HC'8=G5%C/MS/A8 %.7"5
M'4@+U,!H5(:Z%([@ON7R&W #&AG<C7OF08L:801\N"#[NJW$-9?1.-!O@"P-
M'ZS%\J6?8DI'T*&/B=XE#BB"A8._ P7W&-E 49>[". 5L<?*7RUZ+\<&CYJ-
MQ U8!IXE([C?@DB"G/)5AFAS20@CZS^TB9EPZ-4QR$&4.+^]V1);F^VM%GIR
M&+<P?3N?@\Q($:8G-G$XJ>^;+0I4572R&;V%BD)DRGX\*(NXV< ?:NZU[%-,
MB'L?E"P@[7-G,,1:%2<'9R6^((-I8B/>&S[32L,Q+!^HSV-_>0).2M ,:QRT
M@K2G02[A1G5]_UL/Q,=UH$<J0!DB"BA!.S0;.>"&">$?D_L+"3."R3A0C#AB
MIW 09_#U#?J.OI!>BR0O73A7-M_6!C^"U&MSU=/JB,SBF(7!-S+"0:+,NKK2
M>*&"M2[QD8W/L94%7VO.0?#'J/2FLVLV-"Z'M'%4811(QB00?25#BG,S0@8U
M2&S"RW2 ZYZL+O3 O"+M !?8B1!Q18(21HHV*.@@T."7]0E?]BE./.''AYW[
MCOA32G<A 5X[5]<IRA&&U.FUIMXG,P]ME,]RCUO'=:=C'V(VW(/BT9[$/B8P
M#YAYEGL468;A%U1N]Z',0LR25Z"(\2!F\11R$5G@*\+"RI!+S866?8H9+N01
M:?T>^)X*<KER]P+OX<>_P\&R?<(GWE<>YB'4BE/E]USU\E&9.L0YYU[7#(U3
M4)!/(_J<'9-_ IE+BQWP&(V3B;S..[^9H;*&9",&F2)7,DQ3>:%YGDTUP%[)
M47YW>PI9,:(5(_?O^9X-\[55#Q8L#G#NP!_1IJ/5)1$ZL%02%3%@O=GXZ/%N
M-+R9[@=H?BCY?K'Q%&B08XJ,QE!M1D6#JV$("A_-*53!#7P,[2.8/% )\'J\
M&>&NBQ$_"IHC[BP#)V27-(<2H--%!B 'P',87IX%OD<6;-XKN3<MU$2!N$8)
M2EK(8!KW+*+DBG9*Z>AU&3#$7GAMZ@!8<NC +4H(Y24=?U' *@C^K4-@>5AN
MB.>),SME+']7:0 -' UB^_7@.4]7)*#M"3FN03$NAA1'#MQ]A-4U0N^HBL9"
M*6ZOE<;LXL!VAK#+-.T@9E\8#UC9^!++ "0#Q>22#\KHCRU36OQ,KQ/',22-
MX'2NQA<72"50SJ!'NX=;2K41*$K>N/V@75=%D:XRG)HFN0,,^/># 2XO;P,L
M2910-]) GI@SG<.(KN_=[OQ _A/;5^8@./>O0?[ER2"5-$Z>3Z X42)0R8E)
M8KVQU__<-V*J7I'I]0!.B(?(CX)"A(#4];JL?2O9#I/8H)-',D4KSM006E5,
MI46*S/1?2S?+/L7,3=>7L5N6@H!,)LDHH$L))6K-$>$+#5J*#XKNC4Y3T,WA
MXT8+TOK+E4..=GC&TTCY 4A,0V;H9*.CFS "28NJK;3@L%!946: V* $S0 ^
M[Z&*H\JZK>ERV:>8H4O7\=#]&6&!$>_;8USM;S?:FX485U[#E["2CW2[OW^)
M;O>MVNU>;;)=J2EF>%Q(Q8W0='>D.)[YI-^'R['$S.EX#I<\8J^:3\_E,@,U
M K=QTY&\YI2E8W&ZR@>3: L4W"=LX4SL<=I\DI'2$HPOK5T"'+W;4R8X */T
MI..A<X]^S90B*X#/D_IY8B+T,I_7U_>R3S$E;33EH@H-I$V%=DMB5- 8;+*S
M=1)[)D>=E2^/51>?-%JM-U(B ,J6CO83ZWQ82H! !2R(AY$UPB,#U\T-VN):
MS8;K_!T[MC3";%YC' :^!4HPA>NO.=!QT@$<(%O+M#TU\G5J>J92P16H6TI'
MDZ9'1(;:0C+02.XZ,I4\A6R*IO&"?N@J1N!>-WGT2:F_5A*VVA*V0X:=U-.-
M5FRN1>APP0&0;SP:O:.3U[5_P,YF# .]I?)1>V-SAYU\>WM[3P$H_+\9?$*.
M*,)L YCI^<]R,/QP2NF9]V$F[DFY-4O41&BO/6E<7WW?'ADMG1,[G)O,KJ>Q
M!!:")' T03'+?SQ_OV/?P#N!*?& '+7W2O*'%!ZL#XB=G(XD>2>)T?)\[Y4V
M>*2)%#5G7/8IIIR1:FIP$D2Y+T$R*QR@==1)RK/43H/EV-DP[S=(SC4\\./X
M)6CKVCNPSQ/<1Y/*M-;T4'UZ&%!)RF8C6UZH7!#"5)*U#-:8%.<RB@.;:UB>
MQQ[\M)X6IT3'4EKOAX0>3GSTA\HKAO R8'  7:$/))O  E3WV0\CE!N^PC4'
MBD0,HEK$MFJ<\I]^ '*_^2GG\4X^/(]\4.Z[WQF\@6Y/&$1]8RW[%$OH>$Y*
MZIV8(8FV^AA-U?4YRLTI*WD]C1K+)8MK#75EIIA0]<\J#OP/H&Z4N#YR(652
M]-W8BF))O),BKH#84L"Q\FIWD^KEY7@H-9:6_[H_C!0#F2@ BJ6$M/J72"-6
M@99U8B2IFB!5DC$3\4D<[C8M+->%^9\<<V$Y*F*'7W=A8<3YM1]$KRXPX_:,
M AQ,@)8*4E4(GQPJA,94Z'9T^82; G>Z/AV[234,G/R&0HQ.,8<>,U%?K!'3
M(<9U6:?XBEQ:9KMM*ONUQ '<9]_Z<1 EOB/2VW/SS5;)PRIL5K8P'H+'44 "
M!\&EY?%RH>39X#B:\>7927%M=!$\7/@DD#>[D8ME&C6#>"2#Z'8[S4;J63_4
M#D\GG_:91]K0D0M.^BP#0R06@KZ#90@SH9\.1W- 9^(KIU3L89A(,.(30['4
M!<"W,!XBY8;ZQ* ?%-X^4Z'O<I>=.+HFJ,046@-]^M%HO.>)'5.@""+BD@>.
MN\E."ZYQ*W!ZW([EREB#1!K@.8*G<#@,BG$S:!S]9#VSC4TSK&8C,RZLF>G8
M#D;V3#4TWB$<1Z]LB,24\PN-#FZT*Y'XD%EQ&(9AQ+PXM4BP[%/,G_@\U95K
M:UHU'_"C8:*:Y^Y$$#:1^ \MY0)YM3!XR[K&L+Y(.1Z'YQS[P:U\OCRZFH*>
MA8+*.'$Y';%44HA]%]*\)+0@I44HE+%@0LJ %=W]<A*S6L+A,T@9).:"U'*E
M0.+28!@,UQ$ZO7Q&<)#.*]-TZ0U9EYV8&&&QO?D2(RRVZPB+:I/M2DTQY<?]
M/A=$;C;V"W!Y*3::S=6XLVC).L8P%,HT4*:-9URIVQN;9+;BU7W!N"XK-<64
MCI*:[LW&J2LC],Z67>F9XN\B',%=/4AN3[AD@8Q887$\BF?780[F+DZ32%QG
MX$22E:>DP/8Z@P.2F>80S2U'#EK]3[Q7^VJ TN0??O M'$I+A3]3:L4'':DS
M8"<"_H,Y 0AAKS/V2, HL>NP_8F1LQ*L25,3I2;K99]BAJRY[@@#"6MGTJD$
M>;,,4@93A[3GR4AZ)$"FY4LP;<KD$VCC@S90F"?V=,5Y)0XIF*?%B)J9,CV1
M#@CJBZVWFVB!I7 QC 3GU)VQD!91&M'2:5,\.265%")13@M?Y8-!F@U,R8&E
M]^%<&.=!;@K:09O6MRTBV"4E+P)%3CG,R;WR*%>H%_C?0&RSE731VY_Q3V0"
MYIJ-I+-CF4G:(/C^I)01O$,&3MR6^DPN^Q1+SZ0Y*]ESY:B[2GL6GJ3C2F%S
MQ-OO.8F]'-U3DM$=A&_-GO!%D>YU1GDYX4^:='T89C[%!=$]4V:IH)7&@F*6
M6A;_V08"MAR7B(M)5=\N9+,UL95BZ$HKGTS*CX\QW^<FI]6BG JP4?;)W 66
M5WB$N6:V=%48#XQ]5YKJ"YC&Z;LW!AB/XG%T+09=U63HQB&7LT]?RF*7I\0H
M<\4;"%<C%PZ4[RI<UXFDQ :+@_=-WC0L@"<9D,?67NO2%VYEF)9#3)S8/[8W
M-UN;^K_$:YW/.^4%NC>R=ZT-(EXQM-?33FJV++H<$%*P99(:XFDKJ$:_'U=(
MR*^=]][@\VDDN$!\%@,X9D+"<S'?QGV,F66,+T;[CQR%'+\831TQH@NJ4#H^
MESA*+MG8Q)WP]NBI$?C*&!VFBMV]ZZ>7?XN]]]K'&% \0EX0C@N"< RO:K+5
M2YQWN2=KC$Y*F,OX$A,Z"TG?3(CZ@'5>)8 P"+&6$:[- ]NY!W(B=I$2ZOMZ
MV:=8QG6UL#C.;G68;(N!OEU0PE#<S$B7O\FAA M9B3\5]'U^"U<]A7M8\ YZ
MS-05(A-J.!9\ ,Y#>$T?2 [F+T"VU 2V[%,L(;#I=:*,.I1@'Q2$QI:XQPIG
M)3(IHDYDF?X'2JG)8N;I#;G\A+U1+.-$]8RC#_%*28#"$F@/D\,C=9&1;(D1
MC#U(BW5J4(Q>[L,T0LVA(!2NIF#*>7C^31)R)5E^21*+$O"9#!:'&0Q!=156
M [I/EJ,^:LL^Q9*CEN+&/<X(D1@@6)!!%+S4UMR/X03T)5H2"!]68[_T6YF(
MW69C<>D/-:$](Z&==V=CYAH):"K56J:S&3<;GS]_?C71;/Q9RNT[#,<UM,1]
M@0_MEQCXL+/4@0]S)5W]F:OZ2*55K/+P^!&6,+="?GM)]@QCJZ>8@G(\)UZ.
M>=1..#^^I9,*6$Q#2;#PX)@!(E,'/3"X7RS@D2F>U/VMW9\2LU'J!QAKQUXO
M"(AI^K^@['_"N6LV,MZ%5HKWASGUZ*^>Z&DK?GZLA7+TO?V% P]NE/UO!I]+
M@H0)@]"&E40H6[P4,MX(=&W8:JAHTS#T([!?X9*-C&<\,,AMV)T.N];XLX@G
M1R!V1KPN=X(X81:8T)*@H*[1DYYO;"2GA[^#Z#S$N6A"6$^,+?V .$5$Q:A@
M[G_',#P58&+56@)/@-8J*4*=-V53<+6;NE#)Z(<-IG44N5ZX1[*6A^$((2$K
M4E95T6HH<D;#.W;_/YE5IP"#$>>I4%URN',9P1%M:FO9*KA4$%!B8HW;;-"Z
M$^#ENEEOV$"L.Z@A%/3!8 W%=23%)CH,94D![G_'.&>S*^'XP$]2((FTI9QI
MS$!-I& *WPIVX&33M54-JV.R%X+Z*AY7I%N0;BVT>$0(")D"7E ??9T/E!B"
MN49"FEO$DP_Y:38J%BURL'(HWTB-A1DX\!=(0DR6A/W'2X;$SHG&M+BD*L:(
M?8&9H18EZYF4@_*YZ'P / )NAM-@>DP4<96^GN(\4XT'J@VQA415PN6( PJC
M2LI(9E(DT%@[B)$L0#?( E[H'(9$+TZLD7!6B2B)@V [?F X*Y9D-I4R8>IG
MZBIV>3[[&2-M1I+L6-&ZCO%'R#EM"M  W*&FQ(F$1;;^,@-KSB!,9^&. S58
M+P(\IA1H7B>5/3$ADTV# 3]S-G K4R\8UTX& 2;I#ICMP3H2U![0D&+K0\+G
MF@VRVP;JQE&WA+&&4\YWJN5KK]PK<"?7@$:4OBM<U[]ME2TTIRW?>\@T2J>'
MN6YV;!FCAN8@8_Z5\B8T3RBVT&R8=#_\-@5CT8_W"?+4L'G?,UBV=PU5I^ -
M_3 :^IXRO(TTX7'VW2+33A*D: !BF"VDT/?FNB\]N/J9E'4%-/#L]939O-)Q
MTRA*ESA9V%:"T!@P@+$5_W_VWK6Y;23)&O[."/X'Q,;LAA@OK)5DN[O=O=$1
MLBSW:*?;[9#LG9U/;X D*&$, ER D*SY]4^=S*P;+A0ERQ(E8B.VQR)!H%"5
ME967DR>)VC%T1[S.LX3!AJK)-4#=G Z6?;53LJ!SU21F&9]Y6L2C5!]Q1F&6
M%TI;,B6E4;0X=A/27="X8SIN+^UHN/>O&<Z-IV. =U56HBX?S"K"X>=%K:V[
MULZ.GK<CR7E>0VZ"$T(_Z\XW+7UOV/TM0*U5NFG";GV#Y-?EB#)5$3$OTZE!
M$46D*KF@V^DJ#R9F?:#9E!?U%6E=4-(2>;N6^&:5IE;$T6D[M.*PBQCI&&?"
M&CI:K>Z"F[7=[D;[&T_7(_KH!JW;DO/-JW1^WO4)FFID;$)"D,P\K2.@VI[/
M%3)Q0<Z .$AW<TV4Q,T,"6XG#FHXT$"HYDU\U!,SA7\WJXLT_).RNFY</(W.
M] QX3=YE&+IMED0M!CNO(.WR4BG]UG^ K>^MWIIZP/T)*07CA[:!P$H? ::<
MS@X(6'TGW@S0J$,:9%%:?@=ZNI8@IDME1^QUW"/;NYW2:.U^@8;2V.-WQ32M
M :?97PVG(5VQ$DX#J,KWA-*TO".U/I(^1ZT6SLM1C<Y1C&EP2Q30DO;IKMG4
M?)1D6YM JG5Q/).[XGB$^PFS/U.2T ;8&3T48F>#U4U-(=Z8ESCX)?B3HG#E
MSQBS3+U)5NR_WOQLQ3KSKAYVEP3&ZXU(8-Q*6.Z<ZGA @7[4P[OK7-;G76N9
M9&<J7D<8;$#L^.B=+CG_\$@6U%,UC"28V&8 J6WT0IVR,W5H&(.%]((R:<KX
M5K;/K=#O&SR!3W.)&]NCG1VB>9V'"5]%#FJH')0W _!.K$8:I'EV_@)9&23B
MQNV61ULI'4740$L,7]4G*(4%US U )30;U-'23@&!\ 6AG?-0BUZ@7L @;O'
MBK*5>I_4#_>M6[-N\YL@.!N],(\J.MY@.GCB6NR!%1("_CQ'*-0I V50"\.5
MAMC?<Z'*D9 B"AK7L/-)L$W]Z)280%^].G3&8#$.B/K&RDU#Y$;I.R$3!>5?
MI'ZVT_9C^[19$<?V6=RW7MX=Q2],]NZ0V2""5EW'16FT%67R)9.JFQ I;6@>
M.W* O6. C>.Y"=6U#UFY Q@3)?35%>*?"NL.74^S2;M)Y\ U.KFDDA^) '([
MO)GI2ZH_1K8]T@&YENB;@P;1<\1XS#2."O&5AX/#*7>N.TJC9,Y13B^\QL'T
M"\#P->_!.,[B66)>AZ^0SB/$%UD2Q692(-^-E#^BC8@*,)&B3I@C\J&SX@Z(
MP'F3Z^"=S4R:8*G.(C0:1:QJPA<*+W>@?.LT]"0]%0I<PZ?LM).@)$P92ZG7
ME!=WF922DW&;\/F@$::XM2%+/?+AH![HU6.E/7(1I\VN!!WMHS\6.3VL(B'Z
MSV;O@H_*(9W@#4G&3AVIVQ"U^M@J]):G;W:!!5!3&;0QS;8V+W<J#9'3-K]C
MN="IXV/TXWYAOSQ;*#=[:MMP![H)MZ%2)1)):Z;]*RZ4K.D!.H\Q7,B>PL+E
M&R("FWBRWE(L_,53WC2MWDV2H2F$G:PQ(1,L^;#V_D*.A(+#&MB$2M-JYE(T
M#T9YX?F5436&5-*0' N^D^HWU)2:"5P!*W#KC2/L>B5DV>T[7:T<;N"/=IZ7
M@#-.&#IG'[OJ+7KAOB_A/CTY.VRATZ:9GR_2_%H9%:?Q,BDX6W^242-/<WX?
M\MF\_^;'5P2&);P#G ;9"DIP)DJ+Y4RY61'MR0;/RU-;N>'@MR*O%BVZJ YQ
M=0V.T#<_<%3A%&%N5 8T,]13F5)J(Y[C$518)C5DVJ[%KX8#,LK):]"!*7@7
MM:[6268*T*:Z%![I[CS33V+5H8:6G_,OC1UDAPW+<$DL[5.VNX%]@;L<LZCJ
M[M/:1WVU_TH;L2<95:VF2I@OXZP"F<KT:0FC%_%>E1QYV>=!. _RPY;D0;8R
M_U&@4#Q7OM%'!@*NZ#8,_CU4THI_!UL&,=5FZV'B@WQXI? $#Q\]^\.!3#^,
MA*I E'(&G[1&(U!O_[S9Z_%<+8;FHIU5XR(7!,4IX4_[5=N,$=I5^ZP\GB1]
M<9*AF=-Y4@HL3_=>:L_\VE\%;3]JNED4\?V#V=H.E<$^273ZJF;(4X"KS+,1
MV?MJ\9EOER$H2S5%9&VJ_^TEX-XDX/3D[9^GW,ZJQ5?C!LTU^DNXS6RDCV/&
MS)M@["1*448D/6^\]CO4\ZCB<"GZY/1K>%]KB 9-IH'V<&#ZDW7")N]M/6W;
M[A/]BWYIUS0R,>GM'5\I\$O>I\FN4Z6+@T)6:[1&NY$MPMDTIO>2JD;4M+QC
M@.=*&QX$.\H=0R<?S^+X07C< \-UO4WF>V-.O^*8#CZ:$&U3P>SOO?SW+9NE
MN^ELZ8\Z'!Q.ENUFEI.1-=U434CT92TDJC.HA3+ 6)47ILK"*(>SXR.GI(QN
M0#5B"54[%ZSU%T4LVIYB-.Z/P\!!>LNE$56U<K%8+-S<0&,X-#_FV4(KJ#36
M#(6 :8H1&-MN.!#CSAI^+:'>-+H*Y2TIHV!>DN> JQ*=4XI^3>'AO+AV?H*_
M;.$>I;J&@WJN*VJY5RWHO.*N_2EXLTIYKQR)JHA7>89&-U.U@^\.[NV,1WU<
M93V5\_[PTU%;.D:F4^GN5S_NJYDO\NK\ G^LCF]K?A*R.DQ;%+15,7Z=:"<N
M'M7;!C"+A$AI@=OAPA*N*[T$Y(6*T0K#!$+\(U*2H;XE*A*0."(X1Z01\X7Z
M&.'\D=G_NADJ*INK947$XXXNE![!W'30:C&A%Y>:%Y,]YR3F>K^G',(WO XJ
M:>W[].KCO@1?+2,<S[*[\SI#'; ?=)(]J!:F36UNO)Q9/"7>#M1$EB[HA]=^
MDF<HB(^G_=K=W]IAPH<#6D!'T9S6^C?9%6Q!T7Q+Y=V%6GA@$)S.S4XI7@UV
MX;O+%/$X??OA'V$P9I"613M8!/0:PC4<< FM[@QM>AX(L8&<F/0LF0GKT8"L
M!6!_[@]X%8_+9!DW0VH<<R/B"7<<PX'M>44ONR,US!K7H89R'F=<_-^(_/&(
MA(*<_W"W8)#,E;&5<#MG.B*H8M!,TB@4*J &C@D[U-!+F0WNW9R67IXL;]0F
M1!;F9/$J%'S4;VZ&W_H4[Q7 )."_P1I%@.8%T;Y:X/PX&6<W#QTUE;DK%X[D
M"[F!>B\#]5JC+'7E?O@E</:.>H7J5PWG=G8$CQJ]S==X=SOEAB\"0V]'GID;
M\VO"8%]4Q2(O=?C#;=GVY&L4;TS%O^I3\9R*_W%+4O$/7)+X7"T*W: 6G668
M<B[X70CDFD0#(5IA0*/BB&1C(HN7#H$4/M'\<]>V3)TAVPB5H54O7%I&#\61
M4G%M0S!,@:0$Y7>&9(W(.?C'$T#3'96?9T(*HJ;NQ9R3;,K:X.+V.O3[-SZI
M4X#K0&B(P,\ALU3AU/K(!8%IO"D@[V<I;BWE54S[:#@0 9==F%H.=F)+]]NV
MC] \O)AVW2.GHC_E87)"@<IGY$-;PN?\MJT.@C[N+I-07RN'=GE.V-T\3=7?
M3&KP(DTR4'RC-1TZZF&ROMIB#AJ+Y9 B7ARJ2/0((&9),2<?FOKEC*^]!CO.
M$%J*,]ROKY1-^()#DW"WY7WYQLYPRJMHP?_ENK49[ XU2GR:%SS:PKLQQT7+
M9)[0-Y:%BF_.7[LU'VSF:2M-N0C5TE3)Z*H13<D/TM12,W) AC.087H]SC9X
M,SRI[?H5@K$RA7KVYWM.F.N6J(VF)?RM6YV+,CCCZ)F[]S&>=4+$Y$NTK(,F
M8]3):N6PZ6Y5>[M[?1IJ'7'7QP(*']K+SO&-H?O*B_.(B<LL#T\:70FN^Y]*
M&Y731*K@W-+T:-G.NX5[JJ4C K_A@+1?]#707MUN\![4B'4?CZC$$M;+C:KW
MD*TD^L-0&.GL&/%0)YQ#.\K3:CY.(N-LH@Q>>YNFI6UL@.#>V_7[]KX$$#$A
M+RGAA&+=^,<I\WJS.*KEP\C_D1=?6E*$4C_)8J=#4N6-T91^3>]S3=>*M=-6
M-90CB/RXO/'2 \F4*--]3=ST N$)Q(H$=M@OWQI'J0._NZ&NA[+QV%=D$5F3
MQ808#>!+^:I)/OVY/VT[UGXG&KF]8-;_KX@]<JY+#@O4UR+QS-$P.)QB).J2
M3P!/TQ?P6N1&T;BDP!AX89H7XHISJG\JI.*8>Y5RQ-4K.::X>K18I,F$,IMO
MU6TO$'H(:JW/_)B]O8R)0S]GD1Z&_>HT)BXB)B&U 7Q'<$6!Z YI]&9M8W'N
M).^+?VZTJ#P!81[?69A9G&Z29A>0''8IF[ AK5]'04U8KT>!I6Q7 B+(5DGF
MO%47 CYIJ#[DN7O[YIB:%."+GB:E$B/#V(TZ8W8XQFR( !XTE:R1,/W3)^-K
M?E\#R/PCS^)K0<&7AD_$@B787F;\N[:4HR\Q)PA9ROU. F0.1\3;%(\"(D%9
MJ,WW-9ES,FI__^>]O2#:G>]2N\PO2"])QN\JYVD_BY<4]W./ZE(Z;0@.E7B#
MLXEAIJ>5JRT'DG2W_(GTH^ J#U";7T9IS!P>WN5AAP(3B^]"^7RI.JV*/%/[
M/_5JO MJFD.@..,+0)Z<V*ED*9F$9*<E7KHHXLLH20ENRZ'5!>)%R21&J)?H
MWT??E$"#K#K)LTW>^G=_3=,#L^U%;\QSO>[S7)SG^JG/<WTO.])(+.6G']%:
M]P=B.J9/1L$J:U HD#GG<Q0INPHMD4UG9?SNZ)TZ5''M+ZQR3';\T5]R\XV>
M;U'P:ND:S-WK__=&" 4HM^I0A[7\!G71805;(G5$A2TFWPNHVU7*"7!.50M]
M,K%73>05O 6I]]E5M%"FN$91OTW$6,+M6F(V9,)<(@3OG\V&)/+L'Z8Y6E3Z
M@"-KT^UH,(D85=16I7!Z((!;#0<[N0QE7A636' X9 ZIIPP'.VJLHT ]RJ [
M2R5"UPQ+0;&J"_-RVH9XH"JDC_&J8S0PV-_[^:589#M_Q*GZK,B4(6'607ZB
MS;/AX)[LLW6-+7TYID^<MN&@_J4$9\QR1Z:+S2R8JPU[H0,)K<];.EUO]/7!
M),VIPW7[<$;4;VB5$1@\D TX'+08@1A%G\=9(_C4Q!X$K= #+QK<60Q0*]3:
MW]T[L,W6'ZM:ZRD<9LZ"F#[>S:J )LD/;39-'KP48.VY;06N,?_G3 9,S2"6
M!1$P<K.YY6.MRN9OE6]</H!+#JOE15XD_^*SJB65I\[B&;5V3$IJ4T=,DNH?
MJ=)C&7W$9V]$N UNL^-"%R+O :1^U2WEL3T&X;LM['LZ>KI6E+\,)1H*#6D6
MF3$M@D=!6M5<K-.A;C-5W(SZ%P)K4I8":C']4[D3Z2+.HI2@-9'0.,1B7- Q
MS \(;:_17CJ^@W2<'7=PZEFY$;IM9:#]H0%9#N]&Z*5"5UYJ1$5?_5<P]#&?
MAUP.7)NA;NM7^;Y6N8K4/E[&L;?6PK NZ%"+T<B=1G? M*E=&->Z08;&.9!?
M3Y-"G>RI'-7FKW/]8-UL\R0#%B^>PO^@*A@;K)8[*1FQ'5N)AUI'RZ4P!*>_
M;FJ:%_%Y3EJB/G >@CN<[I>QC3]E#%2:DQL^Y(!;17-P?7I)QCSYA N4UW&!
MC<;:U7XC&G&D?1'[]H9W,"J2DMP!M1Z72;&LXD#8&=3KEA?)PH/_A42,KY&"
M&.67.%Z\N(K3-/3&S"B_4!E5^=0',F+H<7&I3NJ2?H+$P NT_XBNI25L'H!:
M%93>U#>6$*=,#4$/16%:8NL7]3R.-&$K!34ITZ[NY$P,@#<"0*R$&,19?ZX^
MXCP'K60<.RZHG3C3@%=F5\-R>.#*Z%ABX=EAE]M$YV"*5>*44R\2GQN; A-(
MDN3HLUM073!F?Q2V)R I9PE?U.PJAY!=YQ'C;)H7I2 V9X+QC VC]S16<Y$L
MM1?*3<P+H% K]2N21PUDV T^Z0?*AC;/U2=X56J62:6RQ]*Y7;F=>,V<4YWB
M\3Q1C=IZBP?O;.!J5%<@/:4J*LU7JDLIHT+X0*NV:4599NGHJ10.1(CZ8?C*
M2(C;QWQ! ZOK$"-PA(5_]6@+?5_4H#_T>1K.T[S9DCS-4])'&S-"1Q]IU#*'
M.=?@66:X'$%GI<5(+;!O3MI2R:0IZX ;ETC;[B53K".0*Y%C,F0$%:&[RI,R
MLP_BN+])05$%$@%^'>B1E%KD6<Q173ZIH]DR=L!#]1LXV'GE1MP6/.\^DTP6
M-"F1D+)]NBEK-IAC!/$I8FQ"R@8^-!Q\R!'8Q>C>ZO<W#K.Y(RU$8QHUMB2-
ME.$":*(L1J;DP"D-K@?4'? 2*"!:YMZ\9^/V].HS9U5+)T(:C?/+^%:O'_#;
MTYEXE&="U=&PJF2;??X5UA4^>'CPW[-2"G=&"/)_6P!2NE<"%1?99C1Q)O6"
M5!^N&P1R$7TG(,A68ZNA,Z&+3N1 L&W9OI3-M-ZCRJ@*G82[^ZJ9>A#7+6:\
M_2=('$VC@K=U:(L(2(6T8Y%XN/*J+?NO\_$;+2-/0(KO"@V\28K'L1I0Z:F_
M;A'B!@.>V'"+9"WV<.U,(4H12X/DK.).B>J,1%F@ZX@1U80^N+S[BFM)HM:>
M>=6=OQQIO''\PT']!39ZV9^ 8$X>4+VRQ8.%_D099@ZCOG-QR^4RCJ:N2-2O
M%(C.YL[H$UCSZ3>MN=((ZJC+F8N%PC-C@(&+> YPBN \_%HTKP^=3DO_M+OW
M"KWGS!%J42=$>*(L^V0F,05#ZN,88<8&?:)AH$T9H5M'.!SH,FK7Y1%F9.LI
MF26S5V4N18,&4LVC:5QS$/S?6OXD>18'3)W65 C/:EJ\O)"@=V6JO\WC>B&X
M3]\[0W;5931LIV%M)3]D$M:??EBO+Y7)HGU2 E)6Q;5+*$@,5_,JE1Z1AIZU
M7^Q[6VS=U)(:EJJ#NJ6:_!!L&D?1(EDB$QIET;GT)#L)?O_]""U)*;&E5LB0
MO3"W(Y(A*XJBW\7J7U'15R=^C]4\D@7HI%!V^IDZU_+F?;7W[0S*:/YC*)2#
MQV!0IA$T8*</SZ"LW6Z/LTVGUGH:Y8W;.FY[W\#M[GNG=G^:TM8NFA%ZI]$P
M<UBF"3"$4V;[%JBX<>Y](N%1Z.#/IKJ;L[I'1!59C29^IC8\L?L^IQ[/ZHZ$
M9C(?+^3]&==$-77Q.3'_X&_G0K??-BD,25/;N^I;A<YM1'\XK;H%.:XY'K7:
M0;QWL4CIL&$58MU)HUA:0,F'-F;[._:SQ7]Y0 P'[^,W^ Z=OX>#]?GEVS6J
M(7.W+7MD00]Q [K<7]HGM:G72G_^V*<_*?UYL+<EZ<\'+E-[OH=2GE;9,BJN
MAX/?D_^KDBD[OA^-S;!6<P =HJ7P*K#+NDC$5 C\M',QLHSV;6KL22FE#1RA
M7508KD4+3)50,QD;ME0!Y'+N$6(F"X[5HQ(<;'\""X;*'X#4)B,=HOEHNR"I
M93U" 8DRI$&2V:_?S54X_QTI:8^5=?&/V".W\[M/*1]A5J6&+9+2*O3+GE3M
M9NE7!EF+Z%-QS$1C=-$_0XHLE#T+JHG0DHXQ'%8^92AL@DQ^G*D;0&F!#9.2
M4V%PKA2FLJE11YBR(?C/*I/'^.TIE*WYSVIZSK\G*R,4&&.&2C8R8Z\M9I2(
MR2=I-!<;TD2IZ"_K-N+?2FL7\B,XEOQ?R(SQ-0D@2PSTPP$_"0#7Y9(M7PN/
M#77,C';]E5(-H:[TT\4$U\:GY7YH%>H;REC>&9\1DM?T]NGKCM96#IH'.8E7
M]FI5"T=D?8TJO!]W]U[W[7C6U!*)IX!7UMT1,IP1\YIA%X5;,>0]C:?X2SEP
M!?Y7#M1KV\)QQXNPD'M)N&^EUZOYN&!L/'.9!%\2\G[-\W7V00:@]YTQS4(N
M1B: OPYLF1'0+N0KD5-Q0?%Z3]/SU'59!#[CX>#J(EJ6.3B&@? 6ES9L]6FI
MTX^&M0/L'A$87/-.)DJU! C$95S'8O#W\@Z"DE?23'$W)>.7W E0M^\Q<#G"
MTL7J4?D\F6CW-I+"BUI5PZBQ?.[T62>=*R7UD!RL&W)#;AN#$94?QUPC:_C$
M*>#'ZQ<7IMT$/:57<_>V/^&+*#DV#.GM)7C"S2R28%!VG"FDAE#"Y8PPB@E_
M<>4\]7B9(1RD2USB<J)^SW^'7C@(]*2&=<"4:-@*/G%KM#,5M/M2'&2=QO.%
MJ0:9)@#VH2(F(0;R3)2Y":_QKREF=Z:TC%H<70ASH?QBBDZIET2;*Z2Z>*YH
M['%4S%$P/]4]:'9DV$=J"7)PE.B(W2@8Y_D7'39#J,LO5/%#8$I/=(;^5CPB
MR]5P*$8YB:>@3^_WRJ/1HL@^@T,'\N$4RUH+.^>Z%Q<GZ#5E@U'_N@F#1SP2
MG<MF"]1Y04SQ4(\+)A=0EXWY47K#$&AZ]TD0<-7F<//%PU&EM,KO= "_)<6@
M:ZW0,R\,_".0P]<?J'> &\F^#LP=^?-9'+N'JE!S@*QE4B1CJ"_?6CW8W?M1
M>A<%#E$TG<WX7Z7<ZZD'3@YH7H-2NSZZ0Y%5[RX8J/8Z- S;RL.-LL->XX-B
MC:Q (^O7J[-[E=<_36UJ&_E\K4&%2W<>61.84UXSW;.MF8?IF6/N=]&\X&#;
MNBV\Z*%UDOSUJ\8OVB\<L;E#@4@K($]J$=?.:/W49[0XH[6_)1FM;8C5M*F-
M%2F%#JJ-,E;V2D%P')/*:$M/;&<@;*6.;II_PT%*M8N$I&5.@'',?]70)AH*
MQ9@1U\;RS;I]:M'ZR''?)WR6$@"2PF%O\VFS*1ZE\6Y&!;W-T8\,($A*8>2%
MT\%*5\BW13M=<I&0P=)C?:NIN96--PK%T5P&K2Z>]FQCMU"!?]"WP=DRGWQ9
M$?8'U! !*/9V*.)('!?JIZ<F&Q1\WDZ5=]O]Q7@Y B13/SU&1[7OM,CBZR*Y
MW =9:4!R/08)+I>*"#'C0AD@<XK!N2WH",5:#SGK"+G<C3<9'6V.OTVY^IO&
M19R:)C)7H'P[E,@\.]+"\4[UY^/X(DIGU,]KJ8Y7V[2)E+VA_[1] B7UP4C3
M9<WC;H\2<!T@H7PQ&!UO1 /GF,F-S+#U+!"3K<9UUZ>)/[]YLB9K3-:E$B$.
M-U-N1JW7)/86]M9K!-C$=(TG:]Z:T%('(4E;2HNM7$E/9*+%'>%NB;HZN!J!
MVO<*>!T%_#695_/@<-Z:9F DYI(S=+<+AR*WA>S PQ?H/P6%_$V\WM&W\'K?
MCN-[O\GQS:AK%AO;C)C(B SEE<U%Z4[P3/I)=48YPI!*0WIZLQM5O +[N\DK
M_,QE</QP,GCP4#)(:LOD^:DRP+"A4(H21HQ35=""3.\L;NAE]?%D]9OZ(-PD
MJZ>>K+Z\H2="4SJY>.DBNHQ]*D0/I[%3BK_JH=&& X_R\L:-@$*0"758(/U:
M$4%1J6PV)JA$0RGB>OJ:E$M=7;-RC\%)7[7)UGZ:MPT94>+TM^XI"1YS]TP?
M3M._^IZ:7B.Y+I,< 0.U:738[O7N_AM)PV[T,CZ2H/W;KV[6./2+K2)A3VUU
M#OHV"#<$8_)\>JVC%"WQ?N][,3,0@#PSC+PGV62WI= VHC870NS&<(*9$[YF
M0G4*S#"$KP8\' X(>3@3.'?O2#\V6.F/LR,7%5!VP:,[PZ2D*R=Q033-MC+R
M0[X;O"1Q.)** 'RR'])V)II@=&RMSBN01;Y4GQ_L[;]F5FG 5.:YF!ZUZ#OG
M2)#$XF XF3-3&^%Z&K GM0"GO[8=6EB=EN2RNY)6+N4E3W]MIL%7IL#?]"EP
M3H$?]"GP7K7>?)16Z XR7Z3Y-?(*'].H#8/#W-J$7$,/>+X<YF)&]3KC.(MG
M".BK7Y.]*+Z;5J].3>>KO;W]G6@$AT]]>GQZ<G8(I2O8Z^P:1[CN-4;T G3%
M;T5>+4#=M$1[Z7GTA>Y*YW51,3K?1781M_Z7F&B9BF1<F5 X]+XS/LLP.4.5
M.X8_'%S':*M'N6SO]U['%@Z>EX9QOW0)R87O$D4*&F88!=VO-:UL00#&P4,0
M=MC>AFB,\.4;TA-&A#_DV8OCK\1;,@T^15]75D(I$ZVC']G![MX;"7D$CY2)
MEC?;C!3'A[RXBL_1:O)O18XN&9VUI\,!%Y\&;NTIYOQO:L*G^1Q_XF[1(Y3[
M;E36"(CHG7*T5G5\"_3YE0]][B>S3OM]UWU_(*FA?F+]B;6$XBTSR\[VJ@Z/
M-+.]R+;-[&DL=6!W%=G7.^=;/+%W,G6=.$!;L3\1_=J&,Z$'NX$;GMI2ZS;<
MCA\F,CY[R)%ZIQN #OGY^! "D4B;*H>8M+W)5C16;FBUC"WW*#]J3D6Y4P:Z
MR!\H.^:Z0OV%_5N*C^F+X:#*Y*_0#(2>2L?ZM!-2<P.JA>_AUB<[/^ 6&-J,
M<+$ISD542.32\-EJ'M<SB:DH<J*+=7LXX3UOG^.C=\$?Y,4,!Q\ZJS7$SQ%N
M;%G!/YEODS^#\W2LB[./\A<&K40;YUU\&:?Y8L[AK@V>F*>T=+H5B],;''SV
MZ\&$L9F.JR)OZ^@22JR3<4[28MC%I$ 5T-6+M"J#X^P"M9S3X2#XCUC=\I>S
M3Z<-$CK)BUROAAR?J?<@3L$[CDI:7]"PWD5)JNZ8S!?JR[,_/YP<=@ZJE\F;
MS9R6%6G1%,-!EU"1^E^YP%N4(*M/[D?A#SB-)\DBN<F"[$QL6/Z7_?TM,QZ;
M,[HLDGQ9YR1>FT+GS>[^7F^*W^I XD!I*^466;G*DJNB-.0.F[I3<2BUH-*Q
M=27#-\-KW0;*H.ZHJ&R4.K/"B!<+<43&KRUC 76+L.,X9HO'!1.<V\;-X,S)
MX19,0&E3C3%ZW1< @SCGB)AKMW)_W=Y O6>A\G,71J1ND[SPBXJ]Y$B ^X]L
M#ZY)SKP!XVOUOBB0./D?D](@9T[)PC^=2JMYDA$:!ZV,29^ ZB(";0H[5B9#
MLG]@R6':&AE0?[F$Q@ESC1I:<"-A[FB ;DB2MR#%+WGGZQ4I")CD>F*,Y=1]
MN;0@IAZXSNQR9H7+OVJI%4ZJ4$<6?[!!QUB]5,H5/X@/,%K'[L&1CFZ^S)WO
M]Z2VYSH9\E=[?8:<,^0OMR1#;J1BX^5W T=HCY=\R:QXP\$[T'="6I84\6LK
M_W$/':Y(0SO6J+3);ENW!CV:Y4OFB/'#BH ?1<%[Y9]614P7YA,.QS$-/IU#
MU'M(6KW7PFRVLWQBF4H1UU\6>1H<SF;*:G([R&*D(7=^[1ZK>@P:WBM-&[%C
M'BG5JASK:X-B! 9*C6[%2W&'I)A./G+WUAVI6$T8R'#@/>#0,+!AD$S+(PRF
M3%&D'JO.^:LDY3;R,!75F"FX@ H%?3 WRBV=$F>4O5N,-1WS$[48R=*G*]0%
MSI:RT&-2+%SV5!RF"29<-RYC'M6+'.B""$R,IFT-?1D%!<-P9]ILG:3*TI4R
M3#7"[/P%>7DEMS$W45TFP$GU&F3!V[=O7^"\/?N/:+[XY2,>^S:*7N(C#T&Y
M&WPRZ\^P>S#++I9HO%BB*9Y@)8E_16U5#5U3XUY<:TG,./=!8+DZ1X#N5,N(
M.Z]'VY,Z?A_+@<TK< 'J@,GM\_2?,_*B)%W?.[!K' 9U@L4U&-+:J _5MI>;
MGK%/>HA65E/NIW,:HS$/12S-\P)^G'X4E!?*62QQY,(ACIP%?SEXO;NW!RP1
M=FXA?<UR(JY.J,XT^&EO+]Q3U]#WI2A_?U!O;QB4G@1W5.2=?\.P]L.#VL"D
M)WEC=$=V=.@.M]:<?>OH#C R9W2]FOI>&ROH)B&D[4,%%@Y#V\>JF%R I<]A
M(]SAXU5]!J(?M-$Z,V1]47'MBE;;-AT.CM10T"72*=7W& %W'%_?5L<<O!IY
M7($N0Z#/%-M3!#Z$9"43BHE_-&RR[2WH&EIZP;\D*;E4GK/6&?HVRMI?*E%0
MJZ<MGY+BP_@(1/H'> [EI&R-B#27NAN/9$MW*2<>K937JT>-1S]? ;I42S0<
M2"'IOQI8$H=C>@:6=F7*4KLQJJHK <28Q!E]%"U@\T9I:7I*E$[CM,A[ %G0
MZI8<PE+:R M2NH6MH^ &!O8E>15P]J!;+_*4FAWBP>S%Y(5&K^"Z!E]4$4W5
MV5I\*=$$C6NI OZ;OPNRB!8&=C_3M83DNU3483>?+=%7$QOGO(CF^%$\N<@H
M;F[?_4N67[VXR*]ZL;TWL=6%]QW,>"WZSI3JN_5,_UUE<8 R)BYF0A?+)%7?
M&F9OM+MT"Y)/H?Q>O?G1:;+JMK#C+G2E]/^8M8^EB,\3:M('S68ZG2 C_Q[T
M2!]>[+\*=M1N2J]U.;=N[J<C !0P@,8L9==1S)ZCU"4(M/0VJ UAI#6V?6QI
M;O8MZMO))#$MNK]+X7[SXA!#(>(>ZLVH'J&#, DONT8_0%BY9:G;EGICX[:H
M*UH!OJPW WP".Z E-KXR+K[?Q\4Y+OYJ2^+B6TPNV7E:$,3F+%Y2A/&MT(P-
M!^^B%DY)V![O<C4@Y529:Y5ZN)98*RRA$G' S[MGNZZR<J\-8;KJ ""9K?CQ
MP[-?;>(JK:/F=J+1MY!+)#,#;</)$ %I*P@[P[1-74)*EHE2\@)"G:N&DA-K
M 7LE0'25W.A'HNDE ,SE6!U<FI7$]A C6W,X$"1\:6[0DL?@= %!^W(W'B^-
MA9W?<KW=)"H*:O!=U6D&/?2R?1!1"=:>U+H72+XUV+5=^FT)8#Z?QP4E-<:,
M#%?F;[Z(&0.;<':?FR$-!YK3SVFCY+W>.] HXHV)YZ\D6O/WRLOX@@;%@22#
MHN#3X>EOQY\PCHT6VR>PL<8;M+$B)V9OG3\6"8+&0_A]B1T.VD162_CTCG(:
MW%9,J8[M]SR;"K[;O59?I)E"89I>8J>:E\5 T#*LFBP9:H-;C./E%9 D/%;Y
MK3S"5 E$!NZ+K3TKE8<<\ZO@9^2V<G4-SX=^XB\]:](W;YS)]]HXZYXI@7ND
MK+5URL91</=M6*XXHRA=N\8ME'MZMW.L<6 &]6A1N_91WJZO(88#3T6TZ 78
M^$H:@EB[GD8UF/)ZW</))O?9K=&^-C4>*ZX-_$!/31_\N3GK2[K^<Q9=1DFJ
MT:]<8%A#,7.HH[584X>,?^(:V.U$,#<FED).7C/LVX#!]W[H2S-O&Z,4-GID
M_9J4M6LWDS^KQDH3+:!?_E@)H>W5R_VNFQ+\X>!3,T#@-!GX9,.KTA?B-X+0
MYS;P^CZ>$DG\:8S<@K)CK]4NG-=X\QKYT5!W?B,S+Z%#IJCXP#64]::CMD1P
M-:QKVH/POZ-$?%XI$9][B=@ZB?C?E1+QO[U$;(E$L)L_'/QFRJC4BJS?N C9
M<&(."%N%0L2G:/\2WC^:IV,:_I$77]A;HQ@(J&^1'F<12:^#.)LJX>-$W@1D
M*!E'(>[Z5,S]<&"?ZI&/"N7CZK+GPY2#,6B7+&XD!RN)R=J6.#>O S:.MAI0
M?)CK)R7/:V7P#OH,'F?P7F])!N^!*ULVS$U=*,'D^$^]"F5M)B'E^/^PO;YJ
MRY0J=8O3"$"'N]$(O@&-X#;3B=W1)."NW.@LGWUI0],[%56A\"P!N$.XS*5T
M34+?K'\2$D[;B[:Y?)4MHF3JQ"0M*[XE(D++)EL5FA=AD,R"+-??%C$3D#J-
MZD.TH%A[$$=D9'"S+7J\,)H:V_47M4PMZ7"OGDSS]P.8CA%=Y; E9C$J::3S
MFDRLGE7^N E2=,G-&WEX$9_/OR*_>,'A,'XV@K^&]]3AKL<T^(\,&2-=JY=S
M4D?M,$6DA.Q4#0<\5V07T4J,I P)_=N3$G-;H'J(DCDY54#!(3 %;>@7%R6<
ML/5'\J1,H T<H;-_R<X=#C[&!>P>=4JW[.&9V+S"R:-$:6$N#W;BKP108[PA
MVK5/DGF4.A7W72Q!2Y<^..6:0@/(%TBV:7%1: $EDF N18>1C>'K>C_')WUW
M:Y]T.&"GE)@F? O?J0PLS"-*SG(1?%%(6F0X>JR4RAHI-0(A7NK-C3R1227]
M;KGI#,)SAXXLZ KB?%$O5W(6RWV]$:DX>JK+;W<%[>*HN7ZCW-]& 7,?14,,
M;KL-6A4<'Q\&]FH+\J9CJ<TU_/PW927K/-N)+:(%]%-]UW:O?EGO;UFI91DL
MF(]-9D^G,RS47T),A18>C%/,$(V;CMFZ.G;GZB(6XD-4&UT(::,04>I;J*-;
M*=/E]8@QQ77AT$5T598LG5]!P2QM3KCDYNC3^AAL3 +WDNSZRH%1:71M9!Z%
M#L:49$3DCK2^JQL%%A(V9B+GNA?';%M(M1<0V--XOF!Y5QI?U": S1/UCKHS
MZ@05,ZDH/\1<;-,=+W.^YG3U^^?>]L]EGEZ28W7$]?0?B?Z^O4*+J?$YSLOQ
M6[?II8]4)T"@LB_CK^XUGYQU)SS[1D_3XWG'K:/T%@XU'ONO7AVV1/;U5[9I
MM5>R<#AY!(;/52_U%*;9F<#FC+OJ5Q0Y&;?*LJ/2YLRN23_S[9#O&U="R#*:
MDW\F?%[@-L4EP<<\-W5,L,$L,=R,"#7^F/Q61%?!7\%'PE"'Y%:MR7S":=N7
M#"&,6F.R8#/ZDJTUTQN\"\\BGL!5D<$:-,BPNNWN_Z#LOW[;W=% .#L^ZBA?
M=$X4[ -3"$<!I-(R,6J\Y;F;<XRL5^51H9PM"7>*+FYS]:*3*)">F12!BZ:(
M=@$C1MNM>:Z%@CUJZ[ZM4X1NQ=YS+*=[V2?C.!GWPY8DXS9?9C=PA%;!^971
M[8Z/KV6DSO=EK<Y7ND\452HJT8TUBII#J;9%N= -#+L$:,4,(H9C ;0'W1];
M^A(//',9Z_)B<IK3>+G$[_R@ IZ-LI(EE6C/9B%9,R@GU[@=0K^3IC4AWQ:+
M*(VN0GG+W NH"MPGNPXLK8\.@ZA15H2 L#_!7Y3XH+.",@O# 5(+ -?;!F[-
M>YF1W'C7WKW\#KNDR?33MFF<_JTK68*$ZD"LA3%24O]=*>N9"0\.]@.$TVME
M_\-!=]U_-Z//**P7,GE!+J+W1=:L%N)2^RB%S3'5Y14R*_I5U*[5C#-Z#@PO
MC61!>C&\7S&\5JKZ=K)W[=)2N>0:2]T8B#$#86>3X",U0B5:5,PS9=M3$U^"
MRUIIKYE00<;IS!P&DHW5A!;?S$#45-6];-V[;'4SG[61"S8E3*->V_HFH1+3
M)3-;E8\?#I17A. "^512*$I4Y);?U'*DA%Z*54E8_%6-3$1I&J<)TZ9W<)E<
M^[VE)'+H]FZ)>FJ@^Q,U,,0.!QT=6H(C(I8]"?@Z;N32TM=;+:?R-\X^G9[\
M[?C7\+_^4_XE/;QE0KZAF7M>.'W/AP,SKEL.C'&^^K?^CVMC[B7LGB7,,;T,
MR YJX\3IN+=VG1>^F"5%N20V8<W:J2-M^S_MG(]L^9<.P0P'3@RF7]_OL[[K
MU^K=:0V#?@F_QQ(61&K_.5,?X)@^+-5*M2$PG9YJRYA97B)<:U&!RPMU=@?4
MW!T>$),W("O%Z=@VMI0211841K6@+MR=>G1D@3^J?M'O:]'5C(,9XS3J7G%N
M_*=NF\#N<DR_C]$"WHCYZK>S8V.^.1\[#2.##Y)J!P.]O?13 N-N7]V;FSS%
M;1<$!]W??YM5$3AF!3WI97"C%6&&@BX0WEC4_>@FKX*Z-=$Q? ML1#>"(I)8
MFQK_A:'DAYWN<_%OM'QM3A[7$_8_WY^VF;>T),I7@?83+\2TPS4]!ZV+0Y=#
M*YGLCQ/35(\(#N6+ M&_S4BR;O2:^!/6D=Y;44E'Y7L,LW43Y>Y-M0UQT[H^
M0F+VZ2U7JYL(?ZR-*D<SVG"<,RJX/XU0STRB=,*$#]A 7F3]< H5H[X 1(OV
MU:8NS=IEB:_Z3"AG0G_L,Z%;>3+?TC9% ^:6T\"K'HF"65I-EA473A32P\HH
MF 4E4K)JSN>[#C*>*RD2^BF L?=V]_;^W4";*6F*&SE=K/AX1YA?:+;JO/N)
M+N'B4@SUY"*:@(0I%/-.PNS2L+&N[782Y[G18B&*4OB7WZ9Y#O/Y')@RZ7F"
MR=$*N)P42!^)G]W2,/G$\-T=JL\@HZ?LNK68,/I@/5:> 4V)BYH9#A9N \5E
M] 59UTMA]7:.7,&W<1D+#E8J70/O]M=DKOY&1FW_Y[V](-J=[X::M4_*[;A1
M!_V60];4^*I@$C_=R2L0QJL4ISIST$,RIDFY2"-B ?=2%FYQVJUF*;#YOC)&
MK!W8?IDK$H?>%+^O#;^()Y16&@[^P/94/N;-*0_D->;Z:FZOBQ1%I'MS<$.Q
M,??Q=3-CM;H&U#HQ_,#D0[BU'DO@50%2B,QYE%NMY5<GR'[A/FQGU;A,IDE4
M2)5&HY-=Z</2W'=1&B]BY$3]861IF;S0C864%*+1).XFQ<=_V"R?Q7)P?F\2
M<7V29(T?SS9^=H*^I,#!V5*I[99X"WT=\+>LCB&'GZAMM8Y\JB,(TC6)%M$$
M,00JE:1K#9JG7ZY[6RX^*H8#>U;0R="5+VOS@VK-^6[M#Y'Y43NK\)/3OFKE
M'E=:*^OKIMW94FPIK7A8OSH=ZIU",>DA/Q.#J:UB+[^23O9.^9V0"2@34TD0
M^ME=YJ3^%]RU,P_($FGA&/@CRJ)SXBG/IZ:U//$#N,#E:5*HGZ?2CM[^=26V
M+IE>_'*];'7R:EBQN8J5V7D1_*W(L\@S6=;KNRD--RGSI6X5/\*D;]A\)F5)
MI/:3[MD,>#*' W<VU2^7_U(:5FG7+9O#.^D[;A*PHJV'Q_W,5Q_ ([1L ;H(
MN&2R@PF#?AGQ@WI?0@.'KC/G_P)WHO;%8=/?EE[#&GE;5@D7/A66\FB$O(FA
MHN80K^8 AT TFDKT^NQ>9>>@(US_26W>\@5F?*$^ ]- /B>[YC2.TA=T"/VF
M5J.D+@6R7,=,_,&_G34D1:2P6BJ_Z5^ M*-P_!SN/XJTIX&2B25</W;;^&)D
MC].HR@C]J@3Y0W[)B<C]-X#S[OW8B\/-ZMA$X)O.>*]C[[L=#]4,LD$IS@ ,
MRJ;I:3(QH2EDY\].C== /@K=30TQR]TPFCY#W>X8QJ7@DGL=?,01L&-9=ES$
M.5V73)R'OXN77D7]M8C+R+2" DW5SL&(>T%9WD\/&N;C0A8%X'DR8,8*T;$D
M!U!MV*&A?*)8JGHB!0S+"WNJF.$.!U[F\1<3+PJ#"V5H7S+6&N.>">KE-4*6
MB]WY;K#S-B^7$K(<$2.%6K)U9L0,0;URQWK5.#QY\0"C D!@C%!O]SOYR52&
M_@9OU?TOE"Q_ ?FGI0LD7H1&=\]5TJ0'D4_(ZIJ&'/2VUU\ES,=5F^>6EV1^
M-7JU:-4BU5XH=S%CZKR8Q$3F4!.GP"T0\?K?X-'BBV$ *_>-,\2KVXS1DH\)
MC=SZH_4[2 DFA!!4U+C# JO6N 79=<[^T5[=C2(:/K7F-VNE7U_WZ5=.O_ZT
M)>E7(Q4;+[^;-T(D0N]FP+28+^U45&]1=V?BJ/H(-4;&6A:-.I+S#/5(F;I_
MI\%BTZ;VF?=@LW2I[;K*Q3"HL>Z:9DEPSU8)7IHAGFO9)9V3_BUF2<W4JMLE
MP0.8)53,>^-+?E>SI-/*?2"S9#CP2%$WR"Q9:V-NB;-.(PGV^+]K$=*X*XZO
MVPM1(T)O:)Y5 XC9V]W?^W>+E+F725[[%>Y[TNX6RK+>6!<45:;PZ(]CQ*VJ
MA:.Z#GW4R^_(NZO-N'/T]G"T'BJUVQO4B!,_("K)7V6+E7E&NGB:  .$Y]]/
MEOX.L[D1XN]/7PM(E91T7EQ%Q?1%FN?$.TF\N'0LCZ.2XX3WAC=]>AM!]"VT
M=,L,!O]=*7OKQO*(_5?UXH=O*='8/W J-,*;GWZP=W"OSU?W^\$= 9&:TK$5
M1T6*8@\JV;>PN N7XKTT[**$;2.N=OU!L_X97Y7WV3%@ [;RG0CV/BF;H@2U
MOU#D-X//9%-[I6B4%@1W.$,[DU'P>E>=;2#:RT'S105.P@M#&,._O [W]O;P
M_Z2I\7L4K5]&*=7-,]^\SJ)+WU:!)$K6\7OHVX?EQ_LFA;&R<JN5G-*I).OX
MC:9Q+Q@/2TP4PN*>NRTV]G?W7N'^2A#>OGW[ IMK3$Q#."UUY52.9@C12__+
MOI3JNV0$21BZRO2^31AV]D>W%(A5\K!*'$0['/#SX.=0.=\*&>\%Z%X%Z.5F
M"- *^;E?\3$5H\[.\:M*GYJ,K16._Z$/QW,X_DT?CG]4^37VON=#Z-<S7L2F
M;K^.X=>4ZJOOJE0ML6.4\1_*)<KGR21)4<V19*P5!=6*V(7MOT5Q7YCH8QUB
M3 33T,7!&QKUVE3FKB8/@Z.CH_^O4XT?1='^*D7.."($-=?5Y#<0%;BZ?L4A
MM[MA0O?$; @X>L,!>WK=_>.$NH0J?G!EO2)(DS(T*_U^BS,4HJ=@GP$5.W@S
MN!D)9/LCRW4*W('I-34!UQ03YJ%.@Q]8+9">"<912O<N+U#M41_%HH@7!&YC
M3]?A1;G$V3EM&R!NH(8QH8J%CT4^B:<5-3&I-7:C#R2CQ']35LGUE*6_&F2?
M*XQBJI>$B[S@ZB'D"5U0^Y6#WM1OH6;".'0)"B-F494NT>@+\Z<#'VI5">PI
M7>WL'"2E99)#QSG$3I9+II6+EMPO!_!0FA'3Z,N)JW#4KYT^*)3IRBG15)6&
M*=&Y_*.R)"::5UQW^ '![(BI[ QJE8&J5^ V0A3"C(%H):AC#NYT75]EK7%\
M\+X8DI,1)BPN^.W/HRSY%\7G0%J.ZK39C-C'U?0MXJQ\8H;B!HZPKDB<CFHW
M:1-"'U<$X\>N<?NH?8-V 0UTBWH).K2+^]1O5#'0%VE5BD.DZPJG%66 N;!P
MZ;6U]%MI-L2;SCD(K6U/1M60D3JZ]31?WZRFL)V-GG*6IT5986W21.F.J:X'
M-?D!B1OR)WC]4M/QM+>^ZO?5/>VKSW\;#EK[T[57(+P]/7VG+,$I^',I6[.C
ML]>ZG:%2CZ1]N6<CJ?/30^IP,\[S+W2]D-L&1%X*;(2AJQT!73&OTO/(R;*)
MX:G+<CX6%=XE(?89TS+1-,\;Z0)>*8V?*2G$0+%AU X_>?_Q]'.PO[_[@VD4
M>70X'/Q5;83F^!H<T6L,S]M-TTIM)C.TT"@:V@^EIB$>#B;<72NQTU]*"RUS
M[,V28B[A#,U>'#E%RZ(JVFY$567^??KM<X_;IZV%8WNC@#J9@U=JSDP*'FO#
M9>RT0A%W#2 <M:H)ZV?L(3:H"CL*4:9=G2?[Q;^OQ<\BH44:#EJQ4^U2X("V
MVA%7?E,\(AM Z^;6:RW"I%_6>UM6)K<4M_7VG)L 9 FS#/PS\0TI' ,3)V%J
M;F%)0<BCR+_$Q8MI'*5T9$9+<'\/!W*/281.FH+RBIJ4%0T;4E*G#8O/.06B
MZ652 KH(V!K1[!31E,$6408!I"9(O4C=ETCMGNV".1[D:^T;N47*6E&ZYK=4
MED?]4X/C2W+^+>(Q2I4UEO$!8OA]$?BC:RA$KUR5-+^2;@A11DW;.PH^6\"F
MW4C1GS=Z039>9.Y<J/;M?.Y8XHOD_,*B-<@Z3G/!!Q-"P\'=./[USHT8H.0^
M 4!?G5&,@(Q*E(-^ELR5(\ZX,QKNS6.ZUT%=NX,2%.?._M[NWG PCDH@S/,$
M#>-_"8!DW%P)? )[9/Q->\3*[<]&RK7"C)4>U)J-D@&D'X%G)T!]._[3='/1
MY^]Y0I;ZM&*B[60:"Q@5P<^=0V[7S?<2>I(BGH#(.9/ "(P+MZR^/BI1R/,8
MQW12SIEJS:%4(U]0J'1EK*?J>9<4_?S-;;5(Q"2P =[RL'3'9WE&]F)1Q&!V
MPT<8@#I-U#OAP,% Z\^-ZB,E(B3W373\E^ZMV?GL<8(;\C'YPF7L*:^S*:)<
MZI_BX<ZBB0XT&>7T;*WEM3+X/_89?,K@O]SK,_A;FHW\MU]/Q!5JW?TH ':,
M7!?K.TFCJN1TFCA$T5BI21O6IPR25->(512N>)0NO/:Z%5+M&QM4VJ968UCD
MI4Y)*"O!;Q-%YCHY@3[%X(9HK\U:_76<,#E<AH-C@RONSB-1Z%=W@?.JGP2#
M_#,)3)N?)KF7=O9MYM\9#OBB7PS5[?HWHG2IL5F.-.72CD,'T?(U([=U/67(
M!W%6$0.+>DW-#4XVCW"LZC:'4YO,[KPQIHU3 9@W4[R!WYBNRD)T6SK.9D_?
M^AU##C>7#W8S30D@ *H*8AX%9]&R*JB*EQ1D<%9E]!<NF. #CY^*M)WST)-L
MJD9>7-=RCG^045D"XI"K#VA[&7.XM "$6?*59%]]@]VXB HIYQ!FUSDQ"96<
M@LU+3B^QB,-8+;@2&2_CZ=PBFC+G8PW?9/N1.X"*C5[Y)R2;L%.EK$D=FGG1
M5AT)KT%]4T_\ADYG3EIG#ZM&"7:(1H)B]T+"LVC02J",R'(^LA@*B[83&*W'
M4O4I[,!9[JD2J!<$%@2WJFTXJ+<G YCB7- \3IXY,]#" Z6;=E[M]WW)'F;%
M_J[V3OSB77Z5,2#S",& @GIT?\2&:8/E=!E)Q\>'05ORE WK*WK25#V)D][V
M042[JFQYG?3NND\S@>^@$MY&2?KB) M^C\^34D $+9%NW%NZ91W!R"E,%M^.
MCV>B,4!"V$WC<E(D8]L?^OASZZ-UD^BPTQIL8@U"0;&9V:B-O75.5L\ 7"&@
MDU+0DD\K-$P@]G&*$8D-)T6[C*PR"*=K&L&JO+-.=T\TRBAWN]_*P+3M$"WM
MG=5$)B5D':.C65YR ]V"=#WO_&@Y'-A?)!GT!9@(86W[-+]C)?"10"/XEQHK
MXN?CA4T8Z$4&0/&UTF3^HN,]U&E"A)L7D7(?X]F,B(%+8@<)"B*+OHBF'$Z,
MOZ)U6VG ,@G=BA2=6G50<F P9KB0("T/>N#VC0W//=L\(H)ZM:-E^W+3"Q4V
M;*8>3C>:)/ %KO5.I<?AL.7;]MJTBPKQO][^>G9\].GDSP_ O!_LWC&-\Y]O
M?PW4K1RHX2<J1(9N\'@X<&7/^M@A"9\SBMJ8KB/#0:E[6E!)-Q5" '-NIYGK
MO:O27"$PQG',=."+(J8:A]K/O.A :4G_[:_GT33F<P(?S(Q^M!VZZPVZ;5/N
MEML9F.AM(?' H!O0:D1$O**DFH>EG%A=A1_!CC4+UH7A.]8! A!T6 GL(. T
M&65,2@*?[S@>*)\]]#63"F%T-=_  3HH!S$F83"P*AY-A!2<B64,!_.\7,+=
MI(!;-:47;5V<NE]@5T<W'(FR+^43;?>P5G[AISZ_P/F%_:W-+WA/7G^>FR.L
MC^_?'NL0\S+^>-Z+631/TNN?;WHB75LF_XIY@ 8/0/)L)YMA!<_KW:R-,QPH
M(^?EKC97OB4KS_]MQ)8IZ/;VU^<YD8\K)+<X+[[7!!S3^<[$,=I(0^D4>.?3
M:]LOC P191L<<>[?Y,A"#NG1=:4 )UHOM(:34YS*_(^&M6LXT#:&N@NL$.70
M<8A)0E*,]D!BI&DJL6%Y+:9;%H-?#/X3G"FTV5L4A-147Q?QC)K%D*\^S1<.
M8GLX* 2DT81:D.NJNQCZ'<C:DT&[6RQ76Z1]7]VC]CU3QCBUL%*"U:O=Y[L]
M3H MA^($LAS*50J"L^MU5*EM^R-0K((%QJWGAY_KE>_3)Z+/2XG6<<,:\\"D
M=)4S/;N-"R:H_<QH=E'9[)$A\FR0]%S0?!EK\C \*D(P(*52*<:-R4L@5HWV
ME)G^* #L[#Q7NGQ'#2?>/<<H=M4PD(=$21E!Y>@O;M%%%=(43".^@]JL'$71
M08/<0.?B!7XK#R8,"><A0XU*4;^T/*\M@Q32-7)1F[?ISX3GJ=%J9\)K/A.^
M_4!0]P5@HS\+GN^V^&3[:$_SF&N,KJ*BB+@!;431O):B0\Y3V1IO2G=P@;?.
M2-036%"ME+;/$16L--098<!ZIVHBD9DG9:G_=+OO@&6^UJ,7C#%."H/C<:6&
M&ZUB&0\%$PP<DKDF#)Q_V@<YJ;7W54:XD5--(TIYK;F:))I)U$ G+E*,0-X4
M/S45[FJ<<O;8RZ6[+]Y8;NJ4\H0.<3%AQBW<4+#JS+5AVP_72H8<@.(H#.Q5
M5Q<QO1]%1.DMI+"(XZYP.I0L*>&<F+HW!IBO/[:UQF1YX<M$R7:$7%C(?D^.
M7"13.D1SC<90W\1*F,!L9'E"B4R ?D4B:7^2IQ6W,V<* FG3VQ051PXZ926X
MHZB$ON3::3#TZPD:78,_6C9)QB6"52;]U86505?M7>@<HUK/N32.CLS:N4LY
MZYYX)/&1T,4HC]@'#JE:S!B)(>UQLK HF:LN/*=^<5E\KI17+*-4ZX>&FG,:
M/M6^2]B<H7W!)Z]F JBMR.N[S;,B&UG9J&C7BJPM?.XX.T=T$EL&E6\1<[Y(
M!I,S&*1<?$5Q)TW@,(#?=GEON677VA;$;XRO370@,F4,I=[U9.<ZZX6\D)JW
M+,-HIP FF"YCAD/#60_,,%>D>!W;R[PJ)B!/@HG+!:OE2KYSBD>4FJ#@[K/?
MV%O4E'(]/5S;6_[,=# \-^#7[OD&13(<9+ESMM6F,I3.'BCO;V((2%%QZV$J
MF(GFD829<.47==*[VIC[_[J]@$,.+T6IFH5%A9/BDE9XDDRYB(?V>E92)H*(
M,>01ZMS,2S LIVJO\A;3Q$3!CM;Z6*>\6(8>GL&&X[A[(U]*&(OHBL=&*G=Y
MK4X2W6-&G6LLY[5-: X,EGFMF3+CD.6SD0WV29TT_: IBZXH]NY,8P)NS.*]
M^27XDV*.Y<]XMKC7)K7W\F"K4WL'G:F]CNS9G1)\CY',>UAO[9&<Q.__V*:<
M/A_?]"'?#>"FTT\G1[\?#P<G)P\;7VA]SV<WO9_^JJ;VZ/3XW<FG#9C>[_>>
M%C'W/"-4;FSO8'=O_QYC>UY3E#SX/4:;T><ZCUL?Z3OCY IS[1G'1Y#KTX3=
M:<,68W+N]62[<:H!=RM! TFPOPB7D1C-HR_(0!#;5=U+0N)<#<#-G$^K0C-=
MG1KR 4DZ2>OK:L%-MN?1UV1>S1V*2\M;K<DNJV6YC-@G%*PVLB3T)-UB33)/
M> .3GK);08H9&\27(C^??T7$ 1\P-M+6E :VI%1/TJJ!$BOI</ [390[;'!2
MV+@J()!@ W4J4I=^6QV)JO(D$UUM)&Z;CA =FF$T7O,7H=5.O(=.J!C:PSMJ
M1'N4M3*,$IFH^Q::""LA-BF"X?*<_"&+*-/LQYD<.*I;3+H;'..*L7E%#6M7
M#] )0@>GZP^R,?6FU9ZZ[!#@C$LB<#,WUP)@ P""WQ7<!R**+/>R"UA2/"%1
MGFY$0M*"SZ6W[9*^CZ8EX.YP0&]-E=\\CCD*,'EMQS$70E;\YR*ZIG@(&E Z
MJ!DG@:K.CM<T(E/"MK6:<%M2@0>H0+@_>,B'?)DP5:_9*WUF\!%WR?[W?'UU
MK*!/\]K"\<D]+%A;G2>2?^$0\\[_HD0\8R$JJS&."@0KTVN=!]-%94IK'7^]
M2,:),E;>6K4:+9<1JN0"G>>* EN T"*<;JT!'6M(*Q0,G=@_Z&C23'WGXC1>
M7.19,I'A(OB[WL^5*06"7=:^J!!D-J:U7C:@=PWJKZD>C:BK>7;'HT=D. C?
MPCMU-B!?YS<*5D_3>,D%5<C; Y5*^>HMP(O@3Z!&4+0F#:OQ><C6@CRI1 9N
MRK\ZBY?TOMY#.1:V^L&4#\"]VSC;3EW.MK!.V?;MO'=@"8@<\K;@^//IR=L_
M3^5E;QR2FJ862@R:P1IKQU&41=,D,CP@0?UEQ!2SLZLLG&+%Y")7>N/L9IW#
M2U 7BJQ[Z@RJEBX18"L9IOML3DZ%<Y1)3,S#=%VL,9FB#C&4#4"WOTGNS"=1
M^RQ0]^KF'=\3680KL@<CD\4@L]+.D1EORUA@!#J#<3\/N(^Z_LL5&LX!=4[[
M3B[9]BCKN#V_L'M+D+--P\:+9L-!QU-0]<I3Q>Y<!W.++J&667HY6L-O\>=/
M-^9Y-5IC&;A 7XU"B87V[B@#1"0CKOP@0Y0*AL2W8@]V)B/'D!WI ?P#QPLR
MC\F,J.("(0[@-DA2 /TO%+*IS]'O^9KJNXRSDL%U!=!!O:Q4.H.,0#>Q5[?+
M!((P%;2%.A'4:YCS1AU6)#S,6W%%)#=2)!;6SY^N\T/VO=YB5,G;NJV9Z^[_
MJIA2IIA=[2^TG(1F3B5_'S.]AEH% Q>@-!_C?J[K=766A*4K4F!7:#AX:9>(
MG.B=*2\7GH _8UD]>)/,JJA&4,X2RQ;D*AAM,-#XA%1KY0\<C;2[Y3;<'7.$
MK_?Z=""G U_VZ<!GSQI7VWXU;WI;5<>M.':' \_[([16VEY2#K?M9&19/!"?
M=:*&-4N0HK[&.5#VR8G_V^' _;&YD']7M^1@89S@!BC"RD$?<AD7C1'43!9N
MVD0PNZ^+Q.!3R?*J&S(^WE6\-R(B:5A"^@0G9*+N71[BW!7N8.,H2PB=7&@$
MKM?S)(]:/<D.A]E2^'@>L^\)DPN,'W@>;G1K'[=U9*.;H^W# =S;-A8AAW>'
M)ALX.[6\M+K=5FC;ZUM7 *&+3+<,(DPH2>^"%UK3!,E:T4/:K"Y<1S9,??6C
M3O.)#=Q(K"=RM+.<O8Q *!E%_FD![.O"&")Y+MTM0SZ;L"BHYY!1G=A(]$K#
MFG?,P6@X2,B+I"X#'.OGCH&>=4R SE)CNSF/H0N+V)&L_%AV5"GEI_;3A 1&
MPME-7Y AT6QI3R/3K(_['-1WH*V*%(F/>5,[.28/5\O0M/J+C4)QPB.TQO)7
M3M:@,>.-_9VEU]HZK8^]/FH'SFC G#O)I9IX=R7;5[]EPK[MP>1*72I?3GB$
MC%:?14E*&3T*ZT6DSM6C6O<1 0+;]UTM1NA1Y#)E$E.L4YI2%BONW$7K*5;=
M.BFB7.!<W?2B,1<FM8-)&PYN-6N[SKN7K);DAF;YI',77MF</6"F<I)6+B>L
MU,LY4%6: 4T9K]1'+M5MT6QI&>=C@X/FQ5PK!^D,$O1[EWJGT!367][F"!N<
MR#J5%M0S:;O!H??:1"'3"$7H5"B=*LK7/D_=D[$^4<%]SY.:^1LGJB/44JX4
MNK6F<CA8=RXWRB+MLR_?R_R>?$/V!2<%00?(!E<2U=!UI)XS-;:&BF8D.2E=
M0EH;8[M;Y8;@MDOF2H>CC@-0D.ZM)O6WAE7=UK*6R==@FLRH), >[,,!#[G<
M++G?@"#.L\BQUI+5+^\1V_;!N$^$T?C%5(HH74U*N\]</],-LW[F^O."N<;C
M9+'L]N(XF9,#[B,!=U&@-A[O@7RX-W.G3V<3XFP H*/L8IF2R@:#C$$'&99K
M];JVTHM\EJF)CGLP(H".B,B&B$^#'4/!WXHO*D?-9,YN0'/B!MZ]5D=PJ?3X
MA(FA9<KHY/ F3-LZ09IGY]1\3GUUF;,57<\V6-R5<)\VH6A2EHR/V0*SJ1"!
M&!J(8EM.P;[OUNZ2;5<2MXMO?KA5]L[JCG<B=;$'7PR=3:Z!?5^4I\85OFI'
MH+R2]W!;FEUIF_?QE/"'IF9V5J%9@F>%V;ME 8\R]**)0%A2">YT"KZM>F&Z
MH[_>[.[M$^O)<""4JO8FIH^'+L5% :SUD$W",+#4JWQS*?\(3E#^0?G 4IPA
M/R58!%=1<HD4ZM)2%5 FD":M,56.6M;<_3PY9<ZZ_C)VO'VI%25-86>LAEL.
M)/M)S];:5CF,R.J443+54QBVI6\=W0HK'6$48#BI&GA6E5C$F:T>U?CIQEAD
MR2R\4_GJ3%#KS0!N5(<V8%:+.$UB86BP[\SS0#<00*M+CNURF6ZIFMAV+;FV
M&WKBR# $N!0'D[Q&RU],/+_U+C%VGS%S.JB-KP7ZT!*(R;Q\#1Y@N._] (R.
M!K&QHBT"'7Y> %XB^ I [$TC&3-LO1>%)U -RO3EHB@K_&$:UG!@(.6T^\6-
MG:"^G^9EI+3:\@J*C2)R_"[C&./GS2H!],:W>&I21Z%;W<"6DU:*->RWW]*L
MB)4%Z+2N=*TIJU], P1F2_;,S&YL.3EO;[S4@3!K4.2?(]>[P?MZ[QT7O@_W
MCYH(J1>E1R)42.AV"?2UQ(NYI5K@-5=VBC"TO>RT?!/]S-F#*4F9KC.H/V\<
M3Z(6@/U.:W0C9WH"Y^ [+Z*)3AB->B#*W8 H^ST0A8$HKWH@RO<)7V_$5MQH
M0,Q]AONV5?_M3&\7SF]X69:'QOHP$I\A$S[B$]JP2'$+OZ7 <,<V,&//._H!
M^5'P#U8Y'<U 4X?#Y0:W<.A'95G-8WO& B"K'@I/CPP9^C7?J^/1.A9%[])2
M2J=MG/&H85!H>\H.9V=<H3O/TD]B.ETWB!2-7"5Z0F5"8?0BQ)H2=LR4,:>\
M$4=*#@KFSN.*5,[A#0<G',63'RLY9'O%6YL:MUZ9KSEIH6NRU5N3FX)=Y#N+
M.';L;>\6!OJ":Y2A5$I69QK/J?KPNO$\L5N7^3FC[&E]$IUY8ELL8ZX@1#\X
MQ6[\<)HN]SY)63=VZS.-WB)IYX_%<O;?"O$))B%:H.U?E&75//!L=S-@[E[>
M2/5[N68_Q/N#6UT9G,P:2]F<9ZE$CJ3@U'V%,O>-?P>[W=R/4LT!!BFVS6N!
MD$;72Z^P>Y?Q>X92UU[BO^!+C>1N#RO8UV65Y'%!UJG'MO8HV*)TWJL[=K_R
M,GE2O4H2+AV%E.'Z(5_&ZG].8QP'?2KON6Z6NQ2A<CZ(SHZQFTVK'Q\FGA C
MHJ'.^ZGF_5;*DG )*2$>1.8HIU6PO*F[JW,B2J2ZR"H^@;VJ:Y(,W1_43PN_
M0RT'@6W J]!IL&L (KE"J?1'308'BA2%E2'7@2 ZSY")'.?5THL[QX8W(#?!
M:P*PJN_<?"<(WR6JI?ZTT3;W%E0"Y_2P(""PX* Y^.S-4V"GR24U!/*T8I9>
M^4[Z8&B(E'I+R<Y;H"@UGFX$DD:<W7/>@QGA^45X@CT:$!,ZM.E"#WUK#J]U
M7H10Y\VW\24BTM9ULX.G+YZ)TYF$$-#)//+@S[-HDE"#7".FMBQ,5DMC!DV\
MRR8_JDP;04X@="S"HC,19 'B-0PY+?,XPHS07Y%Q;WE_948SGHW&W-FI<TR%
M-)DG=6I)2]OJ=+FL=UISHL>%T[V4LQ@<_GV73RI#8T3[1:2A;,@UX92UD2?A
M0%Z3JXLX0[BOMTVV]/65%[GF:?.I+I]C2X!$O#<S4ZJ;+Y+,Y5^F+1@1ZB,!
M+3#A/EB_LT2[^WP*5IW$=H8,O69"H)*-RZ30WI'N+$1LLTJ[2;5JH]^M,W:U
M"ZJ4JX0-;,)JJ%#:T9KSQCWLR-E74UPQB(9Q'FZ^H!7O;= N\==X0H6H:C]*
MF2Q!OIV?-V=I!Z<2)1>B.=H[3N$S+83VFI/%5KM0W^*$)LTO>W$;CG-9]01P
M_@EH==-K:<7A_\+K6[EVK<MA6ZU+:%()[MMJUJ)Z/FD-IJH 9/S)C-#8=<BW
M' "=5=P-+U+=89%6)5B9?,_=R_Z,XS2_:M3LT >&'8N@HC;]#U!!65::Z1J3
MRL$6RXA-L:J%,HB2O"H1H< /U-/H6MI7B!P1/B#-RV5-OF <R#X)R!N>QO.L
MK0T!?NOT:R[9777D+J$"ACF7E<M:3V++=WTM\(1H0D7D===VR[7H77,]!WVN
MAW,]K_M<S[=M@4=(ZSQ7FZS/!6U$:8<'/#-1B$[W,FR&LLNV8C_I J=# '5D
MB.<Z=?M-5.P68P),;P$J=;/M&@1148=2)!D\Z2R3"+,TY78CTR9_89V]P/IZ
M=_6<VP("ZD%L]]DO.]Z=#*KZ5)$EPPM1ORU!87+G+=R>!DX;3]?XII_)K-'S
MW&FK/]OZQ^SR-QUD.V>];_L<H\2UN/OK>^1\_$/)%',E?92(BNX?H?;%1P.*
MZT/PSW7?W#8$WTY9&QI-WG!%==32XOO\8R(T' "?",7'BA/ ^EHLG8,%S$&]
MB$P1?/U79BC*3]3/9.Z!L7(1*L+.UX8P''3?*TU]C>]&GETL0%C+C!,&=3*A
M?J5.J+;I=N-@\L]1]Q$]1GOK-^C:44N+U*Z1B3=S8@FX*YGE0U#1;A21;0P+
M#BB'@]>[^V^L^947Q@Q[O7NP9[]P^YV51$)7RC/FW/!\EE:39>5'*[LYUML[
MGS.3P*@U_NA6R"Q6 \W=5"#O[9W:%I;M6]^S%#AJ<#76JJ9UJ$Z@'XP3M['!
M#IC)3T+B3720_XGHK &HBX[@!:G3JOM (]N>7N@1;B[?SG7;90\&WWPP:OP8
MZJ7EAVN]XZ])N6'D!;V.>DB?]S;5=B<W[7L_R-VV>9N',3=2*(.;5-!P<!\Z
M2$A;P7G-:5)M!*A['7,_!%N)JQ_"31U,-4NMHX.49JQHYL",3?\8>?P_G530
MQ)V%UYA&!9/B2(F=[2UQQU'<H'?!226Z5Y2*OWXT 7?6OJU$N;=2OFBRN%K[
M,I]PN^[E17@Y"M2&O# #$<FTFA>5U$B)9P:[R&TR>AVYI:^_,[VMCHQ,"U%#
M2/R=5*;ZAZA,-B2& [$DOI\1)PK4JL6&/A*ZY0=02*W6X'#P8 JIPQH<#AY$
M(6WYOGPJKV]'MBK+^K+/LG*6]8<^R_I DKE)M6T/>J#'WT2AS#4XNLIK1W"J
MW-R=2^=U*QT#L:0#A]WW500[([_&"JP\AMJ$:78;C1P<OQ]$/Q[EJ)J0_?V?
M7^ZI(Z6=#J73 [%WY3,J,8\&V+G]V<V#,UHJ"R&B\Q;%2IW-4DI)H.IY,\5R
M+G+:'1+_FRN[#3?EU46.-FLV@D9#;Q)=JTL74;&\N1L=86,-^>-?]L.]O3W\
M/_,O7U#;0K&6* S.]?4WK%!W]Y&1-&]7=M@Y)2.7\3F(/^;  2Y2K@_ZRW[G
M&'2\GB-,=QP#(0G5I1K\W4P*$.AP(150-QA:>EJR[L7\;C:8]0EU^PVVOW2*
MS!F"[8N#3#PS&(C5R<1=UVX:00@MO#Z#W15>F^4U]L;8]SI29K<X4FK1-"=/
M!IDK.77%@'\TK'&@]^VT*]<M)-?B?6JDA^&O=9BG.7=W$U-WV(@OBYO&(N_L
MS/+66W.S-D?ONSS<=CEOV2ZMR;)/S0!!K7OA;3L7!N]7-2[$(%HZ,9QJZ??@
MYCZI&!?P:.-%J.2<@[>H'\-MV]P:-;=K]];UH)8&:UU#2DI^?ENGM<Z.:7Q\
MJS'D;7W-7+XY_3NDIVI*9\0%3D[C-GMCK\U([9[-V]RB3YH[1[I/&AFX;6 P
M82+0918B2D+*Z12\Q7Z?KU/[""NP-["+FBS#K>E%:^P/]@5[/;NEK[]SL2X$
M07K0:T/=U%$XQL?-+>8"=)CC@A.)Q&I'P7/IZF"=0/?NB WGVLKK>W%^CG"^
M&E;RAWO$2IIS H=:CXA\KKMC?42DH^UJ5#&F/Z:<QUX+'QS ]'E+9UCB]J8P
M0E0T\/AN[JX+9QD:CD=I9C7)Y^KPGN W@L!W"768648*UJL%E6C"_D34R@(I
MVG\C2AGE=%6:UMAW@A;R'3L/FB6H-C5$PE"SSNPD>?O/WJ*U?:]G]$84V1.H
M4R.4MPO>$8W3' [J0,T\N_4BVE"0+84((F6XHB>TNE];IS,;[-+A+VEJ%;6!
M.()9,EO&,1H=.9V,W)RG6BDD=XF;H?9[Z4+=TFTM3>WC6T"K81?FMC]*M_3U
MUP>GWJ@K=?]@S1O^/T(<+CJT'INB+8;^Z ^C)^N/%Y6I>^A00QV@SHN\.K\@
M#>I@*B[NV*KM)GU:5G/CYAW:&]  ::@HG$HK*F[GBZ:0$370/XG!6%[(?7;>
M^KJ[=KQ:'=HKQ-5NZ+PUF]19S=S:7Y/9F-NUSI9OOKM68K_J,0*,$?BQQPCT
ME=A]Q?*6J]';%FP?IFF#3%Z?>;8ZMU;+;%'IC/L HQLQ9M%Q%G*\7M_5([2R
M.>,='7\'C:SZH3I_J?HN67)K:31-2F/=P]JARADQMY>^?6N9-[.AN)>AYGL4
MM+BCH7O$,V&LY7T-#.TK5U4W7$B=)]#AZ*N(*L=O\CP1N ;H- ULN'T-^PB_
M4T;FWK^#14\2/M:38XI9MS&K:\98WU9W!5!#O8I1V >:&BA]):_3<XQFM(MX
M/5;6\M)EU^#8U9A:,A,+(#$II]1@7R5Z624(Q+<4)[30.X>CKC9=7LIW5?_C
M1OMCQN*\Y0R']'<V5P\'C3;0]6JPX(?=O?V=<P*:[%PX7<_:S>YQE$9.<;[P
M\[4$.;"<P\&J]3Q7Q^V2D<)PH>OK6HB<6/G6&Z#-Q.6!N*EE+(I2>RVDOQJ\
MU"E)-S>_^&&MYA<HJVKI?M$"K-;;YSLTOQ@.&L5A*YM?;.W)L>T'YRU9[S_5
M<I=&=#EXU<G,[1)K^F08"7A;]6WXW-/[PNAQI1#585)24W,PFR>LH*C%(Q*H
M>L]JW/RXU-I0S4@RPXB(+[,7\^>8ZZBEBWZ\QW31^[A/$CW;/7%;V@RG: EV
MM<&XZH@A@7 9F"%Y"XG9*_NG6+JE^UW<%?NO[YP,Z."JF-3&?.,0^K1 OSMN
MF1;XDR7GF"Q-G-&$Y# ,+NQV45=!ZQ.,HS(IV]EGZWU.A@.<\\1O<67HJYGQ
M?*I$-2F7<)=A&IR+F ?4O.::>[(0%RD1_TZE6TR\B K>4V['/Z^UL7EZ+_[/
M\>"K60P_W:/%X.I/2-)I/*T,=LJ>(+U5\5SWS9W(N&Y@CU9Z4PU$?0 [0/H4
M*;$BO^HO>Q;'X-YF.'#NPS_2/E;<8P!ZH?TF@JI.),!KW7]*9^B=L.9I?)FG
M%)0Z4N*;Z.RQ;P4,!U1722>UJ1J<Y55!J.S6,D53-,A0T:L"370S'73UNXLA
MYFBW ;YP=+)Z( ?Q 2FRY8ZRUYKU@S=P&E \WZTKM+#SO[PV)81Y6X$?00*<
M.D,DV)F11L=&=FK$[L&Z'%&F0\BR=E+%IC*NT&>6\.RORUAQB^ Q,TXA3\ $
M%IUS.1SP9(Y048O T4)T5V.Z2^-X:18**L@S'@\OXU08\3T>6J#F:1);VA>J
M.R6%-Z F*9#..U!A1N(4_XD,@OV_V20G;"KMH*&S$4'6\CK=#3Y*K0 ZVTMS
MFYA7&.N:F7(#/[7 O1L IJZ%RG5TVRU*T/TF48I@IU$7.VJJ?5/G*I4/Y/P:
M#\"D>[2P%=8,*ES)6\L%,# ? 9:H)Q#&S:RZ'28%SY'M\:OB0#1,/>[@'2S1
M1$;[RKE'M2'W,J-%1L@9>U(7/2V=9>VU](U<Y6*@[>AK0*NYY8?.7;$OKWOL
M"V-??NJQ+\^ZX_1W1LG85=F(EWU>7G MQ/"&0PS?'E]0]_TMSHAPX*-M!LO\
M]1][HN_G?6+N1'?@%FBIFZ;V>UY?B5OTD5"74BK!3^-2"?.RWDK"7$,=*1T.
MF\"AL(DO8]U9FVQ**C_.4F[T28VW=IA,)P$A0ND8ALHI>/FS<H\6N_-=G]?&
MJ9" 30^8N6[=%A,_P?X!?O@A1RF'^\-1Z-5RZX:#5(WR/I[2QM.X+&5I9M/2
M=[IT*^R0"[^5<[, !9\\GH L\=>%FMF2V(VE61=>._&L<#AS\$BG4UR+OG%Q
MP1W0:X66;W;W]HE!(:CGYDU=\10Q\F1<+1FA93N7TA.<;G6F:MCZ@EI 3$M[
M#\2D#7/35-*QQ7>#OZO) SF*V\24/%L7'!=J#UBD+:Q3%]%TSUK25Y120+;,
M2 =D+&H/$H1F33F?4(>PV5:S8$V<QJ8M>:8^<)-O[4Q)WI;A>[&'H0,@PM:G
M[@V-O6LH/Z:Z#JJST:MZ+S,F=+]=&'C@3&VH*P\E&#:9#1N8?CR,X7+V5;F$
M*C7 O'*M#B:$-.376-W\A2K3DDQB"*7>%_ A@1ASG]N0CIHR$J>YBX6@\<A:
M)5KS=WW,<TM?_[8QS\^94(#Y6I:2C$8[2@2&8X4^HT^#R2QCQ<4A1X=Z [K-
M5%LBJ&'WGCXD[7UUM(;/=$]EFZ)..V3$(**RK.:QN=5P8/=X)$6D;;?Q(S)N
MVPP_8TK/V $*V#1.QO H\B'<&<M\%'([IC3A6!(G9JEO,4:WX-"0VTS;GF&D
MF>T99D92Q7HT.IKC 4]MZ5BF9]C09[ ZIM?P2/B;TVU?B-:]S)L3YH3U3+*F
M+:*UO*#XHL%?2Y-F&6?M?6T34I]GK:[NVT#<?A6<W!]RYCU"'D_/8$RU_SOZ
M0FBIW!OY\769+VTIO2<#Z;1/+3T!-;L>.>T/??"-@V]O^N#;PTOFIHULRU7&
M!E5SW;_C@L+T+L\E>!#'15F&JSR7&D.&+DDKXV4^FP54U%[A^9,T2KB4:P;R
M7?QCDJ)L1XC$] ^G)L\E_JCRSZ*O6+8TODSPO\E\D9>(GDRK)7TPN5"2@W]P
M<U%SAY(KY"[R%#XS+LSGBRJE+O$I\[AB6HI$.A)Q!;[FE)*D749MZ1 Y(B?7
M8@EI&-Q*GD8VY4S[M9+5(BFGB4DT,J%>JFX[B5"U,YXF'#$U;C^U9_I*C>!T
M4">JU'2@((\O0@?4RIK^MIUHZ9'!P1/?01F<K>41[_,\S]7,1[#6E,4U*6(W
M06@;N3+$D3",1/YL['E41SC)4V=>=P,'A^& ,-[L@ "/&3B##WGVXOBKD-)^
MPGH&"/(XQCBDCNZJ#H,FGPC$0$R]F[N;JO&MM</"%B>F ?S4T263Z_53O8!G
M-)/J(_<&'BNCN%L-*[A6/]5\&;&,6]Y#&%&C*4NN):BP&@.A>;.W_4X.F::*
ML"_DE0>*4\D8C!*U7EF\U$_@=^GX,:,K?,^TX2==1%/=":Q-2 @WJZ6$*SNM
MF'34RIFFP*&FSFS>6"@S20@):[.FBAD.ZCJFMAMJ>B/X#FK#@![6TALNX2["
MW5@]=4"@CR6]=+!SH:3_D@ :62X0#[5Q9X5RBB\0*9;+],"ABM(DKO"B]9N!
MKYM^A[#O#*J$?^RW>2X3=3Y'A7RG[VLP->+;\PQPY%WTDJ4F&0Y^CQGB\^=L
MEDS4AA-UX,VB+:)6BI%6Q@JL>4K'$X+Z Y /*,ZC3!D,4V)K2?1>Q@_=4Q?7
MX_(TGU!M->T*KL[0/P@@+J63TUBUX*%>9;.X]/S6!1>IT*%\RCT8 3=S7>O&
M0X3LI<P':$9C.@EUOVT7H$[31H]?=]YT7,9;&1J(B4BKP;EB&KD/C]2OZ,(\
MI=1&2;6]9NAW6DJED[AK43Q!W"%TL$E0*'%!<S!MM+/,"Z/)A@-C<Y&440(A
M!D?K)"8PH:^(U#K(0A",34<F',51WPTDNN\//QT=UKK7TC$E P:AI:17O,#.
M)"Z4N9Q,J)^[$95+94Q/@\M<37FLS@1=N,@/-E>)JA,5%T\Y?$/)BJ1Q,CO3
M0";C&H=RUS&V&]3YQY7*+/.,^.['ZGV5DBH#6XGL*O7A@(^+JYA4KIH =0\U
M0J3OO/M$:!"UC*<-ZEX2'9I:1/O,+PA.EA=+RFQ/<DY[H+R9(TP02O4QD:T!
MO,AM[>MFU<CR0)EW4[?+Q\L(:4&DU2J'2E?TK=@)%CA(\U\OV"]SI6;0XBJ2
M@)@>K\$VAFTF8-P"$\,4A%HK2!>1.7*E"4P*:UU,^&B4E^5=D91?2M(*X]@I
MEE>69C2]C BEF%<TAPD(#@ZU8B>G0.,&ZQ082I9LX+H#,LB&)@KBL==*LA Z
M%G!'*94R*9>,+ERRVB;7B-HO*,4K9-!I?"[IYR(^KU)N:NXZ"F09JVV2G<<-
MS4:9Q97J!R8Q?J5,:SJY9=4C?4=>N.@R3Z:2^L,>S%G#:,2]"Q8,+<!1II!V
M9:N13-MG'LEA(5P4G"(D)ZPA-,Y$:H8*C_,Y7+GBM!XVP+U1L80^<+(AU?QK
MTYW@'Y%V:I7JP$;'WF\AR7@CH/%FALI/ ;&#2]K'*CB3E<_%'JJC"XQAVN*G
MMIY+?/(Y0X8E/KZ6W<4F&"*QZ-1R[60Z=/-5<YR+;Z . S;8^!./_IJ0QN@R
M,*N*+"DOQ&_R9H/'8^=K?U],16],36)W=7JD\&K(^HW&C&96-Y='M=PW8"[6
M1 EH).T%+ "!7R6+KYB@R(S<+%#;.+D@ I":6:?;"+?.L:TDA&1]KZQQV'C9
M+3G=J;S"?CJ.X>C <D:_IFMS%!DSCTS/:5RJC4>&5Z1T]U60LO;'P3!C&+YH
M^I(=AS1BL+PX%V:-ZQ[%R(;]FNG!YE(I2T>-@R:+9E;M21 DJ5\DRQ0&D/N2
MF'RZ7GH#&+>_&55 F*V15Z[O@XYU\?OEWK"#-^NTZ /O=\W5_=CGZBA7]VJO
MS]4]#\QVW]#R)@LPOIT%>%*+XT1\X)HL1DGN"$Y+QQVQ:8R0ST!$U:+2B="X
MGK6-@3%*W0;B(HDR8V;F&5?.U=VFO'G$.:%O%[E$3KH]-'76PN>'6WGR[>^%
M%K2$= 0HUW3]&KU.W9HCG!-AE7W+ -V3Y*V6UX$7J.$&1XVSG88?-EZ_8;ZV
MC5K9)P@'ZT92U?)%/GNQR"=?XB5 GCI84%MJQ^ARDH F8[GCA@6S:_L%S;.,
MLXC3&#YG<(ZI(AL&KV0"H[@KQ0P]\X0G<_2+P3^'3:15:*/2L$DIA]KU J'$
M(-AZ6K"/'9BD58*@\65<-%</Q-H<_(W54G"^P:9LZV$Y;<.N]^Y^!U>*T-@9
MKR'?6U?%33":%ZL)(_W9_OS=P# +R/2$@K<U$ULGCKR6 4G-<)$P^BZB*/$]
M;%[RAM;;O<%=-^^*0"(]?JX><*YKOZ4JVBU4I1D('?92]4[:L6 7F85"? N=
M<] (;NXK0;=UFH3133E0.;ZF7'@:R]VF.J LN:29\NPD*J=F_07U8.0HU+R4
MN>-0D<2C$/OV6\)32+]-Q6R66=\;\=^O >FM3 !+[.CE#I ;95WR+TDC)H5N
M5XV2$@3Y'32T\6KI+TM"PEUVW6;,PNT .$J>IM0:E[/TE5,-H0-!#8TR\P+6
M75S-H7NF,<!Z5A6T<2TM!(-.2H?*P!X^ZNMIC!:1]#2./^V4HP9LPZ076(';
M%N"+:$*'  %[D>VP@R[EWJ37KZ*"@\U>5V8_J&PP"CQ972_=I"_FF\@J1APD
M)Y5#J]<LOY=UUU.EQ"G+K])X>JX3R7+,XA39B1RHA8N%SW(G<T>'E#.7&N1L
M9Q3W]7^=)CJ^=:4>5.9QV]FM%:Z.BV'!<NH]285?XU$;;ALX]FO8(Y3^H2/0
MCK23]]O$*CVXUY4<#K4@O\FZZ<JQS=*ZVQ-,><CRWOV]>V00.P)4;FGR@Z;7
M"N2ZYR-]W/WRG2?@$*C3Q%WP6J6MPX@,(5$G"-1P2P^PX$\7/&$]N3-U;S(P
M6UJ>E0#,<?*&Z!DY.7(M2-&7/^RAI*04L%PR==(SQ.F?5?,QG]!TF3)<%R5%
MNT4?MXVR.9SAP!]/T#F<UW<9SD9KXV>]O1Y4'^_OW@/3@FCTOSM(H4_*MSK^
M&G.!6J^(GZGA<F<*1XF&ZD+T]WD1JW=P2P'%V6^&HD@[ GZWT+'$X8 Y#I"W
M-6E<!"*@5%&SKU2G"2:HD^#D] Q/G =_?_&&\J'B1@!R+.#"D>2SK]GGTB$W
MB39AT*4!E \'A)<;JQFI%G6X'&GF?%55J[VS3=Y*;2&;V3Y*SX#I='!*>8YC
M8+S*">)3A'E*N.Y=" ,(4@<GP4U?+Y2'FN05N!4LL% ;Z1PIS*;M3'X:DV,'
M4(L[NE&MGANX53^L2D;^U"<C.1FYWR<CMRP9V1_3CTS@ -2K=QCK<UIC<AA!
M!E@ZFW8&>5VX]-VU0Q!U84Z5@SXG?+1]UI;PH-1.F4P-A8XR*W4Q3:@+$I;H
ME'5MDRX4./,!KXF!1(4-]\I$JKJJLYHX\-O9*.PI:AXF#]-4T/^65-LP*9(Q
M'\(N+I=Y:QQXN!RV[4DD)\K,3 MB_0P'UOQA%#B7%013>2..HJP<!OK!4?D9
M$MY+C\FAE.(XPM?K!*D';LL+Z6 GW+*Z?9E7I'>2F62,PPU!!7IKO[6W,!;'
M/QS<XDWO-N$V$];>\U"FSZUF:[L11]1ULRC=!3$OQ.ITDI[6!&TS/LGV@ZTG
MX>PB7N0%Y=(D62JA\+^[@]4IAG-FSA.K$9_@##W/J:5C*QO9>GL601NZ^G-&
M8?VS):$0N<GR^DZ SZ.R8TB$321#[;PD]DL*[8H:@]5-44\2]0LX$3?:Z]PS
MVAWL&H9[L$/A%T-*;%/+'<;["ML=Z1A;/--IRC?'">=&6_0,N.TPZ=V<\ KC
MWE5K-#>4@# "HW-62>E4L?R\4:?P5IL<NZ^^J]&1W(*"T<%?L^/."?_*\]ME
M4^M0/RX^A1*J8@SI$LE*<>M_>GO\P1;NJ$UQGDBB;$;U/UE,A9_<,I2+0PE_
MW3 EFJHJ<<#54'U\H)4>O*"L&T ;+@?;'B+[WALAN=G\OE_Q/SXZV? 9[T7N
M.XM<A\R)^44\$)0F\@P$HS(IE^2H249L&I\/!I(R)M41G^06!Z@Y( 1I]M-/
M^P: %C=E]B@'Q'/GZT@-0G<B<<T:6S/B#5'"KV@6'6GNA#$5E= _AP.H7GG+
M>1QENG[1&]3.RQ%N<,/0WCJ/V-^#WS,1WZ^(H=SC0E,TU&RC&P?QX_[.!0WB
M[4V#0'',D3,.*C13EA4CW6A:)KFRK=EH-)-@NUV8U>$VY8'&R:FW00G5NK-U
MM'J@G+N\'IGXNQ*#>SK'U>P66[R5>UV67-Y@2#)L38BF);FQ,HP129X<>LQ:
MB8V05N0W-/'MP!9Z!#8A:\+NLU"2/BLK-2+R"E$QZL<E(M/^9.5+(&S%81A?
M[WBQ WQ5BPA8@J0:K1$B-YN=IMEZD^$[$\G=QED[(3X6P6%2T(_0[T[TPT"\
M3<B4P=CCV U;4>)TUDXTXE81$,>(+J8=#KBN.68P(W"-S'PQ!W;4X$P=XHSV
MT!<.(+[QC@W=+2_4,_TJ;HV<WW^ECFU$TM4^4O\^ %1G]>$=N8&/4>A$[VX3
MWO(#QFJ/MT2,$54GW*F83'YT^=;!3"' ZHB8#@=-A>1,850?7&T"V9Q =?FJ
MV1.\:XTUS!L2S)S;OIC5KY9B3..A.N:_*5M)X5+NZ.P&RY)P([M:V*U]IA(.
MNAW*0.R9X-5%NWP^[KTY(NDK>$8^B^:'<C> ;NPE/LO<4/UN<,8L1;,V7C*_
M<,3K6+B_[[4K%'N4!F;,3A9K%@6A+%#/G#KD.VJ8,D^SI62$_';(?:^OUM>_
M$37PID<-,&K@H$<-/&/4P/.Q )O;Y;N"/@]//YT<_7ZL;+>3DX?%8[:^Z+.;
MWZ,_/[P[ :SV[!'1KOMO7I-J>B9;Y+%PT2]W]_;OL4[%&#AH@M1CH9]MV< G
M94$#BZQ3_AIZ0-RSMN6OR[5,SH';BMEFS1V:;Z?JCRK)2^4;E*@C#XVK8ET&
M8O>SC55,31Z[X[:@/2H=7L594I1+&'\%/]Q"H7R<":[EIT<&[-4U[.%@1].\
M!E<1.;HM7:/]!FVO'1]CM%E0@2TJ0=FTUHR4S4 7-*^E'L%\B+<?Z?@RT/WI
M..^@+G7W%2Y!TD%F%-<N\X>GO7FF O/X;O,Z$%<1HQL;,ZY 'CI,*I0]I6"_
M!E,.!Q_R)2OVJ<#(V(ML"7-(2$FC!5E&;9O:>O!E[Q44X_8N[[9+]WKA><G[
MUD5<"=/./I?Y*XFJB&_(L5*,OO2)'2BC>\ TH!$1CHLTNDGZ!LTB: O&H%58
M)LIFN=984<8MDE ??[U(P''P5T@TCSM:+M66D^ZNZ 9+/)\V3<R(1' ^TY_,
MQ0/$*FRA."K4;\M C WTLDLNHY1X9)IM+5U8>*E#\OK>G I+,AXNQY_I928N
M?-0:0'GA<YK_HCG472()9M.9)>KAGX^.U#\R=3_BG$ BD4.CS;&W=.2L#]T&
MCUOOJ5^&NKC>Y6UT9^#+D<N'/K7,(4E6+@NA?E"7_B=2IEJL',*3X0 1]UJH
M/N'DC8@5\::56C8-9$'FX @-0I:4(^+&,3.W:TQ3I$V_9$T\-1QX<[>]>F3;
MU>CT6]0H=H.TD&&5Q"3L2DMEX@F=56FJ]F\6_$<T7_P2'"GE>!4KS^WWWS^&
M9*N6<=K(-H6>CM2J<#A@78B$E:,T3WHS8)OE-_Y&,R!R#^]0&K[K6JBR^R@@
MV5?CK>A,MQ:#$O5#37TU#<Z(^TW]-C1LWL(;YY%_ZQPCIWA#W6O K1]1!]4\
M63+Q&[B:$B;>>VOB$Q+&\&WJ4&Z-R,.$\\?4W\LWIE_N[AU@%\G9[T$.N8$N
MV>\M)KND=M<P$905U&DC;*WT;OOF79MMKGOWUK=@JRFN!!V\707UE3DLT4^$
M;"#G\_J.N[/%R_#.S@U3ZHN3;(+:K&R"ME#2\G&L+'?L97ZI #I(S6<6,(5D
M59#M+SVYFTH&KL'51<[=T>S7:!?'[CAO5PI]3APH!1=CUHC+F".-G/9Q?!&E
MLR;/'36#M)P0#+;!6<U!3^VJD+>D=.K1150 X&"?L2-UB,0NQ# C6Z[EDG?Z
MN@I(8:@K;?#CYA94P=TAM<T?.M!"IUO2/)^:S@RE=&8S7I;X5GE:F9:2[HL;
M3,H?41:=XUW?YE-+>*BQXLLBRDH]ST!/Q?,%XXR9*4]WER*ZB(]%3@=.55J,
MCVWB4R(44Z$^-.5>-QI+"3F,>;%D'DZR2_7VY,5^1&^<1-CW3MV.F4"+%_$L
M9:+11'B;[!A"=G%82LW]YGA==I"-3^,U&6N A9S!'$XODQ)?D1=$X%$^")48
M<2<D7DJ#6FU_,)'<CMM&4OH52N[1J8N36IZ](Z]YI)2?6D0W54%GY64R:E][
M<LB2N?8SHU00=:55.FJ#QXR>77(<]I<M5_=WQ/'\L-?C>!C'\[+'\?0XGKLD
M\GN-LY6OOW-^.RZR;BN;XSKQ5VK$-V%#DAH3&KI@S^ZNQ7.&@S9+?,9U(_C'
M'^J#E#Q?-IPC(6S$@-00\.'VKN*V"_'%'=.8'-P!WXP8\*Z(HMUCYI0)-KP;
M;9!^HV\1&-="GF[S2NU;@;[!'P1:T1MC>Y=_VZ7_-I01-\8ZT]1-5DF87@CZ
MG<Q5PLU&FZ4D/@<,1Q7,YG&Y73 &Y>Q*.T@N[K  )[<.J4K%0Y6NK30@D,)4
MZ7GDU*[HXD+ER,;%)38JR.\I0D&[SF]D N)\IPVL;FQ"35IXZ/HD:[+W7\1.
M$QH=!L&GAGF&Z**X:;1FFV^9 ?TS("!*BNDJ[S:L-5573OX279U-0QBM+KAJ
MY,YI5WK\UNZ:;5<:_[Q'I>'VEE RB6B>0X7D-8RRS:6=VC?G8B(DYQX2Y;@J
M2EMT2)%.E,C74X)"8TMQ&]WTTR Q=3I>#6G&O27:KG*HZX(R7D3$LZ:N5T8M
M]I[>F4]07-8;TE/;&FV(P+N\Z7]]_E7W"+.X&N%F\WC(&$O,78;KP&1JC3Y.
MI%\3-VCA:*(DHZM,'6 E-T^KT<*Y>.6HB'4&#"8@'D8 CH!BW_^__)_Z1Q@<
M[.V_W T^7?CM40S),7K0S&KUG/JH\7+QM4P@'TA,"L?I0Z<A '9K28UCD85P
M7A=/%IPHO_!F5<0_UR,$2.J'#A+YU1X']UCM<:BDR"2J'[W<8ZL$J0VB_\ 3
M\(D)V4VOI%O68D#CFBH,EU*TI4@CO*$V@WSJKN*,QZZM>,PUV@@A?3I-&[KC
M36W(G,AIQJE^X:/8#]2S=_Z7\MDXHI$+M5EMXZR+BVZX:U>XZ$CW*T]1[;?R
MXM:>]W"PKNL=RD_-1%@^!_$4/,*,9I#!A(1[#-#C;SWG31]8\^R,[S/ Y>RZ
MM^#S.Z6D_!H[\!^C38"1/MXR;+L4WH;L24LA&1+1A F_E>DQG\?31$ Z1.5"
M&M Q3BBT>*[\3FHBG%=+DSU;%,JN21:FWZ[VX:B5&<5<B"@=;F/\=1(SMFPX
M@.O)]-+@;K0NH9%_BH^\U<TV]9./\OD\$5P./RXJ+2H&1ACK;J3=;(C%C&!"
M8%4:@'T;?]P-O(S[LN_B,1]3YDV"/Z*OR;R:RW"V5PXW;1O^VVUP.OL]3H=Q
M.J]ZG$Z/TWFJN[\')7W_DJLUG<T5!H9445,RL=76R')USLZB*O7Z:^<3JA2=
M<C"80[_+)*O43S9+[K;. WO4$JJ[R*/ Y,%KJ=DGV<F_BHH"Q<YQ SGODXAV
MY<M;FDLY/6N6115S(D;#Q QS3#ZK[0+#^RB!P#DE9P2^)L8N+-]9 "+&X<"[
MK3&!48JLDX2Z.-I]:R2)Y)VOJ2_85WR+WC,$%:("#$M40Y2/&M]&:<]9,J'G
M<$,D_63OJ]'V2N>V;\[9K5B(&[T,:!M)$5^<Y=R,A;8?"A538IF%1TC\ 9/K
M4,B);$K4.S9H"TPNHNR<"OZR2#AHJ3$3WXL^& Y,7408+)39ODPF?%FL5( :
MQ<3-C8)R7)X/GY!O7Q"E.'ZA/Q&>_U*J/))&6R9;=NRTE]-<MZ<Z_L,Y4J9>
MIM1#L@2O<H$, 4=&9[D<I]V3YY;2MTQC#[_9ZCU[?JL]6V^^2(<K)=TG51H5
M$E//TFLRZF0SM-ATO*F9^)K:]>FH/N]I@X6AG;H ])138E*=)-5X#$B(@O=1
MDE9%/.+AB,@[A?WT,;..^ULI9:PX WCT-3K-9[;59L$(MGQS?+^717?SX:"-
M1,\8=%/8?[J*/*K;5HY!>=VD,<]6&G^ZU%:=1A'5\K-)Q3M%ZN+!ZQVB)I[C
MG/'((#DE0_!H@OI\)/#1:'W_IV?UO?_I/3W^>'I\=OSATR%1^PX'AQ_>!7\_
M/#T]_/#IY/A1J7[W?^JI?K\!HV/TJM'!GD-?TGG^:"B99TPN^H \SJ\,C_.W
MP_K4?8^]BL"/D)Y?W++_HWR^4#;I8T/^GJO</+HQ>UO@U*<&-8-;@P=XD[+.
M=+/H&*Y,Z17%N<6BC)&V-:;J=L0]FA?G40;FDY K=HB.5(FI#@@JX\\O75WS
M>?1C]*J!X:J''0<+/+WD\"55"WI,AQQ07 "('J4."@5544JM7@>$Y2J#<54F
M&0')0<]Q1>&1"O0<_EL&^B7_KU*O1K8LNMSDRL8V-\ KELVW1'X?L$N7]P\?
M6LX,IIBATDAO1-RE>Q$77#]U0U-WW D<AH"JM118&43 G[:C3ZCGI60;7EZ.
M2RA#P@FH[7-%D2F.09-ORJ\>E+GN@.FR3:7)%^1)U"5,94G>L5I+X50YG%ZJ
M5=,@^5VU 1+Q?IW)SB1VU,)C MG-@D/ZM5J$]X8&Y"13DK:L'M5U>'2UL!%:
M\5$Q;6MJQ19]F*+#VXN8V>4TS8W#AC/A(Q7Q'9R]!9?+T[ZQBLQ*[' @9W!P
M.%DZY/@.'H>ZMY8&EZT\X[+46J!<YI,O!$"R*0Q20$E95M++%'Q3LPH<7(LH
MX8^R/'NA[H)N8N,4F0U"$-5NX;R!';EPER)[=#AAPA\T[4( RB54XM:4#"+E
M^\@9TG8GY:-,#'>K/Q"Z.8)K>$*YU$%G#H5Y%*E65T++SY(4M0QM/2-UL9F!
MV@X'=&/-YHI7HX/&3PH]MK;85M#3(\!*'A!4<2-HZZ ';3%HZW4/VNI!6T\(
MQ_3=8P9:SIZKZUX+B]QKP:/K _X2'!NB#)@@[YCB\CH,CI>3W><[OQOA!#QN
M\RME^L7>V@N]:4LJ:V9M<]=[;EY'9GFC'6Y8@U.%9,N;>L=63)4AS$3:UM!D
M.CZ"$'&:FJW0I5"2T(;EWVSA.#6@+B8\A:. F$'",8]Z#"64"(OG)#A$MF#7
M3E,VN<MDJ5ELZW.$B$D36>9V/EH]&QWTH7>=%W!:-"8F\.:E]LJZ>8XK,5WM
M2-2].=[ D1'*O4O<RZWE=PMPF[ \PV63HCXEPILUV)#K3<J6U/-98 M@#D '
MYM($:Y1+ZC/D<,L+Y2)1L$A6TU8CCJ/L2U$MEH @J>?GZ27#D69%5*E)8<=7
M.;77& 'B11+EDQ#1''*DQ*2:D\>H'@'D!'E9$=,@8 Z(^8='I2E-)FIF$_7+
M4N)209&<7RAI.(\SU#P*WZX:JWQ _4B6-&2IV4$5Y<[514Q"X=X=I<AYI>Z&
MGR^*',4N\!D)I46W(3KJ"$P05Z/'=O^VMK/;PUH9+^\Q^?(ASP@3I[1'AFW0
MFQ+/=H=(>%I4V+HF1<,FL+QCWN'7:0D0^=FU<]2%ZC1S612=]D9@%(\+"87A
M9$NR0#>[3#*Z5]M!J"\9$[R-(W<XU*JY5+K+8>5&_[@3C'=_[]Y\IWKM.]V%
M#RF7F(>S&[K+G&#A](W5/^O3BC+(X?]C[\V6VT:V=.%[1O =<'%.!QD!:WNL
M8;NB(E2R:[=.NUP5EMW#)4B $LH@P,8@F?_3_VO, 0 E:K)$"M'GU+9($,A,
M9*[Q6]\:32+LQI4O0'_5=/N0,7<VU8#A #0YRN \+3*=BZZ#*NT(>S=1E89$
M#7-#5]GARP^#R<P^58"#LJPD!!+FVL=8K]6L'Z(+X;4G\"Y=.Z\;8BPWG/ N
MYP^^5-69K1UEQI>B78,!7N(1++7)%WY9DC5Z4::PW_YNXE/9>1?$&9#F?S?Y
M7%'S,3)@)C=X=B"/YJXFMUYU^AJL;C!,N$9W/D^RQ!*#TH,= A.P+%)CULC>
MGC6UD 6:;EYT*I3([#0]ISDNE'U)/E_!5#!:@R\=) +U/0-9="; 2P97.D.G
M0'_4V@7AQGEOG*<I9O FBY-I;Q-_YOBM/?,%B*2X(T4V6-"T3&LK:?Q7:E.,
M^)-9T6"TGLDF)>RN([8#"NU0P,*UG=@"8I],L"4<;L[8VR-X/"3[=Y1%Z3)H
M5D+L1;NJ;1T/AME^VA0MP^SU'89_^+__<AE)O8A0]3;XJTS/48-ZGP\&W-Z>
MI#_5?(NDLQWE#VVO\4ZWRMX6>,IIU=.S5!'ZBP4J%]2H<VVZZS?$E&PDJV5/
M4B.VI9A)@1[5_R1SS."";7G)7F;D5]]VEH .5[S![=R;C$>_2P;5/D15Y?<*
MF>'K\(@@KQ<G\FQE,Q(;^.F)"KG\1Z[!R@9MRQKF//HE2Q_V+SO>Q/L1K[2,
M^BRJA.HRR<W;)N6)[XD(U%HY;;,EY)K. K/UG0NCCK&UMW^-]/@>W-!6D4['
MC-CTSE2%V\S98Q4_#S/"ER\9.+U]UOC5D#7FK/$/0]9XR!H/6>,GFS5^<X=N
MPR>G \+G,/A">O._]W<IG[Q3X">(0VLC45#R<I.V'=JMM=-$*TUYA?4Z'OGF
MZ^5=*S5&&;LEQ887;A)55;,DF#U\TF8-_1TF4WE!8K ;#['*&1&2Q\?';DTS
M6:?;Y4&MY8TH^U6)!#E<=+R@B&S-R1'C3Z598EDV\+JIA,P2,D.IE3'&VZBP
MI0Y,6TH3),8?VZ.*)]7YZPN:H\[?_SV$C_93>+7TP ]WJ <^%OFSPP5&""+K
M41%MQ: +]O:LG!18IDX-<D&0)5'I,"27"6(O*AOQX"C0U[RXR)*8D@=^*"<,
M<JEG0<E%PC 7-UDW5J*)#?J6REG&(^_++M@D+_+.-T'??3L)@'S#<]L_-FP4
M@]C<SW/>$IL_WB$<XJ2956F<1M@'?1"4NS@WOPJ=(Y6!^UH?3"H,[_2.#OQ/
M=.!O?][1TG*++DUGA.'D/YQ>O.]2\VTVQGCTV2;48&O8A!IZ?EWOT:0K8)=*
MC@;+FRW-VU]E01C7!D9:%Z>,\S2_RLGEKK5KH_)FH"V7EAF!6<D;7FKAL2!F
M)3?&J1/<O)C-H[O^RR!/#^<(I861P#^0%AT]Z[\LZ+3VYKDJJM3!2SERM,62
M:5F0!#KUJ$VM_2]3?L 3M469\DF*\2>796MC]MH[;*TXC]-Q Y4 G&5I>$-[
MD%0]A7Q WR?GDM2;I^6\64K34P)#G5$?#P3R"-O=QGK^)_M.G_J6GE^]I3?I
MA[;?ROK"TP^]=1"6*XXMG(!%?V YE%SYSX3;Q$RJ($*"O'7OO*TB&#;[/EI[
M+;OYYSNTFS_ ECL=C.7]#B)]1L5*I$B@4SFA$P95@ZAL6XO$=+!(%>(T9\2
MW->4,E",RY:2,,+2]H0>6X'"^JQ,0-@1AHQ_2'D5 ^MN@<Y,(P,$'3<EPWG*
M65I309<)$)J&[)R]0O@]0Z.=#GBSA!I0SUW.=6LBC$>^C:!H^NY-"&U=-DRL
M,@<)S/1)<$OJL">,NK8=?%%VN\%S[43%2;B+M$(2D"3Y2K!VM(CHQTCZ3M/S
MDG2,69Y/@R66HH6$Y3M/XX94 ;TP 9I)ZZ70*!>L5N,Y4@LJYK>7VX]'>O^#
M)W\V-BS E:BGUP/JB5%//^XMZJGO_W92(>XE&*=M%KUX?@NS".DK/QV?'.[3
M\CQ^T7ZG#L'U"2BM"^CF)Q&]$@7+9#EC< UH8]H:P;_*HED9XD>PI$SA%ZIA
M)>W7C"88/8NT!K%9(D<_Z_*_LH@0V7\T&3AZRU56K+$0@#YV.E73XYZ.)_<4
M=^K6I( ^%H2-0P)9>16,_Y;%2%@ QOQ9.B-&!0>[]6\E?:EL&V@O+I,HEZ"=
M"<4]_P'_Y*T.>]1\_O./;TP<^9@;NR"0ZSS)&^P>&G./%"W+$S(^ EG)63J/
MTHR8_S#R1\BI.(DQY,>!/#A('Q("CU$%A4QE)N=GA6>#W9*BE)EPG>/FJ;R:
MO'XY56=D.$P[K<1:.O[%[73\Y^C;/N$!'OIE/X#[U@<,2#+CYU-3N"12H*@R
M(Q.5LI$MT@V'\@9M*M7+A273J;(,'(]<(=BB9L9AU3 /\+TY=.S%?;_D)*-/
MF&)4P;$(-5W"^*-OB%1M2B6,AE\R?-?\WKD$9"%+WC)IUVJ9'"?&>;AE76C,
M%V9GS>A>"?)()\&J*:LFXMIM:6U'C[ _QHIQYR+XC O_JTKR//,D/>]C)Q(B
M(*V)YV=24$1_K)V\<!ZS!)>; ,>59'>(OGH182B<N8(4W3L>.6PZML>?TT))
M[AO#XF#6JF0(LLNX"D\!_9169Y))ND[L':PWFX6U4.%,"(UD'UH-B62XJVA-
MZ\5!*Y^L^HK 52NW%=I.B?,S.)IX;F#X98/\XOB-F:W$J69%\;7+^>2;K^;M
M\*X[=<L'S5-D2\#SRR3L;0GE 09E]1^U'MXSX7S/FOCEP<VT\)%A8AGT\ Y;
MF7?C:Q/DI<O,TVT:0OS?(NK&HQ8ON-<3 %EO<B3#,K<E6 '=^TX$+M'G$-R'
MBM4YQ!_T/@^Y2ZZARUQB.(=)1SRJ<YAXF8!*(4:BO'@FC(?RF8%-F!)M&@?A
MQED3+#$!0ZT?I,_!%F_#&!_CD4\CA(H&OG-8^T!G4B(==PV3^52ARWY#4P)+
MAQ63L@%9(#L]:F&9F222 AK&/@/^-\DKJ6MB\II*V>>Y3-Y-#W5Z16S_QH2H
M\5JOC!N4RKNZ\6LA&AT>,MH*][2/^UX^SKG[]AU2SS9KP0;V@X+NI_&L-FM/
M'\,/=@5L<J*$DK8#$8S4>6_WL!#CT>:5</?&)LR><SYX1H[0^JN C9KR-D4W
MP5!K/2%\QL[HQ* SX^V299/95.9VTSMLAJUN5*P?B^"=L'CU=7TE?M)$<$4-
M"*7N?NLFLK9:W&LD$9_:!KI#HVH+Q-IV"0PGF]"E /2Z^VZVMZ8BM8FDMV*J
M/<EW$&P!]APRWL7)#"0M=H?JB8'@6"@U37I41F,IXTQ!K57:]#0"65S]O">T
M-1[V+-RI']F9PV4PBS=O@S\IG5#]$Y\A(7Z#O7C]T[Y@+^0%WP2!\=-&!,;=
M8"_Z5J^[.C=%60RM?6YV:G8S4/(4@"BOKAT:LTDM*F6KYN!H_$\2E?NT2(_"
MFON.6:DH6/"+7,.+5$<9G.:+) .3';Y(\AB^6,*=SLA3#)WJ+/9-,8[PCE"=
M<"W%\+T!"Y 1;"N8R<GG3\?_\?[7/^=U,4M@X\C?NM[N[SIZKTFLVC/XR!E\
M#/=M?OWERZ_ODCGA83!K_\L_&KLGZ7_&HU<O3,= G.W!WKW>O0[EO[ZEO&K
M#WT'>STKJJ8<POJ[G;0Z1$;[U-90!US.2L#\15/FG"9M5\Y**<#AJ5*GTK=(
M4T.YSU53KHJ*N9:*#22A?IN>JXD\M1S 03I=T50@N(A,2V3$]'/8&6,G&,EM
M!?HPV"Z1/LF=4M$CBVB6YI0D=Y<*[T\U9,2/*HROV(( ']2Y.BX2=I!QU!&R
MK5^<)?"HZ"O\-T).??B@R*0LP 0@EVE5)E)/%KE,[ 5\0YQ4F+^G)J.U]EN
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M;7S%+P<G!\&[!#$B+L7&9[28FW)MC/4_N6L)?/T[F-KPWH-#:O 5'/%8@XG
MN'_Y0B<48U*"VIXRB4S?HPAKS>7F@K[^R.<T,/U3CHHFGZ<97_2^08 *F/]?
M<JJ6_W=8ZS^BO\'+L"/5H8<6+%LF67(>H0-K5D:[UL(3)G-<:HKK(1V4G<>)
M7NQ.AA!@ZVF0%7-N9"=M3GEY05NEL4P.6X"ACEXCX.J4QHLH(G@5)?8S77NO
M'WQ*<#TLJI<^]UXRK)89_(20!01H/FIF41@<EWB&/I(-\Q_P@N"CDR:.6 R>
MK$&33I^0L'AZTG%V ^GH.?K&S.T1681F2=%.Q9TI@!8$R)$I:C%R*P=@Q1"\
MN"FQC $.Q6G.1F:28S32@7*-1S-I&K?56"2*Y3<V5G%=&7E=68&MW9ZYG &C
M6BU383SZ0%V(\2J+R#"'[5%;GL/!^;[8GJW/3.\^U<W)O]3]28Y@N 5O"V)O
MS%9W=C6W;>_!";=MXDOW.36][G5!AQ-P.1KFAP'XX@)??AZ +S?<VOL 3=F'
M.0SPFNM'=7Z\40TX5G^G=4:)&G8H]VF)'K\Y]1T0-U2EPQY#^36IR>BH]9VC
MO6&[A=-E[+)+)<HZ].N%%E&:H?^@%23D./#=3-4)1K5O6'_SI%[5]]Z=72/E
MCL71X:?/QT<?WH]'__E]A<B]3^SHS_]\__'PX^>3!Q2.+WYF,VMGM]\C.'&^
M<*2""P[KAF#C!UF!2(K*MMXYDS^.BN4RY9BI[>DFD>IHB3'&8!6M2;#R=^@V
MMF Y4M$X'C4YDDS\\TFM^_ZFT]X</']QNW3:7C;F>.A7_@BD"]&124M&'P@X
MB4C24(1H7JPP8(MH0+>MN@"\%EUXG%2RV5Z/&/[%[$E9Y.E\/.(KIV_[6<7\
M1%R2Q.[-.'6%#]0(% T!?],:@=L 9-7,LG2.S"[*: :#D,;UA']SZ>$'L?>X
MIOP8DL2(#BT0,%#9+:2=7W!'<K<+89YZ\?)Y$$?K2B"+!%%$GT5@]FYM09=N
MQX?JL,O#*""WST W[$N[G7BISQ"_6-:+(DL+JG W):*56Z<@0Z*SY PI-!C@
M,F$PKL7QC$<( @:72_*OA$TZ0Y),PN[D2:T^6J<) \B.[I/\/CR8B(0IU 9$
M15'RW))$C$?OR[QBD/+_@$5S&GSX\)=-X.)^0:YS7#H^\,0'!99/Q&0504[C
M)CXH[,5XRAE91!_ARCVE0_#T3OU-DI_7.O4_;SKTW%NGA(U;)<OT693G#39Z
M@H$6EPD%JZ8W2(7@?H7">,1#O$P@!+>6!^89&./)'0SV>!0G=828CE6)<) ;
M$+PYS57"7H(WGIH!^P<36WO/:)1H5E%: H:_*(HZ-XVY<[0T^'4]PS6+8MS%
MM"937$ZPI;!]#):ZXX]=S'^X]: 5_"D#GZ^)P2;7BGN472=P@K#!POHIG>6G
M)[SF-Q!>Z<(]V%2<@7_,FBKE;<GHXRP"P?2N6&)'C'GPFW[[+EH;V60*'B^2
MY&LPH<\B!P)U%&5S;92.-8\N$DI;@S'ER2PQC2Q@ $VMJI=03"1GMY"WZ V@
M(')8,$  EW'_+&0 ))51D+((PH/V&S(5?6);@_+=E*#E:?#'+58C'%:]>35)
MGK77XBEMTZ=W+N,;G,LJ7389[/ND:*IL;3U/<7#ML:L8J]G3XZQJ]^6;9U&#
M-7K83P>W,K;$B6;%><+%R?@,.&V@4AN"=+ :HH=L/@[T=?M$.#Z]2R?+SZ=N
M-_38T-"Y4JU$F238MZ;G=+KF$DFB6.0.K81?:8VG5W3UG#I@-C.4'S5WS)&B
M# P!X U ++W_1HSJX]'_H]A"5-<P(RDNK OI#]"G2]V:L8@T-.>CW/@(O@M<
MM8LS]F!0/+T_%_M,>)[&H^0;:&Z_"E%=+G<F])*8EK5SDZ"O#'Q[B ;*51U'
MB%N*1LUU++SKT,BJVI D:35ERS$\FJ(Z^BI=IS #1]6AN#A8^.%2^(KHK8L=
ME G7 L \^MEM!U'Z<8 H.1"E-\\'B-+][,'OA3&R:S: FZX_AV'9=L,&36Y"
M/ AZ>[FB2,B&:!9R,1<YF'0OIAN\0S;<F.F!$,O= B?BS:U\M#*5/(EM$YKL
MD1H[:<6>H*7![%A]7"6P.1)RM9$CU/O"!@W&:3!Y=?DL:8R]#^N=HSNE_O%3
M0<.F"4A!&E9P1?%Y6G$ +ZK]I<H9#) @<S%;=U)TU)W_1F..&HMN:<T%NVO,
M#1[MUM)D<6V/5OU:*U*,1R?]Y=6W\'IP,[<+5@AYUUQ9.2_):)0D62:IHHH"
MMM595";R.SAUX"C'EORZ:E92FE2I(]?A&L$"O*KF8+9UML-6L3\UWOVV=KSQ
MT/KH, KKI%N@HLU54\F?=>DU>86M96U-!<B!IAQ"1_L\X<GI#4)'YH@UJR)W
MR7=]_3%+YL62&'<NL.9'ZGW=YM$B[$W[:.'N!W\(Z_#F93KC= O6MVHSN8/G
M/V,<A<D8L,R78Z9\_4K;*9L@@G-.<^VD1*5'6!+(J21S[@>ELM<3GIS=8*]3
MFX4Z77+<#?^7K)\HCE-.X@>QP2VR$6O1/U%E(W6AQNR1Q428IA0\R410:&?I
ME\1G$J-AA%%-W*X2H95L!YIYS]9%4SZ;P\J!Q:B-#1UACR')9UC #0>S6H;\
M]Q*,Z760182]I+.)2BF%!8W*H&RR1)L^&18*-E(UY^J5S:*5Y\0H=?#81[PT
MZ5ZK9,"F2Y5MS"8L-B>+3;B8"+TE6IR!:L0O5>/B.-K1X8J6X0GM[*=WE-,;
MVX=P#+,$0_P+K'*=O-G@<6%_D;0P:$3,?C=+.==R=&$+-N7\#/,5Q*80:]M2
M=+W0"*S M]/='/9O9[;I-(MR0K^:=@\%<M?5"?'B";.%M-?K'T$H/E;K9Y3\
MY+XT6 P_MSG""K[C]$N[+%?T;A6\.7CQ,YVV-P<OGV,J(4+538F.*)A%53J4
MWNXL +F%TGYYT_*XOZ0M(>S//V?P-J('YS%Z>C#5[P+5;B1DMVIR\$4I\;F*
MB"AU3AE89FBC#J$$^6(L$=@ ;"(APP^:0+FI_F@W*N52$6KR1+!L FMS<M5E
M>35YPCYZUQ8]*(T<1TDD=6G%C2C)+D.#A)(DZ/L2E4_H-A-K>^@@PJ.+10/?
MVTW>0<%QJ4RZ"+B()92:OQNWC;.&4<C=JT&7!)XJB;ZY PB[S<NJ:)F0J2D-
M?J[;3XZ3Z:A"E% EO!T8SGV2Z3.ZD)",="%5;2OO N?PJ!7-GHF<>U8UMVQT
M\ ?NPX1Z!N(&.4;"GJ$QZ'W3XM\['T2/RC$43B1BC%,)0J;"QG_BM:X:QLBD
MNA&D*3?)0^.[MOL[MXJZM9R;/=]-GFH0G6+&I0Z,0T$F^>U@,N"I?[5X6Y27
M24Y#GIB^U'D1G%)_\A)9H[]BBVUX,ZB"IB:+YHU(52G"!MT6WT*JU^W<-1X=
MSNNW1MHK9[N)5V.]5<BQ/W'Y0R_L(2AC5BT.FS6GOP26S)52^I:J @R'LDR3
M^*%E^XTV^@ZA=-IJ:CM(SD\#),>%Y+P8(#EWL.%V#\_QL"=X;Y$I#[ K]I;2
MZI[M]5LV^CDJ\KAA@E@3;$4[HV7'O__&E4:#';_+,=(;53AW0S:"P4J8D?44
M51G8E6VSG&(;IQQYX PR]8Z]P)_CEF.#-\5*0#^WC,:_156P[1W9P)-77]"R
ME]TFW8';HQMOX+1CYS"7WY#MH>W<IQ,LWY4JWYY@I<3$D),[AX?C-ON:)"O<
M6PMLF4;TZ%PEPUL--W.BPI,\/A"MY3ICA[)<%8(J(D<1ZW>P"09!B=+S-$M.
MM=AS@6[968H8/-M40TI;I.9T;D4YWDG/8U_0U:5?WCQN%_9$-<\1U[?%5-D*
MRPXGGX[=7!I,6_Z@_N[3PQ';XPG?J!:UNS6QB),@>GC&*F;XMQB]%BZNB&%:
M;C#ZZ"PJ,1#C=93CE"XH!@IV*[$X%L)J/$80@2$L4+E,\T@!4>YCZ6%2(W?+
MU,%!OVPA_:;X**^H3$"-%KIH%D?^<E",H0LO=,:LBGD\ZJZ%:3>W815;]:Z(
M,+9UMHNB@:N3/)B\>#UEJ@-;6>M+'\R3D %!^)F-38L,'K1GI)I?ZHSQ<0F7
M093<KGSVYKSJM,.PUPG\3TT/7F61*#>C]V@'%1GM8MAY$[)!%VG.%BA!D;6%
MB$EM3O4K0GC%:W.>CNCO-,H?UQ;<9_UVST[U+7O^';4@.\B</SC..YWS[4F
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MH"QV5P:VE,6+#7[U%;B='C*E#5;?>.2:?8,VV>FCT.-A>XQN;@/.[5,OAJL
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ML5S2H8T"2P#+"E"?)K4(J 1Q$OB_F66(Q6$7Y6F4FQ(!\"[YAR4XALFB8V[
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MNEO1^=,]6YZGYZ2,)*KOD1C@!NZ>J'8$?PIV;);YU2=@,ZX*#N='_)WCJX,
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MQS_&(Z,R'1F&LHGD&(+MK$#3!FVE]M86O)N*U1:\37&]RB8ZJQ)I6XZS*RY
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M1V ['GTYCY^*?3 H!W[V>Z5;4L0U*A+F1))^&FFE4A/C0CP$CK/I-$T>UT\
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MB:*L3(6<UBI]DL>=K*LZ66(!'E@>R$ 1)\0X2-0P34D>042\**JQ-9?E/M\
M^.%* LB%>A\F*23*"TW.6<XWUN3<>8_2\;%465[+0"D-"A87(9 F6N[/+]&F
M4\=>P1[/*3<4I (JJL3JM<-:9@OKX2=T*';!;;A[.7!30: BP-N:/=NNXJ"
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M:#9VFHW=A=%K+TS2GK@6;.>Y:L&Z4%MNY*G7WSOL ">LD;)5T=<R9T/N56<
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M<X9HO28QHT5XG]-#/Z]8PY5".:]X+[2VK]=NI>[G/N<E5OIFBZ=I_;G/TXN
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M%3$T/Q&E&2L"B$@ZEOD<+"*6R>CBH^5NV5#!QL]K*>+H@%U!QG8(PS_EF%D
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M"2%)7*ZX]<YX*LX@]J4D9W6:O70]D\V'0&0O.[5?"N#LC_Y5J_Q_4$L#!!0
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M?:IYE8<AQINXX$M@D41C5^. <,D@]\)2T%A5 <<XP<3S&H4@.>!6 )84389
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M#8>$!7/U"#1+0%%-EW *5GGZOP^=*%L!0A_'4B9+W0V'I@&!ZD#4H[3@#(T
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M!SG9:G8UVG]DB0L)[LU6*.G/1)@?+Z\_+RD?39!A=L,Z;I3/#)"20CPNF8B
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M!"?I%$3:P,&]O\W==!F8GP32D^Y=XT4)W)CJ&:>#L4CVCNC?&%V;$V>&[LX
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M=-/\Q6*:6ZLDT)<SC:C^1,3^2.$KU"TBQV5(^$YV^O'SVHN*3%-A5.6W<NR
MY40CNN4A"X/INHN;1KSP[8"J.%(\!Z@6Y\/':&<.]'B369J.O.E ,X@K0!57
MMP &T%1C7OPF4ZS(!PU_4Q%P=7+]"/1RP3Q1LG>96\NL_N_9J1+W 54O$;>Z
MNN32E"D,X:$,SCL>"@"[H_XL.?P1];A5;J9]P+;^D3J#617;&CV8' X&( !8
MH"/Z0W#)#0B,\,:"/ <@-O "PZ<=#&+VHC?P-H\%H.=PQ&@K5:A3I<:#_H<D
M%BH@X =U.I^?2/H-F--'#4J=4USZ8C@4C<BOWE&2X,4+M_"^!>&]-,\\*>^7
MLP$?L_]J0CG&[<03P9N@%N"0.%,@U^3D+AMX)$;NQQPA* &4K<C)(F='YT"D
M"9*\FHTP5JN/*":&:9)&>#.'9EHP +'8TP,OAD96",DXUU"L>*EWGA70=LD.
M^Y^__;7;/NZ^^5^ISXB5TWU9-MK\#:L1Q_713BE>#9Z=<C<4<N2$!\]5N5=B
M\EE%4[P:X4J+6B"BD8)#P& #A*'4+/L*.%I1IF+,AW'0Z71>&QVS<]BRNIV:
M<>?%7E(6Y_>L#]^#7GE_?U_'W>$R=PC/Q'78MM<H'$CEERS.R1-LTSXB"%U%
MC'0US! ?D44G^\?0ZGOGRCC)31RSB7?H!$&*/C@D2?Z1ZYM<][PGXR3.)A/F
MS0*VX68S9C/I?B!XXX_4BSPFS&4 *C_!RL !^9$6Z=PYGD]\1(1)J CDMI>1
M/$Z2Z<G1$>(:Q&]]%-Z]SK:-!F2'$QC1(/T@YF)#R&LW'*3*3\1W"1'Q_XJ!
MZCE2%^1+.INP?1WTZJ""A@$\+.;%1\F^J\TG"WF]"]98M0*W43&^R8"0RK@;
M<;.;]WTNT>[>TH"DL H=U#Y%:G!9>((JKSY@NS0@+D<'KSI,14SSLHY(3:[S
M< U*D&)*,^!.FQ(9(0OZ;.3X0(C. U*K%B3L8H>PW)&!PZ9^PB7L#(U(3&Z!
MDW+(2/<1;Y$:Z<12;&43U+3A82XN4X!OR*L1,9_=.4H'-^+42YR^YWL)]VH$
MND*OV58OV5A\Q*AP0]I-I?!1OXMIB,>)**,'LFC$Y0ZZXTE@@H#$ET:I@R&+
MC"NA</B%44R'6XT4IKX3?,OVP(-]);\K'SU$-1(HR$M2KF[H P^9BSEX_DR]
M):U\_H/Q08!XCC]3L.*I.%QI+/W1:UA6! K6^]")>,8L.L0()!"L+ IHL]$)
M-ICMO@I;;*JE\5FEKK.M!>VL,+=?OC O@?T=(ON*=';;>__IS+C\:)Q>7MR>
M7=S>;(NPOE\.Q?R<"4X.;_I MR/0J0+WD$>/1:/^@=5HUBR[4[-:K=<XALH+
MX'-V,8+WK6.,(TQ-^*OSM=$POV*EC)'WT L&X[ RHF*M;($LNLJX^?+Y<^_Z
M7^H*VN$1_"7H3$"(MNETE_!<X+9*T&%:P6.;0"@N0&AO"4*!1:3ZCU\N/AAG
M_[PZN[@YNUF UL>0N2U0NVLA<TF*+JRAN:4U?#R_Z%V<GO<^&;^=__K;)_C?
M[5-0O2TP37-CA-O:$HA?;DA4@T X/3O[\!0D;@M"TWI&@FUO:1&WOYV18'@"
M?K<%VIKXK<+>\99 _'!V<WI]?H4AU$BL-[_UKI\D6K<%Y[.2:F?+I"J,P!OC
M_.+WLYO;ST*36Q?GVP+7;&Z,?+M; O'3V>]GU[U?SYZ O6V!9JUW0JU%L69C
M2XNX/K_Y[R>0YM;@LC9&FN:V-.O?+O]A2(8W/O<N@$IO#,3G$]"Y+5BM]<R
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MV3);MM4\ L7=-!O-=JMK-1NVV;3MHV1B-9N-ENF:7X-!'-7'R41Y*ZD1,*
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MSIDJJL<R>^G$<,,4%/AGY[DGS[X:WW5UOJ.M^:Y\UZQWV[MQ1"G[7W,'5'L
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M^@%#VWP\VF-YT:Q*WNYN-78AI:]YE76MDY\2A[D80'DQ7(XIJH[JT4JGBW]
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M"G_*<_5O?^U8YO&;&!^.0Y^>K>4@!\J[]_@)FTYKQH'WVD"ZA:EQ5SF,C-
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M;YYGD2_TJVF^X>%"59174V1'-'CMQ=_BFHBK>7OD2"8S1%@8!<Q[,6;PA!$
MR*/Q9T86N3^&?SW81<J3IYI1:1S/6[>7013F>&$J@,H"!1>_0Y%0P>$0'L0,
MSD2%@5*HY&#L!*-"XK^J'J-%Y:DJ,G-R55XZ!W*Q<@5T-03\AL8IGB:!B"&\
M98-QX/V1_J@"B,<B!L@:?C[^MU8FS*G"$>:N/&"JB\J1PAC1R,-4$?@G&'A3
MRL03Y*W%!,VF/% R(]CXY,5B5*_U]>Z&)P]_"IT T[J\N16M7L[ZJBA&+-/'
M91H'0M#J:Q=R\K66D(F"A$?RHD@76=;3,/9D!#I5AG&F'HHH0%HZ2%)>9=*1
MR<X13UP'^A%5^:B"".,2R\"T*TP'-RB,*L%IB7U%H/[ =[R)S&$2D9?P\U$H
M,S@%G<JY>+(X!F%K">'PC0P'2 ,Y^P#^XV$QA!H&;(>12Z'!KH$9VX8>U:Q%
M'F.8=3(KSLF%^L3Y=QB)7SF*55PKBFW.-11U'E'8-LIO!KRE'P CK%<(PTE4
M40 ^Q480K])\/'4<8^TQ+CCA%3BT7:QIF*?(_YJ*S\< : E\[HTIG+PCIF_!
M@1;$+G9.5"'!P/'7>LXK)J]AV*[O33PA553BZ7T847ZMI!"^@S45X>[PF)I8
MY"=3&!Y5!0.<!!@W_D:O& *GGH=/D(^C-%;$8 (X[Z8L2@!S_=3S$3Z^B;AS
M4\3Q&SW#%,/KQ9C%T:AT)!82%1'I#IXL(D;]C<A4O1/#B)(XN,F /=C,F-+V
MLM!R2:E8=L=S/8>77H+S>3CT? SYCBDD>L)K!B@QGMM7>?A+^J7,B[Y*:Q:L
MJ':>!R[E9L0Z<6J#<33*&HX3K105+_TF0KHI?]9Q0:E5,<U4J80G[T1"2\%7
MTTA$J(L ZUR1A:'$*<W \XEC^"T>SBB1=Z81K#JP1#8(92GP$CDY9)2J258D
M!5:9V$OD+RZ3P2A,SSFV:1.#7)KF<55&5V4.X_)6_C:3&K>3R[CI;,9F&>JC
M0A;C9O(6,[ SK%7A;+L[LI@4%:4M<I-TK*Y.BD6WR'.J'I_XN:@T 3KD(\H2
M)\622T\N1_"8U(J<N8Z'YR$<?LD8/V0U)Z@VQ,0[Y(8F%XJ9_4;'(V9"&S[C
MX><X7TWD8:N"P%A#@10"4$A0Z-6-'OX,X*1^0M69XC'HT(=TA"I .>AP%&*J
M&ZME/\CL0:VX%$^J\A+=XB.QG<,-S(+R,1N2RO<MFETDVFUR=CDD*3: N1+Z
M>(84F M "G@\4!*\/)?N6!10\5"T7N4;F;YY^?%:Z9E"+SE+HQ#./X"^C_5]
M+H>X>6"\Z^_!,QY('/4JX@6F#,% 5B @0$RF=/(Q@!:PG)G,HB$ES?A2OZD;
M.%66B8KI=;PJ$>/9BZ3CBK%DHE$%'M*83X*Y#RP:>'"RX@.@+[Z @L?/GA$<
M,:G%4,:;U"Z<.V!NHE@MR\EP^NC.(+LC1Z1RRZ3.$'-M1!;20W]L+,R2F,DZ
M'[+^I;)BLS*&NBZK%3<4A6E1K\K*I"#,(U"9B+:RTGW"O9(E!U'E/IC%[-HV
MK^V&=;C@G<SLTA\M,H3V*Z[V[(%[?+11F_E1\27)*-K#<EPN1C*$Z<K]F*I3
M>*$+-AAWTA%U:QFEE*#&O7VB;(8MK0A]LA^'X"^P:B;YX= *0'2(C@)(O.P!
M568D*ZK+H9,F1S-]S2U J;+K>==:^FU(B<&.#X*V%\R4.)O)Z7"2'.F7Q_,B
M($A*>Y6@$N0>6D#WG@M<XKE'3OQ-'&O"&'I(.-V0D8.5E1*?MEI00JR7$O$F
M4\?C9"EKGY%U'S/?YW8I&EY8_HRJ\O#L2<ZC<,(.G!1+%6'=11@:I".F6\*!
M+NV5 *LZ44IS+NVR4-^Z.EU4LU/D<2<E"NKV84S#X9F7EQ^B,X2P=LA'^N A
M@/ %OH35YFCY:B:>V(PK%BF>-!#/09\9]R37\'A!C&MM!P)9UY&K$<H4PG(Y
M:"#1+N660PH1K(.FXA)+/Z\Q[SP88=XWH(^S,[GF= &%N<U@3,<Q$A*BQ,%B
M490ZBRGR#%"-*-$,+* ^9;S'Z73*=2J>I8Z^Z Q:+@D*!.FX<.+'/&MY2&19
M]#[./.:[/XYX.)>EK<(!U>0=&OUT!OM0HVWC"?/<;82?\P(BM]NR*)MP:$W1
M)!=I_D,F+@OP"&-"X?(R-N#U!S-]C].'&-!5EP7\9(,AG %G71R+E_;UN,N)
M?Z'*1.H/T#V'2LB7E:VG+'!\,5+=N*1B"V$P"LD5Y,3>W$469LV7)X*G(^<^
M($>U=KM"1ZP_HRH2*#7@:Z&F:P_F/0,H+"K+8LR%JWIQ65EN[??B;%173',$
M4LEJOF%J+\0MC>8)Y'N"-1P"].#=._!<I# OOIW B:S*9-*(2@_-[]:/PU@;
M*Q#Y[@-5N@4;#KN&\;(8PJ^/>AI?(?^O*MR1^;RI6$3,V+=<JX2<W*.*?KR<
M+AY?8A)._T"!6G$2^7Y<(!PLCU9\'S311/>3IP/>60!M6*Q?,69ZD8RRBPP?
MH,%[LBZKY",^!R_&PKUIJ ^"OC$AP,27<T=1U5%B9S(7!B>NG&I/GF7R)/1>
M4<D2;RH.X7GT&=+^@(H4<;TMX39.B7B*\DTJ!;)N3S95T>SG]Q>Y9W)""X\=
ML9FY"\4J\:N1+[&1T'R\B@8'H.OPWE7HN\+8 AXFX',@Q]Z4N[CY+1%I701"
MC70^19&9[,TY;"JTJK'6 $4*_ZS6Z3"[_=0\*;)Y LE?>$\$#"2YDNF\!A+Z
M5\CWS7E)J@))";7$-_@*'3 $"1!A?Z8ODN"1L*FAL[7>D!JI5Q<NW@Y$V547
M/Q+#(! 1&X0[(9>HX$N..C3<%42B["BCL,C06A_P&V3?HRL 03?:!938IUP5
MS;QXP1WE30B$9"FVV: =2*F3QD"4]^S/<NIQ2%Z *$Q'6,,G.0R'0)<C!^]2
M\O!(YT'.@."\A)Y#6/ 0=E=A7+L10\U8&,>%^S->)4L0!M8JE3+?+>\^[05^
MR^XT\0QPACY\,5!WBT1<LTRAS(]2H.\^&JJ,KA3)W!#[IJXXE>'!1WV9$CEW
M8W\JHW6,]V R+[ZT?QG+FU>4I>("684J 5DC4RAW.;\7Q5BF"=-=69E,%DZM
M_HS"BS+3\I!NGC,/4<U(8^Y,QZ&Y :?W&$3RXU]2A83R. B7]'45-DLZI? Z
M,O>#)F]$Z1E>VQA-UY*M4Z-[9UV?_O_9>]/FN(TL7?C[_(H*W?$=,@(L<=5B
M3W<$K<6MN9:M5Y2[W[E?.E!5J"JT4$ -@")5_O4WSYHG$T"1LBE9E#DQT19)
M()'+R;.?Y\PX1SD90?8[V.QKN"D>+-JM]^!]#@P >)%85]:^YLND7&:VJ96'
MH[-[2XYE@LDB\T],+03FGV3F\K/0Z[AUW!W-<F1>;M!+6+[MJ>)^NW%:U10Q
M7M77:-V5R,/"&,K*";U\C0Y41TWMAE/G.'7A#T-ZI=C3CCCIV<G)TR\:Z?5N
M!$7/[H.B/62U(RAZ>GQT>OI'!T4->O_2*3X'Q%"1=Z+?T&0H<3:4XQ>0P)4M
M0+A39M2E;V_; [RE>4P-)1"U2Q$/%%?$E Q10D VU ;"E-5A3LAA_CO;H"J]
M4KX73,U,BKO3R!J078.0\DS>I%V)EL=96Z+%<BA-."G-4 V(3MK9W51L!ER,
M&/A"U.^.G)0@0J#:#G8H49\A>M\GK9Z<#J.6!NCTE.(64 ]YZM!<F;OC*C',
MB9")0%E--<U1]T2U/=0](4P/DXE<^/&"JKDS;,D'?>V:T!F'R5,K4,=_S="=
MW;U 'A$4X@%>D.>EFP1DB@6>QKP.S% WG8I,2M";$\9.-6)ZFI:JI"" )AH'
M4!"U9:6%$][6@*Z:I])OAJ:8E4NPELCX03LG)S-KF97]&^#W?9W5&",%:RMO
M)(=+O338W W#.!B;H5Q?L>QP?-!&<G;9@-*87KJCH.!K_[<=:3I*K:D-ATY1
M#AJTFVJ53]VB+G.G?Z/#*&\X2?3R*[J4M^?_N6#^1GHRW$=GAH([W3B!./4B
M?,)P3SAX5/4RUC*!<QX@UW"Z&KD0>A+KNKFZY HTAB\TRLQ*\<QW[R)GX3H[
M':)4J>;:2C,5Q#M6CSI0(G* GZ\\YG$NHD)3B0E ,K:V$Q4%?B/D-[0A+6,2
M Z'7.:;\*/V[FP>B**?TR!13/NK-NG5F=HH0L>N46X7XM&#DD"CDJHX' *\_
ML9&&5.UZPYC+Z)")#PN9+&2TN".']B^.)SD)!F<,\\&L!/9RL,]#Y1YGHM]?
MG.CB_%(&]!!<F.?9.L//:N0&PM9@Z@G_IO,!UIV5_ZJV&,0.*)<Z8_I<\)T4
M318H-WP<N$ ]%Y"NSW@4+<58=,#>80R\Q9.LO8)N.7U7F42LQO903VL;%N'C
MT7^#K/$WQ&F&V G0)[T1,#EZV9A9!"4C?#.!,O/^"7P="EC@63HO',F4%/E^
M1AO\RESTK];1%#(TZS)B]XK[$RBD/D\.@Y7"'!$+&'FG"0EU'B@P\F5B1NHB
M^O'GQB0KP14Y +##R/-!%']0Y.5[%0"^,:U0X8RU):NPB;?'J'"A,<)?FVP=
MX5<%&D6J<W&LBV*O6H."$9;I$AT]V",,4PY+R6?AOIP47 DJ8SK*9)2+C]M(
M%2+(3L[/S^'^?J^%#.VV9SG^Q%;I^RP,87A;3E5]+2S!7+B2A?170]&W)W(<
M:9I\/"-O(&T&_A@62V%2L5;;\:F2OS HKHNOPAC&(J*<DB\_\1TW*+-I+28+
MA;*:]WBV=>;HJH2:4#!>W"K<YZ;2%4$GXGXTN10B@X T80E"1K^ZK1$QA_H9
M3"AOJ+-=*]E4NT<E,026>F/)DX).,G8T6;[0K'(-3+3;0:*;K<GA)UB3OP_5
MU#UFPFCH4)Y#Z14=7>M?O,F&70+BOZWVTH-+N8$8J';I0KK.V0(O^H.O4@.B
M%:V%%P5SERB5*3W#8A[/SKZ:BZHQ#K)4&W);2*BC]X1QOXWD,-=3$VEQ@^V5
MPT+&,!=K!FDWT(N6AA4S-\B5'8]>X4&A=]^I1 T6BVFADR$1*]:$*#0P:&+I
MEU@?A@%5$:U:+A<HGP7-TM>_H5Q@H4-]+%$BP9>TN;8V^V8WCMD_MQ4S*B77
M+>ZM B JUTO2F!2MOK7B2GPI@)9L<.S3>Y8,,8>'-HY^]FY%]_VT)07<UCPD
M&ND**B&J.O$5J0UW^# ;&GX%HL[85#089;0'2KW[%X9G-.::L:Z<S\ [9/>&
M+FV=%=DE9&VY;^PS*Z=N+\$)^--#=NA5AB'&"*?JGV*%O\8]495&QPP5&E#1
M%MRD06WT9+3*?OTU+=WY)+&U\Y!H)N&V2(&Q/LL@6(_] YW<(0IYGT%>1&JT
M&I(EJNIP&C[;2]P/6C-\_1ZRS01Z5YB9#RX^]MHUV$.J",B?OXANNFXN));9
M<@Y>HK,#W:@)7'W=-\&;D')[U.DR4Y5,$Q:)%XO.Q.E>P/_!G;8A#^V*^S91
M)Y_>\7AV#3>LZ9D24J0( YQ^EG$:\ =*#=-^I\9/H<VAH/&64U[WO(J<.QTH
MK37)$ IYB7QENC1]CH-B0TKM<6ENTAXZ5^@V[.NZ]LB-JQ$(\.D3"3"O)@*3
M+C?\VC[S&[-^[=+:8&ZZJ!_.#&V\TAH<--QC>"2'MK)MFA?"".S%M Y-]R;8
MJWR%S >);(96(+:_G8"LA^,F_.05',;<W43Y,U[E@#EJ2HS-+M5*%<MCM2P7
M2W*##K?4.'>9I;-@4VPY76@!5!J5[DK6E.Y3X*LWW98;_N8*8OS1+4F8TML(
M*R B^L1<E4LG,:H-."@:+3T&&W,B&44<4Y!J!*P(5&8(\\()P)3_J  WQ1&'
M ]R/X)^']P'NWQO@?G0?X.XAJUT![D>'?WS5+_!U*[ C-<]"=-Q,P( ]QUEU
MS&;)>I./^.K00!6B)%G%_! %*BX.+5.*DF+FS;1:E-3@"J)G#2(N\XONA853
MH7X5'];5,B..7:,K6%NKJU+&#!8R Z%_/9KFP.'<QTO[8Y.WU@O' 3TS0TEY
M5#\="\]=\G4TJS+JJR=)KU9_M+5#[LGI1@I)PA:5VH2P>XKY"BNM,D<,.4=I
MI^Y/4.T5X;9XE2T)0]BFKHP?Z$/'4MNYXKHU:\.@TX%F(L4?:LL?8"$<>>4X
M'AUVS/QJC.GH:,);("5>0-N;NLEBBU5T3*D>=QP]LXG-74^/>4F31BHN60 I
M7\TAQZ]LW%Z[24+5_J -2)*_A@_R=[% PC=V[#-#91IUY[M6:[%A#IU69.)V
M'$$#QB[""&$PQ!*I]QJA,>RW/-3WNI:&6U)L"K_IMYC5U]QSQ"NZ#"/>9T@2
M\%IR?>_9'?+LGF.8X7MR_ ^Y>/M#$8Q.,6G#H(DDXOI@@C=K?0:'0 V%L7QV
M$T.%&S,PR%7%P_?@2$CL[!C2JG72T;,/J=.9LR2 (B!_SH7!WXE2L-3Q.]/\
M>21_<I]@S(>C[I2D(CV>-0F9?-=*M54=W]KY4"89VS.+3>IHN\TPP\CV3$Y7
M! T%+Q'ZHORE!9@'*E6F/2Z<E4CTSA(>'\>==^?#Z$2(P;@-K!U_)B9OUMU]
MQ66:F0(&C']!:H]?>>*C3_QAD]GCS6BW7/?SUW,%=UT*\@&8"G547.ITG<],
M#!U+F,BU!/I5!@EI+6%H <H4HT2YKQ(B1U1$39[%ICD0DD4BRWJ+>7K$!M^*
MYY3,P27OW+.\(#=([&\,2T"I_#L61#T; JD&C@ LX&(ZG68%RAK'7,315FQ[
M,!M-SILV-I>@/ &,4<=J$V(IL,T[E6$+D.EL,]4WHKQ.O&"F][6.1%N-_B"0
M_F9O$\TR"%+RV&-/'A>(1\47O^5T&]0LMI28$+9*M\G_&0""=,^!^C?#_S@"
M=C*<=%-?%>=+S]7/+AW3^Z+)[9*;/:LF,X"9&>_Q)23S(V,@](N&TGDPN3^:
ML3%"V(VG'@P,++L7>3?(URD^$>7] [/?(9D@4C%-ZWIKF.$LFZ=P><![ZPM4
M.>,7W4Z]']K*BXVX/?46V"A_*VAP%$*#( G3ACL3],DC)@8FLYK2):%7QV\9
MO@'>E9H*A$"(;FZ$$1D<N9Z;R?K"^CH>-/216NP(19\!X 7*.PM4M#A>?S<9
M>8AX:HWMZW%/[\8*/Z*$JAMH&X^^SPBLI/LW<C';7RN^28%5A<"9NYYAP76(
M_HJY88[4.L 06_F.Q>8QR=L8\E>:]U'L& *5_+V$@QDD+7+20<V>V!S=S8FH
M*: I.;UGFF>$*HI0(0T8'1MPNGA_._IY%SE6[V8,^5&9)%1?A-HU,"UFJF,8
MN*3<LDE(Y.8JA&#'?88F'8FNPON&\3X;S;L#RXG2 *H,NIBSH"1WCMW,"J*1
M"\S+J D]9G19@8M$V%P$I&; NA'IBA!4O@;&P6; A5.6I>[?K?6BK8G%P@_/
MP0"@'SU$^Y^,P:!M:)4-7YA3:<$.P1L9(\(8DPE:,Z SE7EF:SRQ'_W(0_)@
M'G@-"B)!RM8L,1&1)2''#  @(]0B0O*CP0FV(B89:5(T3K/. N=FXDN3\<\&
MV-5DWEF8>M&(*A]M9.>,C5E;JUDJF)>>]P&DCL_5-N_K-Z]R'$45&U@YJ3?X
M<L99N_)GJG\B]=0H\H%E2JQ:8F;$9-'2!/T(*D(Y']9 (TABDAF2OQAQOU#5
M18 ,2**$7.62K5K2ZI[WOK["BOL)?2IG^ #BPT56+MKEUNZ7GDMXF'8?$ZF(
M\>DIK S2IX"58AHA(1+SINC (@ON)D,;*+BBI?IF#*:BQ_W:70)"=F*<!@ 2
M1-.)&6(C#%$CG*"'(UA<XQ/VZ!I3VQMW S5X(1YXK@OVFC%BP#3-?%,D]-L6
M3@7]1>Z.D]:*-%K'>!MIX(A!;@(: P0IW+;UVD'P$!&$3 "%EQCK'@N')*"%
M%^UFY'GN$#A9Y-:'N>?T5=S88-:YQU%R$IKX"<*BD\E22GK.+(IC<,0#@+0
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MVJ^&#!49]8,3>:MNL&8"2!I7R%1MHSAU7$B[CJD"=$INJ1$U/O>2O]^8"1B
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M_MH 5T&ZXM"7OQP6<7_YOXS+?_P[+_\K@SL/&6,;[JK]X.9NG^0!O;$C[/4
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M?"&,R)21JF>*1,#=5N?@6JPR H!GXO>N-\,EVBQ=@6V%(M&)5_>I'(O:0N9
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MPT0@?583T="T1V(:4,%!3Z;<.'*ADR)J^+?.'W*^9-+NW!+5ANL,"R68]3?
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M[4W=I".21WQ6A07 +C%!*KJ')8KN\3O+CM"_).A+X7)9(6*;"U5W:[BYC?!
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M#F^R7'Z^R3('^>9'7=HO'6ULEV.N4>P+W5!9=-,G0JFYMT+V,6:.#11*K/B
M\)N'[&_4#K4S ;%V<@&V!L&F8<0$"];?(RD3WT24QBA[0/ZC@6/YB81#?0J5
MHTG7'^.ZUVY]"D)M@)_]#80WF8BN[<V@3)_-1TI7;4)-A?FB$>1^$!'H\ANG
MSR^@X05='=]DC@"/D /H[PR6MFH+ED-FR( 2W ;3X2/ 8F2011*E\& 7LQ&0
M]0UVK@1$;(<*PTYXY^)^%7W2T20$((0H@)\B@YC!/UL")2'04M0'M,&$ /.0
M"2ZZ';_%SJ.P1U"$;0N!;_)&!EVAF&2"#>*3M2*/,K2FQO+OWSAJ92 6WL I
MP.XZB?\W[2!GXD(TS0;WO3,Q9GW7DFC0N2EL^@ 7B6RXVB33D8Y?!5C;-).[
MVS )TS0011BQ;4^_@?A/0&9HHD?(PD)9V@E",,4-UHY ?K%<8TQD:LS%#6*0
MA2G/ZF-63Y^H'5#5[M*"FT#T:@R<$31NV'4^ZOV%..E 3(KL$TT@8')/GXR/
M]9O#','^%3ML[*4SV&KN\B(VETX:GLEX"BF(Y0/\-N-9>.%#K GV^N=I6TV@
M[07,ZN1([E<X][W=Z*2;/KAC@TB]C]AN/K2-ZA2'Y1@<G(0/JMF3+,9A@ZT6
M^>5!J0W-:'8G@R_/; >3&>&C4=0072^DJ 7M1-#^/@B-S)HJ$\*6 2SN,5F:
MRO<2;]RMH2LL-&:@'D O 21=<J,\X^)9QZH!IEEGW#(4\^+M-A"O(6XO%3MY
M2]C^ XH"M,')"],8U'2O,S?'C(R)OQ$QDNZ+OH8051P.$-H+1^#@[O$=UUM:
M0''F'"0Y-)(QP.A>D!R<HQN"2:-7V>ZV: HFKCMJMA"1L"#% -'8![#-@R-"
MNJ464I>:?QR<6)%;2/>0CP&F8L#%M:D0Z%/"PU991F0)5OZBXIQ+3X;&G_+G
M ;LZOD\8NE'"T%S88ZCF"Y4Z?0?*#>9I7E@7X6YGX\T<@E3(X*[?IL:T^UB+
M&3)>,,'3.,FCBTP7";)3T4&"6F\1]X#KPSXU_J_P8=:K+7?8]X4F\OD.;+[1
M!!1UU\SQVE384'7I8V%]K=S&D YLK#$1\)*\Q(+<>VL";^M5)HB+U"=957!?
M5R.0H:KZ=/S1WG"/U\W" $4?^% "Z-GT [WNLQ.:2.41'NFGQ:"E,V,Z1-_P
M]!1Z=T-UPE-VBLR?UR13(@\[.LTA)(.)FD)@$3U'S56-E(P)! BPMQE?VM(K
M0E:0Z 3?A^_%,[?&QISR;NUB9.JDS8D2QRXTZI)R5057GUHOE0D%X6?D@NN,
M]UNV0ILV %SM B+]M.IT*UJ[6$F335X HV+[+;36TL6BQOXJ^%?;APJM=-]4
MB!ML^.=1_25\7)P?:D@3Z/<IW62#[5RF,_JK]//.9OLCP/(RN6&0IMXQRC@"
MP6Z0<#&Z]EEX)F[6<P@LT!G?41N-(.VTY+"_W"#L/.+]72PS.'K*A'87=^*V
MPM^YAO^4X7LPW^8_'^82#1^/GHD5=TTS7BI4RYJXP$#R>GW9WH=A^>1+*HS$
M#!-2$TJWKS=4.@ 1JT1S7I/1%=::TB_!GT(A+2.2H*1FGPTZ: #4%S54^>-H
M#%I87X',:M9HOM>F^L4W-L&G"-["%QV1O4O6'HL0'%Q&I[Q=< Y=D=?,W=Q^
M1Q$.LDOV@5&6+Y8ZS(!'C_#&0R="8@%[94J!S4XMYZT8!']P8/@;%QMWS;59
M,^AZYYC,?F) >*DWDO6H> ;N^_6PS41NO31LBF8K3BG:M">#<\,FL*=\\T$L
MU*68]!6U8=5298ALIH77'IHHU@D\1TW@:NI^#Q_+NU\KM""WI_.QAZ*FN^"S
MF$V^-FLGEWHN[F9@]R>Y+"AIP,IC1WT<UQ"/JE$*8UL?W.-]<66CM"D(K=-4
M)D[BH:.T&5:?S?V=HAA$<QHL(7L$TLVV!1SJ1=B,'";74:=[JW2\R[8J<RRL
M084]WD-MURS[#O,4-Y%_I*M:K3E.:M/EP:_0Y@MILNTQL5O<%K-\TKG0+H?!
M^%S"/'#)[B=I-/+-/4#R^^!N=W;$=E"=\]TGH2 )8M645YXCBR3%VVI;&17)
M$_BXMEZ#H4#UHKJ+NR@8 P<^B:6PN9@XV24"6C)RO!%A"X@ FO,>6YG(NC]P
MJ^V:P[2>,K E'I>IV4(6C-/X;MS4D&[H]MAJSSHCO''Q"$T+]-).@ /RH%(<
M@VPL()<IM7A#;W"]L8&DH0 2=LH(XD<)LT?BRE?4J+PEGB"R3!'"W/VB>,DD
M!7-I0E6"5U LAYY9&[5?NDW7!!6UL>"0)@5<+1P8B9EZMK*78$(REBKR)UE[
M!=KSNG;;EZ]9NS#>-C=W%.BK:J;7KK'=C_$ 8:;Q9U.WAO)]O5FWTRTOXCUL
M.@2IW080_!G9-,(-O7+!)T.\SW"\0&E*I:U\8,$9SZ)/'$*2JN$Z@T,!+Z>W
MDZK(XQRZ"ON(C-8OWL,[>,M%%\6#LZD(4V:.-G] X>O4>1"_QOU,:A]8A1:)
MC,'0,@X:7(;QZ =?.FQ<II+0,7"K\L9^/0HP2V23H\*4XQ"ZF[!_K&7\D<O8
MKG:G28V.*B24P:A]+;[Q,-C5UUQVG[M++@DJ26/LW'XG07?T"+2UQ5)10/"A
M5-SF4O.E]Q_JRMPM'A7D/<A!+=TTU+=7&9P]ORWU?_X3=2X_.;EW.]_0[:RW
MPH.8IQ'U5.AEPDPZ,'-8^IG&,FR4@1^+4K YLDEW')])HF _<H:>Y_Q]45N#
M?I]K+DDD?27S:/1+R=VME:F]S\)(IQ?S<08(+E'0"B9IDT.^IX% *+?B-V(/
M%<>#PK1/G]PA'97-E?8"&*./T1XOTTO3Q66 +<8A[6Y4G7QQ8,'HUW@*2:<S
MB\FBI%WI),;(SE8]/&4,/:&"N?J@- U'@%38.'J6YMA1U\GEHD!U!MOFZE$Y
MY24'V$S0WB"[;8KMECTH$W[9Z^F>U"(B61>;QN;XZ=PDGDM]?56(B%4?"$(V
M$\7M*QV(,#:,B3OSN=.+,1<1#7JOY-U%/:'/&LA!702$DPCF2%.5 \5@V,;U
M<2?U<)@-)CV=&\^%WELGZV)W  OP5V\O8G G%*[QURA_.9AZZ\N4*,,K>H1
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M3O4-,LMZMN\N\N&782G;-A2#51G7NFW5G^AKTQ+/: G(YL!]H:*.FX'B:=Z
MO=[UEA3#F5>X4*Z_/HY=+>Q$EF[I1\=GC\PS/<GV7BD08;O#4(,OWU6!^\I(
M3ME)9.P*7F(."@!,G1K;U:%8Y^]7?C513845^[A*_B+P%T7@349%NN9@<<AW
M4K%G0>PB8_8AKMZZB:TMJ35%V/LP$^C!8$K5._+>>L/CVDIT==+4D?6H9BX
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MXY8IFIZZ74C-$P.BBRJH"JF7C&XDGR WBHG_"96W]-I@&^HDOA.RQ*)^HDQ
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MN6\^0_)"(H8+<U!C8#@TGB!DXRS]'X:"0K 8PFA8X,$,+B#,=!7( @$SU%:
M"WC[DI#+:A_"O%/YE-AGL6-?J.04.\?Y)DYN&?BB=@N2IB'N*X(M .DB1M\"
M70U1TE1RS\S6'DMBNYFIT781G6"6,"P%FV0VKU4CL.!YS"H&ZS#"?1V:=UL
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M>@,J%\LI<+=KLOY[[=.%MGDFMDO4VVHG,86@^J#RG=I]"EJX 07\H$2=+&:
MS;$[7)7EI=76&[;-3?>K# H?L!MXP[V/\ULI9S*1@XF+(T' @>Y7SE"J.CY(
MU_:G.!A[]BX6^JD*[)2B)0YD^_K(A2UX.[;-.9M>];9\1%QCK)B"MEG=?VV[
M5;12HLERO__+T1[GA$=DWD@@';2OL-W8FV33(4;8<)I8:Z&)RNL#DCJ:#F\D
MQ :V ]N&[HZL'H)3Y,$U@9BZ<T(]'NTF1IKOL),)YR&?A(.!\2Q;QQ0N),,%
M;",91]U[A_P<+AD@JZGB,1Q[]IS;K-Q'7&W5E%/<E"]R$9 PYPWGG;8(ZM'K
M=J1E9* [+6:_!EOQMJQ <)/"YA^$N#H^"9!CH!JU*>$OTUYO4[9T,DE:ET <
ML('Z6@KP296!RUR8H_PW&(B.A")W>COF[H()G, "YMXU:CZ,,2LY)DLELSG"
M?AKQHA"GDX;HF!;,LRRWD$%Q;)UB8\'(<0FKAK>Q([)%7ORX;1J\CIZ3I20A
M4XQN5:&+14D^);!-L ^PG')22GAJJM\"FTT9#JMD%/<))L&> ERI0M>QMMZ*
M[YR));=A 4DTTR?\DN@N80EDH4:"NVLSI^[Q6TT9_O+-IPR=_H81EE=B*/:$
M_5 ,:8PBC.5NSA'[Z8)]8=@$D4WS].F%9'MR,QKK8^KCID9O!4RN.%A-(=6R
M+:1'M<4M^C1NVWJ]]V-M5YQ*+?6@A--)JA]PHPI^,JMQCH7=Z\B9N85_N[^-
M)]$.OE+T:Y+>9^'8"EWKSF^DF=WD5-]8/GL$M6TC2VL.PBU3W0\DO4WN8,O]
M37Y?$#5ST9BQ8@R6?6>_1ID]#6C:ALEJ.I=J5KQZZNO$8\DM3%S=M>936\T7
MM5E3K.$+'DKA2[+4CRJ[]]9H&0JAUO]WX]9@,Z;9C27\K@B<Y*:?<#',0W R
M_3[[*YK]MI*T;:0BWXPY/DZ30:R]LE_7/"^_M;?:ZSLLN4F'!C+AX!6""SC7
M.2]C/4.\2\DMU.>2+\7_7:$Y36@4RT"9X-L=_;C*^&"=PETE/+07.RN75U/,
M6RHD*U,QV-?TB(88:78Q02?73=L.!!AZ*S11LIE)HK%SC)7R.EO7YB;"G0W'
MFP,WW=>3;N:=G@6YM<)UJ](.+_+@JQD+6#59:P9$8!V_3S,*_#8G;')I:B-O
MI0&)RR8QG8NAV6O0NE,L<L:P;*3-.7X1Y6S&:3\-7%]P:?&G'%S8VI_% \SM
M]@03)I=$[[5A(Z(8KM8QN UP^+,^UFAQ&H'?':-!(VQUX:YF+YSNU'C8"@FN
M/A&]@/$R#_G>UB0VI*^V7+<SB <8N0\1, L[</3SNF*112I5)7]B5@?AZ01?
MGZ'MJ#JF4,>S_EGAPN3.K5?FFA?X$6<CW(QKK/GZ#:AIUCH&_8FI<%[_%?M4
MNS05RX(U1B81'@M$J.W,@%D<E5?K>JI T][R-+P.3!!VR3[.4SNF58(4P#UH
M#4:=-F6@IM_EME0_/ULB: -'"96%S%=^F&:Z"^,AX_J%RMTB%2(.+FB:I-SY
M1[-IM(3Y(?&RS'N<)(MFJQ<=FAT6%3?IG_.O-.6](+_<2C3.4LQLA9+?XW7T
MI *U8:T0_4E2Y#[O_V?O7;O:QI*VX>_^%7IR=S\#:QD").38D[4<<#K,$. &
M,CW]]IHU2[9ET,26/)(,[>?7OW7:)VG+-H2#3?PE 6-IGVK7KEUUU56=R"5I
MKB3Z*.; BF39T=)-#!);6]U*,:U%K4]3Q\2O[-F_2Y9R^H<#C%*3U50F A@(
MMGG C)$:@4GIF0Q:O*5&);9WE!3!TO&!^D=@.$+JDWALR7:K(?K5Q&S#0T-9
MSQC3I<T*SXAS(?W$;:RZ.K,!FN&)9],0.0-OF*G:U50QK3:AU ,FJLPTL6Z[
M;Z?V[CYVK<F)U]NTKL" 2H&_6?U*2I)?*)24WTZ:-O&$ R@OE6T1S<J$%A C
MENOM$@'1K+Q(%82=*#"F#Q):0RGA+C<Q,V%>>YF:@-Z.(T-9%42.8HJX@:;6
M#"'W)#^+K^//K3*^"!'J(Y@4?ZRB]7'XYO0OR)SK<S&]P125@SPE>M^7<UU=
MGI,N.@B<A,[U>971W>F>:0H'+X[2$8V)SW.A2M:DUA%!MQ&[H[]*4 1R)O*Y
M0[@B#58H4N1,KDNB,W..MEUEHK''3G8UY9'H2:(DDA\6[;.]]</#?6J]/XHH
MD-TG1$N/)I?(K/9*6)N2DJIS\5OD[U;8&#\VIHI^D6[LOOVYM!LZ#P9;L92B
M!H?:2O,$DTZ(%L?K&%91C+H(EQ!BO[X[ZNA_<D,L@/RS.AKPYU-B5V(P^"+'
M$\]1MZLNXW3SS\SDA3^IB>??TC[_WX)3S_8SP\F0WV,DTO[R(GK?O4K,6]O,
M2J8RQ3!5<DW5AV/XNU09PE281B:^J%535YJ=7H>LRO-1MH&I: @9DY3O6<[C
M(6B^=""\N,@BQ-A[V +U^V?1&0DW0IV185EH4MEW;F]'9^)/13+5I:9G*CFO
MO0[M06DOUY&S@)[NX&'&*U[IAB&.,5_4.?XN*\VL]+SY)*J8D46\&?RA<POE
M<D7IXY+5IUYI,5C=M'K>+6\KBW_3/7>28@GO7RCV0XXJ4L+D@(MY>\@HU$5F
MAKS[?4?SAF,D0V&:S\=\>08=QF(MBHF">JLE+D_XL\J&HWPEXX3L4,S$Y90-
M3.]S<OM(]]O>/>-*X9L@9UYZ,ZZU;(X3H^8,V=TT[@'-AZKTO$,"2]P3OB+3
M!,2P66)U GT-_*+I)3+M8][.%,Z("NMW"F=87,__847_F_-UR01/Z_D =+)^
MJ3OK0F1*MVUXXV#"\S'2(6*WI)R5SZP6S<,98I4QQ[0?7PJ1D[A,A9!T7GX6
MH6],YWM*V4K\3I-RL="!X-9@;[I$8[G#8F!UADZ3L"@PW<H1.AVXXD-/.7*<
M9"7#7<&T.F K(^> .('2<8&!=^K%UR0FXF]D2\N);9FS_ZFF8- Z.<://L%_
M\@K)W_/5C.=^8TDTW%7>$N<81A^3Y]XCY?3J/!*><&5\J1+M=0_XI@ZN>PC^
MZY+SV3>'U8W+)PO3O2)YWB",AU7>U/J-S6F<S,5@>CM*<_0*08<N4U76+R?N
M#8(?T=J%.D/6$('4;PXO$XAG"DJ#M@P+N^H==+,?9[F5<6=;(-)DB913CEI.
MG/07"%<N,3ME4LP<H7\O4Z_5#(/-@:G=4;8\#UC<R#1F<OV56U(,GRA>H>3H
M7T9N[RP&U IG#2?/]L;=R.]Y=!U]IOQZI1MH\D2=";],G0:J#!OF04;75D4_
MJC58M0.5?>'L'*>BJ"@A5P&%?XH=;&BT=.%8Q=O+?%::L3OE+8$=K9C+F[IF
MF^)(32N=4<1:I&C@WRR"CN'EC_IQ3NQ@*LM78I/=$%U&,!N";7)R8E5")5RL
MZ$KGX>WP]]M:*\. I)4W(148AZA4 *9?YMW+"/W6--&9YGMR.*"T)[@JQNCZ
M%C5=/4ODB. .&[X!G)9$NJ+CE(E+)L5-(/;+@C;BRY#>#3G=[)(++A$5,ED-
M*HUJ\DRIZE?>&F0-0 --E6W"3(N2BT?LHWR9D0Q;N[T#)T8D,X@--:6;;A"I
MRN!&AU(GBA)S*$@7KR-\!G^7HB@\8IM3OS)KLB,1PV7KO#!3G2*D(TXF6!4#
MT/*4?N@[U.P-Y6ZFA0H=6>!'5X4NC\%O\8^"&7T5I^,<R<>E+HW+P>Z.T:(J
ML&EK'2<!@Q_8[NH6K@XD?32(J4JI31R@;JKNY3Z%Y5=;07&O*0YSVQHB;6F_
M6I<_R*/L"HFK-X/J)<=SU-78-)[NZ'WKCET$EPKD> Y911X'-N8%SG30BZD,
MN<08>3P,>=-L.83MI)?90\;O]-%IHMXE>]/MC39YE*'I7-#2RK#8?BAU6@$J
M+8(RO6YJ*DDY)GBJ#IBN%U]_G>ACQ([XW9@^70%)T;-Q%PSA=^U%6)X(X/8/
M'P%TG39&&RR/\K8L_ KQZ-Q$HB0HNHH$R\045E'OUPW%Z -R>?H[_JC$GOXN
MS<U!N10"=Q4.QB5XDK%AK;HO \?)8)N\Y0)$RD>'4*JKN(=TLE;B@/J2AO'Y
MLJ;HE(==##:X\>?,]TC5$^BS;>?S#GK7?[%<A34R>AO?X<*+ZQ]E+FJ2-!TC
M@?U-UUTD*2W75:K&20AW.YDWT#%7D,/L&^4YJ*U.=\F&6V[[*YW:/C!R15SI
M<6O<1Z\7*P3CUU=369/].T&IL*4@3J[IK- E;\Q+E_R=Y]9#\!@OOK9Q4ZXP
M9$:W,<,'&](1DQA?CL^+-$,Z5<4DI,>G^QW3_N/IDH"MA>']L'<%MZ-,A5O-
M'X@D>:'FT9C@4_FRE](B=VH#A0$"%@93T.$^CG'4(2G7NH0C.,UR+Y3%?HL8
M^.S'K2&_Q,_(*\RFM<6'&[0"9#ZS2A3<;BQK</^F@\DB&^0WK?O&V9FHY'%Q
MP%2LKREYZ\Q:/% S9"XY]'K.4*U$+I6_2B)*TX>LP@IRE&+Q3_5=U4R$Y9PY
MEU8QDF.PH3X5("T_+LVI!;:G1V9."LK&7 L5N<BGMU%Z8R<<D!CX7<(.NKL4
M@[3,4/</)7KJE!DAM9_%C&ZA=,Y4W(/%66S"(>C5SQ \[@B*<9Y-$W=QWB$A
M[*@ *=5O+44%A5,3+56+U=06A3*=N+IHR:6%6!<8>.^_PC0MCM(9HE.2"I)L
M[(5[F[*DU]IQQ Q?3FRI2'-34:6;L'WEJ2S"4]-ZQ#:6+<K2.CU%FW7*,#U5
MQ] $M@ C,+GQ2#S4J 1@X:?;04=S19? 1!H,%"!@$@QB%:/$+52:UDJ$+9X6
M,E<P+BT5J+-B*<9@4HODXKO<OHBVRWOK\X [L[[&]KB2;0K*.K4KL$Z& K\1
M$\ Z9QP[<:F^BW?4,=XU"P'@A6GH381;F:);ZP:ZP43'2=1EL*<F/!??>E/@
M+_IY9S4KH-V:P*T1)=MS0T%1M,)UX+(ZWM0:J&JDDV9)Y$R@1]077XK.]?+K
MJGAY)>ZLQJPOV8Z9)?&?I@'VLMO$F\A7QN#HATF&.0PB:5*JZKBIDO6O8*T"
M<%;1)]^W41WX$WM]WVZ78EVZ5N0/&R/96<5(] 5M.?&L%0P4F,\U(8P:O)0*
M,NM2Q:(M5 9^!"T-0U.XZJ<Z)S!>NC*V,OKJQ-(!4A6<-L4:HWC8&<-]QM!H
M"2.*UL19- BKSFT'P%2!,.H!</6DA(L@(46] FWPL!9*<5O,W"9TNVR2>'#T
MOU\/3@_:9\''WX/6X6'P^?APOWUZ%AQ_"DX/?OU\?A:<?3[^>K@??&P'^P>G
M[;WS]GYP?OPN./_<#@Z./AV??FF='QP?!:U?VT?GS1HQ?J_?>W+8;IVU@SUL
MZ_SX\'#CTVF[';3.:Q_\V#KZ^UG0.H(>G![_O?R*FEVS2//N\R952\$LC\B4
M3 9]/'<FNIBDE''/X;F9OB&.;,8$_HAUC88HH6 K.5+P]M1K.B +QS-SJ:M8
MJD*0T"Y"G6?X.=QKJ%M)Q68*5,@6RXU<,<K=,GOU17QL@XL 2,X4VM4HV5[G
MHA+EZU:3(B]"C@]7BY(AK8+OHK^IOD84^<QYTJVJ_3M KJ +*\RT&]]4E<:J
MY-6K@1=4O%";U[L#]K2T3;GS6G23=Q?*]09DA6Q3M8:N. M+/XQ"+LTTDR#S
MQD)MRK;_GH[+GG^[#O!$;UXF^QM&O9@SXB9!/!Q1X@(T'O8&R,QC>06LU(,H
MS :Q0J[=<(ZF)^LX:R6>L8ZG8+SK^^7[E&$%E+2)N\ZSOX<COQ]\G,!FBP<+
MU==G'UJH6O<G23B,N\$>3#P<!RW#WT%T5MS:0=+=_*63/?_@/_X7:5A3E@ S
MQA.*\._!]@'97JW'0UIC57VV/#9834*DH$0J"!'/14RLAQ1U;R<JKJ,H*2DT
MKCI,;8AR7 H.D9G^E8#8+_[Z##G#;TX-OK6Y&R?3>37D*VO;Z_,0-K>JAAL"
M$_-(KMQUIU:=Q1JK=<R&?.IW+Z/N-^5G)E.$G<)1)6YH<X3+04H/K]>8P:6T
M[!I!"XF%L*_=E$U=@[F6:_#V_ 9-[V'M<$CYR#_/R1 /N^B[Q[L&&:\\H;X:
MBV"==,?3[+_F?#9?6 3&QVWE;F)U++C*=&"@,^W"J29/U7$DKE4F+:6R<Z8V
M(JYU[O0X+MQP#*(VX!UC@1.!,9?2-4,H+WK:N3\"\64L22J=HO*!UF6BPFI1
MUV-B,J.5@8V17W*FIK9JZRG=[Y4?Y8FKKIWY5-< Q3#$(I$##("6R$$4S%MV
ME7<'Q/W9(-$:"?<D=V."G D]!]<91H:3&?<>O".!,4SA)/J!?*JA[QK3Y(C[
MT>]G[8 K[S7-*PF3IEY*FE>#0%SWQ$SM09@*SD91BM<S!/'L7L&B@,9"YI59
M7HNB1O]5E976=-SNM*U)',<S+Y=R1[W]G."U=JHNE<\T$KZCX'L*N<8HTA*F
MF/&*M?IS^J#4M$4&*^E3\368.:H>/^.*.>MTN%\EMSPAL1<_?$C,>TUH!2>M
MW[^TC\Z#DZ^G9U];\,/Y<7#^^> L^-(^_WR\'WSY>G:.KOV#H^#KT0'Z]L_.
M6^?MLV#_^/"P=4IA@;W/[;V_!VN_?3[8^\P/'!SM'7[=;U,,X*CUI8W1 OSY
M['/KM,V>_N#XB#ZBA]>#_=/6;T?X68L<^L'A\5X+6SN0;QT?G1\<04=;AVX_
MFKJ',)+6Q\,V#@ :@0[^#BT?[ 5[I^W]@W.,7> K,1+QZ>O1OKJ8'NUM4NR
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MW.V)_JF3'B&V$>(E@<Z-1'-91LHR)U'2@HT! 5B'G+)LL8DR.=CW,K7/*B]
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MAZ-!.HDB.!S0RU8$A)S"@<*E)]@3<OUPR8[C:GJ2YKJ-U( [,N#1 &-4%NC
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MZ(P?9>EEW(&Y4&)90@]<I8,K7=\2/08"/:M(JGI>">J:GPV2HNSB-!9XD,U
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M"(AH+J_6*< @2/7<[L:K+?LYZ'+D:?X"Y"7#WI>:?;6Q\V+NN=F "<XC_PS
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M3+MQJ-"3LK.E&#-R$%?2D\C<QP4+*1&#D$EB#8<%._65)Z:<YRM\#.1"5:G
M6!@'KZ-@IX.FFD1A)NB-BYA<1RJO)K4JM_0<.%3Y&!/D2)/,TB%/#=@CUY%
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M)<R:*?3%C]LRMAFT0X6*UM. ?9$* [S.= E,BAA4Y$1["G37&=.CAEK7$8$
MI!V97XV;($E'W@.I%*;9DR.NU"(A)PHFPR5I/(ARWOLL)H8&!P4$[L3DX+C$
MXKZ!G4$$S>C3Y#KJY'#&!FN713%Z]_SY]?7U9AYU-R_2JQ\X]>/%T@9[IXY,
M-6:&5FKMS1T=CC7MZS/QM'T6[/]^U/IRL!?LG;;AA Q:AX?'>W0V!I^^'NTW
MN:\'1WN;UEE9V_&'G::[LB%F3%.-@6PAW&N^83.8Y3_L]#EN:(4&2L$L8/B
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MBU_RA ^C,T/ 9Z![+#4-)4R6OA;Q>[? R).;-L_WA2W/?0%/4@96_/49 EE
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MW3"_5+K4>G E'0LH'6&6D3HPR*4L[DHM25KMFVJ>U2HOX"I+G6,^7M OKTH
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MF6*3ITNRQ"7 3!\H$]HXFFD@%E+(+BK&_C[+4'JGR!1#3I!1%@6?5:3KDTC
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M3<ONZE%*DR8PO6Q\U]5%DY!<I*P V.-B% 89>N-D#&\ +809V!F..9.>4/4
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M/U(JE7]#+3?+23OWA-S!!'K]*+/,UGL&7YS !)+UDST0VN,T*N!<H0/P8Y3
MH5[D#]1RJ]O-QE3M',SOK'B@5D'=TVFK*@/?P?9\"F[Y>T*UO/PN8,EWPE)>
M/R*DYC&?WME:P7F>+JO>_8<C=N\Y O'T SHK<-4"@JM6^W6U7Q]YOR[J;GP,
MA-O3W8Z[J^VX'-MQ>8_/'Q8"]Y0>6?QS8076NU]5]-#S5YFJ:E\)4+(L\_<4
M5/D*__C$-ME3F[\E!4#=M.#!':+[J+:U+ B7WPY>V1%K [,@^@*%@R@1Z858
MJW0\"CH4ENG&Q"N'*?&]@$J/%I?0W^V?9U7.;B"A6YHPFT:^::.8E@U-LVAK
MF<"^,W2&GNB)LZ0,*$$4P' 8]:AT,?=*EX+EQ777FY -\+HTZS4056,*H"OH
MC8!+EG-EY2HSC9/T6/;'TH+ %H8.[%%H>A:#G^?8HV2_B_C+)J]I*&Q8QV;:
M]=/WV=PG5/K&T['E(["Y$=3X]0IJ3%#C5RNH\:,=.2=I5O1!.M+@"U$\+V=M
MX&=8<;L\E"QHY80?9K"L/;YXZ<8W'1SM(4;M@_[,[4+%8,"1$B9SV8'WLI(G
MZE4]A4SX+>S?HRR&[J"%!I;S")FSL7EU-/;""6RP#?BO\CS7=/?S5#40)_ND
MF*B^,Q.L#M0Y$V)YE]YTQ2?%2$6SI?AWV5BW "_>-PP3#987;Z>6-GGTXF%X
M"IJYE>K?,V,5"S:9BUB5[3S%THS_4YU;1VQO@[E= +%=L%XM[OK+:<]+O@:W
M$'C? *E:UU<+/_]<ZH[53-DBKC_M?/^>)RN%/V$S1Q2$RI'Z%$7R$6:QA%R'
M1 X_KEF"*2\+*$!S+-5B2O<B"I!'@1C#^'82LZQ::(Y<>X63ODUI/6\FP:,$
M$>^Y)[=3\'?9@]/H(LX1&],+?&64%G-N'G8%[K>LX&+.\./WX*$@C_>ZNMO-
MMR^GUMI=K?"3V,53 :RK-5[R7;Q@J[O<QM="B^L#]>"8?.RC-!VX9M=5!'>)
MP<KJ6EE=3V"-']/J>KG]=C'G]_%[\(1V\=2Z]ZLU7O)=O+-8<[NRNI:]!VQU
MA3JBNHA3\92T\\K(>LKJ^57SS<M7BSF_C]^#)[2-5[OX*>_B[>;.HNWB&QA:
M*S-JU8,GJW@7>IX?OP>KE?Y1>K!:Z1^E!ZN57AC3:@%]6'^/XN(R:.6719HL
MUKRN,%L_U-Y>Q1V>\I7XU8N7BSF[C]^#)[2'%PS3LS@]>!)[>,%6=[GMKH46
MUP>-':X06X^VHU\OY@P_?@^>A+[>?M5\^7K!E/;B]. );>,%BS4M3@^>QC;>
M;;YYNV#;>&5[+7L/5KBM!SZ+%W.*'[\'3T)'OVR^?+O"]/P VWBUR$]Y&[]H
M[KQ97DMK94>M>O!D->]"S_/C]V"UTC]*#U8K_:/T8+72"V-:+: 3:^\RS ;P
M1"OKC>,D7JRI76&W?JCMO<)N/>5;\0J[]2/LX07S>RQ.#Y[$'EZPU5UNTVNA
MQ?5!XX<K[-:C[>@%8W)9G!X\"7V]W7SU8A5K>OJ[>'5S>LJ[&*R3Q9K=E=VU
M[#U8X;8>5C\OV,5I<7KP)!3TB^;NZQ6IZ=/?Q@MV#"].#Y[$+MYN[KQ=,'SM
M"K:UZL$B;,K'5KP+/<^/WX/52O\H/5BM](_2@]5*+XQIM8 ^K+,0OE5<AL&7
M>)!@/>]%FMH5;.N'VMZK -/3OA6_6:6K_0"[>.6A?LJ[>,%6=[F-KX46UP<-
M(*Z 6RO@UJ+UX$GHZ^WFJZW5"C_]7;Q@Y_+B].!)[.(%6]V5U;7L/5C!MA[V
M%%Z!>IZR>G[5?/MBA9Q^^MMX!=MZRKMXN_GZU8(Q4&M#ZWD1=@;1AU]Z\=6'
MQB_/\;]?1G:K_))9;0[#["*&N<.O;F&+VZ^VH,&1O+AQ5Z]^']@K]9]Q7L3]
M"<Q5_.$DS8I^.HC3X$N8A!=@A.REPU&4Y&$1ITEP#';D51Q=__(\_G /_7KH
M(<N'<=*+\*5;F[MQ\NS#^644].*\.\YS'',G&J3702_*NUG<B?(&F&;!2$_3
MD*<I1^G8?OV>PI%ZNL(\2/O!?M2-AITHX[&]V&X&.UL[+S:?]/RU>E=QCD.F
M6<F#?IR$23<.!XTPR\+D(D(G8AY<8S4IG-"*W$$W8O@"36<1%_%55)K:I,=?
M"+,('90AO"@:CB[#/,Z#L C"P2 81%?1( ^RJ#^(N@6U<Q4.QE&01TF<9@U>
M.W)GC@9A%^8"7OPMFL 3>3K.X(--5_R'X22(D^Y@W(N"$-Z5Q5$QP27&KJ4)
M#0D[AM^#OTZ"?I8.@TD49D&1\O^=,(]ZV$X8)&.4B@8\W@^[19I!:^?>J:#W
M92!%, M-&ED*%[MT2%/2@9FESJ7]9I"' V@6OH,3E(S# 5STDC%W*DXP=IY#
M%^.$Y@*F#@9@_M" S[MP3PQC?%G0@L_,^L$-,7^Z(GMWI\0OG0\?88D;MMS
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MPIW2BH0@2PLZ0)_8+:8AJM -Y72$O-&5@V8<ZK"@Q:"A10%J7#B9YV(6QEX
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M?5/W^#QJEXE)W28<Z-W'2UDN)W7;>BIV$KE4'$15Q/V9Y=K/DR'WNQU?=!!
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MSZ"=P,W_#X/[>8RRHN)Z)?>_Y51L=%J3*\.1ZVHC8:$])GWP:.R[D,],-^=
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M7E1UF9FN.]/_L=@]PI?)L;DMLQ\EYO7HBO60<1P=S.!".'.\*F3>4!H[A$<
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MT!5UTP((]T]*K-UB18I-FN;@4G^_ZFZZ "QEPC"HZM\<9Q1S&!7+6@>5 LB
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ME?"E)Z."(F^6$5\:/[0M^XTL-V:0NQUX10'F!7D.'([I/.&A3'8\I77&]I%
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MI<N\W7!MJUH?#XYT B]2&S1 X?PI.<T_&AWBJC9,8>.-:CJ96GNO'+T#2$S
M5AF7:\VJ=2O7U.CWPO]G=?D^(=(JE46M8C]V*<LUGL GP)K&WJ9Q2960FIU#
M5R0\W$IZLYZ7RMKY,WRWG#Z#+%&OP(1[$*WJ)8#A75/M!LI3F8H7'91MH4CJ
MQE+,%W!T"=#&N9,LYR25>2-3BMH%MYO#D'_0#7CN02N@54*,B*R3>)(*6"5C
M_>6A@.:/LK0Z\^-AXC+H@DSGEGX&GBCPX(FTQ#"N-0AN^7Q7WH-?]&9\1-*[
M<#78 Y;%.'@1& 'NOM<V9OK 5,?K8''FEXV-1*DC.Q"8\*,'MM@Z"14<E*F]
M0G(8%(D.AQAZ,NME*9W$679YW )C0"0]C9L0:=Y8(&W!:J(+\!(.^#<T@08*
M];0IES]Y]@O:Z[ABW]FD;;"N6(G;VOR:B]!8C=,A&7\6F(15X\&C\?5[F]!J
M'+[L<3"X&&NQMSOTE$=+_T=MGX6X! /7@.?T=,EM6:%2$E-U:[R5C@AZ"!W#
M#(D9YLOYB*-=5$)6%^6E5P&K/5VIA";P1U1_I4Q(O0.^=DQN8?1<:G1OR;)?
MAB#:5S'C^E?Y_FIA+"BGXS'I43,0<D&'=R>4GH08]?)GB3QC6<[$^^$U&S6-
M1HM'W+S^M:$*JZB* A+X[-:U,$3G=PNQX,G+D!O&N]C9L2EY7M=8NFL6WMN#
MMKO)T]:5L_G)5,CHW- ]-:-VL )<:<I-F!VF*;"6Z :EVE/"CK6AA$5\*=VM
M7;D=_D^<+T&;%V G*@"DU(=Q%I?6=63@(05T,PK?%>?)W,!OPEQ>P[SM!]V5
M\BAM,)Y13J1,"PN(697@WJ6,[2T.07BZ/A-THH8*U11UFSHC1PGF/;3/QBK*
M9M]A@OZ2+,0HXT_G3L:'G9BS>0W@)@-YVD$MA$?*\M1+,FVGI+H9I\*Q-%JV
M2!ES/1Z;$F^2U5:(MA:^E5"'= ^30;$ UF!A;H>3)24XM&"Y:<WT*9I%$>UD
MAUXB!61FSQO88TQU/DYX8[\]#1457V"O7!Y)E^#1\K]/9Z;VL*%:!5I*P\6Z
M"/"'/(.QK2V&K*-[<7OL<3%O(N"A=$4*E!'%,'*8(4X1I\&5V1*%Q&N-]UAP
MKCSF)*H:'7?K.SI60R669<.X<X]GIY@#(^@#& $!^0>3'TO9HZ,A*D=7&?^X
MZ<%&M2KD07CGTAQ[AW*5F>4K@C%-D2.Z5%H9R'W2'?(@QF%Z4*NF/EGE7729
MRN/>ZY7Z?="\C^V<$=+5T &Q(IV I+,+T7ME_8KO!D4N&OAS:)6M&$QQHU2@
MN(T1XP$M5AJXD5ZVPICQ7V0*7*KTBTCNH%GBX@B [I8"[9R*%E9YAS/!\=XJ
M\#)'X.A50=RLVN\<;UOE?JO;$@FSAF]9=TI,>DG08)WFF@3"& :$V<7I$$0%
M#. @@_A/;2GD1WU6JB:+O>P*O.YC/VSN^#8K+_]B.Y#F>W'X8K"#N4J2JS=*
MX&I0I_#=/N8PH<Z$7CAIWS)QOV'&0D:MKMID>RL:N[]Q+>6@##Q3O?6(@;(P
MFV5M?!\;W=G$!YAS?>V8Y,%33))CDB^?8I+W7&PBM^0T6TQ(GFEM&DJ9P(6\
M:[+'<9Q+/0#!+H5>$XLFBIRV@D'^U,S)C+U<YT9&!4/"X1>O!I*V:12FM+33
M\T53[*TH='K5(!-$%U%NPA.N>Y#8V2H92I@P:ID5DK7-(@#S3;8C-;O()&_R
M:T6?0$O:@ 4HX*1MF^$9_.VV&9RC.BV0E>JK_'8@QA"S;[B0-JB15Q#!9H$K
MC1SY ,;#>9HE,]$[@'MSI->F_G >O-6:L-Z.>#^#:A0K<UH\B5))8$+@PVV[
MHH9\>6#RXBMA<Q 59XD):G&(#362$I22:5)RUR/-R*K8EC*4[SH,."VS8]-E
M.]WS9^= (L"_^)J5U5/<FVR5$F&3G[QW-]N$24*AA2EOY"WQ5&P$0P.D!DLH
M"H1*;(?)SE6ZI1X2'%A%BW!+440B>R\NI ^=Z]C!D"HHD%0_F7.I46U,K$!
M]Q,I3>(;>^ "[Q.2>?\'-TVNN6S,YZW0-0YDA'UMJG@*]D)<CC EO^%_;"J_
M=OJ!M#8TJ%WL,W/"\YWK"RTG89!1MUV)2QL42772XIK?.TBWS!($PTYS_I,8
MF>!TF=E)&4"@Z<KCL7-V#LH!)G/.B7F>BAFVK+GJ160,H2B-J:5!UZNF5%)(
MT?"T'"_GV#-R_)@#0)B-*T=(KL+VG@1^RF8W 6TY3=XDXKA8<(T.%3*8AYR+
MXV;57WV'M@.#OL8BW!?U)GW>WI6:>L<V &FC%MOHZ(ZTP@6&@2,K^[NFW!^X
M4VY=5(=-DB6^1=4:]%;Z>X-=T(PH=P'6=>3=Q2US[UJ3=)=E6]WZ05^%@&^X
M!Z4P1AV<;3>]RA1WAIH\)(L'8V42>4X4)\G,1CZB,.TEO:@C2RIJ^2#,N;2B
M\FO2N6QK!X+RU'8A[.9VNG+9O!+) E@?\@ZN%#@M<]JEBN[CO"JDSQJ:-(<A
M3[.BHWCB6&^G3RH=R?8\/:O+,2>GB"BEJY@M<4*W#J$^7H[IY^?EA>6>WJ7T
M$R.8HY#SJ\TRO$L6V\HV+L7+,L.8?<W-$V8>J;@3J3#S*9P44D*?95U#<39:
MBR*8W7(%I8>AWVC$DXL9IMJZ70*ZTQQ-7J?46)5< G<"4KV1</$&3Y"B)5VB
MR@=:M]R[N=.!?ZL90 /3TCB;C_K#-7:.T;FOE']:&E USZ^ULTYGE)7')+^G
MI!719=<)J95'TRVC]K?&HK[Q"@+NGIFO0&=QRA[TG*_2E]N;T#S<TZ6T9NV<
M=]"9)&7"MRW_\U>S^L<, O*W%<%I+#\,N/1);4>YAAB$[&R!L HON@(%NYI>
MMH*]?E(R"7^_XYC ,X!)V=$%MZN%@"V5C+.JH^<#)8SFN92B&MFD'B4#1=A
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MAP'HORXQU2_.5P@\N2_%-#SDGF?RP: ?_KJ<8(C]G_"\^(?PU:A\1J'^"X,
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MWF-=C)UPR@!<6G:]%6]'P.5 .8W"P1YY3/:-6)?[>_Q%@%4/QW44.FT?<X-
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M!T:V]X\HBWG!?JLGJKPIJMSM/S2RO -N^DUD^C:MT"<3YTFQ?*+0&Y#W#XU
M[QO??'/R[N,A1E.?B/';'5#[T?Z#(L;OS2UWKR#.3T4=9T^$^>V$^6(0[=XQ
M9;H _"OCR0\B!/6L*V;FX&U^7&;)CHNYJ>]S$3]W.Q _=QWPPN$^@A<Z#[N1
M? =.E09K8:F:Q=/<VHB@K2G>]O;<"W#0M5D@*R(CB!-Z.UTH'.9RDV :$M'$
M@/LHKCAAD"+CLUF9S/";JX.>DR7%-F-XL$R2G<LDAKT[2[*IC7LNX#_%I-?1
MIO(!YHA<=:.;@,G#)VQD6/;PCX"-? ^I=;-,D(->^"$I*^SR?@3O*8$74@_Q
M\'T9_@US:8(C+N:6;\-_8&[#)R]O^7'GA[PK\N2A90&UCOE5+WRWG(^2$A-]
M?BVR":9'P3]/J43_<1_@G8 (5H&%63A<SA  17+N?UR-A7YO,GNNK4J]6*M)
MW6QF3X?2=9;6R0ZN UZ:%Q=EO+"([0<_/+L)\FK(VE%+UHZZ;4],?L2;=93%
ME;U8:Y)J=INJXW5MS?4S[>IU8C?KU8WJK<!TF,O(K-]/Y1\?DS%,4OX0]L-[
ML]8!T78T_*^CH^/C-V_:)-&98-WV:76Y%VZV/@B%)4V.T4\BF$09GJ,:&/ZI
MW^OW!Z@3\Y?721C7JW"C6>CJT+G=GK2#_J/0_C?2IW;[O;"!X?\'$J[?1"9O
MX_(RP]R&++[ .S)/ZPIL2_TXU*QP#-:!(0I6:+:<@,$:+LKB/*WPXQ3^'QX:
MP^4"&@XS1(FDI%Y05[,4S!,%*<)?3;QN"85V2Q!((^=M 7Z/3]"E/1/E">R0
M$*YZ<AE.XCE8!["RY,LX@>W#;^S;@ <L,\XM*HMYN!5K^5\\KK'(#R:1I O"
MZH"-3.>P&F00HR1/IBE\7.+Z\%]I'M#[HI!_@BL!1J+8Q/#OK9$S=GJ>T,(F
M298"1T:+?I)69S "'!8L,:8V$ CZ-LK@<^GQ'4[3'";U^W(R(^PW6GH5HA^@
M3.$+WIU@'"^KA*9,"<^]AD'P9WL&DGI?>>=$;T_P>'(8N/*/X\_>>?S9V4HY
MFGG\)9TOY[#=-:(V,ZE(L8"A%B0B[8MA(9@-*-WAF'9\\&JO'X5QQ<W-DXDP
MJ@A>-4LH0=ZD<I?++*ET>V'@,IE)>5F%*YLO,_2:3#!?O$RX+&(+GY,RB.XY
M2"'$]D.S+ZZ97M])&: !GA4E,( J2 E)K !"),\3D$.23;G< TEC!$=Z4<&.
M_WN98KUM'7630KB>%*KEZ'<'M$R&8V1NKL4-ND\I8G[#7)U:J$9$%\6REE'8
M#;8HA:9+8 I)C9/)8RU Q%<B(R"OFQ3)T(N<L45B1,$BILM=)NE\M"PKG&P,
M-CJI],8;!]PNGIQ3Q0:,SQ<7KOBBJ%)]*5VZ<9),B L6+O>A,AH@AG2"7.CB
MK,![3FM@Z* 2^=@<['^]F/B1W$K:3GED'@,3+DKR <+2L,B&W83T18SJC[VZ
MSFRHL@<7A?/$@@@8 R^<,#2NDP V,8[17*DO Y_!M:8/1W*&-=%QV#7A-@8O
MU1+5AA+@V-L_BF@VS%S/@$O07Q.0!P7Q!D=&D)I7Y\"PSM)%%/Y>I/"*<]C(
M99E$+(A@8RPKD_*C"'6W"MZ3S!=9<9DDAN\OJ&P*)DYO(IUL4:9 "<BLS!*C
M0!9HWA_!OB.\L?X#MWJ>D.6/AX1O2Y*;/K^@^_SPD&1/T6LW*_ Y.<\TJ=9(
M#9R?W/HXJPJYV'3S#4..%RA0X/!7UM$'HR(N4918X=*^RN8.N5[NCMO!9T_?
MP!V9@-2NJJ*+L/R%V^4&7@V0O8D^78\*D=LXAJ$*^ V<:3>6='GUG% GI9JW
M<H)+#<P>KN1W_CNHC@Z(WMNY2SP5//^I3,$3U' 9QV? <N%_Y&<7Q3*;(&$)
M'PX\#N#\\L]<N#==9N$\K:;PDYBJ_T;Q))S&,/4H!*.PJL(\F8'$(&\R,<OQ
M9Q#1J$E4&,+@D\>53):X_S#Y\R([MT6 H)I,EC /Y3]TDQZQ)/8$HD@_5\,.
M7 U[:YG39KKZ-"EPA'^!3.D"N%$DYURONLB3 GX.E+/=N'>=3!JO&;#98(1H
MPT 02,Y !9'&ID :X724*_($Y# GR92:<)(:?=D0>SS),R*3ZBS9F.T%UQ52
M/5_KV,2*T2W!WZGPQ1^R]+6<*W"U8M"-P!:8\3[@7S/4L6NCMZ/;(0%] .D^
M0M4 _U,EM>@<;/)TZ11LE&27-L@W0F,AF?L5CLQ!5FTT_/X2]O'2;.>5XL7;
M9W@\;6QQ4256&#HLU1!ITY:A4[$\EFM^B5D6P%,J1R?K),2X9?+@WTC0,Y )
ML%82Q2VA2&>TE>I;<1B$PF65%!9B.!A9:ZGW0U9$T%94NVJ= 1<Y,F/%*@)S
MEF1BLO"R!B;SVC@S&@?,[RK[<JRO5 X:VQL'HFU.*JC=#I(CG?KC6>R1'YN3
M1!=9FL"ZZ?BZ#@UW"@X]O@"^T L/N^\5DEY#6G7.0OA-2/PFGN#E$24M8_T%
MF!!LS(@V0I9,[FN+<VQ?BN/R3T9QE5:\A+BUS0&N0 _!.1M<S+A8EC7-GCRZ
M3;, *])A.FI9))7=IJ[5(5A#G.([O,M^:2KT@P[+(X3=IPNWG)VM''F23FA_
MYXCZSC? J#9P!_.)R%X1L!&=6G-_._PL1=GYR_:VMFAWQ:;^%)X5%["B,FKM
M)2LMJ/PE:%\9AT>:!]<Y]D@,)3AI,P3\RG$V??7DHP">4,L!=DMY]$/34*Z;
M-;'[E#4!R]Y]RIJX[_HTVE232<ILP-7[@JOU/C4ZNW0P_+J3[RX71=YD0'^N
M7 ^RX]\)$00%%*X@AJ<5+(65N54>$D?!G16%JBHDDZ?,NZP*C7)S+NR_@^>#
M;8;:.WK"ID5+D@4R#W=32'4:M:;/@"YU_%E\#F?I7.?($M>9]"@YB[,I[E^9
MH >-%(@YEO8"Y8/,<CUJJ-@&S3FP@(4!U5&764>>*I6K%HQ<G(5B_= X]+5H
MOBJF<8E>J.:9^F&/&#1D/#(+$'2:@$5!:KOUON_NNMYWSV'N_UP=Y9':%=;5
M"\=MW3N!B>/PI>.,)LE$I"RGM@=E ?2PC'/C&+:^*A.QJ**&U=D8PM$BX0&*
M L2UZ@X%]^70-SL+PSD>?P%;.0<^B:%CT7+)&=+2_BICYBT8O7T!\FM\B1L(
MO -4L,KZ-NQ+ MQL#N/0M$N2!1$<3((H2N.$\&C1041(-^?DDF;==9S%<-LZ
M[J^9"$U4#QU7M,4F&@S X\$UY!Y"?-E<O]74]62+L8G1+KRI(]=%$%D>578<
M:;<+CJZI<2$X[@%"B>*P5<2*'H?8Q&;9IGV&K2PEC$!+W'0J*V" *GODHX3,
M1X/$'S7W!5U?>#ILV+8HB/PQP-*J)'/-4D. ;.33S+WYH9"8$*Y5M1S-.> 2
MB\6!%APZ4Q=@[]9)\#O,M9JDO 9\!WG':4%G'!3KI,_1I3#/KZ'24*E4(;MF
M!2CFB# FHH+#&V0:Z O5:PB79ODX_':M;()!+_QE6:&MAZ"P$P'M.C(D5@6(
MVV6=N(?$?LK'G7+PB=Q]:' NW.":K-V!I!O'_ .1*$[?1WGD#?RV@46W,&!P
MZMM$1UQ%?BI^+*WD^HK24"EV5]1$KPL\,&!DO6F.G-:"U\4FWV!%-H*_MD98
M.FV-1($'^L%(R(:\.=.$Y$H4G!=Z=TH)+NAVH-$[0KVF1I]7'F/@*DSR63P3
MU]7E-:8I>YG%P 7JBR+$R@#<3[[;@:1N3#1?(V9<=&.7>]N+Z@$R5D/CL;S$
MAT4^?/WW-BAR?[#S$O[Q2D&1+6G8.Q/(I*M5.0&1)D%XP(1\FAX^(<>S9+@_
MHS<7GD@7:.GK'09[H22^7H7#?K\?'H*X79)4(G98TS8-AG"V;[("Q<UO!5[\
M69+AO3F"VP'[DZ=Q^*K??_'R<?*\80]6+=0 W$W >9C_<1[A(\]7?B^*;5,O
M1:%:+MG_CFW*8<_"W2&!&[OPX,/'21:[/;=Q[ZFXI1\W);2:1CS\A;;.=:_'
M=29LXC_R [7@_WBT\>,ZVA5+'O[QEKRK2[Z9_X!:$:PQ(8W-1%677,H98]@P
MOF23&@W!-%\6RTKB$*"X8*H:IX[E5(DLK]H;[*]TV?1(%I=H)6>7+;M5_71)
M==<8MG=YLO'-GJQ&<(L %=3(5-1R<DU:D(K,9@@=+KDZJQC;%V#G$:8$C*1'
M&&HLJGHG@9])[!C55\TPO$>0PW=Q7 .?V=[T89G<<TZ 4/1PR:DAY\LI&^CR
MS*"/G5]V&YU?_.MU.[&W^W .P]LZ!S"],LSH;=GN=#+3>,S90N34A,^FM? U
M>TDFF%;1<"#ZUR/<*OBA.5POBK6@R]B[:H%SU= N+*;;?&DC)XDP<\/)ILH^
MPE"%9OV$4V"B.%8--J-XA>4!U]2ODIJQR?5+#SK:3+P'EG"-?@**5F@9A'%N
M1Y+D.,80%(5U)HG\&X8]+[+EG';&$3PJ7[92WK :<5;""1;]:8F3]T"@#W#J
M'T9'L$1"(RG,US!N8F79MLE]G"3GJ;@$L&Z"_ G%!85ZTME9F.0FO<\"%6@Z
MN($?H 8-@80,A%JL^Q&W% =QZ(;]!,9Q>WI\Y)EAKJ0<[MEP53J-.HZ6?%!T
MC)7=4\H16I0I!?_TZ/,"R*M,V&\>A\/^#XWSUY59> 8+L4!CM8A"G%Z--C@>
MJ;Q)$O5^U9KSXE^/;D?73WA(#XQ;73<+8>\I"P&6O?>4A7#/9>L-FQK=.H[)
MA73%$#%)X%\+IZ9F(<U>)D[W$.+[P.C.4S! ,*">5N.L<*) *^0N9Y4'YMW"
M$.%-$GZR4UD[T&/4J\0<D83L263SW#C%+"[C61DOSJH@!BT81#WH8-(^IZ&%
MII7IW#,IZ*C01+\,1<2[NVS46P,#9+SX:XP/"AS <0=V4NC^]EKRE-3HT).^
MF%:W+'/)YBV,-)8XQ(KP?4/KWL5A&I_M;TWL!@0--=P$XVV&PIZ7E>#^0',2
M)%R^MA-DFINJL\[0$>8^_O_M7>U/XT83_[Y_Q0JI$E<%.%[O#MJ3D@!M3MR!
M@#YJ5565@Q>2PXE3.SG(?__LS+YX[=B.$^Q-"/E2KI#8.R\[.S,[\YLD5YQL
M!Z6(3Z):/*.;JZRWKW(JIEV-?>2\Q8(7-'HC+G-1"*V*A500']7#9"55:I0Y
MT/F2M7W"CB.2.R[CLE)[SZ%]]A23)M'2A-2.,Y0%^8GJ ^60#\7U54VWR&IO
M4EVJ&U]R9$$(][)9QGJ$J>C"W2%I^WUH(W:-A\JH:(4M<50:7WZ,VX.6, R"
M8MN7VY<><T1%4X[]-7K1<G.(&(SQEW'SPY65.Z6Z/=)H9"7R24JRKS$2F$6J
M;F76HS;-?$PW'>K"GS^ 'THA"]:9O-E^=.^326RL[?!P*F B+[[_OD'_WOU
MF^?7=&___3;\XI_597B]$H:?\:..3#@S^2[=A'L3.;#I9]%T?P>*.Z3OA_D_
M45^&?E6T-LA+R>>J)V(=B.'U9K]A5>VB4(Z&%>5(A!L%'%\,<N#GX;N:Q$/9
M_* KRB-/V,G2"^->C*3L?].QPCA7NC?8RIBU,AYPX-#WS2XL[EFN[%GW_J4<
M R*LDXX320W!TF\8\JX7,CRWV76;.+K>BSF!UXW0%7 SH?>8$KC@[. @'-(1
MA/XB%Z_]%2R.DHPP4_+B&UC(ZHB(#"Z_$EEF522;,6O3O!?8IO50M3'CGQ,B
MKB7 >Z10-,%8:AKH'+6L^I61%E&.,E+@],U9M#591XP<RG'ITV\F,M0UV]$G
MN1(T.W4A6V#N.0\ ><J*"X@1%]#LN& ;1O"F)C+ZOK%JW&88%V>0)0JY%2UF
M_$OR&0E03OKAKG\WDM; B.;Q?@0IFSO(Y\\@&>N;(FA1$RY+/"-_3V1*'"$
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MZRO>;GW%3MMWQ_P'5WGO\_\!4$L! A0#%     @ _9 .6;P&##D@#   GXD
M !D              ( !     &-K,# P,34Q-3,R-"TR,#(T,#@Q-"YX<V10
M2P$"% ,4    " #]D Y9V9#+HH$0  "NW0  '0              @ %7#
M8VLP,# Q-3$U,S(T+3(P,C0P.#$T7V1E9BYX;6Q02P$"% ,4    " #]D Y9
MZJ'>-P$[  "G;0, '0              @ $3'0  8VLP,# Q-3$U,S(T+3(P
M,C0P.#$T7VQA8BYX;6Q02P$"% ,4    " #]D Y9(9P0'(02  !/^   '0
M            @ %/6   8VLP,# Q-3$U,S(T+3(P,C0P.#$T7W!R92YX;6Q0
M2P$"% ,4    " #]D Y9O:WI='E2   500( &0              @ $.:P
M=&TR-#$V,S<S9#1?97@Y.2UX87@R+FAT;5!+ 0(4 Q0    ( /V0#EE45>H+
M> \  *1!   7              "  ;Z]  !T;3(T,38S-S-D-%]E>#DY+7AE
M+FAT;5!+ 0(4 Q0    ( /V0#EE[7^KVP#   #<> 0 7              "
M 6O-  !T;3(T,38S-S-D-%]E>#DY+7AG+FAT;5!+ 0(4 Q0    ( /V0#EEE
M_A/!8WD  !K@ @ 7              "  6#^  !T;3(T,38S-S-D-%]E>#DY
M+7AJ+FAT;5!+ 0(4 Q0    ( /V0#EE&?AQMJCT  *&! 0 9
M  "  ?AW 0!T;3(T,38S-S-D-%]E>#DY+7AK>#$N:'1M4$L! A0#%     @
M_9 .65"TV&(>,@  0%P! !D              ( !V;4! '1M,C0Q-C,W,V0T
M7V5X.3DM>&MX,BYH=&U02P$"% ,4    " #]D Y9#>Q\;#L:  "'C@  &0
M            @ $NZ $ =&TR-#$V,S<S9#1?97@Y.2UX:W@S+FAT;5!+ 0(4
M Q0    ( /V0#ED_9*]]]QD! 'IW!@ 9              "  : " @!T;3(T
M,38S-S-D-%]E>#DY+7AK>#0N:'1M4$L! A0#%     @ _9 .69B;3WL,+0
M0Q ! !D              ( !SAP# '1M,C0Q-C,W,V0T7V5X.3DM>&MX-2YH
M=&U02P$"% ,4    " #]D Y9RX%RM54)  "!+P  &0              @ $1
M2@, =&TR-#$V,S<S9#1?97@Y.2UX:W@V+FAT;5!+ 0(4 Q0    ( /V0#EE$
M!(BVG(\! %/W#  9              "  9U3 P!T;3(T,38S-S-D-%]E>#DY
M+7AK>#@N:'1M4$L! A0#%     @ _9 .6;3<()WV#P  !U(  !<
M     ( !<.,$ '1M,C0Q-C,W,V0T7V5X.3DM>&PN:'1M4$L! A0#%     @
M_9 .65!F53IU P  F@H  !<              ( !F_,$ '1M,C0Q-C,W,V0T
M7V5X.3DM>&XN:'1M4$L! A0#%     @ _9 .65KP%R\^"0  ^LH  !<
M         ( !1?<$ '1M,C0Q-C,W,V0T7V5X.3DM>',N:'1M4$L! A0#%
M  @ _9 .6>?+9+CE!@  5B(  !<              ( !N  % '1M,C0Q-C,W
M,V0T7V5X.3DM>'0N:'1M4$L! A0#%     @ _9 .65GS>['46 ( O%T/ !,
M             ( !T@<% '1M,C0Q-C,W,V0T7VXR82YH=&U02P4&     !0
,% "$!0  UV '

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>tm2416373d4_n2a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:ck0001515324="http://www.www.arespublicfunds.com/20240814"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001515324-20240814.xsd" xlink:type="simple"/>
    <context id="C_20240814to20240814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <context id="C_20240331to20240331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-03-31</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_20231231to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230930to20230930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-09-30</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_20230630to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230331to20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220630to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220331to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20240806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <instant>2024-08-06</instant>
        </period>
    </context>
    <context id="C_20240806to20240806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-08-06</startDate>
            <endDate>2024-08-06</endDate>
        </period>
    </context>
    <context id="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:PreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <context id="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001515324:PreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <context id="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <context id="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001515324:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USDPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20240814to20240814" id="F20240812221526044_0">0001515324</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="C_20240814to20240814" id="F20240812221526044_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20240814to20240814"
      id="Fdei_DocumentType20240813154129236">N-2/A</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101936164">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityFileNumber
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095342882">333-279977</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095409603">811-22535</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813153530270">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095735844">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendmentNumber
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100053971">1</dei:PreEffectiveAmendmentNumber>
    <dei:PreEffectiveAmendment
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095809200">true</dei:PreEffectiveAmendment>
    <dei:PostEffectiveAmendment
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095834440">false</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813095913940">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendmentNumber
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240814013928637">6</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:InvestmentCompanyRegistrationAmendment
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240814033509624">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:EntityRegistrantName
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100134625">Ares Dynamic Credit Allocation Fund, Inc.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100209304">2000 Avenue of the Stars</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813134715877">12Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100258989">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100323475">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100344161">90067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100417005">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813100441809">201-4100</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813100636897">Ian Fitzgerald</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813100710388">2000 Avenue of the Stars</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813134756249">12th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813100739956">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813100748083">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20240814to20240814_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240813100804198">90067</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101019177">As soon as practicable after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101101839">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101126027">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101153751">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101217858">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101247417">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101410817">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101453588">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101524507">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101602905">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101633578">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101711607">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101744579">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101804016">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813101834864">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813102009257">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813102041250">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813162519030">
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following table is intended to assist you in understanding the costs and expenses that an investor in our common shares will bear, directly or indirectly, based on the assumptions set forth below. We caution you that some of the percentages indicated in the table below are estimates and may vary. The table reflects the use of leverage in the form of borrowings in an amount equal to 36% of the Fund&#x2019;s Managed Assets (after the leverage is incurred), and shows Fund expenses as a percentage of net assets attributable to common shares. The extent of the Fund&#x2019;s assets attributable to leverage following an offering, and the Fund&#x2019;s associated expenses, are likely to vary (perhaps significantly) from these assumptions.&lt;/p&gt;
    </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="C_20240814to20240814" id="F20240813093858837_1">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"&gt;

            &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
              &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;Shareholder Transaction Expenses&lt;/td&gt;
              &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="font-size:10pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom"&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in"&gt;Sales load paid by you (&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;as a percentage of offering price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;)(1)&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;None&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in"&gt;Offering expenses borne by the Fund (as a percentage of offering price)(2)&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;None&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom"&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in"&gt;Dividend reinvestment plan fees(3)&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;None&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-bottom:0pt"&gt;
          &lt;div style="margin-top:3pt;margin-bottom:3pt;width:25%"&gt;
            &lt;div style="font-size:1pt;border-top:Black 1pt solid"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="padding-bottom:10pt;width:4%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares. &lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="padding-bottom:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="padding-bottom:10pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:0pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="C_20240814to20240814" id="F20240813093858836_0">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20240814to20240814"
      decimals="2"
      id="F20240813093858837_2"
      unitRef="Pure">0</cef:SalesLoadPercent>
    <cef:OtherTransactionExpense1Percent
      contextRef="C_20240814to20240814"
      decimals="2"
      id="F20240813093858837_3"
      unitRef="Pure">0</cef:OtherTransactionExpense1Percent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20240814to20240814"
      decimals="0"
      id="F20240813093858837_4"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="C_20240814to20240814" id="F20240813093858837_5">
      &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"&gt;

          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;Annual Expenses (as a percentage of net assets attributable to common shares)&lt;/td&gt;
            &lt;td style="font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="2" style="font-size:10pt;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;width:87%;padding-left:0.25in"&gt;Advisory Fees(4)&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.74&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25in"&gt;Interest payments on borrowed funds(5)&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;2.42&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;padding-left:0.25in"&gt;Other Expenses(6)&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.80&lt;/td&gt;
            &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:0.375in"&gt;Total Annual Fund Operating Expenses&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.96&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;

        &lt;div&gt;&#160;&lt;/div&gt;

      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="padding-bottom:10pt;text-align:justify;width:47px"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(4)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="padding-bottom:10pt;text-align:justify;width:1196px"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#x2019;s use of leverage in the form of higher fees as a percentage of the Fund&#x2019;s net assets attributable to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an &lt;span&gt;amount of leverage of &lt;/span&gt;36&lt;span&gt;% of the Fund&#x2019;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal 55% of the Fund&#x2019;s net assets. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="padding-bottom:10pt;text-align:justify;width:47px"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="padding-bottom:10pt;text-align:justify;width:1196px"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Interest payments on borrowed funds&#x201d; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023. We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December&#160;31, 2023. This item is based on the assumption that the Fund&#x2019;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#x2019;s Managed Assets &lt;span&gt;and 55% of the Fund&#x2019;s net assets&lt;/span&gt;) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#x2019;s and the Board&#x2019;s assessment of market and other factors at the time of any proposed borrowing. See &#x201c;Credit Facility.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="text-align:justify;width:47px"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(6)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify;width:1196px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Other Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d; are based on estimated amounts for the current fiscal year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="F20240813093858837_6"
      unitRef="Pure">0.0174</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="F20240813093858837_7"
      unitRef="Pure">0.0242</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="F20240813093858837_8"
      unitRef="Pure">0.008</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="F20240813093858837_9"
      unitRef="Pure">0.0496</cef:TotalAnnualExpensesPercent>
    <cef:OtherExpensesNoteTextBlock
      contextRef="C_20240814to20240814"
      id="F20240813093858838_15">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Other Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d; are based on estimated amounts for the current fiscal year.&lt;/span&gt;</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20240814to20240814"
      id="F20240813093858837_10">
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual expenses of &lt;/span&gt;4.96% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font-size:10pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="-sec-ix-redline:true"&gt;One&#160;Year&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="-sec-ix-redline:true"&gt;Three&#160;Years&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="-sec-ix-redline:true"&gt;Five&#160;Years&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="-sec-ix-redline:true"&gt;Ten&#160;Years&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt"&gt;&lt;span style="-sec-ix-redline:true"&gt;Total expenses incurred&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;$&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;51&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;$&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;152&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;$&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;254&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;$&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;506&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;strong&gt;The example should not be considered a representation of future expenses. The example assumes that the estimated &#x201c;Other expenses&#x201d; set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/strong&gt;&lt;/p&gt;
        &lt;/div&gt;
      </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20240814to20240814"
      decimals="0"
      id="F20240813093858837_11"
      unitRef="USD">51</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20240814to20240814"
      decimals="0"
      id="F20240813093858837_12"
      unitRef="USD">152</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20240814to20240814"
      decimals="0"
      id="F20240813093858837_13"
      unitRef="USD">254</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20240814to20240814"
      decimals="0"
      id="F20240813093858838_14"
      unitRef="USD">506</cef:ExpenseExampleYears1to10>
    <cef:CapitalStockTableTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813111650959">
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_007_integixAnchor"&gt;&lt;strong&gt;DESCRIPTION OF SHARES&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Common Shares&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shareholders are entitled to share pro rata in the net assets of the Fund available for distribution to shareholders upon liquidation of the Fund. &lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Shareholders are entitled to one vote for each share held.&lt;/span&gt; &lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Shareholders do not have preemptive, conversion or subscription rights and the Fund&#x2019;s common shares are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund intends to hold annual meetings of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required as a condition to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to all of its shareholders.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise. Shares of closed-end investment companies frequently trade on an exchange at prices lower than NAV. Shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and during other periods have traded at prices lower than NAV. Because the market value of the common shares may be influenced by such direct and indirect factors as dividend levels (which are in turn affected by expenses), call protection on its portfolio securities, dividend stability, portfolio credit quality, the Fund&#x2019;s NAV, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that its common shares will trade at a price equal to or higher than NAV in the future. The common shares are designed primarily for long-term investors and you should not purchase the common shares if you intend to sell them soon after purchase. See &#x201c;Repurchase of Common Shares&#x201d; below and &#x201c;Repurchase of Common Shares&#x201d; in the SAI.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund&#x2019;s outstanding common shares are, and when issued, the common shares offered by this Prospectus will be, publicly held and listed and traded on the NYSE under the symbol &#x201c;ARDC.&#x201d; The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.&lt;/p&gt;
      &lt;/div&gt;

        &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;During Quarter Ended&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;NYSE&#160;Market&#160;Price&lt;br/&gt;Per&#160;Common Share&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;NAV per Common&lt;br/&gt;Share on&#160;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Premium/(Discount)&#160;on&lt;br/&gt;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Trading&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Volume&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:30%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2024&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.29&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.41&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.69&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.56&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.72&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.90&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,951,700&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.93&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.51&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.77&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.24&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.43&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,020,500&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.90&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.10&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.78&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,500,400&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.33&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.68&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.87&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.58&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.65&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.99&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,473,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.77&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.42&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.11&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.39&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.22&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.78&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7,627,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.09&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.27&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.66&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.17&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.90&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,699,200&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.45&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.34&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.44&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.26&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,773,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.67&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.89&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.95&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.03&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.44&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,461,400&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16.29&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.76&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.66&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.22&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,201,000&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;As of August 6, 2024, the NAV per common share of the Fund was $14.65 and the market price per common share was $15.09, representing a premium to NAV of 3.00%. Common shares of the Fund have historically traded at both a premium and discount to NAV.&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;As of August 6, 2024, the Fund has 22,915,000 &lt;/span&gt;outstanding common shares.&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Preferred Shares&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;The Charter provides that the Board may authorize and issue preferred shares, with rights as determined by the Board, without the approval of the holders of the common shares. Common shareholders have no preemptive right to purchase any preferred shares that might be issued. The Fund has $100 million of preferred shares outstanding. The Fund has authorized and issued 800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B MRP Shares for gross proceeds of $30 million and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif;font-size:10pt"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Each of the MRP Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and the distribution of assets upon the Fund&#x2019;s dissolution, liquidation or winding up, (i) on a parity with each other and any other class or series of preferred shares and (ii) senior to the common shares.&lt;/span&gt; &lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of MRP Shares do not have any preemptive rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common shares or other securities of the Fund.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;Except for matters which do not require the vote of holders of MRP Shares under the Investment Company Act and except as otherwise provided in the Charter and the Bylaws, (i)&#160;each holder of MRP Shares is entitled to one vote per share on each matter submitted to a vote of the Fund&#x2019;s stockholders, and (ii)&#160;the holders of MRP Shares, outstanding preferred shares and common shares will vote together as a single class on all matters submitted to the Fund&#x2019;s stockholders; provided, however, that the holders of MRP Shares and outstanding preferred shares will be entitled, as a class, to the exclusion of the holders of all other classes of stock of the Fund, to elect two directors of the Fund. &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif;font-size:10pt"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of preferred shares, voting as a separate class, are also generally entitled to vote on (i) certain amendments to the Charter and the Bylaws, (ii) the Fund&#x2019;s ability to enter into certain agreements, (iii) the authorization, issuance or reclassification of shares of the Fund&#x2019;s stock that would rank on a parity with or senior to the preferred shares, (iv) the liquidation or dissolution of the Fund and (v) the Fund&#x2019;s ability to incur, authorize or guarantee any indebtedness for borrowed money.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly dividend date.&lt;/span&gt; &lt;/span&gt;&lt;span&gt;We generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares of our stock ranking junior to the MRP Shares as to dividends or upon liquidation, including our common shares, or on a parity with the MRP Shares or call for redemption, redeem, purchase or otherwise acquire for consideration, unless (i)&#160;immediately after such transaction, certain asset coverage would be achieved, (ii)&#160;full, cumulative dividends on the preferred shares have been declared and paid and (iii)&#160;the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained in the terms of the MRP Shares.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;The aggregate redemption amount of the MRP Shares is $100 million. The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is 2.81% per annum. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject to redemption, at the option of the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. All rights and preferences of the holders of the MRP Shares of a particular series &lt;/span&gt;&lt;span&gt;will terminate if no MRP Shares of such series are outstanding. &lt;/span&gt;Under the Investment Company Act, the Fund is not permitted to issue preferred shares unless immediately after such issuance the value of the Fund&#x2019;s total assets is at least 200% of the liquidation value of the outstanding preferred shares (i.e., the liquidation value may not exceed 50% of the Fund&#x2019;s total assets). In addition, the Fund is not permitted to declare any cash dividend or other distribution on its common shares unless, at the time of such declaration, the value of the Fund&#x2019;s total assets is at least 200% of such liquidation value. Please see &#x201c;Description of Shares&#x201d; in the SAI for more information.&lt;/span&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Authorized Shares&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The following table provides the Fund&#x2019;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"&gt;

                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Title of Class&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Authorized&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Held&#160;by&lt;br/&gt;Fund or for its&lt;br/&gt;Account&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Outstanding&lt;br/&gt;Exclusive of Amount&lt;br/&gt;held by Fund&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;Common Shares&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;996,000,000&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2014;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;22,914,939&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;Preferred Shares&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,000,000&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2014;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,000,000&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          </cef:CapitalStockTableTextBlock>
    <cef:SecurityTitleTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      id="Fxbrl_20240813142352079">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Common Shares&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      id="Fxbrl_20240813151941914">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Shareholders are entitled to one vote for each share held.&lt;/span&gt;</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityPreemptiveAndOtherRightsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      id="Fxbrl_20240813152025187">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Shareholders do not have preemptive, conversion or subscription rights and the Fund&#x2019;s common shares are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.&lt;/span&gt;</cef:SecurityPreemptiveAndOtherRightsTextBlock>
    <cef:SharePriceTableTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813145756573">
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;During Quarter Ended&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;NYSE&#160;Market&#160;Price&lt;br/&gt;Per&#160;Common Share&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;NAV per Common&lt;br/&gt;Share on&#160;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Premium/(Discount)&#160;on&lt;br/&gt;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Trading&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Volume&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:30%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2024&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.29&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.41&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.69&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.56&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.72&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.90&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,951,700&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.93&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.51&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.77&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.24&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.43&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,020,500&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.90&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.10&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.78&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,500,400&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.33&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.68&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.87&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.58&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.65&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.99&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,473,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.77&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.42&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.11&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.39&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.22&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.78&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7,627,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.09&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.27&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.66&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.17&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.90&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,699,200&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.45&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.34&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.44&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.26&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,773,900&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.67&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.89&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.95&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.75&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.03&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.44&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5,461,400&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2022&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16.29&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.76&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16.69&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.66&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.22&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(12.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6,201,000&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20240331to20240331"
      decimals="2"
      id="Fxbrl_20240813113734958"
      unitRef="USDPerShare">14.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240331to20240331"
      decimals="2"
      id="Fxbrl_20240813114059742"
      unitRef="USDPerShare">13.41</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240331to20240331"
      decimals="2"
      id="Fxbrl_20240813114407869"
      unitRef="USDPerShare">14.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240331to20240331"
      decimals="2"
      id="Fxbrl_20240813115207908"
      unitRef="USDPerShare">14.56</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240331to20240331"
      decimals="4"
      id="Fxbrl_20240813115924099"
      unitRef="Pure">-0.0272</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240331to20240331"
      decimals="4"
      id="Fxbrl_20240813120119633"
      unitRef="Pure">-0.079</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231231to20231231"
      decimals="2"
      id="Fxbrl_20240813113753501"
      unitRef="USDPerShare">13.75</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231231to20231231"
      decimals="2"
      id="Fxbrl_20240813114121396"
      unitRef="USDPerShare">11.93</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20231231to20231231"
      decimals="2"
      id="Fxbrl_20240813114424684"
      unitRef="USDPerShare">14.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20231231to20231231"
      decimals="2"
      id="Fxbrl_20240813115228214"
      unitRef="USDPerShare">13.77</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231231to20231231"
      decimals="4"
      id="Fxbrl_20240813115942914"
      unitRef="Pure">-0.0524</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231231to20231231"
      decimals="4"
      id="Fxbrl_20240813120140663"
      unitRef="Pure">-0.1343</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230930to20230930"
      decimals="2"
      id="Fxbrl_20240813113758982"
      unitRef="USDPerShare">12.9</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230930to20230930"
      decimals="2"
      id="Fxbrl_20240813114126133"
      unitRef="USDPerShare">12.1</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230930to20230930"
      decimals="2"
      id="Fxbrl_20240813114431104"
      unitRef="USDPerShare">14.21</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230930to20230930"
      decimals="2"
      id="Fxbrl_20240813115414196"
      unitRef="USDPerShare">13.78</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230930to20230930"
      decimals="4"
      id="Fxbrl_20240813115952506"
      unitRef="Pure">-0.0819</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230930to20230930"
      decimals="4"
      id="Fxbrl_20240813120148394"
      unitRef="Pure">-0.1219</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230630to20230630"
      decimals="2"
      id="Fxbrl_20240813113804361"
      unitRef="USDPerShare">12.33</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230630to20230630"
      decimals="2"
      id="Fxbrl_20240813114135765"
      unitRef="USDPerShare">11.68</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230630to20230630"
      decimals="2"
      id="Fxbrl_20240813114443885"
      unitRef="USDPerShare">13.87</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230630to20230630"
      decimals="2"
      id="Fxbrl_20240813115421188"
      unitRef="USDPerShare">13.58</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230630to20230630"
      decimals="4"
      id="Fxbrl_20240813115958594"
      unitRef="Pure">-0.1065</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230630to20230630"
      decimals="4"
      id="Fxbrl_20240813120153275"
      unitRef="Pure">-0.1399</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230331to20230331"
      decimals="2"
      id="Fxbrl_20240813113815654"
      unitRef="USDPerShare">12.77</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230331to20230331"
      decimals="2"
      id="Fxbrl_20240813114141300"
      unitRef="USDPerShare">11.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230331to20230331"
      decimals="2"
      id="Fxbrl_20240813114451525"
      unitRef="USDPerShare">14.11</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230331to20230331"
      decimals="2"
      id="Fxbrl_20240813115726220"
      unitRef="USDPerShare">13.39</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230331to20230331"
      decimals="4"
      id="Fxbrl_20240813120003563"
      unitRef="Pure">-0.0922</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230331to20230331"
      decimals="4"
      id="Fxbrl_20240813120158882"
      unitRef="Pure">-0.1478</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20221231to20221231"
      decimals="2"
      id="Fxbrl_20240813113825574"
      unitRef="USDPerShare">12.09</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20221231to20221231"
      decimals="2"
      id="Fxbrl_20240813114304199"
      unitRef="USDPerShare">11.27</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20221231to20221231"
      decimals="2"
      id="Fxbrl_20240813115103798"
      unitRef="USDPerShare">13.66</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20221231to20221231"
      decimals="2"
      id="Fxbrl_20240813115736683"
      unitRef="USDPerShare">13.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221231to20221231"
      decimals="4"
      id="Fxbrl_20240813120008940"
      unitRef="Pure">-0.099</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221231to20221231"
      decimals="4"
      id="Fxbrl_20240813120205386"
      unitRef="Pure">-0.1469</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20240813113837613"
      unitRef="USDPerShare">13.45</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20240813114315950"
      unitRef="USDPerShare">11.75</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20240813115123292"
      unitRef="USDPerShare">14.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20240813115804955"
      unitRef="USDPerShare">13.34</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20240813120018914"
      unitRef="Pure">-0.0844</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20240813120215930"
      unitRef="Pure">-0.1226</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220630to20220630"
      decimals="2"
      id="Fxbrl_20240813113843966"
      unitRef="USDPerShare">14.67</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220630to20220630"
      decimals="2"
      id="Fxbrl_20240813114343726"
      unitRef="USDPerShare">11.89</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220630to20220630"
      decimals="2"
      id="Fxbrl_20240813115132508"
      unitRef="USDPerShare">15.95</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220630to20220630"
      decimals="2"
      id="Fxbrl_20240813115814972"
      unitRef="USDPerShare">13.75</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220630to20220630"
      decimals="4"
      id="Fxbrl_20240813120033953"
      unitRef="Pure">-0.0803</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220630to20220630"
      decimals="4"
      id="Fxbrl_20240813132127089"
      unitRef="Pure">-0.1244</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220331to20220331"
      decimals="2"
      id="Fxbrl_20240813113929526"
      unitRef="USDPerShare">16.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220331to20220331"
      decimals="2"
      id="Fxbrl_20240813114353469"
      unitRef="USDPerShare">13.76</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220331to20220331"
      decimals="2"
      id="Fxbrl_20240813115139204"
      unitRef="USDPerShare">16.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220331to20220331"
      decimals="2"
      id="Fxbrl_20240813115820007"
      unitRef="USDPerShare">15.66</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220331to20220331"
      decimals="4"
      id="Fxbrl_20240813120046795"
      unitRef="Pure">-0.0222</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220331to20220331"
      decimals="4"
      id="Fxbrl_20240813132133193"
      unitRef="Pure">-0.1219</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20240806"
      decimals="2"
      id="Fxbrl_20240813134647500"
      unitRef="USDPerShare">14.65</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20240806"
      decimals="2"
      id="Fxbrl_20240813134655999"
      unitRef="USDPerShare">15.09</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="C_20240806to20240806"
      decimals="4"
      id="Fxbrl_20240813134719455"
      unitRef="Pure">0.03</cef:LatestPremiumDiscountToNavPercent>
    <cef:SecurityTitleTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813142429996">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Preferred Shares&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813152806209">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Each of the MRP Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and the distribution of assets upon the Fund&#x2019;s dissolution, liquidation or winding up, (i) on a parity with each other and any other class or series of preferred shares and (ii) senior to the common shares.&lt;/span&gt;</cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityPreemptiveAndOtherRightsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813152431122">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of MRP Shares do not have any preemptive rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common shares or other securities of the Fund.&lt;/span&gt;</cef:SecurityPreemptiveAndOtherRightsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813151820242">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of preferred shares, voting as a separate class, are also generally entitled to vote on (i) certain amendments to the Charter and the Bylaws, (ii) the Fund&#x2019;s ability to enter into certain agreements, (iii) the authorization, issuance or reclassification of shares of the Fund&#x2019;s stock that would rank on a parity with or senior to the preferred shares, (iv) the liquidation or dissolution of the Fund and (v) the Fund&#x2019;s ability to incur, authorize or guarantee any indebtedness for borrowed money.&lt;/span&gt;</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityDividendsTextBlock
      contextRef="C_20240814to20240814_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813152619531">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Holders of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly dividend date.&lt;/span&gt;</cef:SecurityDividendsTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813145909403">
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The following table provides the Fund&#x2019;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto"&gt;

                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Title of Class&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Authorized&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Held&#160;by&lt;br/&gt;Fund or for its&lt;br/&gt;Account&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Outstanding&lt;br/&gt;Exclusive of Amount&lt;br/&gt;held by Fund&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;Common Shares&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;996,000,000&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2014;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;22,914,939&lt;/td&gt;
                        &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;Preferred Shares&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,000,000&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2014;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,000,000&lt;/td&gt;
                        &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      id="Fxbrl_20240813135254076">Common Shares</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135105847"
      unitRef="Shares">996000000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135133841"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324CommonStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135200964"
      unitRef="Shares">22914939</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      id="Fxbrl_20240813135312751">Preferred Shares</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135124246"
      unitRef="Shares">4000000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135136625"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20231231to20231231_usgaapStatementClassOfStockAxis_ck0001515324PreferredStocksMember"
      decimals="INF"
      id="Fxbrl_20240813135204076"
      unitRef="Shares">4000000</cef:OutstandingSecurityNotHeldShares>
    <cef:InvestmentObjectivesAndPracticesTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813142524060">
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_008_integixAnchor"&gt;&lt;strong&gt;THE FUND&#x2019;S INVESTMENTS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Investment Objective and Policies&lt;/strong&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Please refer to the&#160;&lt;/span&gt;&lt;span style="color:#0563c1"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit"&gt;section of the Fund&#x2019;s most recent annual report on Form&#160;N-CSR&#160;entitled &#x201c;Additional Information &#x2013; Fund Investment Objective, Policies and Risks,&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline:true"&gt; &lt;span&gt;which is incorporated by reference herein, for a discussion of the Fund&#x2019;s investment objective and policies. The Fund&#x2019;s investment objective is non-fundamental and may be changed by the Board without shareholder approval.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;strong&gt;Portfolio Contents and Techniques&lt;/strong&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Under normal circumstances, the Fund&#x2019;s portfolio is expected to be comprised principally of the following types of investments:&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Senior Loans.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Senior loans (&#x201c;Senior Loans&#x201d;) generally hold the most senior position in the capital structure of a borrower, are typically secured with specific collateral and have a claim on the assets and/or stock of the borrower that is senior to that held by unsecured creditors, subordinated debt holders and holders of equity of the borrower. The majority of loans the Fund may invest in are rated below investment grade. Typically, in order to borrow money pursuant to a Senior Loan, a borrower will, for the term of the Senior Loan, pledge collateral (subject to typical exceptions), including but not limited to (i)&#160;working capital assets, such as accounts receivable and inventory; (ii)&#160;tangible fixed assets, such as real property, buildings and equipment; (iii)&#160;intangible assets, such as trademarks and patent rights; and (iv)&#160;security interests in shares of stock of subsidiaries or affiliates. In many instances, a Senior Loan may be secured only by shares in the borrower or its subsidiaries. Collateral may consist of assets that may not be readily liquidated, and there is no assurance that the liquidation of such assets would satisfy fully a borrower&#x2019;s obligations under a Senior Loan.&lt;/p&gt;
          &lt;/div&gt;

            &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Senior Loans typically have rates of interest that are determined daily, monthly, quarterly or semi-annually by reference to a base lending rate, plus a premium or credit spread. As a result, as short-term interest rates increase, interest payable to the Fund from its investments in Senior Loans should increase, and as short-term interest rates decrease, interest payable to the Fund from its investments in Senior Loans should decrease. These base lending rates are primarily the secured overnight funding rate (&#x201c;SOFR&#x201d;) or the Euro Interbank Offered Rate (&#x201c;Euribor&#x201d;) and secondarily the prime rate offered by one or more major U.S. banks and the certificate of deposit rate or other base lending rates used by commercial lenders.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;There may be less readily available information about most Senior Loans and the borrowers thereunder than is the case for many other types of securities, including securities issued in transactions registered under the &lt;/span&gt;Securities Act of 1933, as amended (&#x201c;Securities Act&#x201d;) or the Securities and Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), and borrowers subject to the periodic reporting requirements of Section&#160;13 of the Exchange Act.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;No active trading market may exist for some Senior Loans, and some loans may be subject to restrictions on resale. Any secondary market for Senior Loans may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability of a seller to realize full value and thus cause a material decline in the net asset value of the common shares. In addition, the Fund may not be able to readily dispose of its Senior Loans at prices that approximate those at which the Fund could sell such loans if they were more widely traded and, as a result of such illiquidity, the Fund may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. A limited supply or relative illiquidity of Senior Loans may adversely affect the Fund&#x2019;s yield.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;In the process of buying, selling and holding Senior Loans, the Fund may receive and/or pay certain fees. These fees are in addition to interest payments received and may include facility fees, commitment fees, amendment fees, commissions and prepayment penalty fees. On an ongoing basis, the Fund may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a Senior Loan. In certain circumstances, the Fund may receive a prepayment penalty fee upon the prepayment of a Senior Loan by a borrower. Other fees received by the Fund may include covenant waiver fees, covenant modification fees or other amendment fees.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Direct Assignments.&lt;/i&gt;&lt;/span&gt;&#160;&#160;The Fund generally will seek to purchase Senior Loans on a direct assignment basis. If the Fund purchases a Senior Loan on direct assignment, it typically succeeds to all the rights and obligations under the Loan Agreement of the assigning lender and becomes a lender under the Loan Agreement with the same rights and obligations as the assigning lender.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Loan Participations.&lt;/i&gt;&lt;/span&gt;&#160;&#160;To a lesser extent than direct assignments, the Fund may transact in participations in Senior Loans. The participation by the Fund in a lender&#x2019;s portion of a Senior Loan typically will result in the Fund&#x2019;s having a contractual relationship only with such lender, not with the borrower. As a result, the Fund may have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the participation and only upon receipt by such lender of payments from the borrower. Such indebtedness may be secured or unsecured. In connection with purchasing participations, the Fund generally will have no right to enforce compliance by the borrower with the terms of the Loan Agreement, nor any rights with respect to any funds acquired by other investors through set-off against the borrower and the Fund may not directly benefit from the collateral supporting the Senior Loan in which it has purchased the participation. In the event of the insolvency of the entity selling a participation, the Fund may be treated as a general creditor of such entity.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Corporate Bonds.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may invest in corporate bonds that are fixed income securities typically issued by non-investment-grade borrowers, usually at a yield premium to the yield for investment-grade bonds (&#x201c;Corporate Bonds&#x201d;). Corporate Bonds generally provide for cash interest payments, but may include deferred, zero coupon, or payment-in-kind terms. These investments may be acquired during the primary offering process and may also be purchased in the secondary market as either private securities or publicly registered securities, and typically have multiple institutional holders.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Holders of high-yield bonds, as creditors, have a prior legal claim over common and preferred shareholders as to both income and assets of the issuer for the principal and interest due them and may have a prior claim over other creditors but are generally subordinate to any senior secured lenders in the issuer&#x2019;s capital structure.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;In most cases Corporate Bonds restrict the borrower&#x2019;s ability to incur additional debt and may restrict payments to equity shareholders based upon financial ratios associated with general credit quality. In addition, Corporate Bonds often limit the borrower&#x2019;s ability to repay or amortize its high-yield bonds, particularly during the initial portion of their contractual tenor. As such, these securities can provide the opportunity for capital appreciation or yield enhancement, especially when the borrower&#x2019;s financial performance is consistent with or superior to expectations, when conditions are favorable in the borrower&#x2019;s industry, or when the general economic environment is positive.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Secured bonds and notes. &lt;/i&gt;&lt;/span&gt;These bonds and notes generally constitute the senior-most layer of a borrower&#x2019;s capital structure and benefit from a lien on the borrower&#x2019;s assets as well as senior ranking in repayment priority. Owing to their claim position and collateral support, secured bonds and secured notes tend to experience superior recoveries in a bankruptcy as compared to unsecured debt due to the collateral securing these instruments. Such bonds and notes may rank &lt;i&gt;pari passu&lt;/i&gt; in many respects with secured loans.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Unsecured bonds. &lt;/i&gt;&lt;/span&gt;Dependent upon their terms, these bonds can enjoy a senior ranking or subordinated ranking in repayment priority, but do not benefit from a lien on a borrower&#x2019;s assets. Unsecured bonds typically form a layer between a borrower&#x2019;s credit facility and its equity. Yields tend to reflect a premium in respect of a bond&#x2019;s position within a borrower&#x2019;s capital structure.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Alternative Credit Instruments.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;These instruments typically include trust certificates, collateralized debt obligations, collateralized loan obligations (&#x201c;CLOs&#x201d;), asset-backed securities, credit-linked notes or other structured finance securities. These securities are generally backed by pools of financials and other assets and tranched into different asset classes. The structure of these securities may consist of debt rated from AAA to B and equity. These securities typically make interest and principal payments in order of seniority.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;CLO Securities&lt;/i&gt;&lt;/span&gt;. A CLO generally holds a portfolio consisting principally of loan obligations. CLOs are created, in part, to reapportion the risk and return characteristics of a portfolio of underlying assets. The CLO securitizes payment claims arising out of its portfolio of underlying assets and issues securities with payment characteristics linked to the underlying assets. The redemption of the securities issued by the CLO typically occurs from the cash flow generated by the portfolio of underlying assets. The vast majority of CLOs are actively managed by an investment manager that is independent of the CLO and the holders of its securities.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund expects to invest in securities issued by CLOs (&#x201c;CLO Securities&#x201d;) that principally hold Senior Loans, diversified by industry and borrower. It is also possible that the underlying obligations of CLOs in which the Fund invests will include (i)&#160;subordinated loans, (ii)&#160;debt tranches of other CLOs, and (iii)&#160;equity securities incidental to investments in Senior Loans. The cash flows on the underlying obligations will primarily determine the payments to holders of CLO Securities. CLO Securities may have floating interest rates, fixed interest rates or, in the case of subordinated CLO Securities, no set interest rate (but rather participate in residual cash flows of the relevant CLO). CLOs issue securities in tranches with different payment characteristics and different credit ratings. These tranches are generally categorized as senior, mezzanine, or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization of the cash flows from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual interest payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#x201c;equity&#x201d; tranche). The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#x2019;s indenture. These provisions are referred to as the &#x201c;priority of payments&#x201d; or the &#x201c;waterfall&#x201d; and determine the terms of payment of any other obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for each CLO.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The tranches of CLO Securities senior to the subordinated (or residual) tranche (called the &#x201c;rated tranches&#x201d;) are generally assigned credit ratings by one or more nationally recognized statistical rating organizations (whether or not such tranches are issued as part of a component of a composite instrument with one or more other instruments). The &#x201c;equity&#x201d; tranche does not receive ratings. The transaction documents relating to the issuance of CLO Securities impose eligibility criteria on the assets of the CLO, restrict the ability of the CLO&#x2019;s investment manager to trade investments and impose certain portfolio-wide asset quality requirements.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;CLO Securities are generally limited recourse obligations of the CLO payable solely from the underlying assets of the CLO or the proceeds thereof. Consequently, holders of CLO Securities must rely solely on distributions on the underlying assets or proceeds thereof for payment in respect thereof. The cash flows generated by the underlying obligations held in a CLO&#x2019;s portfolio will generally determine the interest payments on CLO Securities. Payments to holders of tranched CLO Securities are made in sequential order of priority.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Asset-Backed Securities&lt;/i&gt;&lt;/span&gt;. Asset-backed securities are debt instruments that are backed by a pool of financial assets, generally consisting of certain kinds of receivables or loans, including, for example, commercial loans. Such assets are generally securitized through the use of trusts and special purpose corporations. Payments or distributions of principal and interest may be guaranteed up to certain amounts and for a certain time period by a letter of credit or a pool insurance policy issued by a financial institution unaffiliated with the trust or corporation, or other credit enhancements may be present.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Asset-backed securities are often subject to more rapid repayment than their stated maturity date would indicate as a result of the pass-through of prepayments of principal on the underlying loans. During periods of declining interest rates, prepayment of loans underlying asset-backed securities can be expected to accelerate. Accordingly, the Fund&#x2019;s ability to maintain positions in such securities will be affected by reductions in the principal amount of such securities resulting from prepayments, and its ability to reinvest the returns of principal at comparable yields is subject to generally prevailing interest rates at that time. To the extent that the Fund invests in asset-backed securities, the values of the Fund&#x2019;s portfolio securities will vary with changes in market interest rates generally and the differentials in yields among various kinds of asset-backed securities. Asset-backed securities also carry credit or default risks. If the issuer of an asset-backed security defaults on its payment obligations, there is the possibility that, in some cases, the Fund will be unable to possess and sell the underlying collateral and that the Fund&#x2019;s recoveries on repossessed collateral may not be available to support payments on these securities.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Subordinated Loans.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may invest in subordinated loans. Because subordinated loans are subordinated and thus lower in priority of payment and/or in priority of lien to Senior Loans, they are subject to the additional risk that the cash flow of the borrower and property securing the loan or debt, if any, may be insufficient to meet scheduled payments after giving effect to the senior secured obligations of the borrower. This risk is generally higher for subordinated unsecured loans or debt, which are not backed by a security interest in any specific collateral. Subordinated loans generally have greater price volatility than Senior Loans and may be less liquid.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Special Situations and Stressed and Distressed Investments.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may invest in debt securities, preferred or common shares, or other instruments, of companies that are facing liquidity constraints or are undergoing, or that have recently completed, bankruptcies, reorganizations, insolvencies, liquidations or other fundamental changes or similar proceedings. These instruments may be the subject of bankruptcy proceedings or otherwise in default or at risk of being in default as to the repayment of principal and/or interest at the time of acquisition by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make any interest or other payments.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;In any investment opportunity involving any such type of special situation, there also exists the risk that a contemplated transaction either will be unsuccessful, will take considerable time or will result in a distribution of cash or new securities, the value of which will be less than the purchase price to the Fund of the securities or other financial instruments in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can be prevented or delayed by a variety of factors, including but not limited to (i)&#160;market conditions resulting in material changes in securities prices; (ii)&#160;compliance with any applicable bankruptcy, insolvency or securities laws; and (iii)&#160;other factors resulting in the inability to obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled companies in which the Fund intends to invest, there is a potential risk of loss by the Fund of its entire investment in such companies. Distressed instruments may be highly illiquid and the prices at which they may be sold may represent a substantial discount to what the Adviser believes to be their ultimate value.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Equity Securities.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;From time to time, the Fund may invest in or hold common shares and other equity securities incident to the purchase or ownership of a Senior Loan, Corporate Bond or other instrument or in connection with a reorganization of a borrower. Investments in equity securities incidental to investment in Senior Loans entail certain risks in addition to those associated with investments in Senior Loans. Common shares represent an equity ownership interest in a company. Historical trends would indicate that common shares are subject to higher levels of volatility and market and issuer-specific risk than debt securities. The value of equity securities may be affected more rapidly, and to a greater extent, by company-specific developments and general market conditions. These risks may increase fluctuations in the net asset value of the common shares. In addition, the Fund frequently may possess material non-public information about a borrower. Because of prohibitions on trading in securities while in possession of material non-public information, the Fund might be unable to enter into a transaction in a security of the borrower when it would otherwise be advantageous to do so. The equity interests held by the Fund, if any, may not pay dividends or otherwise generate income or appreciate in value and, in fact, may decline in value. Accordingly, the Fund may not be able to realize gains from its equity investments, and any gains that the Fund does realize may not be sufficient to contribute materially to the Fund&#x2019;s investment objective of seeking current income. Equity securities held by the Fund may be illiquid.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Short Sales.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may, from time to time, engage in short sales. A short sale is a transaction in which the Fund sells an instrument that it does not own in anticipation that the market price will decline. To deliver the securities to the buyer, the Fund arranges through a broker to borrow the securities and, in so doing, the Fund becomes obligated to replace the securities borrowed at their market price at the time of replacement. When selling short, the Fund intends to replace the securities at a lower price and therefore profit from the difference between the cost to replace the securities and the proceeds received from the sale of the securities. When the Fund makes a short sale, the proceeds it receives from the sale will be held on behalf of a broker until the Fund replaces the borrowed securities. The Fund may have to pay a premium to borrow the securities and must pay any dividends or interest payable on the securities until they are replaced. The Fund&#x2019;s obligation to replace the securities borrowed in connection with a short sale will be secured by collateral deposited with the broker that consists of cash and/or liquid securities. Short sales involve certain risks and special considerations. If the Fund incorrectly predicts that the price of the borrowed security will decline, the Fund will have to replace the securities with securities with a greater value than the amount received from the sale. As a result, losses from short sales differ from losses that could be incurred from a purchase of a security because losses from short sales may be theoretically unlimited, whereas losses from purchases can equal only the total amount invested.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Warrants.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Warrants give holders the right, but not the obligation, to buy common shares of an issuer at a given price, usually higher than the market price at the time of issuance, during a specified period. The risk of investing in a warrant is that the warrant may expire prior to the market value of the common shares exceeding the price fixed by the warrant. Warrants have a subordinate claim on a borrower&#x2019;s assets compared with Senior Loans. As a result, the values of warrants generally are dependent on the financial condition of the borrower and less dependent on fluctuations in interest rates than are the values of many debt securities. The values of warrants may be more volatile than those of Senior Loans or Corporate Bonds and this may increase the volatility of the net asset value of the common shares.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Non-U.S. Securities.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may invest a portion of its capital in non-U.S. securities. Some non-U.S. securities may be less liquid and more volatile than securities of comparable U.S. issuers. Similarly, there is less volume and liquidity in most foreign financial markets than in the U.S. and, at times, greater price volatility than in the U.S.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Because evidences of ownership of such securities usually are held outside the U.S., the Fund will be subject to additional risks, including possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions that might adversely affect or restrict the payment of principal and interest on the foreign securities to investors located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may trade on days when the common shares are not traded on the NYSE, the market value or net asset value of the common shares can change at times when the common shares cannot be sold.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Foreign Currency Transactions.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may engage in foreign currency exchange transactions in connection with its investments in foreign securities. The Fund is not required to hedge its currency exposure, if any, and may choose not to do so. The Fund generally will conduct its foreign currency exchange transactions either on a spot (i.e.,&#160;cash) basis at the spot rate prevailing in the foreign currency exchange market or through forward contracts to purchase or sell foreign currencies, including the payment of dividends and the settlement of securities transactions that otherwise might require untimely dispositions of Fund securities.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;A forward foreign currency exchange contract involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days (usually less than one year) from the date of the contract agreed upon by the parties, at a price and for an amount set at the time of the contract. These contracts are traded in the interbank market conducted directly between currency traders (usually large commercial banks) and their customers. A forward contract generally has a deposit requirement, and no commissions are charged at any stage for trades. Although foreign exchange dealers do not charge a fee for conversion, they do realize a profit based on the difference (the spread) between the price at which they are buying and selling various currencies. At the consummation of a forward contract, the Fund may either make delivery of the foreign currency or terminate its contractual obligation to deliver the foreign currency by purchasing an offsetting contract obligating it to purchase, at the same maturity date, the same amount of such foreign currency. If the Fund chooses to make delivery of the foreign currency, it may be required to obtain such currency through the sale of portfolio securities denominated in such currency or through conversion of other assets of the Fund into such currency. If the Fund engages in an offsetting transaction, the Fund will incur a gain or loss to the extent that there is a difference between the forward contract price and the offsetting forward contract price.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;It should be noted that this method of protecting the value of the Fund&#x2019;s portfolio securities against a decline in the value of a currency does not eliminate fluctuations in the underlying prices of the securities. Rather, it simply establishes a rate of exchange that can be achieved at some future point in time. Additionally, although such contracts tend to minimize the risk of loss due to a decline in the value of the hedged currency, at the same time they tend to limit any potential gain should the value of the currency increase.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Derivatives.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may use derivatives. Derivatives are financial instruments the value of which is derived from another security, a commodity (such as gold or oil), a currency or an index (a measure of value or rates, such as the S&amp;amp;P&#160;500 Index or the prime lending rate). Derivatives may allow the Fund to increase or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments. Pursuant to Rule&#160;18f-4 under the Investment Company Act, among other things, the Fund must either limit its derivatives exposure to no more than 10% of its net assets (the &#x201c;Limited Derivatives User Exception&#x201d;) or comply with an outer limit based on value-at-risk as specified in the rule. The Fund is currently relying on the Limited Derivatives User Exception. The Fund may or may not use derivatives for hedging purposes, as a form of leverage or to seek to enhance returns, including speculation on changes in credit spreads, interest rates or other characteristics of the market, individual securities or groups of securities. If the Fund invests in a derivative for speculative purposes, which it initially does not intend to do, the Fund will be fully exposed to the risks of loss of that derivative, which may sometimes be greater than the derivative&#x2019;s cost. The use of derivatives may involve substantial leverage.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Swap Agreements.&lt;/i&gt;&lt;/span&gt; The Fund may enter into swap agreements, including interest rate and index swap agreements, for hedging purposes, as a form of leverage or to seek to obtain a particular desired return at a lower cost to the Fund than if the Fund had invested directly in an instrument that yielded the desired return. Swap agreements are two-party contracts entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#x201c;swap&#x201d; transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross returns to be exchanged or &#x201c;swapped&#x201d; between the parties are calculated with respect to a &#x201c;notional amount&#x201d; (i.e., the dollar amount invested at a particular interest rate, in a particular foreign currency, or in a &#x201c;basket&#x201d; of securities representing a particular index). The &#x201c;notional amount&#x201d; of the swap agreement is only a basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange. The Fund&#x2019;s obligations (or rights) under a swap agreement generally will be equal only to the &#x201c;net amount&#x201d; to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may enter into credit default swap agreements and similar agreements, and may also buy credit-linked securities. Among other purposes, credit default swaps provide investment exposure to changes in credit spreads and relative interest rates. The credit default swap agreement or similar instrument may have as reference obligations one or more securities that are not currently held by the Fund (including a &#x201c;basket&#x201d; of securities representing an index). The protection &#x201c;buyer&#x201d; in a credit default contract may be obligated to pay the protection &#x201c;seller&#x201d; an upfront payment or a periodic stream of payments over the term of the contract provided generally that no credit event on a reference obligation has occurred. If a credit event occurs, the seller generally must pay the buyer the &#x201c;par value&#x201d; (full notional value) of the swap in exchange for an equal face amount of deliverable obligations of the reference entity described in the swap, if the swap is physically settled.&#160; If the swap is cash settled, an auction process is used to determine the &#x201c;recovery value&#x201d; of the contract, and the seller may be required to deliver the related net cash amount.&#160; The Fund may be either the buyer or seller in the transaction.&#160; If the Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is held through its termination date.&#160; However, if a credit event occurs and the credit default contract is required to physically settle, the Fund may elect to receive the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund may elect to receive a cash amount equal to the &#x201c;par value&#x201d; (full notional value) of the swap contract minus the &#x201c;recovery value&#x201d; as determined by the auction process.&#160; As a seller, the Fund generally receives an upfront payment or a fixed rate of income throughout the term of the swap, which typically is between six months and three years, provided that there is no credit event. If a credit event occurs and the credit default contract is required to physically settle, generally the seller must pay the buyer the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund will be generally obligated to pay the buyer the &#x201c;par value&#x201d; (full notional value) of the swap contract minus the &#x201c;recovery value&#x201d; as determined by the auction process.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may enter into total return swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising a given market index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total return refers to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is then exchanged for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility of gaining exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the Fund with the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities or other instruments underlying the swap. Similar to interest rate swaps, the cash backing total return swaps is actively managed to seek to earn a return in excess of the floating rate paid on the swap.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Swaptions.&lt;/i&gt;&lt;/span&gt;&#160; The Fund, to the extent permitted under applicable law, may enter into &#x201c;swaptions,&#x201d; which are options on swap agreements on either an asset-based or liability-based basis. A swaption is a contract that gives a counterparty the right (but not the obligation) to enter into a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future time on specified terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option agreement, the Fund generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption. When the Fund purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire unexercised. When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the underlying agreement.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Credit-Linked Securities.&lt;/i&gt;&lt;/span&gt;&#160; Among the income-producing securities in which the Fund may invest are credit-linked securities, which are issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative instrument or basket of derivative instruments, such as credit default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets. For instance, the Fund may invest in credit-linked securities as a cash management tool in order to gain exposure to a certain market and/or to remain fully invested when more traditional income-producing securities are not available.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;i&gt;Indexed and Inverse Floating Rate Securities.&lt;/i&gt;&lt;/span&gt;&#160;The Fund may invest in securities that provide a potential return based on a particular index of value or interest rates. To the extent the Fund invests in these types of securities, the Fund&#x2019;s return on such securities will be subject to risk with respect to the value of the particular index: that is, if the value of the index falls, the value of the indexed securities owned by the Fund will fall. Interest and principal payable on certain securities may also be based on relative changes among particular indices. The Fund may invest in so-called &#x201c;inverse floating obligations&#x201d; or &#x201c;residual interest bonds&#x201d; on which the interest rates vary inversely with a floating rate (which may be reset periodically by a Dutch auction, a remarketing agent, or by reference to a short-term tax-exempt interest rate index). The Fund may purchase synthetically-created inverse floating rate bonds evidenced by custodial or trust receipts. Generally, income on inverse floating rate bonds will decrease when interest rates increase, and will increase when interest rates decrease.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Repurchase Agreements and Reverse Repurchase Agreements.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Subject to its investment objective and policies, the Fund may invest in repurchase agreements. Repurchase agreements are transactions in which the Fund purchases securities or other obligations from a bank or securities dealer (or its affiliate) and simultaneously commits to resell them to the counterparty at an agreed upon date or upon demand and at a price reflecting a market rate of interest unrelated to the coupon rate or maturity of the purchased obligations. The Fund maintains custody of the underlying obligations prior to their repurchase, either through its regular custodian or through a special &#x201c;triparty&#x201d; custodian or sub-custodian that maintains separate accounts for both the Fund and its counterparty. The obligation of the counterparty to pay the repurchase price on the date agreed to or upon demand is, in effect, secured by such obligations.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Reverse repurchase agreements involve the sale of securities held by the Fund subject to the Fund&#x2019;s agreement to repurchase the securities at an agreed upon date or upon demand and at a price reflecting a market rate of interest. Reverse repurchase agreements are a form of effective leverage and may be subject to the Fund&#x2019;s limitation on borrowings and may be entered into only with banks or securities dealers or their affiliates.&lt;/p&gt;
      &lt;/div&gt;
    </cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:EffectsOfLeverageTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813130256755">
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;strong&gt;Effects of Leverage&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;As of December&#160;31, 2023, we had outstanding borrowings of approximately $163 million. In order for us to cover our annual interest payments on our outstanding indebtedness at December&#160;31, 2023, we must achieve annual returns on our December&#160;31, 2023 total assets of at least 1.29%. The weighted average stated interest rate charged on our principal amount of outstanding indebtedness as of December&#160;31, 2023 was 4.1%.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;The following table illustrates the effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate of 4.1% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately $163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses vary frequently and may be significantly higher or lower than the rate estimated above.&lt;/span&gt;&lt;/p&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;Assumed Return on Portfolio (net of expenses)(1)&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(10.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(5.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;0&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;5.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;10.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;Corresponding Return to Common Shareholder(2)&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(17.83&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(9.93&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(2.04&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;5.86&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;13.76&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December&#160;31, 2023.&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the "Corresponding Return to Common Shareholder."&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </cef:EffectsOfLeverageTextBlock>
    <cef:EffectsOfLeveragePurposeTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813130347793">
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="-sec-ix-redline:true"&gt;The following table illustrates the effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate of 4.1% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately $163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses vary frequently and may be significantly higher or lower than the rate estimated above.&lt;/span&gt;&lt;/p&gt;
        </cef:EffectsOfLeveragePurposeTextBlock>
    <cef:AnnualInterestRatePercent
      contextRef="C_20231231to20231231"
      decimals="3"
      id="Fxbrl_20240813130828136"
      unitRef="Pure">0.041</cef:AnnualInterestRatePercent>
    <cef:EffectsOfLeverageTableTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813130326546">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;Assumed Return on Portfolio (net of expenses)(1)&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(10.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(5.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;0&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;5.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;10.00&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;Corresponding Return to Common Shareholder(2)&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(17.83&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(9.93&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;(2.04&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;)%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;5.86&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="-sec-ix-redline:true"&gt;13.76&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="-sec-ix-redline:true"&gt;%&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December&#160;31, 2023.&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="-sec-ix-redline:true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:0.25in"&gt;&lt;span style="-sec-ix-redline:true"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="-sec-ix-redline:true"&gt;In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the "Corresponding Return to Common Shareholder."&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </cef:EffectsOfLeverageTableTextBlock>
    <cef:ReturnAtMinusTenPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="Fxbrl_20240813130938642"
      unitRef="Pure">-0.1783</cef:ReturnAtMinusTenPercent>
    <cef:ReturnAtMinusFivePercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="Fxbrl_20240813130950435"
      unitRef="Pure">-0.0993</cef:ReturnAtMinusFivePercent>
    <cef:ReturnAtZeroPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="Fxbrl_20240813130956563"
      unitRef="Pure">-0.0204</cef:ReturnAtZeroPercent>
    <cef:ReturnAtPlusFivePercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="Fxbrl_20240813131017531"
      unitRef="Pure">0.0586</cef:ReturnAtPlusFivePercent>
    <cef:ReturnAtPlusTenPercent
      contextRef="C_20240814to20240814"
      decimals="4"
      id="Fxbrl_20240813131023322"
      unitRef="Pure">0.1376</cef:ReturnAtPlusTenPercent>
    <cef:LongTermDebtTableTextBlock
      contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember"
      id="Fxbrl_20240813150245156">
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Credit Facility&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Under the Investment Company Act, the Fund is permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately thereafter the Fund has asset coverage of at least 300%. In general, the term &#x201c;asset coverage&#x201d; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund is a party to a senior secured revolving Credit Facility that allows the Fund to borrow up to $212 million at any one time outstanding. &lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a) limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b) limitations on certain investments, (c) limitations on certain restricted payments, and (d) maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </cef:LongTermDebtTableTextBlock>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember"
      id="Fxbrl_20240813150307556">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Credit Facility&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember"
      decimals="-6"
      id="Fxbrl_20240813150334973"
      unitRef="USD">212000000</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtStructuringTextBlock
      contextRef="C_20240814to20240814_usgaapDebtInstrumentAxis_ck0001515324CreditFacilityMember"
      id="Fxbrl_20240813150517564">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a) limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b) limitations on certain investments, (c) limitations on certain restricted payments, and (d) maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.&lt;/span&gt;</cef:LongTermDebtStructuringTextBlock>
    <cef:RiskFactorsTableTextBlock
      contextRef="C_20240814to20240814"
      id="Fxbrl_20240813131638043">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_010_integixAnchor"&gt;&lt;strong&gt;RISKS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Please refer to the&#160;&lt;/span&gt;&lt;span style="color:#0563c1"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit"&gt;section of the Fund&#x2019;s most recent annual report on Form&#160;N-CSR&#160;entitled &#x201c;Additional Information &#x2013; Fund Investment Objective, Policies and Risks,&#x201d;&lt;/a&gt;&lt;/span&gt; &lt;span&gt;which is incorporated by reference herein, for a discussion of the general risks of investing in the Fund.&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskFactorsTableTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F20240813093858837_2"
          xlink:label="F20240813093858837_2"
          xlink:type="locator"/>
        <link:footnote id="FN20240813151557943" xlink:label="FN20240813151557943" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_2"
          xlink:to="FN20240813151557943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20240813093858837_3"
          xlink:label="F20240813093858837_3"
          xlink:type="locator"/>
        <link:footnote id="FN20240813093858838_17" xlink:label="FN20240813093858838_17" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_3"
          xlink:to="FN20240813093858838_17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20240813093858837_4"
          xlink:label="F20240813093858837_4"
          xlink:type="locator"/>
        <link:footnote id="FN20240813093858838_18" xlink:label="FN20240813093858838_18" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_4"
          xlink:to="FN20240813093858838_18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20240813093858837_6"
          xlink:label="F20240813093858837_6"
          xlink:type="locator"/>
        <link:footnote id="FN20240813151619745" xlink:label="FN20240813151619745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#x2019;s use of leverage in the form of higher fees as a percentage of the Fund&#x2019;s net assets attributable to common shares than if the Fund did not use leverage.  The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#x2019;s Managed Assets.  Based on the same assumptions, leverage would equal 55% of the Fund&#x2019;s net assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_6"
          xlink:to="FN20240813151619745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20240813093858837_7"
          xlink:label="F20240813093858837_7"
          xlink:type="locator"/>
        <link:footnote id="FN20240813093858838_20" xlink:label="FN20240813093858838_20" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Interest payments on borrowed funds&#x201d; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023.  We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December 31, 2023. This item is based on the assumption that the Fund&#x2019;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#x2019;s Managed Assets and 55% of the Fund&#x2019;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#x2019;s and the Board&#x2019;s assessment of market and other factors at the time of any proposed borrowing. See &#x201c;Credit Facility.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_7"
          xlink:to="FN20240813093858838_20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20240813093858837_8"
          xlink:label="F20240813093858837_8"
          xlink:type="locator"/>
        <link:footnote id="FN20240813093858838_21" xlink:label="FN20240813093858838_21" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Other Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d; are based on estimated amounts for the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20240813093858837_8"
          xlink:to="FN20240813093858838_21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240813130938642"
          xlink:label="Fxbrl_20240813130938642"
          xlink:type="locator"/>
        <link:footnote id="FN20240813131137276" xlink:label="FN20240813131137276" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December 31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December 31, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130938642"
          xlink:to="FN20240813131137276"
          xlink:type="arc"/>
        <link:footnote id="FN20240813131152589" xlink:label="FN20240813131152589" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December 31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December 31, 2023 to determine the "Corresponding Return to Common Shareholder."</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130938642"
          xlink:to="FN20240813131152589"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240813130950435"
          xlink:label="Fxbrl_20240813130950435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130950435"
          xlink:to="FN20240813131137276"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130950435"
          xlink:to="FN20240813131152589"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240813130956563"
          xlink:label="Fxbrl_20240813130956563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130956563"
          xlink:to="FN20240813131137276"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813130956563"
          xlink:to="FN20240813131152589"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240813131017531"
          xlink:label="Fxbrl_20240813131017531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813131017531"
          xlink:to="FN20240813131137276"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813131017531"
          xlink:to="FN20240813131152589"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240813131023322"
          xlink:label="Fxbrl_20240813131023322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813131023322"
          xlink:to="FN20240813131137276"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240813131023322"
          xlink:to="FN20240813131152589"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139761932963104">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 14, 2024</div></th>
<th class="th"><div>Aug. 06, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001515324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333-279977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">811-22535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreEffectiveAmendmentNumber', window );">Pre-Effective Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PostEffectiveAmendment', window );">Post-Effective Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ares Dynamic Credit Allocation Fund, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2000 Avenue of the Stars<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">12Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Los Angeles<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">90067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">201-4100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">As soon as practicable after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
              <td style="font-size:10pt">&#160;</td>
              <td colspan="2" style="font-size:10pt">&#160;</td>
              <td style="font-size:10pt">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Sales load paid by you (<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">as a percentage of offering price</span></span></span>)(1)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Offering expenses borne by the Fund (as a percentage of offering price)(2)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom">
              <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Dividend reinvestment plan fees(3)</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>

        </table>
      </div>

      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <div style="margin-bottom:0pt">
          <div style="margin-top:3pt;margin-bottom:3pt;width:25%">
            <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares. </span></td>
              </tr>
              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
                <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.</span></td>
              </tr>
              <tr style="vertical-align:top">
                <td style="padding-bottom:10pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt">(3)</span></td>
                <td style="padding-bottom:0pt;text-align:justify;height:15px;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</span></td>
              </tr>

          </table>
        </div>
      </div>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherTransactionExpense1Percent', window );">Other Transaction Expense 1 [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:bold 10pt Times New Roman, Times, Serif">Annual Expenses (as a percentage of net assets attributable to common shares)</td>
            <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="font-size:10pt;text-align:right">&#160;</td>
            <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:10pt Times New Roman, Times, Serif;width:87%;padding-left:0.25in">Advisory Fees(4)</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">1.74</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25in">Interest payments on borrowed funds(5)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">2.42</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;padding-left:0.25in">Other Expenses(6)</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">0.80</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:0.375in">Total Annual Fund Operating Expenses</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right">4.96</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
          </tr>

      </table>

        <div>&#160;</div>

      <div>
        <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

            <tr style="vertical-align:top">
              <td style="padding-bottom:10pt;text-align:justify;width:47px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(4)</span></p>
              </td>
              <td style="padding-bottom:10pt;text-align:justify;width:1196px"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage of </span>36<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal 55% of the Fund&#8217;s net assets. </span></span></span></td>
            </tr>
            <tr style="vertical-align:top">
              <td style="padding-bottom:10pt;text-align:justify;width:47px"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(5)</span></span></td>
              <td style="padding-bottom:10pt;text-align:justify;width:1196px"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023. We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December&#160;31, 2023. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets <span>and 55% of the Fund&#8217;s net assets</span>) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. See &#8220;Credit Facility.&#8221;</span></span></td>
            </tr>
            <tr style="vertical-align:top">
              <td style="text-align:justify;width:47px"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(6)</span></span></td>
              <td style="text-align:justify;width:1196px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-redline:true"><span><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</span></span></span></span></span></td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual expenses of </span>4.96% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

              <tr style="vertical-align:bottom">
                <td style="font-size:10pt"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="-sec-ix-redline:true">One&#160;Year</span></td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="-sec-ix-redline:true">Three&#160;Years</span></td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="-sec-ix-redline:true">Five&#160;Years</span></td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="-sec-ix-redline:true">Ten&#160;Years</span></td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt"><span style="-sec-ix-redline:true">Total expenses incurred</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">$</span></td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">51</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">$</span></td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">152</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">$</span></td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">254</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">$</span></td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">506</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The example should not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table is intended to assist you in understanding the costs and expenses that an investor in our common shares will bear, directly or indirectly, based on the assumptions set forth below. We caution you that some of the percentages indicated in the table below are estimates and may vary. The table reflects the use of leverage in the form of borrowings in an amount equal to 36% of the Fund&#8217;s Managed Assets (after the leverage is incurred), and shows Fund expenses as a percentage of net assets attributable to common shares. The extent of the Fund&#8217;s assets attributable to leverage following an offering, and the Fund&#8217;s associated expenses, are likely to vary (perhaps significantly) from these assumptions.</p>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">as a percentage of offering price</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_008_integixAnchor"><strong>THE FUND&#8217;S INVESTMENTS</strong></span></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Objective and Policies</strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span></span><span style="-sec-ix-redline:true"> <span>which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objective and policies. The Fund&#8217;s investment objective is non-fundamental and may be changed by the Board without shareholder approval.</span></span></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Portfolio Contents and Techniques</strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under normal circumstances, the Fund&#8217;s portfolio is expected to be comprised principally of the following types of investments:</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Senior Loans.</i></strong></p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior loans (&#8220;Senior Loans&#8221;) generally hold the most senior position in the capital structure of a borrower, are typically secured with specific collateral and have a claim on the assets and/or stock of the borrower that is senior to that held by unsecured creditors, subordinated debt holders and holders of equity of the borrower. The majority of loans the Fund may invest in are rated below investment grade. Typically, in order to borrow money pursuant to a Senior Loan, a borrower will, for the term of the Senior Loan, pledge collateral (subject to typical exceptions), including but not limited to (i)&#160;working capital assets, such as accounts receivable and inventory; (ii)&#160;tangible fixed assets, such as real property, buildings and equipment; (iii)&#160;intangible assets, such as trademarks and patent rights; and (iv)&#160;security interests in shares of stock of subsidiaries or affiliates. In many instances, a Senior Loan may be secured only by shares in the borrower or its subsidiaries. Collateral may consist of assets that may not be readily liquidated, and there is no assurance that the liquidation of such assets would satisfy fully a borrower&#8217;s obligations under a Senior Loan.</p>
          </div>

            <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior Loans typically have rates of interest that are determined daily, monthly, quarterly or semi-annually by reference to a base lending rate, plus a premium or credit spread. As a result, as short-term interest rates increase, interest payable to the Fund from its investments in Senior Loans should increase, and as short-term interest rates decrease, interest payable to the Fund from its investments in Senior Loans should decrease. These base lending rates are primarily the secured overnight funding rate (&#8220;SOFR&#8221;) or the Euro Interbank Offered Rate (&#8220;Euribor&#8221;) and secondarily the prime rate offered by one or more major U.S. banks and the certificate of deposit rate or other base lending rates used by commercial lenders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">There may be less readily available information about most Senior Loans and the borrowers thereunder than is the case for many other types of securities, including securities issued in transactions registered under the </span>Securities Act of 1933, as amended (&#8220;Securities Act&#8221;) or the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and borrowers subject to the periodic reporting requirements of Section&#160;13 of the Exchange Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">No active trading market may exist for some Senior Loans, and some loans may be subject to restrictions on resale. Any secondary market for Senior Loans may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability of a seller to realize full value and thus cause a material decline in the net asset value of the common shares. In addition, the Fund may not be able to readily dispose of its Senior Loans at prices that approximate those at which the Fund could sell such loans if they were more widely traded and, as a result of such illiquidity, the Fund may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. A limited supply or relative illiquidity of Senior Loans may adversely affect the Fund&#8217;s yield.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In the process of buying, selling and holding Senior Loans, the Fund may receive and/or pay certain fees. These fees are in addition to interest payments received and may include facility fees, commitment fees, amendment fees, commissions and prepayment penalty fees. On an ongoing basis, the Fund may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a Senior Loan. In certain circumstances, the Fund may receive a prepayment penalty fee upon the prepayment of a Senior Loan by a borrower. Other fees received by the Fund may include covenant waiver fees, covenant modification fees or other amendment fees.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Direct Assignments.</i></span>&#160;&#160;The Fund generally will seek to purchase Senior Loans on a direct assignment basis. If the Fund purchases a Senior Loan on direct assignment, it typically succeeds to all the rights and obligations under the Loan Agreement of the assigning lender and becomes a lender under the Loan Agreement with the same rights and obligations as the assigning lender.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Loan Participations.</i></span>&#160;&#160;To a lesser extent than direct assignments, the Fund may transact in participations in Senior Loans. The participation by the Fund in a lender&#8217;s portion of a Senior Loan typically will result in the Fund&#8217;s having a contractual relationship only with such lender, not with the borrower. As a result, the Fund may have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the participation and only upon receipt by such lender of payments from the borrower. Such indebtedness may be secured or unsecured. In connection with purchasing participations, the Fund generally will have no right to enforce compliance by the borrower with the terms of the Loan Agreement, nor any rights with respect to any funds acquired by other investors through set-off against the borrower and the Fund may not directly benefit from the collateral supporting the Senior Loan in which it has purchased the participation. In the event of the insolvency of the entity selling a participation, the Fund may be treated as a general creditor of such entity.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Corporate Bonds.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in corporate bonds that are fixed income securities typically issued by non-investment-grade borrowers, usually at a yield premium to the yield for investment-grade bonds (&#8220;Corporate Bonds&#8221;). Corporate Bonds generally provide for cash interest payments, but may include deferred, zero coupon, or payment-in-kind terms. These investments may be acquired during the primary offering process and may also be purchased in the secondary market as either private securities or publicly registered securities, and typically have multiple institutional holders.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Holders of high-yield bonds, as creditors, have a prior legal claim over common and preferred shareholders as to both income and assets of the issuer for the principal and interest due them and may have a prior claim over other creditors but are generally subordinate to any senior secured lenders in the issuer&#8217;s capital structure.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In most cases Corporate Bonds restrict the borrower&#8217;s ability to incur additional debt and may restrict payments to equity shareholders based upon financial ratios associated with general credit quality. In addition, Corporate Bonds often limit the borrower&#8217;s ability to repay or amortize its high-yield bonds, particularly during the initial portion of their contractual tenor. As such, these securities can provide the opportunity for capital appreciation or yield enhancement, especially when the borrower&#8217;s financial performance is consistent with or superior to expectations, when conditions are favorable in the borrower&#8217;s industry, or when the general economic environment is positive.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Secured bonds and notes. </i></span>These bonds and notes generally constitute the senior-most layer of a borrower&#8217;s capital structure and benefit from a lien on the borrower&#8217;s assets as well as senior ranking in repayment priority. Owing to their claim position and collateral support, secured bonds and secured notes tend to experience superior recoveries in a bankruptcy as compared to unsecured debt due to the collateral securing these instruments. Such bonds and notes may rank <i>pari passu</i> in many respects with secured loans.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Unsecured bonds. </i></span>Dependent upon their terms, these bonds can enjoy a senior ranking or subordinated ranking in repayment priority, but do not benefit from a lien on a borrower&#8217;s assets. Unsecured bonds typically form a layer between a borrower&#8217;s credit facility and its equity. Yields tend to reflect a premium in respect of a bond&#8217;s position within a borrower&#8217;s capital structure.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Alternative Credit Instruments.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">These instruments typically include trust certificates, collateralized debt obligations, collateralized loan obligations (&#8220;CLOs&#8221;), asset-backed securities, credit-linked notes or other structured finance securities. These securities are generally backed by pools of financials and other assets and tranched into different asset classes. The structure of these securities may consist of debt rated from AAA to B and equity. These securities typically make interest and principal payments in order of seniority.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>CLO Securities</i></span>. A CLO generally holds a portfolio consisting principally of loan obligations. CLOs are created, in part, to reapportion the risk and return characteristics of a portfolio of underlying assets. The CLO securitizes payment claims arising out of its portfolio of underlying assets and issues securities with payment characteristics linked to the underlying assets. The redemption of the securities issued by the CLO typically occurs from the cash flow generated by the portfolio of underlying assets. The vast majority of CLOs are actively managed by an investment manager that is independent of the CLO and the holders of its securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund expects to invest in securities issued by CLOs (&#8220;CLO Securities&#8221;) that principally hold Senior Loans, diversified by industry and borrower. It is also possible that the underlying obligations of CLOs in which the Fund invests will include (i)&#160;subordinated loans, (ii)&#160;debt tranches of other CLOs, and (iii)&#160;equity securities incidental to investments in Senior Loans. The cash flows on the underlying obligations will primarily determine the payments to holders of CLO Securities. CLO Securities may have floating interest rates, fixed interest rates or, in the case of subordinated CLO Securities, no set interest rate (but rather participate in residual cash flows of the relevant CLO). CLOs issue securities in tranches with different payment characteristics and different credit ratings. These tranches are generally categorized as senior, mezzanine, or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization of the cash flows from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual interest payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche). The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for each CLO.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The tranches of CLO Securities senior to the subordinated (or residual) tranche (called the &#8220;rated tranches&#8221;) are generally assigned credit ratings by one or more nationally recognized statistical rating organizations (whether or not such tranches are issued as part of a component of a composite instrument with one or more other instruments). The &#8220;equity&#8221; tranche does not receive ratings. The transaction documents relating to the issuance of CLO Securities impose eligibility criteria on the assets of the CLO, restrict the ability of the CLO&#8217;s investment manager to trade investments and impose certain portfolio-wide asset quality requirements.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">CLO Securities are generally limited recourse obligations of the CLO payable solely from the underlying assets of the CLO or the proceeds thereof. Consequently, holders of CLO Securities must rely solely on distributions on the underlying assets or proceeds thereof for payment in respect thereof. The cash flows generated by the underlying obligations held in a CLO&#8217;s portfolio will generally determine the interest payments on CLO Securities. Payments to holders of tranched CLO Securities are made in sequential order of priority.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Asset-Backed Securities</i></span>. Asset-backed securities are debt instruments that are backed by a pool of financial assets, generally consisting of certain kinds of receivables or loans, including, for example, commercial loans. Such assets are generally securitized through the use of trusts and special purpose corporations. Payments or distributions of principal and interest may be guaranteed up to certain amounts and for a certain time period by a letter of credit or a pool insurance policy issued by a financial institution unaffiliated with the trust or corporation, or other credit enhancements may be present.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Asset-backed securities are often subject to more rapid repayment than their stated maturity date would indicate as a result of the pass-through of prepayments of principal on the underlying loans. During periods of declining interest rates, prepayment of loans underlying asset-backed securities can be expected to accelerate. Accordingly, the Fund&#8217;s ability to maintain positions in such securities will be affected by reductions in the principal amount of such securities resulting from prepayments, and its ability to reinvest the returns of principal at comparable yields is subject to generally prevailing interest rates at that time. To the extent that the Fund invests in asset-backed securities, the values of the Fund&#8217;s portfolio securities will vary with changes in market interest rates generally and the differentials in yields among various kinds of asset-backed securities. Asset-backed securities also carry credit or default risks. If the issuer of an asset-backed security defaults on its payment obligations, there is the possibility that, in some cases, the Fund will be unable to possess and sell the underlying collateral and that the Fund&#8217;s recoveries on repossessed collateral may not be available to support payments on these securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Subordinated Loans.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in subordinated loans. Because subordinated loans are subordinated and thus lower in priority of payment and/or in priority of lien to Senior Loans, they are subject to the additional risk that the cash flow of the borrower and property securing the loan or debt, if any, may be insufficient to meet scheduled payments after giving effect to the senior secured obligations of the borrower. This risk is generally higher for subordinated unsecured loans or debt, which are not backed by a security interest in any specific collateral. Subordinated loans generally have greater price volatility than Senior Loans and may be less liquid.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Special Situations and Stressed and Distressed Investments.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in debt securities, preferred or common shares, or other instruments, of companies that are facing liquidity constraints or are undergoing, or that have recently completed, bankruptcies, reorganizations, insolvencies, liquidations or other fundamental changes or similar proceedings. These instruments may be the subject of bankruptcy proceedings or otherwise in default or at risk of being in default as to the repayment of principal and/or interest at the time of acquisition by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make any interest or other payments.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In any investment opportunity involving any such type of special situation, there also exists the risk that a contemplated transaction either will be unsuccessful, will take considerable time or will result in a distribution of cash or new securities, the value of which will be less than the purchase price to the Fund of the securities or other financial instruments in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can be prevented or delayed by a variety of factors, including but not limited to (i)&#160;market conditions resulting in material changes in securities prices; (ii)&#160;compliance with any applicable bankruptcy, insolvency or securities laws; and (iii)&#160;other factors resulting in the inability to obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled companies in which the Fund intends to invest, there is a potential risk of loss by the Fund of its entire investment in such companies. Distressed instruments may be highly illiquid and the prices at which they may be sold may represent a substantial discount to what the Adviser believes to be their ultimate value.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Equity Securities.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">From time to time, the Fund may invest in or hold common shares and other equity securities incident to the purchase or ownership of a Senior Loan, Corporate Bond or other instrument or in connection with a reorganization of a borrower. Investments in equity securities incidental to investment in Senior Loans entail certain risks in addition to those associated with investments in Senior Loans. Common shares represent an equity ownership interest in a company. Historical trends would indicate that common shares are subject to higher levels of volatility and market and issuer-specific risk than debt securities. The value of equity securities may be affected more rapidly, and to a greater extent, by company-specific developments and general market conditions. These risks may increase fluctuations in the net asset value of the common shares. In addition, the Fund frequently may possess material non-public information about a borrower. Because of prohibitions on trading in securities while in possession of material non-public information, the Fund might be unable to enter into a transaction in a security of the borrower when it would otherwise be advantageous to do so. The equity interests held by the Fund, if any, may not pay dividends or otherwise generate income or appreciate in value and, in fact, may decline in value. Accordingly, the Fund may not be able to realize gains from its equity investments, and any gains that the Fund does realize may not be sufficient to contribute materially to the Fund&#8217;s investment objective of seeking current income. Equity securities held by the Fund may be illiquid.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Short Sales.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may, from time to time, engage in short sales. A short sale is a transaction in which the Fund sells an instrument that it does not own in anticipation that the market price will decline. To deliver the securities to the buyer, the Fund arranges through a broker to borrow the securities and, in so doing, the Fund becomes obligated to replace the securities borrowed at their market price at the time of replacement. When selling short, the Fund intends to replace the securities at a lower price and therefore profit from the difference between the cost to replace the securities and the proceeds received from the sale of the securities. When the Fund makes a short sale, the proceeds it receives from the sale will be held on behalf of a broker until the Fund replaces the borrowed securities. The Fund may have to pay a premium to borrow the securities and must pay any dividends or interest payable on the securities until they are replaced. The Fund&#8217;s obligation to replace the securities borrowed in connection with a short sale will be secured by collateral deposited with the broker that consists of cash and/or liquid securities. Short sales involve certain risks and special considerations. If the Fund incorrectly predicts that the price of the borrowed security will decline, the Fund will have to replace the securities with securities with a greater value than the amount received from the sale. As a result, losses from short sales differ from losses that could be incurred from a purchase of a security because losses from short sales may be theoretically unlimited, whereas losses from purchases can equal only the total amount invested.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Warrants.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Warrants give holders the right, but not the obligation, to buy common shares of an issuer at a given price, usually higher than the market price at the time of issuance, during a specified period. The risk of investing in a warrant is that the warrant may expire prior to the market value of the common shares exceeding the price fixed by the warrant. Warrants have a subordinate claim on a borrower&#8217;s assets compared with Senior Loans. As a result, the values of warrants generally are dependent on the financial condition of the borrower and less dependent on fluctuations in interest rates than are the values of many debt securities. The values of warrants may be more volatile than those of Senior Loans or Corporate Bonds and this may increase the volatility of the net asset value of the common shares.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Non-U.S. Securities.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest a portion of its capital in non-U.S. securities. Some non-U.S. securities may be less liquid and more volatile than securities of comparable U.S. issuers. Similarly, there is less volume and liquidity in most foreign financial markets than in the U.S. and, at times, greater price volatility than in the U.S.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because evidences of ownership of such securities usually are held outside the U.S., the Fund will be subject to additional risks, including possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions that might adversely affect or restrict the payment of principal and interest on the foreign securities to investors located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may trade on days when the common shares are not traded on the NYSE, the market value or net asset value of the common shares can change at times when the common shares cannot be sold.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Foreign Currency Transactions.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may engage in foreign currency exchange transactions in connection with its investments in foreign securities. The Fund is not required to hedge its currency exposure, if any, and may choose not to do so. The Fund generally will conduct its foreign currency exchange transactions either on a spot (i.e.,&#160;cash) basis at the spot rate prevailing in the foreign currency exchange market or through forward contracts to purchase or sell foreign currencies, including the payment of dividends and the settlement of securities transactions that otherwise might require untimely dispositions of Fund securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A forward foreign currency exchange contract involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days (usually less than one year) from the date of the contract agreed upon by the parties, at a price and for an amount set at the time of the contract. These contracts are traded in the interbank market conducted directly between currency traders (usually large commercial banks) and their customers. A forward contract generally has a deposit requirement, and no commissions are charged at any stage for trades. Although foreign exchange dealers do not charge a fee for conversion, they do realize a profit based on the difference (the spread) between the price at which they are buying and selling various currencies. At the consummation of a forward contract, the Fund may either make delivery of the foreign currency or terminate its contractual obligation to deliver the foreign currency by purchasing an offsetting contract obligating it to purchase, at the same maturity date, the same amount of such foreign currency. If the Fund chooses to make delivery of the foreign currency, it may be required to obtain such currency through the sale of portfolio securities denominated in such currency or through conversion of other assets of the Fund into such currency. If the Fund engages in an offsetting transaction, the Fund will incur a gain or loss to the extent that there is a difference between the forward contract price and the offsetting forward contract price.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">It should be noted that this method of protecting the value of the Fund&#8217;s portfolio securities against a decline in the value of a currency does not eliminate fluctuations in the underlying prices of the securities. Rather, it simply establishes a rate of exchange that can be achieved at some future point in time. Additionally, although such contracts tend to minimize the risk of loss due to a decline in the value of the hedged currency, at the same time they tend to limit any potential gain should the value of the currency increase.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Derivatives.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may use derivatives. Derivatives are financial instruments the value of which is derived from another security, a commodity (such as gold or oil), a currency or an index (a measure of value or rates, such as the S&amp;P&#160;500 Index or the prime lending rate). Derivatives may allow the Fund to increase or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments. Pursuant to Rule&#160;18f-4 under the Investment Company Act, among other things, the Fund must either limit its derivatives exposure to no more than 10% of its net assets (the &#8220;Limited Derivatives User Exception&#8221;) or comply with an outer limit based on value-at-risk as specified in the rule. The Fund is currently relying on the Limited Derivatives User Exception. The Fund may or may not use derivatives for hedging purposes, as a form of leverage or to seek to enhance returns, including speculation on changes in credit spreads, interest rates or other characteristics of the market, individual securities or groups of securities. If the Fund invests in a derivative for speculative purposes, which it initially does not intend to do, the Fund will be fully exposed to the risks of loss of that derivative, which may sometimes be greater than the derivative&#8217;s cost. The use of derivatives may involve substantial leverage.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swap Agreements.</i></span> The Fund may enter into swap agreements, including interest rate and index swap agreements, for hedging purposes, as a form of leverage or to seek to obtain a particular desired return at a lower cost to the Fund than if the Fund had invested directly in an instrument that yielded the desired return. Swap agreements are two-party contracts entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221; transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect to a &#8220;notional amount&#8221; (i.e., the dollar amount invested at a particular interest rate, in a particular foreign currency, or in a &#8220;basket&#8221; of securities representing a particular index). The &#8220;notional amount&#8221; of the swap agreement is only a basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange. The Fund&#8217;s obligations (or rights) under a swap agreement generally will be equal only to the &#8220;net amount&#8221; to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into credit default swap agreements and similar agreements, and may also buy credit-linked securities. Among other purposes, credit default swaps provide investment exposure to changes in credit spreads and relative interest rates. The credit default swap agreement or similar instrument may have as reference obligations one or more securities that are not currently held by the Fund (including a &#8220;basket&#8221; of securities representing an index). The protection &#8220;buyer&#8221; in a credit default contract may be obligated to pay the protection &#8220;seller&#8221; an upfront payment or a periodic stream of payments over the term of the contract provided generally that no credit event on a reference obligation has occurred. If a credit event occurs, the seller generally must pay the buyer the &#8220;par value&#8221; (full notional value) of the swap in exchange for an equal face amount of deliverable obligations of the reference entity described in the swap, if the swap is physically settled.&#160; If the swap is cash settled, an auction process is used to determine the &#8220;recovery value&#8221; of the contract, and the seller may be required to deliver the related net cash amount.&#160; The Fund may be either the buyer or seller in the transaction.&#160; If the Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is held through its termination date.&#160; However, if a credit event occurs and the credit default contract is required to physically settle, the Fund may elect to receive the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund may elect to receive a cash amount equal to the &#8220;par value&#8221; (full notional value) of the swap contract minus the &#8220;recovery value&#8221; as determined by the auction process.&#160; As a seller, the Fund generally receives an upfront payment or a fixed rate of income throughout the term of the swap, which typically is between six months and three years, provided that there is no credit event. If a credit event occurs and the credit default contract is required to physically settle, generally the seller must pay the buyer the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund will be generally obligated to pay the buyer the &#8220;par value&#8221; (full notional value) of the swap contract minus the &#8220;recovery value&#8221; as determined by the auction process.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into total return swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising a given market index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total return refers to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is then exchanged for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility of gaining exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the Fund with the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities or other instruments underlying the swap. Similar to interest rate swaps, the cash backing total return swaps is actively managed to seek to earn a return in excess of the floating rate paid on the swap.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swaptions.</i></span>&#160; The Fund, to the extent permitted under applicable law, may enter into &#8220;swaptions,&#8221; which are options on swap agreements on either an asset-based or liability-based basis. A swaption is a contract that gives a counterparty the right (but not the obligation) to enter into a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future time on specified terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option agreement, the Fund generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption. When the Fund purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire unexercised. When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the underlying agreement.</p>
        </div>

          <div>&#160;</div>

      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Credit-Linked Securities.</i></span>&#160; Among the income-producing securities in which the Fund may invest are credit-linked securities, which are issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative instrument or basket of derivative instruments, such as credit default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets. For instance, the Fund may invest in credit-linked securities as a cash management tool in order to gain exposure to a certain market and/or to remain fully invested when more traditional income-producing securities are not available.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Indexed and Inverse Floating Rate Securities.</i></span>&#160;The Fund may invest in securities that provide a potential return based on a particular index of value or interest rates. To the extent the Fund invests in these types of securities, the Fund&#8217;s return on such securities will be subject to risk with respect to the value of the particular index: that is, if the value of the index falls, the value of the indexed securities owned by the Fund will fall. Interest and principal payable on certain securities may also be based on relative changes among particular indices. The Fund may invest in so-called &#8220;inverse floating obligations&#8221; or &#8220;residual interest bonds&#8221; on which the interest rates vary inversely with a floating rate (which may be reset periodically by a Dutch auction, a remarketing agent, or by reference to a short-term tax-exempt interest rate index). The Fund may purchase synthetically-created inverse floating rate bonds evidenced by custodial or trust receipts. Generally, income on inverse floating rate bonds will decrease when interest rates increase, and will increase when interest rates decrease.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Repurchase Agreements and Reverse Repurchase Agreements.</i></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subject to its investment objective and policies, the Fund may invest in repurchase agreements. Repurchase agreements are transactions in which the Fund purchases securities or other obligations from a bank or securities dealer (or its affiliate) and simultaneously commits to resell them to the counterparty at an agreed upon date or upon demand and at a price reflecting a market rate of interest unrelated to the coupon rate or maturity of the purchased obligations. The Fund maintains custody of the underlying obligations prior to their repurchase, either through its regular custodian or through a special &#8220;triparty&#8221; custodian or sub-custodian that maintains separate accounts for both the Fund and its counterparty. The obligation of the counterparty to pay the repurchase price on the date agreed to or upon demand is, in effect, secured by such obligations.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Reverse repurchase agreements involve the sale of securities held by the Fund subject to the Fund&#8217;s agreement to repurchase the securities at an agreed upon date or upon demand and at a price reflecting a market rate of interest. Reverse repurchase agreements are a form of effective leverage and may be subject to the Fund&#8217;s limitation on borrowings and may be entered into only with banks or securities dealers or their affiliates.</p>
      </div>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_010_integixAnchor"><strong>RISKS</strong></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective, Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the general risks of investing in the Fund.</span></p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true"><strong>Effects of Leverage</strong></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">As of December&#160;31, 2023, we had outstanding borrowings of approximately $163 million. In order for us to cover our annual interest payments on our outstanding indebtedness at December&#160;31, 2023, we must achieve annual returns on our December&#160;31, 2023 total assets of at least 1.29%. The weighted average stated interest rate charged on our principal amount of outstanding indebtedness as of December&#160;31, 2023 was 4.1%.</span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>

          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">The following table illustrates the effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate of 4.1% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately $163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses vary frequently and may be significantly higher or lower than the rate estimated above.</span></p>

        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>

          <div>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify"><span style="-sec-ix-redline:true">Assumed Return on Portfolio (net of expenses)(1)</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">(10.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">(5.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">0</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">5.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">10.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="-sec-ix-redline:true">Corresponding Return to Common Shareholder(2)</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(17.83</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(9.93</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(2.04</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">5.86</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">13.76</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="-sec-ix-redline:true">&#160;</span></p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></span></td>
                  <td style="text-align:justify"><span style="-sec-ix-redline:true">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December&#160;31, 2023.</span></td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></span></td>
                  <td style="text-align:justify"><span style="-sec-ix-redline:true">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the "Corresponding Return to Common Shareholder."</span></td>
                </tr>

            </table>
          </div>

      </div>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_AnnualInterestRatePercent', window );">Annual Interest Rate [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_EffectsOfLeverageTableTextBlock', window );">Effects of Leverage [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify"><span style="-sec-ix-redline:true">Assumed Return on Portfolio (net of expenses)(1)</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">(10.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">(5.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">0</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">5.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><span style="-sec-ix-redline:true">10.00</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="-sec-ix-redline:true">Corresponding Return to Common Shareholder(2)</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(17.83</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(9.93</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">(2.04</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">)%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">5.86</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">&#160;</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="-sec-ix-redline:true">13.76</span></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="-sec-ix-redline:true">%</span></td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="-sec-ix-redline:true">&#160;</span></p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></span></td>
                  <td style="text-align:justify"><span style="-sec-ix-redline:true">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December&#160;31, 2023.</span></td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
            <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                <tr style="vertical-align:top">
                  <td style="width:0.25in">&#160;</td>
                  <td style="width:0.25in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></span></td>
                  <td style="text-align:justify"><span style="-sec-ix-redline:true">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the "Corresponding Return to Common Shareholder."</span></td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ReturnAtMinusTenPercent', window );">Return at Minus Ten [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7],[8]</sup></td>
<td class="num">(17.83%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ReturnAtMinusFivePercent', window );">Return at Minus Five [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7],[8]</sup></td>
<td class="num">(9.93%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ReturnAtZeroPercent', window );">Return at Zero [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7],[8]</sup></td>
<td class="num">(2.04%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ReturnAtPlusFivePercent', window );">Return at Plus Five [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7],[8]</sup></td>
<td class="nump">5.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ReturnAtPlusTenPercent', window );">Return at Plus Ten [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7],[8]</sup></td>
<td class="nump">13.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_EffectsOfLeveragePurposeTextBlock', window );">Effects of Leverage, Purpose [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">The following table illustrates the effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate of 4.1% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately $163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses vary frequently and may be significantly higher or lower than the rate estimated above.</span></p>
        <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">During Quarter Ended</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NYSE&#160;Market&#160;Price<br/>Per&#160;Common Share</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NAV per Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">Trading</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Volume</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:30%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2024</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.29</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">13.41</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.69</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.56</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(2.72</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(7.90</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">6,951,700</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.93</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.51</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.77</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(5.24</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(13.43</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,020,500</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.90</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.10</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.21</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.78</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,500,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.33</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.68</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.87</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.58</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(10.65</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(13.99</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,473,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.77</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.42</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.11</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.39</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9.22</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(14.78</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">7,627,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.09</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.27</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.66</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.17</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9.90</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(14.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,699,200</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.45</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.34</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.44</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.26</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,773,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.67</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.89</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.95</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.03</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.44</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,461,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">16.29</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.76</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">16.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.66</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(2.22</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,201,000</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.41<span></span>
</td>
<td class="nump">$ 11.93<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 11.68<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="nump">$ 11.27<span></span>
</td>
<td class="nump">$ 11.75<span></span>
</td>
<td class="nump">$ 11.89<span></span>
</td>
<td class="nump">$ 13.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.29<span></span>
</td>
<td class="nump">13.75<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">12.33<span></span>
</td>
<td class="nump">12.77<span></span>
</td>
<td class="nump">12.09<span></span>
</td>
<td class="nump">13.45<span></span>
</td>
<td class="nump">14.67<span></span>
</td>
<td class="nump">16.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.56<span></span>
</td>
<td class="nump">13.77<span></span>
</td>
<td class="nump">13.78<span></span>
</td>
<td class="nump">13.58<span></span>
</td>
<td class="nump">13.39<span></span>
</td>
<td class="nump">13.17<span></span>
</td>
<td class="nump">13.34<span></span>
</td>
<td class="nump">13.75<span></span>
</td>
<td class="nump">15.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.51<span></span>
</td>
<td class="nump">$ 14.21<span></span>
</td>
<td class="nump">$ 13.87<span></span>
</td>
<td class="nump">$ 14.11<span></span>
</td>
<td class="nump">$ 13.66<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 15.95<span></span>
</td>
<td class="nump">$ 16.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.72%)<span></span>
</td>
<td class="num">(5.24%)<span></span>
</td>
<td class="num">(8.19%)<span></span>
</td>
<td class="num">(10.65%)<span></span>
</td>
<td class="num">(9.22%)<span></span>
</td>
<td class="num">(9.90%)<span></span>
</td>
<td class="num">(8.44%)<span></span>
</td>
<td class="num">(8.03%)<span></span>
</td>
<td class="num">(2.22%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.90%)<span></span>
</td>
<td class="num">(13.43%)<span></span>
</td>
<td class="num">(12.19%)<span></span>
</td>
<td class="num">(13.99%)<span></span>
</td>
<td class="num">(14.78%)<span></span>
</td>
<td class="num">(14.69%)<span></span>
</td>
<td class="num">(12.26%)<span></span>
</td>
<td class="num">(12.44%)<span></span>
</td>
<td class="num">(12.19%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_007_integixAnchor"><strong>DESCRIPTION OF SHARES</strong></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common Shares</span></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders are entitled to share pro rata in the net assets of the Fund available for distribution to shareholders upon liquidation of the Fund. <span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders are entitled to one vote for each share held.</span> <span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders do not have preemptive, conversion or subscription rights and the Fund&#8217;s common shares are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.</span></span></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund intends to hold annual meetings of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required as a condition to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to all of its shareholders.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise. Shares of closed-end investment companies frequently trade on an exchange at prices lower than NAV. Shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and during other periods have traded at prices lower than NAV. Because the market value of the common shares may be influenced by such direct and indirect factors as dividend levels (which are in turn affected by expenses), call protection on its portfolio securities, dividend stability, portfolio credit quality, the Fund&#8217;s NAV, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that its common shares will trade at a price equal to or higher than NAV in the future. The common shares are designed primarily for long-term investors and you should not purchase the common shares if you intend to sell them soon after purchase. See &#8220;Repurchase of Common Shares&#8221; below and &#8220;Repurchase of Common Shares&#8221; in the SAI.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s outstanding common shares are, and when issued, the common shares offered by this Prospectus will be, publicly held and listed and traded on the NYSE under the symbol &#8220;ARDC.&#8221; The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.</p>
      </div>

        <div>&#160;</div>

        <div>

            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">During Quarter Ended</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NYSE&#160;Market&#160;Price<br/>Per&#160;Common Share</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">NAV per Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="6" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">Trading</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">High</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Low</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Volume</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:30%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2024</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.29</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">13.41</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.69</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">14.56</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(2.72</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">(7.90</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:7%;font:10pt Times New Roman, Times, Serif;text-align:right">6,951,700</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.93</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.51</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.77</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(5.24</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(13.43</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,020,500</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.90</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.10</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.21</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.78</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,500,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.33</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.68</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.87</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.58</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(10.65</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(13.99</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,473,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.77</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.42</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.11</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.39</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9.22</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(14.78</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">7,627,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">December&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.09</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.27</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.66</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.17</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9.90</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(14.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,699,200</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">September&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.45</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.34</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.44</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.26</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,773,900</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">June&#160;30, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.67</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.89</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.95</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.75</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(8.03</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.44</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5,461,400</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">March&#160;31, 2022</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">16.29</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.76</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">16.69</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.66</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(2.22</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(12.19</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">6,201,000</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>

            </table>

          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">As of August 6, 2024, the NAV per common share of the Fund was $14.65 and the market price per common share was $15.09, representing a premium to NAV of 3.00%. Common shares of the Fund have historically traded at both a premium and discount to NAV.</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">As of August 6, 2024, the Fund has 22,915,000 </span>outstanding common shares.</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Preferred Shares</span></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">The Charter provides that the Board may authorize and issue preferred shares, with rights as determined by the Board, without the approval of the holders of the common shares. Common shareholders have no preemptive right to purchase any preferred shares that might be issued. The Fund has $100 million of preferred shares outstanding. The Fund has authorized and issued 800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B MRP Shares for gross proceeds of $30 million and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif;font-size:10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Each of the MRP Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and the distribution of assets upon the Fund&#8217;s dissolution, liquidation or winding up, (i) on a parity with each other and any other class or series of preferred shares and (ii) senior to the common shares.</span> <span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of MRP Shares do not have any preemptive rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common shares or other securities of the Fund.</span></span></span></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">Except for matters which do not require the vote of holders of MRP Shares under the Investment Company Act and except as otherwise provided in the Charter and the Bylaws, (i)&#160;each holder of MRP Shares is entitled to one vote per share on each matter submitted to a vote of the Fund&#8217;s stockholders, and (ii)&#160;the holders of MRP Shares, outstanding preferred shares and common shares will vote together as a single class on all matters submitted to the Fund&#8217;s stockholders; provided, however, that the holders of MRP Shares and outstanding preferred shares will be entitled, as a class, to the exclusion of the holders of all other classes of stock of the Fund, to elect two directors of the Fund. <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif;font-size:10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of preferred shares, voting as a separate class, are also generally entitled to vote on (i) certain amendments to the Charter and the Bylaws, (ii) the Fund&#8217;s ability to enter into certain agreements, (iii) the authorization, issuance or reclassification of shares of the Fund&#8217;s stock that would rank on a parity with or senior to the preferred shares, (iv) the liquidation or dissolution of the Fund and (v) the Fund&#8217;s ability to incur, authorize or guarantee any indebtedness for borrowed money.</span></span></span></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly dividend date.</span> </span><span>We generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares of our stock ranking junior to the MRP Shares as to dividends or upon liquidation, including our common shares, or on a parity with the MRP Shares or call for redemption, redeem, purchase or otherwise acquire for consideration, unless (i)&#160;immediately after such transaction, certain asset coverage would be achieved, (ii)&#160;full, cumulative dividends on the preferred shares have been declared and paid and (iii)&#160;the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained in the terms of the MRP Shares.</span></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="-sec-ix-redline:true">&#160;</span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true">The aggregate redemption amount of the MRP Shares is $100 million. The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</span></p>
        </div>

          <div>&#160;</div>

            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="-sec-ix-redline:true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is 2.81% per annum. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject to redemption, at the option of the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. All rights and preferences of the holders of the MRP Shares of a particular series </span><span>will terminate if no MRP Shares of such series are outstanding. </span>Under the Investment Company Act, the Fund is not permitted to issue preferred shares unless immediately after such issuance the value of the Fund&#8217;s total assets is at least 200% of the liquidation value of the outstanding preferred shares (i.e., the liquidation value may not exceed 50% of the Fund&#8217;s total assets). In addition, the Fund is not permitted to declare any cash dividend or other distribution on its common shares unless, at the time of such declaration, the value of the Fund&#8217;s total assets is at least 200% of such liquidation value. Please see &#8220;Description of Shares&#8221; in the SAI for more information.</span></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Authorized Shares</strong></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

                <div>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table provides the Fund&#8217;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.</p>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

                      <tr style="vertical-align:bottom">
                        <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Authorized</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Held&#160;by<br/>Fund or for its<br/>Account</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Outstanding<br/>Exclusive of Amount<br/>held by Fund</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                        <td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Common Shares</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">996,000,000</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">22,914,939</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom">
                        <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Preferred Shares</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
                <div>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table provides the Fund&#8217;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.</p>
                  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">

                      <tr style="vertical-align:bottom">
                        <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Authorized</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Held&#160;by<br/>Fund or for its<br/>Account</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Outstanding<br/>Exclusive of Amount<br/>held by Fund</td>
                        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                        <td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Common Shares</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">996,000,000</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">22,914,939</td>
                        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>
                      <tr style="vertical-align:bottom">
                        <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Preferred Shares</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
                        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2000 Avenue of the Stars<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">12th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Los Angeles<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">90067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ian Fitzgerald<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001515324_CreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LongTermDebtTableTextBlock', window );">Long Term Debt [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Credit Facility</span></strong></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under the Investment Company Act, the Fund is permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately thereafter the Fund has asset coverage of at least 300%. In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a party to a senior secured revolving Credit Facility that allows the Fund to borrow up to $212 million at any one time outstanding. <span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a) limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b) limitations on certain investments, (c) limitations on certain restricted payments, and (d) maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.</span></p>
      </div>
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Credit Facility</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 212,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LongTermDebtStructuringTextBlock', window );">Long Term Debt, Structuring [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Credit Facility is scheduled to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a) limitations on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b) limitations on certain investments, (c) limitations on certain restricted payments, and (d) maintaining a ratio of total assets (less total liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001515324_PreferredStocksMember', window );">Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityTitleTextBlock', window );">Security Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Preferred Shares</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityDividendsTextBlock', window );">Security Dividends [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly dividend date.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of preferred shares, voting as a separate class, are also generally entitled to vote on (i) certain amendments to the Charter and the Bylaws, (ii) the Fund&#8217;s ability to enter into certain agreements, (iii) the authorization, issuance or reclassification of shares of the Fund&#8217;s stock that would rank on a parity with or senior to the preferred shares, (iv) the liquidation or dissolution of the Fund and (v) the Fund&#8217;s ability to incur, authorize or guarantee any indebtedness for borrowed money.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityLiquidationRightsTextBlock', window );">Security Liquidation Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Each of the MRP Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and the distribution of assets upon the Fund&#8217;s dissolution, liquidation or winding up, (i) on a parity with each other and any other class or series of preferred shares and (ii) senior to the common shares.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityPreemptiveAndOtherRightsTextBlock', window );">Security Preemptive and Other Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders of MRP Shares do not have any preemptive rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common shares or other securities of the Fund.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Preferred Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001515324_CommonStocksMember', window );">Common Stocks [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityTitleTextBlock', window );">Security Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common Shares</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders are entitled to one vote for each share held.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityPreemptiveAndOtherRightsTextBlock', window );">Security Preemptive and Other Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Shareholders do not have preemptive, conversion or subscription rights and the Fund&#8217;s common shares are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">996,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,914,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders may have paid in connection with their purchase of common shares.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as a percentage of the offering price.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage.  The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#8217;s Managed Assets.  Based on the same assumptions, leverage would equal 55% of the Fund&#8217;s net assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023.  We had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December 31, 2023. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets and 55% of the Fund&#8217;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. See &#8220;Credit Facility.&#8221;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">In order to compute the "Corresponding Return to Common Shareholder," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at December 31, 2023 to obtain an assumed return to us. From this amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common shareholders is then divided by the total value of our net assets as of December 31, 2023 to determine the "Corresponding Return to Common Shareholder."</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent, our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations, this table is calculated as of December 31, 2023. As a result, it has not been updated to take into account any changes in assets or leverage since December 31, 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeveragePurposeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeveragePurposeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtStructuringTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtStructuringTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpense1Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpense1Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtZeroPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtZeroPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityDividendsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityDividendsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityLiquidationRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityLiquidationRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityPreemptiveAndOtherRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityPreemptiveAndOtherRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001515324_CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001515324_CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001515324_PreferredStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001515324_PreferredStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001515324_CommonStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001515324_CommonStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>18</ContextCount>
  <ElementCount>93</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="tm2416373d4_n2a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ck0001515324-20240814.xsd</File>
    <File>ck0001515324-20240814_def.xml</File>
    <File>ck0001515324-20240814_lab.xml</File>
    <File>ck0001515324-20240814_pre.xml</File>
    <File doctype="N-2/A" isN2Prospectus="true" isUsgaap="true" original="tm2416373d4_n2a.htm">tm2416373d4_n2a.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="112">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>40
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2416373d4_n2a.htm": {
   "nsprefix": "ck0001515324",
   "nsuri": "http://www.www.arespublicfunds.com/20240814",
   "dts": {
    "schema": {
     "local": [
      "ck0001515324-20240814.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ck0001515324-20240814_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001515324-20240814_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001515324-20240814_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2416373d4_n2a.htm"
     ]
    }
   },
   "keyStandard": 93,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 3,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 18,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 329,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 112,
    "http://xbrl.sec.gov/dei/2023": 39,
    "http://fasb.org/us-gaap/2023": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20240814to20240814",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2416373d4_n2a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240814to20240814",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2416373d4_n2a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Risks of Foreign Options, Futures Contracts, Options on Futures Contracts and Forward Contracts",
        "label": "Additional Risks Of Foreign Options, Futures Contracts, Options On Futures Contracts And Forward Contracts [Member]",
        "documentation": "It represents additional risks of foreign options, futures contracts, options on futures contracts and forward contracts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_AffiliatedTransactionsRestrictionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "AffiliatedTransactionsRestrictionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of affiliated transactions restrictions.",
        "label": "Affiliated Transactions Restrictions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ck0001515324_AntiTakeoverProvisionsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "AntiTakeoverProvisionsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti Takeover Provisions Risk [Member]",
        "terseLabel": "Anti-Takeover Provisions Risk",
        "documentation": "It represents as a anti-takeover provisions risk."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_AssetAllocationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "AssetAllocationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Allocation Risk [Member]",
        "documentation": "It represents as a asset allocation risk.",
        "verboseLabel": "Asset Allocation Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BankLoanRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "BankLoanRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Loan Risk",
        "documentation": "It represents as a bank loan risk.",
        "label": "Bank Loan Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BankObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "BankObligationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank Obligations [Member]",
        "documentation": "It represents risk of bank obligations."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BorrowingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "BorrowingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing [Member]",
        "documentation": "It represents risk of borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ck0001515324_CertificatesOfDepositRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CertificatesOfDepositRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for risk of certificates of deposit risk.",
        "label": "Certificates Of Deposit Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "ck0001515324_CollateralizedLoanObligationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CollateralizedLoanObligationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Collateralized Loan Obligation (\"CLO\") Risk",
        "documentation": "Collateralized Loan Obligation Risk [Member]",
        "label": "Collateralized Loan Obligation Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommercialMortgageBackedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CommercialMortgageBackedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Mortgage Backed Securities Risk",
        "documentation": "It represents as a commercial mortgage backed securities risk.",
        "label": "Commercial Mortgage Backed Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommercialPaperRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CommercialPaperRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a commercial paper risk.",
        "label": "Commercial Paper Risk [Member]",
        "verboseLabel": "Commercial Paper Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommodityRelatedInvestmentsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CommodityRelatedInvestmentsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commodity-Related Investments Risk",
        "documentation": "It represents as a commodity related investments risk.",
        "label": "Commodity Related Investments Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stocks [Member]",
        "documentation": "Common Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ConcentrationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Member]",
        "documentation": "Concentration Risk [Member]",
        "verboseLabel": "Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConstructionAndDevelopmentRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ConstructionAndDevelopmentRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a construction and development risk.",
        "verboseLabel": "Construction and Development Risk",
        "label": "Construction And Development Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConvertibleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ConvertibleSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Member]",
        "documentation": "It represents risk of convertible securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConvertibleSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ConvertibleSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a convertible securities risk.",
        "terseLabel": "Convertible Securities Risk",
        "label": "Convertible Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CorporateBondsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CorporateBondsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Bonds Risk [Member]",
        "verboseLabel": "Corporate Bonds Risk",
        "documentation": "Corporate Bonds Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CorporateLoansRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CorporateLoansRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Loans Risk [Member]",
        "verboseLabel": "Corporate Loans Risk",
        "label": "Corporate Loans Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CounterpartyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CounterpartyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Risk",
        "documentation": "It represents as a counterparty risk.",
        "label": "Counterparty Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditDefaultSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CreditDefaultSwapsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents credit default swaps.",
        "label": "Credit Default Swaps [Member]",
        "terseLabel": "Credit Default Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CreditFacilityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Member]",
        "documentation": "Represent information about the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CreditRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for represents as a credit risks.",
        "terseLabel": "Credit Risk",
        "label": "Credit Risks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CurrencyFuturesAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "CurrencyFuturesAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency Futures And Options Thereon [Member]",
        "terseLabel": "Currency Futures and Options Thereon",
        "documentation": "It represents currency futures and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r7",
      "r8",
      "r10",
      "r11",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "ck0001515324_DebtObligationsOfNonUsGovernmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "DebtObligationsOfNonUsGovernmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of debt obligations of non-U.S. governments.",
        "verboseLabel": "Debt Obligations of Non-U.S. Governments [Member]",
        "label": "Debt Obligations Of Non Us Governments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of debt securities issued by real estate investment trusts.",
        "label": "Debt Securities Issued By Real Estate Investment Trusts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "ck0001515324_DerivativesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "DerivativesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives Risk",
        "documentation": "It represents derivatives Risk.",
        "label": "Derivatives Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DistressedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "DistressedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a distressed securities risk.",
        "terseLabel": "Distressed Securities Risk",
        "label": "Distressed Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DoddFrankActRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "DoddFrankActRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dodd-Frank Act Risk",
        "documentation": "It represents dodd frank act risk.",
        "label": "Dodd Frank Act Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ck0001515324_EmergingMarketsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EmergingMarketsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Markets Risk",
        "documentation": "It represents as a emerging markets risk.",
        "label": "Emerging Markets Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EmergingMarketsSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EmergingMarketsSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Markets Securities [Member]",
        "documentation": "It represents risk of eerging markets securities."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ck0001515324_EnvironmentalRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EnvironmentalRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of environmental risk.",
        "label": "Environmental Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EquitySecuritiesAndRelatedInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities And Related Investments [Member]",
        "documentation": "It represents risk of equity securities and related investments."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EurodollarInstrumentsAndSamuraiAndYankeeBondsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of eurodollar instruments and samurai and yankee bonds.",
        "label": "Eurodollar Instruments And Samurai And Yankee Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventLinkedBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EventLinkedBondsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Linked Bonds [Member]",
        "documentation": "It represents risk of event linked bonds."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventLinkedSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EventLinkedSwapsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Linked Swaps [Member]",
        "documentation": "It represents risk of event linked swaps."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "EventRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Risk [Member]",
        "terseLabel": "Event Risk",
        "documentation": "It represents as a event risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedNoteRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ExchangeTradedNoteRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Traded Note Risk [Member]",
        "verboseLabel": "Exchange Traded Note Risk",
        "label": "Exchange Traded Note Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ExchangeTradedNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Traded Notes [Member]",
        "documentation": "It represents risk of exchange-traded notes."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedProductRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ExchangeTradedProductRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange Traded Product Risk",
        "label": "Exchange Traded Product Risk [Member]",
        "documentation": "It represents Exchange-Traded Product Risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ExchangeTradedProductsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Traded Products [Member]",
        "documentation": "It represents risk of exchange-traded products."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ExclusionFromDefinitionOfCommodityPoolOperatorMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exclusion from Definition of Commodity Pool Operator",
        "documentation": "It represents exclusion from definition of commodity pool operator.",
        "label": "Exclusion From Definition Of Commodity Pool Operator [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ck0001515324_FloatingRateLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "FloatingRateLoansMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of floating rate loans.",
        "label": "Floating Rate Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignCurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ForeignCurrencyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a foreign currency risk.",
        "terseLabel": "Foreign Currency Risk",
        "label": "Foreign Currency Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ForeignSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of foreign securities.",
        "label": "Foreign Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ForeignSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a foreign securities risk.",
        "label": "Foreign Securities Risk [Member]",
        "terseLabel": "Foreign Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForwardCurrencyExchangeContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ForwardCurrencyExchangeContractsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Exchange Contracts [Member]",
        "terseLabel": "Forward Currency Exchange Contracts",
        "documentation": "It represents forward currency exchange contracts."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_FuturesContractsAndOptionsOnFuturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "FuturesContractsAndOptionsOnFuturesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Futures Contracts And Options On Futures [Member]",
        "documentation": "It represents futures contracts and options on future.",
        "verboseLabel": "Futures Contracts and Options on Futures"
       }
      }
     },
     "auth_ref": []
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ck0001515324_GeneralRiskOfInvestingInFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "GeneralRiskOfInvestingInFundMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Risk Of Investing In Fund [Member]",
        "verboseLabel": "General Risks of Investing in the Fund",
        "documentation": "It represents general risks of investing in the fund."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GoldAndOtherPreciousMetalsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "GoldAndOtherPreciousMetalsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gold and Other Precious Metals Risk",
        "documentation": "It represents as a gold and other precious metals risk.",
        "label": "Gold And Other Precious Metals Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GovernmentInterventionInFinancialMarketsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "GovernmentInterventionInFinancialMarketsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government Intervention In Financial Markets [Member]",
        "documentation": "It represents risk of government intervention in financial markets."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "GuaranteedMortgagePassThroughSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guaranteed Mortgage Pass Through Securities [Member]",
        "documentation": "It represents risk of guaranteed mortgage pass-through securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_HighYieldJunkSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "HighYieldJunkSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a high yield (\"Junk\") securities risk.",
        "label": "High Yield Junk Securities Risk [Member]",
        "terseLabel": "High Yield (\"Junk\") Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ck0001515324_HybridInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "HybridInstrumentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of hybrid instruments.",
        "label": "Hybrid Instruments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "IlliquidAndRestrictedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a Illiquid and restricted securities risk.",
        "label": "Illiquid And Restricted Securities Risk [Member]",
        "terseLabel": "Illiquid and Restricted Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_IncomeAndDistributionRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "IncomeAndDistributionRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income and Distribution Risk",
        "documentation": "It represents as a income and distribution risk.",
        "label": "Income And Distribution Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InfectiousIllnessRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InfectiousIllnessRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Infectious Illness Risk [Member]",
        "terseLabel": "Infectious Illness Risk",
        "documentation": "It represents infectious illness risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InflationInterestRateAndBondMarketRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InflationInterestRateAndBondMarketRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a inflation, interest rate and bond market risk.",
        "label": "Inflation Interest Rate And Bond Market Risk [Member]",
        "terseLabel": "Inflation, Interest Rate and Bond Market Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InflationLinkedFixedIncomeSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InflationLinkedFixedIncomeSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inflation Linked Fixed Income Securities [Member]",
        "documentation": "It represents risk of inflation-linked fixed-income securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InfrastructureRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InfrastructureRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Infrastructure Risk",
        "documentation": "Infrastructure Risk [Member]",
        "label": "Infrastructure Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InterestRateFuturesContractsAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest Rate Futures Contracts and Options Thereon",
        "label": "Interest Rate Futures Contracts And Options Thereon [Member]",
        "documentation": "It represents interest rate futures contracts and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_InverseFloatingRateSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InverseFloatingRateSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inverse Floating Rate Securities [Member]",
        "documentation": "It represents risk of inverse floating rate securities."
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ck0001515324_InvestmentGradeCorporateSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InvestmentGradeCorporateSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of investment grade corporate securities.",
        "label": "Investment Grade Corporate Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InvestmentGradeSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InvestmentGradeSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Grade Securities Risk [Member]",
        "verboseLabel": "Investment Grade Securities Risk",
        "label": "Investment Grade Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InvestmentsInDifferentPartsOfCapitalStructureMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments In Different Parts Of Capital Structure [Member]",
        "documentation": "It represents risk of investments in different parts of capital structure."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Where Other Funds Hold Related Investments [Member]",
        "documentation": "It represents risk of investments where other funds hold related investments."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ck0001515324_LeverageRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "LeverageRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leverage Risk",
        "documentation": "Leverage Risk [Member]",
        "label": "Leverage Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_LimitedPartnershipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "LimitedPartnershipsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Limited Partnerships [Member]",
        "documentation": "It represents risk of limited partnerships."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity Risk [Member]",
        "documentation": "It represents as a liquidity risk.",
        "terseLabel": "Liquidity Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_LoansOfPortfolioSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "LoansOfPortfolioSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans Of Portfolio Securities [Member]",
        "documentation": "It represents risk of loans of portfolio securities."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ck0001515324_ManagementRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ManagementRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Risk [Member]",
        "terseLabel": "Management Risk",
        "documentation": "It represents as a management risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MarketDiscountRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "MarketDiscountRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Discount Risk",
        "documentation": "It represents as a market discount risk.",
        "label": "Market Discount Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MasterLimitedPartnershipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "MasterLimitedPartnershipsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Master Limited Partnerships [Member]",
        "documentation": "It represents risk of master limited partnerships."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MasterLimitedPartnershipsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "MasterLimitedPartnershipsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "MLP Risk",
        "documentation": "It represents as a master limited partnerships risk.",
        "label": "Master Limited Partnerships Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MortgageAndAssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "MortgageAndAssetBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mortgage And Asset Backed Securities [Member]",
        "documentation": "It represents as a mortgage and asset-backed securities.",
        "terseLabel": "Mortgage and Asset-Backed Securities"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiple Class Pass Through Securities And Collateralized Mortgage Obligations [Member]",
        "documentation": "It represents risk of multiple-class pass-through securities and collateralized mortgage obligations."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_NaturalResourcesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "NaturalResourcesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Natural Resources Risk",
        "label": "Natural Resources Risk [Member]",
        "documentation": "Natural Resources Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r61",
      "r68",
      "r69",
      "r71",
      "r72",
      "r75",
      "r85"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ck0001515324_OptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "OptionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options",
        "label": "Options [Member]",
        "documentation": "It represents options."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_OptionsOnForeignCurrenciesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "OptionsOnForeignCurrenciesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents options on foreign currencies.",
        "terseLabel": "Options on Foreign Currencies",
        "label": "Options On Foreign Currencies [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_OptionsOnSecuritiesIndicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "OptionsOnSecuritiesIndicesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options On Securities Indices [Member]",
        "documentation": "It represents options on securities indice.",
        "terseLabel": "Options on Securities Indices"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of other risk factors associated with mortgage-backed securities.",
        "label": "Other Risk Factors Associated With Mortgage Backed Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ck0001515324_OverCounterTradingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "OverCounterTradingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over Counter Trading Risk [Member]",
        "documentation": "Over Counter Trading Risk [Member]",
        "verboseLabel": "Over-the-Counter Trading Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PortfolioTurnoverRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PortfolioTurnoverRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a portfolio turnover risk.",
        "label": "Portfolio Turnover Risk [Member]",
        "verboseLabel": "Portfolio Turnover Risk"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ck0001515324_PotentialConflictsOfInterestRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PotentialConflictsOfInterestRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a potential conflicts of interest risk.",
        "label": "Potential Conflicts Of Interest Risk [Member]",
        "terseLabel": "Potential Conflicts of Interest Risk"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ck0001515324_PreferredSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PreferredSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Securities Risk [Member]",
        "verboseLabel": "Preferred Securities Risk",
        "documentation": "This member stands for Preferred Securities Risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r9",
      "r175",
      "r178"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ck0001515324_PreferredStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PreferredStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stocks [Member]",
        "terseLabel": "Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrepaymentOrCallRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PrepaymentOrCallRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment or Call Risk",
        "label": "Prepayment Or Call Risk [Member]",
        "documentation": "It represents as a prepayment or call risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_PrivateCompanyLiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PrivateCompanyLiquidityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Company Liquidity Risk [Member]",
        "documentation": "It represents risk of private xompany liquidity risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateCompanyManagementRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PrivateCompanyManagementRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of private company management risk.",
        "label": "Private Company Management Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateCompanyValuationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PrivateCompanyValuationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Company Valuation Risk [Member]",
        "documentation": "It represents risk of private company valuation risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateInvestmentRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "PrivateInvestmentRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Investment Risk [Member]",
        "documentation": "It represents risk of private investment risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ck0001515324_RealEstateInvestmentTrustsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RealEstateInvestmentTrustsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate Investment Trusts [Member]",
        "documentation": "It represents risk of real estate investment trusts."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RealEstateInvestmentTrustsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RealEstateInvestmentTrustsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REIT Risk",
        "documentation": "This member stands for real estate investment trusts risk.",
        "label": "Real Estate Investment Trusts Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RealEstateMarketRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RealEstateMarketRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a real estate market risk.",
        "verboseLabel": "Real Estate Market Risk",
        "label": "Real Estate Market Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RecentMarketEconomicAndSocialDevelopmentsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a risks of recent market, economic and social developments risk.",
        "label": "Recent Market Economic And Social Developments Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_RepurchaseAgreementsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RepurchaseAgreementsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a repurchase agreements risk.",
        "terseLabel": "Repurchase Agreements Risk",
        "label": "Repurchase Agreements Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ResidentialMortgageBackedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Residential Mortgage Backed Securities Risk",
        "label": "Residential Mortgage Backed Securities Risk [Member]",
        "documentation": "It represents as a residential mortgage backed securities risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ck0001515324_ReturnOfCapitalRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ReturnOfCapitalRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return Of Capital Risk [Member]",
        "documentation": "It represents as a return of capital risk.",
        "verboseLabel": "Return of Capital Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ReverseRepurchaseAgreementsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ReverseRepurchaseAgreementsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Repurchase Agreements Risk [Member]",
        "terseLabel": "Reverse Repurchase Agreements Risk",
        "documentation": "It represents as a reverse repurchase agreements risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithLongTermObjectiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksAssociatedWithLongTermObjectiveMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risks Associated With Long Term Objective Not a Complete Investment Program",
        "documentation": "Risks Associated With Long Term Objective [Member]",
        "label": "Risks Associated With Long Term Objective [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of risks associated with long term objective not a complete investment program.",
        "label": "Risks Associated With Long Term Objective Not Complete Investment Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksAssociatedWithPositionLimitsApplicableToDerivativesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Associated With Position Limits Applicable To Derivatives [Member]",
        "terseLabel": "Risks Associated with Position Limits Applicable to Derivatives",
        "documentation": "It represents as a risks associated with position limits applicable to derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksAssociatedWithStatusRegulatedInvestmentCompanyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a risks associated with status as a regulated investment company.",
        "label": "Risks Associated With Status Regulated Investment Company [Member]",
        "terseLabel": "Risks Associated With Status as a Regulated Investment Company"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksOfCurrencyTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksOfCurrencyTransactionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Of Currency Transactions [Member]",
        "terseLabel": "Risks of Currency Transactions",
        "documentation": "It represents risks of currency transactions."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Related To Funds Clearing Broker And Central Clearing Counterparty [Member]",
        "documentation": "Risks Related to Funds Clearing Broker and Central Clearing Counterparty [Member]",
        "verboseLabel": "Risks Related to Fund's Clearing Broker and Central Clearing Counterparty"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "RisksRelatingToRussiaInvasionOfUkraineMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of risks relating to Russia's invasion of Ukraine.",
        "label": "Risks Relating To Russia Invasion Of Ukraine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ck0001515324_SectorFocusRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SectorFocusRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sector Focus Risk",
        "label": "Sector Focus Risk [Member]",
        "documentation": "It represents as a sector focus risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SecuritiesIndexFuturesContractsAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Index Futures Contracts and Options Thereon",
        "label": "Securities Index Futures Contracts And Options Thereon [Member]",
        "documentation": "It represents securities index futures contracts and options thereon"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SecuritiesLendingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SecuritiesLendingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Lending Risk [Member]",
        "documentation": "It represents as a securities lending risk.",
        "terseLabel": "Securities Lending Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r133",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r132",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ck0001515324_ShortSalesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ShortSalesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short Sales Risk",
        "label": "Short Sales Risk [Member]",
        "documentation": "It represents as a short sales risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ShortTermDebtObligationsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ShortTermDebtObligationsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Short-term Debt Obligations Risk",
        "documentation": "It represents as a short term debt obligations risk.",
        "label": "Short Term Debt Obligations Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special Risk Considerations Relating to Futures and Options Thereon",
        "label": "Special Risk Considerations Relating To Futures And Options Thereon [Member]",
        "documentation": "It represents special risk considerations relating to futures and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SpecialRisksRelatedToCyberSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SpecialRisksRelatedToCyberSecurityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of special risks related to cyber security.",
        "label": "Special Risks Related To Cyber Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StapledSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "StapledSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a stapled Securities risk.",
        "label": "Stapled Securities Risk [Member]",
        "verboseLabel": "Stapled Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "ck0001515324_StrippedMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "StrippedMortgageBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stripped Mortgage Backed Securities [Member]",
        "documentation": "It represents risk of stripped mortgage-backed securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StrippedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "StrippedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a stripped securities risk.",
        "terseLabel": "Stripped Securities Risk",
        "label": "Stripped Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StructuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "StructuredNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Structured Notes [Member]",
        "documentation": "It represents risk of structured notes."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StructuredSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "StructuredSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of structured securities.",
        "label": "Structured Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SubordinatedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SubordinatedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subordinated Securities [Member]",
        "documentation": "It represents risk of subordinated securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SubscriptionRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SubscriptionRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Rights [Member]",
        "documentation": "Subscription Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SwapAgreementsAndOptionsOnSwapAgreementsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Swap Agreements And Options On Swap Agreements [Member]",
        "terseLabel": "Swap Agreements and Options on Swap Agreements",
        "documentation": "It represents swap agreements and options on swap agreements."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SystemicRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "SystemicRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a systemic risk.",
        "label": "Systemic Risk [Member]",
        "terseLabel": "Systemic Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_TemporaryDefensiveStrategiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "TemporaryDefensiveStrategiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents temporary defensive strategies risk",
        "label": "Temporary Defensive Strategies Risk [Member]",
        "terseLabel": "Temporary Defensive Strategies Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ck0001515324_TrackingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "TrackingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tracking Risk",
        "label": "Tracking Risk [Member]",
        "documentation": "Tracking Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ck0001515324_UnratedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "UnratedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrated Securities Risk [Member]",
        "documentation": "Unrated Securities Risk [Member]",
        "verboseLabel": "Unrated Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_UsGovernmentSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "UsGovernmentSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Us Government Securities [Member]",
        "verboseLabel": "U.S. Government Securities [Member]",
        "documentation": "It represents risk of U.S. Government Securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_UsGovernmentSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "UsGovernmentSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a U.S. government securities risk.",
        "terseLabel": "U.S. Government Securities Risk",
        "label": "Us Government Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ValuationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ValuationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Risk",
        "documentation": "It represents as a valuation risk.",
        "label": "Valuation Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "VariableAndFloatingRateDemandAndMasterDemandNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of variable and floating rate demand and master demand notes.",
        "label": "Variable And Floating Rate Demand And Master Demand Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_VariableAndFloatingRateSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "VariableAndFloatingRateSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a variable and floating rate securities risk.",
        "label": "Variable And Floating Rate Securities Risk [Member]",
        "terseLabel": "Variable and Floating Rate Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_WarrantsAndRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "WarrantsAndRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants And Rights [Member]",
        "documentation": "It represents risk of warrants and rights."
       }
      }
     },
     "auth_ref": []
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240814",
     "localname": "ZeroCouponAndPaymentInKindSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of zero coupon and payment in-kind securities.",
        "label": "Zero Coupon And Payment In Kind Securities [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "59",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
